0001214659-14-003468.txt : 20140512 0001214659-14-003468.hdr.sgml : 20140512 20140512160552 ACCESSION NUMBER: 0001214659-14-003468 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140512 DATE AS OF CHANGE: 20140512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIRTUAL PIGGY, INC. CENTRAL INDEX KEY: 0001437283 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 352327649 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53944 FILM NUMBER: 14833443 BUSINESS ADDRESS: STREET 1: 1221 HERMOSA AVENUE, SUITE 210 CITY: HERMOSA BEACH STATE: CA ZIP: 90254 BUSINESS PHONE: 310-853-1950 MAIL ADDRESS: STREET 1: 1221 HERMOSA AVENUE, SUITE 210 CITY: HERMOSA BEACH STATE: CA ZIP: 90254 FORMER COMPANY: FORMER CONFORMED NAME: Moggle, Inc. DATE OF NAME CHANGE: 20080610 10-Q 1 v5714010q.htm FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014 v5714010q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q

x  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from         ______________    to   ______________                
 
Commission file number:          
0-53944
 
 
 VIRTUAL PIGGY, INC.
 
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
 
35-2327649
(State or Other Jurisdiction of
 
        (IRS Employer
Incorporation or Organization)
 
       Identification No.)
 
1221 Hermosa Avenue, Suite 210
Hermosa Beach, CA  90254
 (Address of principal executive offices) (Zip Code)

(310) 853-1950
(Registrant’s telephone number, including area code)

 
(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   YES ý NO ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     YES ý NO ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer
¨
Accelerated filer                     
ý
Non-accelerated filer
¨
Smaller reporting company    
o
(Do not check if a smaller reporting company)
     

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES ¨  NO ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:  116,589,055 shares of common stock outstanding at May 1, 2014.
 


 
 

 
 
 
 
 
 
 
 
 
PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS.
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)

CONTENTS

 
 
 
 
 
 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)

   
March 31, 2014
   
December 31, 2013
 
   
(Unaudited)
   
(Audited)
 
ASSETS
           
             
CURRENT ASSETS
           
Cash and cash equivalents
  $ 4,108,065     $ 1,752,461  
Accounts receivable
    1,285       1,000  
Insurance receivable
    -       4,325  
Prepaid expenses
    280,526       220,908  
                 
TOTAL CURRENT ASSETS
    4,389,876       1,978,694  
                 
PROPERTY AND EQUIPMENT
               
Computer equipment
    93,654       89,021  
Furniture and fixtures
    83,981       57,238  
Leasehold Improvements
    8,350       -  
      185,985       146,259  
Less:  accumulated depreciation
    (46,016 )     (41,544 )
      139,969       104,715  
                 
OTHER ASSETS
               
Deposit
    346,949       118,118  
Patents and trademarks, net of accumulated amortization of
               
   $52,258 and $42,129
    784,152       739,657  
      1,131,101       857,775  
                 
TOTAL ASSETS
  $ 5,660,946     $ 2,941,184  
                 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
CURRENT LIABILITIES
               
Accounts payable and accrued expenses
  $ 1,596,488     $ 2,149,681  
Embedded derivative liability
    3,834,200       -  
Notes payable, net of discount of $0 and $86,087
    -       913,913  
                 
TOTAL CURRENT LIABILITIES
    5,430,688       3,063,594  
                 
CONTINGENCIES
               
                 
STOCKHOLDERS' EQUITY
               
                 
Preferred stock, $.0001 par value; 2,000,000 shares authorized;
               
  50,450 shares issued and outstanding at March 31, 2014 and
               
  none issued and outstanding at December 31, 2013
    5       -  
                 
Common stock, $ .0001 par value; 180,000,000 shares authorized;
               
  116,589,055 and 111,396,768 shares issued and outstanding at
               
   March 31, 2014 and December 31, 2013
    11,659       11,140  
 
               
Additional paid in capital
    43,820,350       35,318,751  
                 
Deficit accumulated during the development stage
    (43,582,321 )     (35,450,446 )
                 
Cumulative translation adjustment
    (19,435 )     (1,855 )
                 
STOCKHOLDERS' EQUITY
    230,258       (122,410 )
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
  $ 5,660,946     $ 2,941,184  

See accompanying notes to these financial statements.
 
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)
For the Three Months Ended March 31, 2014 and 2013 and
For the period February 11, 2008 (Date of Inception) to March 31, 2014
(Unaudited)

   
Three Months
   
Three Months
       
   
Ended
   
Ended
   
Cumulative
 
   
March 31,
   
March 31,
   
Since
 
   
2014
   
2013
   
Inception
 
                   
SALES
    425     $ 88     $ 8,020  
                         
OPERATING EXPENSES
                       
      Sales and marketing
    1,197,412       894,647       11,278,549  
      Product development
    885,974       461,385       6,127,836  
      Integration and customer support
    187,039       119,197       1,366,490  
      General and administrative
    1,217,303       1,035,071       12,634,642  
      Strategic consulting
    0       176,794       7,019,422  
Total operating expenses
    3,487,728       2,687,094       38,426,939  
                         
NET OPERATING LOSS
    (3,487,303 )     (2,687,006 )     (38,418,919 )
                         
OTHER INCOME (EXPENSE)
                       
     Interest income
    1,502       3,489       20,888  
     Interest expense
    (94,280 )     -       (632,496 )
     Change in fair value of embedded derivative liability
    (2,185,375 )     -       (2,185,375 )
      (2,278,153 )     3,489       (2,796,983 )
                         
NET LOSS
    (5,765,456 )     (2,683,517 )     (41,215,902 )
                         
Less: Deemed dividend distributions
    (2,366,419 )     -       (2,366,419 )
                         
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
  $ (8,131,875 )   $ (2,683,517 )   $ (43,582,321 )
                         
BASIC AND DILUTED NET LOSS PER
                       
    COMMON SHARE
  $ (0.07 )   $ (0.03 )        
                         
BASIC AND DILUTED WEIGHTED AVERAGE
                       
    COMMON SHARES OUTSTANDING
    114,818,293       101,792,509          

See accompanying notes to these financial statements.

 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)
For the Three Months Ended March 31, 2014 and 2013 and
For the period February 11, 2008 (Date of Inception) to March 31, 2014
(Unaudited)

   
Three Months
   
Three Months
       
   
Ended
   
Ended
   
Cumulative
 
   
March 31,
   
March 31,
   
Since
 
   
2014
   
2013
   
Inception
 
                   
NET LOSS
  $ (5,765,456 )   $ (2,683,517 )   $ (41,215,902 )
                         
OTHER COMPREHENSIVE LOSS
                       
     Foreign Currency Translation Adjustments, net of tax
    (17,580 )     -       (19,435 )
TOTAL OTHER COMPREHENSIVE LOSS, net of tax
    (17,580 )     -       (19,435 )
                         
COMPREHENSIVE LOSS
  $ (5,783,036 )   $ (2,683,517 )   $ (41,235,337 )
 
See accompanying notes to these financial statements.
 
 
 
 
 
 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
For the Period February 11, 2008 (Date of Inception) to March 31, 2014
 
                                             
Deficit
             
   
Preferred
   
Common
                     
Accumulated
             
   
Stock
   
Stock
         
Common Stock
   
Additional
   
During the
   
Cumulative
       
   
Number of
         
Number of
         
Common Stock
   
Subscription
   
Paid-In
   
Development
   
Translation
       
   
Shares
   
Amount
   
Shares
   
Amount
   
Subscribed
   
Receivable
   
Capital
   
Stage
   
Adjustment
   
Total
 
                                                             
Issuance of initial 19,000,000 shares of common stock on February 11, 2008 at $.001 per share
    -     $ -       19,000,000     $ 1,900     $ -     $ -     $ 17,100     $ -     $ -     $ 19,000  
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit
    -       -       7,142,858       714       -       -       249,286       -       -       250,000  
Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share
    -       -       -       -       -       -       8,825       -       -       8,825  
Nonemployee options issued for services on March 3,2008, vested immediately and valued at $.02 per share
    -       -       -       -       -       -       107,859       -       -       107,859  
Exercise of options on May 8, 2008 at $.04 per share
    -       -       500,000       50       -       -       19,950       -       -       20,000  
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit
    -       -       6,642,858       665       -       -       231,835       -       -       232,500  
Options issued for services in June 2008, vested immediately and valued at $.07 per share
    -       -       -       -       -       -       395,467       -       -       395,467  
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share
    -       -       -       -       -       -       918       -       -       918  
Issuance of shares of common stock to investors in August 2008 at $1.00 per share
    -       -       2,560       -       -       -       2,560       -       -       2,560  
Exercise of options in September 2008 at $.04 per share
    -       -       1,750,000       175       -       -       69,825       -       -       70,000  
Exercise of warrants in September 2008 at $.04 per share
    -       -       250,000       25       -       -       9,975       -       -       10,000  
Net loss
    -       -       -       -       -       -       -       (983,886 )     -       (983,886 )
                                                                                 
Balance, December 31, 2008
    -       -       35,288,276       3,529       -       -       1,113,600       (983,886 )     -       133,243  
                                                                                 
Exercise of options on January 26, 2009 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Issuance of shares of common stock on April 7, 2009 at $1.00 per share
    -       -       400,000       40       -       -       399,960       -       -       400,000  
Issuance of shares of common stock on June 29, 2009 at $2.00 per share
    -       -       100,000       10       -       -       199,990       -       -       200,000  
Exercise of options on July 30, 2009 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Nonemployee options issued for services on August 18, 2009, vested immediately and valued at $.31 per share
    -       -       -       -       -       -       10,462       -       -       10,462  
Exercise of warrants on August 21, 2009 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Exercise of options on September 2, 2009 at $.04 per share
    -       -       500,000       50       -       -       19,950       -       -       20,000  
Issuance of shares of common stock on September 17, 2009 at $1.00 per share
    -       -       100,000       10       -       -       99,990       -       -       100,000  
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share
    -       -       1,080,427       108       -       -       1,080,319       -       -       1,080,427  
Issuance of shares of common stock on October 16, 2009 at $1.00 per share
    -       -       100,000       10       -       -       99,990       -       -       100,000  
Exercise of warrants on October 22, 2009 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Exercise of warrants on December 2, 2009 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Exercise of options on December 10, 2009 at $.04 per share
    -       -       250,000       25       -       -       9,975       -       -       10,000  
Exercise of warrants on December 31, 2009 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Stock issuance costs
    -       -       -       -       -       -       (65,000 )     -       -       (65,000 )
Nonemployee options issued for services on March 3,2008, vested immediately and valued at $.02 per share
    -       -       -       -       -       -       37,506       -       -       37,506  
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share
    -       -       -       -       -       -       636       -       -       636  
Net loss
    -       -       -       -       -       -       -       (2,236,476 )     -       (2,236,476 )
                                                                                 
Balance, December 31, 2009
    -       -       43,818,703       4,382       -       -       3,246,778       (3,220,362 )     -       30,798  
 
See accompanying notes to these financial statements. 
 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
Statement of Changes in Stockholders’ Equity (Deficit) (Continued)
For the Period February 11, 2008 (Date of Inception) to March 31, 2014
 
                                             
Deficit
             
   
Preferred
   
Common
                     
Accumulated
             
   
Stock
   
Stock
         
Common Stock
   
Additional
   
During the
   
Cumulative
       
   
Number of
         
Number of
         
Common Stock
   
Subscription
   
Paid-In
   
Development
   
Translation
       
   
Shares
   
Amount
   
Shares
   
Amount
   
Subscribed
   
Receivable
   
Capital
   
Stage
   
Adjustment
   
Total
 
                                                             
Exercise of options on January 5, 2010 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Exercise of warrant on February 22, 2010 at $.04 per share
    -       -       892,858       89       -       -       35,624       -       -       35,713  
Exercise of warrants in March 2010 at $.04 per share
    -       -       1,000,000       100       -       -       39,900       -       -       40,000  
Exercise of warrants in April 2010 at $.04 per share
    -       -       2,500,000       250       -       -       99,750       -       -       100,000  
Issuance of shares of common stock in conjunction with notes payable in May through August 2010
    -       -       483,750       48       -       -       400,694       -       -       400,742  
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share
    -       -       65,000       6       -       -       (6 )     -       -       -  
Issuance of shares of common stock from August through December 2010 through private placement at $.20 per share
    -       -       9,625,000       963       -       -       1,924,037       -       -       1,925,000  
Issuance of shares of common stock on November 1, 2010 for the conversion of notes payable at $.20 per share
    -       -       375,000       38       -       -       74,962       -       -       75,000  
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share
    -       -       111,111       11       -       -       99,989       -       -       100,000  
Exercise of options on December 2, 2010 at $.04 per share
    -       -       3,000,000       300       -       -       119,700       -       -       120,000  
Exercise of warrants in December 2010 at $.04 per share
    -       -       2,500,000       250       -       -       99,750       -       -       100,000  
Nonemployee options issued for services from August through November 2010, vested immediately and valued at $.01 per share
    -       -       -       -       -       -       13,816       -       -       13,816  
Nonemployee options issued for services on August 18, 2009, vested immediately and valued at $.31 per share
    -       -       -       -       -       -       27,899       -       -       27,899  
Net loss
    -       -       -       -       -       -       -       (1,489,190 )     -       (1,489,190 )
                                                                                 
Balance, December 31, 2010
    -       -       65,371,422       6,537       -       -       6,222,793       (4,709,552 )     -       1,519,778  
                                                                                 
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share
    -       -       100,000       10       -       -       48,990       -       -       49,000  
Issuance of shares of common stock in conjunction with notes payable from September through December 2011
    -       -       150,000       15       -       -       82,650       -       -       82,665  
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit
    -       -       1,250,000       125       -       -       499,875       -       -       500,000  
Issuance of warrants in conjunction with notes payable from September through December 2011
    -       -       -       -       -       -       20,930       -       -       20,930  
Fair value of revalued warrants at $.09 to $.76 per share
    -       -       -       -       -       -       88,601       -       -       88,601  
Nonemployee options issued for services from August through November 2010, vested immediately and valued at $.01 per share
    -       -       -       -       -       -       3,146       -       -       3,146  
Nonemployee options issued for services on January 24, 2011, and valued at $.20 per share
    -       -       -       -       -       -       46,019       -       -       46,019  
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share
    -       -       -       -       -       -       52,243       -       -       52,243  
Net loss
    -       -       -       -       -       -       -       (2,724,796 )     -       (2,724,796 )
                                                                                 
Balance December 31, 2011
    -       -       66,871,422       6,687       -       -       7,065,247       (7,434,348 )     -       (362,414 )
 
See accompanying notes to these financial statements. 

Virtual Piggy, Inc.
(A Development Stage Enterprise)
Statement of Changes in Stockholders’ Equity (Deficit) (Continued)
For the Period February 11, 2008 (Date of Inception) to March 31, 2014
 
                                             
Deficit
             
   
Preferred
   
Common
                     
Accumulated
             
   
Stock
   
Stock
         
Common Stock
   
Additional
   
During the
   
Cumulative
       
   
Number of
         
Number of
         
Common Stock
   
Subscription
   
Paid-In
   
Development
   
Translation
       
   
Shares
   
Amount
   
Shares
   
Amount
   
Subscribed
   
Receivable
   
Capital
   
Stage
   
Adjustment
   
Total
 
                                                             
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit
    -       -       20,426,948       2,044       -       -       7,084,888       -       -       7,086,932  
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit
    -       -       2,625,000       262       -       -       1,049,738       -       -       1,050,000  
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share
    -       -       1,363,185       136       -       -       3,312,401       -       -       3,312,537  
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit
    -       -       571,428       57       -       -       199,943       -       -       200,000  
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share
    -       -       350,000       35       -       -       297,465       -       -       297,500  
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share
                    7,942,858       794                       5,559,206       -       -       5,560,000  
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share
                    666,667       67                       499,933       -       -       500,000  
Exercise of options on April 10, 2012 at $.04 per share
    -       -       250,000       25       -       -       9,975       -       -       10,000  
Exercise of options on May 25, 2012 at $.04 per share
    -       -       350,000       35       -       -       13,965       -       -       14,000  
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share
    -       -       -       -       -       -       2,219       -       -       2,219  
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share
    -       -       -       -       -       -       759,292       -       -       759,292  
Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.17 to $.40 per share
    -       -       -       -       -       -       39,751       -       -       39,751  
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 to $.53 per share
    -       -       -       -       -       -       283,460       -       -       283,460  
Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share
    -       -       -       -       -       -       150,631       -       -       150,631  
Stock issuance costs
    -       -       -       -       -       -       (28,000 )     -       -       (28,000 )
Common stock subscription for 62,500 units through private placement at $.80 per unit
    -       -       -       -       50,000       (50,000 )     -       -       -       -  
Net loss
    -       -       -       -       -       -       -       (12,039,726 )     -       (12,039,726 )
                                                                                 
Balance December 31, 2012
    -       -       101,417,508       10,142       50,000       (50,000 )     26,300,114       (19,474,074 )     -       6,836,182  
                                                                                 
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit
    -       -       125,000       13       -       -       49,987       -       -       50,000  
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share
    -       -       1,133,334       113       -       -       849,887       -       -       850,000  
Issuance of shares of common stock on April 15, 2013 for services
    -       -       26,521       3       -       -       49,068       -       -       49,071  
Issuance of shares of common stock  and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share
    -       -       2,872,553       287       -       -       5,170,308       -       -       5,170,595  
Fair value of warrants issued with notes payable
    -       -       -       -       -       -       92,469       -       -       92,469  
Fair value of revalued warrants at $0.78 per share
    -       -       -       -       -       -       6,540       -       -       6,540  
Fair value of revalued options at $0.34 and $1.07 per share
    -       -       -       -       -       -       1,199       -       -       1,199  
Exercise of options at $0.04 per share in May 2013
    -       -       750,000       75       -       -       29,925       -       -       30,000  
Exercise of options at $0.35 per share on May 14, 2013
    -       -       300,000       30       -       -       104,970       -       -       105,000  
Exercise of options at $0.75 per share in May 2013
    -       -       66,667       7       -       -       49,993       -       -       50,000  
Exercise of warrants at $0.04 per share on May 26, 2013
    -       -       2,000,000       200       -       -       79,800       -       -       80,000  
Exercise of warrants at $0.50 per share in May through October 2013
    -       -       2,705,185       270       -       -       1,352,323       -       -       1,352,593  
Nonemployee options issued for services from January 2012 through December 2012, vested immediately and valued from $0.11 to $0.95 per share
    -       -       -       -       -       -       34,372       -       -       34,372  
Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share
    -       -       -       -       -       -       784,247       -       -       784,247  
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $0.11 to $0.80 per share
    -       -       -       -       -       -       447,975       -       -       447,975  
Employee options issued for services on January 2013 through December 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share
    -       -       -       -       -       -       310,795       -       -       310,795  
Common stock subscription for 62,500 units through private placement at $.80 per unit
    -       -       -       -       (50,000 )     50,000       -       -       -       -  
Stock issuance costs
    -       -       -       -       -       -       (395,221 )     -       -       (395,221 )
Net loss
    -       -       -       -       -       -       -       (15,976,372 )     -       (15,976,372 )
Cumulative translation adjustment
    -       -       -       -       -       -       -       -       (1,855 )     (1,855 )
                                                                                 
Balance December 31, 2013 
    -       -       111,396,768       11,140       -       -       35,318,751       (35,450,446 )     (1,855 )     (122,410 )
 
See accompanying notes to these financial statements. 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
Statement of Changes in Stockholders’ Equity (Deficit) (Continued)
For the Period February 11, 2008 (Date of Inception) to March 31, 2014
 
                                             
Deficit
             
   
Preferred
   
Common
                     
Accumulated
             
   
Stock
   
Stock
         
Common Stock
   
Additional
   
During the
   
Cumulative
       
   
Number of
         
Number of
         
Common Stock
   
Subscription
   
Paid-In
   
Development
   
Translation
       
   
Shares
   
Amount
   
Shares
   
Amount
   
Subscribed
   
Receivable
   
Capital
   
Stage
   
Adjustment
   
Total
 
                                                             
Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit
    50,450       5       -       -       -       -       3,396,170       -       -       3,396,175  
Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share
    -       -       5,042,287       504       -       -       2,520,639       -       -       2,521,143  
Exercise of warrants at $0.50 per share in March 2014
    -       -       50,000       5       -       -       24,995       -       -       25,000  
Exercise of options at $0.75 per share in March 2014
    -       -       100,000       10       -       -       74,990       -       -       75,000  
Fair value of revalued warrants at $0.22 to$ 0.76 per share
    -       -       -       -       -       -       9,228       -       -       9,228  
Nonemployee options issued for services from January 2012 through December 2012, vested over three years and valued from $1.11 to $1.55 per share
    -       -       -       -       -       -       6,335       -       -       6,335  
Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $1.04 to $3.05 per share
    -       -       -       -       -       -       43,112       -       -       43,112  
Employee options issued for services on January 2012 through December 2013, vesting over three years and valued at $0.50 to $0.92 per share
    -       -       -       -       -       -       201,494       -       -       201,494  
Employee options issued for services on January 2014 through March 31, 2014, vesting over two to three years and valued at $1.05 to $1.43 per share
    -       -       -       -       -       -       28,382       -       -       28,382  
Deemed dividend distribution in conjunction with Preferred Series A offering
    -       -       -       -       -       -       1,648,825       (1,648,825 )     -       -  
Deemed dividend distribution in conjunction with warrant exchange offering
    -       -       -       -       -       -       717,594       (717,594 )     -       -  
Stock issuance costs
    -       -       -       -       -       -       (170,165 )     -       -       (170,165 )
Net loss
    -       -       -       -       -       -       -       (5,765,456 )     -       (5,765,456 )
Cumulative translation adjustment
    -       -       -       -       -       -       -       -       (17,580 )     (17,580 )
                                                                                 
Balance March 31, 2014 (unaudited) 
    50,450     $ 5       116,589,055     $ 11,659     $ -     $ -     $ 43,820,350     $ (43,582,321 )   $ (19,435 )   $ 230,258  

See accompanying notes to these financial statements. 


Virtual Piggy, Inc.
 (A Development Stage Enterprise)
For the Three Months Ended March 31, 2014 and 2013 and
For the Period February 11, 2008 (Date of Inception) to March 31, 2014
(Unaudited)

   
Three Months
   
Three Months
       
   
Ended
   
Ended
   
Cumulative
 
   
March 31,
   
March 31,
   
Since
 
   
2014
   
2013
   
Inception
 
CASH FLOWS FROM OPERATING ACTIVITIES
                 
Net loss
  $ (5,765,456 )   $ (2,683,517 )   $ (41,215,902 )
Adjustments to reconcile net loss to net cash
                       
used in operating activities
                       
Fair value of warrants issued in exchange for services
    -       -       638,516  
Fair value of options issued in exchange for services
    288,551       191,494       3,263,914  
Fair value of stock issued in exchange for services
    -       -       4,791,035  
Change in fair value of embedded derivative liability
    2,185,375       -       2,185,375  
Amortization of deferred costs
    -       -       78,243  
Accretion of discount on notes payable
    86,087       -       518,565  
Depreciation and amortization
    18,518       11,671       108,417  
Provision for bad debt
    -       -       42,768  
Loss on disposal of fixed assets
    8,109       -       16,942  
(Increase) decrease in assets
                       
Accounts receivable
    (285 )     (88 )     (1,285 )
Insurance receivable
    4,325       75,000       -  
Other receivable
    -       -       (42,768 )
Prepaid expenses
    (59,618 )     (3,464 )     (280,526 )
Deposits
    (228,831 )     (8,900 )     (346,949 )
Increase (decrease) in liabilities
                       
Accounts payable, accrued expenses and litigation settlement
    (553,194 )     (301,789 )     1,918,987  
                         
Net cash used in operating activities
    (4,016,419 )     (2,719,593 )     (28,324,668 )
                         
CASH FLOWS FROM INVESTING ACTIVITIES
                       
Purchase of equipment
    (51,751 )     (22,867 )     (213,068 )
Patent and trademark costs
    (54,624 )     (91,745 )     (836,411 )
                         
Net cash used  in investing activities
    (106,375 )     (114,612 )     (1,049,479 )
                         
CASH FLOWS FROM FINANCING ACTIVITIES
                       
Proceeds from note payable - stockholders
    -       -       1,747,500  
Repayment of note payable - stockholders
    (1,000,000 )     -       (1,572,500 )
Proceeds from notes payable
    -       -       75,000  
Proceeds from issuance of preferred stock and warrants
    5,045,000       -       5,045,000  
Proceeds from issuance of common stock
    -       900,000       23,796,584  
Proceeds from exercise of options
    75,000       -       644,000  
Proceeds from exercise of warrants
    2,546,143       -       4,424,449  
Stock issuance costs
    (170,165 )     (60,783 )     (658,386 )
                         
Net cash provided by financing activities
    6,495,978       839,217       33,501,647  
                         
EFFECT OF EXCHANGE RATE ON CASH
    (17,580 )     -       (19,435 )
                         
NET INCREASE (DECREASE) IN CASH AND
                       
CASH EQUIVALENTS
    2,355,604       (1,994,988 )     4,108,065  
                         
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
    1,752,461       7,371,036       -  
                         
CASH AND CASH EQUIVALENTS - END OF PERIOD
  $ 4,108,065     $ 5,376,048     $ 4,108,065  
                         
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:
                       
                         
Income taxes paid
  $ -     $ -     $ -  
Interest paid
  $ 8,193     $ -     $ 2,498  
Fair value of common stock issued as discount for notes payable
  $ -     $ -     $ 483,409  
Conversion of notes payable and accrued interest into common stock
  $ -     $ -     $ 275,000  
Fair value of warrants issued as discount for notes payable
  $ -     $ -     $ 20,930  
Issuance of common stock for settlement of payable
  $ -     $ -     $ 297,500  
Fair value of beneficial conversion value as discount against Preferred Stock
  $ 1,648,825     $ -     $ 1,648,825  
Fair value of warrant liability as discount against Preferred Stock
  $ 1,547,925     $ -     $ 1,547,925  
Accretion of discount on preferred stock as deemed distribution
  $ 1,648,825     $ -     $ 1,648,825  
Deemed dividend distribution in conjunction with warrant exchange.
  $ 717,594     $ -     $ 717,594  
 
See accompanying notes to these financial statements.
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)
 
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of the Business
Virtual Piggy, Inc. (“the Company”) is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.   Virtual Piggy is a technology company that delivers an online ecommerce solution for the family. Its system allows parents and their children to manage, allocate funds and track their expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent’s permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits. Our principal office is located in Hermosa Beach, California and in 2013 we opened an office in London, England to support the sales and marketing efforts in Europe and the development of our mobile applications.
 
The Oink (formerly Virtual Piggy) service enables online businesses to interact and transact with the “Under 18” market in a manner consistent with the Children’s Online Privacy Protection Act (“COPPA”) and other similar international children’s privacy laws.  Oink was launched in the US in 2012 and in the European market in 2013, and now has the capability to offer and deliver gift cards.

We secure agreements with merchants, retail and gaming e-commerce platforms and payment processors, which allow us to offer our Oink service to our user base. Over 20 retailers and gaming companies are using Oink with their e-commerce systems and the Company is in the process of integrating the other signed retailers and gaming companies. The Company is continuing to add merchants. To date, the Company has over 1 million users of its system. The Company defines a system user as a registered account that has accessed the Oink service within the past 12 months.

Basis of Presentation
The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 915 for development stage entities.  The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States (“U.S. GAAP”) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission (the “SEC”). Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.

Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from these estimates.

Comprehensive Income
The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  The Company has one item of other comprehensive loss, consisting of a foreign translation adjustment.

Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Fair Value of Financial Instruments
The Company’s financial instruments consist of accounts receivable, accounts payable and accrued expenses, embedded derivative and warrant liability. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities. 

The Company follows FASB ASC 820, Fair Value Measurements and Disclosures, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:
 
Level 1: Quoted market prices in active markets for identical assets or liabilities
 
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data
 
Level 3: Unobservable inputs that are not corroborated by market data
 
The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
 
Foreign Currency Translation
The functional currency of operations outside the U.S. is British Pounds.

Concentration of Credit Risk Involving Cash
The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance (“FDIC”) coverage.  The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.  
 
Cash and Cash Equivalents
For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.

Property and Equipment
Property and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, principally three to seven years. Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is included in operations.  Depreciation of property and equipment was $8,389 and $5,875 for the three months ended March 31, 2014 and 2013 and is included in general and administrative expenses.

Patents and Trademarks
The Company has one issued patent with the United States Patent and Trademark Office (“USPTO”), entitled Systems and Method for Verifying the Age of an Internet User, and filed for nine provisional patents.  Additionally, the Company has been issued two patents in Germany, entitled Virtual Piggy Bank and Parent Match, while the remaining patents in Germany are still pending.  The Company also has patents pending in Australia, Brazil, Canada and Europe under the Patent Cooperation Treaty (“PCT”).  Costs associated with the registration and legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents which were determined to be 20 years.
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements
 
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Long-Lived Assets
The Company evaluates the recoverability of its long-lived assets in accordance with FASB ASC 360 “Property, Plant, and Equipment.” The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.

Revenue Recognition
In accordance with Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale of the associated product.  
  
Income Taxes
The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.  Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.  Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.

Stock-based Payments
The Company accounts for stock-based compensation under the provisions of FASB ASC 718, Compensation—Stock Compensation which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC 505 -50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid-in capital in stockholders’ equity over the applicable service periods.
 
Advertising Costs
Advertising costs are expensed as incurred. Advertising costs were $53,628 and $222,847 for the three months ended March 31, 2014 and 2013 and are included in sales and marketing expenses.
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Research and Development Costs
In accordance with FASB ASC 730, research and development costs are expensed when incurred.  Research and development costs for the three months ended March 31, 2014 and 2013 were $852,744 and $454,378.

Loss Per Share
The Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the three months ended March 31, 2014 and 2013, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

Start-up Costs
In accordance with FASB ASC 720, start-up costs are expensed as incurred.

Segment Information
The Company is organized and operates as one operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.

Recently Adopted Accounting Pronouncements
As of March 31, 2014 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted
As of March 31, 2014, there were no recently issued accounting standards not yet adopted which would have a material effect on the Company’s financial statements.

Reclassifications
Certain amounts in the 2013 and cumulative since inception statements of operations have been reclassified in order for them to be in conformity with the 2014 presentation.

Virtual Piggy, Inc.
(A Development Stage Enterprise)
Notes to Financial Statements

NOTE 2 – MANAGEMENT PLANS

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  The Company has incurred significant losses and experienced negative cash flow from operations during the development stage.  These conditions raise substantial doubt about the Company’s ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Since inception, the Company has focused on developing and implementing its business plan.  The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months.  The Company currently needs to generate revenue in order to sustain its operations.  In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities.  The issuance of additional equity would result in dilution to existing shareholders.  If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would likely be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

The Company’s current monetization model is to derive a percentage of all revenues generated by online merchants using the Oink service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month.  As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.

If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained.  For the three months ended March 31, 2014, and for the year ended December 31, 2013, the Company raised $7.5 million net of stock issuance costs of $0.2 million, and $8.3 million net of stock issuance costs of $0.4 million, respectively, through private placements of its equity securities and from exercises of warrants. Additionally, in April 2014, the Company raised an additional $5.8 million through a private placements of its equity securities.

The Company is in the development stage at March 31, 2014.  Successful completion of the Company’s development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company’s cost structure.  However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.

NOTE 3 – PATENTS AND TRADEMARKS

The Company continues to apply for patents and purchased the Oink trademark in November 2013.  Accordingly, costs associated with the registration of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years).  The trademark is also being amortized on a straight-line basis over its estimated useful life of 20 years. At March 31, 2014 and December 31, 2013, capitalized patent and trademark costs were $784,152 and $739,657.  Amortization expense for patents and trademarks was $10,129 and $5,265 for the three months ended March 31, 2014 and 2013.

Virtual Piggy, Inc.
(A Development Stage Enterprise)
Notes to Financial Statements

NOTE 4 – NOTES PAYABLE

On December 27, 2013, the Company entered into two identical agreements with two stockholders that each include a note payable in the amount of $500,000 and two-year warrants to purchase 37,500 shares of the Company’s common stock at $0.01 and two-year warrants to purchase 50,000 shares of the Company’s common stock at $1.00 per share. The note payable bears interest at 10% per annum and is payable upon the earlier of:
 
 
a.
5 days after the sale of the Company’s securities in one transaction or series of related transactions, which sale results in gross proceeds to the Company of at least $3 million;
 
b.
Upon (i) the sale or other disposition of all or substantially all of the Company’s assets or (ii) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is a party other than a transaction or series of transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction continue to retain, as a result of shares in the Company held by such holders prior to such transaction, at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such transaction or series of transactions;
 
c.
February 28, 2014.
 
The warrants were valued at $92,470, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of .4% and expected option life of 2 years.  The warrant values were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, Recognition and are being accreted over the term of the note payable for financial statement purposes.  These notes were repaid in full in January 2014 and therefore the remaining unamortized discount was fully accreted.

During the three months ended March 31, 2014 and 2013, $86,087 and $0 of interest was accreted on the notes payable.  

NOTE 5 - INCOME TAXES

Income tax expense was $0 for the three months ended March 31, 2014 and 2013.

As of December 31, 2013, the Company had net operating loss carry forwards approximating $39.7 million.

As of January 1, 2014, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2014 related to unrecognized tax benefits.  There has been no change in unrecognized tax benefits during the three months ended March 31, 2014, and there was no accrual for uncertain tax positions as of March 31, 2014.  Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.

There is no income tax benefit for the losses for the three months ended March 31, 2014 and 2013, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements

NOTE 6 – LITIGATION SETTLEMENT

The Company entered into a settlement agreement with an investor in 2012, whereby the Company agreed to pay the investor a settlement of $450,000 and the investor agreed to cease trading in the Company’s stock and to return warrants issued to the investor.  The Company’s insurance carrier agreed to reimburse the Company with respect to this litigation.  Both the settlement payment and the insurance company settlement were completed in 2013.

NOTE 7 – CONVERTIBLE PREFERRED STOCK

In January 2014, the Company, pursuant to a Securities Purchase Agreement (the “Purchase Agreement”), issued to certain private investors 50,450 shares of the Company’s Series A Cumulative Convertible Preferred Stock (the “Preferred Stock”) at an original issue price of $100 per share (the “Original Issue Price”) and warrants to purchase 5,045,000 shares of the Company’s common stock (the “Warrants”) for an aggregate purchase price of $5,045,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Preferred Stock shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative.  As of December 31, 2013, the Company had incurred and capitalized approximately $131,000 of costs associated with this offering, which were charged to additional paid in capital in January 2014 when the transaction was consummated.

In accordance with FASB ASC 480 and 815, the Preferred Stock has been classified as permanent equity and was valued at $3,396,175, net of the beneficial conversion feature of $1,648,825, at January 27, 2014.
 
The conversion feature of the Preferred Stock is an embedded derivative, which is classified as a liability in accordance with FASB ASC 815 and was valued in accordance with FASB ASC 470 as a beneficial conversion feature at a fair market value of $1,648,825 at January 27, 2014 and $3,834,200 at March 31, 2014. This was classified as an embedded derivative liability and a discount to Preferred Stock.  Since the preferred stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.
 
Because the Preferred Stock can be converted at any time, the embedded derivative is classified as a current liability at March 31, 2014.
 
The warrants associated with the Preferred Stock were also classified as equity, in accordance with FASB ASC 480-10-25.  Therefore it is not necessary to bifurcate the warrants from the Preferred Stock.
 
The Preferred Stock has a preference in liquidation that the holders of the Preferred Stock are to be paid out of assets available for distribution prior to holders of common stock. The Preferred Stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred Stock can be converted.
 
The conversion price of the Preferred Stock is currently $1.00 per share. There are no arrearages on cumulative dividends.

Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements

NOTE 8 – FAIR VALUE OF FINANCIAL INSTRUMENTS
 
Derivative Liabilities
 
For purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity’s own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity’s own common stock. 
 
The Company has identified the following liabilities that are measured at fair value on a recurring basis, summarized as follows: 
 
March 31, 2014
 
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Derivative liability related to fair value of beneficial conversion feature
  $ -     $ 3,834,200     $ -     $ 3,834,200  
                                 
Total
  $ -     $ 3,834,200     $ -     $ 3,834,200  

The following table details the approximate fair value measurements within the fair value hierarchy of the Company’s derivative liabilities using Level 2 inputs:
 
   
Total
 
Balance at January 27, 2014
  $ 1,648,825  
Change in fair value of derivative liabilities
    2,185,375  
         
Balance at March 31, 2014
  $ 3,834,200  

Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements
 
NOTE 8 – FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)
 
As of March 31, 2014, the beneficial conversion feature of the Preferred Stock is treated as an embedded derivative liability and changes in the fair value were recognized in earnings.  The shares of Preferred Stock are convertible into shares of the Company’s common stock, which did trade in an active securities market, therefore the embedded derivative liability was valued using the following market based inputs:
 
Closing Trading Price of Common Stock
  $ 1.45  
Series A Preferred Stock Effective Conversion Price
    0.69  
Intrinsic value of conversion option per share
  $ 0.76  

The Company has no assets that are measured at fair value on a recurring basis. There were no assets or liabilities measured at fair value on a non-recurring basis as of March 31, 2014 and December 31, 2013.
 
NOTE 9 – STOCKHOLDERS’ EQUITY

During the first quarter of 2013, the Company entered into a private placement for shares of the Company’s common stock. The shares were sold at a purchase price of $.75 per share.  Through March 31, 2013, 1,133,334 shares were sold resulting in proceeds of $850,000.  Issuance costs related to this private placement were $60,783.

On April 15, 2013, the Company issued 26,521 restricted shares of the Company’s common stock to five members of the Board of Directors that were valued at $49,071.  In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company’s common stock. These options were valued at $519,080, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted will be expensed over the three year vesting term.

On May 28, 2013, the Company entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the “Offering”), with each unit being comprised of one (1) share of the Company’s common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional    300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company’s common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.

 Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements

NOTE 9 – STOCKHOLDERS’ EQUITY (Continued)

During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.

During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,410,342.

During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.

In October 2013, an investor exercised 10,000 warrants to purchase common stock at $0.50 per share, resulting in proceeds of $5,000.

In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock (“Warrantholders”), pursuant to which Warrantholders who were not directors or executive officers of the Company were given the opportunity to immediately exercise all outstanding vested warrants for cash in exchange for (i) the applicable shares of common stock underlying the exercised warrant and (ii) a new two-year warrant, granting rights to acquire an equivalent number of shares of common stock as issued pursuant to the exercised warrant(s), at an exercise price of $1.00 per share (each a “Replacement Warrant”). Pursuant to the offering, the Company received aggregate cash consideration of $2,521,143 from exercised warrants to purchase 5,042,287 shares of Company common stock.

Modification of Warrants Issued in February 2012 Private Placement and Deemed Dividend
Effective February 7, 2014, when the market price of our common stock was $1.18, we entered  an exchange offering  with certain investors in the 2011 to 2012 Private Placements to exercise their current warrants at $0.50 per share and receive a new warrant which would be convertible into the same number of common shares as the original warrant.  The new warrant has an exercise price of $1.00.  Many investors exercised the original warrants and received the new warrants.  The Company has recognized a deemed dividend of $717,594 in the Statement of Operations for the three months ended March 31, 2014, attributable to the incremental fair value resulting from the modification of these warrants.  The fair value of the new warrants was valued using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 143.2%, risk free interest rate of 0.30% and expected option life approximating two years.  The warrants expire two years from the date of issuance.

Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements

NOTE 10 - STOCK OPTIONS AND WARRANTS
    
During 2008, the Board of Directors (“Board”) of the Company adopted the 2008 Equity Incentive Plan (“2008 Plan”) that was approved by the shareholders.  Under the Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company.  The Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”).  All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”).  As of March 31, 2014, options to purchase 14,023,330 shares of common stock have been issued and are unexercised, and 463,336 shares are available for grants under the 2008 Plan.  Of the options to purchase 14,023,330 shares that have been issued and are unexercised, options to purchase 12,228,330 shares were granted to employees or persons who later became employees and options to purchase 1,795,000 shares were granted to non-employees.

During 2013, the Board adopted the 2013 Equity Incentive Plan (“2013 Plan”), which was approved by stockholders at the 2013 annual meeting of stockholders.  Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant.  The 2013 Plan is intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options.  All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options.  As of March 31, 2014, under the 2013 Plan options to purchase 3,789,166 shares of common stock have been issued and are unexercised, and 1,210,834 shares of common stock remain available for grants under the 2013 Plan.  Of the options to purchase 3,789,166 shares of common stock that have been issued and are unexercised, options to purchase 2,264,166 shares were granted to employees or persons who later became employees and 1,525,000 options to purchase  shares were granted to non-employees.

The 2008 Plan and 2013 Plan are administered by the Board or its compensation committee, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the applicable Plan.

In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

Prior to January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company.  Beginning January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the volatility of the Company’s stock history.

Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements
 
NOTE 10 - STOCK OPTIONS AND WARRANTS (Continued)

Employee and Non-Employee Director Grants

In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company’s common stock at exercise prices between $0.99 and $1.05 per share.  These options were valued at $62,662 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company’s common stock at exercise prices between $1.07 and $1.21 per share.  These options were valued at $199,843 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
            
In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company’s common stock at an exercise price of $1.36 per share.  These options were valued at $728 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In April 2013, the Company issued an employee options to purchase 5,000 shares of the Company’s common stock at an exercise price of $1.67 per share.  These options were valued at $933 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company’s common stock at an exercise price of $1.56 per share.  These options were valued at $74,159, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company’s common stock at an exercise price of $2.16 and $2.29 per share.  These options were valued at $26,954, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements

NOTE 10 - STOCK OPTIONS AND WARRANTS (Continued)

In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company’s common stock at exercise prices of $2.40 and $2.92 per share.  The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore   such options have not been valued.  The remaining options were valued at $129,343, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company’s common stock at exercise prices of $2.00 and $2.35 per share.  These options were valued at $124,392, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company’s common stock at an exercise price of $1.97 per share.  These options were valued at $4,500, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In November 2013, the Company issued an employee options to purchase an aggregate of 10,000 shares of the Company’s common stock at an exercise price of $1.04 per share.  These options were valued at $2,613, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In December 2013, the Company issued four employees options to purchase an aggregate of 255,000 shares of the Company’s common stock at an exercise price of $1.13 per share.  These options were valued at $65,523, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of 1.51% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In addition, in December 2013, an employee met a milestone relative to options to purchase 50,000 shares of the Company’s common stock at an exercise price of $2.40 per share.  These options were valued at $687, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.3%, risk free interest rate of 1.75% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

Virtual Piggy, Inc.
 (A Development Stage Enterprise)
Notes to Financial Statements
 
NOTE 10 - STOCK OPTIONS AND WARRANTS (Continued)

In January 2014, the Company issued 11 employees options to purchase an aggregate of 90,000 shares of the Company’s common stock at an exercise price of $1.05 per share.  These options were valued at $53,927, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 1.77% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In January 2014, the Company issued two employees options to purchase an aggregate of 35,000 shares of the Company’s common stock at an exercise price of $1.05 per share.  These options were valued at $27,806, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 3.01% and expected option life of ten years.  The options expire ten years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2014, the Company issued to one of our new board of directors members options to purchase an aggregate of 250,000 shares of the Company’s common stock at an exercise price of $1.10 per share.  These options were valued at $264,882, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 128.5%, risk free interest rate of 2.70% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2014, the Company issued two employees options to purchase an aggregate of 20,000 shares of the Company’s common stock at an exercise price of $1.18 per share.  These options were valued at $21,048, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 142.1%, risk free interest rate of 1.47% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In February 2014, the Company extended warrants previously granted to two of its executive officers, which included 1,142,588 warrants exercisable at $0.04 per share and 100,000 warrants exercisable at $.75 per share for an additional two years.  The increase in fair value of this term extension was $9,228 which was expensed during the three months ended March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions: no dividend yield, expected volatility of 89.3% to 89.5%, risk free interest rate of 0.33%, and expected warrant life of 2 years.
  
In March 2014, the Company issued to an employee options to purchase an aggregate of 100,000 shares of the Company’s common stock at an exercise price of $1.43 per share.  These options were valued at $136,454, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 122.6%, risk free interest rate of 2.73% and expected option life of ten years.  The options expire ten years from the date of issuance.  Options granted are expensed over the two year vesting term.
            
Virtual Piggy, Inc.
(A Development Stage Enterprise)
Notes to Financial Statements

NOTE 10 - STOCK OPTIONS AND WARRANTS (Continued)

Cumulatively and for the three months ended March 31, 2014 and 2013, the Company expensed $1,533,213, $239,104 and $133,698 relative to employee options/warrants granted.  As of March 31, 2014, there was $1,594,574 of unrecognized compensation expense related to employee non-vested market-based share awards. A summary of stock option/warrant transactions for employees from January 1, 2013 to March 31, 2014 is as follows:

               
Weighted Average
 
   
Option/Warrants
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2012
    17,258,644     $ 0.04 to $1.82     $ 0.48  
                         
Granted
    3,067,500      
0.99 to 2.92
      0.28  
Reclassified to non-employee
    (235,000 )    
0.65 to 2.30
      (0.02 )
Exercised
    (2,816,667 )    
0.04 to 0.75
      (0.01 )
Expired/terminated
    (698,333 )    
0.50 to 2.92
      (0.01 )
                         
Outstanding, December 31, 2013
    16,576,144      
0.04 to 2.40
      0.74  
                         
Granted
    495,000      
1.05 to 1.43
      0.03  
Reclassified from non-employee
    200,000       0.50       0.01  
Exercised
    (100,000 )     0.75       -  
Expired/terminated
    (460,003 )    
0.65 to 2.16
      (0.02 )
                         
Outstanding, March 31, 2014
    16,711,141     $ 0.04 to $2.40     $ 0.74  
                         
Exercisable, March 31, 2014
    11,436,145     $ .04 to $2.30     $ 0.49  
                         
Weighted Average Remaining Life,
                       
  Exercisable, March 31, 2014 (years)
    1.7                  

Non-Employee Grants
 
In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company’s common stock at an exercise price of $1.00 per share.  These options were valued at $441 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement.

 Virtual Piggy, Inc.
(A Development Stage Enterprise)
Notes to Financial Statements

NOTE 10 - STOCK OPTIONS AND WARRANTS (Continued)

In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company’s common stock at exercise prices of $0.75 and $1.48 per share.  130,000 of these options vested immediately and were valued at $54,228, fair value.  The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 22.6%, risk free interest rate of .25% and .25%, and an expected option life of two to five years.  The options expire two to five years from the date of issuance.  The vested options granted, were expensed immediately.  The remaining unvested options will be expensed when it is probable that the milestones will be achieved.

In March 2013, the Company issued to a consultant options to purchase 100,000 shares of the Company’s common stock at exercise prices of $1.34 per share.  These options vest over a one year period and were valued at $32,155 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.8%, risk free interest rate of .8%, and an expected option life of 5 years.  The options expire five years from the date of issuance.  The options will be expensed over a one year period.

In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company’s common stock at an exercise price of $2.04 per share.  These options were valued at $44,603, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company’s common stock at exercise prices ranging from $3.05 to $3.28 per share.  These options were valued at $51,869, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years.  The options expire two years from the date of issuance.  Options granted are expensed over the term of the agreement.
 
In May 2013, the Company, as part of the cost of the Company’s Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company’s common stock at an exercise price of $1.80 per share.  These warrants were valued at $409,749, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years.  The warrants expire three years from the date of issuance.  The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.

In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company’s common stock at exercise prices ranging from $.75 to $2.61 per share.  These options were valued at $124,338, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years.  The options expire five years from the date of issuance.  $124,338 was expensed immediately.
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
Notes to Financial Statements
 
NOTE 10 - STOCK OPTIONS AND WARRANTS (Continued)

In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company’s common stock at an exercise price of $1.17 per share.  These options were valued at $26,208, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement, which is three years.

In October 2013, the Company issued a consultant options to purchase 20,000 shares of the Company’s common stock at an exercise price of $1.06 per share.  These options were valued at $6,132, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2%, risk free interest rate of 1.33% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement, which is six months.

In November 2013, the Company issued a consultant options to purchase 100,000 shares of the Company’s common stock at an exercise price of $1.04 per share.  These options were valued at $26,128, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement, which is one year.

On November 18, 2013, Company approved an amendment extending the term of outstanding warrants to purchase in the aggregate 8,931,505 shares of common stock of the Company at an exercise price of $0.50 per share.  These warrants were scheduled to expire at various dates during 2013 and 2014 and were each extended for an additional one year period from the applicable original expiration date, with the new expiration dates ranging from December 20, 2014 to December 28, 2015. The Warrants were originally issued in private placements to accredited investors to raise additional capital during 2011 and 2012.The value of these warrant modifications was $6,540, computed by measuring the warrants immediately before and after such term extension. This was taken as a charge to operations in November 2013.  

In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock as described in Note 7.

Cumulatively and for the three months ended March 31, 2014 and March 31, 2013, the Company expensed $1,893,237, $49,447 and $73,163 relative to non-employee options/warrants granted.  As of March 31, 2014, there was $73,163 of unrecognized compensation expense related to such non-vested market-based share awards.

Virtual Piggy, Inc.
(A Development Stage Enterprise)
Notes to Financial Statements

 The following table summarizes non-employee stock options/warrants of the Company from January 1, 2013 to March 31, 2014 as follows:

               
Weighted Average
 
   
Option/Warrant
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2012
    16,531,438      
0.35 to 2.30
      0.63  
                         
Granted
    2,048,750      
0.01 to 3.28
      0.18  
Issued under Private Placement
    1,723,533      
1.80 to 3.00
      0.30  
Reclassified from employee
    235,000      
0.50 to 1.01
      0.01  
Exercised
    (3,005,185 )    
.35 to .50
      -  
Expired/Cancelled
    (1,405,000 )    
0.50 to 1.00
      -  
                         
Outstanding, December 31, 2013
    16,128,536      
0.01 to 3.28
      0.98  
                         
Granted
    50,000       1.13       -  
Issued under Private Placement
    10,087,287       1.00       0.49  
Reclassified to employee
    (200,000 )     0.50       0.01  
Exercised
    (5,092,287 )    
.35 to .50
      -  
Expired/Cancelled
    (410,000 )    
0.60 to 2.30
      -  
                         
Outstanding, March 31, 2014
    20,563,536     $ 0.01 to $3.28     $ 1.11  
                         
Exercisable, March 31, 2014
    18,968,537     $ 0.01 to $3.28     $ 1.08  
                         
Weighted Average Remaining Life,
                       
  Exercisable, March 31, 2014 (years)
    1.7                  
 
NOTE 11 - OPERATING LEASES
 
For the three months ended March 31, 2014 and 2013, total rent expense under leases amounted to $138,843 and $55,648, respectively.  At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:

2014
 
$
293,696
 
2015
   
300,194
 
2016
   
200,696
 
   
$
794,586
 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
Notes to Financial Statements
 
NOTE 12 – RELATED PARTY TRANSACTIONS
 
During the three months ended March 31, 2013, a consultant owning more than 5% of the Company was paid for consulting and travel expenses to provide strategic advice to the Company.   On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year.  In June 2013, this contract was terminated.  Consulting fees paid for the three months ended March 31, 2013 were $25,000. Reimbursable business expenses of $2,946 and $23,566 were paid during the three months ended March 31, 2014 and 2013, respectively. 
  
       
NOTE 13 – SUBSEQUENT EVENTS
 
In April 2014, the Company issued options to purchase 55,000 shares of common stock to various employees at an exercise price of $1.27 per share.

In April 2014, the Company, pursuant to the Purchase Agreement described in Note 7, issued in a private placement to certain accredited investors an additional 58,150 shares of the Series A Preferred Stock at an original issue price of $100 per share and warrants to purchase 5,815,000 shares of the Company’s common stock for an aggregate purchase price of $5,815,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Series A Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Series A Preferred Shares shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative.  

In April 2014, the Company entered into an agreement with a consulting firm to provide strategic consulting services.  In connection with that agreement, the Company issued 300,000 restricted shares of common stock and an option to purchase 500,000 shares of the Company’s common stock at $1.27 per share, which will vest subject to meeting certain milestones.

On April 10, 2014, the Company was named in a law suit in superior court for the State of California from a former employee alleging wrongful termination and is asking for damages and legal fees to be paid. The Company intends to vigorously dispute the claims made by the former employee, while pursuing reasonable efforts to achieve a resolution of this matter.  At this time it is not possible for us to provide any opinion as to any ultimate outcome or any definitive estimate of the amount of loss, if any, although we do not believe that any outcome will be significant to the Company’s financial condition.
 
 
30

 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
 
CONDITION AND RESULTS OF OPERATIONS.

Cautionary Statements Regarding Forward-Looking Statements

This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act").  All statements other than statements of historical facts included or incorporated by reference in this quarterly report on Form 10-Q, including without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs and plans and objectives of management for future operations, are forward-looking statements.  In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expects," "intends," "plans," "projects," "estimates," "anticipates," or "believes" or the negative thereof or any variation thereon or similar terminology or expressions.

We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, but are not limited to:  our ability to raise additional capital, the absence of any operating history or revenue, our ability to attract and retain qualified personnel, our dependence on third party developers who we cannot control, our ability to develop and introduce a new service to the market in a timely manner, market acceptance of our services, our limited experience in a relatively new industry, the ability to successfully develop licensing programs and generate business, rapid technological change in relevant markets, unexpected network interruptions or security breaches, changes in demand for current and future intellectual property rights, legislative, regulatory and competitive developments, intense competition with larger companies, general economic conditions, as well as other factors set forth under the caption "Risk Factors" in this and prior quarterly reports on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission.

All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing.  Except as required by law, we assume no duty to update or revise our forward-looking statements.

Overview

Virtual Piggy, Inc. (“the Company”) is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.   We are a technology company that delivers an online ecommerce solution for the family. Our system allows parents and their children to manage, allocate funds and track their expenditures, savings and charitable giving online. Our Oink product is designed to allow the child to transact online without a credit card by gaining the parent’s permission ahead of time and allowing the parent to set up the rules of use. In addition to our main focus, we are also working on technology that will make the overall online experience safer for U18s.
 
 The Oink product enables online businesses to interact and transact with the “Under 18” market in a manner consistent with the Children’s Online Privacy Protection Act (“COPPA”) and other similar international children’s privacy laws.  Oink was launched in the US in 2012 and was launched in the European market in 2013.
 
 
We secure agreements with merchants, retail and gaming e-commerce platforms and payment processors, which allow us to offer our Oink service to our user base. Over 20 retailers and gaming companies are using Oink live with their e-commerce systems and we are in the process of integrating the other signed retailers and gaming companies. We are continuing to add retailers in all categories along with gaming companies. To date, we have over 1 million users of our system. We define a system user as a registered account that has accessed the Oink product within the past 12 months.

In addition, Oink has the capability to offer and deliver digital gift cards.

We earn revenue by charging a percentage to the merchant for each transaction processed through such merchants using the Oink product.

Strategic Outlook

We believe that the virtual goods market will continue to grow over the long term.  Within the market, we intend to provide services to the online industry to allow them to transact with children in compliance with COPPA and similar international privacy laws.  We believe that this particular opportunity is relatively untapped and expect to be a leading provider of online transactions for children.

Sustained spending on technology, our ability to raise additional financing, the continued growth of the online market, and compliance with regulatory and reporting requirements are all external conditions that may affect our ability to execute our business plan.  In addition, the online payment industry is intensely competitive, and most participants have longer operating histories, significantly greater financial, technical, marketing, customer service and other resources, and greater name recognition.  In addition, certain potential customers, particularly large organizations, may view our small size and limited financial resources as a negative even if they prefer our offering to those of our competitors.

Our primary strategic objective over the next 12-24 months is to continue our merchant acquisition and commence and rapidly expand our consumer acquisition program which will generate revenue that we believe will ultimately cover our operating expenses and allow us to become profitable. We intend to focus heavily on the online gaming industry and additionally expect to enter the in-store market through Oink branded debit cards.  We plan to achieve this objective by advertising our product and services to consumers through public relations programs, merchant promotions and affiliate marketing programs.  As our service grows, we intend to hire additional information technology staff to maintain our product offerings and develop new products to increase our market share.

We believe that our near-term success will depend particularly on our ability to develop customer awareness and confidence in our service.  Since we have limited capital resources, we will need to closely manage our expenses and conserve our cash by continually monitoring any increase in expenses and reducing or eliminating unnecessary expenditures. Our prospects must be considered in light of the risks, expenses and difficulties encountered by companies at an early stage of development, particularly given that we operate in new and rapidly evolving markets, that we have limited financial resources, and face an uncertain economic environment. We may not be successful in addressing such risks and difficulties.
 

Results of Operations

Comparison of the Quarters Ended March 31, 2014 and 2013

The following discussion analyzes our results of operations for the quarters ended March 31, 2014 and 2013. The following information should be considered together with our financial statements for such periods and the accompanying notes thereto.



Revenue/Net Loss

We are a development stage company and have not generated significant revenue since our inception.  For the quarters ended March 31, 2014 and 2013, we generated revenues of $425 and $88, respectively.  We commenced our user acquisition campaign in March 2013 and currently have over 1 million system users.  We define a system user as a registered account that has accessed the Oink product within the past 12 months.  We have run and continue to run many consumer acquisition programs in conjunction with our retail and gaming partners. During this initial start-up period, not all users have made a purchase, and some have made more than one purchase.  As we add additional retailers and in particular, online gaming companies, we anticipate that our transaction volume will increase.  Additionally, the addition of the Discover Card program in 2014 is also expected to increase our transaction volume.  We earn revenue by charging a percentage to the merchant for each transaction processed through such merchants using the Oink product.  In 2013, we added online gaming sites which have generated repeat transactions from gaming users.

Our net loss increased $3.1 million to $5.7 million for the quarter ended March 31, 2014 compared to $2.7 million for the quarter ended March 31, 2013, as a result of increased expenses as further described below.
 
Sales and Marketing Expenses

Sales and marketing expenses increased by $0.3 million, or 34% in the quarter ended March 31, 2014 to $1.2 million compared with $0.9 million in the prior year period. During 2014, we expanded the size of our sales and marketing team in the United States and Europe to help increase our merchant base and to continue our user acquisition campaign.  We commenced that campaign in March 2013 and incur costs for targeted advertising and promotions to achieve additional user sign-ups. We additionally increased costs to rebrand our product to Oink and to promote our product to the target market.

Product Development

Product development expenses increased by $0.4 million, or 92% in the quarter ended March 31, 2014 to $0.9 million compared with $0.5 million in the prior year period. During 2014, we expanded the size of our product development team in the United States and Europe to develop and build our new mobile applications.

Integration and Customer Support

Integration and customer support expenses increased by $0.1 million, or 57% in the quarter ended March 31, 2014 to $0.2 million compared with $0.1 million in the prior year period. We added additional personnel to integrate our product with our merchants, and hired personnel to provide customer support.

General and Administrative Expenses

General and administrative expenses increased by $0.2 million, or 18% in the quarter ended March 31, 2014 to $1.3 million compared with $1.1 million in the prior year period. During 2014, added several support staff in line with the growth of the Company and increased the size of our offices with related increases in rent expense.  
 

Strategic Consulting Expenses

Strategic consulting expenses decreased by $0.2 million, or 100% in the quarter ended March 31, 2014 to $0 compared with $176,794 in the prior year period. During 2013, we engaged various consultants to advise the Company and compensated them in the form of cash and stock options.  During 2014, we did not have any strategic consulting contracts in the first quarter.

Change in Fair Value of Embedded Derivative Liability

As described in Note 7 to the financial statements, in January 2014, the Company, pursuant to a Securities Purchase Agreement issued in a private placement to certain accredited investors 50,450 shares of the Company’s Series A Cumulative Convertible Preferred Stock at an original issue price of $100 per and warrants to purchase 5,045,000 shares of the Company’s common stock for an aggregate purchase price of $5,045,000. The conversion feature of the Preferred Stock is an embedded derivative, which is classified as a liability and was valued as a beneficial conversion feature at a fair market value of $1,648,825 at January 27, 2014 and $3,834,200 at March 31, 2014. This was classified as an embedded derivative liability and a discount to Preferred Stock.
 
For the quarter ended March 31, 2014, the Company recorded a non-cash charge of $2.2 million for the change in the value of these embedded derivative liabilities.
 
Liquidity and Capital Resources

Net cash used in operating activities increased $1.3 million to $4.0 million for the three months ended March 31, 2014 as compared to $2.7 million for the three months ended March 31, 2013.  The increase resulted primarily from expanded operations including marketing the Oink product, hiring employees and establishing the infrastructure of the Company.

Net cash used in investing activities was $0.1 million for three months ended March 31, 2014, materially unchanged from the $0.1 million for the three months ended March 31, 2013.  

Net cash provided by financing activities increased $5.6 million to $6.5 million for the three months ended March 31, 2014 from $0.8 million for the three months ended March 31, 2013.  Cash provided by financing activities during the three months ended March 31, 2014 consisted of the issuance of shares of common stock and warrants, netting $5.5 million, offset by the re-payment of our $1.0 million bridge loan.

Subsequent to March 31, 2014, additional cash was provided from financing activities as described below.

In April 2014, the Company, pursuant to the Purchase Agreement described in Note 7, issued in a private placement to certain accredited investors an additional 58,150 shares of the Series A Preferred Shares at an original issue price of $100 per share and warrants to purchase 5,815,000 shares of the Company’s common stock for an aggregate purchase price of $5,815,000.

As of April 30, 2014, we had cash resources of approximately $8.4 million.  As we have not realized significant revenues since our inception, we have financed our operations through public and private offerings of debt and equity securities.  We do not currently maintain a line of credit or term loan with any commercial bank or other financial institution.  
 
 
Since our inception, we have focused on developing and implementing our business plan.  We believe that our existing cash resources will not be sufficient to sustain our operations during the next twelve months.  We currently need to generate sufficient revenues to support our cost structure to enable us to pay ongoing costs and expenses as they are incurred, finance the continued development of Oink, and execute the business plan.  If we cannot generate sufficient revenue to fund our business plan, we intend to raise such financing through the sale of debt and/or equity securities.  The issuance of additional equity would result in dilution to existing shareholders.  If we are unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to us, we will be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.
 
Even if we are successful in generating sufficient revenue or in raising sufficient capital in order to complete the marketing of Oink, our ability to continue in business as a viable going concern can only be achieved when our revenues reach a level that sustains our business operations. We raised approximately $8.3 million through sales of common stock and warrants, in addition to a bridge loan, in 2013, and $12.3 million in 2014 as of April 30, 2014, net of repayment of the bridge loan.  The Oink product was introduced to the marketplace in the third quarter of 2011.   We do not project that significant revenue will be developed until late 2014. There can be no assurance that we will raise sufficient proceeds, or any proceeds, for us to implement fully our proposed business plan to aggressively develop, complete, and market our Oink product.  Moreover there can be no assurance that even if our Oink product is marketed effectively and we achieve our user acquisition goals, that we will generate revenues sufficient to fund our operations.  In either such situation, we may not be able to continue our operations and our business might fail.

The foregoing forward-looking information was prepared by us in good faith based upon assumptions that we believe to be reasonable. No assurance can be given, however, regarding the attainability of the projections or the reliability of the assumptions on which they are based. The projections are subject to the uncertainties inherent in any attempt to predict the results of our operations, especially where new products and services are involved. Certain of the assumptions used will inevitably not materialize and unanticipated events will occur. Actual results of operations are, therefore, likely to vary from the projections and such variations may be material and adverse to us. Accordingly, no assurance can be given that such results will be achieved. Moreover due to changes in technology, new product announcements, competitive pressures, system design and/or other specifications we may be required to change the current plans for our Oink products.

Contractual Obligations

At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:
 
2014
 
$
293,696
 
2015
   
300,194
 
2016
   
200,696
 
   
$
794,586
 

Critical Accounting Policies

Our financial statements are impacted by the accounting policies used and the estimates and assumptions made by management during their preparation. A complete summary of these policies is included in Note 1 of the Notes to Financial Statements included elsewhere herein. We have identified below the accounting policies that are of particular importance in the presentation of our financial position, results of operations and cash flows and which require the application of significant judgment by management.
 
 
Stock-based Compensation

We have adopted the fair value recognition provisions Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 718. In addition, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 107 “Share-Based Payment” (“SAB 107”) in March, 2005, which provides supplemental FASB ASC 718 application guidance based on the views of the SEC. Under FASB ASC 718, compensation cost recognized includes compensation cost for all share-based payments granted beginning January 1, 2006, based on the grant date fair value estimated in accordance with the provisions of FASB ASC 718.

We have used the Black-Scholes option-pricing model to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are, expected stock price volatility, the expected pre-vesting forfeiture rate and the expected option term (the amount of time from the grant date until the options are exercised or expire).

Compensation expense for unvested options granted to non-employees in previous periods is being amortized over the term of the consulting agreement.

Revenue Recognition

In accordance with Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin No. 104, Revenue Recognition (Codified in FASB ASC 605), we will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, we will generally recognize revenue from Oink at the time of the sale of the associated product.

Recently Issued Accounting Pronouncements

Recently issued accounting pronouncements are discussed in Note 1 of the Notes to Financial Statements contained elsewhere in this report.
 
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

There have been no material changes in market risk from the information provided in “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” of the Company’s 2013 Annual Report on Form 10-K.

CONTROLS AND PROCEDURES.

As of March 31, 2014, we carried out the evaluation of the effectiveness of our disclosure controls and procedures required by Rule 13a-15(e) under the Exchange Act under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer.  Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2014, our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There has been no change in our internal control over financial reporting identified in connection with this evaluation that occurred during our fiscal quarter ended March 31, 2014 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
 
PART II – OTHER INFORMATION

LEGAL PROCEEDINGS.

On April 10, 2014, the Company was named in a law suit in superior court for the State of California from a former employee alleging wrongful termination and is asking for damages and legal fees to be paid. The Company intends to vigorously dispute the claims made by the former employee, while pursuing reasonable efforts to achieve a resolution of this matter.  At this time it is not possible for us to provide any opinion as to any ultimate outcome or any definitive estimate of the amount of loss, if any, although we do not believe that any outcome will be significant to the Company’s financial condition.
            
RISK FACTORS.
 
Investing in our common stock involves a high degree of risk. Before you invest you should carefully consider the risks and uncertainties described below and in our 2013 Form 10-K, under the caption “Risk Factors”, our Management’s Discussion and Analysis of Financial Condition and Results of Operations set forth in Item 2 of Part I of this Quarterly Report on Form 10-Q, our financial statements and related notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q and our consolidated financial statements and related notes, as well as our Management’s Discussion and Analysis of Financial Condition and Results of Operations and the other information in our 2013 Form 10-K. Readers should carefully review those risks, as well as additional risks described in other documents we file from time to time with the Securities and Exchange Commission.
 
 
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
   
None.

DEFAULTS UPON SENIOR SECURITIES.

None.

MINE SAFETY DISCLOSURES.

Not Applicable.

OTHER INFORMATION.

None.
 

EXHIBITS
   
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS
XBRL Instance Document
   
101.SCH
XBRL Taxonomy Extension Schema Document
   
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   
VIRTUAL PIGGY, INC.
       
       
       
Date:
May 12, 2014
By:
/s/ Joseph Dwyer
     
Joseph Dwyer
     
Chief Financial Officer
(Duly authorized officer and principal financial officer)
 
 
38

EX-31.1 2 ex31_1.htm EXHIBIT 31.1 ex31_1.htm
Exhibit 31.1

CERTIFICATION

I, Jo Webber, certify that:
 
 
1. 
I have reviewed this quarterly report on Form 10-Q of Virtual Piggy, Inc.;
 
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date:  May 12, 2014
By:
/s/ Jo Webber
   
Jo Webber
   
Chief Executive Officer
 
 
 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2 ex31_2.htm
Exhibit 31.2

CERTIFICATION

I, Joseph Dwyer, certify that:
 
 
1.
I have reviewed this quarterly report on Form 10-Q of Virtual Piggy, Inc.

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
  
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:  May 12, 2014
By:
/s/ Joseph Dwyer
   
Joseph Dwyer
   
Chief Financial Officer
 
 
 

 
EX-32.1 4 ex32_1.htm EXHIBIT 32.1 ex32_1.htm
Exhibit 32.1
 
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER
OF VIRTUAL PIGGY, INC.
PURSUANT TO 18 U.S.C. SECTION 1350


In connection with the Quarterly Report on Form 10-Q of Virtual Piggy, Inc. (the "Company") for the period ended March 31, 2014, as filed with the Securities and Exchange Commission (the "Report"), I, Jo Webber, Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, that:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:  May 12, 2014
/s/ Jo Webber
 
Jo Webber
 
Chief Executive Officer
 
 
 
 
 

 
 
EX-32.2 5 ex32_2.htm EXHIBIT 32.2 ex32_2.htm
Exhibit 32.2

CERTIFICATION OF
CHIEF FINANCIAL OFFICER
OF VIRTUAL PIGGY, INC.
PURSUANT TO 18 U.S.C. SECTION 1350


In connection with the Quarterly Report on Form 10-Q of Virtual Piggy, Inc. (the "Company") for the period ended March 31, 2014, as filed with the Securities and Exchange Commission (the "Report"), I, Joseph Dwyer, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, that:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

Date:  May 12, 2014
/s/ Joseph Dwyer
 
Joseph Dwyer
 
Chief Financial Officer
 
 
 
 
 
 

 
EX-101.INS 6 vpig-20140331.xml EXHIBIT 101.INS false --12-31 Q1 2014 2014-03-31 10-Q 0001437283 116589055 Accelerated Filer VIRTUAL PIGGY, INC. 2149681 1596488 1000 1285 86087 41544 46016 -1855 -19435 35318751 43820350 638516 88601 88601 65000 28000 395221 170165 65000 28000 395221 170165 131000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Advertising Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Advertising costs are expensed as incurred. Advertising costs were $53,628 and $222,847 for the three months ended March 31, 2014 and 2013 and are included in sales and marketing expenses.</div> <!--EndFragment--></div> </div> 53628 222847 124338 133698 73163 1533213 239104 1893237 49447 518565 86087 78243 28541 10129 5265 2941184 5660946 1978694 4389876 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.&nbsp;&nbsp;The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by <font style="DISPLAY: inline">accounting principles generally accepted in the United States ("</font><font style="FONT-STYLE: italic; DISPLAY: inline">U.S. GAAP</font><font style="DISPLAY: inline">")&nbsp;</font> for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements should be read in conjunction with the financial statements and notes included in the Company&#39;s Annual Report on form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission (the "SEC"). Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.</div> <!--EndFragment--></div> </div> 7371036 1752461 5376048 4108065 4108065 2355604 -1994988 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash and Cash Equivalents</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.</div> <!--EndFragment--></div> </div> 0.04 3.00 1.80 0.50 0.50 0.50 0.50 0.01 1.00 1.00 1.00 0.04 0.75 0.5 287255 5815000 8931505 37500 50000 5042287 1142588 100000 5045000 5045000 0.0001 0.0001 180000000 180000000 111396768 116589055 111396768 116589055 35288276 43818703 65371422 66871422 101417508 111396768 116589055 50450 11140 11659 -41235337 -5783036 -2683517 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Comprehensive Income</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 220 in reporting comprehensive income.&nbsp;&nbsp;Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.&nbsp;&nbsp;The Company has one item of other comprehensive loss, consisting of a foreign translation adjustment.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Concentration of Credit Risk Involving Cash</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance ("FDIC") coverage.&nbsp;&nbsp;The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.&nbsp;&nbsp;</div> <!--EndFragment--></div> </div> 38426939 3487728 2687094 20930 275000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 4 - NOTES PAYABLE</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> On December 27, 2013, the Company entered into two identical agreements with two stockholders that each include a note payable in the amount of $500,000 and two-year warrants to purchase 37,500 shares of the Company&#39;s common stock at $0.01 and two-year warrants to purchase 50,000 shares of the Company&#39;s common stock at $1.00 per share. The note payable bears interest at 10% per annum and is payable upon the earlier of:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: justify"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%"> <tr style="TEXT-ALIGN: justify"> <td style="TEXT-ALIGN: justify" valign="top" width="4%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: justify" valign="top" width="3%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> a.</div> </td> <td style="TEXT-ALIGN: justify" valign="top" width="69%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> 5 days after the sale of the Company&#39;s securities in one transaction or series of related transactions, which sale results in gross proceeds to the Company of at least $3 million;</div> </td> </tr> <tr> <td style="TEXT-ALIGN: justify" valign="top" width="4%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: justify" valign="top" width="3%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> b.</div> </td> <td style="TEXT-ALIGN: justify" valign="top" width="69%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> Upon (i) the sale or other disposition of all or substantially all of the Company&#39;s assets or (ii) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is a party other than a transaction or series of transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction continue to retain, as a result of shares in the Company held by such holders prior to such transaction, at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such transaction or series of transactions;</div> </td> </tr> </table> </div> <div style="TEXT-ALIGN: justify"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%"> <tr style="TEXT-ALIGN: justify"> <td style="TEXT-ALIGN: justify" valign="top" width="4%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: justify" valign="top" width="3%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> c.</div> </td> <td style="TEXT-ALIGN: justify" valign="top" width="69%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> February 28, 2014.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The warrants were valued at $92,470, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of .4% and expected option life of 2 years.&nbsp;&nbsp;The warrant values were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, <font style="FONT-STYLE: italic; DISPLAY: inline">Recognition</font> and are being accreted over the term of the note payable for financial statement purposes.&nbsp;&nbsp;These notes were repaid in full in January 2014 and therefore the remaining unamortized discount was fully accreted.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> During the three months ended March 31, 2014 and 2013, $86,087 and $0 of interest was accreted on the notes payable.&nbsp;&nbsp;</div> <!--EndFragment--></div> </div> 1648825 1648825 3834200 1648825 1.00 500000 500000 0.1 0.1 86087 483409 1.36 1.00 2.04 1.67 1.80 1.97 1.17 1.56 1.04 1.13 2.40 0.75 1.06 1.04 1.05 1.05 1.10 1.18 1.43 1.34 118118 346949 8389 5875 108417 18518 11671 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 10 - STOCK OPTIONS AND WARRANTS</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> During 2008, the Board of Directors ("Board") of the Company adopted the 2008 Equity Incentive Plan ("2008 Plan") that was approved by the shareholders.&nbsp;&nbsp;Under the Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company.&nbsp;&nbsp;The Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended ("Incentive Stock Options").&nbsp;&nbsp;All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options ("Non-Statutory Stock Options").&nbsp;&nbsp;As of March 31, 2014, options to purchase 14,023,330 shares of common stock have been issued and are unexercised, and 463,336 shares are available for grants under the 2008 Plan.&nbsp;&nbsp;Of the options to purchase 14,023,330 shares that have been issued and are unexercised, options to purchase 12,228,330 shares were granted to employees or persons who later became employees and options to purchase 1,795,000 shares were granted to non-employees.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> During 2013, the Board adopted the 2013 Equity Incentive Plan ("2013 Plan"), which was approved by stockholders at the 2013 annual meeting of stockholders.&nbsp;&nbsp;Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant.&nbsp;&nbsp;The 2013 Plan is intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options.&nbsp;&nbsp;All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options.&nbsp;&nbsp;As of March 31, 2014, under the 2013 Plan options to purchase 3,789,166 shares of common stock have been issued and are unexercised, and 1,210,834 shares of common stock remain available for grants under the 2013 Plan.&nbsp;&nbsp;Of the options to purchase 3,789,166 shares of common stock that have been issued and are unexercised, options to purchase 2,264,166 shares were granted to employees or persons who later became employees and 1,525,000 options to purchase&nbsp;&nbsp;shares were granted to non-employees.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The 2008 Plan and 2013 Plan are administered by the Board or its compensation committee, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the applicable Plan.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> Prior to January 1, 2014, volatility in all instances presented is the Company&#39;s estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company.&nbsp;&nbsp;Beginning January 1, 2014, volatility in all instances presented is the Company&#39;s estimate of volatility that is based on the volatility of the Company&#39;s stock history.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Employee and Non-Employee Director Grants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company&#39;s common stock at exercise prices between $0.99 and $1.05 per share.&nbsp;&nbsp;These options were valued at $62,662 fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company&#39;s common stock at exercise prices between $1.07 and $1.21 per share.&nbsp;&nbsp;These options were valued at $199,843 fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company&#39;s common stock at an exercise price of $1.36 per share.&nbsp;&nbsp;These options were valued at $728 fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2013, the Company issued an employee options to purchase 5,000 shares of the Company&#39;s common stock at an exercise price of $1.67 per share.&nbsp;&nbsp;These options were valued at $933 fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company&#39;s common stock at an exercise price of $1.56 per share.&nbsp;&nbsp;These options were valued at $74,159, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company&#39;s common stock at an exercise price of $2.16 and $2.29 per share.&nbsp;&nbsp;These options were valued at $26,954, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company&#39;s common stock at exercise prices of $2.40 and $2.92 per share.&nbsp;&nbsp;The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore&nbsp;&nbsp;&nbsp;such options have not been valued.&nbsp;&nbsp;The remaining options were valued at $129,343, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company&#39;s common stock at exercise prices of $2.00 and $2.35 per share.&nbsp;&nbsp;These options were valued at $124,392, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company&#39;s common stock at an exercise price of $1.97 per share.&nbsp;&nbsp;These options were valued at $4,500, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In November 2013, the Company issued an employee options to purchase an aggregate of 10,000 shares of the Company&#39;s common stock at an exercise price of $1.04 per share.&nbsp;&nbsp;These options were valued at $2,613, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In December 2013, the Company issued four employees options to purchase an aggregate of 255,000 shares of the Company&#39;s common stock at an exercise price of $1.13 per share.&nbsp;&nbsp;These options were valued at $65,523, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of 1.51% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In addition, in December 2013, an employee met a milestone relative to options to purchase 50,000 shares of the Company&#39;s common stock at an exercise price of $2.40 per share.&nbsp;&nbsp;These options were valued at $687, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.3%, risk free interest rate of 1.75% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2014, the Company issued 11 employees options to purchase an aggregate of 90,000 shares of the Company&#39;s common stock at an exercise price of $1.05 per share.&nbsp;&nbsp;These options were valued at $53,927, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 1.77% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2014, the Company issued two employees options to purchase an aggregate of 35,000 shares of the Company&#39;s common stock at an exercise price of $1.05 per share.&nbsp;&nbsp;These options were valued at $27,806, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 3.01% and expected option life of ten years.&nbsp;&nbsp;The options expire ten years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2014, the Company issued to one of our new board of directors members options to purchase an aggregate of 250,000 shares of the Company&#39;s common stock at an exercise price of $1.10 per share.&nbsp;&nbsp;These options were valued at $264,882, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 128.5%, risk free interest rate of 2.70% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2014, the Company issued two employees options to purchase an aggregate of 20,000 shares of the Company&#39;s common stock at an exercise price of $1.18 per share.&nbsp;&nbsp;These options were valued at $21,048, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 142.1%, risk free interest rate of 1.47% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In February 2014, the Company extended warrants previously granted to two of its executive officers, which included 1,142,588 warrants exercisable at $0.04 per share and 100,000 warrants exercisable at $.75 per share for an additional two years.&nbsp;&nbsp;The increase in fair value of this term extension was $9,228 which was expensed during the three months ended March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions: no dividend yield, expected volatility of 89.3% to 89.5%, risk free interest rate of 0.33%, and expected warrant life of 2 years.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</font></div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2014, the Company issued to an employee options to purchase an aggregate of 100,000 shares of the Company&#39;s common stock at an exercise price of $1.43 per share.&nbsp;&nbsp;These options were valued at $136,454, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 122.6%, risk free interest rate of 2.73% and expected option life of ten years.&nbsp;&nbsp;The options expire ten years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the two year vesting term.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Cumulatively and for the three months ended March 31, 2014 and 2013, the Company expensed $1,533,213, $239,104 and $133,698 relative to employee options/warrants granted.&nbsp;&nbsp;As of March 31, 2014, there was $1,594,574 of unrecognized compensation expense related to employee non-vested market-based share awards. A summary of stock option/warrant transactions for employees from January 1, 2013 to March 31, 2014 is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="96%"> <tr> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrants</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">17,258,644</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04 to $1.82</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.48</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,067,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.99 to 2.92</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.28</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified to non-employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(235,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.65 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,816,667</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.04 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.01</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/terminated</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(698,333</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.92</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.01</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2013</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,576,144</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.04 to 2.40</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.74</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">495,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1.05 to 1.43</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.03</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from non-employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">200,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(100,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.75</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/terminated</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(460,003</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.65 to 2.16</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,711,141</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04 to $2.40</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.74</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11,436,145</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">.04 to $2.30</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.49</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, March 31, 2014 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.7</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> Non-Employee Grants</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company&#39;s common stock at an exercise price of $1.00 per share.&nbsp;&nbsp;These options were valued at $441 fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the term of the agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company&#39;s common stock at exercise prices of $0.75 and $1.48 per share.&nbsp;&nbsp;130,000 of these options vested immediately and were valued at $54,228, fair value.&nbsp;&nbsp;The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 22.6%, risk free interest rate of .25% and .25%, and an expected option life of two to five years.&nbsp;&nbsp;The options expire two to five years from the date of issuance.&nbsp;&nbsp;The vested options granted, were expensed immediately.&nbsp;&nbsp;The remaining unvested options will be expensed when it is probable that the milestones will be achieved.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the Company issued to a consultant options to purchase 100,000 shares of the Company&#39;s common stock at exercise prices of $1.34 per share.&nbsp;&nbsp;These options vest over a one year period and were valued at $32,155 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.8%, risk free interest rate of .8%, and an expected option life of&nbsp;5 years<font style="FONT-WEIGHT: bold; DISPLAY: inline">.&nbsp;&nbsp;</font> The options expire five years from the date of issuance.&nbsp;&nbsp;The options will be expensed over a one year period.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company&#39;s common stock at an exercise price of $2.04 per share.&nbsp;&nbsp;These options were valued at $44,603, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted were expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company&#39;s common stock at exercise prices ranging from $3.05 to $3.28 per share.&nbsp;&nbsp;These options were valued at $51,869, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years.&nbsp;&nbsp;The options expire two years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the term of the agreement.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2013, the Company, as part of the cost of the Company&#39;s Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company&#39;s common stock at an exercise price of $1.80 per share.&nbsp;&nbsp;These warrants were valued at $409,749, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years.&nbsp;&nbsp;The warrants expire three years from the date of issuance.&nbsp;&nbsp;The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company&#39;s common stock at exercise prices ranging from $.75 to $2.61 per share.&nbsp;&nbsp;These options were valued at $124,338, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;$124,338 was expensed immediately.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company&#39;s common stock at an exercise price of $1.17 per share.&nbsp;&nbsp;These options were valued at $26,208, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the term of the agreement, which is three years.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In October 2013, the Company issued a consultant options to purchase 20,000 shares of the Company&#39;s common stock at an exercise price of $1.06 per share.&nbsp;&nbsp;These options were valued at $6,132, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2%, risk free interest rate of 1.33% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the term of the agreement, which is six months.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In November 2013, the Company issued a consultant options to purchase 100,000 shares of the Company&#39;s common stock at an exercise price of $1.04 per share.&nbsp;&nbsp;These options were valued at $26,128, fair value.&nbsp;&nbsp;The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the term of the agreement, which is one year.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On November 18, 2013, Company approved an amendment extending the term of outstanding warrants to purchase in the aggregate 8,931,505 shares of common stock of the Company at an exercise price of $0.50 per share.&nbsp;&nbsp;These warrants were scheduled to expire at various dates during 2013 and 2014 and were each extended for an additional one year period from the applicable original expiration date, with the new expiration dates ranging from December 20, 2014 to December 28, 2015. The Warrants were originally issued in private placements to accredited investors to raise additional capital during 2011 and 2012.The value of these warrant modifications was $6,540, computed by measuring the warrants immediately before and after such term extension. This was taken as a charge to operations in November 2013.&nbsp;&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock as described in Note 7.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Cumulatively and for the three months ended March 31, 2014 and March 31, 2013, the Company expensed $1,893,237, $49,447 and $73,163 relative to non-employee options/warrants granted.&nbsp;&nbsp;As of March 31, 2014, there was $73,163 of unrecognized compensation expense related to such non-vested market-based share awards.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; DISPLAY: inline">&nbsp;</font> The following table summarizes non-employee stock options/warrants of the Company from January 1, 2013 to March 31, 2014 as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,531,438</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 0.35 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.63</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,048,750</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.01 to 3.28</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.18</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,723,533</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1.80 to 3.00</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">235,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.01</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(3,005,185</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .35 to .50</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/Cancelled</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(1,405,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.00</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2013</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,128,536</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.01 to 3.28</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.98</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">50,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.13</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">10,087,287</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.49</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified to employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(200,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(5,092,287</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .35 to .50</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/Cancelled</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(410,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.60 to 2.30</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,563,536</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.11</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">18,968,537</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.08</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, March 31, 2014 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.7</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> A summary of stock option/warrant transactions for employees from January 1, 2013 to March 31, 2014 is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="96%"> <tr> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrants</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">17,258,644</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04 to $1.82</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.48</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,067,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.99 to 2.92</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.28</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified to non-employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(235,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.65 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2,816,667</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.04 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.01</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/terminated</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(698,333</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.92</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.01</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2013</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,576,144</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.04 to 2.40</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.74</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">495,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1.05 to 1.43</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.03</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from non-employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">200,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(100,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.75</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/terminated</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(460,003</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.65 to 2.16</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(0.02</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,711,141</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04 to $2.40</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.74</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11,436,145</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">.04 to $2.30</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.49</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, March 31, 2014 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.7</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> -0.07 -0.03 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Loss Per Share</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share.&nbsp;&nbsp;Because the Company reported a net loss for the three months ended March 31, 2014 and 2013, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> -19435 -17580 3834200 1648825 3834200 -2185375 -2185375 2185375 1594574 73163 2013-04-15 2013-11-18 2008-02-11 2009-04-07 2008-03-03 2008-03-03 2009-08-18 2011-01-24 2008-05-08 2009-01-26 2010-01-05 2012-04-10 2008-06-19 2008-03-08 2009-08-18 2009-06-29 2009-07-30 2010-12-02 2012-05-25 2013-05-14 2009-08-21 2010-02-22 2013-05-26 2009-09-02 2009-10-09 2010-11-19 2011-06-01 2012-05-21 2009-09-17 2009-10-16 2009-12-31 2009-12-02 2009-12-10 2008-06-19 2010-11-01 2011-12-20 0.75 0.001 1.00 0.20 0.02 0.02 0.31 0.20 0.01 0.04 0.04 0.04 0.04 0.04 0.035 0.80 0.80 1.80 0.80 0.75 0.70 0.07 1.00 0.04 0.04 0.04 0.04 0.50 1.00 0.90 0.49 2.43 0.04 0.04 0.50 0.25 0.70 0.09 0.22 0.76 0.76 0.11 0.10 0.95 0.19 0.70 0.85 0.75 0.17 0.40 0.11 0.22 0.22 0.53 0.68 0.68 0.14 0.50 0.42 0.92 0.80 0.04 0.04 0.04 0.04 0.35 0.04 0.75 0.09 1.66 1.80 0.04 0.35 0.75 1.27 0.01 0.02 0.31 2.00 1.00 1.00 0.04 0.04 0.75 0.04 0.04 0.04 0.01 0.20 0.78 0.34 1.07 100 1.27 100 1.11 1.55 1.04 3.05 0.222 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 8 - FAIR VALUE OF FINANCIAL INSTRUMENTS</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivative Liabilities</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> For purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity&#39;s own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity&#39;s own common stock.&nbsp;</div> <div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company has identified the following liabilities that are measured at fair value on a recurring basis, summarized as follows:&nbsp;</div> <div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 1</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 2</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 3</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivative liability related to fair value of beneficial conversion feature</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The following table details the approximate fair value measurements within the fair value hierarchy of the Company&#39;s derivative liabilities using Level 2 inputs:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="90%"> <tr> <td valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at January 27, 2014</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,648,825</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Change in fair value of derivative liabilities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,185,375</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> As of March 31, 2014, the beneficial conversion feature of the Preferred Stock is treated as an embedded derivative liability and changes in the fair value were recognized in earnings.&nbsp; The shares of Preferred Stock are convertible into shares of the Company&#39;s common stock, which did trade in an active securities market, therefore the embedded derivative liability was valued using the following market based inputs:</font><br /> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: center" cellspacing="0" cellpadding="0" width="80%"> <tr style="TEXT-ALIGN: center" bgcolor="#cceeff"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Closing Trading Price of Common Stock</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.45</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Series A Preferred Stock Effective Conversion Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.69</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Intrinsic value of conversion option per share</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.76</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has no assets that are measured at fair value on a recurring basis. There were no assets or liabilities measured at fair value on a non-recurring basis as of March 31, 2014 and December 31, 2013.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> The shares of Preferred Stock are convertible into shares of the Company&#39;s common stock, which did trade in an active securities market, therefore the embedded derivative liability was valued using the following market based inputs:</font><br /> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: center" cellspacing="0" cellpadding="0" width="80%"> <tr style="TEXT-ALIGN: center" bgcolor="#cceeff"> <td valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Closing Trading Price of Common Stock</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">1.45</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Series A Preferred Stock Effective Conversion Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.69</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="85%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Intrinsic value of conversion option per share</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="12%">0.76</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company has identified the following liabilities that are measured at fair value on a recurring basis, summarized as follows:&nbsp;</div> <div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 1</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 2</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 3</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivative liability related to fair value of beneficial conversion feature</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s financial instruments consist of accounts receivable, accounts payable and accrued expenses, embedded derivative and warrant liability. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities.&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 820, <font style="FONT-STYLE: italic; DISPLAY: inline">Fair Value Measurements and Disclosures</font>, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> Level 1: Quoted market prices in active markets for identical assets or liabilities</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> Level 3: Unobservable inputs that are not corroborated by market data</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> 42129 52258 739657 784152 P20Y P20Y 739657 784152 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Foreign Currency Translation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The functional currency of operations outside the U.S. is British Pounds.</div> <!--EndFragment--></div> </div> 57238 83981 -16942 -8109 12634642 1217303 1035071 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> NOTE 5 - INCOME TAXES</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> Income tax expense was $0 for the three months ended March 31, 2014 and 2013.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> As of December 31, 2013, the Company had net operating loss carry forwards approximating $39.7 million.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> As of January 1, 2014, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2014 related to unrecognized tax benefits.&nbsp;&nbsp;There has been no change in unrecognized tax benefits during the three months ended March 31, 2014, and there was no accrual for uncertain tax positions as of March 31, 2014.&nbsp;&nbsp;Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> There is no income tax benefit for the losses for the three months ended March 31, 2014 and 2013, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.&nbsp;&nbsp;Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.&nbsp;&nbsp;Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&nbsp;&nbsp;Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.&nbsp;&nbsp;Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.</div> <!--EndFragment--></div> </div> 1918987 -553194 -301789 1285 285 88 346949 228831 8900 -4325 -75000 42768 280526 59618 3464 4325 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 3 - PATENTS AND TRADEMARKS</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company continues to apply for patents and purchased the Oink trademark in November 2013.&nbsp;&nbsp;Accordingly, costs associated with the registration of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years).&nbsp;&nbsp;The trademark is also being amortized on a straight-line basis over its estimated useful life of 20 years. At March 31, 2014 and December 31, 2013, capitalized patent and trademark costs were $784,152 and $739,657.&nbsp;&nbsp;Amortization expense for patents and trademarks was $10,129 and $5,265 for the three months ended March 31, 2014 and 2013.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Patents and Trademarks</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has one issued patent with the United States Patent and Trademark Office ("USPTO"), entitled Systems and Method for Verifying the Age of an Internet User, and filed for nine provisional patents.&nbsp;&nbsp;Additionally, the Company has been issued two patents in Germany, entitled Virtual Piggy Bank and Parent Match, while the remaining patents in Germany are still pending.&nbsp;&nbsp;The Company also has patents pending in Australia, Brazil, Canada and Europe under the Patent Cooperation Treaty ("PCT").&nbsp;&nbsp;Costs associated with the registration and legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents which were determined to be 20 years.</div> <!--EndFragment--></div> </div> 632496 94280 2498 8193 20888 1502 3489 4791035 8350 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 11 - OPERATING LEASES</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> For the three months ended March 31, 2014 and 2013, total rent expense under leases amounted to $138,843 and $55,648, respectively.&nbsp;&nbsp;At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="TEXT-ALIGN: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: center" cellspacing="0" cellpadding="0" width="30%"> <tr style="TEXT-ALIGN: center" bgcolor="#cceeff"> <td valign="bottom" width="77%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 293,696</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="77%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 300,194</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="77%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2016</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px double" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px double" valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 200,696</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="77%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 794,586</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 6 - LITIGATION SETTLEMENT</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company entered into a settlement agreement with an investor in 2012, whereby the Company agreed to pay the investor a settlement of $450,000 and the investor agreed to cease trading in the Company&#39;s stock and to return warrants issued to the investor.&nbsp;&nbsp;The Company&#39;s insurance carrier agreed to reimburse the Company with respect to this litigation.&nbsp;&nbsp;Both the settlement payment and the insurance company settlement were completed in 2013.</div> <!--EndFragment--></div> </div> 2941184 5660946 3063594 5430688 3824200 3834200 89021 93654 33501647 6495978 839217 -1049479 -106375 -114612 -28324668 -4016419 -2719593 -983886 -2236476 -1489190 -2724796 -12039726 -15976372 -41215902 -5765456 -2683517 -983886 -2236476 -1489190 -2724796 -12039726 -15976372 -5765456 -43582321 -8131875 -2683517 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Adopted Accounting Pronouncements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of March 31, 2014 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company&#39;s financial statements.</div> <!--EndFragment--></div> </div> -2796983 -2278153 3489 913913 -38418919 -3487303 -2687006 794586 200696 300194 293696 138843 55648 39700000 857775 1131101 -1855 -17580 -1855 -17580 -19435 -17580 -19435 -17580 6127836 885974 461385 1366490 187039 119197 2946 23566 450000 400000 658386 170165 60783 60783 836411 54624 91745 213068 51751 22867 1648825 1648825 0.08 0.08 0.0001 0.0001 2000000 2000000 50450 50450 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> NOTE 7 - CONVERTIBLE PREFERRED STOCK</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In January 2014, the Company, pursuant to a Securities Purchase Agreement (the "Purchase Agreement"), issued to certain private investors 50,450 shares of the Company&#39;s Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") at an original issue price of $100 per share (the "Original Issue Price") and warrants to purchase 5,045,000 shares of the Company&#39;s common stock (the "Warrants") for an aggregate purchase price of $5,045,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Preferred Stock shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative.&nbsp;&nbsp;As of December 31, 2013, the Company had incurred and capitalized approximately $131,000 of costs associated with this offering, which were charged to additional paid in capital in January 2014 when the transaction was consummated.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In accordance with FASB ASC 480 and 815, the Preferred Stock has been classified as permanent equity and was valued at $3,396,175, net of the beneficial conversion feature of $1,648,825, at January 27, 2014.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The conversion feature of the Preferred Stock is an embedded derivative, which is classified as a liability in accordance with FASB ASC 815 and was valued in accordance with FASB ASC 470 as a beneficial conversion feature at a fair market value of $1,648,825 at January 27, 2014 and $3,834,200 at March 31, 2014. This was classified as an embedded derivative liability and a discount to Preferred Stock.&nbsp;&nbsp;Since the preferred stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> Because the Preferred Stock can be converted at any time, the embedded derivative is classified as a current liability at March 31, 2014.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The warrants associated with the Preferred Stock were also classified as equity, in accordance with FASB ASC 480-10-25.&nbsp;&nbsp;Therefore it is not necessary to bifurcate the warrants from the Preferred Stock.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Preferred Stock has a preference in liquidation that the holders of the Preferred Stock are to be paid out of assets available for distribution prior to holders of common stock. The Preferred Stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred Stock can be converted.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The conversion price of the Preferred Stock is currently $1.00 per share. There are no arrearages on cumulative dividends.</div> <!--EndFragment--></div> </div> 5 220908 280526 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassifications</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the 2013 and cumulative since inception statements of operations have been reclassified in order for them to be in conformity with the 2014 presentation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 23796584 900000 5045000 5045000 8300000 7500000 5800000 4836157 850000 75000 1747500 644000 75000 185000 4424449 2546143 1410342 17250 5000 2521143 7019422 176794 146259 185985 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Long-Lived Assets</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates the recoverability of its long-lived assets in accordance with FASB ASC 360 "Property, Plant, and Equipment." The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.</div> <!--EndFragment--></div> </div> 104715 139969 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, principally three to seven years. Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is included in operations.&nbsp;&nbsp;Depreciation of property and equipment was $8,389 and $5,875 for the three months ended March 31, 2014 and 2013 and is included in general and administrative expenses.</div> <!--EndFragment--></div> </div> P3Y P7Y 42768 2366419 2366419 25000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 12 - RELATED PARTY TRANSACTIONS</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the three months ended March 31, 2013, a consultant owning more than 5% of the Company was paid for consulting and travel expenses to provide strategic advice to the Company.&nbsp;&nbsp; On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year.&nbsp;&nbsp;In June 2013, this contract was terminated.&nbsp; Consulting fees paid for the three months ended March 31, 2013 were $25,000. Reimbursable business expenses of $2,946 and $23,566 were paid during the three months ended March 31, 2014 and 2013, respectively.&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;</div> <!--EndFragment--></div> </div> 1572500 1000000 852744 454378 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and Development Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In accordance with FASB ASC 730, research and development costs are expensed when incurred.&nbsp;&nbsp;Research and development costs for the three months ended March 31, 2014 and 2013 were $852,744 and $454,378.</div> <!--EndFragment--></div> </div> -35450446 -43582321 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition</font> (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale of the associated product.&nbsp;&nbsp;</div> <!--EndFragment--></div> </div> 8020 425 88 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The following table details the approximate fair value measurements within the fair value hierarchy of the Company&#39;s derivative liabilities using Level 2 inputs:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="90%"> <tr> <td valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at January 27, 2014</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,648,825</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Change in fair value of derivative liabilities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,185,375</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,834,200</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> For the three months ended March 31, 2014 and 2013, total rent expense under leases amounted to $138,843 and $55,648, respectively.&nbsp;&nbsp;At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="TEXT-ALIGN: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: center" cellspacing="0" cellpadding="0" width="30%"> <tr style="TEXT-ALIGN: center" bgcolor="#cceeff"> <td valign="bottom" width="77%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 293,696</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="77%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 300,194</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="77%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2016</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px double" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px double" valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 200,696</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="77%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="20%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 794,586</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following table summarizes non-employee stock options/warrants of the Company from January 1, 2013 to March 31, 2014 as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,531,438</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 0.35 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.63</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,048,750</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.01 to 3.28</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.18</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,723,533</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1.80 to 3.00</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">235,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.01</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(3,005,185</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .35 to .50</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/Cancelled</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(1,405,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.00</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2013</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,128,536</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.01 to 3.28</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.98</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">50,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.13</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">10,087,287</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.49</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified to employee</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(200,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(5,092,287</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .35 to .50</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/Cancelled</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(410,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" nowrap="nowrap" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.60 to 2.30</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,563,536</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.11</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, March 31, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">18,968,537</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.08</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, March 31, 2014 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.7</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Segment Information</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company is organized and operates as one operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 11278549 1197412 894647 3263914 288551 191494 P3Y P3Y P3Y P3Y P3Y P3Y P5Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P2Y 0.76 P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P2Y P3Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P10Y P5Y P5Y P10Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P2Y P3Y P5Y P5Y P5Y P5Y P2Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P2Y P2Y P5Y P10Y P5Y P5Y P10Y P5Y P2Y 0.225 0.233 0.29 0.225 0.265 0.218 0.221 0.253 0.256 0.222 0.223 0.226 0.302 0.256 1.432 0.677 0.677 1.285 1.421 1.226 0.258 0.893 0.895 0.261 0.251 0.253 0.263 0.232 0.237 0.303 0.266 0.233 0.225 0.235 0.236 0.231 0.234 0.242 0.238 Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model 0.0076 0.0078 0.0069 0.0076 0.0068 0.0049 0.0171 0.0139 0.004 0.0076 0.0131 0.0151 0.0175 0.0025 0.0133 0.0131 0.003 0.0177 0.0301 0.027 0.0147 0.0273 0.008 0.0033 0.0089 0.0088 0.0085 0.0148 0.0031 0.0161 0.0166 0.0078 0.0078 0.0084 0.0103 0.0029 0.0138 0.0135 25000000 5000000 463336 1210834 18968537 11436145 1.08 0.49 P1Y8M12D P1Y8M12D 1405000 410000 698333 460003 400000 260000 760000 2500 5000 130000 100000 1050000 5000 55000 125000 287255 210000 10000 100000 100000 200000 10000 255000 50000 20000 100000 55000 500000 90000 35000 250000 20000 100000 100000 2048750 50000 3067500 495000 235000 -200000 -235000 200000 16531438 16128536 20563536 17258644 16576144 16711141 14023330 3789166 2264166 12228330 1795000 1525000 0.63 0.98 1.11 0.48 0.74 0.74 300000 -0.01 -0.01 -0.02 0.18 0.28 0.03 0.01 0.01 -0.02 0.01 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stock-based Payments</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for stock-based compensation under the provisions of FASB ASC 718, <font style="FONT-STYLE: italic; DISPLAY: inline">Compensation-Stock Compensation</font> which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC 505 -50, Equity-Based Payments to Non-Employees ("ASC 505-50"). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid-in capital in stockholders&#39; equity over the applicable service periods.</div> <!--EndFragment--></div> </div> 0.99 1.07 2.16 2.40 3.05 2.00 0.75 1.05 1.21 2.29 2.92 3.28 2.35 2.61 6540 1.45 1.18 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Nature of the Business</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Virtual Piggy, Inc. ("the Company") is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.&nbsp;&nbsp;&nbsp;Virtual Piggy is a technology company that delivers an online ecommerce solution for the family. Its system allows parents and their children to manage, allocate funds and track their expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent&#39;s permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits. Our principal office is located in Hermosa Beach, California and in 2013 we opened an office in London, England to support the sales and marketing efforts in Europe and the development of our mobile applications.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Oink (formerly Virtual Piggy) service enables online businesses to interact and transact with the "Under 18" market in a manner consistent with the Children&#39;s Online Privacy Protection Act ("COPPA") and other similar international children&#39;s privacy laws.&nbsp;&nbsp;Oink was launched in the US in 2012 and in the European market in 2013, and now has the capability to offer and deliver gift cards.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We secure agreements with merchants, retail and gaming e-commerce platforms and payment processors, which allow us to offer our Oink service to our user base. Over 20 retailers and gaming companies are using Oink with their e-commerce systems and the Company is in the process of integrating the other signed retailers and gaming companies. The Company is continuing to add merchants. To date, the Company has over 1 million users of its system. The Company defines a system user as a registered account that has accessed the Oink service within the past 12 months.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.&nbsp;&nbsp;The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by <font style="DISPLAY: inline">accounting principles generally accepted in the United States ("</font><font style="FONT-STYLE: italic; DISPLAY: inline">U.S. GAAP</font><font style="DISPLAY: inline">")&nbsp;</font> for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements should be read in conjunction with the financial statements and notes included in the Company&#39;s Annual Report on form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission (the "SEC"). Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;Actual results could differ from these estimates.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Comprehensive Income</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 220 in reporting comprehensive income.&nbsp;&nbsp;Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.&nbsp;&nbsp;The Company has one item of other comprehensive loss, consisting of a foreign translation adjustment.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s financial instruments consist of accounts receivable, accounts payable and accrued expenses, embedded derivative and warrant liability. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities.&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 820, <font style="FONT-STYLE: italic; DISPLAY: inline">Fair Value Measurements and Disclosures</font>, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> Level 1: Quoted market prices in active markets for identical assets or liabilities</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 36pt"> Level 3: Unobservable inputs that are not corroborated by market data</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Foreign Currency Translation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The functional currency of operations outside the U.S. is British Pounds.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Concentration of Credit Risk Involving Cash</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance ("FDIC") coverage.&nbsp;&nbsp;The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash and Cash Equivalents</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, principally three to seven years. Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is included in operations.&nbsp;&nbsp;Depreciation of property and equipment was $8,389 and $5,875 for the three months ended March 31, 2014 and 2013 and is included in general and administrative expenses.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Patents and Trademarks</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has one issued patent with the United States Patent and Trademark Office ("USPTO"), entitled Systems and Method for Verifying the Age of an Internet User, and filed for nine provisional patents.&nbsp;&nbsp;Additionally, the Company has been issued two patents in Germany, entitled Virtual Piggy Bank and Parent Match, while the remaining patents in Germany are still pending.&nbsp;&nbsp;The Company also has patents pending in Australia, Brazil, Canada and Europe under the Patent Cooperation Treaty ("PCT").&nbsp;&nbsp;Costs associated with the registration and legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents which were determined to be 20 years.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Long-Lived Assets</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates the recoverability of its long-lived assets in accordance with FASB ASC 360 "Property, Plant, and Equipment." The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition</font> (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale of the associated product.&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.&nbsp;&nbsp;Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.&nbsp;&nbsp;Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&nbsp;&nbsp;Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.&nbsp;&nbsp;Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stock-based Payments</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for stock-based compensation under the provisions of FASB ASC 718, <font style="FONT-STYLE: italic; DISPLAY: inline">Compensation-Stock Compensation</font> which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC 505 -50, Equity-Based Payments to Non-Employees ("ASC 505-50"). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid-in capital in stockholders&#39; equity over the applicable service periods.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Advertising Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Advertising costs are expensed as incurred. Advertising costs were $53,628 and $222,847 for the three months ended March 31, 2014 and 2013 and are included in sales and marketing expenses.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and Development Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In accordance with FASB ASC 730, research and development costs are expensed when incurred.&nbsp;&nbsp;Research and development costs for the three months ended March 31, 2014 and 2013 were $852,744 and $454,378.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Loss Per Share</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share.&nbsp;&nbsp;Because the Company reported a net loss for the three months ended March 31, 2014 and 2013, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Start-up Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with FASB ASC 720<font style="FONT-STYLE: italic; DISPLAY: inline">,</font> start-up costs are expensed as incurred.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Segment Information</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company is organized and operates as one operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Adopted Accounting Pronouncements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of March 31, 2014 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company&#39;s financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements Not Yet Adopted</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of March 31, 2014, there were no recently issued accounting standards not yet adopted which would have a material effect on the Company&#39;s financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassifications</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the 2013 and cumulative since inception statements of operations have been reclassified in order for them to be in conformity with the 2014 presentation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Start-up Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with FASB ASC 720<font style="FONT-STYLE: italic; DISPLAY: inline">,</font> start-up costs are expensed as incurred.</div> <!--EndFragment--></div> </div> 3396175 5815000 133243 30798 1519778 -362414 6836182 -122410 230258 3529 4382 6537 6687 10142 11140 11659 50000 -50000 1113600 3246778 6222793 7065247 26300114 35318751 43820350 -983886 -3220362 -4709552 -7434348 -19474074 -35450446 -43582321 -1855 -19435 5 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 9 - STOCKHOLDERS&#39; EQUITY</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During the first quarter of 2013, the Company entered into a private placement for shares of the Company&#39;s common stock. The shares were sold at a purchase price of $.75 per share.&nbsp;&nbsp;Through March 31, 2013, 1,133,334 shares were sold resulting in proceeds of $850,000.&nbsp;&nbsp;Issuance costs related to this private placement were $60,783.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 15, 2013, the Company issued 26,521 restricted shares of the Company&#39;s common stock to five members of the Board of Directors that were valued at $49,071.&nbsp;&nbsp;In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company&#39;s common stock. These options were valued at $519,080, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted will be expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 28, 2013, the Company entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the "Offering"), with each unit being comprised of one (1) share of the Company&#39;s common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional&nbsp;&nbsp;&nbsp;&nbsp;300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company&#39;s common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,410,342.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In October 2013, an investor exercised 10,000 warrants to purchase common stock at $0.50 per share, resulting in proceeds of $5,000.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock ("Warrantholders"), pursuant to which Warrantholders who were not directors or executive officers of the Company were given the opportunity to immediately exercise all outstanding vested warrants for cash in exchange for (i) the applicable shares of common stock underlying the exercised warrant and (ii) a new two-year warrant, granting rights to acquire an equivalent number of shares of common stock as issued pursuant to the exercised warrant(s), at an exercise price of $1.00 per share (each a "Replacement Warrant"). Pursuant to the offering, the Company received aggregate cash consideration of $2,521,143 from exercised warrants to purchase 5,042,287 shares of Company common stock.</div> <div style="TEXT-ALIGN: justify; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Modification of Warrants Issued in February 2012 Private Placement and Deemed Dividend</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> Effective February 7, 2014, when the market price of our common stock was $1.18, we entered&nbsp;&nbsp;an exchange offering&nbsp;&nbsp;with certain investors in the 2011 to 2012 Private Placements to exercise their current warrants at $0.50 per share and receive a new warrant which would be convertible into the same number of common shares as the original warrant.&nbsp;&nbsp;The new warrant has an exercise price of $1.00.&nbsp;&nbsp;Many investors exercised the original warrants and received the new warrants.&nbsp;&nbsp;The Company has recognized a deemed dividend of $717,594 in the Statement of Operations for the three months ended March 31, 2014, attributable to the incremental fair value resulting from the modification of these warrants.&nbsp;&nbsp;The fair value of the new warrants was valued using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 143.2%, risk free interest rate of 0.30% and expected option life approximating two years.&nbsp;&nbsp;The warrants expire two years from the date of issuance.</div> <!--EndFragment--></div> </div> 297500 1133334 19000000 285714 2572553 14285716 625000 1500000 1436277 614286 10213474 1.00 26521 49000 58150 50450 300000 3005185 5092287 2816667 100000 750000 300000 66667 49071 100000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 13 - SUBSEQUENT EVENTS</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> In April 2014,&nbsp;the Company&nbsp;issued options to purchase 55,000 shares of common stock to various employees at an exercise price of $1.27 per share.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2014, the Company, pursuant to the Purchase Agreement described in Note 7, issued in a private placement to certain accredited investors an additional 58,150 shares of the Series A Preferred Stock at an original issue price of $100 per share and warrants to purchase 5,815,000 shares of the Company&#39;s common stock for an aggregate purchase price of $5,815,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Series A Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Series A Preferred Shares shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative.&nbsp;&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2014, the Company entered into an agreement with a consulting firm to provide strategic consulting services.&nbsp;&nbsp;In connection with that agreement, the Company issued 300,000 restricted shares of common stock and an option to purchase 500,000 shares of the Company&#39;s common stock at $1.27 per share, which will vest subject to meeting certain milestones.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 10, 2014, the Company was named in a law suit in superior court for the State of California from a former employee alleging wrongful termination and is asking for damages and legal fees to be paid. <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> The Company intends to vigorously dispute the claims made by the former employee, while pursuing reasonable efforts to achieve a resolution of this matter.&nbsp; At this time it is not possible for us to provide any opinion as to any ultimate outcome or any definitive estimate of the amount of loss, if any, although we do not believe that any outcome will be significant to the Company&#39;s financial condition.</font></div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;Actual results could differ from these estimates.</div> <!--EndFragment--></div> </div> 114818293 101792509 717594 -717594 50000 -50000 -50000 50000 P1Y 0.69 1648825 -1648825 717594 717594 717594 150631 150631 201494 201494 28382 28382 283460 283460 447975 447975 310795 310795 8825 8825 9228 P5Y P2Y 2013-01 2013-02 2013-03 2013-04 2013-05 2013-06 2013-08 2013-09 2013-11 2013-12 2013-12 2013-04 2013-01 2013-03 2013-04 2013-05 2013-05 2013-07 2013-09 2013-10 2013-11 2008-02 2013-05 2008-06 2008-08 2008-09 2008-09 2010-03 2014-03 2010-12 2014-03 2010-04 2013-05 2013-05 2014-01 2014-01 2014-02 2014-02 2014-03 2013-03 1 75 29925 30000 750000 30 104970 105000 300000 7 49993 50000 66667 1750000 175 69825 70000 250000 25 9975 10000 250000 25 9975 10000 3000000 300 119700 120000 1000000 100 39900 40000 1000000 100 39900 40000 1000000 100 39900 40000 350000 35 13965 14000 500000 50 19950 20000 500000 50 19950 20000 892858 89 35624 35713 200 79800 80000 2000000 10 74990 75000 50000 5 24995 25000 270 1352323 1352593 2705185 100000 2500000 250 99750 100000 2500000 250 99750 100000 1000000 100 39900 40000 250000 25 9975 10000 1000000 100 39900 40000 1000000 100 39900 40000 1000000 100 39900 40000 1000000 100 39900 40000 155118 519080 62662 199843 728 74159 26954 129343 124392 4500 2316 655523 687 933 1106 54228 44603 51869 409749 124338 26208 6132 26128 92470 53927 27806 264882 21048 136454 32155 1199 1199 6540 6540 9228 9228 1547925 1547925 92469 92469 504 2520639 2521143 5042287 19000000 1900 17100 1900 9625000 963 1924037 1925000 125 499875 500000 1250000 204426948 2044 7084888 7086932 7142858 714 249286 250000 287 5170308 5170595 2872553 571428 57 199943 200000 2625000 262 1049738 1050000 6642858 665 231835 232500 125000 13 49987 50000 100000 10 48990 49000 1363185 136 3312401 3312537 1080427 108 1080319 1080427 65000 6 -6 483750 48 400694 400742 150000 15 82650 82665 400000 40 399960 400000 100000 10 199960 200000 375000 38 74962 75000 111111 11 99989 100000 100000 10 99990 100000 100000 10 99990 100000 7942858 794 5559206 5560000 666667 67 499933 500000 1133334 113 849887 850000 2560 2560 2560 350000 35 297465 297500 5 3396170 3396175 50450 3 49068 49071 26521 20930 20930 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 2 - MANAGEMENT PLANS</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.&nbsp;&nbsp;The Company has incurred significant losses and experienced negative cash flow from operations during the development stage.&nbsp;&nbsp;These conditions raise substantial doubt about the Company&#39;s ability to continue as a going concern.&nbsp;&nbsp;The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Since inception, the Company has focused on developing and implementing&nbsp;its business plan.&nbsp;&nbsp;The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months. <font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> The Company currently needs to generate revenue in order to sustain its operations.&nbsp;&nbsp;In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities.&nbsp;&nbsp;The issuance of additional equity would result in dilution to existing shareholders.&nbsp;&nbsp;If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would likely be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s current monetization model is to derive a percentage of all revenues generated by online merchants using the Oink service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month.&nbsp;&nbsp;As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained.&nbsp;&nbsp;For the three months ended March 31, 2014, and for the year ended December 31, 2013, the Company raised $7.5 million net of stock issuance costs of $0.2 million, and $8.3 million net of stock issuance costs of $0.4 million, respectively, through private placements of its equity securities and from exercises of warrants. Additionally, in April 2014, the Company raised an additional $5.8 million through a private placements of its equity securities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company is in the development stage at March 31, 2014.&nbsp;&nbsp;Successful completion of the Company&#39;s development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company&#39;s cost structure.&nbsp;&nbsp;However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.</div> <!--EndFragment--></div> </div> 12500 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements Not Yet Adopted</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of March 31, 2014, there were no recently issued accounting standards not yet adopted which would have a material effect on the Company&#39;s financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 43112 43112 784247 784247 13816 3146 13816 6335 6335 759292 34372 759292 34372 2219 2219 52243 52243 918 636 918 636 10462 27899 10462 27899 46019 46019 39751 39751 107859 37506 107859 37506 1723533 10087287 1.00 1.80 3.00 0.30 0.49 395467 395567 151408 3000000 250000 1130000 0.04 2.30 0.01 3.28 0.75 0.04 0.75 0.35 0.35 0.50 0.50 0.50 0.60 1.00 2.30 0.50 0.65 2.92 2.16 50000 1000000 1.13 0.01 3.28 0.99 1.05 2.92 1.43 0.5 0.50 1.01 0.65 2.30 0.50 0.35 0.01 0.01 2.30 3.28 3.28 0.04 0.04 0.04 1.82 2.40 2.40 2000000 34500 2660685 10000 14950002 62500 xbrli:shares iso4217:USD iso4217:USD vpig:warrants iso4217:USD xbrli:shares xbrli:pure 0001437283 us-gaap:SubsequentEventMember 2014-04-01 2014-04-30 0001437283 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2014-04-01 2014-04-30 0001437283 vpig:ConsultingFirmMember us-gaap:SubsequentEventMember 2014-04-01 2014-04-30 0001437283 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2014-04-01 2014-04-30 0001437283 2014-04-01 2014-04-30 0001437283 vpig:FebruaryTwoThousandTwelveModificaitonOfPrivatePlacementOfferingMember 2014-02-01 2014-02-28 0001437283 vpig:FebruaryTwoThousandFourteenPrivatePlacementOfferingMember 2014-02-01 2014-02-28 0001437283 us-gaap:FairValueInputsLevel2Member 2014-01-28 2014-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-03-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2014-01-01 2014-03-31 0001437283 us-gaap:RetainedEarningsMember 2014-01-01 2014-03-31 0001437283 vpig:IssuanceOfSharesOfPreferredStockAndWarrantsThroughPrivatePlacementMember 2014-01-01 2014-03-31 0001437283 us-gaap:PreferredStockMember 2014-01-01 2014-03-31 0001437283 us-gaap:PreferredClassAMember 2014-01-01 2014-03-31 0001437283 vpig:ExerciseOfWarrantsTransactionFourMember 2014-01-01 2014-03-31 0001437283 us-gaap:PatentsMember 2014-01-01 2014-03-31 0001437283 us-gaap:MinimumMember vpig:FairValueOfRevaluedWarrantsMember 2014-01-01 2014-03-31 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2014-01-01 2014-03-31 0001437283 us-gaap:MinimumMember 2014-01-01 2014-03-31 0001437283 us-gaap:MaximumMember vpig:FairValueOfRevaluedWarrantsMember 2014-01-01 2014-03-31 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2014-01-01 2014-03-31 0001437283 us-gaap:MaximumMember 2014-01-01 2014-03-31 0001437283 vpig:ExerciseOfWarrantsTransactionTwoMember 2014-01-01 2014-03-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:WarrantMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MarchTwoThousandFourtteenOptionsIssuedToEmployeeMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:FebruaryTwoThousandFourteenExtensionOfWarrantTermMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:FebruaryTwoThousandFourteenOptionsIssuedToEmployeesMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:FebruaryTwoThousandFourteenOptionsIssuedToMemberOfBoardMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JanuaryTwoThousandFourteenOptionsIssuedToEmployeesTwoMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JanuaryTwoThousandFourteenOptionsIssuedToEmployeesOneMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2014-01-01 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember 2014-01-01 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:WarrantMember 2014-01-01 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember vpig:FebruaryTwoThousandFourteenExtensionOfWarrantTermMember 2014-01-01 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2014-01-01 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember vpig:FebruaryTwoThousandFourteenExtensionOfWarrantTermMember 2014-01-01 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2014-01-01 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember 2014-01-01 2014-03-31 0001437283 vpig:ConsultantAndBeneficialOwnerMember 2014-01-01 2014-03-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2014-01-01 2014-03-31 0001437283 vpig:CommonStockSubscriptionsMember 2014-01-01 2014-03-31 0001437283 us-gaap:CommonStockMember 2014-01-01 2014-03-31 0001437283 2014-01-01 2014-03-31 0001437283 us-gaap:PreferredClassAMember 2014-01-01 2014-01-31 0001437283 us-gaap:WarrantMember 2013-12-01 2013-12-27 0001437283 2013-12-01 2013-12-27 0001437283 vpig:OctoberTwoThousandThirteenWarrantsExercisedMember 2013-10-01 2013-10-31 0001437283 vpig:JulyAndAugustTwoThousandThirteenWarrantsExercisedMember 2013-07-01 2013-08-31 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedTransactionOneMember 2013-05-01 2013-06-30 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedMember 2013-05-01 2013-06-30 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionTwoMember 2013-05-01 2013-06-30 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionThreeMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionTwoMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionOneMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-01 2013-05-31 0001437283 vpig:WarrantTypeOneMember vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-01 2013-05-31 0001437283 2013-04-01 2013-06-30 0001437283 us-gaap:RestrictedStockMember vpig:AprilTwoThousandThirteenIssuanceMember 2013-04-01 2013-04-30 0001437283 vpig:AprilTwoThousandThirteenIssuanceMember 2013-04-01 2013-04-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2013-01-01 2013-12-31 0001437283 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0001437283 us-gaap:PatentsMember 2013-01-01 2013-12-31 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsAndWarrantsIssuedForServicesTwoMember 2013-01-01 2013-12-31 0001437283 us-gaap:MinimumMember vpig:FairValueOfRevaluedOptionsMember 2013-01-01 2013-12-31 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsAndWarrantsIssuedForServicesMember 2013-01-01 2013-12-31 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionTwoMember 2013-01-01 2013-12-31 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2013-01-01 2013-12-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsAndWarrantsIssuedForServicesTwoMember 2013-01-01 2013-12-31 0001437283 us-gaap:MaximumMember vpig:FairValueOfRevaluedOptionsMember 2013-01-01 2013-12-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsAndWarrantsIssuedForServicesMember 2013-01-01 2013-12-31 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionTwoMember 2013-01-01 2013-12-31 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2013-01-01 2013-12-31 0001437283 vpig:FairValueOfRevaluedWarrantsMember 2013-01-01 2013-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2013-01-01 2013-12-31 0001437283 vpig:ExerciseOfOptionsTransactionThreeMember 2013-01-01 2013-12-31 0001437283 vpig:ExerciseOfOptionsTransactionTwoMember 2013-01-01 2013-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2013-01-01 2013-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2013-01-01 2013-12-31 0001437283 vpig:TwoZeroZeroEightEquityIncentivePlanMember us-gaap:MinimumMember vpig:MarchThirtyFirstTwoThousandTwelveOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:TwoZeroZeroEightEquityIncentivePlanMember us-gaap:MaximumMember vpig:MarchThirtyFirstTwoThousandTwelveOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MarchTwoThousandThirteenOptionsIssuedToConsultantsTwoMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:NovemberTwoThousandThirteenOptionsIssuedAmendmentMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:NovemberTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OctoberTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:SeptemberTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JulyTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MayTwoThousandThirteenOptionsIssuedForPrivatePlacementMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MayTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MarchTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:AprilTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JanuaryTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:DecemberTwoThousandThirteenOptionsIssuedMilestoneMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:DecemberTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:NovemberTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:AprilTwoThousandThirteenOptionsIssuedToEmployeesTwoMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:SeptemberTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:AugustTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:JuneTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MayTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:AprilTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:JanuaryTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember vpig:FebruaryTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember 2013-01-01 2013-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2013-01-01 2013-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2013-01-01 2013-12-31 0001437283 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0001437283 2013-01-01 2013-12-31 0001437283 us-gaap:PatentsMember 2013-01-01 2013-03-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2013-01-01 2013-03-31 0001437283 vpig:QuarterOneTwoThousandThirteenIssuanceMember 2013-01-01 2013-03-31 0001437283 vpig:NonStatutoryStockOptionsMember 2013-01-01 2013-03-31 0001437283 vpig:IncentiveStockOptionsMember 2013-01-01 2013-03-31 0001437283 vpig:ConsultantAndBeneficialOwnerMember 2013-01-01 2013-03-31 0001437283 2013-01-01 2013-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2012-01-01 2012-12-31 0001437283 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsIssuedForServicesTransactionThreeMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:FairValueOfRevaluedWarrantsMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsIssuedForServicesTransactionThreeMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:FairValueOfRevaluedWarrantsMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 vpig:CommonStockSubscriptionForUnitsThroughPrivatePlacementMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockWithRespectToSettlementAgreementMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsToDischargeNotesPayableAndAccruedInterestMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockThroughPrivatePlacementTransactionTwoMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockThroughPrivatePlacementTransactionOneMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2012-01-01 2012-12-31 0001437283 vpig:ExerciseOfOptionsTransactionTwoMember 2012-01-01 2012-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2012-01-01 2012-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2012-01-01 2012-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2012-01-01 2012-12-31 0001437283 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001437283 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2012-01-01 2012-06-30 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2011-07-01 2011-08-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2011-07-01 2011-08-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2011-01-01 2011-12-31 0001437283 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2011-01-01 2011-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2011-01-01 2011-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2011-01-01 2011-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2011-01-01 2011-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2011-01-01 2011-12-31 0001437283 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0001437283 2011-01-01 2011-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2010-08-01 2010-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2010-08-01 2010-11-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2010-01-01 2010-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2010-01-01 2010-12-31 0001437283 us-gaap:RetainedEarningsMember 2010-01-01 2010-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionFourMember 2010-01-01 2010-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionThreeMember 2010-01-01 2010-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForConversionOfNotesPayableMember 2010-01-01 2010-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForRetirementOfOptionsMember 2010-01-01 2010-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2010-01-01 2010-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionTwoMember 2010-01-01 2010-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2010-01-01 2010-12-31 0001437283 vpig:ExerciseOfOptionsTransactionTwoMember 2010-01-01 2010-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2010-01-01 2010-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionTwoMember 2010-01-01 2010-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2010-01-01 2010-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2010-01-01 2010-12-31 0001437283 us-gaap:CommonStockMember 2010-01-01 2010-12-31 0001437283 2010-01-01 2010-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2009-01-01 2009-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2009-01-01 2009-12-31 0001437283 us-gaap:RetainedEarningsMember 2009-01-01 2009-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionThreeMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionFourMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionThreeMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfOptionsTransactionFourMember 2009-01-01 2009-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockFourMember 2009-01-01 2009-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockThreeMember 2009-01-01 2009-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockTwoMember 2009-01-01 2009-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionTwoMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfOptionsTransactionThreeMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfOptionsTransactionTwoMember 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2009-01-01 2009-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionTwoMember 2009-01-01 2009-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2009-01-01 2009-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2009-01-01 2009-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2009-01-01 2009-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2009-01-01 2009-12-31 0001437283 us-gaap:CommonStockMember 2009-01-01 2009-12-31 0001437283 2009-01-01 2009-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2008-05-01 2008-09-30 0001437283 2008-02-12 2014-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2008-02-11 2008-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2008-02-11 2008-12-31 0001437283 us-gaap:RetainedEarningsMember 2008-02-11 2008-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2008-02-11 2008-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockToInvestorsMember 2008-02-11 2008-12-31 0001437283 vpig:OptionsIssuedForServicesMember 2008-02-11 2008-12-31 0001437283 vpig:ExerciseOfOptionsTransactionTwoMember 2008-02-11 2008-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2008-02-11 2008-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionTwoMember 2008-02-11 2008-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2008-02-11 2008-12-31 0001437283 vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2008-02-11 2008-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2008-02-11 2008-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2008-02-11 2008-12-31 0001437283 vpig:TwoThousandEightWarrantsIssuedInPrivatePlacementMember 2008-02-11 2008-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2008-02-11 2008-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2008-02-11 2008-12-31 0001437283 us-gaap:CommonStockMember 2008-02-11 2008-12-31 0001437283 2008-02-11 2008-12-31 0001437283 2014-05-01 0001437283 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2014-04-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2014-03-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2014-03-31 0001437283 us-gaap:RetainedEarningsMember 2014-03-31 0001437283 vpig:IssuanceOfSharesOfPreferredStockAndWarrantsThroughPrivatePlacementMember 2014-03-31 0001437283 us-gaap:PreferredStockMember 2014-03-31 0001437283 us-gaap:PreferredClassAMember 2014-03-31 0001437283 us-gaap:PatentsMember 2014-03-31 0001437283 vpig:TwoZeroZeroEightEquityIncentivePlanMember vpig:OptionsIssuedToNonEmployeesMember 2014-03-31 0001437283 vpig:TwoZeroZeroEightEquityIncentivePlanMember vpig:OptionsIssuedToEmployeesMember 2014-03-31 0001437283 vpig:TwoZeroZeroEightEquityIncentivePlanMember 2014-03-31 0001437283 vpig:TwoZeroOneThreeEquityIncentivePlanMember vpig:OptionsIssuedToNonEmployeesMember 2014-03-31 0001437283 vpig:TwoZeroOneThreeEquityIncentivePlanMember vpig:OptionsIssuedToEmployeesMember 2014-03-31 0001437283 vpig:TwoZeroOneThreeEquityIncentivePlanMember 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2014-03-31 0001437283 vpig:NonStatutoryStockOptionsMember 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:WarrantMember vpig:FebruaryTwoThousandFourteenExtensionOfWarrantTermMember 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember vpig:PointZeroFourPerShareExercisePriceClassMember vpig:FebruaryTwoThousandFourteenExtensionOfWarrantTermMember 2014-03-31 0001437283 vpig:IncentiveStockOptionsMember 2014-03-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2014-03-31 0001437283 vpig:CommonStockSubscriptionsMember 2014-03-31 0001437283 us-gaap:FairValueInputsLevel2Member 2014-03-31 0001437283 us-gaap:FairValueInputsLevel1Member 2014-03-31 0001437283 us-gaap:FairValueInputsLevel3Member 2014-03-31 0001437283 us-gaap:CommonStockMember 2014-03-31 0001437283 2014-03-31 0001437283 vpig:FebruaryTwoThousandTwelveModificaitonOfPrivatePlacementOfferingMember 2014-02-28 0001437283 vpig:FebruaryTwoThousandFourteenPrivatePlacementOfferingMember 2014-02-28 0001437283 us-gaap:FairValueInputsLevel2Member 2014-01-27 0001437283 us-gaap:CommonStockMember 2014-01-27 0001437283 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2013-12-31 0001437283 us-gaap:RetainedEarningsMember 2013-12-31 0001437283 us-gaap:PatentsMember 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:NovemberTwoThousandThirteenOptionsIssuedAmendmentMember 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2013-12-31 0001437283 vpig:NonStatutoryStockOptionsMember 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2013-12-31 0001437283 vpig:IncentiveStockOptionsMember 2013-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2013-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2013-12-31 0001437283 us-gaap:CommonStockMember 2013-12-31 0001437283 2013-12-31 0001437283 vpig:AgreementTwoMember 2013-12-27 0001437283 vpig:AgreementOneMember 2013-12-27 0001437283 vpig:OctoberTwoThousandThirteenWarrantsExercisedMember 2013-10-31 0001437283 vpig:JulyAndAugustTwoThousandThirteenWarrantsExercisedMember 2013-08-31 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedTransactionOneMember 2013-06-30 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionTwoMember 2013-06-30 0001437283 vpig:WarrantTypeTwoMember vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-31 0001437283 vpig:WarrantTypeOneMember vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-31 0001437283 2013-03-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2012-12-31 0001437283 us-gaap:RetainedEarningsMember 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember 2012-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2012-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2012-12-31 0001437283 us-gaap:CommonStockMember 2012-12-31 0001437283 2012-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2011-12-31 0001437283 us-gaap:RetainedEarningsMember 2011-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2011-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2011-12-31 0001437283 us-gaap:CommonStockMember 2011-12-31 0001437283 2011-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2010-12-31 0001437283 us-gaap:RetainedEarningsMember 2010-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2010-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2010-12-31 0001437283 us-gaap:CommonStockMember 2010-12-31 0001437283 2010-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2009-12-31 0001437283 us-gaap:RetainedEarningsMember 2009-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2009-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2009-12-31 0001437283 us-gaap:CommonStockMember 2009-12-31 0001437283 2009-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2008-12-31 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2008-12-31 0001437283 us-gaap:RetainedEarningsMember 2008-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2008-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2008-12-31 0001437283 us-gaap:CommonStockMember 2008-12-31 0001437283 2008-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2008-02-10 0001437283 us-gaap:AccumulatedTranslationAdjustmentMember 2008-02-10 0001437283 us-gaap:RetainedEarningsMember 2008-02-10 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2008-02-10 0001437283 vpig:CommonStockSubscriptionsMember 2008-02-10 0001437283 us-gaap:CommonStockMember 2008-02-10 0001437283 2008-02-10 EX-101.SCH 7 vpig-20140331.xsd EXHIBIT 101.SCH 002 - Statement - Balance Sheets link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - Balance Sheets (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - CONVERTIBLE PREFERRED STOCK link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40701 - Disclosure - CONVERTIBLE PREFERRED STOCK (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40802 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Fair Value MeasurementsWithin the Fair Value Hierarchy of the Company's Derivative Liabilities using Level 2 Inputs) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40801 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on a Recurring Basis) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 308 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40201 - Disclosure - GOING CONCERN (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - INCOME TAXES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40501 - Disclosure - INCOME TAXES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 305 - Disclosure - INCOME TAXES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - LITIGATION SETTLEMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40601 - Disclosure - LITIGATION SETTLEMENT (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - MANAGEMENT PLANS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - NOTES PAYABLE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40401 - Disclosure - NOTES PAYABLE (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - OPERATING LEASES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41101 - Disclosure - OPERATING LEASES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41102 - Disclosure - OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 311 - Disclosure - OPERATING LEASES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 103 - Disclosure - PATENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40301 - Disclosure - PATENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 112 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41201 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 113 - Disclosure - SUBSEQUENT EVENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - STOCKHOLDERS' EQUITY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41301 - Disclosure - SUBSEQUENT EVENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40901 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - STOCK OPTIONS AND WARRANTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41002 - Disclosure - STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41001 - Disclosure - STOCK OPTIONS AND WARRANTS (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41003 - Disclosure - STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 310 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 008 - Statement - Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 006 - Statement - Statement of Changes in Stockholders' Equity (Deficit) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 007 - Statement - Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - Statements of Comprehensive Loss link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - Statements of Operations link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 vpig-20140331_cal.xml EXHIBIT 101.CAL EX-101.DEF 9 vpig-20140331_def.xml EXHIBIT 101.DEF EX-101.LAB 10 vpig-20140331_lab.xml EXHIBIT 101.LAB Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Debt Instrument, Unamortized Discount Debt discount Patents and trademarks, accumulated amoritization Finite-Lived Intangible Assets, Accumulated Amortization Preferred Stock, Par or Stated Value Per Share Preferred stock, par value per share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Document Type Document Type Entity Central Index Key Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Going Concern [Text Block] Management Plans [Text Block] MANAGEMENT PLANS INCOME TAXES [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Income Tax Expense (Benefit) Income tax expense Net operating loss carryforwards Operating Loss Carryforwards Operating Loss Carryforwards, Expiration Date Net operating loss carryforward expiration date Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Components of Income Tax Benefit (Provision) Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Deferred Tax Assets, Liabilities and Related Valuation Allowances Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Reconciliation of the Statutory Tax Rate to the Company's Effective Income Tax Rate Legal Matters and Contingencies [Text Block] LITIGATION SETTLEMENT LITIGATION SETTLEMENT [Abstract] Cash payment for settlement Payments for Legal Settlements Proceeds from Insurance Settlement, Operating Activities Proceeds from insurance carrier NOTES PAYABLE [Abstract] NOTES PAYABLE Debt Disclosure [Text Block] OPERATING LEASES [Abstract] Leases of Lessee Disclosure [Text Block] OPERATING LEASES Operating Leases, Rent Expense, Net Total rent expense under leases Total Operating Leases, Future Minimum Payments Due 2016 Operating Leases, Future Minimum Payments, Due in Three Years 2015 Operating Leases, Future Minimum Payments, Due in Two Years Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2014 Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Future Minimum Rental Commitments Under Non-Cancelable Operating Lease Arrangements PATENTS [Abstract] PATENTS Intangible Assets Disclosure [Text Block] Amortization of Intangible Assets Amortization expense for patents Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Asset, Useful Life Amortization period Unamortized capitalized patent costs Finite-Lived Patents, Gross Patents [Member] Schedule of Finite-Lived Intangible Assets [Table] RELATED PARTY TRANSACTIONS [Abstract] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] SUBSEQUENT EVENTS [Abstract] Subsequent Events [Text Block] SUBSEQUENT EVENTS STOCKHOLDERS' EQUITY [Abstract] STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] Consulting Firm [Member] Equity issuance, price or exercise price per security issued Series A Preferred Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Options granted Stock Issued During Period, Shares, Restricted Stock Award, Gross Restricted shares issued Subsequent Event [Line Items] Subsequent Event [Member] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] STOCK OPTIONS AND WARRANTS [Abstract] STOCK OPTIONS AND WARRANTS Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Exercisable, exercise price, September 30, 2013 Exercisable, shares, September 30, 2013 Exercisable, weighted average exercise price, September 30, 2013 Incentive Stock Options [Member] IncentiveStockOptionsMember Maximum [Member] Minimum [Member] Options Issuances In Period Private Placement Issued under Private Placements, shares Options Issuances In Period Private Placement Exercise Price Options, Issuances In Private Placement, Exercise Price. Issued under Private Placements, exercise price Options Issuances In Private Placement Weighted Average Exercise Price Options, Issuances In Private Placement, Weighted Average Exercise Price. Issued under Private Placements, weighted average exercise price Range [Axis] Range [Domain] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Life, Exercisable, September 30, 2013 (years) Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Abstract ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceAbstract Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Exercise Price Exercised, exercise price Expired/terminated, shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price Extended Expired/terminated, exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Retirement of options, shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Terminated, exercise price Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Extended ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Exercise Price Granted, exercise price Options, Issuances In Period Private Placement. Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period Reclassified from (to) non-employee, shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Other Share Increase Decrease In Period Exercise Price Reclassified from/to non-employee, exercise price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePrice Outstanding, exercise price, end of period Outstanding, exercise price, beginning of period Outstanding, shares, beginning of period Outstanding, shares, end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Option/Warrants Shares Outstanding, weighted average exercise price, beginning of period Outstanding, weighted average exercise price, end of period Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired/terminated, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Terminated, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price Reclassified from/to non-employee, weighted average exercise price Exercised, shares Issued under Private Placement, shares Issued under Private Placement, exercise price Issued under Private Placement, weighted average exercise price Expired, shares Expired, exercise price Retired, shares Retired, exercise price Reclassified from (to) employee, shares Reclassified from/to employee, exercise price Option/Warrant Shares Expired, weighted average exercise price Retired, weighted average exercise price Reclassified from/to employee, weighted average exercise price Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Summary of Stock Options and Warrant Transactions for Employees Schedule of Share-based Compensation, Nonemployee Director Stock Award Plan, Activity [Table Text Block] Summary of Non-Employee Stock Options and Warrants Change in fair value of embedded derivative liability Fair value of warrant liability as discount against Preferred Stock The fair value of dervative liability in noncash investing or financing activities. Fair value of warrants issued in exchange for services Adjustment of Warrants Granted for Services Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities Amortization of Debt Discount (Premium) Accretion of discount on notes payable Amortization of deferred costs Amortization of Financing Costs CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS - END OF PERIOD NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) Debt Conversion, Converted Instrument, Amount Fair value of warrants issued as discount for notes payable Debt Conversion, Original Debt, Amount Conversion of notes payable and accrued interest into common stock Fair value of beneficial conversion value as discount against Preferred Stock Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Fair value of common stock issued as discount for notes payable Depreciation, Depletion and Amortization Depreciation and amortization Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations EFFECT OF EXCHANGE RATE ON CASH Fair Value Of Warrant Liability Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Loss on disposal of fixed assets Income taxes paid Income Taxes Paid Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable, accrued expenses and litigation settlement Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Deposit Assets Increase (Decrease) in Insurance Settlements Receivable Insurance receivable Increase (Decrease) in Operating Assets [Abstract] (Increase) decrease in assets Increase (Decrease) in Operating Liabilities [Abstract] Increase (decrease) in liabilities Increase (Decrease) in Other Receivables Other receivable Increase (Decrease) in Prepaid Expense Prepaid expenses Deposits Interest Paid Interest paid Issuance of Stock and Warrants for Services or Claims Fair value of stock issued in exchange for services Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities Net Income (Loss) Attributable to Parent NET LOSS Noncash Investing and Financing Items [Abstract] SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES: Stock issuance costs Patent and trademark costs Payments to Acquire Intangible Assets Purchase of equipment Payments to Acquire Machinery and Equipment Preferred Stock, Accretion of Redemption Discount Accretion of discount on preferred stock as deemed distribution Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Proceeds from notes payable Proceeds from Notes Payable Proceeds from note payable - stockholders Proceeds from Related Party Debt Provision for bad debt Provision for Doubtful Accounts Repayment of note payable - stockholders Repayments of Related Party Debt Share-based Compensation Fair value of options issued in exchange for services Statement of Cash Flows [Abstract] Stock Issued Issuance of common stock for settlement of payable Costs and Expenses Total operating expenses Costs and Expenses [Abstract] OPERATING EXPENSES Earnings Per Share, Basic and Diluted BASIC AND DILUTED NET LOSS PER COMMON SHARE Embedded Derivative Gain Loss On Embedded Derivative Net General and Administrative Expense General and administrative Statements of Operations [Abstract] Interest Expense Interest expense Interest income Investment Income, Interest Payroll Labor and Related Expense NET LOSS Net Income (Loss) Available to Common Stockholders, Basic NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS Total other income (expense) Nonoperating Income (Expense) Nonoperating Income (Expense) [Abstract] OTHER INCOME (EXPENSE) Operating Income (Loss) NET OPERATING LOSS Other Cost and Expense, Operating Product development Other General Expense Integration and customer support Strategic Consulting Professional and Contract Services Expense Professional fees Professional Fees Redeemable Preferred Stock Dividends SALES Revenues Selling and Marketing Expense Sales and marketing Travel Travel and Entertainment Expense Weighted Average Number of Shares Outstanding, Basic and Diluted BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING Less: Deemed dividend distributions SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Patents and trademarks Advertising Costs, Policy [Policy Text Block] Advertising Costs Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Comprehensive Income, Policy [Policy Text Block] Comprehensive Income Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Involving Cash Earnings Per Share, Policy [Policy Text Block] Loss Per Share Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Translation Income Taxes Income Tax, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements Intangible Assets, Finite-Lived, Policy [Policy Text Block] New Accounting Pronouncements Not Yet Adopted Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Prior Period Reclassification Adjustment, Description Reclassifications Property, Plant and Equipment, Impairment [Policy Text Block] Long-Lived Assets Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Segment Reporting, Policy [Policy Text Block] Segment Information Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-based Payments Start-up Activities, Cost Policy [Policy Text Block] Start-up Costs Use of Estimates Use of Estimates, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Not Yet Adopted The policy for a new accounting pronouncement that has been issued but not yet adopted Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment, Useful Life Deemed dividend distribution in conjunction with warrant exchange offering Deemed dividend distribution in conjunction with warrant exchange offering Equity issuance date Common stock authorized in private placement, value Equity Issuance Common Shares Authorized During Period, Value. February 2014 Private Placement [Member] February Two Thousand Fourteen Private Placement Offering [Member] Modification of Warrants Issued in February 2012 [Member] February Two Thousand Twelve Modificaiton Of Private Placement Offering [Member] April 5, 2012 Private Placement [Member] April Fifth Two Thousand Twelve Private Placement [Member] April 5, 2012 Issuance [Member] April Tenth Two Thousand Twelve Issuance [Member] April 10, 2012 Issuance [Member] April 10, 2012 Issuance [Member] April Two Thousand Thirteen Issuance [Member] April 15, 2013 Issuance [Member] April Two Thousand Thirteen Issuance [Member] April Two Thousand Twelve Issuance Of Equity [Member] April 2, 2012 Issuance [Member] April 2, 2012 Issuance [Member] August Seventeenth Two Thousand Ten Issuance [Member] August Seventeenth Two Thousand Ten Issuance [Member] August 17, 2010 Issuance [Member] August Two Thousand Ten Issuance In Exchange For Option Retirements [Member] August Two Thousand Ten Issuance In Exchange For Option Retirements [Member] August 2010 Issuance in Exchange for Option Retirements [Member] Award Type [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class Of Warrant Or Right Number Of Warrants Required To Call Single Security Unit Class Of Warrant Or Right Number Of Warrants Required To Call Single Security Unit Number of warrants required to purchase one additional share common stock Common stock subscription Common Stock, Value, Outstanding Fair value common stock December Two Thousand Twelve Issuance [Member] December 2012 Issuance [Member] December 2012 Issuance [Member] December Two Zero One One Private Placement [Member] December Two Zero One One Private Placement [Member] December 2011 Private Placement [Member] Deemed Dividend Distribution In Conjunction With Warrant Exchange Offering EquityInstrumentPeriodFromIssuanceToExpiration Equity Instrument Period From Issuance To Expiration Expiration period after issuance Equity Issuance Amount Of Capital Expected To Be Raised Equity Issuance Amount Of Capital Expected To Be Raised Estimate of capital to be raised in private placement Equity Issuance Common Shares Authorized During Period Shares Common stock authorized in private placement, shares Equity Issuance, Common Shares Authorized During Period, Shares. Equity Issuance Common Shares Authorized During Period Value Development Stage Entities, Equity Issuance, Date Shares per unit Equity Issuance Number Of Shares Per Unit Equity Issuance Number Of Shares Per Unit Equity Issuance Number Of Warrants Authorized Equity Issuance Number Of Warrants Authorized Warrants authorized in private placement Equity Issuance Number Of Warrants Per Unit Equity Issuance Number Of Warrants Per Unit Warrants per unit Equity Issuance Shares Registered Equity Issuance Shares Registered Shares registered Equity Issuance Since Inception [Axis] Equity Issuance Since Inception [Axis] Equity Issuance Since Inception [Domain] Equity Issuance Since Inception [Domain] Equity Issuance Units Agreed To Be Sold Periodic Installment Amount Value Equity Issuance Units Agreed To Be Sold Periodic Installment Amount Value Installment amount Equity Issuance Units Agreed To Be Sold Remaining Amount To Be Funded Value Equity Issuance Units Agreed To Be Sold Remaining Amount To Be Funded Value Final payment to be received Equity Issued [Line Items] Equity Issued [Line Items] Expense Allowance For Placement Agent Fees Expense allowance Expense allowance for placement agent fees. February Two Thousand Eight Private Placement [Member] February Two Thousand Eight Private Placement [Member] February 2008 Private Placement [Member] February Two Thousand Fourteen Private Placement Offering [Member] February Two Thousand Twelve Modificaiton Of Private Placement Offering [Member] July And August Two Thousand Thirteen Warrants Exercised [Member] July and August 2013 Warrants Exercised [Member] July And August Two Thousand Thirteen Warrants Exercised [Member] July Fifth Two Thousand Twelve Issuance [Member] July 5th, 2012 Issuance [Member] July 5th, 2012 Issuance [Member] Q2 2011 Issuance [Member] May And June Two Thousand Thirteen Warrants Exercised [Member] May and June 2013 Warrants Exercised [Member] May And June Two Thousand Thirteen Warrants Exercised [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction One [Member] May and June 2013 Warrants Exercised Transaction One [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction One [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction Two [Member] May and June 2013 Warrants Exercised Transaction Two [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction Two [Member] May Second Two Thousand Twelve Issuance [Member] May 2, 2012 Issuance [Member] May 2, 2012 Issuance [Member] May Twenty Fifth Two Thousand Twelve Issuance [Member] May 25, 2012 Issuance [Member] May 25, 2012 Issuance [Member] May Twenty First Two Thousand Twelve Issuance [Member] May 21, 2012 Issuance [Member]. May 21, 2012 Issuance [Member] May Twenty Seventh Two Thousand Eight Private Placement [Member] May Twenty Seventh Two Thousand Eight Private Placement [Member] May 27, 2008 Private Placement [Member] May Two Thousand Thirteen Options Exercised [Member] May 2013 Options Exercised [Member] May Two Thousand Thirteen Options Exercised [Member] May Two Thousand Thirteen Options Exercised Transaction One [Member] May 2013 Options Exercised Transaction One [Member] May Two Thousand Thirteen Options Exercised Transaction One [Member] May Two Thousand Thirteen Options Exercised Transaction Three [Member] May 2013 Options Exercised Transaction Three [Member] May Two Thousand Thirteen Options Exercised Transaction Three [Member] May Two Thousand Thirteen Options Exercised Transaction Two [Member] May 2013 Options Exercised Transaction Two [Member] May Two Thousand Thirteen Options Exercised Transaction Two [Member] May Two Thousand Thirteen Securities Purchase Agreement [Member] May 2013 Securities Purchase Agreement [Member] May Two Thousand Thirteen Securities Purchase Agreement [Member] November And December Two Thousand Ten Issuance [Member] November And December Two Thousand Ten Issuance [Member] November and December 2010 Issuance [Member] November And December Two Thousand Twelve Issuance [Member] November and December 2012 Issuance [Member] November and December 2012 Issuance [Member] November Nineteenth Two Thousand Ten Issuance [Member] November Nineteenth Two Thousand Ten Issuance [Member] November 19, 2010 Issuance [Member] October Ninth Two Thousand Nine Issuance [Member] October Ninth Two Thousand Nine Issuance [Member] October 9, 2009 Issuance [Member] October Twenty First Two Thousand Nine Issuance [Member] October Twenty First Two Thousand Nine Issuance [Member] October 21, 2009 Issuance [Member] October Two Thousand Thirteen Warrants Exercised [Member] Payment Of Placement Agent Fees Placement agent fees The cash outflow for fees to the placement agent. Stock issuance costs including commisions Proceeds issuance of equity units Proceeds from Issuance or Sale of Equity Proceeds From Stock Option And Warrant Exercises Proceeds From Stock Option And Warrant Exercises Proceeds from stock option and warrant exercises Proceeds from exercise of options Proceeds from Stock Options Exercised Proceeds from Warrant Exercises Proceeds from exercise of warrants Quarter One Two Thousand Eight Issuance [Member] Quarter One Two Thousand Eight Issuance [Member] Q1 2008 Issuance [Member] Quarter One Two Thousand Nine Issuance [Member] Quarter One Two Thousand Nine Issuance [Member] Q1 2009 Issuance [Member] Quarter One Two Thousand Thirteen Issuance [Member] Quarter One Two Thousand Thirteen Issuance [Member] Q1 2013 Issuance [Member] Quarter One Two Thousand Twelve Issuance [Member] Quarter One Two Thousand Twelve Issuance [Member] Q1 2012 Issuance [Member] Quarter Three Two Thousand Eight Issuance [Member] Quarter Three Two Thousand Eight Issuance [Member] Q3 2008 Issuance [Member] Quarter Three Two Thousand Nine Issuance [Member] Quarter Three Two Thousand Nine Issuance [Member] Q3 2009 Issuance [Member] Quarter Two Two Thousand Eleven Issuance [Member] Quarter Two Two Thousand Eleven Issuance [Member] Quarter Two Two Thousand Nine Issuance [Member] Quarter Two Two Thousand Nine Issuance [Member] Q2 2009 Issuance [Member] Restricted Stock [Member] Schedule Of Equity Issued [Table] Schedule Of Equity Issued [Table] Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Warrants exercised Expired/terminated, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Options exercise prices Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Units issued Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Market price Stock Issued During Period, Shares, Issued for Cash Equity issuance, number securities issued for cash Stock Issued During Period, Shares, Issued for Noncash Consideration Number of shares issued for services Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised, shares Stock Issued During Period, Value, Issued for Cash Equity issuance, value of securities issued for cash Stock Issued During Period, Value, New Issues Issuance of shares of common stock, value Value Of Shares Committed In Agreement Value Of Shares Committed In Agreement. Value of shares covered in agreement Warrant Investor One [Member] Warrant Investor One [Member] Warrant Investor 1 [Member] Warrant Investor Two [Member] Warrant Investor Two [Member] Warrant Investor 2 [Member] Warrant Type One [Member] Warrant Type One [Member] Warrant Type Two [Member] Warrant Type Two [Member]. October 2013 [Member] October Two Thousand Thirteen Warrants Exercised [Member] December 2013 Options Issued to Employee [Member] December Two Thousand Thirteen Options Issued Milestone [Member] December 2013 Options Issued to Employees [Member] DecemberTwoThousandThirteenOptionsIssuedToEmployeesMember December Two Thousand Thirteen Options Issued To Employees [Member] Equity issuance date by month and year Date of issuance for equity securities of development stage entities, in CCYY-MM format. February 2014 Extension of Warrant Term [Member] February Two Thousand Fourteen Extension Of Warrant Term [Member] February 2014 Option Issued to Employees [Member] February Two Thousand Fourteen Options Issued To Employees [Member] February 2014 Options Issued to New Members of Board of Directors [Member] February Two Thousand Fourteen Options Issued To Member Of Board [Member] January 2014 Option Issued to 11 Employees [Member] January Two Thousand Fourteen Options Issued To Employees One [Member] January 2014 Options issued to 2 Employees [Member] January Two Thousand Fourteen Options Issued To Employees Two [Member] Share-based compensation Allocated Share-based Compensation Expense April First Two Thousand Twelve Options Issued To Consultants [Member] April First Two Thousand Twelve Options Issued To Consultants [Member] April 1, 2012 Options Issued to Consultants [Member] April Two Thousand Thirteen Options Issued To Consultants [Member] April 2013 Options Issued To Consultants [Member] April Two Thousand Thirteen Options Issued To Consultants [Member] April Two Thousand Thirteen Options Issued To Employees [Member] April 2013 Options Issued To Employees [Member] April Two Thousand Thirteen Options Issued To Employees [Member] April Two Thousand Thirteen Options Issued To Employees Two [Member] April 2013 Options Issued To Employees [Member] April Two Thousand Thirteen Options Issued To Employees Two [Member] April Two Thousand Twelve Options Issued To Employees [Member] April Two Thousand Twelve Options Issued To Employees [Member] April 2012 Options Issued to Employees [Member] August Fifteenth Two Thousand Eleven Options Issued To Consultants [Member] AugustFifteenthTwoThousandElevenOptionsIssuedToConsultantsMember August 15, 2011 Options Issued to Consultants [Member] August Second Two Thousand Eleven Options Issued To Consultants [Member] AugustSecondTwoThousandElevenOptionsIssuedToConsultantsMember August 2, 2011 Options Issued to Consultants [Member] August Two Thousand Thirteen Options Issued To Employees [Member] August 2013 Options Issued To Employees [Member] August Two Thousand Thirteen Options Issued To Employees [Member] August Two Thousand Twelve Options Issued To Consultants [Member] AugustTwoThousandTwelveOptionsIssuedToConsultantsMember August 2012 Options Issued to Consultants [Member] August Two Thousand Twelve Options Issued To Employees [Member] AugustTwoThousandTwelveOptionsIssuedToEmployeesMember August 2012 Options Issued to Employees [Member] Award Type [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Warrants outstanding Class of Warrant or Right, Outstanding December Two Thousand Thirteen Options Issued Milestone [Member] December Two Thousand Thirteen Options Issued To Employees [Member] December Two Thousand Twelve Options Issued To Consultants [Member] December 2012 Options Issued To Consultants [Member] December Two Thousand Twelve Options Issued To Consultants [Member] Deferred Compensation Arrangement with Individual, Exercise Price Option exercise price Incentive Stock Options [Member] Employee Service Share Based Compensation Incremental Increase Value Represents the incremental increase in value of equity-based compensation arrangements (for example, shares of stock, units, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Incremental increase in value Unrecognized compensation expense Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Equity Issuance Date 2 February Twenty Eighth Two Thousand Twelve Options Issued To Employees [Member] FebruaryTwentyEighthTwoThousandTwelveOptionsIssuedToEmployeesMember February 28, 2012 Options Issued to Employees [Member] February Two Thousand Fourteen Extension Of Warrant Term [Member] February Two Thousand Fourteen Options Issued To Employees [Member] February Two Thousand Fourteen Options Issued To Member Of Board [Member] February Two Thousand Thirteen Options Issued To Employees [Member] February Two Thousand Thirteen Options Issued To Employees [Member] February 2013 Options Issued to Employees [Member] January Second Two Thousand Twelve Options Issued To Consultants [Member] JanuarySecondTwoThousandTwelveOptionsIssuedToConsultantsMember January 2, 2012 Options Issued to Consultants [Member] January Seventeenth Two Thousand Twelve Options Issued To Consultants [Member] JanuarySeventeenthTwoThousandTwelveOptionsIssuedToConsultantsMember January 17, 2012 Options Issued to Consultants [Member] January Twenty Fourth Two Thousand Eleven Options Issued To Consultants [Member] JanuaryTwentyFourthTwoThousandElevenOptionsIssuedToConsultantsMember January 24, 2011 Options Issued to Consultants [Member] January Twenty Seventh Two Thousand Twelve Options Issued To Employees [Member] JanuaryTwentySeventhTwoThousandTwelveOptionsIssuedToEmployeesMember January 27, 2012 Options Issued to Employees [Member] January Two Thousand Fourteen Options Issued To Employees One [Member] January Two Thousand Fourteen Options Issued To Employees Two [Member] January Two Thousand Thirteen Options Issued To Consultants [Member] January Two Thousand Thirteen Options Issued To Consultants [Member] January 2013 Options Issued to Consultants [Member] January Two Thousand Thirteen Options Issued To Employees [Member] January Two Thousand Thirteen Options Issued To Employees [Member] January 2013 Options Issued to Employees [Member] July First Two Thousand Eleven Options Issued To Consultants [Member] JulyFirstTwoThousandElevenOptionsIssuedToConsultantsMember July 1, 2011 Options Issued to Consultants [Member] July Twenty Second Two Thousand Eleven Options Issued To Consultants [Member] JulyTwentySecondTwoThousandElevenOptionsIssuedToConsultantsMember July 22, 2011 Options Issued to Consultants [Member] July Two Thousand Thirteen Options Issued To Consultants [Member] July 2013 Options Issued To Consultants [Member] July Two Thousand Thirteen Options Issued To Consultants [Member] July Two Thousand Twelve Options Issued To Consultants [Member] July Two Thousand Twelve Options Issued To Consultants [Member] July 2012 Options Issued to Consultants [Member] July Two Thousand Twelve Options Issued To Employees [Member] JulyTwoThousandTwelveOptionsIssuedToEmployeesMember July 2012 Options Issued to Employees [Member] June Two Thousand Thirteen Options Issued To Employees [Member] June 2013 Options Issued To Employees [Member] June Two Thousand Thirteen Options Issued To Employees [Member] June Two Thousand Twelve Options Issued To Employees [Member] June Two Thousand Twelve Options Issued To Employees [Member]. June 2012 Options Issued to Employees [Member] March Fifth Two Thousand Twelve Options Issued To Employees [Member] MarchFifthTwoThousandTwelveOptionsIssuedToEmployeesMember March 5, 2012 Options Issued to Employees [Member] March Second Two Thousand Twelve Options Issued To Employees [Member] MarchSecondTwoThousandTwelveOptionsIssuedToEmployeesMember March 2, 2012 Options Issued to Employees [Member] March Thirty First Two Thousand Twelve Options Issued To Consultants [Member] MarchThirtyFirstTwoThousandTwelveOptionsIssuedToConsultantsMember March 31, 2012 Options Issued to Consultants [Member] March Thirty First Two Thousand Twelve Options Issued To Employees [Member] MarchThirtyFirstTwoThousandTwelveOptionsIssuedToEmployeesMember March 31, 2012 Options Issued to Employees [Member] March Two Thousand Eight Options Issued To Directors [Member] March Two Thousand Eight Options Issued To Directors [Member] March 2008 Options Issued to Directors [Member] March Two Thousand Fourtteen Options Issued To Employee [Member] March Two Thousand Thirteen Options Issued To Consultants [Member] March 2013 Options Issued To Consultants [Member] March Two Thousand Thirteen Options Issued To Consultants [Member] March Two Thousand Thirteen Options Issued To Consultants Two [Member] March Two Thousand Thirteen Options Issued To Employees [Member] March Two Thousand Thirteen Options Issued To Employees [Member] March 2013 Options Issued to Employees [Member] Maximum [Member] May Two Thousand Thirteen Options Issued For Private Placement [Member] May 2013 Options Issued for Private Placement [Member] May Two Thousand Thirteen Options Issued For Private Placement [Member] May Two Thousand Thirteen Options Issued To Consultants [Member] May 2013 Options Issued To Consultants [Member] May Two Thousand Thirteen Options Issued To Consultants [Member] May Two Thousand Thirteen Options Issued To Employees [Member] May 2013 Options Issued To Employees [Member] May Two Thousand Thirteen Options Issued To Employees [Member] May Two Thousand Twelve Options Issued To Consultants [Member] May Two Thousand Twelve Options Issued To Consultants [Member] May 2012 Options Issued to Consultants [Member] Minimum [Member] Non-Statutory Stock Options [Member] Non Statutory Stock Options [Member] NonStatutoryStockOptionsMember November Two Thousand Thirteen Options Issued Amendment [Member] November Two Thousand Thirteen Options Issued To Consultants [Member] November Two Thousand Thirteen Options Issued To Employees [Member] November Two Thousand Twelve Options Issued To Consultants [Member] November Two Thousand Twelve Options Issued To Consultants [Member] November 2012 Options Issued to Consultants [Member] November Two Thousand Twelve Options Issued To Employees [Member] November Two Thousand Twelve Options Issued To Employees [Member] November 2012 Options Issued to Employees [Member] October Two Thousand Thirteen Options Issued To Consultants [Member] October Two Thousand Twelve Options Issued To Consultants [Member] October Two Thousand Twelve Options Issued To Consultants [Member] October 2012 Options Issued to Consultants [Member] October Two Thousand Twelve Options Issued To Employees [Member] October Two Thousand Twelve Options Issued To Employees [Member] October 2012 Options Issued to Employees [Member] Senior Vice President of Marketing and Licensing annual compensation Officers' Compensation Options issued to employees [Member] Options issued to employees [Member] Options issued to non employees [Member] Options issued to non-employees [Member] Options issued to non-employees [Member] Point Zero Four Per Share Exercise Price Class [Member] PointZeroFourPerShareExercisePriceClassMember $.04 per Share Exercise Price Class [Member] Range [Axis] Range [Domain] Reclassification from Non-Statutory to Incentive Stock Options [Member] Reclassification From Non Statutory To Incentive Stock Options [Member] ReclassificationFromNonStatutoryToIncentiveStockOptionsMember Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] September Two Thousand Thirteen Options Issued To Consultants [Member] September 2013 Options Issued To Consultants [Member] September Two Thousand Thirteen Options Issued To Consultants [Member] September Two Thousand Thirteen Options Issued To Employees [Member] September 2013 Options Issued To Employees [Member] September Two Thousand Thirteen Options Issued To Employees [Member] September Two Thousand Twelve Options Issued To Consultants [Member] SeptemberTwoThousandTwelveOptionsIssuedToConsultantsMember September 2012 Options Issued to Consultants [Member] September Two Thousand Twelve Options Issued To Employees [Member] SeptemberTwoThousandTwelveOptionsIssuedToEmployeesMember September 2012 Options Issued to Employees [Member] Share Based Compensation Arrangement By Share Based Grantee Ownership Percentage Of Shares Outstanding Considered In Determination Of Discount From Market Price Offering Date ShareBasedCompensationArrangementByShareBasedGranteeOwnershipPercentageOfSharesOutstandingConsideredInDeterminationOfDiscountFromMarketPriceOfferingDate Grantee ownership percentage considered in determination of options exercise price Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date Percent of fair market value of common stock the exercise price of options may not exceed Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date When Grantee Ownership Percentage Exceeds Ten Percent ShareBasedCompensationArrangementByShareBasedPercentOfStockMarketPriceExercisePriceMayNotExceedWhenGranteeHoldsGreaterThanTenPercentSharesOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Warrants vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value Value of vested warrants Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Options, expiration period Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk free rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk free rate, minimum Options authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Options available to be issued Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Grants In Period Aggregate options issued The aggregate net number of share options (or share units) granted during the period which includes options excluded from valuation due to their vesting being predicated upon certain conditions per the agreement. Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Excluded In Valuation Options issued, excluded from valuation Net number of share options (or share units) granted during the period which are excluded from valuation due to their vesting being contingent upon certain conditions per agreement. Outstanding options Incremental cost charged to expense Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost Share Based Compensation Arrangement By Share Based Payment Award Warrants Issued In Period Percent of fair market value of common stock the exercise price may not exceed, when grantee holds greater than 10% shares outstanding Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Minimum option exercise price Maximum option exercise price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost Value of warrant modifications Fair value of equity issued in exchange for products/services Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity Two Thousand Eight Warrants Issued In Private Placement [Member] TwoThousandEightWarrantsIssuedInPrivatePlacementMember 2008 Warrants Issued in Private Placement [Member] Two Zero One Three Equity Incentive Plan [Member] Two Zero One Three Equity Incentive Plan [Member] 2013 Equity Incentive Plan [Member] Two Zero Zero Eight Equity Incentive Plan [Member] TwoZeroZeroEightEquityIncentivePlanMember 2008 Equity Incentive Plan [Member] Warrants to Purchase Common Stock [Member] Zero Point Seven Five Per Share Exercise Price Class [Member] ZeroPointSevenFivePerShareExercisePriceClassMember $.75 per Share Exercise Price Class [Member] March 2014 Option Issued to Employee [Member] March Two Thousand Fourtteen Options Issued To Employee [Member] March 2013 Options Issued To Consultant [Member] March Two Thousand Thirteen Options Issued To Consultants Two [Member] November 2013 Options Issued Amendment [Member] November Two Thousand Thirteen Options Issued Amendment [Member] November 2013 Options Issued to Consultants [Member] November Two Thousand Thirteen Options Issued To Consultants [Member] November 2013 Options Issued to Employee [Member] November Two Thousand Thirteen Options Issued To Employees [Member] October 2013 Options Issued to Consultant [Member] October Two Thousand Thirteen Options Issued To Consultants [Member] Warrants issued Number of warrant instruments newly issued under a share-based compensation plan. Deemed dividend distribution in conjunction with warrant exchange offering Deemed dividend distribution in conjunction with warrant exchange offering. Common stock subscription for 62,500 units through private placement at $.80 per unit Value of common stock subscriptions for 62,500 units through private placement at $.80 per unit. Deemed dividend distribution in conjunction with Preferred Series A offering Deemed dividend distribution in conjunction with Preferred Series A offering Employee options issued for services from January 2012 through December 2013, vested over 3 years and valued from $0.50 to $0.92 per share Employee options issued for services from January 2012 through December 2013, vested over 3 years and valued from $0.50 to $0.92 per share Employee options issued for services on January 2014 through March 31, 2014, vesting over two to three years and valued at $1.05 to $1.43 per share Employee options issued for services on January 2014 through March, vesting over two to three years and valued at $1.05 to $1.43 per share. Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $0.11 to $0.80 per share Employee options issued for services on January 2012 through December 31, 2012, vesting over three years and valued at $0.11 to $0.80 per share. Employee options issued for services on January 2013 through December 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share Employee options issued for services on January 2013 through September 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share. Exercise of options on May 8, 2008, at $.04 per share, values Exercise of options at $0.75 per share in March 2014, value Exercise of options at $0.75 per share in March 2014 Exercise of warrants at $0.50 per share in March 2014, shares Exercise of warrants at $0.50 per share in March 2014 Exercise of warrants at $0.50 per share in March 2014, value Exercise of warrants at $0.50 per share in March 2014 Exercise of options at $0.75 per share in March 2014, shares Exercise of options at $0.75 per share in March 2014 Fair value of revalued options $1.07 per share. Fair value of revalued options $1.07 per share Fair value of revalued warrants at $0.78 per share Fair value of revalued warrants at $0.78 per share. Fair value of revalued warrants at $0.22 to$ 0.76 per share Fair value of revalued warrants at $0.22 to$ 0.76 per share Fair value of warrants issued with notes payable Fair value of warrants issued with notes payable. Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share, shares Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares. Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, value. Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, values Issuance of shares of common stock in conjunction with notes payable from September through December 2011, shares Issuance of shares of common stock in conjunction with notes payable in September 2011, shares Issuance of shares of common stock in conjunction with notes payable from September through December 2011, value Issuance of shares of common stock in conjunction with notes payable in September 2011, value Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares. Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, value. Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, values Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit, shares Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit Issuance of warrants in conjunction with notes payable from September through December 2011 Issuance of warrants in conjunction with notes payable in September 2011 Accumulated Translation Adjustment [Member] Cumulative Translation Adjustment [Member] Additional Paid-In Capital [Member] Adjustments to Additional Paid in Capital, Other Fair value of revalued warrants at $.09 to $.76 per share Stock issuance costs Adjustment To Additional Paid In Capital Deemed Dividend Distribution In Conjunction With Warrant Exchange Offering Balance, shares Balance, shares Common Stock Subscriptions For 62500Units Through Private Placement At 80Per Unit Common Stock Subscriptions [Member] Common Stock Subscriptions [Member]. Common Stock Subscribed [Member] Common Stock Subscriptions Receivable [Member] Common Stock Subscriptions Receivable [Member] Common Stock Subscription Receivable [Member] Deemed Dividend Distribution In Conjunction With Preferred Series AOffering Employee Options Issued For Services From January 2012 Through December 2012 Vesting Immediately And Valued At 14 To 42 Per Share Employee Options Issued For Services From January 2012 Through December 2012 Vesting Immediately And Valued At 14 To 42 Per Share Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share, values Employee Options Issued For Services From January 2012Through December 2013Vesting Over Three Years And Valued From 50To 92Per Share Employee Options Issued For Services On January 2014Through March 2014Vesting Over Two To Three Years And Valued At 105To 143Per Share Employee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 11 To 53 Per Share Employee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 11 To 53 Per Share Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values Employee Options Issued For Services On January Through December 2012Vesting Over Three Years And Valued At 11To 80Per Share Employee Options Issued For Services On January Through December 2013Vesting Over Three Years And Valued At 22To 68Per Share Employee Options Issued For Services On March 32008Vested Immediately And Valued At 02Per Share Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share. Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values Exercise Of Options At 04Per Share In May Two Thousand Thirteen Exercise of options at $0.04 per share in May 2013, value Exercise of options at $0.04 per share in May 2013, value. Exercise Of Options At 04Per Share In May Two Thousand Thirteen Shares Exercies of options at $0.04 per share in May 2013, shares Exercies of options at $0.04 per share in May 2013, shares. Exercise Of Options At 35Per Share On May 14Two Thousand Thirteen Exercise of options at $0.35 per share on May 14, 2013, value Exercise of options at $0.35 per share on May 14, 2013, value. Exercise Of Options At 35Per Share On May 14Two Thousand Thirteen Shares Exercise of options at $0.35 per share on May 14, 2013, shares Exercise of options at $0.35 per share on May 14, 2013, shares. Exercise Of Options At 75Per Share In May Two Thousand Thirteen Exercise of options at $0.75 per share in May 2013, value Exercise of options at $0.75 per share in May 2013, value Exercise Of Options At 75Per Share In May Two Thousand Thirteen Shares Exercise of options at $0.75 per share in May 2013, shares Exercise of options at $0.75 per share in May 2013, shares. Exercise Of Options In September 2008At 04Per Share Shares Shares issued for Exercise of options in September 2008 at $.04 per share. Exercise of options in September 2008 at $.04 per share, shares Exercise Of Options In September 2008At 04Per Share Values Value of Exercise of options in September 2008 at $.04 per share. Exercise of options in September 2008 at $.04 per share, values Exercise Of Options On April 102012At 04Per Share Shares Exercise of options on April 10, 2012 at $.04 per share, shares Stock issued for Exercise of options on April 10, 2012 at $.04 per share. Exercise Of Options On April 102012At 04Per Share Values Exercise of options on April 10, 2012 at $.04 per share, values Value of Exercise of options on April 10, 2012 at $.04 per share. Exercise Of Options On December 102009At 04Per Share Shares Stock issued for Exercise of options on December 10, 2009 at $.04 per share. Exercise of options on December 10, 2009 at $.04 per share, shares Exercise Of Options On December 102009At 04Per Share Values Value of Exercise of options on December 10, 2009 at $.04 per share. Exercise of options on December 10, 2009 at $.04 per share, values Exercise Of Options On December 22010At 04Per Share Shares Stock issued for Exercise of options on December 2, 2010 at $.04 per share. Exercise of options on December 2, 2010 at $.04 per share, shares Exercise Of Options On December 22010At 04Per Share Values Value of Exercise of options on December 2, 2010 at $.04 per share. Exercise of options on December 2, 2010 at $.04 per share, values Exercise Of Options On January 262009At 04Per Share Shares Shares issued for Exercise of options on January 26, 2009 at $.04 per share. Exercise of options on January 26, 2009 at $.04 per share, shares Exercise Of Options On January 262009At 04Per Share Values Value of Exercise of options on January 26, 2009 at $.04 per share. Exercise of options on January 26, 2009 at $.04 per share, values Exercise Of Options On January 52010At 04Per Share Shares Stock issued for Exercise of options on January 5, 2010 at $.04 per share. Exercise of options on January 5, 2010 at $.04 per share, shares Exercise Of Options On January 52010At 04Per Share Values Value of Exercise of options on January 5, 2010 at $.04 per share. Exercise of options on January 5, 2010 at $.04 per share, values Exercise Of Options On July 302009At 04Per Share Shares Stock issued for Exercise of options on July 30, 2009 at $.04 per share. Exercise of options on July 30, 2009 at $.04 per share, shares Exercise Of Options On July 302009At 04Per Share Values Value of Exercise of options on July 30, 2009 at $.04 per share. Exercise of options on July 30, 2009 at $.04 per share, values Exercise Of Options On May 252012At 04Per Share Shares Exercise of options on May 25, 2012 at $.04 per share, shares Exercise of options on May 25, 2012 at $.04 per share, shares Exercise Of Options On May 252012At 04Per Share Values Exercise of options on May 25, 2012 at $.04 per share, values Value of Exercise of options on May 25, 2012 at $.04 per share. Exercise Of Options On May 82008At 04Per Share Shares Stock issued for Exercise of options on May 8, 2008 at $.04 per share. Exercise of options on May 8, 2008, at $.04 per share, shares Exercise Of Options On May 82008At 04Per Share Values Value of Exercise of options on May 8, 2008 at $.04 per share. Exercise Of Options On September 22009At 04Per Share Shares Stock issued for Exercise of options on September 2, 2009 at $.04 per share. Exercise of options on September 2, 2009 at $.04 per share, shares Exercise Of Options On September 22009At 04Per Share Values Value of Exercise of options on September 2, 2009 at $.04 per share. Exercise of options on September 2, 2009 at $.04 per share, values Exercise Of Warrant On February 222010At 04Per Share Shares Stock issued for Exercise of warrant on February 22, 2010 at $.04 per share. Exercise of warrant on February 22, 2010 at $.04 per share, shares Exercise Of Warrant On February 222010At 04Per Share Values Value of Exercise of warrant on February 22, 2010 at $.04 per share. Exercise of warrant on February 22, 2010 at $.04 per share, values Exercise Of Warrants At 04Per Share On May 26Two Thousand Thirteen Exercise of warrants at $0.04 per share on May 26, 2013, value Exercise of warrants at $0.04 per share on May 26, 2013, value. Exercise Of Warrants At 04Per Share On May 26Two Thousand Thirteen Shares Exercise of warrants at $0.04 per share on May 26, 2013, shares Exercise of warrants at $0.04 per share on May 26, 2013, shares. Exercise Of Warrants At 05Per Share In March Two Thousand Fourteen Exercise Of Warrants At 05Per Share In March Two Thousand Fourteen Shares Exercise Of Warrants At 05Per Share In March Two Thousand Fourteen Value Exercise Of Warrants At 50Per Share In May Through August Two Thousand Thirteen Exercise of warrants at $0.50 per share in May through August 2013, value Exercise of warrants at $0.50 per share in May through August 2013, value. Exercise Of Warrants At 50Per Share In May Through August Two Thousand Thirteen Shares Exercise of warrants at $0.50 per share in May through August 2013, shares Exercise of warrants at $0.50 per share in May through August 2013, shares. Exercise Of Warrants At 75Per Share In March Two Thousand Fourteen Shares Exercise Of Warrants In April 2010At 04Per Share Shares Stock issued for Exercise of warrants in April 2010 at $.04 per share. Exercise of warrants in April 2010 at $.04 per share, shares Exercise Of Warrants In April 2010At 04Per Share Values Value of Exercise of warrants in April 2010 at $.04 per share. Exercise of warrants in April 2010 at $.04 per share, values Exercise Of Warrants In December 2010At 04Per Share Shares Stock issued for Exercise of warrants in December 2010 at $.04 per share. Exercise of warrants in December 2010 at $.04 per share, shares Exercise Of Warrants In December 2010At 04Per Share Values Value of Exercise of warrants in December 2010 at $.04 per share. Exercise of warrants in December 2010 at $.04 per share, values Exercise Of Warrants In March 2010At 04Per Share Shares Stock issued for Exercise of warrants in March 2010 at $.04 per share. Exercise of warrants in March 2010 at $.04 per share, shares Exercise Of Warrants In March 2010At 04Per Share Values Value of Exercise of warrants in March 2010 at $.04 per share. Exercise of warrants in March 2010 at $.04 per share, values Exercise Of Warrants In September 2008At 04Per Share Shares Shares issued for Exercise of warrants in September 2008 at $.04 per share. Exercise of warrants in September 2008 at $.04 per share, shares Exercise Of Warrants In September 2008At 04Per Share Values Value of Exercise of warrants in September 2008 at $.04 per share. Exercise of warrants in September 2008 at $.04 per share, values Exercise Of Warrants On August 212009At 04Per Share Shares Stock issued for Exercise of warrants on August 21, 2009 at $.04 per share. Exercise of warrants on August 21, 2009 at $.04 per share, shares Exercise Of Warrants On August 212009At 04Per Share Values Value of Exercise of warrants on August 21, 2009 at $.04 per share. Exercise of warrants on August 21, 2009 at $.04 per share, values Exercise Of Warrants On December 22009At 04Per Share Shares Stock issued for Exercise of warrants on December 2, 2009 at $.04 per share. Exercise of warrants on December 2, 2009 at $.04 per share, shares Exercise Of Warrants On December 22009At 04Per Share Values Value of Exercise of warrants on December 2, 2009 at $.04 per share. Exercise of warrants on December 2, 2009 at $.04 per share, values Exercise Of Warrants On December 312009At 04Per Share Shares Stock issued for Exercise of warrants on December 31, 2009 at $.04 per share. Exercise of warrants on December 31, 2009 at $.04 per share, shares Exercise Of Warrants On December 312009At 04Per Share Values Value of Exercise of warrants on December 31, 2009 at $.04 per share. Exercise of warrants on December 31, 2009 at $.04 per share, values Exercise Of Warrants On October 222009At 04Per Share Shares Stock issued for Exercise of warrants on October 22, 2009 at $.04 per share. Exercise of warrants on October 22, 2009 at $.04 per share, shares Exercise Of Warrants On October 222009At 04Per Share Values Value of Exercise of warrants on October 22, 2009 at $.04 per share. Exercise of warrants on October 22, 2009 at $.04 per share, values Fair Value Of Revalued Options 107Per Share Fair Value Of Revalued Options 78Per Share Fair Value Of Revalued Options At 22To 76Per Share Fair Value Of Warrants Issued With Notes Payable Issuance Of Common Stock From Exercise Of Warrants Through Warrant Exchange Offering At 50Cents Per Share Issuance Of Common Stock From Exercise Of Warrants Through Warrant Exchange Offering At 50Cents Per Share Shares Issuance Of Initial 19000000Shares On February 112008At 001Per Share Shares Shares issued for Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share. Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, shares Value of Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share. Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, values Issuance Of Initial 19000000Shares On February 112008At 001Per Share Values Issuance Of Share Of Common Stock From August Through December 2010Through Private Placement At 20Per Share Shares Stock issued for Issuance of share of common stock from August through December 2010 through private placement at $.20 per share. Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, shares Issuance Of Share Of Common Stock From August Through December 2010Through Private Placement At 20Per Share Values Value of Issuance of share of common stock from August through December 2010 through private placement at $.20 per share. Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, values Issuance Of Shares And Warrants December 2011 Private Placement Issuance Of Shares And Warrants, December 2011, Private Placement. Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, values Issuance Of Shares And Warrants December 2011 Private Placement Shares Issuance Of Shares And Warrants, December 2011, Private Placement, Shares. Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, shares Issuance Of Shares Of Common Stock And 10213474Warrants Through June 302012Through Private Placement At 70Per Unit Shares Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares Issuance Of Shares Of Common Stock And 10213474Warrants Through June 302012Through Private Placement At 70Per Unit Values Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values Issuance Of Shares Of Common Stock And 14285716Warrants In February 2008Through Private Placement At 035Per Unit Shares Shares issued in Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit. Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, shares Issuance Of Shares Of Common Stock And 14285716Warrants In February 2008Through Private Placement At 035Per Unit Values Value of Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit. Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, values Issuance Of Shares Of Common Stock And 1436277Warrants In May Two Thousand Thirteen Through Private Placement At 180Per Share Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value. Issuance Of Shares Of Common Stock And 1436277Warrants In May Two Thousand Thirteen Through Private Placement At 180Per Share Shares Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares Issuance Of Shares Of Common Stock And 285714Warrants To Discharge Notes Payable And Accrued Interest Valued At 70Per Unit Shares Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares Issuance Of Shares Of Common Stock And 285714Warrants To Discharge Notes Payable And Accrued Interest Valued At 70Per Unit Values Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values Issuance Of Shares Of Common Stock And 562500Warrants Through June 302012Through Private Placement At 80Per Unit Shares Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, shares Issuance of shares of common stock and 562,500 warrants through June 30, 2012 through private placement at $.80 per unit, shares Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, values Issuance of shares of common stock and 562,500 warrants through June 30, 2012 through private placement at $.80 per unit, values Issuance Of Shares Of Common Stock And562500 Warrants Through June302012 Through Private Placement At80 Per Unit Values Issuance Of Shares Of Common Stock And 614286Warrants In May And September 2008Through Private Placement At 75Per Unit Shares Issuance of shares for Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit. Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, shares Issuance Of Shares Of Common Stock And 614286Warrants In May And September 2008Through Private Placement At 75Per Unit Values Value of Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit. Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, values Issuance Of Shares Of Common Stock And 93750Warrants Through March 312013Through Private Placement At 80Per Unit Shares Issuance Of Shares Of Common Stock And 93750Warrants Through March 312013Through Private Placement At 80Per Unit Values Issuance Of Shares Of Common Stock And WarrantsThrough Private Placement, Shares, One. Issuance of shares of common stock and warrants through private placement, shares Issuance Of Shares Of Common Stock And Warrants Through Private Placement Shares One Issuance Of Shares Of Common Stock And Warrants Through Private Placement Value One Issuance Of Shares Of Common Stock And Warrants Through Private Placement, Value, One. Issuance of shares of common stock and warrants through private placement Issuance Of Shares Of Common Stock For Future Services On June 12011Valued At 49Per Share Shares Stock issued for Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share. Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, shares Issuance Of Shares Of Common Stock For Future Services On June 12011Valued At 49Per Share Values Value of Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share. Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, values Issuance Of Shares Of Common Stock For Future Services On May 212012Valued At 243Per Share Shares Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares Issuance Of Shares Of Common Stock For Future Services On May 212012Valued At 243Per Share Values Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values Issuance Of Shares Of Common Stock For Future Services On October 92009Valued At 100Per Share Shares Stock issued for Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share. Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, shares Issuance Of Shares Of Common Stock For Future Services On October 92009Valued At 100Per Share Values Value of Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share. Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, values Issuance Of Shares Of Common Stock For Retirement Of 400000Options At 25Per Share Shares Stock issued for Issuance of shares of common stock for retirement of 400,000 options at $.25 per share. Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, shares Issuance Of Shares Of Common Stock For Retirement Of 400000Options At 25Per Share Values Value of Issuance of shares of common stock for retirement of 400,000 options at $.25 per share. Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, values Issuance of shares of common stock in conjunction with notes payable in May through August 2010, shares Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In May Through August 2010Shares Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In May Through August 2010Values Issuance of shares of common stock in conjunction with notes payable in May through August 2010, values Stock issued for Issuance of shares of common stock in conjunction with notes payable in May through August. Value of Issuance of shares of common stock in conjunction with notes payable in May through August. Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In September 2011Shares Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In September 2011Value Issuance Of Shares Of Common Stock On April 72009At 100Per Share Shares Stock issued for Issuance of shares of common stock on April 7, 2009 at $1.00 per share. Issuance of shares of common stock on April 7, 2009 at $1.00 per share, shares Issuance Of Shares Of Common Stock On April 72009At 100Per Share Values Value of Issuance of shares of common stock on April 7, 2009 at $1.00 per share. Issuance of shares of common stock on April 7, 2009 at $1.00 per share, values Issuance Of Shares Of Common Stock On June 292009Valued At 200Per Share Shares Stock issued for Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share. Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, shares Issuance Of Shares Of Common Stock On June 292009Valued At 200Per Share Values Value of Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share. Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, values Issuance Of Shares Of Common Stock On November 12010For Conversion Of Notes Payable At 20Per Share Shares Stock issued for Issuance of shares of common stock on November 1, 2010 for the conversion of notes payable at $.20 per share. Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, shares Issuance Of Shares Of Common Stock On November 12010For Conversion Of Notes Payable At 20Per Share Values Value of Issuance of shares of common stock on November 1, 2010 for the conversion of notes payable at $.20 per share. Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, values Stock issued for Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share. Value of Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share. Issuance Of Shares Of Common Stock On November 192010For Future Services Valued At 90Per Share Shares Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, shares Issuance Of Shares Of Common Stock On November 192010For Future Services Valued At 90Per Share Values Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, values Issuance Of Shares Of Common Stock On October 162009At 100Per Share Shares Stock issued for Issuance of shares of common stock on October 16, 2009 at $1.00 per share. Issuance of shares of common stock on October 16, 2009 at $1.00 per share, shares Issuance Of Shares Of Common Stock On October 162009At 100Per Share Values Value of Issuance of shares of common stock on October 16, 2009 at $1.00 per share. Issuance of shares of common stock on October 16, 2009 at $1.00 per share, values Issuance Of Shares Of Common Stock On September 172009At 100Per Share Shares Stock issued for Issuance of shares of common stock on September 17, 2009 at $1.00 per share. Issuance of shares of common stock on September 17, 2009 at $1.00 per share, shares Issuance Of Shares Of Common Stock On September 172009At 100Per Share Values Value of Issuance of shares of common stock on September 17, 2009 at $1.00 per share. Issuance of shares of common stock on September 17, 2009 at $1.00 per share, values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70Per Share Shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70 Per Share Shares Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70Per Share Values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70 Per Share Values Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75Per Share Shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75 Per Share Shares Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75Per Share Values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75 Per Share Values Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, values Issuance Of Shares Of Common Stock Through March Thirty First Two Thousand Thirteen Through Private Placement At 75Per Share Shares Issuance Of Shares Of Common Stock Through March Thirty First Two Thousand Thirteen Through Private Placement At 75Per Share Values Issuance Of Shares Of Common Stock To Investors In August 2008At 100Per Share Shares Shares issued for Issuance of shares of common stock to investors in August 2008 at $1.00 per share. Issuance of shares of common stock to investors in August 2008 at $1.00 per share, shares Issuance Of Shares Of Common Stock To Investors In August 2008At 100Per Share Values Value of Issuance of shares of common stock to investors in August 2008 at $1.00 per share. Issuance of shares of common stock to investors in August 2008 at $1.00 per share, values Issuance Of Shares Of Common Stock With Respect To Settlement Agreement Valued At 85Per Share Shares Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, shares Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values Issuance Of Shares Of Common Stock With Respect To Settlement Agreement Valued At 85Per Share Values Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values Issuance Of Shares Of Convertible Preferred Stock And 5045000Warrants Through March Thirty First Two Thousand Fourteen Through Private Placement At 1Dollar Per Unit Issuance Of Shares Of Convertible Preferred Stock And 5045000Warrants Through March Thirty First Two Thousand Fourteen Through Private Placement At 1Dollar Per Unit Shares Issuance Of Shares On April 15Two Thousand Thirteen Common Stock For Services Issuance of shares on April 15, 2013 common stock for services, values Issuance of shares on April 15, 2013 common stock for services, value. Issuance Of Shares On April 15Two Thousand Thirteen Common Stock For Services Shares Issuance of shares on April 15, 2013 common stock for services, shares Issuance of shares on April 15, 2013 common stock for services, shares. Issuance Of Warrants In Conjunction With Notes Payable In September 2011 Net loss Nonemployee Options And Warrants Issued For Services From January 2013Through December 2013Vested Immediately To Three Years And Valued From 104To 305Per Share Nonemployee Options And Warrants Issued For Services From January 2013Through September 2013Vested Immediately To Three Years And Valued From 009To 166Per Share Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share Nonemployee options/warrants issued for services from January 2013 through September 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share. Nonemployee Options Issued For Services From August Through November 2010Vested Immediately And Valued At 01Per Share Value of Nonemployee options issued for services from August through November 2010, vested immediately and valued at $.01 per share. Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values Nonemployee Options Issued For Services From January 2012Through December 2012Vested Immediately To Three Years And Valued From 111To 155Per Share Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values Value of nonemployee options issued for services from January through June 2012 vested immediately and valued from $.11 to $.95 per share. Nonemployee Options Issued For Services From January Through June 2012Vested Immediately And Valued From 11To 95Per Share Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share, values Value of nonemployee options issued for services from July through August 2011 vested immediately and valued from $.10 to $.19 per share. Nonemployee Options Issued For Services From July Through August 2011Vested Immediately And Valued From 10To 19Per Share Nonemployee Options Issued For Services From July Through August 2011Vested Immediately And Valued From Ten To Nineteen Per Share Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share Nonemployee Options Issued For Services In June 192008Vested Immediately And Valued At 01Per Share Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share. Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values Nonemployee Options Issued For Services On August 182009Vested Immediately And Valued At 31Per Share Value of Nonemployee options issued for services on August 18, 2009, vested immediately and valued at $.31 per share. Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values Nonemployee Options Issued For Services On January 242011Vested Immediately And Valued At 20Per Share Nonemployee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 17 To 40 Per Share Nonemployee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 17 To 40 Per Share Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at$. 17 to $.40 per share, values Nonemployee Options Issued For Services On March 32008Vested Immediately And Valued At 02Per Share Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share. Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values Options Issued For Services In June 2008Vested Immediately And Valued At 07Per Share Options issued for services in June 2008, vested immediately and valued at $.07 per share. Options issued for services in June 2008, vested immediately and valued at $.07 per share, values Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Cumulative translation adjustment Preferred Stock [Member] Deficit Accumulated During the Development Stage [Member] Statement [Line Items] Statement of Changes in Stockholders' Equity (Deficit) [Abstract] Statement [Table] Balance, values Balance, values Nonemployee options issued for services from January 2012 through December 2012, vested over 3 years and valued from $1.11 to $1.55 per share Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $1.04 to $3.05 per share Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $1.04 to $3.05 per share Nonemployee options issued for services from January 2012 through December 2012, vested over 3 years and valued from $1.11 to $1.55 per share Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share Exercise Of Options Transaction Four [Member] Exercise Of Warrants Transaction Four [Member] Exercise Of Warrants Transaction Three [Member] Fair Value Of Revalued Options Two [Member] Issuance Of Shares Of Common Stock Four [Member] Issuance Of Shares Of Common Stock Three [Member] Issuance Of Shares Of Common Stock Two [Member] Issuance of Shares of Preferred Stock and Warrants Through Private Placement [Member] Issuance Of Shares Of Preferred Stock And Warrants Through Private Placement [Member] Common Stock Subscription for Units Through Private Placement [Member] Common Stock Subscription for Units Through Private Placement [Member] Employee Options Issued For Services Transaction One [Member] Employee Options Issued for Services Transaction One [Member] Employee Options Issued For Services Transaction One [Member] Employee Options Issued for Services Transaction Two [Member] Employee Options Issued for Services Transaction Two [Member] Exercise Of Options Transaction Four [Member] Exercise of Options Transaction One [Member] Exercise of Options Transaction One [Member] Exercise of Options Transaction Three [Member] Exercise of Options Transaction Three [Member] Exercise of Options Transaction Two [Member] Exercise of Options Transaction Two [Member] Exercise Of Warrants Transaction Four [Member] Exercise of Warrants Transaction One [Member] Exercise of Warrants Transaction One [Member] Exercise Of Warrants Transaction Three [Member] Exercise of Warrants Transaction Two [Member] Exercise of Warrants Transaction Two [Member] Fair Value of Revalued Options [Member] Fair Value of Revalued Options [Member] Fair Value Of Revalued Options Two [Member] Fair Value of Revalued Warrants [Member] Fair Value of Revalued Warrants [Member] Issuance Of Shares Of Common Stock And Warrants Through Private Placement [Member] Issuance of Shares of Common Stock and Warrants Through Private Placement [Member] Issuance Of Shares Of Common Stock And Warrants Through Private Placement [Member] Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member] Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member] Issuance of Shares of Common Stock for Conversion of Notes Payable [Member] Issuance of Shares of Common Stock for Conversion of Notes Payable [Member] Issuance of Shares of Common Stock for Future Services [Member] Issuance of Shares of Common Stock for Future Services [Member] Issuance of Shares of Common Stock for Retirement of Options [Member] Issuance of Shares of Common Stock for Retirement of Options [Member] Issuance of Shares of Common Stock for Services [Member] Issuance of Shares of Common Stock for Services [Member] Issuance Of Shares Of Common Stock Four [Member] Issuance Of Shares Of Common Stock [Member] Issuance of Shares of Common Stock [Member] Issuance Of Shares Of Common Stock [Member] Issuance Of Shares Of Common Stock Three [Member] Issuance of Shares of Common Stock Through Private Placement Transaction One [Member] Issuance of Shares of Common Stock Through Private Placement Transaction One [Member] Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member] Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member] Issuance of Shares of Common Stock to Investors [Member] Issuance of Shares of Common Stock to Investors [Member] Issuance of Shares of Common Stock Two [Member] Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member] Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member] Issuance Of Shares Of Preferred Stock And Warrants Through Private Placement [Member] Nonemployee Options And Warrants Issued For Services [Member] Nonemployee Options/Warrants Issued for Services [Member] Nonemployee Options and Warrants Issued for Services [Member] Nonemployee Options And Warrants Issued For Services Two [Member] Nonemployee Options Issued for Services Transaction One [Member] Nonemployee Options Issued for Services Transaction One [Member] Nonemployee Options Issued For Services Transaction Three [Member] Nonemployee Options Issued for Services Transaction Two [Member] Nonemployee Options Issued for Services Transaction Two [Member] Options Issued for Services [Member] Options Issued For Services [Member] Units Subscribed Units subscribed Units Subscribed. Nonemployee Options And Warrants Issued For Services Two [Member] Nonemployee Options Issued For Services Transaction Three [Member] Conversion of notes payable, price per share Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Accounts Receivable, Net, Current Accounts Receivable Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Cumulative translation adjustment Additional Paid in Capital Additional paid in capital TOTAL ASSETS Assets ASSETS Assets [Abstract] TOTAL CURRENT ASSETS Assets, Current CURRENT ASSETS Assets, Current [Abstract] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Commitments and Contingencies CONTINGENCIES Common stock subscribed Common Stock, Value, Subscriptions Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Common stock subscription receivable Common Stock, Value, Issued Common stock, $ .0001 par value; 180,000,000 shares authorized; 116,589,055 and 111,396,768 shares issued and outstanding at March 31, 2014 and December 31, 2013 Deposit Deposit Assets Embedded Derivative, Fair Value of Embedded Derivative Liability Embedded derivative liability Patents and trademarks, net of accumulated amortization of $52,258 and $42,129 Finite-Lived Intangible Assets, Net Furniture and fixtures Furniture and Fixtures, Gross Insurance Settlements Receivable, Current Insurance receivable Leasehold Improvements, Gross TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities and Equity [Abstract] Liabilities, Current TOTAL CURRENT LIABILITIES Liabilities, Current [Abstract] CURRENT LIABILITIES Litigation settlement Loss Contingency Accrual, at Carrying Value Computer equipment Machinery and Equipment, Gross Notes Payable, Current Notes payable, net of discount of $0 and $86,087 Total other assets Other Assets Other Assets [Abstract] OTHER ASSETS Preferred Stock, Value, Issued Preferred stock, $.0001 par value; 2,000,000 shares authorized; 50,450 shares issued and outstanding at March 31, 2014 and none issued and outstanding at December 31, 2013 Prepaid expenses Prepaid Expense, Current PROPERTY AND EQUIPMENT Property, Plant and Equipment [Abstract] Gross property and equipment Property, Plant and Equipment, Gross Total property and equipment Property, Plant and Equipment, Net Retained Earnings (Accumulated Deficit) Deficit accumulated during the development stage Balance Sheets [Abstract] Stockholders' Equity Attributable to Parent STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY Stockholders' Equity Attributable to Parent [Abstract] Leasehold improvements Advertising Expense Advertising costs Cash, FDIC Insured Amount FDIC insured limit Computer Equipment [Member] Computer equipment [Member] Depreciation Depreciation Estimated useful life of patents Furniture and fixtures [Member] Furniture and Fixtures [Member] Number Of Merchant Agreements With Gift Card Providers To Deploy Technology On Their Websites Number of merchant agreements with gift card providers to deploy technology on their websites Number of merchant agreements with gift card providers agreeing to deploy technology on their websites. Number Of Merchant Agreements With Merchants To Deploy Technology On Their Websites Number of merchant agreements with merchants to deploy technology on their websites Number of merchant agreements with merchants agreeing to deploy technology on their websites. Number Of Merchant Agreements With Partners To Deploy Technology On Their Websites Number of merchant agreements with partners to deploy technology on their websites Number of merchant agreements with partners agreeing to deploy technology on their websites. Number Of Merchants Using Technology In Live Use Number Of Merchants Using Technology In Live Use Number of merchants using technology in live use Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Useful Life Useful life Research and development expenses Research and Development Expense Schedule of Property, Plant and Equipment [Table] Schedule of Property, Plant and Equipment [Table] Going Concern [Abstract]. MANAGEMENT PLANS [Abstract] Stock issuance costs Payments of Stock Issuance Costs Amount raised from private placement Proceeds from Issuance of Private Placement Comprehensive Income (Loss), Net of Tax, Attributable to Parent COMPREHENSIVE LOSS Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign Currency Translation Adjustments, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent TOTAL OTHER COMPREHENSIVE LOSS, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] OTHER COMPREHENSIVE LOSS Statements of Comprehensive Loss [Abstract] Agreement One [Member] Agreement Two [Member] Interest rate Fair value of issued equity The fair value of equity issued during the period. Accreted interest on notes payable Accretion Expense Agreement One [Member] Agreement Two [Member] Exercise price of warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Number of shares entitled by warrants Debt Conversion, Converted Instrument, Shares Issued Common shares issued for notes payable conversion Debt Conversion, Converted Instrument, Warrants or Options Issued Fair value of warrants issued as discount for notes payable Debt Instrument, Face Amount Note payable included per unit Debt Instrument, Interest Rate, Stated Percentage Debt Instrument [Line Items] Note payable maturity date Debt Instrument, Maturity Date Equity Component [Domain] Equity Issuance Number Of Units Authorized Equity Issuance Number Of Units Authorized Units authorized Equity Issuance Price Per Unit Equity Issuance Price Per Unit Price per unit Fair Value Assumptions, Expected Volatility Rate Expected volatility Fair Value Of Equity Issued Fair value per share, common stock, minimum Fair Value Per Share Common Stock Maximum Fair Value Per Share Common Stock Maximum Fair value per share, common stock, maximum Fair Value Per Share Common Stock Minimum Fair value per share, common stock Accrued interest payable Interest Payable Notes Payable Equity Issuance [Axis] Notes Payable Equity Issuance [Axis] Notes Payable Equity Issuance [Domain] Notes Payable Equity Issuance [Domain] Notes Payable, Other Payables [Member] Private Placement September Two Thousand Eleven To December Two Thousand Eleven [Member] Private Placement September Two Thousand Eleven To December Two Thousand Eleven [Member] Private Placement, September 2011 to December 2011 [Member] Repayments of notes payable Repayments of Notes Payable Sale Proceeds Threshold Schedule of Short-term Debt [Table] Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Warrants/Options expiration date Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used Pricing model used in calculation of grant-date fair value Risk free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Statement, Equity Components [Axis] Warrant [Member] Warrant Term Note Payable [Member] Sale proceeds amount The amount of sales proceeds received at which the note becomes payable. Period of time between grant and expiration of warrant, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Stock issuance costs Class of Stock [Domain] Class of Stock [Line Items] Shares issuable upon exercise of warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Common Stock [Member] Debt Instrument, Convertible, Beneficial Conversion Feature Benefical conversion feature Debt Instrument, Convertible, Conversion Price Conversion price Equity Issuance, Per Share Amount Equity issuance, price per share Preferred Class A [Member] Preferred Stock, Dividend Rate, Percentage Dividend rate Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants Proceeds from issuance of preferred stock and warrants Schedule of Stock by Class [Table] Class of Stock [Axis] Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Purchase price of preferred stock and warrants Stock Issued During Period, Shares, New Issues Issuance of stock, shares CONVERTIBLE PREFERRED STOCK [Abstract] Preferred Stock [Text Block] CONVERTIBLE PREFERRED STOCK FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract] Fair Value Disclosures [Text Block] FAIR VALUE OF FINANCIAL INSTRUMENTS Derivative liability related to fair value of beneficial conversion feature Financial and Nonfinancial Liabilities, Fair Value Disclosure Total Series A Preferred Stock Effective Conversion Price The effective price per share of the conversion feature embedded in the debt instrument. Balance at March 31, 2014 Change in fair value of derivative liabilities Debt Instrument Convertible Effective Conversion Price Balance at January 27, 2014 Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Hierarchy [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Fair Value, Measurements, Fair Value Hierarchy [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share Intrisic value of conversion option per share Share Price Closing Trading Price of Common Stock Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block] Schedule of Market Based Inputs Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule Liabilities Measured at Fair Value on a Recurring Basis Schedule of Derivative Liabilities at Fair Value [Table Text Block] Schedule of Fair Value Measurement s of Derivative Liabilities Using Level 2 Inputs Consulting agreement term The period of time between a start and end date of consulting agreement. Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition Value of stock options granted Chief Financial Officer [Member] Firm Owned by CFO [Member] Consultant And Beneficial Owner [Member] Consultant And Beneficial Owner [Member] Consultant and Beneficial Owner [Member] Consulting Agreement Term Consulting Agreement with a Company partly owned by a Director [Member] Consulting Agreement With Company Partly Owned By Director [Member] Consulting Agreement With Former Manager [Member] ConsultingAgreementWithFormerManagerMember Consulting Agreement with Former Manager [Member] Limited Liability Company [Member] Marketing Company Owned by Secretary [Member] Monthly Payment For Consulting Services Per Agreement The monthly payment for consulting services per agreement for a term of one year. Monthly payment for consulting services per agreement Other Selling, General and Administrative Expense Reimbursable business expenses Related Party [Domain] Related Party Transaction, Expenses from Transactions with Related Party Related party expenses Related Party Transaction [Line Items] Related Party Transactions, by Related Party [Axis] Schedule of Related Party Transactions, by Related Party [Table] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted, shares EX-101.PRE 11 vpig-20140331_pre.xml EXHIBIT 101.PRE XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
OPERATING LEASES [Abstract]    
Total rent expense under leases $ 138,843 $ 55,648
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`CP#15]P$``'D:```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F4%OVC`8AN^3]A\B7RMB M;+.NJP@];.MQJ[3N![CQ!XE(;,MV6_CWR&"V-_[X,-S\#N_ MVO1=\4`AMLY63)135I"MG6GMJF*_;Z\G%ZR(25NC.V>I8EN*[&KQ\ZH5['TGFR^Q.&-_\.>-KW,Q]-:`T5-SJD'[K/&'S3\4<7UG?.K;#X61XL_````__\#`%!+`P04``8` M"````"$`M54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@``(````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4'L`D[A^U MC:,D0/?VA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B M(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QRI9$P4P>J/OH\^;*W-$UO>"_F?6*73HQ`GA,[ MRW;E0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;',@ MH@0!**```0`````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````"\F%OH/1OE%TKR8S4\:932G,MIT^@+&5.$QB&TO]R=M7A&`WT)YNS-D$+!/Y MX]KG)\[3\Z_3L?@1QGCHN]*XU=H4H:O[YM#M2_/M]?.'!U/$5'5-=>R[4)IS MB.9Y^_[=TY=PK%+^4FP/0RSR+ETL39O2\-':6+?A5,55/X0NG]GUXZE*^7#< MVZ&JWZI]L+)>;^SXYQYF>[-G\=*49GQIG)KB]3SD2_]_\WZW.]3A4U]_/X4N M_>4:]F<_OL4VA)0WK<9]2*69EJ*]G'&ZRLS&_@,GSX.+\X!P9$/&D0W"T4Z@RAV[63C8+)2=GPKSTR^:GS&=C_FW_&Q^EV-D-(M>?K*XF6!:NKH> M3&_VDP(?%,<>C8.S$7:S$=ALA-UL!#8;97N>0L]3=GPKC&^_:'RG_!XPS`J_ M'-K+)W0Z=F;CR,[\S/>/L,XXMK0=E+9C2]M!:0M;2P*UI(MJ:8K'64_3TC4Q M%3X[RI:50ET)VX<%^K!GEST_6:"]^2]E^QL``/__`P!02P,$%``&``@````A M`&=,+@T9!```RPP```\```!X;"]W;W)K8F]O:RYX;6R4EU%SHD@0Q]^OZKX# MQ?NM`NIN4C%;!,:5^ MO?WSCYM343[_+(IG!03R:JXF=7VX'HVJ*.%[5GTJ#CR'.[NBW+,:EN73J#J4 MG,55PGF]ST;Z>#P;[5F:JV>%Z_*_:!2[71KQ11$=]SROSR(ESU@-Z5=)>JC4 MVYM=FO'MN2*%'0XNVT/>+YFJ9*RJ29S6/)ZK4U@6)]ZY4!X/=\M2B?F.';,ZA/+>U,$O?:+K,_&DL&*;\E/U'B26RLM#FL?%23P*UKZV M*P,2.#6W'M*X3N#^>#QNKWWCZ5-2OUT$^1'2;QR$?9I?)6_*>W.$0J
NT M?J5V?G8_+:"%PG4;*M-4I;Q.X8_2CC61.%:Y8QG+(TX#\72%HG04I5^.HFM6 M0FL27J<1`]/;G0VDT9B+=PYJ5H.Q>5W18D>]`R_/+47Q$Q0_Z>?0C;>*/;"6 M\+Q*?W'JX/K!XK;^Z8?/\RF\<1B54*7P"SN"QS.MIHO4OQFM3+]1^HM:6#?N_;2MDPWI*9E>1LW MQ&E@:Z_Z,BO3->_)BD#HVC'=``=B-[5Q/W)MAA#5"<#&:1)_KA>2@*[-1_/. M(7B?SZA.30+0=BUO16AH_DTZFV%W-`DYQP[M>S.T/9<&)`R=ID2\Z17>5"+. M\MPM\4,;,J5KGRR)[Y,%#4+/^HY$IG#HVPYI$G!+T_;IUG0V1'1I:;NF:]FF M0VTW"/T-UNF<6QDYL>TWSUD0/Z#DQ\8.'W$P/KZ:S)D(IMY:6!%0TUW0!]/W M`15LYM3`A4BL>6OB@Y?N/76(&73:,,5T:1)>/G$`DP5TW0\?:0C[!J;5I((K MP*#!(.W-K6!S%T#5`E&R[2$WQ[^/GQF&4Y?@O&P-,-7.,7@%OE-^?A_B@7CO M"3#@P%C$=^F"URS-*'ES;6Z20D8_KA^!)R6`]),&XU'C&'SPPO=D!%_BXD=\RC9YCM[^#[G]!P``__\# M`%!+`P04``8`"````"$`O+2^Q&8%``!H%```&````'AL+W=O@,W-1$F."DQGCC0CC49S>:;$25`# M1$";GK^?;>R`M].FM`]M`HO-6OOBY7K][:TZ6:^\[[_-34?&/_X)W];?OS3^M+TSYW1\Y["R+4W<8^]OUYY3A= M<>15WBV;,Z_ASKYIJ[R'K^W!ZUK:,L&KGQ&CV^[+@ M65.\5+SN99"6G_(>^'?'\MQ=HU7%G'!5WCZ_G!=%4YTAQ%-Y*OL?0U#;JHK5 M]T/=M/G3"72_$3\OKK&'+S?AJ[)HFZ[9]TL(YTBBMYIC)W8@TG:]*T&!2+O5 M\OW&?B"KC%+;V:Z'!/U;\DNG?;:Z8W/YM2UWOY-BY>?IQJ,"?K;7C^_SEU/_57'[CY>'80[D#4"2$K78_,MX5D%$(LZ2!B%0T M)R``OZVJ%*T!&]8^E"&E;Q4O7-]5_$D14 M*!F$JB`>L%?WZ9>#^"H(_+T&"9<^#2(V@XHC90U9RO(^WZ[;YF)!ZP'Q[IR+ M1B8KB'Q-CQ0S)NRC?$&B1)`'$65CP\Q`*CHH\NLVC-?.*]2E4)#D%D(P(KTB M1!%$U$Q>@-]CU,@=GW%`P*@"$JRK>+^X5[("+,A>WY/("_I[Z/B:@4EZBX@, M]MDM9`J"N$(3S.<: M(YPBA.L%[LW2B!`T]*"MIKY#B2?@[_,S/Z`-_D9F$X71!Y8:F%1AE,@HC&*C MM3*$B%P2^_0C!<*T9O<.D1:G+Y%L*JQA3%-J5?[UYZG+-$_&S(7#S6:^%MV)%V8<+$88GR;F$Q'2)I&(*4MJ%'0K75"P4A(8S982'?->,^GW M%S2*PUAK6"Q`V-]\`=(LD0##3Q.B&^HBB,+`#PR1*<;`BN0%Q(B380SLIT@0 M:V.%50@?G*]"NB928:S["=&==4'%OD!;#H=2I0ISOY?NQD$BJ.'0\P9C>`H[ MM;FX)`HC_Q=8,.(1=C,8&/-^23#&]P)&/3HY$E9CN/5,-;>NK6W'Y(10B8&- M@_AO>!$M7?P3_;(P5U_C$7=I;K4RA?B@EEB98>)"F0\/WI]].(DQ=X3QE#JE M3#=S0GQ&&(W-X5>!E-.X)(IIX)IVHD!WY,-..RKJS3GP/(=UE!(1:>5(D MO_3->3@H>6IZ..$9/A[A1(_#&86[!/"^:?KK%_&"\8QP^S\```#__P,`4$L# M!!0`!@`(````(0`*AF3"CB```/H1`0`9````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`Q=V.L7DG:,MUTF M:<\X6Y)V#7RW4T?6A0.=Q=MKXO4723O,S?&H>O0J[3%G2](N<[;DU$5.V]3K M$.+U"/&ZA'A]0KQ.(:=>\>OO[O43\3J*>#U%O*Y2/^\JUSA:G0Y9R"CGD!7. MN.S(%-/QD2G;./5DP?G>BVH5U^1&@'&))B5:E&@'B+*[F@Y'N@'$+=*C1)\2 M`TH,?:*FM!CY2*2^\#B`W)3<[S,),"XQ#1!J13..S#FRX,B2(RN.K#FRXFI MD)">+E(/V7E"G*S%B,#)VGAX4,)H*#]SXT\YF9LL.,_<6EF%0R/$1*=6):,! M`],R,&T#TS$PW1!3==O<,S!]`S,(,35W74,#,S(P8P,S,3!3`S,S,',#LS`P M2P.S,C!K`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` MQ%M2SY;D[!UIA""U>^34$]XJU:HJ6.74.\Z@LJYTZC'9GI93_S@M\7J#>-U! MO/X@7H<0KT>(UR7$ZQ/B=0KQ>H5XW4*\?B%>QQ"O9XC7-<3K&^)U#O%ZAWC= M0[S^43_O'\[AI!HXG)31*_*O=\6?^G2)G#C=$*S55$+4$P:E3HPZ%#"A=1N(G"513NHG`9A=M8S[71R5@\V.>LNE113YB\A*5$DQ(M2K0IT:%$EQ(]2O0I,:#$D!(C2HPI M,:'$U"=J-^K2]2S$J&M>\Q"C+EPO0HRZ;KWTF5*DVK/RF=J-NIZR#C'J7L(F MQ*C#Q3;$J#/078A1#NT-C$@(4AM(N(W2\.NHS2/<1^%""C=2N)+"G10NI7`K M):"EU]DE8&;M1O5D"W1&GU*#"@QI,2($F-*3"@QI<2,$G-*+"BQI,2*$FM*;"BQI<2.$GM* MB'"$:R<-7H5[)UP\X>8)5T]2]W(.),+E$VZ?CF=)NWIL.1KK.B4NWFMEA5YWT]!XFB M:ME#^@Y2K!S/+-SF#ERD6BL6B_IUCV'*Y&S@D2I3P6,69;6?QBY3BRHW56'%EQ9,V1#4>V'-EQ9,\1O!@>2_SI,J<_X%5QSF16YM7) MK,QC,BOSF$S+]!2[4*F6*B5EE!C$Q%OGR1=+#R758G3C%W+=+%8KI6*YI*XQ M2&9G7K,S/?,8@YYX6YWOCLS/O'49_!2#H&(P%._!\S8;',6[\KR.P5*\3\_K M&#S%*_:\CL%4O(9/Z^#%_#S&36:\J_">9(YQG@(&9FXW4,$DIFX2\W MH9>\GL+QL))6U(DT&V1O!3)'$RK!"ZM(7?/J^`%,W0LU6E<"8]=5TF& MU#VO$D0"(JKUN"(&BQA41.*>M^4VL'%=%TL!#5P9DYN=JK5*Q\!J,AUS7$+4 MGC=6?6.7]=^1M,F[_4[2Z@?7ZL4$RFE@@R--CK0XTN9(AR-=CO0XTN?( M@"-#CHPX,N;(A"/3%,&5EG@NU<+5K7J*8^8"F-I9/9$TYRM9<&3IK@:3UJH+ M*2L-J"L7Z_3OM\E3"*Z3&]Z`+4=V'-ES!%%+Y4+:1V# MA1CL\CH&#S'8Y74,)F*PR^L87$3D\CJ9C:EJI:N"SM-,QIS#KB@?"U?>._0& M(3$G*V]OIF1>:S(K\YC,S#S&("@&NKS-!D4QT*5UD+YYC!N_\:P-[XC?9)(' ME#^]GEN[58?4>CQ_=_XMJ@9'FAQI<:3-D0Y'NASI<:3/D0%'AAP9<63,D0E' MIAR9<62>(NF1I7BE[T(L-%!1Z;KD*UEQ9,V1C6Z)[OM;#114T.\T4(QNG7_< MZ-^[>'2ERB&.$]E.&\^;O,6@(X:^5%F$,6<,1B*,>1V#DPAC7L=@)<*8U\F\ M3$[/]".WF9*GLU`OU#(C4R*ZTMT"$9RTXK0?]>5#7&WF[.4A_I?>F;Z@ M>AMF3N:<$2"!5:'&EQI,V1#D>Z M'.EQI,^1`4>&'!EQ9,R1"4>F*7+27??^F08BU=WG?"4+CBS=U417D1J&KS2@ MWR-8:Z"D3-_P5FPYLN/(GB,(76H8QL"<,6B(V.5U#"(B=GD=@XJ(75['("-B ME]C%96=>14D977FS8AFL1`;S-65>@CP- MU_PW-V+G@DY@Y1TP>5A?OG,M[4=P>)2P?`#RA5E.0K!\"(LZ2;L%9$ MN:03>N,09=Q<E?05\)WS]VJE4HG4JWI[E_#>D!3G[[Q^`=[O'R.@;S<(^7US&XAWN\29UTH%OT!G:9>@E0*>--#;8ERN5K0.RH3+ZE1BHK>K=G,NW0MQ1O]4VX(6F"9=;9#,OKST=/VKP#YU455<_R*\C:W' MW,K`:OG&>QG;E3`J%KRY-C,)1V#KTAEOXZ_I4/.^E1(6Y\*F>M3(7E]RN0OTMKR'4T& M8VQLJ65R&+_MZ=?2_=?D,!+IJ\2HLC;8YT.-+E2(\C?8X,.#+DR(@C M8XY,.#(-(/I2\6VH9-$6:9U;R0WK>(J= M=X1U,B./&];J:D:]2*?M:7"DR9$61]H1_H<&7!DR)$11\85V'A^I<^&]3ZBOC]Q.#+1N462X^L#-[?'5G%,K51LP'/<^<'SIZI-:^36?VV.S!ST?D_ZHD+W+!.BKY](,KM-+B@ MKC]0=7>'7D/F_]L:*C?G+?*>>3(<#7#!G6\+P_$`3Y?I;Z.?2<&9@$)*!=PV M._]'76'/#@EG7SA_DQH.$'CX3+4"-WF=K:B>4,'9PCL_H`X?13Q.4#[_EOJ& MACI\%*_*WJ;+CA\Y8VF<03CMQ&JCMUL)SOE#%$]@8C]_..+NPVF8T\K=5_44 MRFE@@R--CK0XTN9(AR-=CO0XTN?(@"-#CHPX,N;(A"-3CLPX,D^15.W:5;7U MFTK$!4>6?$4KCJPYLG';4KRJN8^;%EN_J;3=ZD^4V"=V^A,5]HF]_D3-#9#( M:Y6(^Y'0=A>#RV*060PVBT%G,?@L!J'%8+08E!:#TY))?>K?-2B*W=G%M#'E"&229]^I'K%UY(=!-*/W%PYV5^&4-1PE1APF\0Z+J^CU<'3;P$?4FAO^1[#"2-AX?8>:)X;`BV7'E5+96 M\]>MCBQX_Z[@;#EL.'5D$75HB:X"9;V#23D`J>-'Z:KD[:6Z.F!@9>HT^+Q] M[EE&/"O+.\XRDDE@ MNP%(7=?J<:3/D0%'AAP9<63,D0E'I@'$VW@S"S2W0`L+M+1`*PNTMD`;"[2U M0#L+M+=`.(?P+?3V"\XB?$KU:IQ%<,9@*\XB>)V0K[H](5TU8[`59Q&\/09? M<1;AU_&WM,%9G"E8*H6\]=<74M<[\N&,P%\CGEUSAXUBTA>G`7XMOUTF@<5D M,/+=7Z/N"2:#):BPGL\"F>ZOS_^&)HDE9+&W?Q#L@36>M3)+ MS'F6XTJ5N^OK40+E7C&@2)-7:7&D'4"\K=^Q0-T`I/I-CR-]C@PX,N3(B"-C MCDPX,@T@WA:>6:"Y!5I8H*4%6EF@M07:6*"M!=I9H+T%0I;[BGG[!5GN4ZI7 M(\LY8[`56<[KA'S5[0GIJAF#K^NL+J>ME M!;+<7V,HRWW*7Z/)7S$)C"RWK#&DL.X))H.1Y8'UG67F<02*+`]0>M`G)HF1 MY7XMU78DN<_@0M`I;MTD1RB_)\ECW+WV7]+O2M2C!,I-9461]H1_H<&7!DR)$11\89(.4"&M>QZ`EPIK7,8B) MJ.9U#&J*P4V$-%^7P4XQZ(EXYNLR"(IA=E(GZ3YX@*58T7-=X#(Z7Y?!4<0R MKV.P%)%,ZR"2\Q@WD.,99=XQM$XFH$'YTZO_5?TS5O4H@7(#F2)-7J7%D39' M.ASIG)1V#HXAD7L=@*2*9US%XBDC. MJ^-&=#XYJ><[H>)1#::'&EQI,V1#D>Z'.EQ MI,^1`4>&'!EQ9,R1"4>F`<2[9S6S0',+M+!`2PNT"D#>;;1U`/*^W<8";2W0 MS@+M+1!RVC?0:SF2VJ>4I[CCS!F#J;CCS.L87,7`F=3SKPCLY,Y:LXS^Z:@ALCUR)_(1K6QP9$F1UH< M:7.DPY$N1WHG_\6^IPW8<&1 MI;?6DOM^Y]NC%\<'0E8^7W'>\5#\VN/+N>_);GB3MQS9<63/$<0[E17ASAF# MT1B&\SH&IS$,YW4,5F,8SNL8O,8PG-EY MI.0IJ8#K9>==-/6&,0;H22O.UJ!>=U-K,-B.T3K_:IGO.6-&C-9YG`*;=R1_,M^-F_SJU<-ZY$^*XR4_19J\2HLC M;8YT.-+E2(\C?8X,.#+DR(@C8XY,.#)-D3>YJ[F'CYG'5]3Q8LY7NN#(TE^/ MZJ,KCZBJ-R3=P]):\Z6">D'5Y3>\D5N.[#BRYPC2G=J&=.=,P\`8M,70G:_+ M("Z&[KR.05T,W7D=@[P8NO,Z!GTQ=.=U#`)CZ)[4>=.S%.6&M>]SJ9IWSHMT MUVNHYL_U8O`;Z7 M>4>Z)W/1N.FNHKL>)5#.%FMPI,F1%D?:'.EPI,N1'D?Z'!EP9,B1$4?&')EP M9)HBZ>&CQN>IF+W[$W/>C`5'ENYZ;ZY*[E&KXLV0L'(_@9\BQRP*Z@K66C,E M?UJ'#6_1V#Q1C%\SH& MCS&*YW4,)F,4S^MD+J>B1H9I7#*W.Z)YSQ M0\$/UCEOQH(C2[U>-:N6/Q'7ROT$IF-4LVQZAZZU_D35GP]NPYNZY+5U58Y<6[H<\9?)9,Z+P&90KG,9FT>8Q!6C%8*P9MQ>!M M/=];-][CV5WLX_52,AF,.UY_FS[V>,NFGD(Y6ZS!D29'6AQIASI MJ>\R(PC MXX@G_VYF51G$(.-R&=>Q^`C\IG7R8Q,NSC> MY8U*^L9,-=HI!3S'XB2CF[3$8BBBF=1#%>8P; MQ?'T+.^(XF0V%S>*E2?UDC_EBSI`-#C2Y$B+(VV.=#C2Y4B/(WV.#%(D]:-R M6Z[H'QT=\BHCCHPY,N'(E",SCLPYLN#(DB,KCJPYLN'(EB,[CNPY@C"FKB&, M.6,0$H-E7L>@)`;+29U?QY]!20R5>6L,4F*HS.MD6N9%K<%+Q#%?E\%,Q#&O M8W`3<(UO?D<8SK M*]]JR%0O)5!.[VUPI,F1%D?:'.EPI,N1'D?Z'!EP9,B1$4?&')EP9,J1&4?F M'%EP9,F1%4?6'-EP9,N1'4?V'$$>4]>0QYPQ"(D\YG4,2B*/>1V#E$AD7L>@ M)1*9US&(B8O7O(Y!35R\YG4,\8'BX;PKJ#9IZ*6_:E^/% M[`9'FAQI<:3-D0Y'NASI<:3/D0%'AAP9<63,D0E'IAR9<63.D05'EAQ9<63- MD0U'MAS9<63/$<0Q=0UQS!F#D(AC7L>@).*8US%(B3CF=0Q:(HYY'8.8B&-> MQZ`FXIC7,.,89]3QS'N!H=%]4FJY<2*'=T3)$FK]+B2)LC'8YT.=+C M2)\C`XX,.3+BR)@C$XY,.3+CR)PC"XXL.;)*D>0T-GEWW+WGON9%-AS9:2H> M7PMTNQKR\ED[8XX^2B>D>VGD)HRZ^V;H,C38ZT.-+F2(8\.1+4=V'-ES!+GL MSZ&DCV,&&_%$%Z]C\!&YS.L8C$0N\SH&)Y'+O([!2N0RKY-YF>9R\AZ"V[V0 MR[R.P4SD,J]CL8+,43UKR.P5/DO7[X=#J_-N]>[SQ\?#\]_'!J'[]]?+NZ?_HI#N%A$!)\67SP?OGZZE'KQ M@S2*E]?^7YKX2ROXES;^T@G^98"_K()_61<_U"7X%WRD$EA_H_@AN':L/+CN M;O%#/U0?31J&ED^QWJ1!UZ=M\O+YX\^[/PZCN^<_'GZ\7'P_?#V>N]1P%O+\ M\$=\=E.XBO_C]>DG-N?EQ>]/KZ]/C\?_^^UP]^7P'`/X^]>GI]?L/[!EK_]^ M>O[SN&L^_Z\`````__\#`%!+`P04``8`"````"$`U"@M3^`.``#C=P``&0`` M`'AL+W=OCL['[[N['1V`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`)Y=2SV,-R+CQVJK&>R-_OU1'K!=!_V(XK9,]5]CJNFLJ9D'[@A3KHW M^ZW)]()\7_`1I;*FV=[LH\R/"JY%_3U48I%82B6N;[CV=;7015W=A^WO"XZW M13LR#U6C";LJK!M+/;Z#JNEIE#6GUU#"C M$\Q8&G.7\QU#--AJ#!^6![`\A.436![!\JE,-`+ M'+W`U0N&LN#X?/9:6AIZ=>9&/3ZC$\RXQAA:,^*?8((33%AGM',ZJ3/:Q2.J M,UK.3D\P<9W1CG-29[1K3%IGM'.1U1A3.\YYG=$NT;,ZHQV?>9WY.#Y*7HC; M)24OFO.AT$H^Z`4/>H&M%PST`DD.D%N5XPTPOF1P5* M+1!/"6?4@D+?7XI8'RVSJ:5-7QKQ\V"T2OJ`PD8Q0.&@<%$,47@H1BC&*'P4 M`8H0Q01%A&**(D:1H$A19"AR%#,4\R:AI)EX;C\CS0HM;E*.4JAM:"U/7QJQ M`9^F&0H;Q0"%@\)%,43AH1A)895W\NV>W@9@!!]%@")$,4$1H9BBB%$D*%(4 M&8H% MBV*(PD,QDD+NB6EU]0>W,4;P400H0A03%!&**8H818(B19&AR%',4,R;A))B MHKM02;'3'J:+3ZFIUC/U]DR:IE1#84MQNTLU0V1:)=))0< M*X9ZE21K[@7;<36[>J96'?HE:DHO)C:3`1.'B+R\?"F9W8U$1X" M?)J=$R81DRF3F$G")&62,9'DCM]2$^+/YT.Q(FZ8'(E>AWP9FV7+L$Y9B_LE"-;6* M`=CCU#JM@\20X[;'*=:NWE=*U)AB2.QR50U1!DP<)BZ384GD52-0\+,:[ MC_,0[B[E\/AQ_EEZ#>D7\W#%W679!M_4]"\^**37K2%V21KS3ZZH@3C*BF[: M-2MR>45#-<]"NX^G#7JW1:%A/:Z>$.B!!PD9#)A$C&9,HF9)$Q2)AF3G,F,R;R1J.E7#)F?T?K)$?;C MUJ_7UH:I^T;3,/RNJ_V!BVVK MTJ_9-#Y?YIXD1^=5/:VV@3$&-41OA9T:HSVRN261FV)U.I5A^"$'\9B,F(R9 M^$P")F%)Y#X;-\6MM'K\)QPD8C)E$C-)F*1,,B8YDQF3>2-1DZ\87#\C^>18 M_''R]=I:MT_?:!JP+Y,/B43"'MCKCFJ)><7`&[^5`JF/%VS!N)FGO% MH/L9N2?'Z(]SKVUIG7)]HVD@O\P]2+8G.400VI-GVX,6X91FY, MIV-V.AUM[LVP9DU:`^HQ&3$9,_&9!$Q")A,F$9,IDYA)4I*RJ>X8K79'N]]* M.4JF1A$=RI7D.ZZ7U?N!F1+`%)-I*_5VWK@92NZ9^C26TX8==A_3^ETJ@^HE M$ETKG_Y/@Y*4A[37,BSMHFASD($2Q&KU;K0T=A10W%7J%SQ7$5;WIJW_%^:A M*JHK\4K0L+2=SC=9<"K<9BXM"5#CN$Q&3$9,_&9 M!$Q")A,F$9,IDYA)PB1EDC')F"4I;Z5;-6/R(XXR9N(S"9B$3"9,(B93 M)C&3A$G*)&.2,YDQF3<2-?_.F^]2?%>:EG]63QNBZ9>HL?7#F2HV1QDP<9BX M3(9,O)+(_.L:MZT;[<%^Q$'&3'PF`9.0R81)Q&3*)&:2,$F99$QR)C,F\T:B MII]($J7Y.['_I?B8V@Q:O0XZK@YJ+YTU^*;Y4MI*# M6C=*OT2-.8CS8VR.,F#B,'&9#)EX-:2G_Z_240VJY"`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`JQZS[@3;]BKEH?&G7A%7K4\,>[$R^JJY;EX!VM=>=^\Z]=NCWDG MWN=3C6.;=^*U/M7R@7DGWNXCRJ\/!T*\8O5M\6,9+-Y_K%XW%\_+[^(8%M_/ M>WGQ+E_2*O^Q7;_MWN/X;;T5+U?=_?6G>)GN4KPZL'4E\/?U>KO_1[&"P^MY MO_X7``#__P,`4$L#!!0`!@`(````(0#S?UT$!P0``',/```9````>&PO=V]R M:W-H965T/`8)/!F9LDF-\_55^5B;WY\E&5RCMJ28'KK6IJ MAJJ@.L?'HCYOU>_?DA=?54B7U<>LQ#7:JI^(J%]VO_^VN>'VC5P0ZA1PJ,E6 MO71=$^@ZR2^HRHB&&U3#G1-NJZR#R_:LDZ9%V;&?5)6Z91BN7F5%K3*'H'W& M`Y].18XBG%\K5'?,I$5EUD'\Y%(T9'"K\F?LJJQ]NS8O.:X:L#@49=%]]J:J M4N7!UW.-V^Q00MX?IIWE@W=_,;.OBKS%!)\Z#>QT%N@\Y[6^UL%IMSD6D`'% MKK3HM%5?S2`U#57?;7I`_Q;H1B:_%7+!M[0MCG\6-0+:4"=:@0/&;U3Z]4B' M8+(^FYWT%?B[58[HE%W+[A]\^P,5YTL'Y78@(YI8F2@B," M??\\$2KFB(@#H3@0B0,Q&YAFYQD&CS%YI!$XIH\T/SAQ.<*RG.9(EX#]T_?, M4'TZ"723UG37:S[./=.`U=B^-J\(I8I(JHBEBD2J2)<4'"M(9LIJ>850,;QU MI_FOQ;<"TRPQDBHBJ2*>*RRA6`F3K/N7E^G:OF\Y?+'211..DLM3HAVU@I?J M,BTZ2:0E],N>:;P^R!?+])V5)T09,@G$.C:=F&HD=XGG+D(HR=3D823ID@>' M"_YWGF\J*A8Q"0SV3,-JN?)7-NS<^%J&3#&E).0723WBN8=(.I&:I(LF'"6Z MKYW\4R\W$Q6+E#R>P9YI8`M'_Z]-S18HANS^$B.)0RQU2*2*=$G!\5GS?)Y; M='22R,D7.#'-G9.AN<*;(V3WESA)%;%4D4@5Z9*"(P6I<*WT'*I^%L_*,X15 ML[^+1EB>R\,,[X(E6C*/6.Z1R"7T[$)K_S@2QHN=3=A^N4+M&86H+(F2XRL] M=SBP<,;1\4STNJ([0F%\;P:PNWTP;@7[1_K0"F"O--='5@!;)AC7QP?`D:?) MSNBOK#T7-5%*=(+0#(T>"5IV:&(7'6[ZW?X!=W#8Z7]>X'"+8)]M:"`^8=P- M%_0!XW%Y]S\```#__P,`4$L#!!0`!@`(````(0#U$W#;AP,``)0-```9```` M>&PO=V]R:W-H965THZ7*`J1P6M\,)]P]R]7W[^-#]2]LSW&`L' M'"J^EXA[M,85_&=+68D$W+*=SVN&4=X,*@L_"H+$+Q&I7.4P M8[=XT.V69/B19H<25T*9,%P@`?Q\3VI^LD5V!#Z;.4?LOE MGV"P;XQ^:E;@)W-RO$6'0ORBQZ^8[/8"EGL,,Y(3F^5OCYAGD"C8>-%8.F6T M``#X=$HB2P,20:_-]4ARL5^XH\0;3X)1"')G@[EX(M+2=;(#%[3\IT1A:Z5, MHM8$KJU)&'W89-2:P/5D$GKI>!PGZ600Q5?3:E)Z1`(MYXP>'2@]`.M;X M`'BFA.#ZE/&[BWBBE(,6;NPZ'UH4JRC3?JAK)3F^I/5TMH46FR)SB9?DN'RDX.&RD]I;(PVA<8X,1F' MRT\.TG.,C?)3FBYCU"N#M2FYO$4:I.RJG=W&7G]2K,,9]:46PD;2#>ZV"FQ_@*[)A6B4ZYY5V,ER% MH>H$]EVP%=GV&DT2)G&:1N/SFNB:$%UW9I5O)]:1U M/+FAW_R>A&K[[^)-@EZS7;6BZP]7U6B5Z'R]/G)C.:I>`)_G9IN8.=H:1LMI MD^B<,-UNCI+SAG*4H_27V]P5Y1D21-T\C6WQBN:R`^B@O0XS4(^J*707W,S1 M;!PFGZGI\ZESM3HQUFB'?R"V(Q5W"KR%+`-/GCR9.E6K&T'KYF2XH0).P\W7 M/?SZP7!L##P0;RD5IQMY;C__GEK^!P``__\#`%!+`P04``8`"````"$`:3,\ MWY$%```1&P``&0```'AL+W=ON;?SPD!VR0.I[UI]/3# M:W+>DY"$U>?OU5GY1IJVK"]KU9CIJD(N1;TO+\>U^N\_T2=75=HNO^SS&Y/O^INJLF;KN:%5>7E2FX#4?T:@/A[(@05V\5N32,9&&G/,.VM^> MRFL[JE7%1^2JO/GZ>OU4U-45)%[*<]G]Z$55I2J\]'BIF_SE#/W^;LSS8M3N MOTCR55DT=5L?NAG(::RA2MO?NLM*?Z+6[*_1_EA4"VP2?JP$M=?Z5HNJ2%M%Y544E6*U[:KJ_\99`Q23,0<1.`ZB!CFTR+6(`+7 MF\B'6S`?;H;K[>:G6P`=[G.QN!2`2.K5X'KV!1G-C?MA?M,2I># MBD$K@N7<=&9/-\:X^0L?1IWYS)CK'^B2QFJE+[T@[_+-JJG?%!C/H-5>#OK;4+G1=)9<2QA>;N9$8@LI&@ MPQX2?LLZC"XNZX^'^)A<2M/DCAWRQ\![^TV^^5N9<%R'9P*960CM#V7$G/,J MT0/$M7@F?L`LA-8D#QA>)67$O6N.N^"9G2 M&-B*@4`,A&(@$@.Q&$C$0,H"?)I<(4T?8#*9,?3W^N`2!5/U$XFB]%J%O[?1 MYRR%X>N"W0&J$*)$A!(Q2B0HD3*"]<36Y[;0DQVJ MD$T1G%'.4T916C1*F/M\QD`#?CFJ4")`B1`E(I2(42)!B901R[[H#+'D=NC] MV13!&06+3&Y$T364!8N]Z:8I3FW7*60I)\QDQX ML46)`"5"E(A0(D:)!"521CA6/RGJ,UU<&*(*V13!646WNT]XU>.\688M+._] M`6+#VUCHAB-L,K<#,>%G@",A]SO6TC9-8V_@]/1HL+TPO[@7]N7^``W+*&?NNJ;0A^V` M3'@;/$"D!]H#1IBL(QR)<209D(DNI3BRXQ#+M>9P7,YOL[/)MO#.T=WV$\ZQ MS3GOG#19,FC"EBT<9].A.X$$.!+B2(0C,8XD.)+BR&Y`!OM%RZ8RPBQC!_CL M%+4BS9%LR?G<*D7]2@_G8;K=K&YA]N8@,3TXIX'C.R$.;Q2^/(K[A@='GS(? M&AX<9LIQW_3\1SI;TX-#)YD/3`_.GN1X:'IP!"7'(].#DR@Y'IL>'$A!7+MU M#%Y(7/,C^3-OCN6E5<[D`#G19PLHL8:]TF!?NOK:'SZ_U!V\BN@_GN#5$X%3 M7WT&\*&NN_$+_8';RZS-3P```/__`P!02P,$%``&``@````A`%[@C0Q?`@`` M404``!D```!X;"]W;W)K&ULE)3;CILP$(;O*_4= M+-\OA@3(02&K;%?;KM25JJJ':\<,8`5C9#N;W;?O&"F9K8WP,MADVK9)(YSIKCL M:"`LS34,7552P+T6>P6="Q`#+7>8OVUD;T\T):[!*6YV^_Y&:-4C8BM;Z5X' M*"5*+!_K3AN^;='W2Y)R<6(/BPN\DL)HJRL7(8Z%1"\]+]B"(6F]*B4Z\&4G M!JJ";I+E74K9>C74YX>$@SV[)[;1AX]&EI]E!UAL;)-OP%;KG9<^EOX1;F87 MNQ^&!GPQI(2*[UOW51\^@:P;A]W.T)#WM2Q?[\$*+"ABHDGF24*WF`!>B9)^ M,K`@_&7X/\C2-06=YE$VBZ<)RLD6K'N0'DF)V%NGU<\@2HZH`)D<(?A_A"19 ME$ZRV?P*"@L9#0;ON>/KE=$'@D.#,6W/_0@F2R2?G(4\1J]O646/'K+QE(+B MM*,+B^UY7N?SZ8H]8TW%47,7-'@=-#0"S!B M-949KXL$__KY>#?'2!M29Z22-4OP&]/X?O7YT_(@U4Z7C!D$#+5.<&E,$_N^ MIB431'NR836\R:42Q,!2%;YN%"-9NTE4?A0$4U\07F/'$*M;.&2><\I22?>" MU<:1*%81`_IUR1O=L0EZ"YT@:K=O[J@4#5!L><7-6TN*D:#Q4U%+1;85Y/T: MC@GMN-O%!;W@5$DM<^,!G>^$7N:\\!<^,*V6&8<,K.U(L3S!#V&<3K"_6K;^ M_.;LH$_ND2[EX8OBV3=>,S`;RF0+L)5R9Z%/F7T$F_V+W8]M`;XKE+&<["OS M0QZ^,EZ4!JH]@81L7G'VEC)-P5"@\:)6!I45"(!_)+CM##"$O+;7`\],F>#1 M%*,MT^:16RJ,Z%X;*?ZXEZ$5TV^.CIM'H/KX/O(FLV`40JQ;2<9'$KB^DT3S M23B97F?Q73JM.RDQ9+54\H"@XT"X;HCMWS`&YLX6ETQOU/]\@APMR8-E:;G` M"@VU?5E-9XNE_P(%H4?,VF%@G'I,>([8=`AKG:5-.UI;6-#;BP8_3T7_NX:= M-@L>:)L'YY'7EYCH'+&Y1,P&\M-+2#3N6<[T0Q_.@ST MTCNFC]Q:N;F*2#]"G*D'*;>KMV"8E1-ET_G`N+7#?*3^*B)UB#!HFV^T\&;! MZ6_4NW&6"82\/1,+'F8RZ)*UPYQF$@U*M;D.@6/01CIE&?:1.^;<(`NF"K9A M5:41E7M[A(5@0O_4G:[K,(;QLG/4OX#3K2$%>R:JX+5&%EV_OIX=$YB;+Z?BAD&;]FX/>G M\Q@G%]O-CX'Y/$U*6F MM5TW`?HW%>>J]]VHCO+\:YGN?D\+`=&&/&$&7J5\0_3[#O^"DZW!V2]-!OXL MC9W8Q^]9_9<\_R;2P[&&="_`(W1LM?L1B2J!B(*9&TUU]W)AS;[;P[;D#N/$JJOHE19.FD;Q7M.Q.=MRI"BSRI@E.%-?Q=EW*LP$5!WJK4XSUZZS`\"4JY$,7IZ_"!*ZA MD6>TLC%AJ4`$*LCMQ];S[+7U`?E(6B8@!MZOS,+A3#BTHQ#1A,L^;?6XB& M%MQEAS#Q<)7IXA%6Q2N!#8CQ&VESNWEU5VZJ*R0"WK]*3J0CF'KO'O4(J^H7 M7%M`C$9;>).(=`13[]^C'N%;94^,3OU-(M(13#W>"?1:I;[%(*S&WE-B3\RB MJ1Q[9E][!97-Y?#79:,CF/3E/=(1YM+G<[7?$-,6O;^PE68?TG%-8B(=P;0[ M,.JGQ[VAN7K/4[I%T$(D'\3#BZX!#:W+E.#3B>,=\XOJ"%O+F M;?&HM=,>U^JGZXPC7#\.MNGZ:0QR_==F3`/7(6C\XE3^MY%(BW`7<+A-=P'I M6[W'(4CKPDTDTEKA+N",F^X"3400T`T=SU,;D',9FWC'-BBAR\&K!67T1=WY M8P@7#V&Z0SS2?!$/6Q#>O`/46\1\C80MH$E0I$6X`SCDID>?1B*/_J`+$=1S M8-"%=).U6261HT.X!SCHIGM`8Y%[,.A"!'W=A72SM=6O0[A^G';3]=-L9/I] M);Z!HQN@;1>ZB41:*]P%''K37:`1"SHYFCKPDTDTEIA+KAW3>.& MY@O9ZST3-?J"%FJKZ''6S./KF_/+@_*\$+9GZ%:V%N$>W36=W9'I[*M)::&^ MOM[C"&5EA%';JQ;A/B@3&A_CYY`I_3VJ.S*I?27600OU??%\16DX`BE(I$6X M,[!HIZ\2%VFUQ-2GG!;B3BC3,!R!!D[0Q?IVK@AW`J?GY*7NTJSEW4J=%RU$ M#\%+]U%M9V$+C*MKJB[2(MP!,'.'`TBK65#'!6Z4`=2-"]=5%D[8$EH/R,@X M0A[0'B!M<^6B/(A09%EE)/(=]_=(H/XH^X/*1%961B#R;MF0]Z2MI4I!^U/#6;:Z^RALW`YNL1-G\%[#;9,X#W M4M:7'[B7U6TG;_\'``#__P,`4$L#!!0`!@`(````(0`FTF#'0P,``'(*```9 M````>&PO=V]R:W-H965T($E//*#(RI.<%)/*G+'FTP"I\"T1-IA MQ6_Q8&E*8Q*Q^%B04FH33G(L@5]DM!*-6Q'?8E=@_G*L[F)65&"QISF5[[4I MLHIX]70H&[YRBED.`/!I M%51U!B0$O]7?)YK(+$33P/;GDZD++&U`<'5:=I0A+O%ES=K*@\P!<5%CUL;L"YR8] M.I@V8?_+%R1*F3PHEQ#!7P92(:#&KYO`GZV=5RA,?-9LAQJWK]@U"E4%91OI M`?AL;;U@V4YR((0V#DAQ-XY_E[?!56*%VRRTU0.]A=IE:I3=4#$W\*.AQ+OD MH`<+?="%54F?0F>/0ZM)(8(:M`'!KW6=.F#F=?7[(8:(\)H3-'CAX5NYU=BDW_>9]MJ39??8-M= M541CBAY]T*>_K8?4I&L]I#5C45Q51&.*7A3S?A3C/:3$9@W,'M*:+OVPAX8: MHT[1F*+'KVX)G>USG%^)3?Z%T4-:LZSWT/EBYOKF'T`+N@&:\#V+Z3+P+WW: M8U]^A%V)3?;+5ESO+5NMT>SNQ/6,][ON>]\+C,T+;@%J"3W=6_BSR_ZJL?49 MKT^O@O`#V9$\%U;,CNK\]B!E[6A[M7CPU"9OC&_=%9PU,.ZT+^#(K_"!/&-^ MH*6P0YZYOC3H!\FJ^LS<,PF'??TS@[L=@=-J8H,X94PV#VJ!]K:X M^0L``/__`P!02P,$%``&``@````A`/HS:X1@!@``5QX``!D```!X;"]W;W)K M&ULG)EO;Z,X$,;?GW3?`?&^`1M"2-5TM6&U=RO= M2J?3_7E-"6G0AA`!W>Y^^QLSKF$&AY+T1=HDCX??S-A^*'[X\*,\.M_SNBFJ MT\85"]]U\E-6[8K3\\;]Y^_/=['K-&UZVJ7'ZI1OW)]YXWYX_/67A]>J_M8< M\KQU(,*IV;B'MCW?>UZ3'?(R;1;5.3_!-_NJ+M,6WM;/7G.N\W37#2J/GO3] MR"O3XN1BA/MZ3HQJOR^R_%.5O93YJ<4@=7Y,6^!O#L6Y>8M69G/"E6G][>5\ MEU7E&4(\%<>B_=D%=9TRN__R?*KJ].D(>?\089J]Q>[>C,*715973;5O%Q#. M0]!QSFMO[4&DQX==`1FHLCMUOM^X'\5]$DK7>WSH"O1OD;\V@[^=YE"]_E87 MNS^*4P[5ACZI#CQ5U3!/VMGE^_3EV/[5_7Z>UX\'UIH M]Q(R4HG=[WY^RIL,*@IA%G*I(F75$0#@U2D+-36@(NF/[O=KL6L/&S>(%LN5 M'PB0.T]YTWXN5$C7R5Z:MBK_0Y'0H3"(U$'@MPXBY=5!`AT$?NL@(EJ$NG[/A4D0T'@1RN0&`5!BRC:O`*J01PQ,O&QR:A!1'"$ M,>)0<"<#D@1!7%'$Z>HI,45;!7WJB(8:1+L3-C:BD+&(HFAE\B-PRD4'N\LT MG!)3N%CT<1$.-1HNC(".+9^$**)U'`2]@K"MKV%38LX6FYR1#37()J*5$"+D M.QR5L'5#Z`2LT_FEZ]1\8^FW3N33(IC\%W>620GE4YOUH+7SEH;`+9YL+I)/ M0"T"%F4D_H(M[T1_;\^#0EYE$P(W?0K'.KC5(@.W&M%AE#ET:A\?E'!Z=0BE M9BV6S+:V6F2_>#<+DDD)K=Y-]B$L_B'[):BG(HKZ*G+WT%&,(.P7&V6$5(>H9%M5HC4Z$<799T(YF16 M(U`T8.AKI9?22'&)DGG-3$J+ZB5A"+3\A6;QHFX+""5E,QPYC%VH_A* M8MW<:I%V1A$&<+O(IFZB-<-9T6="06]R'FEQGM&MCQ:98H8LDT0+YE`RZU'E M#&'<]"8O+184]),*6ZY%0X@XX'/3(KI4SZML2*(-P:NYB9`Q7SI:-"3L+XYK M9U)"^\ULZ)T*HK/`J^&+!6OC5J)HDF]*0OD@S/46I)X><`L:W*GJ3J/(S$=_ M5,7+`LK(/.>=&EJ\)F"7WDH4:39X@C9:T43@+]9]%RC;358C;5;#[R2U"(ID M)@-+(]$24^*H3X-2,J-YIX(V@QFM8Q1-TA&'`1OL\2D=,YAWZ"S&$O1YZ[G' M?&-0&+V"F:`/0-#4`X?KETR*4\BHC"6Q&PN]NM,A^<=UC MC&.74#ZUI<_^?RM``R!='AF)%MDOKODPCEU"^4`SY)MW!Q:H47RE]/]Z=!!; M+=)=EHM^&]&0&$1_+Q9Q?SM!$:_RD6".CVB1N73(V!,JD(OU);:;?"28XR-: M9.^AKB#&,166:_+33VQ:SZM<)9CC*EHTR8[V&HOUC!=6L\&,0W;77NSL6>JA8.]+H_ M#W"`F\/)$3R,=)U]5;5O;]31HSD2?OP?``#__P,`4$L#!!0`!@`(````(0!1 M,NO9Q`8``)4A```9````>&PO=V]R:W-H965T=[X8A;X7G9.RUU^/FS\?_[^\B'RO;I) MSKOD5)ZSC?\CJ_V/3S__]/A:5E_K8Y8U'D0XUQO_V#27A_F\3H]9D=2S\I*= MXJBDQROT^3[//9?I29.<& M@U39*6F`?WW,+_5;M"*=$JY(JJ\OEP]I65P@Q'-^RIL?;5#?*]*'WP[GLDJ> M3S#N[R),TK?8[19(U![S>KZ>0Z2GQUT.(]"R>U6VW_B? MQ,,V7/GSI\=6H'_S[+4>?/;J8_GZ2Y7O?L_/&:@->=(9>"[+KQKZVT[_!"?/ MK;._M!GXL_)VV3YY.35_E:^_9OGAV$"Z%S`B/;"'W8_/69V"HA!F)A M@`#\]8I<3PU0)/G>OK_FN^:X\=5RME@%2@#<>\[JYDNN0_I>^E(W9?$?@H0) MA4&D"0+O)HB4=P=1)@B\FR!B.0OE8A5-H#+'8;4J?4Z:Y.FQ*E\]F'I`O+XD M>B*+!XBLY0EA8#B83K!K>H%0.L@G'67C0\W`Z34D^=M3I*+'^3=(3&HP,6+@ M;X<1%+&U$7*Y[C!S8-S1!B6'M,>S^<9.@S4[G5U--\8?AE1D=YD6L1U!A!V$ M,`'1IC/18!!XH$&D^A$B.<1`#CJ=^BLC.1>"<(,+#;GIY"JH(+=:^B3`#:X? M"<8@1LRJS;18"ADMU+*3!TE2R$*)<#`C"$L8ZI"EFYT&ND8,]AIL&,6=C'Q=PBQN@6!-%*1BM&CD!64BV4ZA"$W(J2 MFY9N0&Q_YR6"QA+G%J]8$0HQ5V40^H=OUY.RV:-;Z!&]]!@3U>;7W.2&4WUT> M(;#CD[:G>-LS(!!)6YR8";DFKZY0L04:^/AP*%?=T@=:3BMF@49`.(=]M\"6 M8T!KI,P98H0I#-_E)6+$3$)+500958-97ZY&1CP^A21@AC*Z&XY>!D(]0/1N MMD62U[0!C5_<\,,XXQ":9F8H$],\XBS22C.".A'7K/JW@@&6?03*\5V^(D:, M15J)1M!0*,E:P-8$ZL8QZ&*4)O.6B5+:)A.%;+[%`D$=A=#BR`#7E&0&,Y'B MF-.P-AT+!'44`^;A6P>`R"B9S4SCV)[%[$9RC@;DS+8;0YDRNYG(%.\I:(MD M2ZY8(LC-U(FA3)GQ3&0Z8D"2%7$L$63R#@;4+C+T0J-]\5E`X<%LT!0H8VT# M=]N/1/,@VO)ZC@W(+"BB]1)N%9C^6X,9ZM^W#DI46\']1-%`"%%K:2D1U$D; M,.VW!C"%)6`X2WU3[;8C_3R!+S$5RVAL0$,2D6*>M1T!7=.3&=(-AK816>OO M6")HR+"_.!JF$T+SSHOG`-7[&.7(;.B&AB/V8ZV#)8*<.;[N4(2=?A[!:^7V,XKV+&9`ULK7@%PL M#:0K^K[F*8\:\QXVUV(#<6S124O-L84'?EP13# M2G8`J(#,8&YP&S&6L$\-UH="4,>-+3^V_/@UU=[E*&K,41B#V(`ZAM8BS0&@ MZL'L&-;(#?4T^M9MC4*0<]JY()0?%,`Z9M[@5;=&L(UK.9T`N10W$3%DR&,KN7:82CID* MU].`G"PQ#CX6ZL^G#)FC3,MX.'(C8SWS,2`G0W:O,VB?E.5=WA*.>(OE>P;4 M=9W>.["HKQ^GS)BWW)A_(YYBN5Z((,/,40B&*,+YPS_*$I(P=)>)6=9G\6KA M#JAO>@`T5@J&WW4`Y<@#O=!E'(:="T+Y,6^9J*'M,;8#PN;X M#0UO.PSNCN.^;Y%5AVR;G4ZUEY8O>N=;P*/A[M=N5_Z3;/?5NP.P*7Y)#MD? M277(S[5WRO9P:C!;008KW%;'+TUY:7>5G\L&ML/;CT?X]X<,]EWAT:[O[?NB-^Z[?ZAX^A\``/__`P!02P,$%``&``@````A`-31ZHB"`@``W@4``!D` M``!X;"]W;W)K&ULC)3;CILP$(;O*_4=+-\O!@)9 M$H6LDHW2KM1*5=7#M6,,6(LQLIW#OGW'.*$Y])";!-L_W_SCF6'V=)`-VG%M MA&IS'`4A1KQEJA!ME>/OW]8/&4;&TK:@C6IYCM^XP4_S]^]F>Z5?3F9`>(C6B$?>NA&$DV?:E: MI>FF@;P/44+9B=TO;O!2,*V,*FT`..*-WN8\(1,"I/FL$)"!NW:D>9GC131] M3C"9S_K[^2'XWIP](U.K_0)G4V+MQ4W#"X4,$&<.A)3#1B`7R2%ZPRX$'KH M__>BL'6.1Z,@2]-DG#T"9L.-70O'Q(AMC57RIU=%1Y:GQ$?*".P?S^,@?0Q' M$03]#X1X1WV"*VKI?*;5'D'30$C34=>"T13`I\R\C2'7OZ4*.3K(PE%R#-T. M21@HSVZ>)9,9V<&=LJ-F>:N)+A7/)X4K!=@;/$+BYQ[_?.LG*T[LK+@J.&]+ MOP'LP5M\%?=6\?C;VH43N*'[G3AQCI.SP./H*O32:Z!\@[GDRMR_%!?>(-#] MWIP8NO`L;I:&EY&77C/IRQF-LBP970I@XAS$"])TG&3#N3?FY\FWF^2ZXL^\ M:0QB:NMF)0;PL#N,\2)VE;O:7\)X][-`A@,8KXY6_#/5E6@-:G@)R#!PXZ3] M@/J%55W?Y!ME8:[ZQQJ^HQPZ(PQ`7"IE3PO7=\.7>?X+``#__P,`4$L#!!0` M!@`(````(0`L01JVT`4``-X7```8````>&PO=V]R:W-H965T&ULE%AK;Z-&%/U>J?\!\3TV\^(1Q5DMK+:MU$I5U<=G@G&,UA@+R&;WW_<. M=P)S!\<+4A3'X7#FS'T=F(U^?G?7YJSN7._UYV_H?'GW]Z>&W:+]VQ+'L/&,[=SC_V_>5^N^V*8UGG MW::YE&>X^'F^K3E@=!N*WSZNPCPWV[A*,Y'*JB_-04 M+W5Y[I&D+4]Y#_J[8W7IWMCJ8@E=G;=?7BYW15-?@.*I.E7]]X'4]^KB_K?G M<]/F3R?8]S_@RHZ^KHFVZYM!O@&Z+0N=[3K;)%I@>'_85[$"'W6O+ MP\[_R.XS(?SMX\,0H'^K\K6S_O:Z8_/Z2UOM?Z_.)40;\J0S\-0T7S3TM[W^ M%]R\G=W]>CSVD6\&.],;N]]\_E5T!$06:#5>: MJ6A.(`!^>W6E2P,BDG\;/E^K?7_<^2+4]GUGRM-Z7O%2]&OM1@X=;8,<=Y/+K(Q2G"(&TC9!IX0&1W4(0:1"JY=(T&.K&6I>'CC2$)$-, M)0OB('3$9S:"18K+D(T<1!J$8+DT#7:D12,M1@TAT2"-0;W1RQFY'`3!>)F( M@J`O%Z7!CJAXI$51"+%3R1,*R1""NJ7@DVXB+%PC3(.I,#'M%X4A!%?E<:#< M3&<$P(,DF+9&A$5KA&FP(VRJ#A2&D+=PQ$D<.368V0B61'&83.U!I&EO7#PS M-)CVI>`T4RE"[&1."P_BLUL((BU9(TV#G:BYXPPA&+5$A,H59E^/DX!/42>R M&/C6\I`-:$>8LW!J,*@L%DD\K8PA(P`5>_ M25-.BV3FNIUOJWEIW%99`,/Q3<0Y19X:#(ICL4IF`XTB))CK-%FH.#V2%_'CF&=)9.#<;T+1.,!8[^C$!B%471>^6WRB78W":D:Q,& M@^I4&`:)G'6N;14\D9#@J4))\/@JLQC0U&"MF8"M:S"WNN,FA,IS#$,7H`#) MMPN0SXU#3NDQ,A%C746FHP1B)+0.0X MZHP^VW;NX)U@`E!MJQQ%S!W%S6%J,*B-BX`K9UIF!'''.(?#H5$^5:='NC6I M%R89C<">V,IY%:/33R7X:SQJ>GA7'7X\PCGZ"4<1`8;`!^:IG_[HD^`QY/YQ_\! M``#__P,`4$L#!!0`!@`(````(0#J<;C,,`,``,0*```8````>&PO=V]R:W-H M965T&ULE)9=;YLP%(;O)^T_(.X;,`GD0TFJ)EVW2ILT3?NX M=L`$JX"1[33MO]\QAP9PFC3)10CQZY?'[S&VY[X\,ZFX*!=/\[V03RIC3#O@4*J%FVE=S3Q/ MQ1DKJ!J(BI70D@I94`VW M%:S4:")93C7PJXQ7ZLVMB"^Q*ZA\VE4WL2@JL-CPG.O7VM1UBGCVN"V%I)L< MQOU"1C1^\ZYOCNP+'DNA1*H'8.+)2!\3\Q=T]HYZ/]05^"F= MA*5TE^M?8O^-\6VFH=PAC,@,;):\WC,50Z)@,PA"XQ2+'`#@VRFXF1J0"'VI MKWN>Z&SA#J-!./:'!.3.ABG]P(VEZ\0[I47Q#T6DL4*3H#&!:V-"@JM-AHT) M7%N38!*2,/H8Q<-AU2G=4TV71/VDG1H\,/"XG,V*+C%AD M*"%^G1CY7M*A] M\7'5):AI$$D43J9^:`6\MD1D.(W&4;OX]1&OVA?@<'%4WM:X043-!XA]T?N( M>`[!';:B6_:#RBTOE9.S%%XG?S"&V2OQ%((W6E3UCKH1&DX/]<\,3HL,MEM_ M`.)4"/UV8\XYA_/G\C\```#__P,`4$L#!!0`!@`(````(0#!!KZ>46,``.&4 M`0`4````>&POM2'$F2[[\?L_,.:9C66FT& M-%>!>F;Z6`F!FAT)&$`]V[9V/A15"=1T4<7616KF:>99YLG.[^\>$9F5F544 M2)HY9GM14QD1'GYW#P^//_Z?W^_ZV:=\-.X-!W]:V5S?6,GR06?8[0UN_K3R M\?)H;7\E&T_:@VZ[/QSD?UIYR,G__V__C@>3S+&#L9_6KF=3.Y__.&' M<>CN_:$_QS=_#"^'^7M[O@VSR=W_1^V-C9>_7#7[@U6 MLLYP.IC\:65W?X^%IX/>_TSS`__3_JM7*S_]<=S[Z8^3G]X..].[?##)@",[ M'$QZDX?L>.`+`/;=ZJ\?VJ/U;'MS-=O: MV-RI_OC(2ME_MZ[&DU&[,_F_U9'?5?^0IKI\N,^K/WZWN;'VE^H?6^RQ:_L\ MZK=OJK]^=]WNCVL3I57.\E%O*.QTL[?M2>V[@+7S_*:G#8#+D_9=[:OO?CD^ MO_S8>I^=';][]^MJ=GQRL%Z%(\QT`#U&[3YTZ.:_9W_.'ZK??;>Q`8*W][;V MMZL_'4Q'(X9G1[UQARE^S=NCN8!_M[:VN;6VO5F=(VT\3!+V?P2KC*O??O>7 M1X<;#,V#F_@D(.&HU\]'V0'XOAF.ZAAH=3HY'_!SE[WRKRI@$9?#N[OA(+N8 M##N_K687M^U1/LY.IQ,3/"2Q.NQ-N]\>='*^1*#&V5(<>M,>W)FP=_2/_GVGO4[L/Q6J898<2UW%VGG=R M/KKJUWCJ>#">PG"`.YK[S7?__,<__U$%XFR4W[=[W2S_'84RSFMK7YY>PJD' M"S=R=GYZ=GA^^6O6.GF;'?[EX_'9!W9=7>E@>'<_G4!)[?1>$EC]XF@Z&O0F MTU%N6+GN_:Y_UR!ZG[?'^>VPW\UZ=_>CX:=<4]6^>C<:CL<9O]_G(Q29=-K< M==_GX_&/6;N#_IOVC8^Z.;JTTVM/&A3?Y7""."TW\^GESX?G<\C_-K\?CGLU M))P!@&@MB)']+MI^]-MX-1ODDVQX/0-E^VXXFO3^;E#JMQ>[6ZM;N_LV],7. MUNKFUNLJBAWXX>06.K3'8QB[]H41?`['!C9X?]QZ<_S^^/+X\*(Z//'J??M! MC&K`@-K1%/&%APU&P_VIU8W^O.OYRAJ,7;.7@].3R^.3=X=_^0[6ZL[NRF7WKCL7`HOA@66BMK3S*,;>W=C=-7@V-S=7MU^_6MU[ MM1]W.A^ZAOT\"G"KV^U)6B6:TF>]0=9IW_<0U>K6WN;7O4X/-ZN)80C\K&C]$8K)NUNW^;CB=-:LT9KL1HIB>78:"J M"3K#9N%SY9,>%OW[>2:I,FJ^-S5/U90Q(QT#8EW)U%%Y-Q<\.B8FE0L.\*Y:]FO2P)5'3(K"4OL87;`HQMH_+P9^L9/%X!^,<&6F'64 M5CP%Z\:J1(MJ=WL\+_.#D\NZE]91E1!;JKMO9:-B==F#-0I:K9#T>X$XZ/DQ!X=!.AG?BR^G]/6:U^OV[?`#Z M^O9MNWO7&YB'+TM5_?("K<#9@5&WI]> MU.RM>QB$$*E=3 MJ>)Q%?PX5=:ZO#P_?O/QLO7F_6%V>9J!M`^G)UE9%5?'OFE='!^8PGY[_/[C MY>';+,T&IZ89?FZ='SX^]*^'Q^]^UARM7^#R=XXK#+"AD1YH0GCXZ;+Y[.6:#H[/SP9R3Q^)?#1H(<#4=Y[V:0>;S9 M><@N2U:QE:QBX<).VK]7M^H#WK5`4'$$ M>1D\.((2XH27P3N8:UR-A:O@%Z;.)LW^^X-Y5[7T15#@3_CH8GHU[L#8\/I2 MDX;O[\TE*<+%N8-+;M,9;M/:,71TMVGND.@_X>FG>.EMX3^]+70N*,9_FCM1 MR9%J9IFY(X.'L^I>-,:`+$=^M9YM;BCAM+%?I4_Z/EKC1[X_QM6V8!J.0=-/ M>BC^39S965<=IX]51]/VZ"'#O;65!8J\?)S\Z.-$**M`?>5%?&N+%@F;9T_8 M@.3=NWN^L[JUO[NZM_DJ^]P>*7-E(I*V)Z3B'8^&TYM;0E_%:'EVWV\31>"0 MADUO[]JF23!.EMGSOQ2<9NPYU/<;P=2,I],%?(N)^\\I60!M?SF>W7N=PQF2(TI:, M#D>FQ5K3&YS[0CUS_K+Q^$Z78,&G+M1,PR;!D7LRR[]?)(=+3?]I\S?`1961]HI"JX4LFW[2RN0BE5/U2+L+"[YNHAN[\S_;`_(&M5\;WKX,U M>+[^7&;"9LPLP<``W,*:][.]$K1?33R6FOU+8'?UYAKFM?N";GZWOI:$BZ*F M0Y=8I'DG\_ADBM.P[>[J5V"2QV9KAFU992Y"N@[==+\`9#_N`FTOH3]&*!S6\E[DLN M\>Q=R"^_GMH)8=D]/^U,AG+T&H3TJRFS+U_ZV;N&W>(..561'^,"\=7VMNP" MS3LH2TA9Y"+,6ULEF)\L(4^=\6DPIF.EKP;C,C,^#F-)TZ0)0W+CF?]"7EUP%A+/W8 MJ'U?EHH2[J,[MRN9V.2EZ&:RMM>CX5WTRB.MDLHT%HQ_G9.NW7I.#N1;@[$D-DC* M5M"!ZCI1*9C<0*\ZW9?R8@N,^'C$):M2C'CLXW\DZ9KAF[9^+Y)ER1I M,EVR1+B_S)'78J=K5QQ;)8S2>L[K[]* MJOC+EFTF[Q*[?=S<&^V+N#T:C3(#@Q;3&E7J_`O7?S8"5"WY:FO7RA231,WH M$,O!;6XFAV>.N=QW7?D5#C>_/CB/8R=M_>LP1)43CMJ]4-$J*SO*@Y%)JWJ4 M\SKCP.3%^MZK0J*J$RVKL22Q,=.^8U9`3/IX3K+L]#QW;9.8_U3&-0I+X2,_ M"H4-?K&.<39<;):T2Q6>I/SMZ5GLS:V$CCD2M/?5).C;@/2X%`7$5GU/P]+J;H@L:DA*JC1C:LY=E`1IR?[X:.2B[JUOK-=:(LOC,T:,L?+KOOL_8HWO+*F M+#Y#*YJFX)_JJ,%,]*WOXVV)7BS:+"%D_>M)T;<#Z]G8LG0$=:KW.<6[*,@V M53B323\4&=V,5/1)N5$9'_M?)W;_XI6?O>>H2Y^L)@(GV,)?(!E?:?U_P_Z_ M#N6?O_^9]9OW/R>"]>2>)_11>%^:!'Y\NB=!9TK1$]1?#MMCDS5#MJP?^*U\ ML7GR]#2X@H=:XS!":K+KB]W5Z"@2F,AI?CW#;.X15AW&98$K.\]`DORVI($* M^'0IBK3:2-]0)OG`'6*_>I%4\`NJ;O<70N+N M$K[$4@`ZV\4`9`D0%Y6*;NX$]"U1,AH*R"EMZ_S&316K#?=:;SE6K[;D[^F& M/^6[D>OF>.,E)[/*1RF0<#:K!AY;<[]W67[T^R4#C]?;JWOTY1=H;ZZ'0U5;^`H1\+0"6QT`L5=MT MR[1=.0Z!_6-)R%.V]919EX>U+.]JO5K;V]@J'#21O:=OMQRFVN!XDM M4ZXJB4MPSK>`I1DQLTFA),8]+[&OGSQ6-S,[OCFI!#_O%_'ADC/$HX07%-"4 M2IZKHYM\-WEJ&S-E#?&\U*EH&K-Y(MTD*,KL'YNH&:7S00IW+VR8WUC@3HIG MQF"N!6#-5O\[6(LG>RIH98VS-+::P)H_T>,@)?9K0#S^D'FI5ELE67P474^: M[N)FD!O\RQ\2)H)8RPV)>CBKNDF%L2Z[FMI( M/7.+U[M=]S?=*T8"/9>\N?YJ03)Y*5?NJSK#4@XZ2L#9W)C1US65L.2]GY(; MW("\D'D-"'S<5Q=46_C[!AZ-&!*75<%[Q`.L7?Y.WSOC5#W`VO?S[)3.ZB<] M=0WA>FNY=89=4N,49Z=RDA/%8L8/0NW%OS<[OZEP4IYR=>__/\&V&GIE+`MC MZ5:?24I>NN"5)#7B)OR!N^<=NQ2+>0+EXB+IR/6RLOAWKS\/#V5[F/;G&KX, MOBM1]4C!2L,=3]7OB^9J5I5EP**[X7#5C=@3X%I^JF:PEG.I3$6\R/"M%BC7 M!F/0>'NR:@,6IANX5&G9AKF:?S.JU\UU&LO,U5\-P/U[+!6:QJ/[[?6-!?`N M9:F6PV1A31=C:GV^;4XL M97+/=PW$S9E3H"J(BUI!2/)K]8ZEV_KH._SR5E)]7SSW7*5:G3F93%-&=C\- M=,5ZXGK/Q/1]86(7?O_4?:U7B2RQZB9S,:_V0AI]>IX:&%9@O M3;Z^8(*CX73T.`"@:@[2E'#X:^PI`#360N`LM!`X2RT$YD%(:1(TF]/7@?J# M^.-F+2U90OSB'Q=61A2[*JD-2[]^X<:29CT-=[A%3`R@(JB+V'O`^F+0"%4- MQDZYRST/2Q_H4G$WO9O_>_OWA;\_&9A%7$GI8*)*3-TZW_>/`EPYBF4DOH5+2%DCPY>"N&@K''EA3A+2\\;O9C+ MED"?U,Z17ZU,VF<>%I><[GSFYD4D^Q=,.M]Z+"LR2T"^W"*+2+W$(L(VW>%( M=Z@EN!+#)U8&=!::IGX!DF;,$D+QEL:H7FDTNX2^HX63]65-_=^^8%U+Z)\7 MM3L71>5.*U7NS)M_QLV:Z6$E3'VT`\WYA)DW:X/Z_R')GJA4-;?S)K*X^1=U M;!6ISF-]:YIKWK@&`+)6V1\*0,P:CP4.WQQ`'I.MT-RL%V]$=FE:5`U(FK[) MKAXR&D5Q1TSVUC=TYW]<V[8.8]9.?^+93%\VH\$1AY[F$-) M78\BNZZH_3EXZM5!*9RT4RSK7'[4'WZ>VTKTH'7QF'4A/+ MUL'E\2_-K:.+7H$*^VG`/1QT:.ANK:_5XT5_51MLZY<^'0,QX;T:?-/65&E+ M_.1/1ILJ]+-YK[C'2$$F23E0J9MX?K%XED"%+YO$"SD")RT+QX&G:_G\>J;N M7K??ENZBW:KT#N_&?'OC;6D9"JRYFZK8\%?GC(-R]6H5870X3UW4O7%J:='J MQ_1L_=0S:R@:7+7IZ9E?U;+SUNN2=8&![NGMOO0QC>)AA>9NYB^/!T#>'N?? M,YW_2TS3_#&[]#[[0#VGS_ZI=4Z?_WMHZEYK1Q3!R%Y&,+X7'+').?JDBH\$ M3.ITWJYT43>4TB&]=^,=J(M:V>I<:I+T9*&IBO#QR2^'%]:9=[X(GTW)9H-M MD26?U^;_#.NCIH&8E$EL<$^6KN&2?@UN[^NU6-BKW5Q9,+>VK2\Q^FFPX MZR%=M4.RJ-R6GZ5\K7CQJ&2X6#NHO^4'S`,LT?A>"D"/`&"&KGL#^F\NIO/A MT='A`>V1C^@4??!SBT;]&9VC#S,:^HH%JI"I;2]MDL\/6Q-:)EKH@ULC^U>@SW#("4^6&0<9L.?F4_=5@1MEVY! M\(_A3-%7%?I9`"._/0NXX^@IP^DS.W7_(-U)D!!ZR+88F"NZA^O5`0P63DT, M^RSUCRTJL-:^H:LVO0K/DF1;+Y/%DX>=)F/R\)PIYUKXFI(!W-A\N^BY787P MXN.'#ZWS7\6C%\?O3HZ/C@]:>@CGX.#TH[VJD9V=OC]N?%ACZ9$+WHDZ.441 M;"*5SX?CI&U]IJ"P7H5X,QWW!CP34]WG+[W19`I5SWHW-P\\Y33@A.'EBD8< MT*.[/7A8P_/2O`"&,)&"("U["&8([K.8QC-I]7XL9KWRXZ^S?MM M2,R_2^U98K_A=;WI\\]_S(#A"T[RSNU@V!_>/(B#!0H;X0RZF_=I&FYEW,S8 M9U<9CC:M;$=$)^-AWUJH6Q9:4%RW[WK]A_7LF(KB\0-M;^^R=M\ M#_0D?GH#H,KO[=]R]MJ(L>DAPK5/FRU MV2%:$2\LF][;/*.I7BI@#+&*#TF/NV3<<1IT-;K?NZ-<>YV7J$8JVL7JW9M; MB[K0"RXTMQ3^C"U^!AR$C/SX50O*=GO MPE#I807M3T=$=T.>Z^&+^_L^KY,H5AC77C6[9.AI;_!;]I*)X3CNT,YP[OPY.I+`EH`32Z,-"(_J^5ZT@;98DB<< MI'_'/!8@#S2-.`B<"\E/?<$S'5#1RQ[G"T&RR*?%@B]7#D[/SEH(M3#ESRB- M(6"?%WT,JH'M7&J^F!*JVER(\=CDU5#P&;W?;].(Y[:0^8\7`A4J!CQ_0VH4"(YSA`.-!5X"!*Z]$A"NWI22 MD984I]SX?)&^Z*82H*[&'$RA]R!H1V0M(#P`+V9D*`:(LE-Y3@^YD&S MGHG=2[/#>>0IIJ8R4%9=1"WBEF^Y$XJ2F>#ESA'EY,Y0V;_SI@-*;]<.6I= MO.%=M@,D^?7FKIF[LDX#)J[FL@5+)YG0"FB!8Z94RTX'[2D6!$`;]W+;YFF. MJQQSR(YD44R>JQOZN'ZQGMV@K4?(!8X;5*!M>:*/U@E&0=H0^3*.'/7N2HOV MBD_.,4\9R=MMD8PW*_7VG5CL8NV_ MU@V)(QFH/FX-//&0=4F^#2=,VNE/N^"B;\D7L4L5@.OA<,*G`#Q2$D!;)Z;3 MU@/%2EMJV'M@-N4Q&0EU-=/+%6MUEEM MT6^TX,KW__R'D4@,UL_E,"56+P0$Y\=-PO`>;P5203CWM"0_YFV5WB$#:<'8 MB8WX=*#'8OL0!47OA9Z*L7CP]'NWBEA-$#X@^34>ZU$+L5O;DXQ!*IU!"M8. MS-!U%=0$,DGFX92W&J_T,B4>%,0%J-D&=.*AQK%NX$3^N)#&Z_.@5C'8K0$= MM_OPKUYMPE\0U,;D?S;X];$.+A#F+IM[6WWX3K'2-8Y+M_`&+HH:=N7B$/V!<4H9:%07[SVYK.F+B9VBN[8,`%"T-?-6'QI/4A61CK/- M%KNFJ-`?$$WSQ'E-6]_1*P%LRG7NF/9QEE^TRYW@B2$TI1=\/^*5LL#A&)=6 M,N:\7KSP>\G*T!W=Y63GVT8J.4F%=KV@8]KGRV0]:(UQB;?E$]RU?V/;$5I3 M8>1QIW>A?L:0TZ:&&3_-D2:.@+#M.\_J`K_G?6UH*?5J_ZVL-H<,CSIN?!),Q`]"AAQYR!>-9K:% M*P;5"^@Z,S,BK.29#-;9I?P'CT\Y"K#`MX_#!J<7N"MFOPQIU@Q;P MA$F)6-P:('PKS5&V2.[BX/CPD&''K*S\'0F=66>TX?!FH`'.>FJ17V"?P1TL6Z'6GP/VM8!X$>I!8F>QX]H$]<9.=4M/& MI_QQYC'7U:SIX$D<74M,N9D@Y!X]"!.>__JBQ15OCH84MTD,X7M<_>OB4.PJ M[[1Q?X-\\AO&""/!Q^$0%QZ=Q1L:TEY<_W%\S^-&?UI!3A25Y"OFM`9\U@5B M?XL*19])WLFW=U!*#/&!XRVT5O"@0;LJ/EPX@DHO@?2-W!>/12WVE[%&-5HV M9I[N=%6-_%_EXH,[WP&:&NA=_)%&3'EP/IQ/B`1[Y$DD?\DCXFMS,!7_$LC, M4>]BN)X,P:3,')^)J&1(.WV&$1OH`]8/=L#5@5[1A3]AK$!S@>M675D9WB,G M[`QY=K!<,J[O]0Q:MOEC]I\/IA%7O:*'E0"\@PX/+"\P%))ED.]R$5J.E!5SC!@+(X!'C?J.9D?)N= MX6_\&R'#IV'_DQA791M-,$6U)L_2?'N>/]?3 MY"$#A!0F@R/K0;K6XL1`%#!HD14U%!RATD&<,(+=A9/P(7$$5FI*EHY\)H'W MVV.<9MB#C`XQ=@JM(PS1-LL;0K@8)+%\L#=^$!R[!'.'L9?!UY[L6#O9*:@E M,"@5`:?7#HEYU-*0W9AK5<:\B@?AQN3?_J'R'[0..*UYQ4>(T_V4;/T8<%BE M<%<,E&LEQV>S.&9E00IN'AIG!N"4%$,72FJHVOF;^:]#\Z.[(S+_YNGQN*FQ MC4GS/=E1GI55REP:JZ-+DY;;<(@"]?PWS^SKX.F^#4;=/4=MW4#2?LD2:BOT M`^ZV'VP)L@V6H9-^%&;8M/U_J=N`F)HHD"ME!4(``24,WDLXJXB>^4K3V5<2 M7M/JIJ55#+`N#L(9X8$]1;K\WL&;F4J7>HI/0HOWT^[=W$[6[!S#_<78L*;P M@#4BOY[VH3]7D+13C75CL1KS*^89NFI'(XSEF?O]XW5NARL-J!-I1KF)0D/9 M1#@?8<]04&<6-\#'^$*>G49W[;^!PAY^-XP?3+5&^%N;\C[7LX_W[%-E-F[, M=1[2)R'(./,42!4N3:.@DCC8LC( M8:F?N*$E^'S!I"-Z'FA(V'1((GCDTXHBP1\WS[G8L#.TN(CC[,7^ MZO;^:X/VQ>[J/C$'BX8,-[^@&J_-A1;%6J0JP3`'!,#Y469E"L+T:N8IW8$.^;V9_%BB%#4XH3_5-BO[9.\ZDT,\EF&=.=+(W;8Y[ M1)PS&`YK^Z$]T=D5MH/DHZ"'V8,JK\]J"7T,#FH3G:=L9,U>D+T:6@([C@X? M"K;65/H!#VH5`]K^>Z^O,[-!N^OG9>%("X.*6A0D@3@'P\3*/&6GH]&&%MN9_?@&95U@U2$))P5R312DK`>17) M)&>!4E=0:F[PK)XS3[A)ST!"OR!Q#,M.NI*;T,&'5?5TIP6 MWJR]1UV23N=8H&X&RR)@]=#@PD^A4#%FW#D.5#X(SI0GT=>$@@\%;Q.*0++; M,^G]D)7/ME]M9"MG0;>N9EP3L_0F.$UV97UEYGR%5$HO_]RTCG@?Q8O&-E_Q M,\]FH]Q)"*+A`8Q?=;X5'H7N]$;H2RP1NE[\;9DX,2JQ@W@DQ:Z>5`IR9SO" MF#Z$M`),'7#0Y_#J//Y'0D@=&=+&*0Q2LMRL'4?@8^@?#-:BM2%G:&]:>"%% MBM")[?I0+,L"VHR!O4IPH)A'.3(1!QR+HW5(+JN'\B>KJF,'K`Q]KY(. MWO:VE",:`W;&IY/Q)!HC0\B!K)@=><#AOIJ2,L0$$;K18F^DP):2Z73F_2*,<6].7-<-CUX8S75BQ' M(&?&"YL%3]#;"O'=K+_L?5(0!:MT*)))BD7#M832>+9Q<]-4`#U4005ZA80Y MD=!ZQB6;&&DP"//$*_-(NVQE#9W%&5T=L4$O6E5,$#$!$'46ZT4[B>O1G78F M9D03*YHQFET3R$AO)>S1#XA%8"&8.O ME$/"@S+U8$HP)E[`&>IN2,6-M%D1"9 M0L^)&(L84JA#S0JY?@BG6F$O2)4 MLI,I+:JB%UM)Q6W\R\N#5-8%-C48@>1@PWQ)]U3TQ_+^9%+281>#XA%/@*R4 MFO^%&UH>+8*RX6>WX38<;%SU2:"@/HPKXG$;=E`73=B8G",.4)0E*-$FP!B, M?1D*G"?$JF^1FS@W<*K&AH,<2;#VHC^%(E'I%BH[,;B&5*-I0D%VSU&(OL!! MXQ\:ZHY)^4#(L27*-(%K3F?!2NXLL[SW;;40CV")OA_A&KY%3NZ`EU,/^>^J M[G%,8H4]=M4V_C;%(<$EDGFL9Z&L5'7-N>#,J^(K0CO?B%ZRVRC,0;(\)XI2 M[OP6)I54X$H[8(7?GF(:8^YD&_;T6&U2-+);W[AH0/!'\-8,&;:E^*<:*/]2 M^^FRE52=N*N:,W])WX;>VB8R:91!B6B"Q@!LE]8[:[L<:BG>FCRLO;$#A2C5(C-W6]<. M$ZE?KE!,E3&*0:J)^&A1=?&W6:\B^C/PB)`Q2TW])9P&)\.^C+8P MD]!,X!*"^?J<,2QQ]1%<,.)K#_[KWRNE1OQ:/B_U%$CP&W"P"(O@>QUDCTBE MF8/E0B7U3@T5@J(A;H@BH\:K,UK9$WL-*]6(Q>YF-R!)--=1\P0FBJ>W8"-$ M3U%\9`4#MTCN&)+$L9D"#3#Y[MD6.4$C2MI)3`U5.4RK2A!&7:?;6U;VKOQ1;/'N_O M[+G?!KQ/3&4*-RI%]+\=$[[",#5#?$Y_KR5&>G[M_!I?^A)]L:= M'R]0`WOJO*,C\#1=N4JR`4_F725,R3&:`:8^.OI`3\"/(WM_=VMU;V?'L;VS MN[.ZO;=?"^O?*U%]!LM/TP;H6K>G"R.? M\C]H\\R`+G15'T.$M(6@<\K(8)P?)21,<'D!QA<*QFTJB*H$(UDRFJQQNZ*! MD>5;_K20E[T0\CJH&(<66)!%-4):4Y45^8ZG2XZ*P MN$J)RQ*78@.'HYNVUU")3SQ_+@=0;AVY`.B+U87)QCZSU;'.]3VV]E$Z$8;S M6`'G;,6UBCR=EC,AMZGMTOB:B@-'=A#@AQ5*5(:B#G077U)-(HO(1 M3,_I",%EE%I!!8='`2^=]WKMNN4:D$X2-)#(12%^G-"*JA%:`S)M58N!NH"@ M'VYHLG9OCG&XFA)2+V29Y+N7D@2!T(([?$,J@AG*]7,A9C"7(@57T`A;/=`9 MPK5J$J+ZDX\R[/?D=^-FI+*!(AM1D^ESCB&UBY!+(-%-LM\R^C_$0%VU;K8&R7SG4"PA: M!@US-QH\M=(^`3'\$<09Y55E.M=W97.SM[WSJYJ)*K^OMC MMUBWN,5:'5.=4]I8)$UW4YHDKX0!;#U5W3`=RFI*JD62E9`A3O1JLS45\EK";I1'FLLZAEP."K/`35"?8G* M9KP&H42R4B%TV7&$Q$7AT-C.FSR.(/SA6`J>X&$&5WP.J="E1D))123646V!#H%?+D2B<(JRIJ MJM68S4^:N8E(O.\6,A)0]+@>]\]3GOPQ+A?ED]>W?%'9UOXT;]%$O"E"@,N<)OL]*<`R[)<*2=!9IF M%`?6E03DQ<-;,.TG6DEQE3`KNA3R8R)Z[&&)!H'>JI1CPD6J-'F)8'&=N=// MLIN3706`#`@9]1B@6J;CRF@?I,@T#E[*#8&'7I^"/V_`%='!(01<.M MI'%DP_SDC7.[(H40!GPV>Q7$#21YA*)\(*G)R+-CA8,AM^!H\IJP2``32,O1 M,VKHH)>6\LOL%AT"/C*/3R%*2=3("84CTZZ_7$!5=+WA[JU!6RJ1HGA?EJ)=YT$X:DE>*.D@C@ M104AD#+@//SOGK:S5*VR;M`%JRW[P5M7ZEU`S!WJH'!QT^EGY&SS7L-E\G3K MME1(6+[Q2L%?O)=KE.5X5;58P4#B2,KMU!5\UU/F.K+P.?"N M"1"DBRN).:<;5Q.N\MMV7Q>.32(X`X9XI@>-/UM&+U+V?AG;LG>&77"-"<=_ M43Y/GK^J3Z7AG<(`)8#!UBUFB,\"#HKV`TH/66[1+#V#)9!1#L0O'90*XR,F MRR(WHR/N[W6WHD;BXCZ9E8HD@Y!(9,)34D(&;8.M`!\5$73K8QJL+%X!A7[7 M0X(VNZ-\5I`SG;--DK(0GD)`=BBM?!Z8@J8I+X M2V2C[!LQC]B*L/QHSLLI&<.91=<89[=H;E`W>[&WOILNCJLL$+[UK$Y2H:X: M^+N>AHG?^K(O]M>WXU\L_;1X]$[\UA*&8AN$TXL)7='#TI_PS>5?A(!.\)@K MX9GV0M4;`YNK%%M.F?J(^2=E8&/F6"M`\!:S]\T[;\2$3O;3D.S%[OI^A%9$ M,#O4\&2>+=H(8,WK+ZDN::?`@C6O54ID-F`UAKB8VNU[E2AW<.)5_X->`#LE M640CEJ=#H7#P`6M+UO59>R(#:WD;!O+S=6B?4DBD:;.BC,N,1CB[-_\`X<<6 MD'.68#G'ZE^,RB,%#Y:#()97*(," M5AJFYN:8Y"*%T6P:I_&?!4L$Y\'[RSD243<&.]^)>P(.''2[KE)C@C/:CS5T M#0M_?BS0VR;0BY^J2=CE>>OM(4V4_EP+(F+>^@5ZYBY MK4`A@6R/^,0L'::J2]WMZ#=Q*OW:=8-/#38VM]W:V+$@1)-T!>^A*.1I+G@- MW!H7+DS?-RYO?1EK6+T\5[@I[0X?2P7"?L^,=,)21;4F\NF0F@C*[PY<6[06 MET,)56799+%VPQP,%E7^@3`NM8D(CF(_U]C;WUG=W-VR+U[L;;]>?;6[YT1Q MZ-T/"HYMKTV)F-\/J!F3U> M<2`EBR4THFX!97/C/^13`PQ=CPTD3%I$20HU&$9.`(_RNM9HL%U3C;M^LZA] MS2JFAF+(-XN4D@L`ZI7++CG5"F8 M(XR2.WVTI["L6 ME2_F9R4OH5]2B&;3K*C*`N@7K[=6=_8XWBO*;;A_8*=E(OML698?/2.VI!"A MOX?^D+43^C/(ABGD)=.[9H5>Q:21(.'T&KU`99!][I7"YH\J]^V]0WY$ZY,H MLGIP^MSW8`4N-,4&*UR?Q>C&RRQ;6^M;_T&,HZNUUZ-<9P]!(?'4EF>*U&9T M.3RM0:K\Z8;L?[H%;-X9A"3_HG&!@CIBZ=FY*-XC8=(@*SWF MNF,,PDI>,F'K%Q?AR.\E3S717NZ<9D+C!]"#1,[FT-Y.K;.3-K&\A[?*'P;6BPUQ<6)K+1R7Q"0;K+[/X!+8_IVVI63/R<'IA\/LLO5?A[7XA3;, MZ;?'/$3*$-6V.7U?6R<5],?DICN^&U_#T6V9&4T.Z/9FDP.J0V%+KN`RH2?0 M5%:G8[>U!`2ZL`L&[W$_K$^)OGBQ_7I]+Z8@*IIU\I,O&]G%%^7^CVB:K)46 M'9()YC`S7IY2A?:5-1I6LT9C]W(<5Q[>A3.A(=8IC"[(#;-3Q>SWRV/EN9UZ M)H=KP;)1%!`SG3]9*09@=M*+!7,!CDLMQ;@IZ\$Z8D^%_][*S*B>SM*\]G[H MOA,T,'(VY%\N_V4U\I<2>66(`)F8([3CCF1+/!O.3&/F[RF2[`?B15)%VHI<%[9YX&>=>Z/*:+^\7AY:5W/:\*?>-'CVF25VB2 MQH'5V:%1DC,Y;BFZI*5F\:A1ZI/JO@4>L2>/D!]T/1*SI6B$P?B40G>47!L' M&72+VG])XV;FAR0O=D*P)XQKCN)+1;8V28>PQ:(D]Y%=/8>UR*!YNM?&FS\\ M'0T*YRP4@P2O(DX>93A"S"S40'MN#=]+K70(#1,`H[QW=\4%./?&XB[-W\+Q M51[8W19XOGBKPM9X0S1AVRIA%9Q8]JW8<5K9JQO*)#!/"1E2PA1L.-JW:RQU M<,K+%>>7QR0KLK/SPZ/#\_/#M]G%Y>G!GZND7_#I8^RU!WLM&%Y=Z7C6'YC1 M[O2D`*&<<1KJVME%T9#P+.3RN/0/!QBJO!=A_0TS1 M_BI\%J.BH`D*#KKPB+N5'7@?"1VY'5@/>[\+=I;J1B^L8#2`,_M7-4Q&@:C6 M)G0>,?F$35AN4<+#C+?)+3^/$QFH?[^>J=I)F0AA1@2(XB3HH'XD.( M5]L,S,)13Y`*7^2O=L%S,F9BJ5M%MC?@EN(4TD!Q9L4@#F=:8ST#Y8E(DLXZ M"6:HZIG(>%OA7@WCK[B%@AY65UZY#D#&CF_]O$TSQC`T[*.*:B$B@N^)G3H( MH-B>U2`_'!7_([."._S5*PYZE5'0R2'B,O:H$>NM)-?J]NM7 MJYM[S!R.!;6`V^3J(Q77&'G,OC#Y8G/UU<[^ZKY"2*9)^_>\;#5#X#=TV;[* M!L3;I9F:]J,T$W6:]4>L(G7X8':KG,Z&RXZZIC,?E:#04"ERA%S$HL])4'C< MO1@AQMJ6)P;(&>WZY'IZH2<2;TBV("NSQK&\!=`W,(^>U MRC4=:[Q&_BYQ3YT&57M]R4Z3T<$3CK?:4V*I"JWI$CM\FEW>3QIUTCJ?89'] M-=IT;^U&7PQ,ZI89+=W8SH#`;>8"\U7O&D,E)2MZ)"A3K6$%M!K2M;?*-Z9= M="2N2R$YIZJ"M]\C$4VF3<*\K#61LL=^7.E,A:!3I?-HDI#E;G^B58(=RLKT MPDB),>09\"=&EJQ5V7H'>Y<8V)R/^*TZL5!6BOO$SL++C:Q*XI7LC`YR^^Z3 MEG^T]@PE+ZB\&)L'DB*-7;@75;15):@1UR6=F!P+05J=3*SKK/K_V+O6I4:. M+/TJ%1U,-(Z0971!P,1.1\@T[6&6!@:$O1,3^T.-U&V%:<0BJ=O,T\RSS)/M M]YV3)RLKLRY2&]L#NS$7XU)69E;FN5^%I;5#$4F^'V>KT3/X!Y0Q%M0#4T/D MLN>N.%2U:J998F^&QQ<9&EU=22`)KR^7HXHK-IF(<:'[CLD9*7N/M M>$&Z!K-]"-9?\.YK1H>P3OX*FJI.5KR`SX54QWU(Z+TJ`5J:"EQV,%A<'.Q<(4GF![0.1C:@G MR`$5AZ6;PHV1'TCH#,O?_032FELI\[U*`3E/&!T/IF8`H)X@O$;$.\XD_B,H M>_//3D!6%/.;8W"!E(F`L04\@;9O[YLI6Q@SP2ME[-PM[,10B0[@*5Q#V&*Q M")C34?F4$IDP"KLZ9^A9>T4Y0-[-'5`='P1)%AX=4=I%/XR_,T1RT-H8.D;8 MX:'3.VGQ4->RE(KEYG-?@G$27T:#>_"5C,!=0M<$"'\&PQLPFY?)!$&8Z^"+ M@!@A%;^PD`.4/Z9;T8$?%`0UQC+/+&WW;H#9W! MM@#3Y.!0$*4X1BE-[5T1NW@L)7PF]#>5"N'^V.AQ1LW1O&0: M9PR^5N0>;U<6K`-GDHQ78)B6;V;TM7Q"O!.BC9/OI-",\-VTQ%H MV(8N/9E27@&VNRK+@8<96`9A74[+256]M+?$Y'DGF6FV)$OY(IXRF.4188 MS`!IMUX]"<0/<[&"R\DIQV^/ZVLT^KT8#?H]4U&SB?7T`I"-9#.1]G@.[?V MU8`M$].()W14#3(!NT%_*4;G1.'!Z@C?&NRT]O93H^Z9Q?S2/`(+#'884`OHQ]=VNX&G\OYJM<0O1&`SBIQ*KAXFZ0+:>`>(;A>,[`3=[.S05B8 M@`C>LIGB[>]VL'_F8.=4W4&&YZ@LJ*S?\"1"-@[:.W^H#]D8'/Q!:$95S(9< ME931\D=AQX=7Z.#*1^1)?A*5`GBAL9N@+^^>:`N-UT7J1)@`,3CT8-7[$L2:(38/-6,JJTB0YTVK)VD0QQF MUG\VM,$WTX\A^Y)`31F@(1S@_R`:6_4%:0[8[- M3E)`),SRM:3A;.^T=[_B-/#)V8S%.4!0(2C]/+U'`0):TLQ!T"NHZ4*W07GQ M)8$[ M!!!!)@CPMO(4#-P6X(-D&T(!;$IBVO$FK?)YQ([#97PBAYLEO_GXE_>L!H9% M^%9N/-SJ['9:_9U]3+1BJ/+N;JO30?D<-70J-C!(4AW*6C/"G802^W@93S#S M0[9;!K$*Z"4%PP*8[N^UNKN[QMGDFCRM@_:PWLU[(%:(V;Y$<-@IHXGW734X MPWRBB_EM4"OK%+;CD&N&5\AM\]_=)4(?]A&TCE[D)R1P[8)!]?2@5PIQ#U0J M6I+ZL#W#_(^X\@JA1:B)\%0CF)Z1:JFFLP\OX,Y.W>GQBO^R M`DU2T<3;9,,O[G*2*)B[:6OMG>`@Y<(KIAY`;AKLAR#=-#4H7N""K?W^5A]Y M!;U^M^H$_K("F/$(AJL/*XB^-8<`)PA"ZC>XG/5W29Q.+^GX-CN[7LXMWX5@ M`]*D;,[3\PEBX.5F2D^W<)(*W^L>73G@8$]YO"UB;8NR+)9S$0YEBH'Y,$DI MS/Y-D0/<-@P7]A]"8Z)0;Q,>,;@"Y[9?_*#.<3/@@D*\%)J43UAS'\!E M]$6#Z(,H<5XD>%SA=;M!>%B[R0%M)248_OY^Y]">K'*5&(@`T7V@,9<>ZKJ-@+F*.3 MN<*+X'TFV]I>X+HH<)6**<6TD&Q;A*MQ]@+UEBP_TW@4ZSF>!](?5S.H*T*J M9\`Y=Y6SAW#!ED8NQ@$`MP6AL`N-LM]383G9?)%?,^BBV^HB/C4_%H.9$!D3 M>O0V[/J+=1VL+C(JHR+?%A"O2[.,A,><^T,@&7NMGDN+;HBY9FZ-\5CL7.(T M2SE@=D8B+RBRZW6X=S$R;77:K%H+,=")[13VY`(=Y-JY\[G(:;ESPDGJ)F>! MYG:(-?AGR6?)^=JIDQX@`]W`,+[700;80=\NY'()TJ6II>^M M9RP+$QE!;@SR)#:K@U2H%>Z6^T1$C/8+&J.REZ^G&T@OW@V,!`IM$T7_+3:( MMZ&YV&W[YS!%1K.CF$F@>,. MQC>08#;!D!_Y-^90:QMQ_XY>4A!P%UPK;,%)*0+(5U)_F)/SU2*7@O5MO$*' M$_6V`8TD)J]4*4$9/9)0D=KJ)'4,(KEQ<@T4'*Q,YZ=6PJ8CU"0AC!&/+(>3 M+:(H%.,\,4+?"?NLX'?X,B"L2O,(ZHBD+@CJU9+10L/YB>Y,/0;+R8F#%T[0 M"4X)VX/VA4IF+O+1M"0+1L3OME=6H@*GEOOT1\\)!IE-4ST%RW!W!-H0( M1IM.WX2%2T7+()-NLY.(0_JPP%IY^6*?!1/ MH'2EUMZ!H+*=2[P0K]E/DPB3GMZ9L\&5['2U(Y62=7HUE`P_*B4S^)20N8"6 M"3Z9%@?QR\^I?4#@D$!I$.@1(*;AT(CD4=U>G^Z-P;8F`J4%;!8#@/>:$!73 M)V;5Y7D+Q9,97+>&?%ZEHJ#FN5J`#]B8J-K-L+,.A"^21?PW)Z*>_OGOAZY4 M0/TO(X+N,",B6$$[9!--5,I?S^-2J1IJI-LJI44A^;1/+<.>'OQP!ZW.P%,5 MW*%)\$*IUR,!1,Y.JPO["@)@#1'CJ5Q/DD::Y?8K7W=63;,:M_X+21@HV`!5 M._*CB0F+@2XN8&T*UH&*K-2JY#8HDSE=.%ZKGHB-3-X2(8&7D6.+L`G7*%-\ M1DZZA_[#2@=@4O"051$`_R'@R!#?G')*-ZFVBBK#O M%JC-=F&:@M5QYP^V'='#G-7`QVYPGP6D@RK'9^9IY-]R$MDV(*W3J9L.%C&9 MCEP=1X`"K\)R->V$IR:=+8`:W)??5FA4=`Q#C^]0C7A?)><&FPKV@MNTZ"F? MT?HISZS'9N#JP?4QII!%G.Y@?Z<1!.YO-0RX^>&.X:4RH8*[#J80),;@0F>+ MX'>,5BYUMT(SJ&N!9%0M%U"EG0Q"$G9QC4`=6A@M/@$".4S84G4$G\`#$AD6LGP() M[$M).&+-2JQJ4R8QL2590/9*/#ZQ0("."Y&.5?RB`MSCPHKXE3="0R6=@P,1 M@V%.0Q\;$"'E,W)C([%Z&$D5XAF$;@RZ\!5U`T.*O6.WSL@'I4/_]C8/:PS7 M[;5[:M7H#MJ=FD`(>Z&]YS*UVON_7U@$T?'+0R(`IMX66PFGJ%R?*^E@`VO` MZ-YCP2@@TU5;Z+01H;0)C'8.#M!:!I9S;^U[#D#:;>\Z(-W=%$@=M!):),;+ M<5BKMY)'YOASLJMVAKI\1(VECB+7F0,1Y91P;O\B(#7#6OS/$IJKT7B5D`Q2 M:K2V%(SA;BDX6>L)*V=+`ULZ;1@4-H'3/?1">A8P"L$!57]V:R@G1K3W!@J_ M3PX,02N'$%%OG)L^@`WS-3:!5\&H@K,(IM@@>@8Q&IN`UT'OF9#`_P>O)NJ5 MA,E\&8#M;DB_6(@3H7G/AH;M0@Z$$:^FI(=H MQ$WJ;);SS&Z[,U!-!%7C#C8B;PA=/T!7N^<#?3T*>%"AD=7,,]JPE(JD1?8HOUR0K%7&E])--).9B.N>D M2ICJX%Y`SXOAV?!84T=98X0@P@#Q;,ASKPT)D@@R:$(0*(_0Z#&TT^X_5>6' M4F<8'5J&))+_L!G9IF-A$[I=CB8LRZ%H$H88&W0&V)!")1J1HLCI\X'*/H)F M"&H]!,?42P]0$`&,`I6#SM/5A2[124[ROJKUHH1%#J66]21''[P4?^R.!79ATL`81A`V=GH%GPYAWP9AK M]290OB<,=CY/NM*\^`6&//R;&(4&N_":/R?8:ZPVWFGO/F'8 MLPI[4@\K`L20V'U$CAS:SYIJH=Y91HE"W#`-`7_Z*+4-E:5RZ!-U:2/H0Q[A M\R%[W6:!;^\I*^CC6VUPD"1A*Y$]LIGL<;*9ZE`/=QB[KW5[K@*UQG@N[ M'>RU]YK8[=[>T]4O@O")*-'/P=WFVD7O<7CMAK$2`+K]'81O_]\!/.3V-_!: MA)E'22'&G9RKV0_X33W-43A$!=R!E2)C&18_QD4P_^G=G%7I\,`";EF=QY5$ M62-88E.3915!1+[*)ER8L9C[^\_(!M/I[C=YG[OM/83HT6;U%&WE8:A.!6QN M[+_I/@XS1D&*C6`/I7A0(OG9T,0.DOSK0L9`&V"#?L+DX9\7A\< M'Y]F\]4"X:$6`02E@_P:YR!=(Y,4=PN,UKAD>$R8]8QPG/U]GWEIP3:2U8FX M1G8"C*L\(#!8U&F_%6>W]N\4"GEIU1G8@GSA&-ED,5L1.T+-V(4$O>8LG%\B M];@8&HV=X0BDN!PS5;8.F*GC(KWY@+1&2A9-5NMW'2I6I?E%X93EGX`C?[1N M7_L'4(*H9.*/A@`@V,=I("_08'==J&_W7AAKUPD'Q0@O]E)[9?F59>VQ.B^^ M>?4?U_,;AE'_B!SB/[V0)_=OD"#(NGY_>G&(Y+QW]S..>S^&FOR@C[M\L+CF M._H`%63G]WSXS?TYE\U^_GCSQ\4=.C+_Z06@FYF%TQ>O,MU?V59V&KNVLU`*`WR-3Z.,P!`1> M;L(0.JBTTW].?OP.0N$:S*$01ES`<94PXJ5@LR;[*_QUQ&27B.W]VR1N24Q\ MWN`$Z$,T7CLS7T:GUE-/'M$08!?%$[NTBF]UT=.W`P(O#D;65!P<[!?L669T ML#/YQA-]QW3DT(;BTE<\<8W)%%<0DBK$&FL>P`&TUR=)+_3=0B!]GL+C-JD[ M8&A['B@C::^NH(HFHKC4/LD\Q`_$E_HUK=.*'1U)98?(-$1C=Z!&"$H_8!CHAF3BI M>2WEK2K.[ZSN]DIF`O;*3/WD8,1ZA]\@%"?O%6Y)X+[VGIS(EWQ?7U(0DMGS MZ^H,XG<*WU?$K'BHW8C$"L4_NANFT-F*,#0>2A$6YX!I4NB)T36[0"]Z+6U_ M`D&I%<_%X*&:I;-M$6P3`"ZD-0E6+>*9(6D8[4G)MR79,^O/UVDH,7L\DO%M M,R-'O]]Y-DJF)"C5.EA]1A*YU;]'C@?5(]&5II`S72^V1*0()5GP_K(8)X@F M.7R5AZ:R]/)FPNNTD+ZAP7^DL4[H0-18),3:`OI%4`K-;.G8?UA[C8)+'/<$ M"9=%',I`TG)PW6'ED7T=:X#J%]LHME`3CF4CMX@B%`]AB4STB.JFB%^_;:MI MEU/2+'.WN\X5QS]4"Q5S:CFZT&0!ZISG/57*X?'`!K/U"/FQ#F0,@IS0"JV< M50&]3!Q`E%\\AXV55&1D@*DCN)8R[M^7PFK:$`F%<=YI22QK<><=Q6P5H=WL MQM=H#X&201&.BNZ]!II"X0SPU&\+A^A]SF:C<7GY#M[SM.6F_%6\`($011'J M]$L>KO:L'HNUGJR/+["\S_ZY^[:H1162"P<;RCK>0?:B?I/*Z=0R`\6?#76:S"I$/,-&0"$FU4LCQ\ MU_#)(Z(T4$^`T:$9CK=HV&G*-'ML)!-`2(IT=PL65J,_`=N+^5N_WQKL/*>X MHD&3.;,]^/TBRZLY18D`WYCWTRA>N3(KCF[/7)WRL$!X(+B5)#3&TA8*)Z`J MQ`=EE5MP&HL>C3]@/*^C[3'0H3SZ_N`Y):#UX$L2S;FQ$B.RI61D8V`E)9FB M7R,BW^55:J6.OS<4AF()RN8^>G'[@&+Z-6/H M[>\LQG4'04S4Q#7\TA"BU^PV5,_(6!7EU6=LS MA63RYV!,`_#R3/W;!L%R(2B4-K^?`()@/M62,(2?H`\/I27D?D*(K-4>4]@W,/G.HIM,;'WL2DO%5ZU00TVK+#1119/KUR=_?5!UQ&P M1X9<3`TELMD;D(QKHX2]@YD`[*1T+ M6U1`?\OH7[&-1"`B&@EL!+Y'BE':V:RN`5J_P"KP;$`/B8G=IGAA1&:(=824 MY=_7?!R`WF+V,\KOW2Y_3/LV@_.ND2CVV^C1<'?5FZMBH1!T#]&,SP?X8))J MYJ=0>BAE/1G@8Q0P=:J$Z*%?F0<]]JE0X<\D(E^4'3P2!9EO)]+L0*/H7!%. M*;A)A2>L(ND%UU!K263!_=8!W.F[T*5S^^JU]DY5N;9H;ZWN?%+L0(SCO$YHT(P)0"F[B_S7NC><@5XP_^O*'3"'E/GT4 M(:-)>#*YC&WG;/9;WZDAJ$3J.U7(%K3J*HM]!M(A([6C7]&=(K1!!(E59Z6QX1,4[OQ,6@6)0T2?'JIU2B+VL;R+.['[-!7O#9 MU^.[V7)\$QQ>QPZOVZ8F$U8[S>\%]##O7P&[/A2:+;3W[*-1)>``37=Q52A8 MJ^UC#=[\G0:B)`I.X"ZP)=J)I9V:U*4H!CSR,"`"<)7E^"=$]>,/\'-$A'R` M8L:D,]?.AA6FV/T>() M7U5B9$@0_Q>&1A5"#B(_**FBQ)`B2&K_`$%2/=@XV$*UWW<%$O=Z**W<*X1( MA8$39M6V:*.%Q>;*/0Q+7(*N+HF"D)L=Y[E1C)2`#+?AO%W5\5$Q)+@FV!K+ M)'`JOBO?`'Y1"-\I!%0M\F^,J-V:852X[JH8*A69+48JWC2"6T67+@OG8)P. M09/VS?B]8^VSI#7&$3E5;*X4CY8.BC+33A)9DT;/6!!9/(M%^D`X2>*'MGL( MHT:?R?TDW,A](-K+Q?,=N9BC0UI-;L`1X@';;&,I42#Q+\%6DFD+'X2/KOJ< M;;3A8.QW//H/[O#2/=0<$_SE?656*K`PL/ZZB2#VPA77W`Q`W$0%-%0&KQS8,2D&44 MZ50,XR"#F*.<]`@R^&A-`N*+Z5Z9./U='$]U:_'"[F^&%2` MFWI8@?87E>+/4CL[+S0.TU-$V7C`8HRD_.1<.:2:O#5TQ\$]V56+%.*:Y(!L MHMLK9?]="_]RH:?%RV7]<=A&P>'Q-F4W"_2Q#`-( M"+EWB>H;AKNB^285:T>T.U1[Y_+Y:/CZM2HK/4("W9!+RHN)]S2?(Q>>33ZG M.1WJ8*'4F&Y)^@:I].(C)?'-,"Y)*!L/4)KR^I-=Z_94)MQ2?UD;87NSC^_0 M&%"@^QV[@4T7/BE$@XZZK8.^5<#KM7;1(4$D8UEVDZ01N6[%\0A#8VB\O/KV M\NBO5T>GH^SH>_Q_0JR2`8WHT`,Z)&_%Z^(>O&^[W_K7/P-@^]<_G>SL#&^$ M11\UDM3)*"@U&&G4Q/@#J-B2P%CT.A)M$#W2#%/6AW7W$JH3=C[B12\2V@'(/T9IQ"C&8Z'@I M[4;T%$Q!4?6$PC-P7-':/(&`9RFQ'GGL+_'?.5=FS)M MFYF>:I'@C&\6KAT9/O-N]N'#P[LQ&FS=@S`(06/GOKR'*(\GT`?J3PODTE0[ M5?32O>#T7(+70&^'OQ%`7AL!2V]>KCZL;Z,"?ID*_UX=OR`VUE-PS)2&,,X1V M$D;T-`)6$K`?9DH!U-1Y!]S'3X7.('*"GE\4;]E1`^MX#8+F^RSI8>*K"U1` M-%7T;!07=9%Z%#UHQ9,M"56(2(19'"6H1T++@@8IUFS*,#@/JDOT0S!2)7X0 M/&D5BK*VR,-O81(2/_8XNQE_1LH(8_=N\4\@*?N#7"/I?.E3;J19)F^?B6U` MNMO96$W^^,?\_B-8II%#M@TAW_R0?;Z?WWYXO[H1/LGD`&(+CPXL<;SX2:X6 M"TW&'Y$B@D?X!6]"7A1.B`M_!X_Z>#91]##^K:WC1+;X-/LPO]?TS\EL08N# M\O2;\0Q=9#Z.)U/K1QCM48[Y!K.SBR[WP<3+^:WPS>E[#$9?':SO0A0)^]/% M_&8E'R!7BB]`PQ.`,'GX<(EE\01-4)"\B5.DQKC,[N:+Q0R1^7*&L%`%$"R] M">\08<\#T:70?A"M!UT;E=42X`9DHX'J`0:!]Q@J/1@!F;[3"LF!RL^\%W1) M68#ZHVW,[0.$NAOT4UQ]^!'79V*MG)^=G)\>'QTF6V?S]'Q!7PD21(X!Y5!FQ.!!@A-$V0BW/^4 MY`F\&1Y?9-\/3ZZ.N-J;X]/AZ>'Q\"0[/KT<75R]I9B1;8]XG^D*E\Z0F)W, MQN]F-_@6`-];`,"*O`R'\X9]'+X?WX#P\7X@5K$3+\'DV_%BENS%SX=;"%YU M,XK-562OU\`KJ-LLDA2N?`4Q[4-V@JM!P7>TVP08URX!7>LG%%_"5K#;\N$C M7%UNE$WX-`GW'/&\]TL!3Q&F\^'%>P_)GA&GR4PD?6`7I0S\5]0S=,'$,>EI MJO%%B*R6FQ5H8J6*"4,?)OE)W+@[>!#96(O.(@B61\*-Y$89G=+U$IK)*?TQ MYC:I)#5R_#D;02]<\"O9YQ#4(3MRW7J2B_K]4^\N M\P\JY-M4?EWR#82>_-R70A1_=V-89/!H1FXBXVH)E,[>@GA^7'T$&M_2&`&: MAA9I1,M%=B6V")Z3VI+D6\_``(&F@I1`LFP8F`42B-N`Y+V>+L>SF\57V?;5 MY>ML*Z%\1XZV3Q@$3K9I2>IW2A+CM5]V=\+`Z<4,T=+XW_+5<"*X+4C$@+;D MAB^05SY&^U`ALA-2GOF=\PV)[3=YX=P90EK2Q9+:SD2Z:NI;?S^!HID=HTCK MXK_C3;Z>WB'B:2:\/_[M*O_,^*>7O?)/>[E7_OR[,QK##L].#X\N3K/MIJ/N M9&_%EYL=LWK M#?G\].L3\`C2=G1>^R`D>KA83`&N=0<]A,UF.?N'"EDBPB7?9:SU[V^E9E!R M5U<0"642+.Y\0K-_X&^%/_",$E`J+.MOEOBE""LKP1Z:X\'BHSX-60_$^WCV MRS$%Q/OY]70Z@3@BUQZ/R77Q,V!`U;FZ5$G.YI1ATWSC^4X94NKV`^;*SHD\ M?TC7*P!&/!H`HI]"S2S^,=_:"(%_55LS#E?U^T5Y;XIX,5,8LX?9]":%.WPV MR2G\A9!Q0-Q$[;@>WUR+\HB+`+$NS>6*UWG9W.,M?@7.`HTP(36-?WSIZG_$ MST6,\UY/IQY._PO3W*1L/_`N@WTB;HKF^1(D59 MHX5KEUZ4TB;Q,]VVKMEF2K1.(1,&!FUH`\#A^_L'B"N`MDE"TH]O1<58CG\V M-E:.MF%;CC.8\$QL1VQO$P`PK)(`60 M%^+QEVJ?((2*[+*Z`S9Y0R16JZ(T'F/+:(>W1'F"!2;N;'VR?1$`JJ;^=GH+ MA17H[;0,*5?T?HJF[/<)`AZ*'B(C9*WX^];2\T(%+-2L-M#I()0U\F:O%;8R MQX\I!I4NB$O(E4:.@H@),2C4(FN9N6J#G4JX-&VQBFSK[[W*]]<9A&:(E*))%57("KU7E3S[$E5DU[@&,#TT3((;R9-G MU64%AIQ!KAI=1F>'__GGLY/71Q>7+S-X)8[AL]L^I>./>OD:R_^U(Z)(YC&Z MZ@I"(3(A3\XVMZMR3?-D$-C-(NF(384(9[E7L-)[9=QCZBX,K5T\0TS`41)'N%30`&:3G2+PNGKR,"J[\LX1B@4Y M7^/>$D9;B-/*SN.@EZL2]J^@`""T3;80O^QA"?W49=%X@)_=1(-$1E>R(G($Y`[5]9P& M0M&=9D!0700_YBS>@TD?9ZZ-Y;MJNW'_"7-W' MK_5RS@FCHUOK[9`_?HW$((@7U((E93-N>1V8AYU57(LV59)J)^>E&&K!F\0_7BJG=I;*;6< MP^VR'K(VH-PZ)*4:97#KZTQ0BS3K3+#F#BH/O0;MUEM>\]]CB*.%9GWNXU., MXVG6/,5&!%SG4PH298I`^1259]F$Q/D4U5A8.\<0YBY-MZG"@P"F^^XP32X% M$4"KDV8V4#*%28AD\MTUIBA2@O0L6358)01Q87]K_0=>(QW^&AAKKQ@(4RN."JX.J4[%1D#9QYC0\)QY\YF.?S,)@MU4CX\;YW> MUVDPNWN>%.)TSQ.]RSU/%![W/"D;Z9XG0?WN^4$LM>KS3A)T[YY7[3.)7W?C MDXAW/N]7G`.>)_,;?(U7B$ZYIV\IWG%0&-/22)(AKB[(^!.\J6+T!*PC4DBE MVWBT.7_G&JIE^H_:5>/!NK_^)Q^:>'UJ(*Z=,AI7/%N(9=$F/C_&J M5S23SA&'1+]C.+#*20&Y'T7JH"'`W#P+"NB+=3">78V9N56\F,$6CQ[ZF%*] M:J.M\3B%&ON5-^K\=N(N/7ZE3*@2Z'23,@("Y_% M$]CT.);Z@4FY7GNS?&.%#_ULE;F1J,'*W-%2F]U>PV3Q!R;7FI[0AC/:A^/( M-GXSA9,-I]CL7->!+'(S`]<63/AWKN^QBT5)Y`?W^?I:P^[7F>\'`PY7MAU. MK$(=:-/T=,%T?U6%GU]VA`EF^YI7L\@Z743]/M23DR(.;`:8Q7=C."RC$?5O M%*ZZ.!3(N@;-T!.+WTQ/,-YJ'9.`)NTE_$B1IBW?Y(8".^`[3=KW>BRA@B,X M6]!*`NL2O=*`._[,A#)D0O"G+LRRZC5WD54_-^VE>!V->R*URG=4_W+3T@W( MNN%>-IS-']N7OE?_[7$>:;-K?52?)1J?1KI`&`%`$%\SFK.`&N5R4'769?A9 MN;U`9#07`<%H^;//MXC=,"-`%6JM^WY\$A=39-]`1CI'"<.'4"2L55_M+18^ M?(``(+Z/A!C7)Q/&.Y%X2A2E"`-_KM743U>.9>=(+)O/PHDG<KBN<.]O:&^4A5XRK3XRI?2'90 M$TX;!`(L\M"?4(_^9K%8OOI?`0```/__`P!02P,$%``&``@````A``OY\_R: M"P``4V@```T```!X;"]S='EL97,N>&ULU%UM;^/&$?Y>H/^!X+5%`]0GB:(L MR;$#J!CD7+=`4!251-F.^*!1U9Z?H?^_,\FU6%*FEM.(Z$7(6*>[, M,\_,SKZ2O/[NQ?>T+TZT<<-@HO?>=W7-"1;AT@T>)_K?'ZR+D:YM8CM8VEX8 M.!/]U=GHW]W\]C?7F_C5EL%D^.;V_>AVLG@%]6 M8>3;,1Q&CYW-.G+LY08+^5['Z'8O.[[M!GHBXAYN[Y8A/[:CMVY MZ[GQ*Y.E:_[BZN-C$$;VW`.H+SW37F2RV4%)O.\NHG`3KN+W(*X3KE;NPBFC M''?&'9!T1O&W_XN M^?/N3^_>=?_SS;?_^L%9_OO'/Y9_^_$;O9.I(3+!!_4RWW=KQ<+/B>1.:L'- M]2H,B"$&T(1L73T'X=?`PM\@&,`\O.SF>O.+]L7VX$P/X2U"+XRT&+P,]K$S M@>T[R14SVW/GD8N7K6S?]5Z3TP:>8(&17N>[X"8\V4DTM*MGCF@RFT8(@[.I MCV>H33Z89./)>IOLG_;8Q.D:'-9U"G^<+F9%O5W2=)7CHL3A*;IR7Q$]T>-\ MHEL6Y)!>MXNT4H>=2=EXU@5]K2F['+1F6=_J6T.IEG&Q6/8;*NQ;,JD\H-#Z M,+QMC4[YRJJL2]-P6S4`*YQ<%EVHNC7U>VCAIXTX:;E!D^HQ+CJ89"[QL^I7 MY,<'UW!O)%SRSIK=,;T$F2B*"J&6-1N>0>C==#R3CW0V'LL6 M:ECPD2STPP`_DH5:\-],&J=IPC1E@CT=CL]TR3 MD3Q/(]H-ELZ+@R,N:325$0P`P;@_&E\:`*1KCIBJ5A'T`F/#A/]9 M=CX_`MF<#G357B4(%'F5(%#D5=;#[TC(_&E-@'DC/P M4+E7"0)%7B4(%'F5S4M)K*LPB:BXKA($BKQ*$"CRJK3.9YJ!Q\J]2A`H\BI! MT+97LV'5[.[.8K,4Y9Z9M/YQJ@L[\-IQP&.1*TG`H)L@ZZ(74?8(EF*N9IP4+0$QD(2%80H:-Q62QJ(VDA)B- MI("@C:2$J(U0=?95KHS)9;B%AK!,4ULAOY3JQM3`#^L=[['T0(FRG0<*[+'R0`E1&_FXR;S+"<^G+C`] M[T&RPS=W^7$P0%%2D.`A&3Y-3[AX,(EU<_VR(JO[L.4"E[]Q\P!^A9GB]&O2NB8'H*NJ M$"S>5Q32[/7:>[W?^G,GLM@^#*:"G;5`3W$T9=V"XOB#YSX&OL.FX?1$S/=1 M&#N+F.T383/H57CZ%7AZJ2`1/*?H-ROT`T_"?)RB'Z9Y]OH#>%&J'X)+6+_, M>,`=,6E0@PMH4-?AD8D`!O,9`G"""@2X@R?E`,)3!0(8)&4(($`+!`"G)BI. MJ0<]DLT@!@J5H/]<*B''9%9R*L]H957Z!?TU5EI<^CV)9I)O(=`+FN&@!L!) M*JM2K*H40]P.-:V@``YJ*+"@U973Y/6JH)K M(15A`#Q*:D713^AQ+4:+-!`(JC(DB09#58JD&%3ER,(5AJH422"HRI#4$ZI2 M),6@*D<25ZA*D00",*(D0U)/J$J1%(.J'%FXHJ\J11((JC(D\43_S"FR0Z=- MDTE4,G]Z:1XU?ZJ]K`Y.I/:J!DW@]ZQX,GI*1H[@"S:6(D-IO&?*SN9.M:

.[6`R50GTO%>N]A=T#-?(WO]X+S`4#19Y7E9[#K)*( M@Y;3@!%6MS]>C@>!TU('ES5V?"\;PSE#0%+EQIRCFB9HWI5CH*Y"/$)51+"V M4E?A0G"SY"%<@RKK"M7_TW83NZO79A!ZT/DY&R-'(<+AXMM"=%:.FD?-60EJ M#D?8795!?$*3AU,L;RM8SNJ=O$*=0-GI_CK82T`56:_RG`YJ'JSM>.<@0;0; M)0YI?Q^FE99*'*0@G(,4D1B2KIRVFBR&8`],IS0XJD#0WYU$X_O6O/T66_;* MADB5&;`$J-$8A/)S;G1L[UJS+D:;\*J]208-#0")5+DC?'PJB[MSJ!)"\-@* MV3\#%HG5X0IIX%Q)@^D6>!5LJ(&^53J_5CV6;0'N$=GE#>!M5->/ MR3ZBW.Z0O#QS;B@$1PHW8F;B0ZXML MTXE20@XJQQR894IA^_>W195>V0>";32"K47D1DW^-LU\(Y*&#T^$!SYW?Z]= M:!\62&O>O\9UQ_G6]>#A*KC#"#>)+6"--_2GRH+(@W)K*ROUH\MP/!+F_W.M'/E9QMZ((+BJK\",?JWW!6*6R M"C_RL8HF-\55^!&D4N[AAZ:R"C_R><(4S!/4QL*///<#0>YW,RH?\89@Q"=2 M"M_!-\(1SBR)<)1(*;S&1WE?,,H3*86_^/@V!>,[D5)X"N01BTSX0=RBW$=] MGEU3D-VIOR^$)#TYBV=M M!@]7R`7Q]0&;41%!=R]KSP[L.(Q>-=R!FXOCG3X0%/?G,,PYXB48<"@"Z"_P M>@QX\X8&O"0,\3&,VUB;B,GK`D\/WH[71`R43M#P\8?=]B9BH'0BAD^JV'\2 M$?,Q6&]S#_&Y%)MN$1&?W.#96?*1PS-L`$@12??.-H[L//[X*F4($G./C^3( M9?`I(GE&=?;\D+3_>0]/X,A(Q,TII.Y@'UH$^-^V,:$12Q$A\'!9(2$/;@S/ M*`AA5WPN8B>C",KXAQT%6%NXJKL3HQ46%?<80.]_^5(\GH7Q M'N,+9-B#6_+Q`!"U=%;VUHL?\A\G>O']K^P)8!!,Z57?NU_"F(F8Z,7W3_AH M-:C%,!B'=/-I`X_K@K_:-G(G^G_OIL/Q[9UE7(RZT]&%V7<&%^/!]/9B8,ZF MM[?6N&MT9_\#RO!M.U?PNI83WF;#WKH#=QGTS*N-!^^\B5)C4_"?BW,3G1PD M\-GSE``V[,;)C.AL\K&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V M&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F M6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$ M/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6; ME8KT81C+RSPA,S*A/D%# M3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8* M)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=VJ^>?__J M^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X M6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@= M\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D M'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#UO5D" M53,+2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1Z!Y%'4Q+33*D M(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(K MA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJB MPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$, M\9BD/M)Z+_NH9IR4Q>Q,O M91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3KX0- M^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[PX7988*0SI>UQH4(. M52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0 ML@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD M_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[M MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T M']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<&ULE)A=CZ,V%(;O*_4_(.Z7ST!(E&0UA(^NU$I5M=M>$W`2 M-(`C3"8S_[['-C"89#"9BY"8QR\^[SFV\6R^OY>%\H9JDN-JJYJ:H2JH2G&6 M5Z>M^NMG],U3%=(D5984N$);]0,1]?ON]]\V-UR_DC-"C0(*%=FJYZ:YK'6= MI&=4)D3#%U3!G2.NRZ2!G_5))Y<:)1GK5!:Z91BN7B9YI7*%=3U'`Q^/>8H" MG%Y+5#5KU\2W%Y`8E#7N3-!Q-5E3)=_SA5 MN$X.!<3];BZ2M--F/^[DRSRM,<''1@,YG0_T/N:5OM)!:;?)G<0+H=B(@&MLX^`D12->>M:KN:LS1L$W#E@$@3Y5125=(K:7#Y'X?,5HJ+6*T(7%L1 MT]$6EK/TGE&Q6Q6XMBK60C,7AOO$2!:M!HR]TU@^J^&V&G!M-6SK:4N6K0A< MGQV(SE/$,AXD3;+;U/BFP#2"))!+0B>EN0;=+M4\,7WRO\H]))V*O%"5K0KS M'])*H&#?=IYK;/0W*+*T97S.P&?/F"*Q[PA:450VN)=UG5&GL&.Z3M&X(1XT MZ!!U'SI4UC#TQ]7=14AA&F'W&+]K^`S']=Q10)R!Y_<[ M06'!B7'#GC?PM8X5^;@A[!H^J\9S1Q41/6)LL6KB>V;HN1`C+&WS8Z3P5@7U MOJH]=R$^V^<,?/;,B-A+B4!*A%(BDA+Q%"%X!$OW?(\H#-O>(/ZE/7+`YPP\ M_TN/I$0@)4).+-FB[!CT3TQ5))6(!0FJT2L(!L'V,32(;B4VO'M,KZNTDVB4 M;8V62)\S4T9)B4!*A)PP#>:4J5G+/DJV&47\_HK?'GC`[L9?]Q8\HJ_(@^UV MVAL*B]YXKB..RN?,E#=2(I`2(2=X$=F/BD@J$4\1@D6K9RRBL&B1NQKM&3YG M^.`7JV'YLM3M^?T)"P,I$4J):#@*QS.=STG$"VA*0?`'*O2)&F*TZ)!MCW83 MOX4F+-BW2+>.+(1E@$40R%5".1+)D5@<"_5R,!U%K^B[WV"^S5N33/[&.%R] MW=5XXK70I&=<9P()6A6^JK"R&(3";`WE#XKD2#R)B)[1M\2!9]-K%)Q#[V?@ M>*=KH0DC]G(DD".A'(E:Q+790FYHAB>NJ/1D32-Z/%CN%#\Y\W-4B>H3VJ.B M($J*K_143)7[UO[$_K*@9X=1>T!/\@_:?6OM,U[O.\`!^Y*UYR_=::8E31]6->"TGV)=3] MZL\)/7NW%Q?V%:=2*)%I!^Q<"WI9\\I=N>"TW:0<*C"Q(\FR&-_YZR3"[G;3 MYO.;LZ/J_4:J$,,T@;&B3:B&10 MZA_B^)7QO-#0[1`*,G6MT[=[IB@$"C9.$!HG*DH`@$]4<7,R(!#RVGX?>:J+ M&,\63KCT9C[(T9XI_<"-)4;TH+2H_EB1?[*R)L')9`;TI_7@6A/7`K7UW1-- MMALIC@C.##Q2-<2<0'\-QJ:P&<1C,;I2/ZH42C0F=\8EQG#88;N"[KQLHS#8 MN"\0*3UI=I<:?ZA(S@K3"<#K&*'P/N._0S^C&+%!,4TP;#M[`[P[MA%9YQ8.4]E939\M6`TEB96LVE,9A)[G=>L# MM,7_H!GQ&&W1^=IS9S5+^]S5?+2<#)9GX>)]?8"U'&)==^+,IC'>*U2R#"P] M9PG,TKX<[(4633MA]T+#4&]_%O`.9S"6/`?$F1#Z?&&&7O>O8/L7``#__P,` M4$L#!!0`!@`(````(0"VJ'[M9@(``/<%```9````>&PO=V]R:W-H965TZ]\?3Y(&NTX]H(U>0XB6*,>,-4(9IUCG_]7#Z- M,3*6-@6M5<-S?.0&/\\^?YKNE=Z8BG.+@*$Q.:ZL;2>$&%9Q24VD6M[`3JFT MI!:6>DU,JSDM_"%9DUX#`,-&/<*BR%(PO%-M*WMA`HGE-+?@WE6C- MF4VR1^@DU9MM^\24;(%B)6IACYX4(\DFK^M&:;JJ(?:ESE^22;S%)/9U-?GM^![<_6.3*7V7[0H MOHF&0[&A3:X!*Z4V#OI:N+_@,+DYO?0->-.HX"7=UO:'VG_E8EU9Z/80`KE< MD^*XX(9!08$FZ@T=$U,U&(!?)(6;#"@(/?CG7A2VRG$_C8:CN)\`'*VXL4OA M*#%B6V.5_!-`R8DJD/1.)/`\D22]1TE(,.3S+:BELZE6>P0S`Y*FI6X"DPD0 MNV"#=X-!(G?FQ1WR1P%MH!F[V7B83,D.*LA.F/DMIM^0U^W&<9!=3_U082O&XI@-?:5YB!,VP'33='?1>SO0C MF@[L-"\=R[+_L@9(J.\H&PS'%V,A:_AVPVRW=,V_4[T6C4$U+V$.XF@$SG7X MP,``+<+```8````>&PO=V]R:W-H965T&ULE)9=;YLP%(;O)^T_(.X;,/EJHI"J4'6KM$G3/J\=,,$J8&8[3?OO=XR! M8"?IDIN$CY?W/#X^Q_;J[K4LG!?"!655Z**1[SJD2EA*JVWH_OKY>'/K.D+B M*L4%JTCHOA'AWJT_?ECM&7\6.2'2`8=*A&XN9;WT/)'DI,1BQ&I2P9N,\1)+ MN.5;3]2-X4\"X7]$$)YUWCWGA+3QP6J]2"B-0:7<;9WH%H!6]18U3Y: M@N_II$`VE/9>B4,7N@G&*V!F7M;^RGN!W">M(M(*^.T5R%3$G4)-'S#T()"9 MRT&46(&HV5)DD7XPC!M8<;4B:*@G:#X[D!L8D(,AABJ6,=3I^WE1'X7N9##J ML1D]T@JHESXO$U,1OZMJ*;#>Q_K]D/P,U_P: M+B4VN="AB'4;:,DP,++[[UARADUMFA>O#$ILL5D-&&F)P69U27PL.<.VN(9- MB2VV@ZW.FY88;%:?Q,>2@XG1!0B6B\L3UZ@M.JL!HU9CX%G-$I_0G.-3*_#% M$XOT>CU<09#5AE&K,?CLECBA.<=WU4Z`]+H^Y`OLKF@U0[[`;HL3FG-\:J4> MY.^R+0*.1785!G:'M)HAYX&A*51UNE(V\V;I06@VO5WXTT.IZD+4QR*]S9>$ M;TE,BD(X"=NI8PZ";_NG_;FM/5#U+^`$5.,M^8KYEE;"*4@&G_JC.&PO=V]R:W-H965T\1>1$R(-4*A$B'(IZYEEB20G)18FJTD%=S+&2RSA MDF\M47."T^:ALK!#91E-2,2274DJJ44X*;"$^D5.:W%4 M*Y-[Y$K,7W;U0\+*&B0VM*#RO1%%1IG,GK<5XWA3@.\W9XR3HW9S,9`O:<*9 M8)DT0<[2A0X]3ZVI!4J+>4K!@8K=X"0+T9,SBSUD+>9-/G\HV8O.N2%RMO_" M:?J-5@3"AF%2`[!A[$6ASZEJ@H>MP=-Q,P`_N)&2#.\*^9/MOQ*ZS26,M@>& ME*]9^AX1D4"@(&.Z31D)*Z``.!HE53,#`L%OS?^>IC(/T<@WG;'M`VULB)`Q M58K(2'9"LO*O9AQ54ZOA'C3@_Z#A>.;8]8*)\P&5T4%E?%)Q32^P1Q\1@:(; M._Y)Q+^[%$MGTT0=88D7<\[V!DQ?L"]JK%X&9P;*QXQU)&WJ_PL=DE(B3THE M1/#>0:`")LKKPO?LN?4*HYL- MATQPJLZ")-HX8)R[<5R>:D?7"E:NC[4L=0/TUK'H]FM9#9DS(AH2P5D*ZR'B MCOO]Q!>0ENA9ALEYOV4%APCF<>MP//):W69$EIJ!Z7IB^L3J)A'=)-8WB?@: MT4L`[-R?@()A)>FX\[U1W]]2,]/F1?`FMOKUB567"+P+1*2)*RFNNQJ3T06- M^)I&+P'HYOX$%-Q/P/&"OK^E9JY4O]*$SL@);,<_FT91%_#M8'(6\KI[?WS) M?1?POIU/VM?.3-8 MF*#=:F_`1E3C+?F.^996PBA(!I*V&4!17&]E^D*RNEF$-TS"'M2&PO=V]R:W-H965T;8MRO*VS&O2HK7]CJC]=?/K M+ZLKZ5]HA1"S@*&E:[MBK$L-JM'IW6]M9+,L^UG7[`=$" M,@HT"W_)F0I20P#PUVHP;PW(2/XV/*^X9-7:#J+%\LD-/#"WCHBR#'-*VRHN ME)'F7V'DC52"Q!])X#F2^-Z-Y(%C,#K"\\[J#QS#T1&>HV/\,$+0,LB$IUP( M@GVP0#0ZP%,Z3/)B.CHBKT.9#CG+-ZN>7"WH?<@<[7*^D[P$R&1]!(.JV/\5 M#"K%2;:<96W#IH5:4.BRUTT4/*^<5^B,8K39F3:>;K&7%KP-..UA#J1S()L` M#BA2LB![GR"+LW!9,J"=!&XZ_9D&:2%=#G,@G0/9!-`T0-=]@@;.LK:A$6^E M\69![X2-#[M;&84S7^4X8/12G M3)0X`TD-))LBFCC8Q7-Q_G(!Z$_N*LXSR)-A[00230L5>?-2*2/I=C"0U$"R M*:*I@:DP57-_0`X&DAI(-D6T^*#Z'X^/&^OQ"<2/ MAJGENT8VU7>5385,=DOLZEV7CD:QH(V#*(YTBTS1`+$FB-]])B/Y<<*YL2Y( M(($G!2WU=??JNQ)D(*E`EH(C<%TOGC59-O71HH>#;AJ].%`63]!>K,+%RXZ( MX_J.J@`B%L<)Y]!%">16I5DR]^J[$B60(%3#.QT166G7+,F411,%5R13%1RX MHZ@?I(-P?T;A0*A+'"$HG-2P-Z'#"(4P66^SVN@^:14.3?`4A\OG6<;XK8\G M62PGQ(I;G+@>-*@_HSVJ:VH5Y,)O:,_`I5!U>]SZ/-P9ON.WRGNXG\!I=\<^ M2."H,/%MF&PA3O/#+DQ@_-[!EPD,LCMXE,```=Q1D<(ML\O/Z(^\/^.66C4Z M@49W:-1>W%/%"QMK>R0,[I=#F2OX/8%@DKF\`4Z$,/G"%U"_4#;_`0``__\# M`%!+`P04``8`"````"$`X`<,=OH"``#V"```&0```'AL+W=OUG>/->5]\25%K))2>@'Q.--)G/1;%/R MY_?]U9QXVK`F9Y5L>$I>N"8WJ\^?EGNI'G7)N?&`H=$I*8UI$TIU5O*::5^V MO($OA50U,_"JME2WBK/<#JHK&@7!C-9,-,0Q)&H,ARP*D?$[F>UJWAA'HGC% M#,Q?EZ+5![8Z&T-7,_6X:Z\R6;=`L1&5,"^6E'AUECQL&ZG8I@+?SV',L@.W M?3FCKT6FI):%\8&.NHF>>U[0!06FU3(7X`#3[BE>I&0=)K?AA-#5TB;HK^![ M??3LZ5+NORJ1?Q<-AVS#.N$*;*1\1.A#CB$83,]&W]L5^*F\G!=L5YE?S:^!9L.UN1?(2;QLIXVL_SE4V'$YEJAC@7O',IGYT^M@$H+H.R34S<@: MO&.&K99*[CW8-2"I6X9[,$R`^+(CL(+8-8)3`KL:YJIA&9Y6\72^I$^0NJS# MW#H,7'M,V",HB/;*H#9>&<&HC+G%J=RZP+%,=%EF\A$9!*&D$6^D^N5UDL-"SX+++V4>D M$#R4Q((]^C0@>"CE(N=F M%D-:-#.!V-N'#0<-Z;O(T,DKVSZ$(C?>BD4/Q;K0N9D03_A1DFPQC"'XMAT[ M[$0"F2`T-#2YO,_"#]4+BSY10)GV?RRK M_P```/__`P!02P,$%``&``@````A`(E>#]4K!```=@X``!D```!X;"]W;W)K M&ULK)=?CZ,V%,7?5^IW0+QO"`3R!R59)4'3KK25 MJM6V?6:(DZ`!'&$RF?GV/1=C8@--L]6\3":'>X]_OK8OSO++6YY9KZP4*2]6 MMCL:VQ8K$KY/B^/*_O/'T^>Y;8DJ+O9QQ@NVLM^9L+^L?_FTO/+R19P8JRPX M%&)EGZKJ'#J.2$XLC\6(GUF!)P=>YG&%K^71$>>2Q?LZ*<\<;SR>.GF<%K9T M",M'//CAD"8LXLDE9T4E34J6Q17XQ2D]"^66)X_8Y7'YVUJ6WD2?CT6O(R?,\S[S?7C1'G77WKV>9J47/!#-8*=(T'[ED7Z*^4787VOR5._/IKF>Z_I05#M;%.M`+/G+]0 MZ-<]24AV>ME/]0K\45I[=H@O6?6=7W]CZ?%48;D#S(@F%N[?(R825!0V(Z_& M2'@&`/RU\I2V!BH2O]6?UW1?G5:VYX]F[G@QF<'EF8GJ*25+VTHNHN+YWS+( M):C6Q&M,\-F8N)/1/`C\Z9Q<[F1.FDQ\-IF343`;3US`WLOSFSQ\JKSI+?$^ MMB-+4%9;,AE9>-\H6P" M&^)U[?O3I?.*14R:F&T_QC4C=BJ"RDRVD28XX&VA4?,/@"87@E;#;95PFX77 M(501*B72!(,0:_L!A.2RLK$L6EEG)M)6QG@X1+<@,V37AK38NF)P8ZP/X"87 M;*B9SM3;#S+H+G@;TH+KB@&.HZ.##[<"M5TIN.93OENI>-APMRKZ\TX=VR"5 M%NF*@3/]&1P*-G&D@MJHD78])=(58VR472\%'>GY@CIATUP>/M5D9'))Q<.N MU\JTZ)2I#5+PD:X8J/1&UKK/_56C8!-'*L!1(^UZ2J0KQM@+_',66W-S"EI&]!MR=%AF0"4"?6`.KWKS<;_?QA=65/-^":-@\@K6"=]_*N M2=2F$!F2R4L-6./]C^TGV[7!I'?P>L5V;D^*#,D$H):K`=0'(?@_]2*CSM&0 MDMG>@LX+=T]K/=D@B<3.AR])SZ>^(-/`G4)[^3@=KX9'@4)0T[`&HP'U!#3Q@\W\O;? M&7@+UD%4D-;7]&[\-,1+;F#2LQ!OE`%]'J+;0W=:(]SZS_&1_1Z7Q[005L8. M*/ZX;O*E_-T@OU3\C$7!W9]7N._7_Y[P^X[A$CJFO77@O%)?:(#V%^/Z'P`` M`/__`P!02P,$%``&``@````A`!#B0XV.`@``B@8``!D```!X;"]W;W)K&ULE%5=;YLP%'V?M/]@^;T8"$E:%%*EJ[I-VJ1IVL>S M8RY@%6-D.TW[[W>-*4N:?:0O@)WC<^ZY]_IF=?VH6O(`QDK=%32)8DJ@$[J4 M75W0[]_N+BXIL8YW)6]U!P5]`DNOUV_?K/;:W-L&P!%DZ&Q!&^?ZG#$K&E#< M1KJ'#G^IM%'#D<4BU+XWC!%)<=#0RY.8=#5Y44<*O%3D'G`HF! MECN,WS:RM\]L2IQ#I[BYW_470JL>*;:RE>YI(*5$B?QCW6G#MRWZ?DPR+IZY MA\4)O9+":*LK%R$="X&>>KYB5PR9UJM2H@.?=F*@*N@FR6^6E*U70WY^2-C; M@V]B&[U_;V3Y27:`R<8R^0)LM;[WT(^EW\+#[.3TW5"`+X:44/%=Z[[J_0>0 M=>.PVG,TY'WEY=,M6($)19HHG7LFH5L,`)]$2=\9F!#^.+SWLG0-?EU&Z>4\ MF2\03[9@W9WTG)2(G75:_1Q1(U=@24<6?(\LLT4T7\:SY/\D+$0T&+SECJ]7 M1N\)-@U*VI[[%DQR)/ZS([3BL1L/+B@V-<9JL0H/ZRQ+5^P!4R=&S$W`X'/" M)!."H>BDC&KG*WNP5_:Y]:').'3@;UP:9]$20_MWC_J#QQ+CSG%5YR]J%NY^N!H*3`WOH&TM M$7KG[W6*S3[M3B-GD_I^?+F?Y9MA%+'I!QP%/:_A,S>U["QIH4+*>/!BPC`) M"Z=[C!SG@78X`X;/!F<^8+_'$1JOM';/"Q1FT[_(^A<```#__P,`4$L#!!0` M!@`(````(0`W?0GP%P,``,X)```9````>&PO=V]R:W-H965TB?WW<75Y08 MR^N,EZH6"7T6AEXO/W]:[)1^,(40E@!#;1):6-O,&3-I(2IN!JH1-?R3*UUQ M"X]ZPTRC!<_1(N26\C?%+(Q M>[8J[4-7SBAKV2J ME5&Y'0`=\XF>>IZQ&0.FY2*3X`#+3K3($[J*YC?1A++EPA7HKQ0[<_";F$+M MOFJ9?9>U@&I#G[`#:Z4>$'J?80@6LY/5=ZX#/S7)1,ZWI?VE=M^$W!06VCT! M1VALGCW?"I-"18%F,')II*J$!."35!*W!E2$/[GOG!POV"-4+FTQ-QX#GQTFZA`,1#ME4.NO MC&!4QGI@*C<^<"@S.B\S_H@,@A,:'R0?CR<=KU?V&&A;9_"E!(%!H.EO$,'0 M@^DA[4EM/:B'-$#Z2R/827?%;2-AHR^[.@0N+S\BA>!0RD?Q07AA)M).SJ]+P;O+!['P<$AU(^&PO=V]R:W-H965T&ULE)K;CMM& M#(;O"_0=#-W'MLZVL=Y@TR!M@!8HBAZNM;)L"VM;AJ3-)F]?DAIKAQR--;H) ML@R''/[#^:A5]/#Q^_DT^U;435E=MIX_7WJSXI)7N_)RV'K__/WEP\J;-6UV MV66GZE)LO1]%XWU\_/FGA[>J?FF.1='.(,*EV7K'MKUN%HLF/Q;GK)E7U^(" M_[*OZG/6PH_U8=%?J_SU7%S: M+DA=G+(6]M\KL M^01U?_>C++_%IA^,\.XO&!!/JW+-X:[>^SYEB]_5J7N]_+2P%JPSGA"3Q7U0NZ?MVA"18O MC-5?Z`3^K&>[8I^]GMJ_JK??BO)P;.&X8Z@("]OL?GPNFAP4A3#S@+:15R?8 M`/PY.Y?8&J!(]GWK!9"XW+7'K1S37#[O$W$/BVIRY"OTO;)F%W&.0)HVP]:%3( MWX"RWQ[#=/VP^`9JY,KG4^<#?_8^?N^Q@-WT6X)MZ%L:EN>6&9TQ,PA/6_G4 M&?0TP7":D*?!RD,XT_OI<-'6B[0BPM6RC]_MH/.!(^D+C7H/5BB$<2\4G>&0 M4BVLJ7'GY)`:7/346'R08-N-U(_K:!>]WLJB"QZN+">;\*SWI49GGJJST-5@ M.H(F>C'WPZ(S#ZLL<&S]@84K2],@B\5U"2)8>3\GKN(YE84W4CC<)FN>\WXJ M=.:IE"4B#.CWS(=NE\7XP\C"S09[Y=$WB(;!MAZ9BOX M`A[$LW3M4I,"1_J.$@H&B7E-\?`I^7CMW6OJ(`'7N;](%&"P)KS5[I'16ZBE M3+S#$TL=`V@(T^5\%`TXRF1B9>("II;$D^C@FWA0IH&FF`0(1*RL8Q`1*TL= M`XSP(VC8D2XW(>$/4N)]KC((^I,P0=ZB2SI0F/(%@A/WZR!O'OEF8OVW?A^; MK(Y`L(%NL!.5:*7(W'&"W^"U93H%@ATC=9J\H`!#-SB8Q`;R%G4H7'`%+3,J M$+Q`!=>C3S:T2F15W=VV94OCLX$XI\A;9.E@,])\``W7$,IBGL&#DC$Q( M!,K$:[+,J6`2.,A;U*3`$1C#-QB@A-,3&"T4688XL;;,J6`2)\A;9%,/%&9- M^/BLMP`>5`C>]P^)5O$4-Q,_),O`"@4P1K(I(FB#EP+`!@8*$D3`@IP.*33A M<#/QFBRS,)P$#/(6"BI@#-0$&Y"'%/L.ERG$A2*+,O&:+',QG`0(\A;9.D`, MG9,@Q$@+F%0(E8GSU3)I0T$%]ZY0--![3YET!:.E932&@ADC92HJZ-DZDXE8 MO*6R*1!G(QD4"?0,RJ0+&2TM`S<:X$6:.CRKTT+>'#<3%](R(?%I3"_W?IGD M+;+USQ7XPD?_I2H2R!@);7*"`D`VKJ!EZ.*OGGHAV(KCHYY6B8(P$)BX?):Q M&(&7GG6D1O06V3J3V8?1)$:0MXBL&,'5LXS"2&"#+O(R@Y9A$@M>4`_ZZ?BOV[10)%8T M80+ZEF$2"W2,"*CXH*&>`@RU8(RWV_E]!7F+.C``F%@+^I8A$@MDH("^TQL? M6BDR*WQP!2U3)!;X&%%0\4%7<`@9O@7U\21DD+>H35&$M:5O07PL,$)MF:P< MVE+A0R]3F;BH%B;'@B@CHBIDZ-DZDWFODTG$(&\NX,W$V])"^$10!`6,ENLY M'/G]DFBA2-P_;6A(]BU(3@101K*9#R`4`#:0&+^S)I.00=ZB$$41KJ"%\(G` M""J81.,=2.M$7@44$/]]IOD6(B<"*","*F)H'4@!AL"8X'UW!B-YBSH4,)A^ M@07PB0"&LW[FTP:%HI;0]`LL0$X$.D;T,WE!`0;UF\2&Q&3#S<00&%CPG@I> MH'YN_SU"*_G)W4R,@8$%]:E@QWT%R5MDZX!A,C"=!`?R%I$5+[B"EB&2"EZ@ M@DZO3VBA2*S0P06T#)%4H&-$0$4'[0I3@*$6Q'>.[E>8O$4=BA?\"EN&2"J` M02WH]&Q#*T5F!0^NH&6*I`(>(PJ:R*``@PH*/%!3P/J1#"8F4F7BK6@9)JE` M!V9U&2:T3NBHN,)UM`R3E8#(_2K)FV=3)O,JKP0DW'2D52*#>KI@.H:6H;(2 M`,&L3F\/::%(K%C"A`PM4V4E6#(BI**%=J4IP%!#KO#Z.T]E\A9U8``P<0$M M4P4^,&+9W`54X-!+4B8NH!PJW?=(W4<_YZ(^%+\4IU,SRZM7_-8H@*]U>FO_ M'=03O3>6]FCSU'T?M>C_!;Y/NF:'XH^L/I279G8J]A!S26]0ZNX+I^Z'MKJ" M0O"54M7"ETGTUR-\B5;`QT/T7\O[JFIO/^`KM?[;ML?_`0``__\#`%!+`P04 M``8`"````"$`,ON2WA()``#G*P``&````'AL+W=O$HR[W_[N=W,?M3[=MWL'N;J-IK/ZMVJ>5[O M7A_F__OOUYM\/FL/R]WSOG<+=IN%G$4I8OME7;9O5]6^\.:&1?;Y8'\+]]6[^W1VO;U11SV^7^V_?WFU6S M?0<33^O-^O"K,SJ?;5=WO[_NFOWR:0.\?RJS7!UM=_\,S&_7JWW3-B^'6S"W M0$>'G(M%L0!+C_?/:V#@PC[;UR\/\R_JSB;Q?/%XWP7HSW7]T7I_S]JWYN,? M^_7SO]:[&J(->7(9>&J:;P[Z^[/["!8O!JN_=AGX]W[V7+\LOV\._VD^_EFO M7]\.D.X$&#EB=\^_;-VN(*)@YC9.G*55LP$'X.=LNW:E`1%9_NQ^?ZR?#V\/ M)EFD%SU??VT&S_0I`B4V@D)B,:O*?K\<5&#!F!WT$RX(S:_$#^'DRFT6G-0M@ M<*(!$?9IC&?WZ*T#.V^/]RGQ`_\^\>DVG2?5$)$)[^T0TAMAOD(5^+ZZD&NH MZ[#/;M'#'#)T"H76ACM9(@;*\H01B.HLPH80C`6XXK,(>^_`P-+S+,^$\P@I MNN*Y2;(T,4G*(16#Q&FN$R6L6`8Q*E9)$7V2!HB33V!:&MPBF8:$NUDB)I2& MLP@;0K`TI->P<(MX.K06P2X1X[.("TZT.@^Q",FZK*8Z3U1_&T8CNX:&6R1I MB((H$8,.Q'F>)*)M*Q^@"F4*T3/6!^@XU8`YQ8%Q<".#V$K/][5;)#GD)_O= MYE,B)IB*\Q"+$(R$R0H5Z;YP&8_B&AYND>0AZJ5$#.5"Y8G.>@]PFT5$B*D- M&6$T%.RI?C[".U2'%@1,+S:8"`*%_*LF8"QA,!)9'IM>*SD%)X!>29VA@'+I M[[+:B'(O%8+PUGD:R7VX(D"(HV5&$LADVB>2$W"B.)T`2B@GT._>E`,$(0&X MM1+=4BD&4.E`J#D@RHVG(MQ[)X;3O7=H64%]8LE[!(6B6ZGS&$L8C(*)L[2/ M`J?@!'$Z!91/N/]I@M"FW^V(`H*H@E0DNKQ2>#U$T1*&DI@6IL\R=Q^L7."^ M0PMU-GUEDOL(\MT3#"OW?`!V`A`;A'`*3@*G9P`%DV>@UTRB-VC?Q+F@ M6"EV/>]+HUMNZ3(&_T;YZ[GG3OFF>XXZZ7L>BSN7RM=2H^.!X_[U+(DBL0%; M,N!GQIM*N/=.[Z9[C^KH>Z^-G"74>96M)F`L82@!H>YU8C>=`THCXR`"6"I? M/F^2(AUNGPRA32JZPW(3<1XE<5^@+`7Q10K7^*2N(0!2Z&"8Z+12NXI"\ M&!01!P##PO1[&"=PD?[&**VP_7F[9V\9>Y=`?@6+`%?G(38(X12$`D][S(E' ME#B1M40@RD62:"5GYXI#=*2R7`3$,@@,X'GAC22<"E3V]&Z('5J4DQS^2P(= M.S%2J5'"P8ICXDP522%DW0I,KF.3?B;)L=-'KZDG9@15E157TJLF%1>"@L5U M%F([!S^3/YX1N)-/)3R?NA=F@XR(2)8$.A:5RF3.*HZ`+2`5^[05"*6C3W-Q MD3C'(^*HY6R62OKZQ>HB4,C#:@+& M$@:CP<=>GI"KM%R/:'G:IYRH(`A=2"(SG+TKLA-B:PDS;H9S$6(^L;A&1#WM MMT;B@J"0HY5&##H*(^*@_"Q#Q#HKTB3O]P[.Q6FJI^AA&=2HP.!`/R:F8OLL M"316$M0=0QV7VX%E1E)C?)*<`,3J`@(.+3H\E3JN$80$X@04PGO)1100`C]/ M@1A2\,T8$QOSV:RN+Y+R#LTYJ,&62R#D<*,R&`^%6%84>(2)<:0:=D)+G8PRI"A.N)6RG,9R_!]55*WJWB9:73/MVT/Z&2 M4VO``)9&_<9"K>%#;E0!3ZB#USAT+S1C5)1'7G6R;)BKA+Q;);GT^48N!$(G M8%B'YQZQ'5<,DND,OG@0$;$$\3/71X13$2H^K4?,B)I[CP1$!4'C\<2TD!V$ MP-<7D#C11I9!PEFY2LT-"C4;>U,YF!!H/)Y$!>T$(#9HA6?%J>GD=C>HO:S= MO>_U*1L(\OV3XE"1H1#&AC&054/&6!`KEA2!A+OZ<(-/+N8PH_/D:@].0G31];GT!X7"J#P6OPZIT0 M82IXJU$KR`3/5>*)P6V]?ZVK>K-I9ZOFNSLS&<.YGM.GI_.<7[KCG.+S4MU5 MW:'(Q>D"'+-\7[[6?RSWK^M=.]O4+V`RNLW`Y3T>U,1_#LU[=T[QJ3G``[_WZ*!%@";J9Q:\8/ M#KOJ,%%+'@`%+O7A/W^_/"_\-7P;/XU>/RYVESJ+"\/7Q]&7I]=O'Q>OKW;^ M6%]<&$\&KU\&SZ/7X_/OP:O?TY_CX<3A9BA-?QQ\7OD\F/ MS>7E\>/WX#+[$4OS\N]3F=U^67P M]+I81MA\RXDQ^OKUZ7&X-7K\^3)\G91!WH;/@TEL__C[TX_Q/-K+8TZXE\'; MGS]__/$X>OD10WQ^>GZ:_#,+NKCP\KBY_^UU]#;X_!S[_7=W9?`XCSW[CPG_ M\O3X-AJ/ODZ68KCELJ&VSQO+&\LQTJ?1Z,\INO]E6A1?O&Q> MO3.;@K.WA2_#KX.?SY.+T:^]X=.W[Y,XW_W8I6G/-K_\LS4OUI MI,?1?X\GHY;:$9EU*4?JK\S#Q'_,P_:7>>K_;7_U?XJQ5<39Z[W&RF[-< M]FTV5%N#R>#3A[?1KX68@+'QXQ^#:3IW-Z>1YX-4]B@-V^]&+0[7-(I,PWQ< MC.K$\1C'N?[K4V]U]8(%I_9(T*>6@2@7\P._CUUO%5I[.6?FK;VB8:_G+VD)>S-GYF%O ML>`."^ZQX`$+I,KG6)Z2H;<&G18WH6$>I=XBK?+VO=6:DC0Q*2/K#8*Y5G.6523$J%*J7>1R,X&00C'W+. M9\$YGV&;L71'%F_"&G=D_NWJ_,9K M2D]OO.9'TK*@GI:]M:)YX0@>TV\R6QX#=W3;&Q9!B_(^Q;IK<., M'G@,7`T/'68-AN?(85::(WCL(.LP$R<>`W%.':9YI#.'P`:?.TPSRH5#0%,N M'02[=.4PS0-=.P0\\14TDQ]&>B>19BLDJGJ9X%A/74SA%B2>J:5.. MJN*YNH:'\V0UA_-\-9`GK!FG#&TV[ M/7^QW>KY"]*IJR^D@'KZFJ.Y^L*)0#U]<2C5T[=YOE5/7A/'DQ?[[[H+ES1U MW<5!\MR%5GOFXM2J9ZX9;,]<.)CGK3F8YZTYF.LMCI'GK8F4(ZYZXN+%0EUQ ML4VNN#AOGKAFG'+,5<]>J"*,$S%QE/7&0\ MFL60J8,DT?8B]&M\O:%\Z M35_56#J5!PP\2][Q&'@&L^LQ\/!BSV'6XJB>2Y:B!/5@-YMAK(T]5`GJ\&\H3=@"NC>,8: MR%/60)ZS!O*D-9!G[0:<9<73UD">MP;RQ-V`$X!XYAK(4]=`GKL&\N0UD&?O M!IR5Q-/70)Z_!O($-I!G,$+J&@R7-G4-1L@U&"Z`ZAH,9S!U#"XZ<`E4Q^"B M`Z<>=0RVD&.PA1R#+>08;"''X*(#CWG4,=A"CL$6<@PN.G#J4<=@"SD&6\@Q MN.C`"4,=@RWD&%QTX%R@CL$6<@RVD&.PA1R#BPYHKH[!10=M<0PN.FB+8W#1 M`5N"8W#1!5N"8W#1!5N"8W#\\`RL/!R#BR[D4_`,-I!G MP0;R##:09W`7,C-X!AO(,[@+^10\@VM08VVU`FNK]C75E&ZLJ`_Y?9S`W&X^!-C]D,")S:/X^J*@I,:DG)O&J9(4H[7(6RDR7M)B5]_&<9. M,M0AC)T$2?.6=$@E*?E324KU5)(2.Y6D-$XE*6E324K15)(2,I6D])N7J,DU M-;FF)M?4Y)JF7$N14V*EDI1%J22E3"HQ^:$F/]3DAZ;\2'%2,J02,_.:9CXQ M:9I3B9E3-7.J9D[5S*F:.54SIVKF5,V/@.*=9$FLSC[N7&RL MK,-]]%:S?@-OH;>A'A^5[-3K5SH=?)]EMUG?Q27?7ED?__Y=#_8I<4")0TH< M4>*8$BVEX%CU9@;6C5*+%.+\302K7VI!*MS:$ M&R>5DDF[> MBGB2@GFIG)L#G3Y<3Z12;M[,/CXFD,JX.=#I003EOFG#MVA+'YJIX%NW#Z=: MK7QKF57EQBDW3KEQ6ADW'].5'CRFTH9O*YU>`8^HU/@&#TN47^"4&Z?<.*V, M:QM7[IPVKG,KG>X:SB^_T&GEW#S/NBN@@Z)Q?1QV,&X5W][0AG$KG;YYT%X9 M-V]#QT3@%SGE5SGEESD%ZU;P[!&X=:&RKF5N0^5=&\+-"]R\P,T+W+S`KW6A M4N*'$+27N*'%/B0=*B'!$.1(XPMT3+I]P^X3K)]P_X0(*-U`@U;&RZ,%S!.5>JN.EF0CE9BHW4[F9ZIA9F#6CXV;1 M@V<*RNU4QTY[,,?/HHYHW@SH0W[/I%BMK[W,R>P9\V$!BB/Y:[=,Y,^2H MB12KO34X^QTWB+XSJ"=U(OX4442:HWY:`OUR8IIU9_.ZWSY3/Z?$!24N*7%% MB6M*W%#BEA)WE+BGQ`,E1#BB'`D*O@_T?2Y;IJW#)`N\7:,ET.[,;W_CKH,U;W]"H M[F[_`<^)MLKZ#>^V>;M>!W%WZG7P\&ZWI6ZOK$O-A078/E3C+S\<8'VSMX>- MZF*I7$F4B[3X=[']!W3CJ/&"[A(TY[A1W<'JD_;JT[*ZY<;I#`+@I^+.H1X? M!5Z0^DNHQ^^\7$$]_K;=-:F_@?H^9-GZPZJN_$C'O4_D%?W@.-O^CQ` M_0I,M@@`^#Z^H$PX']+4R=@FE4XIO?$3'%(YE0#HHE1>O=T/ MCEI3M.Y2'YX9"YJ&7]H35,T`Z)H!4#8#H&T&0-T,@+X5V$TTSD1`QPR`DB&@ M*!F>PM5(!I.O*)DY1-.RM:7:Q$__N69.\]JXE$%R*#H'@Z:HG&D/*F<`HQQV M&94S$5`Y;",:9P*@<09`Y7,9\-0.3B9:F6<>WND:)MY(PIM@Z>>BK*9(4?9H'_!N-:\O@94;1W2)J!J M4N*#$)26N*'%-B1M* MW%+BCA+WE'B@A`A'N'7"M1/NG7#QA)LG7#WA[@F73[A]PO43[I]P`84;*%Q! MX0X*EU"XA<(U%.ZA$N"I=1N(W*;51NHW(;E=NHW$;E-BJW4;F- MRFU4;J-R&Y7;J-Q&Y38JMU&YCV.;+#D5V.['%DGR,''#GDR!%'CCER MPI%3CIQQY)PC%QRYY,@51ZXY2>(P\'LR!(T[F/$X&8I*AJ-QDS-^K`Q+XZYG/$Z&IW%G-!HG[I7&F0Q/-S(\U0Q/-8X,_>T^FS^]`/O MS25=W(^.1\FP-.Y9Q^-D6!JWL>-Q,BP-&9;&7>SXL3(L#1F6QKWOVH[57`M- MM\FK;U!,UD+EKGJ-7_8JX"T^[990R_U9X,@61[8YLL.178[L<62?(P<<.>3( M$4>..3+=&)S<0Y]62*ESO[-BO\!RQJ.<<^2"(Y<+(-4=N.'++D3N.W'/D M@2-Q+43G,>ZCS)D,(>,NRCQ.AI)Q6V4>)T-*R;`RKH7XL3*\C&LA'B?#S+@6 MXG$RW(P[,_,X&7;&M1"/D^%GW+N9Q\DP5#(4C6LA?JP,227#TK@6XL?*\#2N MA6B;YG$R/(V;3?,X&9YJAJ=Q+<2/E>%I7`OQ.!F> MQK40CY/AJ69XJAF>QK40;T^&IW'O:QXGP].X/S:/D^%I7`OQ.!F>QK40C1/7 M0IS)\#2NAGB<#$_C:HC'R?`TKH9XG`Q/XVJ(Q\GP-.[RS>-D>!I70VUQRM70 M\OC[<#C9&DP&GSZ\#-^^#ZR[$K]KDHH7WH9?/RY&M3>G MFZ?'G^6&FC@`F]/MQVV-Q)KXB-*KN8@U<4-YYS6WW4V-6[O;FGBBWXP/M;R: MO5@3]U9W7G,4:^)FZ;9&8@-6G/)XD+@AO.5C(+>/L2.7'G_=W8S;VMLX$N*! MXT;UL68Y#>3XTXA' MG)W%A<^CR63T,OOG]^'@RS!NA-%9BO#7T6@R_\_T`+]&;W_.9OK3?P4```#_ M_P,`4$L#!!0`!@`(````(0`&A!,4@R8``)X+`0`8````>&PO=V]R:W-H965T M&ULG)U;C]RVEH7?!YC_8/B][9)4U\#QX)3NP`PP&,SEN6-W MXD9LM]'=.4G^_2QJ4VIQD;4WNS*`?3SZM$6M15)<*I7JP[_]]>WKFW_>/3[= M/WS_^6WQ;O/VS=WW3P^?[[__]O/;__GO[N;X]LW3\^WWS[=?'[[?_?SV[[NG MM__V\5__Y<.?#X^_/WVYNWM^@PK?GWY^^^7Y^<=/[]\_??IR]^WVZ=W#C[OO MV/+KP^.WVV?\\_&W]T\_'N]N/T\[??OZOMQL]N^_W=Y_?RL5?GK,J?'PZZ_W MG^Z:AT]_?+O[_BQ%'N^^WCZC_4]?[G\\S=6^?OCV`R5^ MN?]Z__SW5/3MFV^??AI_^_[P>/O+5YSW7\7V]M-<>_I'5/[;_:?'AZ>'7Y_? MH=Q[:6A\SJ?WI_>H]/'#YWN<@9/]S>/=KS^__4?QTU@<#F_??_PP*?2_]W=_ M/JW^]YNG+P]_]H_WG__]_OL=Y(91SH)?'AY^=^CXV?V_L//[:.]NLN`_']]\ MOOOU]H^OS__U\.=P=__;EV?XO<,IN3/[Z?/?S=W3)TB*,N_*G:OTZ>$K&H`_ MWWR[=WT#DMS^-?W]Y_WGYR\_OZWV[W:'354`?_/+W=-S=^]*OGWSZ8^GYX=O M_R=0X4M)D=(7P=^^2%&\*[:;_2MJ5+X&_O8URNV[0[$Y58?\AFQ]$?S]4N25 M#<'1)D7PMZ]1O;XA>U\$?\]%7B_KP1?!WW,1G%BF)QCATVF<7G;.;L%[Z213 MGVMNGV\_?GA\^/,-1C*ZP=./6S;PU)WXS0238Q MP45:&^ELI+>1P49&%0GDAG;Y9>+LQ:;M*R-HDF)B*U8X0.TYE$;Q*# M28P:$0B-26TMM)M5ME!)[]]N)Q:<.N]9F,,TYQ0GGBYJV:SXT>@%VK@`F]'9 M2!\Q5+4`:.@RN],\T,R$NR8? M"MK:SEM?]H]ZMXWT@OAF;D_E\>7B-EV$!KO&J"*!VE@JO5YMMQ.K34N"LS"* MF+5)-$*(%)"[/.[H"M&:-3J3Z$UB,(E1(P*]78ZD!:$]=;N=6&]:7IV%$:V. MQY)63;5L5NQH8H)[;VLCG8WT@EQJZ6!7&%4DD!MK;I;;GDS<3BPWC?6S,'(2 M6"<>=W0IK070!(^)2'`;Z6RD%^1R6P>[QJ@B@>0%)FO6/"/SN+U8=.K$YZGT MSV_E3'#CA"]VM0$[OEHN6Y4Y/(/I/>,U/YWX0$-&D5%G0M%=*J)Y M)4-TR5)8=RY7O**@R\VY$$C1M+:1QB,BR'3QC:0WC]/9Q^EM9+"1445"X5T\ M(N'M&::04!4*SV'30[ZW5V[)$J[M:D\HUC0+XKK[?D\CJETVO_0`GH2Z#*;W MS-S6XEC1D8:,*J/.A+J[L/1ZW25BA;K3FN)<"*2H6MM(XQ%19+]/+5[L*IV- M]#8RV,BH(J'R+CN1\O82II#$%2I/U\RSAT2SZK3;[6E,U)Y0O&D2"'?I-H/I M,IC>,TN#M]S@(:/*J#.A^#AS%C]CNG%[T<6UI,GD[&Z"`]K)#<>"1D6];'Z9 M*6A-U"206/GY*"]EF.DRZO0+,]T>Y=8.R^;+AQEU)I3=!:K7]WF)84&?+SF5 M%@+YF7.W)UMJOQVR+=?H2',XXPZ$PKO@M7KA9*HKA;*[A$6R9RPG)9>% MLG-.+002P0ZI-7R<[J(./R-N\!<'6FJT_A#K(1/W];G$BQ;,]$%3]Z\IK%BM4>6/=6LJ99$-??^=9.NVR]W)6[#*;WC+3T=.)A M-634&'4FU/RJR%HF(FO)D=5#BJ2UC30>$3U2-XQ;NTAG([V-##8RJD@H/$56 M_6.C,A%52UJ6GSTD4MV@:@B>"*A\#N=2H+46-%?7-M)X1&R#XKA=?Z`I MK+7+=#;2V\A@(Z.*A))#F74?=Y],V_'4/?3$?9T_7#M[R(N&M0,Z27R(E!V]3*4`?=8_=:NTIG([V-##8RJDBH_%49M4QD MU(IOR'AHU=]I1-2>4*?X.>BZT;^E`FVB0#S'S!4NCXD^:"KZ^XEOVPT91QIU M)I#==>[7=_AI+UI$5K1$/'M($;6VD<8CE\UK[2*=C?0V,MC(J"*A\(F4:G_: M4252:D73R-E#(MGT:39UU]H3BC7-@KC^SL^8MP)5(K)6?&O&0^O3I8FHMI'&(^ON'FEO9N/./E!O(X.-C"H2 M*@]AN+_;L:ER>_&%E>_.>&C6;+NG!4_M`<6:)H%P9VTSF"Z#Z3USL;U#1I%1 M9T+I7>![_50C,3&<:OA!@DH@9:J)PR:-BL;7N!2=ELW:5!,?A=WK@Z8FIQJ[ MR*@W)E3]JL!:)0(KKZ[/'E+Z-`LB_9T6J^VR6>OPTMKU4:+Y/6IL5=#B;,@XU*@SH?(NS]$R M,F.BD108+".WG%BW`JU/F$9%;2.-1Q3_6KM*9R.]C0PV,JI(J'PBM68HGTBM M6TZM6X%FS>+;Y[4G%&^:!4E/\7%>Y=[<+14NCXH^:&IRBK?&&E2>#LS`.D:%K;2..1R]ZU=I'.1GH;&6QD5)%0>!?$:*)Q-Y+UYPJV M$M_"B8:FQ+.'1++41WT>4)QI%D1Z.RTTVF7SY:[<93"]9Z2IJ;R:4634F5#U MJ_+J-I%7.=.1@8;&54D5/ZJO+I-Y-4=YU4/ M*?T]CI)TY6U\C4OW9Y;-6G^/C\*7@#YH:K*_VT5&O3&AZE<%UFTBL.XXL'I( M[>]21T$:7T7M[V:5SFY+;R.#C8PJ$BB_2R16>WZ?]J(+ZXX_8_702C,*K![0 M=%\0-[]'#P$O6Y7NGL'TGI&6)AX"SJ@QZDRH>2*O9FB>R*L[FA_..X$426L; M:3PB>B0?`K:+=#;2V\A@(Z.*A,(G\FJ&\(F\NN.\NA-()$LM9CR@.-,L2'HQ MLVS6>GM&6@V:FIK<,PXTZDRHN@N4KUY"[B2&!DO('6=5#RFBUC;2>&0U4?%# MNJU=I;.1WD8&&QE5)%3>A;"5\OJB?2>1+52<,ZJ'1*N;O;MWR[-ZG/QHEFI\ MD;5MO`1I,Y@N@^G-!@\954:="47':;U"=$?3E93O=)UW`GG1R[+:;_G9Z=HS M:TTCV:7,&HEEMYDN<2BNTV2>0"%]M#OQ* MPMH#:TDCU=(>-`H\Z$ MTE^547>)C,K/S9X]Y/MKXKZO!U3IY_AY8?$X;]86CS%#DUD?M#2Y=HQKL+MC MXFQ63""Z>RJ)^[N]8I_VHHOJGF_'>$C1M+:1QB-B7?J9=[M*9R.]C0PV,JI( MJ/Q5(76?"*E\B3E[2#2K=H>"YN;:`XHUS8*X[GZDJ:I=MBJ]/8/I/3.W=%_2 M>!@RBHPZ$XI^54#=)P+JGC0]>TC1M+:1QB,BR!'O:>0E4VL7Z6RDMY'!1D85 M"85W:9.NJQGSC-N+YQGJ(N>]0")9ZLZ`!Q1GF@5)3^[+9JV[2S/61UE-NM,7 MI_J@J:G9/>-`H\Z$JE,^S7L">)_(J?R.K[.'UJ=+QM0VTGA$O+LPNYMQM[,/ MU-O(8".CBH3*0Y@K^KO;B_L[WY/9"[36+%QZUYY0O&D6Q'5XW($,*[3+9JW# M2SO61XD[_+JM[L8O'6C(.-"H,Z'L%%$S.WPBJO([M\Y[@=:G&W5X$VE\%3%/ M[OR2)*U]H,Y&>AL9;&14D5!YRJI.>?UKCG?=Q M1J23J6VD\8A7Y(B?$8GZNWF\2'@3:98JKL/3-:1=-KZT@_MRE\'T"^,.T2QIED0UPM/G,S:9?/E;MAE,+UGEL9N-_R] MN"&CS*@SH?*)N)JA?"*N'CBN'@129*UMI/&(2'+"#TU%'U>U=I7.1GH;&6QD M5)%0>9?F7CV]'R0#AM,[S=UG#XEFN!Q&'_!Y0+&F61#7X_E.<[MLU3J\-'5] M$+X"]&%+M_`W')M#QH%&G0E%3\35C`D^$5?Y-7/G@YDB:QMI/"+6N:4,>]?: M13H;Z6UDL)%114+AT0VNZ.UN+[ZRTAK@['XV#I"?--VM=UKNU)Y8]T0:,LV" MN.Y>T,6[7;9JW5V:L3Y(W-W73<4SUWS7<\@XT*@SH>J)L)K1W1-A]W(9;,VP\='X5'1!VU-W8[,.-"H,X'LQT1BM66?]J+KZI%F MWK.'E&FDMI'&(V)>^G:D7:6SD=Y&!AL95214_JK,>DQD5GZ>Z.PAW^'Q\`LM M>6H/*-8T"80[:YO!=!E,[YF+[1TRBHPZ$TI/H56_37!,A-7H^3P/R2G<%-OC M";\C&5ZK:L^HJL>9-U;=9KK$H;A.G\$,&:\8>$A$V^)]H]$<(U74OCXC4U2E`JT_PKI`W-/G"I<7.WW8 M4CQ*2`<:,@XTZDPH^E51]9B(JOP*][.'UI+0D*AMI/&(GZBFE7MX?6CM(IV- M]#8RV,BH(J'PB:AJWP$^)J+JD>\1>$@D.Y;1S[C5'E"<:19DZNTTGMIEZ^6> MW&4PO6>6EO)'B$-&D5%G0M$3.35#]$1./?+]@:.=4VVD\8CO[>XV)(W_UB[2 MV4AO(X.-C"H2"N\R'-UUSQ!>DA\6&2\?JO*]N_-1()%L4HPDJSVA=O^0^`AT:ST1Z2E7PRZ(&N\2H(J'LE%9=C\^8YA.IE7/U^220G,<6'9YN MT-<>4$6/DR_WYC91AIDN@^FM]@X914:=":7'B5_1X]U>?(6E='0^"232[\KX MYYH\H$HO-=8(R]HFRC#393"]U=XAH\BH,Z'TE%WU>S2G1&:-[D=Z2"2_*0_E M]G#BN\">64M*SC4)A!5M,Y@N@^DSF,$SVFF->IU0>,JNAO")S'JB1'D^">1; MB"_7;ODGG6J/J+JOJ^SWG(S;1`GVIK.U@UUD5)%`;WQ+ M*!0\;Q4CN_&UE)6?*9'^L#GN3_R+0O7,:.+/C-0I-_S>VW8&UD6B.28'ZF=H M:?+VR'>=AIG1CC8:$)F0R*WV4K+8I((KS7?GF5JWEKHN3)!*"M/,S(L));Z/ M04>#$V:E+H.!#V8=^&`RL$%CR(5$A,UQ(95A:<$.%X02]8I-XBXC7(A#*CD% M%V;&W30K^1E2Z#]OOWQ'#`;8$!P0:&[Q]G3@1V/A@%T(%J@0>>`"YVK^SYV. M)*>N+P1X6BQ<'<`#H91>#@],!AX(XT="\CGMF5&.!1O,8\$%DX$+)@,3-(8\ M2`1;^RY:L8F3;0!1=W7GD,1' MK+!`$#1X^20F'@8SXX8!+WVA_KSYI41B761#T%\@[S6>Y^:??(#\=AWHKT)D M`$7>7`/B[(LU8V2`4(JZ<,!D,`B$$6'P=I!M&:^)S#(8`R8##TP&)I@,/-`8 MLH`B<*X%<18N-S0WX%H@E!\#[OOL=,F&`V9>A@,SX\8`_Y8@QL"\61T#-@3] M!5K:N^7W.$!^NP[T5R$R@`)QK@%Q,B[YY[AA@)EJX8#)P`%A1)@JL;:%"V89 MC`&3@0F+H.!"V:;X8+)P`2-(0]XJ__P0*A1#K<0(R70YY0 M3((!<\QT0R!ZJNIE\ZHI\1"8:UR&(/^ZN8GWT,_`NK6)JX!Z*%(?I:Y1W^U& M5^(B2L6%4.O6TLR,`6`RT%\8<3'Y<-6,*(?"`#`/!0=,!@/`9#``-(8L6#9?[MM0?ZYQ&8+\07.K M4QP',LI`??58)+^+;E?(+XDOE)^$P_RCY<+IG7LPP&1@@#!B8SH.V&7@@7DH M6&`R&`$F`P\TABQPZ8TLR/B8H)#0%UH016)/^)WUA0LSPQ0\FV!!,L"&8(-#E5L,&NPYL4*'0AC(1C#-L MF';CRS$M$L^%I^2$*MP2^<"Q$R=A3!C$#(N"86!#<,"&X($-P0.!U+.#"6HI M,@'=]#4F.)Q'`,TR&`%"23/WQVI?\`L=8($P^'.Q,[9@70?/Z/`[:*'_FDCT M;8B_)BYT_S52[JO-!OT7_ ME_RW[O_XMGW83$@?IT1J)*0W&4P^PHB%3OH"G[O1A1_RFY5@@,F@\YL,##`9 MR*\QI+Z+]"W$I[]VEE3B*0[+?VH.07P<`#H<0#/-K-[S^%`W&&I#&" M_A\SJX'LPW$&!`_L2C#!:#0LL,O``Q4B$UR$(Q-R$H$DO\"$,KI%5PHE)B3F M99@0)\C8A)EQM^CX!U4P`N;-R2]<`1$M^@\)=(=DT/`(XIT<&`.E],0B,?`LET;`QD0#)`C^09O M3T?^B@[TGQMS^6`P0(7(`9?9KG!`HE[H`"WR,0CB0!@/`I.!!<+X05!4^(_J M8!28=3`*3`8FF`Q<,!F8H#'D`61D#S(^JZS<;CP11;?G/"7:X>T^_!)X3$-2 M1Q\$,S-]5!-.S=!^WGJY5T)\&X+Z`BVMY5_%@/9V&8BO0J2^RVHT`G+4EXB' M`[WD#'ZB$",@#H+4"!2I$'KC<1J,@QP.)>\$HX#=N8!1HH7!:)<(#D\$H M$,:/@N.AW.UHW0L?S#JPP63@@LG`!9.!"1I#'KC\1A[DS$02^T(/:'Z`!T*) M=B?\CB]U3CB@Q4&*J'$A/UN2W>NX4$<'^EZ@5$0,ZP0)7+^6Q57DP<*X"S*_*JR=#[(N MP19U.5`_0]+<\H2?ZPG7O\-,:,<:#8CD=PGN]2-@*\$O'`'46L@?QT,2M\Y@ MFID17:9?!:'I#":8AX(')@,+3`8FF`P\T!BRP.6W*RR0V!=:$`7CK5!^0$]? M,@[[%!S0\J._&B_,E,IB]>,2B2%@0]`_;"^^8DP'@_QV'>BO0F0`-+S&`+<; M3T%1*MX*M1ZQ\1@P&8P!8593&0F#,6"6P1@P&7A@,C#!9."!QI`%+L-=,08D M^N$XR^Q=\E?2,0T))=(E[\YY0C$)!LPQ<[H*A(,(VL];5RVA"S[$MR&HOV[M M]#6"\%C0WBX#\56(U,>)7Z.^VXT'`)TTU!=*T193D,E`?V'$Q>27".PJL,`\ M$APP&7A@,K!`8\@!E]VNZ/\2^8+^STM].""4*.=>=D,S!_37HN-\"9B9Z;8$ MU\`(F+>K(\"&H+]`TM[#"2V.1H!=!O*K$.GO""60=CP&3@@A#EX:U0HAWN M5Y4[?L4B1D&<',DG>#`STRC@Q0GTG[>KH\"&X(!`+RVN^*-7.&`7@@4J1!ZX MY':%!Q+X0@^B0+R-8R'I"P],!AX(X\<"#\=M],:\>D9P\5H65613DV)XP=_F M0%T.U,^0.)YJ]3`CZU9SBT8#(AM<@J.AD'&?>B?!+QP*43+VE)S0%F^WY-L* ML$%+D/Z:G&#XI&%#7(@AV&!#L$&@RZVN=V*!"9(,+Q<[O1I!0_1>TI16,,!ZFD,)B5 M8H9[.GP02#Q//20*%]9((C#"`OM(,,&&8((*D0DNTZW&@B6^1$`<8)G(\>1> MN);&%4$HKT>Q.QWVB>?H/*7+KT;.>1C8$`RP(7A@0_!`(/7L8():BDR`!J\Q MP>'A"-C%EP.!YE8>F4#W%P)_+E[&TU#,)+J_#4%_&X+^-@3];0CR"Y0Z?=+> M1;I7#`!)@.L!$*UW,`"$FH^.%WSSJQ`@?YPE8_G7=?`6#0[BF'KB*FP0M+!'<2"_EB+GM5!&)5A@5H(#)@,#3`;ZFPS4UQC2W^6X5^@O ML6^M/XX6S?Y"S9W_L"GX*^M07PV0L_PV!/5M"/+;$/072&DW]+<+P0`5(@=< MB%LYD/GFK9UDO[43Y3:Z3^HI.:,*XP#?P@C=@A-SBG1W'V@KEC_SUI=K!$\O ML,"&8($-P0*!U@V.;M1E%((%ZM%""UP"8PLRPO&T6W@5QA/.H;SGPE.X&EVZ MR-8S(V>-"96K-#.QKA+;D#@40UU.I3X'&G*@T8#(!Q?A7C\4]I+\@J'`7^.& M#T*)QB4>0<1'2:%7\$'-D'Y26J!IO/`;']N<(G#!/A)F!`SW(LQ'@1:1DR9>*8QHQ",L(\&(VP( M3M@0G%`A<@)BLA,93['LW6X\+5%7QW`0:AX.B<]O/*%-.?!!RLAOP-/%`T-A MWOHR][&5<,"&X$#07'R"2<>"_'89R*]")+_+;S00@/YV M&>BO0J2_RW)7Z"\1,!P'%!2AOU!HSJ)N/`YB)C$.!!)AII?:D3)PP:X#%VP( M+M@0C+`A&*%"9(2+=5<8(6DP-"+*;'NA1+\3+J?1.(A#9<(%&X(/-@0?;`@^ M"'2IT?#`K@(/5(@\<,F./,B)"A((0P](8@P&H>1T]A6_8QI7!#57SNM3&X(' M-@0/;`@>"'2IT?#`K@(/5(@\<-'N"@\D$88>T$P.#]8!=%OAQ:G10%"3Y6R" M#<$$&X()-@03!!(3$JV&"W89N*!"H0N'1&AV`=3X_&#:C2[+_+:G,[[G!(OG M3Y3Q\QY;?M-T/2/K*T<\'_DZ&M3F5.IRH'Z&Q(94LX<9T5HT&A#YX+(=C88< M'R02!J-A'SUE=!#*G]"QBE_#X@GM?)HB`X(-:DB=QA5LL"'88+0:+MAEX((* MD0LNUY$+&1]E'B0.AB[0C(/1H(;&21F,!QN"$38$(VP(1M@0C!!(N@\6_<=C M_.V#@+E)0K!"/1I9`36OL<+MQA-3%)L/0JV[>[1>33")F2DNQ!"'0V#U MP=TTSV`R$L@W$O\\4M""_H+@S\7*6'^30?*OB\I<-WWRSU)!N6%.N%)&'R'N]J4.TH04'Z-T,T.]/GU5KP/>D>K7R@N M!,YS<8Y'!22W(6B^/M86"X<-WM`<+J4A^AJZV5:[8UGQNP$@>T#AS6FK8$2R MNR3W"MDE^(6RDVJ072AQW:EV/&UX6$#Y-97\""<@+M2!`U)G[0!U!!A@,M#? M9""_R4!\C1'UWS]]N;M[;FZ?;S]^^''[V]U_W#[^=O_]ZWG^\>'0#XUX>'Y_D?[S]^>/_G MP^/OTS$^_K\`````__\#`%!+`P04``8`"````"$`KK6_$C4#``"^"0``&``` M`'AL+W=O/9`1.L`D:VT[3_?M0$',C8#8:+ MV+QSU^G*M+>;+I_?!)_XZ+_!2WKZQ$C^E308PH8RR0+L*7V0T"^Y'(+)]L7L M^ZX`WYF1XP(=*_&#GCYC2BC$U_:06AX[L`-_:8BWLB*4TC.W)!ZS\*Y)ZI%(EW)O%!_?FY M]\\DBS,)7'N2I;7P@G!UA11;V>I22I%`VPVC)P,Z#X3S%LD^=M?`W,>CS`R! MO947!"5)[B1+;,*6@2@XU/AQ&WD;^Q'JDITAR27$U1&['B&+(%E3-0"_`VOH M#'-L,#"X@(#'+EXO;B]6@J78?IU$#8S7F8C?72+"B?KT$O)"HFF%)AAKE8G[ MT-;SFN6DV(0"#5%$_A!%EU:B(-"4`V2A(W;O(M(YA&8"E(Q-S(N78#`Y4K8* M=6F)@D1=Z]P$X3)8!$L=LM,@WG+E!^Z$)=4@"]=S@\AYHPJ0T_4&)'B2_B3; M1$'FTG\7DMEO78SL%&+OT(ITC MU3FBA?^RB.8A_!\/`#'9XL.^!MB!])PH\(%4#I6")$S=0"K&T'; M[OS94P$'9_>WA.\D#*]^QP)P0:GH;^0"PY?7]B\```#__P,`4$L#!!0`!@`( M````(0`<]YY5BP,``"@,```9````>&PO=V]R:W-H965T:=T#<-X1#@$1)JB959[8T6QJ-]N':`2>Q"AC93M.^_:R% M"=@DFYW>M`%^__[6`;.6C^]EX;Q1(1FO5JX_F;H.K3*>L^JPWE(74?)[$A+(B>\IA4\V7-1 M$@67XN#)6E"2-XO*P@NFT]@K":M<[;`0]WCP_9YE])EGIY)62IL(6A`%_/+( M:GEQ*[-[[$HB7D_U0\;+&BQVK&#JHS%UG3);?#E47)!=`7&_^Q')+M[-Q95] MR3+!)=^K"=AY&O0ZYKDW]\!IO6&\626 M3$,?Y,Z.2O7"T-)ULI-4O/RI17YKI4V"UB0$^O9Y<*^)IX&:^)Z)(NNEX&<' MF@:VE#7!%O078'P)3&-TH?XJ4@@139[09>5"MT,0$LKSMHZCZ=)[@Y1FK69S MK?%MQ?:BP$H`7L<(@9N,MY-^04$QHF`1D&VC;X!WQQ8,]KU6)#V:10(9,DDP M6R$TTS@1+EJYD0$0IL/D:`WT0@<9#2#'%!8C;&0RCK.A&&(P]HVC/G:=0*TQ MV>)HF,)K3<]OT8'-_70H'M*%=EXV6C-OFFX6QD%J/]^:SX,@2*.D$UA@\6?` M4#P$ZP/6:=.:I`%+9T$2#01;4Q#-HC#IT2VRQ":[K^EPD=UT<33K(M>$6@,) M^F73C2DL1OS0&-.A>)B]>,"F-;JL:9C.[<=;\_$L3?K(+*KY9ZA0;%,% M:=\K.F-:,Y:Q,87%YL.Y8:;LOK(VJWY7UU8TACDJL3GQ5+Z[M+X^P^T#99C% M5F3RQ5'?_$VJMS=$_0MD$W[J^^#KT]XD#-+!YIM69!+VF[=\VN>VQ.;#H]O( MX)V5QE6_K;06W89H.<GOAPP;@W?E]@X6_7[THI,OC@:OLLW1'VR-:$> MS/3@4E)QH%M:%-+)^`F'K@#.V.YN-Q`^!3@##.YO<%#$^U[W`.:TFASH5R(. MK)).0?=@.9TD`"WTI*&ULE%5=;Z,P$'P_Z?Z#Y??B0`EI44B57M6[2E?I M=+J/9\09C)6Z*V@E;S5'13T%2R]67W^M-QI\V0;`$>0H;,%;9SK<\:L M:$!Q&^D>.OQ2::.XPZ6IF>T-\'(XI%J6S&894UQV-##D9@J'KBHIX$Z+K8+. M!1(#+7<8OVUD;P]L2DRA4]P\;?L+H56/%!O92OV"LM5RR,\? M"3M[])O81N^^&EE^EQU@LK%,O@`;K9\\]*'T6WB8G9V^'PKPPY`2*KYMW4^] M^P:R;AQ6>XZ&O*^\?+T#*S"A2!,E<\\D=(L!X),HZ3L#$\)?AO=.EJXIZ&42 MS1>SRQCA9`/6W4M/28G86J?5WP"*]U2!)-F3X/M`DDTE82&@P=\==WRU-'I' ML&=0TO;<=V"<(_'[AM")QZX]N*#8TQBKQ2(\K])LOF3/F#FQQ]P&##Y'3#PB M&(J.RJ@V7=F#O;)/K0_E-FP!9]FV<@;E`,&RS8:3$?$ MB4&DF6[0@[$&BV/:L]P&T`1IA$R7]N!!>DSN?N-]E]A$I#SZ5"CO# MG3E)'B;BV,%PX5(,Z/\-ZD^=\N]W3DMZ]<9*N/?A7B@P-7R!MK5$Z*V_TPEV M^K@[CIMUXIOQ[7Z:KX&PO=V]R:W-H965T/?2MP4V_5^W6]?-F]_K0_\]?[A_S M?N]P7.V>5^_UKGKH_ZP._3\?__VO^^_U_LOAK:J./8JP.SSTWX['C\5P>%B_ M5=O585!_5#LJ>:GWV]61_MV_#@\?^VKUW#AMWX>CFYO;X7:UV?5YA,7^DACU MR\MF7=GU^NNVVAUYD'WUOCK2]1_>-A\'$6V[OB3<=K7_\O7CCW6]_:`0GS?O MF^//)FB_MUTO@M==O5]]?J?[_F%-5FL1N_D'PF\WZWU]J%^.`PHWY!>*]WPW MO!M2I,?[YPW=`6OVWKYZ>>A_LA;E^+8_?+QO&NB_F^K[0?F[=WBKOWO[S7.\ MV574VJ034^!S77]AIL$S0^0\!&^W42#?]YZKE]77]V-9?_>KS>O;D>2>TAVQ M&UL\_[2KPYI:E,(,1E,6:5V_TP70S]YVP[H&MOL_;F2UH7B0<1N$?K=!1K>#R6@ZFS=1SGA. M6D_ZW7I.!Z/YU)K>LNK/.%)I<]WT6U0Y&LRLF[OQ[+SC;>LXDXX77BNE3%,E M_;[N6N]:1_I]W;5:U!V:*BUJ?^%ZX=5:I"CWE=)>V+:6T)/]T58[N4Q/2PC* M^N"U5RRDL>B/UO?2*R8U^\AQJ4M)>'5>/]_OZ>X_& M.5+I\+%BHZ:U8.%$,O)^?$K/7V4GI26+\HF%>>B3/R7>@8:4;X^3V=W]\!L- M`^O6Y@EM+-UB*2Q8SK.PM@D<$[@F\$S@FR`P06B"R`2Q"1(3I";(3)";H#!! MJ8`AR7/2B++AG]"(A6$:B=9]$D"*-C($$1;"Q3:!8P+7!)X)?!,$)@A-$)D@ M-D%B@M0$F0ER$Q0F*!6@"4)C#`@RIH&O>P83.<*\'OHTVL@>N-%9U4XF)]6`.$!<(!X0'T@`)`02`8F!)$!2(!F0 M'$@!I%2)IAH)I*EV/J.8=2..:-0G3D8TDBIRF:/:R4BXV4`<("X0#X@/)``2 M`HF`Q$`2("F0#$@.I`!2JD33@I8T5VC!K'4M."$M1#,O@=A`'"`N$`^(#R0` M$@*)@,1`$B`ID`Q(#J0`4JI$:W@:;*YH>&:M-SPG1A*,C6GD9"34L8$X0%P@ M'A`?2``D!!(!B8$D0%(@&9`<2`&D5(FF!2UIK]""6>M:<#*9R20`8@-Q@+A` M/"`^D`!(""0"$@-)@*1`,B`YD`)(J1*MX6GGJ34\VYB,I@,:K:ZPW82>SQ;;/^\E33W$#9T)%"8SK? M:D^]^.Y3DZC=D#(C.@2S9B/C&&S)3BA9CDU.:6>W:$RK$&5&NM73SI%6(NU< M$8L?D[,C,T\@&=Z7CFKXF1X^D%8B?"ABR?"10#)\+!W5\',]?"*M1/A4Q)+A M,X%D^%PZRO!W1J,6TDA$+T6H)KHN/MM^GA/_K_KC5^+3&?])?;Z+U=1O-[;R M\I?L>-F4FZ/QW:D'.*V5@ESA*%O'$TB&]]$Q0!0*1QDK$DC&BM$Q090*1QDK M$TC&RM&Q0%0*QPZ-V+;4U(@>T;!G+!TYJ@T+_FVI9%".K.=*RVIP8EJ0I)#5'8QJ%Y6B`2=U:T0B@6$%2M^%EE_>P1K]% MYVL,A-7MN:2&^B*L+Q:1SMYA(JS.WF$JPLL[S`12D_J2-BU$C6?NL!3!.Y*: MG16(;$0.(A>1A\A' M%"`*$46(8D0)HA11ABA'5"`J-:1K<=UI#3O.-R;`%BD[R24BNT43=9@WITE' M&HE\A$_CU"3O(G0++75)#DI+*D,`^>6T>RDG?-'2=R?G):JXG5 M+!9&UGQ*;Y'I.P!71,(U&74974%S37;95-J$,>Z1[VTGHGGBN`=JIF[&O.N+U0-=SML#6TL@!#9B!Q$+B(/D8\H0!0BBA#%B!)$*:(, M48ZH0%1J2!_5V4)8[9GG%T`COF[6QD:.M!D6D-TZ*E8.(A>1A\A'%"`*$46( M8D0)HA11ABA'5"`J-:1K86X8?J,%;@Q&[<9`CL5+1#8B!Y&+R$/D(PH0A8@B M1#&B!%&**$.4(RH0E1K2M;AN8S#"C4&+V+RMC+#&(?E26LG9$_8*#EJYB#Q$ M/J(`48@H0A0C2A"EB#)$.:("4:DA31[V]N(5PU9CKD_\+5(&I"4B&Y&#R$7D M(?(1!8A"1!&B&%&"*$64(E:7+^7.ZH+Z]9JPL^H;@:WQF,"5X3!]=FX<^-`WZ:TMR>69U?<*U_X MJ\N#IA+8.AD7N916\EYYK/.'D$[K.&:/N;X]W@QFQ@#KBL@=VOXSFPIV@69_ MYHCVTN)NEJV5@FQ$#B(7D8?(1Q0@"A%%B&)$":(4488H1U0@*C6DCRUL`W+Y M\I2Z`6C!D38-3\V'3\O6D:R$8C8B!Y&+R$/D(PH0A8@B1#&B!%&**$.4(RH0 ME1K2Y3%W>.=7K/25'LC#D38-`[);1\7*0>0B\A#YB`)$(:((48PH090BRA#E MB`I$[$-'UH2\);@6_,-%_I74MMJ_5LOJ_?W06]=?V4>)E%N/]R?,OYA\&M_0 M)Y/-Z`0E$RIIGHM#R91*FL,U*+D5'V":)=;=@IWN4DZ9)2.Z`CX80@E%HY5` ME\^,2IKS%O"94TDSPD,)70$M(SNBD4NG!SETVEMTQ?0N6THNDI& M5-*,*>9U650]/99`'SK_7+#C32RA[UP_=<>B4!WV3U1YI_V8Y.JP_S19?*+N MA14_49_H[!+4(SH[!"G8&8?TZY*/WB=:L+>%L&9Z%6C!7O3!$GJ+9\'>T<$2 M>@%GP=ZOP1+;FE`]77?B4PE[#P5]Z"43JJ>KA%X9H7J:DN%)7?KN]V/U6B6K M_>MF=^B]5R^4@K0JH4EHS[\&ULK)S;;AN[DH;O!YAW,'R_ M;9VZ90E)-F+U^83!8,_,M>,HB;%L*["4E;7>?A>;_+O(JDY;#B877\ZO9Y<7^^?[P^>'YZ_O+__E7]H^;RXOC MZ>[Y\]WCX7G__O+O_?'RGQ_^\S_>_3R\_''\MM^?+DCA^?C^\MOI]'U[?7V\ M_[9_NCM>';[OG^F3+X>7I[L3_??EZ_7Q^\O^[G/?Z.GQ>C&;Q==/=P_/EU9A M^W*.QN'+EX?[?7*X__&T?SY9D9?]X]V)QG_\]O#]"+6G^W/DGNY>_OCQ_1_W MAZ?O)/'IX?'A]'GGQ=+\MOSX?7NX^/=)U_S5?W=U#N_^/DG]ZN'\Y'`]? M3E7UAW>]@_[W8?_S MZ/W[XOCM\#-_>?CP?OGX[T71'=$7FPK:?_T[VQWOR*,E<+2*C=']XI`'0WQ=/#R8T MR"-W?_4_?SY\/GU[?[F,KZ+U;#DG\XM/^^,I>S"2EQ?W/XZGP]/_6:.YD[(B M"R="/YW(8G.UGL\VRS6)3#1'F:K6(UC=][Q,-2;8?-OUT/=YBP[5K1S]=NS-'2HG6CY1^#AV>-=*-:T@_T7!VUE#G M%$1V3FG6WC;8.6;2_,,U75TM;J)Y%)MXF'#0''-I_H$!SZ_FJ]FK+6GV[7@Y M#"8GY=K&<)\2R=WI[L.[E\//"UIGZ'J/W^_,JC7?SDD,R6"'/:3'K[*#TL*H M?#0R[R]IPBCPCY32?WZ(E\MWUW]2&MX[FUMM,P\M=K`P.6=D$PE2"3()<@D* M"4H)*@EJ"1H)6@DZ#UR3:P?_4E#\?_C7R!C_PC.W`.SPA7`F+-`DD2"5(),@ MEZ"0H)2@DJ"6H)&@E:#S0.!,2A/ES"6E[OC*C=@TK=Y?4FP/L1G-5Z&S;JW- M@K0&(V&R&TP&ARJ2*I(IDBM2*%(J4BE2*](HTBK2^23P+?E'^=;LBF]<"(P, MK26TY@^.C)?"E;?6:-+;@\G@;45213)%)L<& MWIZ.8&/=.Q7.N+5D08GBN3D*@WHW&*%9HDBJ2*9(KDBA2*E(I4BM2*-(JTCG MD\"'=!YY@P^-=>A#2^Q)L]]N=HHDBJ2*9(KDBA2*E(I4BM2*-(JTBG0^"1Q& M2?D&AQGKT&&6+%;#+K13)+%DR3M5JDCF6MFSM=GGG$-=:A#RWQ?:A(8HD8LTCN=##"F#,G MY+E521=#*]\=<;ANE(,1I"LE72OI9F@U(=T.1I#N?.G`TW2(#SQM3Z97IE@Y M?7NX_^/V0#-*QZZ1&5C2"=2>2XU(.`&6^!.@2&+)DH+`"YIUZ*5T,,*E9$[( MFP`E70RM?.F;4+HE:23=#JPGI=C""=.=+!Q-@BJ+)&?C7X?NO9H`J M'TQ!+Q/.@4,+6JD\!V]"+^S8"F---$J!-GW5,5\OHIM8)G@&(UZ6.ACTG85S:.J2 M\]>KN2UCZ/@&E]\Z1,=LH)U&"9"]R6'6]!1H,33,@)8#RH%8O@!BK1*(M2H@ MUJJ!6*L!8JT6B+4ZH%XK])\I1=[@/UNY!/ZS*(SU2%6^@Q6\G)C[";1V44.@ M%,C&^G(6KZ.9"+P,-AQX.1#/:N'0BJU*1EY21J*JK*#%#6L@'FBC40N$(%[< MS((_XFY!!_N1F#8US!OFQ)8\P9Q8M*1HY_4G$B/8F;LR-`%DA0E(-$J!:+8\ M+7'"R&!%DIZ5V--S6'%H%@ZM-L,@2D:^EMC$*VCY^:$NJ($57V,+%%Z0V/TZ M6/WJ@L(L,G70&V;,EDW!C+E*RE\HHTBL@SMS`RM,F42C%"A%?)M58!*\Z&$HBU*B#6JK56`RO6:H%8 MJP,:V80HV0*_CI0A_B'8F`O_620R06P).UH$34,OBN3T$Q]$ZGNM# ML)/BL,PAQ7-8.!1L.+8A(3_JU8:CY&O(\^[2:-0"+=SQ=BWRJ8/!R/',5(_^ M,O7*+-ABD_2PK-S.+0JB6*'$6051;*V"*':((R_7\H76*H%X7!40:]5:JX&5 M'\5J7!VL1J+8%']O\)^M%0/_611&L3[>#E9P?#)7*'7(1?%J0X=;L4=F:.7' ML!/R8]BB((8'Y,>P.-546KX&\F-8#;V%%6)X)G:A#@8ZALUM\#?,06\>KB0. MA25&+`]';#7,@48ID"TQZ,D$/0W/A?5LSBPQ0WA^LV/L*I4Y^&9R]8WDTA=6O#@#V M1`,K+R^`.)9+(`3N6DV*&R5G7(TV+--HU`+YU[+:J)GQY8.3B_ER(\B+WSJ" M]BIBPHQP7UC[2X$\@KJ&WI*?.!2Q1U.@8"K6(B$,GG$C2FIS(\XZ@ M"R,C9M(B_]Z4L_)0`L3AF@+QA6=`'.$M=PR>&:`L7N9+J>S^2YQQK(WVK.Z;'E'LUS+[,K M=7Z%\LCN8TJYJ2D\,S5L11C,H2L2.=YVYFDD4THP2H`X!%,@#L$,B,,Y!V*M M`HBU2B#6JH!8JP9BK0:(M5H@UNJ`1E+#E)A3?CWKRR-SH)(KCJM=Z8<77:)@ MV;F&P=YA&P:IX9!+C?EJ244;KZ']+IY!B@,U!_)38U#G88VDAK.B./`&+WJL M(,\]UD#<8^/0=#*VL#+?!IG46(FC3`?ED=0PY>34%)Z9&K8J#5+#%:H<;SNJ MXE1J.,0AF,**0S`#XG#.@5B^`&*M$HBU*B#6JH%8JP%BK1:(M3J@D=0P]:'O MU^F2>6'+R+(RH`X_G*M5<"*M4H@ MUJJ`6*O66@VL6*L%8JT.:"1433WHN_3W-F);50:>ML@DB>=I<1C;+9P5CS5Q M*%AMK-72IN+\2JAD4&%7Y0YY4UC`BEU5`G'W%1!KU5JK@15KM4"LU0%IM]-& M-NWV\U:(7J8_5[*3XZ4(YUMG90K)82KDLL\VB.]$HU2C3*-5+M!R$^O(KUY>'9W*/8=&B]%5.[8BEUJ*T9J")1JJTRC7*-" MHU*C2J-:HT:C5J,N0*%+9;W[BDMM.>32XOHN([(VFF4..0_XJ91AH;>PT!`+%_H MAJ5&%1JR5@W$6HU#XK$QL4:U;(5K[*#5RXZ;@AKQVT^^]B.=ZV`I:%;18O@9B^88; M3LBW;`7Y#EHCCC>EFN_XWSI1T%XOZQ>'@OFP5AY*G-4K#\"Q%:XH@SP[+`=B MAQ78N&-:LA7D*VBQ?`W$\@TWG)!OV0KR';1&YL-43E/S<>91PQ9@08)8 M%![Q9)FT6PY6&&RB40KD'H6+HR75E,*M&8SX;)8[Y)_S'(K8TR40#64X`44; ML;Y46KX&XD-=`^0=_8!P#U]^C]_!8.0@:$HU?W9>6:9L91?,@JK_=B;XQ=T2 M("Z]4B`NO3(@+N-R(#ZR%`Y%[)12HPH-6:L&8JT&B,?5`O&X.B!=$M)6]B;_ MZ9*P5Y"WU-6W@&S%43S4DD`IK/`-U(I^/U'>4(>-'\1.B1U:."O_21Q&?A#+ M6R!:O@9B^0;(#^)A$/9^QUQD7XG8^]!!7;W&XY M6,'CB4:I0WB@8+U81O+W^3(TX^#,@3CL"H?\[V(9^0,51_\*6BQ?`[%\`^3' MOKM"?*4ESA$=FNA$H&=QWC('O7E8U3@4+N<;$04[MAKF0*,4R"7"0#$@5HXY.VPA0E#OG?R@+Y\Q'+1S(R:-&:/35K=JAT0Q4]%I#G,V?)B+7BF3P<<8_0 MJH$X>1IH<9RT0/X%CX5`0Q780'JK0D+5J(-9J@'A<+1"/JP,:B6)37;XABFTQ M&D3Q4)]ZL:'._ZO!BJ-8H116-HK-H4>>_F'!,98#<8P50!QC)9"-,7K3QF(3 M_`GO"%4PYWYJ(.ZG`>)^6B`J(8>=962Y=M<^$M"F]GS#A-A2-9@05[T&9Z"- MK`56@Q5/B$*ILT(M,)O=K!08HC-0?B&"R`.%)+('M:%T^&5/B496L@ MEFV`6+8%0A$@;ZET,!A)!U/$O<'[MN8+O&]1L*C',[%4[LQ*2HL.6;'W%4IA M1?,RQ%(\$S.9P8K:#U8C)U`GS]%;H"$/H@3"2BS&7>%S/RV4<`,K%FZ!("Q/ MM1T,1C+"U'1OF!-;`@9S,M2]OH=49398\9PHE)HGX>MP=OQ3*6$L_(/ M;2-S,FBAQ\+)!U6!M3*?>#VJ;!EZA%:-H7)J-!JU0/X%C2Q8OGSP18'YA9A@ M>GZK*NA5PN.E0R*39%7`5KCNQ"&_*@#RYR.>B0C(H#6=2;#R,@GR7E7`R)\U M665#R\LG($Z>!EJ\[+5`_@7I68.63BI:T:=G[;RJH)<1T^8J:3ZD[)R57Q4` M<6RF0'R5&1!O`3D0RQ=`K%4"L58%Q%HU$&LU0*S5`K%6!Z0W$`JZ:;^>]?19 MKR+>ZR!.-<::$WVV,(*C[S,Y^8P.?P1JV>' M?D82Q12Y_NXCE[F#>':TXUB+Y7.Z.K9`5 MB4-!HE@M^OK)W-.?WVQBJJKE7@\I#MLUDBBN`Y?211WB=QCK7ML MSNJQA14216Z*'91'4L,4K5-3>&9JV-HWF$.+@M10**%O*/NC&(=@"L0AF`%Q M..=`',X%$&N50*Q5`;%6#<1:#1!KM4"LU0&-I(8I#GV_3M_3B&PM&?C/E9?A M9B%6^)UK2#<8.0>&AD"IL_)N@F9`''^YUBI@Q;M%"<1Y40&Q5JVU&EBQ5@O$ M6AW02*B:TM9WJ5S%SUMM;($<>-JBX)`:K<42L:/[.OV:Q&--'`I6&VM%CR+T MJXUZ3!,J[*K<(6\*"UBQJTH@[KX"8JU::S6P8JT6B+4ZH!&WF]IPRNUGKA"V MQ`S\[JI.SK$=/?O6.YE1HE&J4:91KE&A4:E1I5&M4:-1JY%Y$3)?D*VY[(N- M[5M[_>/C\>+^\,.\M)B^T/KP;L#NCXV=*;ZK1]<[.EU\P1OQXZIK=W?[_[NF_O7KX^/!\O'O=?*%'H%[7H[/!B MW_]M_W-R+S3[=#C1>[OII$[O0Z;WM._I=5;T'NG+BR^'PPG_,1T,;W[_\&\! M````__\#`%!+`P04``8`"````"$`6HYR68H)``!'+```&0```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`V05(!;;)'>D1]X/_A$9-A'HG6'0J@3+,-0T2$2/%-$)@@-,'8 M!!,33$TP,\'FC3& MR#[B]N_T!A_R&)NT5)`>,I(ATA0@`9`0R!C(!,@4R`S('$@$9`%D"60%)`:R M!I)4B>81M3-XQ,;U&P8%K61N\()%ZUYP MXO;DA#,"X@,)@(1`QD`F0*9`9D#F0"(@"R!+("L@,9`UD*1*M(:GP49K>+XF M:['5Z_E]M_TVS.CAIL7"A<[AT-J+K\B8B.X')S8+^7QTK9XYC(W*`%<:YG/B MT$^E.W7U[A3((-&=PE*HV"86=S,NB9*>R*RJ=$^7GLH@(3T#Z3E(1S*K*FVL M1AD")L*TS'F/<.&6RY"NFY'9 M^25_DI2Q7<>P?UA&U>X;58QZMK@XI0D48%2(:(QH@FB*:(9HCBA"M$"T1+1" M%"-:(THTI/O(S@6J/OYF<.;'"+3-%TTZ9,?'9*&^E1R8!V0J2B3ZB`)$(:(Q MH@FB*:(9HCFB"-$"T1+1"E&,:(THT9!N#_7A6^QAX<;"QN9;O&#AAA<<5;<;[*2- M]1ZU`_%+Y-(5.=F94VF@@D1_"H54L0G1[YSMH&_HY'S#K75RCK3IW1TX^N)V MQ-[IL,JHND7 M1PXM=Z03[L`U:RVCA!5^J>569QX>Y5K%@L*V^AUZ1ZHKA66:HXFP@D)H*0H$N6,1V!W7W?]51C<7W&-KM MQGP^7C7ZADO9T*A7/&6?WO'OP(ZI*>W M=)3N]WECFWUGW]451Y82\X_^Z*3"8YMM&I#ABD-7BK:%*RY=*=;_QI4G^\Y[ MHF(NJ-$5-E]=NL*^.RS6.8;:T*9[H]Z).;3C\-B&`J_01XQ/ES*&5,CE,JB( M"SI#JORENC^YWA.=,6'!0VJ32TTR['C)I1L==KVDV'48E7XB0YYH@88E^#V/ M7L@AG_0\>IN&/.IY]"H,>=SSUI>XW_?H/1'&3_H>O?=!'O4]>H^#/.Y[:_Y, MRJK19YP?F[=TL3F][8YY8Y^^TN-(CS1UA!/_$)3_<2Y?BCUG9_J`D[H;?;5& M'^RF=#)^QSKO:Y:=Q1]4<%M^`OSX/P```/__`P!02P,$%``&``@````A`'CW M18<:"```V2@``!D```!X;"]W;W)K&ULG)IMC]LV M#,??#]AW"/R^E_@Y"2Y77%=T&[`!P["'UV[B7(PF<6#[>NVW'TG)DBC+L;PW MUQY%4^1?](^^Q(_OOUW.BZ]ETU;U=1>$#ZM@45[W]:&ZONR"O__Z]&X=+-JN MN!Z*/_WXP^-;W7QI3V79+2#"M=T%IZZ[;9?+=G\J+T7[4-_* M*ZPKCL=J7'^O]ZZ6\ M=B)(4YZ+#O)O3]6M[:-=]C[A+D7SY?7V;E]?;A#B$)?*[K+^CZZP%- M58DI`=!GG&*+L` M&A7V;T'9KT]9E#TNOX(:>^GS0?C`3^43*H\E9*-2@C3,E-SR]#NC,^Z,6P-+OY;HS-MK426%JA4U6@FPZK,^%:D<[YZ@!#WI<;K^*[2 MPM7/W=J"3OX%HO-`V[4*+(Y5.$':JN218T5>&[?4_2K1F5Q?>4%J[L1@G`]@SA)O&OC[QM;3?V+2.]/,0-$2/>ZI(W+[4W M,7V-A'BM%HM(X&B-?)[0.)0A-3>3,"P1`IXE\G>@]4UN`3'4PQ=X&/ MR@@2_]W1VU)9FKC*.B&N,F1D[H8J;R91C*/3WE6:N,+Q2!];8+I_SX1#'$D3 MC6I>CP4?ZII5])!#>A.[*!(IU"+QL4Q>TPAZPEGL(6_KW"1](GIH,*=RZ&!- ME/G<"4/<4*Q!3:G[G*)9O"%O7E-O&M8463#!@XHAW?N'1%=96V"@04%Z.K/V MB"RH3.PV!`D%@-TE(`9PU^2@ M0QIZW$P(:0L0O8G7-#)P1;_1XE@^^P@N* MGGI`B691@KRMPES/*$9"O-W_+SBB(3AZDWE^R4H_3;"-\6G>OR?)F\HT]%OI MZ2R?[3&FUPB-'6R)X(CN'S5=Q<7N3>8H38S$>,T66Q``>>Y!Z7B(F=[$Q1Z9 MX;%%GHDR%6Y,L?6@EF(++X^.CI$>WO@A;TMD#``F+K).B(OL(-+T\TH\Q%%O MX@J/S/9X%H[(>]#.>L1*A06A?!2>1:Q8$4N-D][$%=8)<84M0M$<6R4>T(\E MFHSG[M[$51X9SCC^9W220I3NXRS2,U*J++P\5$YF(8N\>1_W)K;72B?$5,:_ M%,U:2>68/GV:P!1=:>WL>`1*5B.C-;$P=9\6Y#WH97O^22]6N?N),D&N>-." MO*U:!9@L6NB$N,H6FTCE,)_^`"213#):N3>Q5@Y'YE\"4LPH$[UMD4-[_E%, MK_F7S,(5>5LBRZ1:N$H4KA>7>Q+!L),143BT\42MGZ^E6I@OY\?8F+O+(/$@M M4MT7F;P'K:R!+T267JR]W+Q(9]&*O*U:Y<,5VRO4"7&1+3JAR,EJ\P"WPT39 MDDH&+U)IXB*/C(,4O/QY0=X#D37OI<@8TZN34^2/-Y3)VQ(9`X")BZP3XB); M=$*1L\2CD2643(VE"?Z!(.+;CR0<&0:IQ:F)$U5L,D)'&O=28^'%ZAYIY%FL M2A6K%"UZ$]O+2(AK;+')6^,AI5)I8AI'>CBQ?3.+4OZ&Q]&)U MNS7.9J&*O'D?]R9&9",A7JN%)M0X]/J`.I-,,CJY-S%:1"-_!&46IB945FPR M.]F>>Q33BQ;9+%:1MZ6R`!-_A(MT0EQE.'>33:BRU\=J&5YH;2Q-7.21N9&4[M=' M5UD[R+_M.))TR>P<

2?$8K76?M*QG%3W%DM.:S@$3>]KT2VZ-5>OF<(O+$ MN%,]M<:KK)JEB6EM),:UALSL7;T^&\>OHNR-I8F)'8_,V'P6F,A[(+8]8Z67 MC]BSP)0/P=2;N,@Z(2ZR`TQ^(@^Y!.\7D>Y<9'O$BE>(Q'LZE[)Y*7\JS^=V ML:]?\?4@^/KGZ5&9Y;M+6;9]!N@!>@9]899`USU9%!#-?`A]:N%;@& M/FQUK4"E\`&A:P5T@\^Y'"M)!"N)+VL[N"5,OKO"5XA+.%5*WJ'YUC77?\+;J!>2GSZ#P``__\#`%!+ M`P04``8`"````"$`N?6AIE$#``!%"P``&0```'AL+W=O:9]\*DXJ*(?3(*?8\5B4AYL8_]/[\? M;VY]3VE:I#03!8O]-Z;\N_7G3ZN3D,_JP)CV@*%0L7_0NEP&@4H.+*=J)$I6 MP)N=D#G5\"CW@2HEHZE9E&=!%(:S(*>\\"W#4@[A$+L=3]B#2(XY*[0ED2RC M&O:O#KQ49[8\&4*74_E\+&\2D9=`L>49UV^&U/?R9/FT+X2DVPQ\OY()3<[< MYJ%#G_-$"B5V>@1T@=UHU_,B6`3`M%ZE'!Q@VCW)=K&_(LST+W'Z MQOC^H*'<4W"$QI;IVP-3"604:$;1%)D2D<$&X-?+.1X-R`A]C?T(A'FJ#[$_ MGHVF\W!,`.YMF=*/'"E]+SDJ+?)_%D3,IBR7V=H#U72]DN+D0;T!K4J*IX9H+WOI$GT]QFT)^N'36SL*52 M]1#7TX7;13[41PRZI5:UDAY//;UC2D;SZYYL;X!;7-\?4H5<3],+=0)4,YGO MWR""Z):G*M3C"2]RJTY##AY^J-HB5AK$&&)7CD*W/\!$TV/HMF7(#BUV,LB9 MW+,O+,N4EX@C#B01?.OK:#TL;2(\WNWX9+FQ0U10OX$AIJ1[]H/*/2^4E[$= M<(:F/M*.0?9!BQ(R#Z.,T#"^F+\'&%<9?.]#;"0[(?3Y`92#>@!>_P<``/__ M`P!02P,$%``&``@````A`.DX^(?_`@``_0@``!D```!X;"]W;W)K&ULE%9=;Z,P$'P_Z?X#\GLA)H$T44B57M6[2G?2Z70?SPZ8 M8!4PLIVF_?>W:Q,$2=K2ER1LQC.>W?6:ULE#5/R`O7Y&;]^=/J(-6C+C@W'C#4.B&%,>UX$BP"8UJM,@`-,NZ=XGI`-7=[2*0G6*YN@ MOX(?=.^WIPMY^*I$]EW4'+(-=<(*;*5\1.A#AB%8')RMOK<5^*F\C.=L7YI? M\O"-BUUAH-P1.$)CR^SECNL4,@HT?A@A4RI+V`!\>I7`UH",L&?[?1"9*1(2 M+OSK*)K%UW.@V7)M[@5R$B_=:R.K?PY%6R['$K8L\-VR3&,_FD^F%$3?(0G< MCJS!.V;8>J7DP8.N`4G=,.Q!N@3BRX[`"F(W"$X(=#7L54,9GM8Q7:R")TA= MVF)N'08^.PSM$`&(=LJ@-EX9P:B,N<6MW+I`7R:\+#/]B`R"$S+K;3X.)QVO M4W88R'AG<-8A!@:!9KQ!!$,-YCW:\]PZT`AI@(R71K"5[I+;1OK9C<-7RAA_ M1`K!0ZDV$MOSUV\/R$3?`AZYB/IX7-[N45PWE&@CH-15+`Y?Z1:2]/ M=B#2Z'U#=N&)"')!:&CIE3-%/S0U+/I$S0V."Y9.!H6UM`#TV^T&U\YIB8ZA MH:'HI$;NLG&SN.)JQ[_PLM1>*O=XD80P7;MH=\EM0CPFI_'9R7/@G-C3H]SUY1Z,;"`]<'E(`[>._5G`:P:'"3O!8N92FN,# M*`?=B\OZ/P```/__`P!02P,$%``&``@````A`/EZ3JQ#!```>`X``!D```!X M;"]W;W)K&ULK%==CZLV$'VOU/^`>+_A,V1!2:Z2 M`.V5;J6JNFV?"3@!+6"$GF'__2+^\F`:A65MD-6[1QOQ`Q/RZ_?67]17WKZ1$ MB!K`T)*-65+:199%\A(U&5G@#K7PRPGW34;AM3];I.M15@Q.36VYMAU835:U M)F>(^F4D/:HS"O&3LNJ(8&OR9^B:K'^]=%]RW'1`<:SJ MBGX,I*;1Y-&W]4BR#;4B57@B/$K M,_U6,`B<+TYL.8C1V]TA.?HZ`5/.?JC(SQ'Q_#A0A#&(!.>8B$( M]H&D8'2`IW!X&)G%\SJ4*QG>1$0";JPY>6%?N_@D&E M&,F.L6Q,V+10"P)=]K8-'&=MO4%GY*/-7K>961R$!6L#1AO/@60.I!/``D52 M%F3O$V0Q%B9+!+07P$VGJZH\"`OA$L^!9`ZD$T#1`%WW"1H8R\:$1IR49A;T MGMNXL+NED3_3)4VD,`U)-"2=(HHVB.<3M#$6:-S5)&Z][[C10W'21(K3D$1# MTBFBB(-=/!5W_ZP36X<9#QK$VGN.N-#:LAJ!X\WJ(8V$6ZPAB8:D4T0)&;;^ M\R$S8S5DC@3#73!LW8.&Q!J2:$@Z193XH,33^-@QY2X7(.<)2=5O%01[+*;M`V_ MJQ=L$*)EE;_N,>P*L+G33AZ$/=[4_,:$,U/$N7#^C,ZH+HF1HXO;`2&RF_7 M$I;S^6X8SV?XGLWM3,<<=R.8)^[@7@27L8[O_&@'@>H_[/T(+K@[^#*"6^0. M'D1P>M_!5Q&<@W?PEPC.'\`MJ0#F_BX[HS^R_ERUQ*C1"9)B#_W=\R\'_D+' M9CAB"A/_T!&UL ME%?;;MLP#'T?L'\P_+[8F515E:!$6<@B&V&QXRNY%NB]8J2V(9#G5$+_:\4H= MT8IT"%Q!Y=.^^I2*H@*(1YYS_6I`PZ!(%]^VI9#T,0?=+V1"TR.V>>C`%SR5 M0HF-'@%<9`/M:KZ.KB-`6B\S#@HP[8%DFU5X2Q9WR32,UDN3H+^<'53KY_B4.7QG?[C24 M>PJ*4-@B>[UG*H6,`LS(AI&*'`*`UZ#@>#4@(_3%O!]XIG>K<)R,R"2>@7?P MR)1^X(@8!NE>:5'\LSX$8VHPDAH#WH\8L]%T'H_)>9#(QF/DW5--UTLI#@'< M&:!4%<4;2!8`W*\'@D#?6W1>A7"G(58%17A>3^-E]`QY2VN7.^L"KXT+:3PB MX&R(@6PX,3HC,:8#([FSAC9-TD\SOH0&G5?AI!7\-'X+WS);'ZA:(W#2SPPP MPP6B,Y1@WH+MI-;Z#&`&E^',Z&R8F]S6EG9RI_&)],XNH4)GE\I:3-\ZEP/R MT%9@NBU.1G,([?T;B@==BMKB%G7<7S*FQ(!B87$W3 M_@J1B\:&\?;8[.3HT731I"!V#$##-FU3FWJ0L7&];)%!MQESXEV`H\G-UNQ$ MMK"56\QG:E,W?EN3-?5H\AH?;\!\/N0"=(<`J4VNI/D)2=YH.".I.P]PQD). M>R1YW8^2IF3`S"'=27`TN9*N3DCRYL,92=VA0*RI*RGQ)H#I4W!^G\&<;S28JS%H MA..0]YEKDYM+?V6PR[7=/@LFM^PSRW,5I&*/BW,"^V1C;9;ZVP0'K&^?+&XA M"DQE\PTLVQ7=LA]4;GFI@IQM`#,VW2OMNFX?M*@@:[!S"PU[MOFX@[]5#)9* MD_6-$/KX@`3-'[7U?P```/__`P!02P,$%``&``@````A`$9+VH>:)0``7MH` M`!D```!X;"]W;W)K&ULK)U;;]Q(DH7?%]C_(.A] MK&+=)!FV!^WB_8;%8G;W62W+;:%MRY#4TS/_?D]69C`SXM"E*LWT0]O^&!E) MGHB\!%G%>O?7?WS[>O;WN\>G^X?O[\^S-XOSL[OOMP^?[K__]O[\?_Y6_N7J M_.SI^>;[IYNO#]_OWI__\^[I_*\?_O,_WOWY\/C[TY>[N^/C^]/[\R_/S MC[<7%T^W7^Z^W3R]>?AQ]QU'/C\\?KMYQC\??[MX^O%X=_-IW^C;UXOE8K&] M^'9S__W<>WC[>(R/A\^?[V_O\H?;/[[=?7_V3A[OOMX\X_R?OMS_>!)OWVZ/ M[S^_/?\G> MCMEZ=7[QX=U>H?^]O_OS*?G[V=.7AS^KQ_M/_?WW.\B-0+D0_/KP\+LS;3XY MA,87U+K/K\W\__%G?W?_VY1GQWN"2W)6]_?3/_.[I%I+" MS9OEQGFZ??B*$\#_S[[=N]R`)#?_V/_YY_VGYR_OSU?;-YO+Q2J#^=FO=T_/ MY;US>7YV^\?3\\.W__-&67#EG2R#$_PYX^1`PU5HN(X-EV^R]6+K.C_0#D?W M9XT_I[2_W0(^7H2'^E!Z/.E,,M/V9 MXL_0;GMA(?Z4#K=OEE>;;/.2.!F2R,<449.V1YUL)H%T?SGM=#,)I?M+ M:)I!Y0.29HBZ/\\8_L/1N/#)NQ\+^![G\;%SX8%QH/S\HMS\_XF)#$3&E"AMH0]I MZY;#$R<"YP9S"2;[24B>";S10;4GDTEM(@61DDA%I";2$&F)=$1Z(@.1,25* M;0BKU#ZB(# MD3$E2D.LD2=HZ*RUAIX8#;=&P\EHTI!(0:0D4A&IB31$6B(=D9[(0&1,B=(0 MXU1IZ);_#;+JQ%'OW&AQ/5EB)D\2]-*(.QE-XA(IB)1$*B(UD89(2Z0CTA,9 MB(PI4>*Z4C'=6QT>Y,Y::^@)IDF19TD)S(0&5.B M!,..70GVRFQT;K22GIALO#+9.!F)W#F1@DA)I")2$VF(M$0Z(CV1@3AE?,JH8U8P:1BVCCE'/:&`T*J0E=5OV M$R3U.WPE:;KIW]_&V+D;*SK_D8#(]R832Y(Z^>V MZR?HYW?W2K^PX=*)JN8DH0*5\#:E"14L57-J&'4,NH8]8P&1J-"6E*W M>S]!4K_95Y*&_7^RDW1W&&U*$BK8JF14,:H9-8Q:1AVCGM'`:%1(Z^_B3 MD?DQ"SM^=;MB:6]81BMIF#,J&)6,*D8UHX91RZACU#,:&(T*:4G=+OT$2?VF M7DD:]OEI2A+*,T(%HY)1Q:AFU#!J&76,>D8#HU$AI1]VEM^M(\S=A%JRE;&16,2D85HYI1PZAEU#'J&0V,1H6TVJ=5/NZ. M&I:6-%L#0AH9S0P&A72:KLR)%7[\'V.I:]: ME*13(9,61?;N>FB($Y&7NDR*Z!"@8E8PJ1C6CAE'+J&/4,QH8C0II_5P=D^KW M^FSU%9&2-A1).EOM@XWE9!6SE5#!5B6CBE'-J&'4,NH8]8P&1J-"6FU7]:1J MOY"MODA2DE+=M%L2RAD5C$I&%:.:4<.H9=0QZAD-C$:%M'ZVNGI]MG+AM0R% ME\Y6^^`C6L5LG1H**MBJ9%0QJADUC%I&':.>T])5PD!N:U=LA.P MST>BE:1FSJA@5#*J&-6,&D8MHXY1SVA@-"JDU3ZM\%IQX1506G@QRAD5C$I& M%:.:4<.H9=0QZAD-C$:%M'[())6MA]>FE3,W*>F1TH]0'AHF5@6CDE'%J&;4 M,&H9=8QZ1@.C42&MGRVE7C_:NO32M?_J1K4T!)'NX8Y8P*1B6CBE'-J&'4,NH8]8P& M1J-"6C]7SZ3ZO3Y;?66DI`W%$@9_7)M6]JG4:K*2U,P9%8Q*1A6CFE'#J&74 M,>H9#8Q&A;3:KIY)U7YA;O7ECY(T5$1)E;HBE#,J&)6,*D8UHX91RZACU#,: M&(T*:?ULW?3Z;.62:A7J)YVM]H%+M(K9.C445+!5R:AB5#-J&+6,.D8]HX'1 MJ)!6VU99+V0KEU*K4!&EV4HH9ZN"4;ACE#,J&)6,*D8UHX91RZAC MU#,:&(T*:?ULE?7"VL2EU#H42]/ENY MI%J'^DEGJWV6&JTD-7-&!:.24<6H9M0P:AEUC'I&`Z-1(:VVK;)>R%8NI=:A ME$JSE5#.5@6CDE'%J&;4,&H9=8QZ1@.C42&EW\;63:_.UKTGO4D-R.S[[;/4 M:#5E*Z."4SU7VMU.S[`TIW4HQR1@6C MDE'%J&;4,&H9=8QZ1@.C42&MGRMQTKKI]=GJBZ7TYNK&(Y.M]EEJM(K9.C44 M5+!5R:AB5#-J&+6,.D8]HX'1J)!6VU99+V0KEU*;4$HE/M&RZ_`C):VR=9T2IJ'>JV^('7@JU*1A6C MFE'#J&74,>H9#8Q&A;36_[:*;,,564!&;?LD)EI%M;DB8ZN24<6H9M0P:AEU MC'I&`Z-1(:WV:179ABNR@+2D2WM+*UI%24/=EB8PH9(;5HQJ1@VCEE''J&47ME7QELS:/MR*5C%;IX:""K8J&56,:D8-HY91QZAG-#`:%5)J M;VV1=CA;]^:Z$@L(`15E=HQR1@6CDE'%J&;4,&H9=8QZ1@.C42&MWVEEUY;+ MKH#P#82HG[=*4!ZL\$Q8K`I&I?CR;\AT+^VK!$7W-3=L&+72,/KJ!$5??4#N M#FLRH,SSMR%:R=F/XFOO7DOJ:IZT$GLA)7V)E)9;VU`UQ?/<,-E1XV-4F4MO[$=%*3C9G5`BZWK]H-+M< M;JZV:S,!E&(4IZ]*4/QF>BTH/:WUM2D\&[%2>;(Q5JU8Q1X[0;''7M#!'@>Q MNMQ?XN+-VF3-*`;[SO1DYLJT$R8S7]6IRVPMY.5J)RSJ@0Y'-]M=A>;A8F\4JQB8E7"8J)5P>$IP_2 M7Q-1>J*F.&W%5VS8"=I.OGI&@R!)XN750OUG-L&CV,_DM"O33HB)K^I43GOD MOBN0Q,2RN^TO%!%]2+53H^@I6^(+,.CM+P9Q>D1]%I->F6:]*`S"@R\^`N6HE8.:-" M$*XSB859?4JQPKDD5A2Q4!BG0\LC-;0FE/C:FI';QA[E[#M!Z=`*/48TB)6Z MH*V98D:Q0OO9"](1FZN"T[7_N+T85\!;C_30VYI99A>M1(H\('S.3U`A2$VM M6S.,2_'ULTP-ZU`XK[@JU*$AGGE)CTU$B89;,]C;V*,T[`3%<=8'E%S0($A? M$`4RG.K/+D@%\M(6V'93?=PF;N]&+VP!X:-L5 MBGW58A5]-8*BKU90]-6QKUZLHJ]!4/0U"N)%Z-+5R,B7,RH"PN-%][;];+NYW&:T"99V<46H!,48U@&E"TY$:=;;!4=\1?>= MH'CR/:-!T#)L;R_->!K%@+=GEZ[2/B$*OC!/MP)[#W@A?%1@QR@/2&6Q]X7O MQKUJL8N8U@J*O5E#TU;&O7JRBKT%0]#4*FLEBS"&GZ.?,319[ MI+.8MK>7DY6(E3,J`@I9O+[&YM:LD:6TBDE6"8H1K`-2.>S/P'U<)*Y^6[.K M:<57=-\)2G.8KF80*\GAA5F%1C&8R6%;9A^^WW3)Y71`>G.TM9NC:!5C,-7A M@@JQ\B4&?H9H)@:A54S-2EK%I*L%Q=1L!$D)8.:Z5HY'QYV@Z*5G-`@2QPN[ M9(K!S`@XK4!V]Z+L"`C5L"XF2/W)2J3.@Z]D:B\$J;WWUFY-Q0II&'-Y8]2L MQ"H=%W023;1R*P=^_<>X:<4@'1+DIA>K.$H&0>FUK*\I,L'7S+AP)7$ZM]N= MRU%;T$M?6*LIWR,S7.P6-#1,IOP\('RL1&)8"%*AN*19*_3XLZVWWX)*C^D@ M\@WQT0#IL9$>,0AC\"^-K*WX2H?2=-GBJQ=?\8(&0>J"-F:>'*/[Y"22#-1; M4%=0'@KDD5M07Y>J2'J4WINZ))0+BKE9"(H77@J*>5X)B@5`+2CZ:@1%7ZV@ MZ*L3%'WU@J*O05#T-0J:&2"N$CRDZW$#Q->32E:/]`"YI`$R64D^Y9<>X5O9 M@@I!V[`SO%.+M*L$I8-A\AZ3CF_/2H>85Y+Q89;C5MS''CM! MZ5)S3(]#[#%,H;1_#4K-K#ZNE#L4PB.'AJ\(50Q#D1CS;7=)*!<44[`0%%.P M%!33N1(4W=>"HJ]&4/35"HJ^.D'15R\H^AH$15^C(!X:5R]5O4<-C;T7O=T- MR`P-$_!=M))\S@-*AX:@,#3P^X8HVLSR6XJKF*B5H&1HB*MT4>"A(59Z:)@> M6W$?>^P$Q1Y[\76PQT&LW-,@M[M8FZW,*)YY:%S9`MLN_\<-C;T;$\-0>,=\ MVP6K9"')!<44+`3%%"P%Q72N!$7WM:#HJQ$4?;6"HJ].4/35"XJ^!D'1URAH M9FBXNC6=<@Z7&U>^S$VGEH#,&#"W`W;!*BFL\]A0AD4A*&96*2CF7\6^:K&* MLW4C*/IJ!45?'?OJQ2KZ&@1%7Z.@F51U]6`JJ4W5XV8;Y\5DJD=&:;,9VUT% MJWBN>4!JMO%6>(?'_A;1&^.E%"]1JBJ@)(2U6$6I&D&Q^U90]-6QKUZLHJ]! M4/0U"IJ1W=6AAV0_ MTH9 M#8Q&A;3:KEXY(5M]>:.R-50\:;82RJ\(%8Q*1A6CFE'#J&74,>H9#8Q&A;1^ MKM`Z03]?ERG]/%(+$*'\BE#!J&14,:H9-8Q:1AVCGM'`:%1(Z7<]5[VMKMPO MKY_ZE9>]*[VX!Z2'^Y6Y9;>+5M-P9U0P*AE5C&I&#:.64<>H9S0P&A72 M^[)'96NHEY+%*5@E"9PS*AB5C"I&-:.&4F$GP+74M4?X=HTHLV.4,RH8 ME8PJ1C6CAE'+J&/4,QH8C0II_5Q!DZY-K\]67QJI92M42WINM8\>KBJK)24I%5"[:T(YHX)1R:AB M5#-J&+6,.D8]HX'1J)#2+UO,U5FOV@IX5[K.$F:F5_.X:9>831D[P_"SX>YL MS2\*,\,/AY,=?CF<&'XZG!A^.YP8?CR<&'X]G!A^/IP8?C\\94;\TZJN;,%E MES!\I4ZD@YS>+F'X$79BD),8?H:=&.0D!CF)04YBD),8Y"0&.8E!3F*0,V5& M3E?N'#\99`M?'J6S@;!TJS7#(*=OF]A!3F*0DQCD)`8YB4%.8I"3&.0D!CF) M04YBD#-E1DY;9;UZ)Q\(6 M0DYBR&5BD),8Y"0&.8E!3F*0DQCD)`8YB4%.8I"3&.1,F9'35FC_0BYS]98M M/#.Y;!_<)F9)+D]-A4%\8A"?&,0G!O&)07QB$)\8Q"<&\8E!?&(0/V5&?%O> MO93+7,1EBU"?J5PFAEPF!CF)04YBD),8Y"0&.8E!3F*0DQCD)`8YB4'.E!DY M;?WF,2MF6#G#JAE6S[!F MAK4SK)MA_0P;9MBHF9'3E2:GR.E+&55_9*&\40EKWS^QPP>H]X5PDIQ0F!@4 M)@:%B4%A8E"8&!0F!H6)06%B4)@8%"8&A5-F%';5RBD*^^I&*YQ6//MO74!. M8I"3&.0D!CF)04YBD),8Y"0&.8E!3F*0DQCD)`8Y4V;D=/7'*7+Z>D7+Z9F> M8>U7?*#P9!9G6&90F.R@,#$H3`P*$X/"Q*`P,2A,#`H3@\+$H'#*C,*N)#E% M85_":(73LD82EA@2EACD)`8YB4%.8I"3&.0D!CF)04YBD),8Y"0&.5-FY'1% MQBER^J)$RQD*E73WY5ZDZNXK1@8YB4%.8I"3&.0D!CF)04YBD),8Y"0&.8E! M3F*0,V5&3E=DG"*G+TJTG)Z9\6\?]V;99):,?V)0F!@4)@:%B4%A8E"8&!0F M!H6)06%B4)@8%$Z94=A5$J MI:\[G&&0,[2-[V:#G.0/J_ MM;G)C#A,9M(%XD!=(`[4!>(PM3W0!>(PF4D7B$/:A8X#EB(=!U<8G_SRG6SO MQE1L@:GP,,NE[0LO0TS,Y,)*8?BPIK!J8G'4Y.8B;M66-)%-['8 M12_L+KTB/-[.O>([WF2Y M-C,1(D9=(&*!Q0D:$0LL7AC",]GY+Q':-SPA6*EW$RQ7`:7!>N&>G;OU:;X- ME`66?#L0$?!V"4,$`HL??D$$`HN/JZ!W8/&+?M";_&&$>(9W?2=Z$X.XY`_B MDC^(&U@\/X@;6#P_R)GZ,W*Z3!2*1Y8E!>2>Y:^O"UA:8J;SS$@"M0%HD!= M(`J!J12?['R*9V:,(B:I=Q,35S.=$A-?8^F8>*9?XW-MUDID_626Q(088N*9 MO(_J(26!J9$QV M/B;F_!&2U+D)B:N[3@F)K]-T2$+MIF=6DQ@(R626A(080A)8&":KF9LW/U&KOW83$%6JG MA,07=CHDGNE1LN&03&9)2(@A)(%ANIW6SBV]\FHRPPPPF6V2EZWXM\=,9FKH M^![TT)E8=+>U4B)0X>3BZ$2@`HO#!($BAD4EL/3"^-4_DQE_23W#:]5TM.P> MZZBO5'LW=@OL2TQWCI.Y(`8S-=I"#W%GBVW7Q**[[8*W75.ODHD(8F#QPA#$X"Y>&((86'IA M+^`06TQU[ M,O*'Q<@SO2#*3?(+"Q*!P8%)WX/0W*[.;@.;!*JX%T#PP-0`\T\O-Q.(` MV%R;$T88J`N$@;I`&`*+@P)AF.S\WLS4P6F(-G4?[K"03#2&GB_)4`P`HM](1B3"C*$$8S)+BHS,]6+V20VR6%Q=+J],A8`Q$5K& M'*XF%G,38X)Z0(@"\R_]--_)1$3(-2(R-9$3143(-2(RV?FYQ]X"PF!)O9NY MQ]6*IP3#V=M@>&9V269^W648^_N'9S%S$0QB"$9@V"Q,L=TN:$40,RQVD]G, M+DG,8EXC0-0K`C3UZE4TIX\0!8,X0!&BJ5$2(G*.$$UV/ZM&Q&)NO+C:\900 M^5I3K=EXNX_3WHW*1"RS2"%$DYE<#T)$#"$*#'DUN=LN>,`$,US]9#87HLF; M](H0>::JDE'R3=/7D6;!SOURZQ2=[<+D!&:]T.M+XRR8 MJ7$6>DVK$>D5"B:]4NT?>Y6<0!!#%W$"01!#%W'^11`#2R]L+HC!W=R068VL?'&KAZ)GV"3)E6'<$<.X"RRF+,9=8/%J$9_`8KIC52)_&%'D#Y,> M^<,\1_Z@//F#\N0/RI,_+#ZI/[/XN'KPD,Q'CA5?5FJ50ZF)SJ7B\T6=REY20K>XA*!4%`/",740SPY?@7C9(8\ MG:YAFYF=(P)&O2)@@<71B(`=TRMB&,SDY6_X)&/ZG]FZ(+YI]R:^KA`]%-]C MAY$O:'6`/=/#B!B&46!J&`6FAE%@:AB1/\2._&$8D3]$A?PA*N0/42%_"`'Y M@\RI/R.S*RT/R7SD,/(5JE8Y5*UZ&)E[1YB_)C,9,A#>,SV,`@NO,;VZWJ+6 MYVU#\*:&46`QH1&*J8G`$1;7N'K&7S.QZ*^= M6/3732SZZR<6SV^86/0W3FSOS\CL:METX+QP-VSM:U\U0@)3Q0]^4D67W#N\ MQQI=J=\.@<*>)8M/,;&8Y^7$TO'`_J`P^8/"@45_4#BPZ`\*>Y8\PX?"Y`\* MDS\HG/HS"KO*,U7X=;MAG!;MA@,SPIO)!,+[IKA#':>FP-34)$R6/>,(40B. MHFJ5,!P2YXA"L(N[5$2!3@)1('^(@F?X0_PA"N0/42!_B$+JST3!E9^'HG#L M=.+\V.G$,WRL0DX9FA-#LA-#LA.#S,0@,S'(3`PR$X/,Q"`S,01)3JVN,(Q M?/MJ]MBU.[9_[RJURQ:NO_VDS,=W< M$4B/%ZW-'8'P>(78W!'(CM==S1V!Z'B1T\R1#13R#PYL9FR@D/\<,QV!0O[- MP/;(%E?JO_MDCUSAW/!:XYDSN,*YX>V\,TWB.>.0!U_;\7VLX$ZN,,R MUP9GX'^LA=K@#/P'Y^@(,@L?GYOQMD8;?$!V[@C:K.?;0.OU;#:NH;5_A&;/ M8`VM_4TY>V0#K?WO']HC*[3!9G?NW-`&>\6Y(]`:^XJY(]#:+Y"V'S?%S<]P M:VB]GHWV"FUP[W6FGQ7:^!V"[6<%K7&/::X-M,;]CKDCT!J5\MP1:(WB;N;( M$FW\OL6>P1)M\)1WK@VTQJ/&F2,K:.TW_=;;"EK[1R1T!%KCX<&,MR7:^#7? MMEFB#3X5.-<&6N.S:7-'H#4^(C5W!%KC\SUS1Z"UWSK;,\C0YB>K)]K\9.V$ MUC]9.:$U/@@_.+*$U/BH][GKL2%>8Z[`37#?UF__>4G^P\W.&=:?$089R./ M(,Z.,81P=H0A@'/Q+O_V@#'R7TCX.W^\_Y\S'V4_^W^@_I\#!]Q6,#G M;.SQ@9`%?,X>PZ<*%O`Y>RS?KMX6VSE-:QQI9H_T.#+,'G%?6'%7/:>(^_*) MN^JY8^Z+).ZJYXY]O$)(\$9VUN/C%8*"MX?/'7%AF?>&08(W/G.;?)M!B;EL MK'&DF3W2X\@P>R3?+N%M+H=K'&EFC_0X,O@C%].T\_3AW8^;W^Z&F\??[K\_ MG7V]^XQMO_MYO/.SQ_O?7,7K__'\\`/EP/G9KP_/SP_?]G_][1&<#X M\\/#L_P#%W_QY\/C[_O2XL/_"P```/__`P!02P,$%``&``@````A`.(+/$"< M`@``PP8``!D```!X;"]W;W)K&ULC%5=;YLP%'V? MM/]@^;T82$+2**1*5W6KM$G3M(]GQQBPBC&RG:;]][L7IX@T49L7A"_'Y]QS M_,'JYEDWY$E:ITR;TR2**9&M,(5JJYS^^7U_M:#$>=X6O#&MS.F+=/1F_?G3 M:F_LHZNE]`086I?3VOMNR9@3M=3<1::3+7PIC=7PF'*4LEY)T1.RU;'TBL;+B'_EVM.O?*IL4E=)K;QUUW)8SN@&*K M&N5?>E)*M%@^5*VQ?-N`[^=DRL4K=S\XH==*6.-,Z2.@8Z'14\_7[)H!TWI5 M*'"`L1,KRYQNDN7M@K+UJL_GKY)[-WHGKC;[KU85WU4K(6Q8)ER`K3&/"'TH ML`23V5GL&AM#7LGBYDTY`H$`3I3-D$J:! M!N!)M,*=`8'PYYRF(*P*7^=TDD6S>3Q)`$ZVTOE[A924B)WS1O\+H*1O*G#U MK=UQS]9(E$)_O!9I`[`;!.87M"#(.\GM:9\ELQ9[`M#A@ M;@,&G@,F&1`,1`=E4+M<&<&HC*E@*[>A,)9)S\M,CF4P]`DLW?M&<5).IR,3 M69(-_*&#@('D!Z/3`7%D%&@N-XI@6(OYB/8TXP"Z0!H@8VDTGV:XNS[PC_/Z M+H:\#Y5QX%DR/V\X.U9]/VH$'TL=*EF_;\<[!D(Y<1-/H_F'=G#BL<:A`E+# MZF7)XKP=O'XO/B((/I8Z5,92TV3R1BI<&N%D:FDK^44VC2/"[/!"2.&L#=7A MKMJDF-#;^G2YZ8\)&S[`'=+Q2O[@ME*M(XTL@3+N8[/A%@H#;SKH'&X2X^'V MZ%]K^%E(.&YQ!!F7QOC7`0BSX?>S_@\``/__`P!02P,$%``&``@````A`.`T_[/"T-RTM0J[&R<:=0]94MQ"*?VUJNIV/=] MUI>#1O3/\V;ZY-O&\J_#NKI!CL MJ'#``\@DOD(%22_2,EEFA?+@E!R0\OBM<+'UGB?34`]"OR; M>`2PP?OGG[,O````__\#`%!+`P04``8`"````"$`;OR(Z%H#``!K"@``$``( M`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````"<5EUOHS@4?5]I_D/$^Y2T4ZU6%6'D$B=%2PR+G8IDGK(,V\&?O2*I" MKROU,/&6;/;Y+V]DK%!K46LE)]Z+--[7\-,?0=;HG6QL)*6UNQO? M-T4IM\) MSWBSM[]+NM9%J\^LV,L.!(UE8W8Q,]1_8 M=N6-O@LC6SD3;R^:2B@+LEI8_]&-ZYVQ3?A--X^FE-*:P`=`/]D-C[''X^HZ MO+[J$#`Z1;8,O1)8.-7(*EM+DVXRT5B'Y.L3S9V*7G$OZ+6*''J#8V7!+QZK MOMJ5/E9^R.%6U$(5DM,/R9V!<)`&C5)*"[6#0AU@K7&]#&J%E6TW&:XW/(66 M[(I\8MT9<*2WNT:64IEJ+WGBUGS@;^FC4J@':7BE.+6Z>"R')3E#+H=CNC0B M84H^J_6/,VDL%PN4W_-TQFD\)_$LCA!A'$51NB3,R;]`!,WQ`@,L2Q"A3E"& M&`#<:R1EF/(,W:/;!#NC8Q*E"\P9^A>[*9*8Q7/$XI1PBAE+.CE.JB@E*YRS M&'[%LQS/<)[C*:C*+"2)1C!(>$\KRI3.D([M+DRG. M*ZZ8=_<,9UQ3D,X$]^=";PWI07"R>/$ M#J?1'W(_3\3#MIZGK>'0-!'."9]**ZK:S?ZSPPX>P8B?S4D5L6OAA"MG"$?.G.H M>3Z`*;QTUD^U;,]YXN0_O]/;ZCM#Z/O=[NJ3DUO]W3V>5.K1+'=,3^%F?'VH MG$X&M(2+=0U7^.OZVT1P!V^4IFY)^NMN_8KYN-`^JU;]VS&\O+X8?QG#B^EH M+O#?7HGA_P```/__`P!02P$"+0`4``8`"````"$`(\`T5?&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``J&9,*. M(```^A$!`!D`````````````````CA0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/43<-N'`P``E`T``!D````` M````````````J$@``'AL+W=O&PO=V]R M:W-H965TX(T,7P(``%$% M```9`````````````````"Y2``!X;"]W;W)K&UL M4$L!`BT`%``&``@````A`"T>06JT`@``70<``!D`````````````````Q%0` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`/HS:X1@!@``5QX``!D`````````````````7&```'AL+W=O@``>&PO&PO&UL4$L!`BT`%``& M``@````A`$=RP3A@!```X1$``!D`````````````````(/```'AL+W=O&UL4$L!`BT`%``&``@````A`#CDXV9[ M`P``MPL``!@`````````````````=_H``'AL+W=O&UL4$L!`BT`%``&``@````A M`,*MMA_M`P``Y@P``!D`````````````````;0$!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!#B0XV.`@``B@8` M`!D`````````````````)`T!`'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`!X1_&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`!SWGE6+`P``*`P``!D` M````````````````=F$!`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*[Z'+R9$P``/EX``!D````````````````` M"'0!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`+GUH:91`P``10L``!D`````````````````ZID!`'AL+W=O&UL4$L!`BT`%``&``@````A`%\H&[K% M`P``[0T``!D`````````````````(J4!`'AL+W=OV@``&0`````````````` M```>J0$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.&UL4$L!`BT`%``&``@````A M`&[\B.A:`P``:PH``!``````````````````*]0!`&1O8U!R;W!S+V%P<"YX 8;6Q02P4&`````#,`,P#7#0``N]@!```` ` end XML 14 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on a Recurring Basis) (Details) (USD $)
Mar. 31, 2014
Jan. 27, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability related to fair value of beneficial conversion feature $ 3,834,200  
Total 3,834,200  
Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability related to fair value of beneficial conversion feature     
Total     
Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability related to fair value of beneficial conversion feature 3,834,200 1,648,825
Total 3,824,200  
Level 3 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability related to fair value of beneficial conversion feature     
Total     

XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES (Tables)
3 Months Ended
Mar. 31, 2014
OPERATING LEASES [Abstract]  
Schedule of Future Minimum Rental Commitments Under Non-Cancelable Operating Lease Arrangements
For the three months ended March 31, 2014 and 2013, total rent expense under leases amounted to $138,843 and $55,648, respectively.  At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:

2014
 
$
293,696
 
2015
   
300,194
 
2016
   
200,696
 
   
$
794,586
 
XML 17 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS (Details) (USD $)
3 Months Ended 1 Months Ended
Jun. 30, 2013
Jan. 27, 2014
Common Stock [Member]
Apr. 30, 2014
Subsequent Event [Member]
Apr. 30, 2014
Subsequent Event [Member]
Consulting Firm [Member]
Apr. 30, 2014
Subsequent Event [Member]
Series A Preferred Stock [Member]
Apr. 30, 2014
Subsequent Event [Member]
Common Stock [Member]
Subsequent Event [Line Items]            
Options granted       500,000   55,000
Equity issuance, price or exercise price per security issued       $ 1.27 $ 100 $ 1.27
Restricted shares issued       300,000    
Issuance of stock, shares 49,000       58,150  
Number of shares entitled by warrants   5,045,000       5,815,000
Purchase price of preferred stock and warrants     $ 5,815,000      
Dividend rate         8.00%  
XML 18 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) (Incentive Stock Options [Member], USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2014
Dec. 31, 2013
Option/Warrants Shares    
Outstanding, shares, beginning of period 16,576,144 17,258,644
Granted, shares 495,000 3,067,500
Reclassified from (to) non-employee, shares 200,000 (235,000)
Exercised, shares (100,000) (2,816,667)
Expired/terminated, shares (460,003) (698,333)
Outstanding, shares, end of period 16,711,141 16,576,144
Exercise Price    
Reclassified from/to non-employee, exercise price $ 0.50  
Exercised, exercise price $ 0.75  
Weighted Average Exercise Price    
Outstanding, weighted average exercise price, beginning of period $ 0.74 $ 0.48
Granted, weighted average exercise price $ 0.03 $ 0.28
Reclassified from/to non-employee, weighted average exercise price $ 0.01 $ (0.02)
Exercised, weighted average exercise price    $ (0.01)
Expired/terminated, weighted average exercise price $ (0.02) $ (0.01)
Outstanding, weighted average exercise price, end of period $ 0.74 $ 0.74
Exercisable, shares, September 30, 2013 11,436,145  
Exercisable, weighted average exercise price, September 30, 2013 $ 0.49  
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years) 1 year 8 months 12 days  
Minimum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 0.04 $ 0.04
Granted, exercise price $ 1.05 $ 0.99
Reclassified from/to non-employee, exercise price   $ 0.65
Exercised, exercise price   $ 0.04
Expired/terminated, exercise price $ 0.65 $ 0.50
Outstanding, exercise price, end of period $ 0.04 $ 0.04
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 0.04  
Maximum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 2.40 $ 1.82
Granted, exercise price $ 1.43 $ 2.92
Reclassified from/to non-employee, exercise price   $ 2.30
Exercised, exercise price   $ 0.75
Expired/terminated, exercise price $ 2.16 $ 2.92
Outstanding, exercise price, end of period $ 2.40 $ 2.40
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 2.30  
XML 19 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of the Business
Virtual Piggy, Inc. ("the Company") is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.   Virtual Piggy is a technology company that delivers an online ecommerce solution for the family. Its system allows parents and their children to manage, allocate funds and track their expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent's permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits. Our principal office is located in Hermosa Beach, California and in 2013 we opened an office in London, England to support the sales and marketing efforts in Europe and the development of our mobile applications.
 
The Oink (formerly Virtual Piggy) service enables online businesses to interact and transact with the "Under 18" market in a manner consistent with the Children's Online Privacy Protection Act ("COPPA") and other similar international children's privacy laws.  Oink was launched in the US in 2012 and in the European market in 2013, and now has the capability to offer and deliver gift cards.

We secure agreements with merchants, retail and gaming e-commerce platforms and payment processors, which allow us to offer our Oink service to our user base. Over 20 retailers and gaming companies are using Oink with their e-commerce systems and the Company is in the process of integrating the other signed retailers and gaming companies. The Company is continuing to add merchants. To date, the Company has over 1 million users of its system. The Company defines a system user as a registered account that has accessed the Oink service within the past 12 months.

Basis of Presentation
The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.  The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States ("U.S. GAAP")  for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements should be read in conjunction with the financial statements and notes included in the Company's Annual Report on form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission (the "SEC"). Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.

Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from these estimates.

Comprehensive Income
The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  The Company has one item of other comprehensive loss, consisting of a foreign translation adjustment.

Fair Value of Financial Instruments
The Company's financial instruments consist of accounts receivable, accounts payable and accrued expenses, embedded derivative and warrant liability. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities. 

The Company follows FASB ASC 820, Fair Value Measurements and Disclosures, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:
 
Level 1: Quoted market prices in active markets for identical assets or liabilities
 
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data
 
Level 3: Unobservable inputs that are not corroborated by market data
 
The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
 
Foreign Currency Translation
The functional currency of operations outside the U.S. is British Pounds.

Concentration of Credit Risk Involving Cash
The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance ("FDIC") coverage.  The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.  
 
Cash and Cash Equivalents
For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.

Property and Equipment
Property and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, principally three to seven years. Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is included in operations.  Depreciation of property and equipment was $8,389 and $5,875 for the three months ended March 31, 2014 and 2013 and is included in general and administrative expenses.

Patents and Trademarks
The Company has one issued patent with the United States Patent and Trademark Office ("USPTO"), entitled Systems and Method for Verifying the Age of an Internet User, and filed for nine provisional patents.  Additionally, the Company has been issued two patents in Germany, entitled Virtual Piggy Bank and Parent Match, while the remaining patents in Germany are still pending.  The Company also has patents pending in Australia, Brazil, Canada and Europe under the Patent Cooperation Treaty ("PCT").  Costs associated with the registration and legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents which were determined to be 20 years.

Long-Lived Assets
The Company evaluates the recoverability of its long-lived assets in accordance with FASB ASC 360 "Property, Plant, and Equipment." The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.

Revenue Recognition
In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale of the associated product.  
  
Income Taxes
The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.  Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.  Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.

Stock-based Payments
The Company accounts for stock-based compensation under the provisions of FASB ASC 718, Compensation-Stock Compensation which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC 505 -50, Equity-Based Payments to Non-Employees ("ASC 505-50"). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid-in capital in stockholders' equity over the applicable service periods.
 
Advertising Costs
Advertising costs are expensed as incurred. Advertising costs were $53,628 and $222,847 for the three months ended March 31, 2014 and 2013 and are included in sales and marketing expenses.

Research and Development Costs
In accordance with FASB ASC 730, research and development costs are expensed when incurred.  Research and development costs for the three months ended March 31, 2014 and 2013 were $852,744 and $454,378.

Loss Per Share
The Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the three months ended March 31, 2014 and 2013, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

Start-up Costs
In accordance with FASB ASC 720, start-up costs are expensed as incurred.

Segment Information
The Company is organized and operates as one operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.

Recently Adopted Accounting Pronouncements
As of March 31, 2014 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted
As of March 31, 2014, there were no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Reclassifications
Certain amounts in the 2013 and cumulative since inception statements of operations have been reclassified in order for them to be in conformity with the 2014 presentation.

EXCEL 20 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]D,F1F86,R8U]B,#4P7S0U8V1?83%E85]E.&(W M9#(T-#,Y-#(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?0V%S:%]&;&]W#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DU!3D%'14U%3E1?4$Q!3E,\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQ)5$E' M051)3TY?4T545$Q%345.5#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E9%4E1)0DQ%7U!2149%4E)%1%]35$]#2SPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9!25)?5D%,545?3T9? M1DE.04Y#24%,7TE.4U1253PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+2$],1$524U]%455)5%D\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]0 M15)!5$E.1U],14%315,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E13 M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D9!25)?5D%,545?3T9?1DE.04Y#24%,7TE. M4U1253$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I7 M;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DQ)5$E'051)3TY?4T545$Q% M345.5%]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I% M>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9!25)?5D%,545?3T9?1DE.04Y#24%,7TE.4U1253,\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I%>&-E;%=O#I!8W1I=F53:&5E M=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!);F9O'0^)SQS<&%N/CPO'0^)S$P+5$\'0^)V9A M;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S`P,#$T,S2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T%C8V5L97)A=&5D M($9I;&5R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,SDL.38Y/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO MF5D.R`U,"PT-3`@F5D.R`Q,38L-3@Y+#`U-2!A;F0@,3$Q+#,Y-BPW-C@@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R M8U]B,#4P7S0U8V1?83%E85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9#)D9F%C,F-?8C`U,%\T-6-D7V$Q96%?93AB-V0R M-#0S.30R+U=O'0O:'1M;#L@8VAAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XD(#4R+#(U.#QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R8U]B,#4P7S0U8V1? M83%E85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9#)D9F%C,F-?8C`U,%\T-6-D7V$Q96%?93AB-V0R-#0S.30R+U=O'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO2!A M;F0@=F%L=65D(&%T("0N,#(@<&5R('-H87)E+"!V86QU97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($UA>2`X+"`R M,#`X+"!A="`D+C`T('!E'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO&5R M8VES92!O9B!O<'1I;VYS(&]N($UA>2`X+"`R,#`X+"!A="`D+C`T('!E'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A M;F0@4V5P=&5M8F5R(#(P,#@@=&AR;W5G:"!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A M;F0@=F%L=65D(&%T("0N,#<@<&5R('-H87)E+"!V86QU97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O M9B!W87)R86YT'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($IA;G5A M'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`R-BP@,C`P.2!A M="`D+C`T('!E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($IU;'D@,S`L(#(P M,#D@870@)"XP-"!P97(@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($1E8V5M8F5R(#$P+"`R,#`Y M(&%T("0N,#0@<&5R('-H87)E+"!V86QU97,\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@=F%L=65D(&%T("0N,S$@<&5R('-H87)E+"!V86QU97,\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`U+"`R,#$P(&%T("0N,#0@<&5R('-H M87)E+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO2`R,BP@,C`Q,"!A M="`D+C`T('!E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O9B!W87)R M86YT'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO2!T M:')O=6=H($%U9W5S="`R,#$P+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^ M)SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($1E8V5M8F5R(#(L(#(P,3`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`R-"P@,C`Q,2P@=F5S=&5D(&EM;65D:6%T96QY(&%N M9"!V86QU960@870@)"XR,"!P97(@'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO2!T:')O=6=H($%U9W5S="`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`R,2P@,C`Q,B!V M86QU960@870@)#(N-#,@<&5R('-H87)E+"!S:&%R97,\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@86YD(&%C8W)U960@:6YT M97)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@=F%L=65D(&9R;VT@)"XQ,"!T;R`D+C$Y('!E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO2`R,#$R('1H'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO65E(&]P=&EO;G,@:7-S=65D(&9O65A'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&%T("0P+C`T('!E'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO2`R,#$S+"!S:&%R97,\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO M&5R M8VES92!O9B!O<'1I;VYS(&%T("0P+C,U('!E'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO2`Q-"P@,C`Q,RP@'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO2`R,#$S+"!S:&%R97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`R-BP@,C`Q,RP@'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO&5R8VES92!O9B!W87)R86YT'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO2!T:')O=6=H($%U9W5S="`R,#$S+"!S:&%R97,\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E M(&]P=&EO;G,O=V%R2!T;R`S('EE87)S(&%N9"!V86QU960@9G)O;2`D,"XP.2!T;R`D M,2XV-B!P97(@'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`R,#$R M('1H'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO65A'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&-H86YG92!O9F9E'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO65E(&]P=&EO;G,O=V%R M2!T;R`S M('EE87)S(&%N9"!V86QU960@9G)O;2`D,2XP-"!T;R`D,RXP-2!P97(@'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`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`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`T* M"0DR,#`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^07!R(#'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^36%R M(#,L#0H)"3(P,#@\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^2F%N(#(T+`T* M"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^075G(#$X+`T*"0DR,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO2`X+`T*"0DR,#`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^2F%N M(#(V+`T*"0DR,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO2`Q-"P-"@D),C`Q,SQS<&%N/CPO2`R-2P-"@D),C`Q,CQS M<&%N/CPO'0^2G5L(#,P+`T*"0DR,#`Y/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^1&5C M(#$P+`T*"0DR,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`R-BP-"@D),C`Q,SQS<&%N/CPO'0^)SQS<&%N/CPO'0^1&5C(#,Q+`T*"0DR,#`Y/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^36%Y(#(Q+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`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`M M,3(\'0^)S(P,3`M,#0\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO2!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO&-H86YG M92!F;W(@&-H86YG92!F;W(@&-H M86YG92!F;W(@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPOF%T:6]N(&]F(&1E9F5R M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO6%B;&4@+2!S=&]C:VAO;&1E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2!F:6YA;F-I;F<@86-T:79I=&EE'0^)SQS<&%N/CPO&5S('!A M:60\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO6%B;&4@86YD(&%C8W)U960@ M:6YT97)E6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2!A'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO&-H86YG92!O9F9E'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO&AT;6PQ+T141"]X M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T M1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!.3U1%(#$@+2!354U-05)9($]&(%-)1TY)1DE#04Y4($%#0T]53E1)3D<@ M4$],24-)15,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U7 M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N M9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($YA='5R92!O9B!T:&4@0G5S M:6YE3L@5$585"U)3D1%3E0Z(#!P="<^(%9I2(I(&ES(&$@9&5V96QO<&UE;G0@'!E;F1I='5R97,L('-A=FEN9W,@86YD(&-H87)I=&%B;&4@9VEV:6YG M(&]N;&EN92X@271S('-Y2!G86EN:6YG('1H92!P87)E;G0F(S,Y.W,@<&5R;6ESF5D('-P96YD:6YG(&QI;6ET M3L@5$58 M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@5&AE($]I;FL@*&9O2!06QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@5V4@2!I M2!D969I;F5S(&$@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/F%C8V]U;G1I;F<@<')I;F-I<&QE2!F;W(@82!F86ER('!R97-E;G1A M=&EO;B!H879E(&)E96X@:6YC;'5D960N(%1H92!F:6YA;F-I86P@2!B92!E>'!E8W1E M9"!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,30N/"]D:78^ M(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U19 M3$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE)SY&86ER(%9A;'5E($UE87-U'0M86QI9VXZ(&IU3L@5$585"U)3D1% M3E0Z(#,V<'0G/B!,979E;"`Q.B!1=6]T960@;6%R:V5T('!R:6-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,S9P="<^($QE=F5L(#(Z($]B2!M87)K970@9&%T83PO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P M="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,S9P="<^($QE=F5L(#,Z M(%5N;V)S97)V86)L92!I;G!U=',@=&AA="!A2!M87)K970@9&%T83PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P M.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&QE=F5L(&EN('1H92!F M86ER('9A;'5E('=I=&AI;B!W:&EC:"!A(&9A:7(@=F%L=64@;65A2X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U$14-/4D%424]..B!U;F1E'0M86QI9VXZ(&IU2!O9B!O M<&5R871I;VYS(&]U='-I9&4@=&AE(%4N4RX@:7,@0G)I=&ES:"!0;W5N9',N M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!M87D@:&%V92!D97!O3L@ M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U7 M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@:&%S(&]N92!IFEL+"!#86YA9&$@86YD($5U2`H(E!#5"(I+B9N8G-P M.R9N8G-P.T-O6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[ M($U!4D=)3BU,1494.B`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`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051) M3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($EN8V]M92!487AE M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W M&5S+B9N8G-P.R9N8G-P.T1E9F5R2!D:69F97)E;F-E'!E8W1E9"!T;R!A M9F9E8W0@=&%X86)L92!I;F-O;64N)FYB"!E>'!E M;G-E(&ES('1H92!T87@@<&%Y86)L92!O65A6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+41%0T]2051)3TXZ('5N M9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%-T;V-K+6)A6UE M;G1S/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU2!A8V-O M=6YT'!E;G-E(&]V97(@=&AE(')E<75I2!A8V-O=6YT65E2!I;G-T6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!415A4 M+4E.1$5.5#H@,'!T)SX@061V97)T:7-I;F<@0V]S=',\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^($%D=F5R=&ES:6YG(&-O'!E;G-E9"!A3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE($-O;7!A;GD@9F]L;&]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41% M0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%-T87)T M+75P($-O'0M M86QI9VXZ(&IU'!E;G-E9"!A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P M="<^(%-E9VUE;G0@26YF;W)M871I;VX\+V1I=CX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P M="<^(%)E8VQA'0M86QI9VXZ(&IU7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O M;7!A;GD@:7,@:6X@=&AE(&1E=F5L;W!M96YT('-T86=E(&%T($UA28C,SD[2!I;G9E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z M+R]W=W&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/CQD:78^(#QD:78@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M2!C;VYT:6YU97,@=&\@87!P;'D@ M9F]R('!A=&5N=',@86YD('!U2P@8V]S M=',@87-S;V-I871E9"!W:71H('1H92!R96=IF5D(&%N9"!AF5D M(&]N(&$@65A7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA&AT M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!.3U1%(#0@+2!.3U1%4R!005E!0DQ%/"]D:78^(#QD:78@ M3L@5$585"U)3D1%3E0Z(#!P="<^($]N($1E8V5M8F5R(#(W M+"`R,#$S+"!T:&4@0V]M<&%N>2!E;G1E65A28C,SD[6%B;&4@=7!O;B!T:&4@ M96%R;&EE3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO M9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE M/3-$)U1%6%0M04Q)1TXZ(&IU2<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-"4^/&9O;G0@ M3L@5$585"U)3D1%3E0Z(#!P="<^(&$N/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y)R!V86QI M9VX],T1T;W`@=VED=&@],T0V.24^(#QD:78@7,@869T97(@=&AE('-A;&4@;V8@=&AE($-O;7!A;GDF(S,Y.W,@2<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-"4^/&9O;G0@3L@5$585"U)3D1%3E0Z(#!P="<^(&(N/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y)R!V86QI9VX] M,T1T;W`@=VED=&@],T0V.24^(#QD:78@2!A;&P@;V8@=&AE($-O;7!A;GDF(S,Y.W,@87-S971S(&]R M("AI:2D@=&AE(&%C<75I2!T2!O=&AE2!H96QD(&)Y('-U8V@@:&]L9&5R2!T:&4@=F]T:6YG('-E8W5R:71I97,@;V8@ M=&AE($-O;7!A;GD@;W(@2<^ M(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!T:6UE2<^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!J=7-T:69Y)R!V86QI9VX],T1T;W`@=VED=&@],T0T)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@8RX\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^ M($9E8G)U87)Y(#(X+"`R,#$T+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE M/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@ M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`@("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!% M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO M;F%L+R]%3B(@(FAT='`Z+R]W=W&AT M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@3L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@07,@;V8@1&5C96UB97(@,S$L(#(P,3,L('1H92!#;VUP86YY(&AA M9"!N970@;W!E6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4 M15A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@07,@;V8@ M2F%N=6%R>2`Q+"`R,#$T+"!T:&4@0V]M<&%N>2!H860@;F\@=6YR96-O9VYI M>F5D('1A>"!B96YE9FET2!D:60@;F]T(')E8V]G;FEZ92!I;G1E"!Y96%R"!J=7)I6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4 M15A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE"!B96YE9FET(&9OF%T:6]N(&]F('1H92!N970@=&%X(&1E9F5R'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!% M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO M;F%L+R]%3B(@(FAT='`Z+R]W=W&AT M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&5N=&5R M960@:6YT;R!A('-E='1L96UE;G0@86=R965M96YT('=I=&@@86X@:6YV97-T M;W(@:6X@,C`Q,BP@=VAE2!T:&4@0V]M<&%N>2!A9W)E960@=&\@<&%Y M('1H92!I;G9E28C,SD[2!W:71H(')E7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$58 M5"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ M(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($EN($IA M;G5A28C,SD[6)A8VL@2!H860@:6YC=7)R960@86YD(&-A<&ET86QI M>F5D(&%P<')O>&EM871E;'D@)#$S,2PP,#`@;V8@8V]S=',@87-S;V-I871E M9"!W:71H('1H:7,@;V9F97)I;F6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@26X@86-C;W)D86YC92!W:71H($9!4T(@05-#(#0X,"!A;F0@ M.#$U+"!T:&4@4')E9F5R2!A;F0@=V%S('9A;'5E9"!A="`D,RPS.38L M,33L@5$585"U)3D1%3E0Z(#!P M="<^(%1H92!C;VYV97)S:6]N(&9E871U6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@)FYB3L@5$58 M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@5&AE(&-O;G9E7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS M<&%N/CPO6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($Y/5$4@."`M($9! M25(@5D%,544@3T8@1DE.04Y#24%,($E.4U1254U%3E13/"]D:78^(#QD:78@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R('!U2!S971T;&5D(&EN(&%N(&5N=&ET>28C,SD[6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=. M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@:&%S M(&ED96YT:69I960@=&AE(&9O;&QO=VEN9R!L:6%B:6QI=&EEF5D(&%S(&9O;&QO=W,Z)FYB3L@34%21TE.+4Q%1E0Z(#!P=#L@ M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T)SX@)FYB6QE/3-$ M)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!-87)C:"`S,2P@ M,C`Q-#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ M(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!,979E;"`R/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A M<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@3&5V96P@,SPO9&EV/B`\ M+W1D/B`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`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RPX,S0L,C`P/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`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`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`P<'0G/B!"86QA;F-E(&%T($UA6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@34%21TE.+4Q%1E0Z(#!P=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@/&9O M;G0@28C,SD['0M86QI9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E/C$N-#4\+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.#4E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!);G1R:6YS:6,@=F%L=64@;V8@8V]N=F5R6QE/3-$)U!!1$1)3D3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&AA6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\(2TM M16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R8U]B,#4P7S0U8V1?83%E M85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M9#)D9F%C,F-?8C`U,%\T-6-D7V$Q96%?93AB-V0R-#0S.30R+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($Y/5$4@.2`M(%-4 M3T-+2$],1$524R8C,SD[($5154E463PO9&EV/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU28C,SD[3L@5$585"U) M3D1%3E0Z(#!P="<^($]N($%P2!I M28C,SD[2!O9B`R.2XP)2P@'!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!R971A:6YE9"!A M('!L86-E;65N="!A9V5N="!I;B!C;VYN96-T:6]N('=I=&@@=&AE($]F9F5R M:6YG+B!4:&4@0V]M<&%N>2!P86ED('1H92!P;&%C96UE;G0@86=E;G0@86=G M'!E;G-E(&%L;&]W86YC M92X@26X@861D:71I;VXL('1H92!P;&%C96UE;G0@86=E;G0@65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^ M($1U&5R8VES960@870@)#`N M,#0@<&5R('-H87)E+"!O<'1I;VYS('1O('!U3L@1$E34$Q!63H@8FQO8VL[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M1'5R:6YG($IU;'D@86YD($%U9W5S="`R,#$S+"!W87)R86YT3L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\ M8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P M="<^($EN($9E8G)U87)Y(#(P,30L('1H92!#;VUP86YY(&-O;7!L971E9"!A M('!R:79A=&4@<&QA8V5M96YT(&]F9F5R:6YG('1O(&AO;&1E&5R8VES960@=V%R2!R96-E M:79E9"!A9V=R96=A=&4@8V%S:"!C;VYS:61E&5R8VES960@=V%R3L@5$585"U$14-/4D%424]. M.B!U;F1E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@169F96-T:79E($9E8G)U87)Y(#&5R8VES92!T:&5I&5R8VES92!P&5R8VES960@=&AE(&]R:6=I;F%L('=AF5D(&$@9&5E;65D(&1I=FED96YD(&]F("0W M,3'!E8W1E9"!V;VQA=&EL:71Y(&]F M(#$T,RXR)2P@&EM871I;F<@='=O('EE87)S M+B9N8G-P.R9N8G-P.U1H92!W87)R86YT'!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!%(&AT M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@2!T:&4@2!IF5D('1O(&=R86YT(&]P=&EO;G,@=&\@<'5R8VAA2!O9F9I8V5R+"!O=&AE&5R8VES960L(&]P=&EO;G,@=&\@<'5R8VAA65E3L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P M<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@2!S=&]C:VAO;&1E65E+"!D:7)E8W1O2!3=&]C:R!/<'1I;VYS+B9N M8G-P.R9N8G-P.T%S(&]F($UA&5R8VES960L(&]P=&EO;G,@=&\@<'5R8VAA M6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@5&AE(#(P,#@@4&QA;B!A;F0@,C`Q,R!0;&%N(&%R92!A9&UI;FES M=&5R960@8GD@=&AE($)O87)D(&]R(&ET3L@5$585"U)3D1% M3E0Z(#!P="<^($EN(&-O;FYE8W1I;VX@=VET:"!);F-E;G1I=F4@4W1O8VL@ M3W!T:6]N2!N;W0@8F4@;&5S3L@1$E34$Q!63H@8FQO M8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@2!I;B!A;&P@:6YS=&%N8V5S('!R97-E;G1E9"!I28C,SD[2X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@2F%N M=6%R>2`R,#$S+"!T:&4@0V]M<&%N>2!I6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI='D@8F5T=V5E;B`R M,RXS)2!A;F0@,C8N,24L(')I'!I65A3L@5$58 M5"U)3D1%3E0Z(#!P="<^($EN($9E8G)U87)Y(#(P,3,L('1H92!#;VUP86YY M(&ES65E28C M,SD[2!B971W965N(#(R+C4E(&%N9"`R-2XQ)2P@'!E M8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S+B9N8G-P.R9N8G-P.U1H M92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@ M:7-S=6%N8V4N)FYB'!E M;G-E9"!O=F5R('1H92!T:')E92!Y96%R('9E3L@ M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@36%R8V@@,C`Q,RP@=&AE M($-O;7!A;GD@:7-S=65D(&%N(&5M<&QO>65E(&]P=&EO;G,@=&\@<'5R8VAA M&5R8VES92!P2!O9B`R,BXU)2P@'!I M65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@26X@07!R:6P@,C`Q,RP@=&AE($-O;7!A M;GD@:7-S=65D(&%N(&5M<&QO>65E(&]P=&EO;G,@=&\@<'5R8VAA2!O9B`R,BXU)2P@'!I65A3L@5$58 M5"U)3D1%3E0Z(#!P="<^($EN($%P&5R8VES92!P65A65A6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU28C,SD[2!O9B`R,RXU)2!T;R`R-2XS)2P@'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F M:79E('EE87)S+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E M('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T:')E92!Y M96%R('9E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU&5R8VES92!P6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI M='D@;V8@,C,N-B4@=&\@,C8N,R4L(')I'!E8W1E9"!O<'1I;VX@;&EF92!O M9B!F:79E('EE87)S+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F M:79E('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T:')E M92!Y96%R('9E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@26X@075G=7-T(#(P,3,L('1H92!#;VUP86YY M(&ES2!O9B`R-"XR)2!T;R`S,"XS)2P@65A65A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&IU28C,SD[6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI M='D@;V8@,C$N."4L(')I'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S+B9N8G-P M.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R;VT@=&AE M(&1A=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T:')E92!Y96%R('9E6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M26X@3F]V96UB97(@,C`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`R M,#$T+"!T:&4@0V]M<&%N>2!I6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI='D@ M;V8@,3(X+C4E+"!R:7-K(&9R964@:6YT97)E'!I65A3L@5$585"U)3D1%3E0Z(#!P="<^($EN M($9E8G)U87)Y(#(P,30L('1H92!#;VUP86YY(&ES2!O9B`Q-#(N,24L(')I'!E8W1E9"!O<'1I;VX@;&EF M92!O9B!F:79E('EE87)S+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER M92!F:79E('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T M:')E92!Y96%R('9E3L@5$585"U)3D1%3E0Z(#!P="<^($EN($9E8G)U M87)Y(#(P,30L('1H92!#;VUP86YY(&5X=&5N9&5D('=A&5R8VES86)L92!A="`D+C65A'!E;G-E9"!D=7)I;F<@=&AE('1H6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI M='D@;V8@.#DN,R4@=&\@.#DN-24L(')I65A M6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3L@5$585"U)3D1%3E0Z(#!P="<^($EN($UA28C,SD[2!O9B`Q,C(N-B4L(')I'!E8W1E9"!O<'1I;VX@;&EF92!O9B!T96X@>65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB3L@5$585"U)3D1%3E0Z(#!P M="<^($-U;75L871I=F5L>2!A;F0@9F]R('1H92!T:')E92!M;VYT:',@96YD M960@36%R8V@@,S$L(#(P,30@86YD(#(P,3,L('1H92!#;VUP86YY(&5X<&5N M65E(&YO;BUV97-T960@;6%R:V5T+6)A2`Q+"`R,#$S M('1O($UA6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,"!W:61T:#TS1#DV)3X@/'1R/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!796EG:'1E9"!! M=F5R86=E/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!3:&%R97,\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!0#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI M9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`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`Q M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M,"XT.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`P M<'0G/B!'6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M,RPP-C6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N.3D@=&\@,BXY M,CPO9&EV/B`\+W1D/B`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`R+C,P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M*#`N,#(\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N,#0@=&\@,"XW-3PO9&EV/B`\ M+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^ M(#QT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@17AP:7)E9"]T97)M:6YA=&5D/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@;F]W'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XU,"!T;R`R M+CDR/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#`N,#0@=&\@,BXT,#PO9&EV/B`\+W1D/B`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@1W)A;G1E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2XP M-2!T;R`Q+C0S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP,SPO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XU M,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP,3PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@17AE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^*#$P,"PP,#`\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,"XW-3PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!! M1$1)3D'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M($]U='-T86YD:6YG+"!-87)C:"`S,2P@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^,"XP-"!T;R`D,BXT,#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@17AE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3$L-#,V+#$T-3PO=&0^(#QT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XT.3PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`P<'0G/B!796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN M9R!,:69E+#PO9&EV/B`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@)FYB'0M86QI9VXZ(&IU2!U'!E8W1E9"!V;VQA=&EL:71Y M(&]F(#(S+C,E+"!R:7-K(&9R964@:6YT97)E'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S+B9N8G-P.R9N M8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R;VT@=&AE(&1A M=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T97)M(&]F('1H92!A9W)E96UE;G0N/"]D M:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@26X@36%R8V@@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D M('1W;R!C;VYS=6QT86YT65A3L@5$585"U)3D1%3E0Z(#!P="<^($EN($UA28C,SD[2!U'!E8W1E9"!V;VQA M=&EL:71Y(&]F(#(U+C@E+"!R:7-K(&9R964@:6YT97)E'!E8W1E9"!O<'1I;VX@;&EF92!O9B9N8G-P.S4@>65A M'!I M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@26X@07!R:6P@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D M(&$@8V]N&5R8VES92!P65A65A'!E;G-E9"!I;6UE9&EA=&5L>2X\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z M(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@36%Y M(#(P,3,L('1H92!#;VUP86YY(&ES&5R M8VES92!P2!O9B`R,RXQ)2!T M;R`R,RXR)2P@'!E8W1E9"!O<'1I;VX@;&EF92!O9B!T=V\@>65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB'0M86QI9VXZ(&IU2!O9B`R,RXT)2!T;R`R,RXW)2P@65A3L@5$585"U)3D1%3E0Z M(#!P="<^($EN($IU;'D@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D('1W;R!C M;VYS=6QT86YT2!U'!E8W1E9"!V;VQA=&EL M:71Y(&]F(#(S+C@E('1O(#(V+C8E+"!R:7-K(&9R964@:6YT97)E'!I'!E;G-E9"!I;6UE9&EA=&5L>2X\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4E.1$5.5#H@ M,'!T)SX@)FYB3L@5$585"U)3D1% M3E0Z(#!P="<^($EN(%-E<'1E;6)E2!I2!O9B`R,BXQ)2P@65A65A65A2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F M(#,P+C(E+"!R:7-K(&9R964@:6YT97)E'!I6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!I M2!O9B`R-2XV)2P@65A65A'1E M;F1I;F<@=&AE('1E2!A="!A;B!E>&5R8VES92!P'1E;F1E9"!F M;W(@86X@861D:71I;VYA;"!O;F4@>65A'!I'!I2!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!#=6UU;&%T:79E M;'D@86YD(&9O6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($1) M4U!,05DZ(&EN;&EN92<^)FYB65E('-T;V-K(&]P=&EO;G,O=V%R M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B!%>&5R8VES93PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!3:&%R97,\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`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`P<'0G/B!'6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,BPP-#@L-S4P/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#`N,#$@=&\@,RXR.#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!)6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,2XX,"!T;R`S+C`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#`N-3`@=&\@,2XP,3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T M:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B!%>&5R8VES960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$ M)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%>'!I"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH M,2PT,#4L,#`P/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^ M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M;F]W'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@,"XU,"!T;R`Q+C`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`S+C(X/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@27-S=65D('5N9&5R(%!R:79A=&4@4&QA8V5M96YT/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`L,#@W+#(X-SPO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`P<'0G/B!%>&5R8VES M960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!%>'!I"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH-#$P+#`P,#PO=&0^(#QT M9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N-C`@=&\@,BXS,#PO M9&EV/B`\+W1D/B`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z(#!P="<^($]U='-T86YD:6YG+"!-87)C:"`S,2P@,C`Q-#PO9&EV M/B`\+W1D/B`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@17AE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3@L.38X+#4S M-SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`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`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P M.R9N8G-P.T5X97)C:7-A8FQE+"!-87)C:"`S,2P@,C`Q-"`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`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1- M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@1F]R('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,30@ M86YD(#(P,3,L('1O=&%L(')E;G0@97AP96YS92!U;F1E2XF M;F)S<#LF;F)S<#M!="!-87)C:"`S,2P@,C`Q-"P@=&AE($-O;7!A;GD@=V%S M(&]B;&EG871E9"!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#(Y,RPV.38\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B`R,#$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-SDT M+#4X-CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!. M3U1%(#$R("T@4D5,051%1"!005)462!44D%.4T%#5$E/3E,\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R M:6YG('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3,L(&$@ M8V]N65A2XF;F)S<#L\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M(#!P="<^("9N8G-P.R9N8G-P.SPO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\ M+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]D,F1F86,R8U]B,#4P7S0U8V1?83%E85]E.&(W9#(T-#,Y-#(- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#)D9F%C,F-?8C`U,%\T M-6-D7V$Q96%?93AB-V0R-#0S.30R+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^($Y/5$4@,3,@+2!354)315%514Y4($5614Y44SPO9&EV/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!) M;B!!<')I;"`R,#$T+"9N8G-P.W1H92!#;VUP86YY)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU2P@ M<'5R6)A8VL@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@07!R:6P@,C`Q-"P@=&AE M($-O;7!A;GD@96YT97)E9"!I;G1O(&%N(&%G2!I28C,SD[6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@07!R M:6P@,3`L(#(P,30L('1H92!#;VUP86YY('=A65E(&%L;&5G:6YG('=R;VYG9G5L M('1E2!I;G1E;F1S('1O('9I9V]R;W5S;'D@ M9&ES<'5T92!T:&4@8VQA:6US(&UA9&4@8GD@=&AE(&9O2!O<&EN:6]N(&%S('1O(&%N>2!U;'1I;6%T92!O=71C;VUE(&]R(&%N>2!D M969I;FET:79E(&5S=&EM871E(&]F('1H92!A;6]U;G0@;V8@;&]S2!O=71C M;VUE('=I;&P@8F4@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6EN9R!U;F%U9&ET960@9FEN86YC M:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R M:6YC:7!L97,@9F]R(&EN=&5R:6T@9FEN86YC:6%L(&EN9F]R;6%T:6]N(&%N M9"!W:71H('1H92!I;G-T2P@=&AE>2!D M;R!N;W0@:6YC;'5D92!A;&P@;V8@=&AE(&EN9F]R;6%T:6]N(&%N9"!F;V]T M;F]T97,@6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY5+E,N($=! M05`\+V9O;G0^/&9O;G0@65A&-H86YG92!#;VUM:7-S:6]N("AT:&4@(E-% M0R(I+B!/<&5R871I;F<@&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5-464Q%.B!I=&%L:6,[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF M>3L@5$585"U$14-/4D%424]..B!U;F1E'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2 M051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($-O;7!R96AE M;G-I=F4@26YC;VUE/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!F;VQL;W=S($9!4T(@05-#(#(R,"!I;B!R97!O2!H87,@ M;F]T(&)E96X@2!H87,@;VYE(&ET96T@ M;V8@;W1H97(@8V]M<')E:&5N'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1- M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78@'0M86QI9VXZ(&IU6%B;&4@86YD(&%C8W)U M960@97AP96YS97,L(&5M8F5D9&5D(&1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W6QE/3-$)T9/3E0M4U193$4Z(&ET86QI M8SL@1$E34$Q!63H@:6YL:6YE)SY&86ER(%9A;'5E($UE87-U'0M86QI9VXZ M(&IU3L@5$58 M5"U)3D1%3E0Z(#,V<'0G/B!,979E;"`Q.B!1=6]T960@;6%R:V5T('!R:6-E M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,S9P="<^($QE=F5L(#(Z($]B2!M87)K970@9&%T83PO9&EV/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1% M3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,S9P="<^($QE M=F5L(#,Z(%5N;V)S97)V86)L92!I;G!U=',@=&AA="!A2!M87)K970@9&%T83PO9&EV/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^ M("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&QE=F5L(&EN M('1H92!F86ER('9A;'5E('=I=&AI;B!W:&EC:"!A(&9A:7(@=F%L=64@;65A M'0M86QI9VXZ(&IU2!4'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E# M("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT M='`Z+R]W=W&AT;6PQ+71R86YS:71I M;VYA;"YD=&0B("TM/CQD:78^(#QD:78@'0M86QI9VXZ(&IU2!46QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@5&AE(&9U;F-T:6]N86P@8W5R&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@ M+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U) M3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U$14-/4D%424]..B!U M;F1E'0M86QI9VXZ(&IU2!M87D@:&%V92!D97!O'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T14 M1"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM M/CQD:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R('!U2!C;VYS:61E M'0^)SPA+2U$3T-465!% M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO M;F%L+R]%3B(@(FAT='`Z+R]W=W&AT M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@'0M86QI9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@4')O<&5R='D@86YD(&5Q=6EP;65N="!I2!A M2!A;F0@97%U:7!M96YT M+"!T:&4@8V]S=',@86YD(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;B!A2!R97-U;'1I M;F<@9V%I;B!O'0^ M)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q M+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD M:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!415A4 M+4E.1$5.5#H@,'!T)SX@4&%T96YT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@:&%S(&]N92!IFEL+"!#86YA9&$@86YD($5U2`H(E!#5"(I+B9N M8G-P.R9N8G-P.T-O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[ M($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U) M3D1%3E0Z(#!P="<^(%)E=F5N=64@4F5C;V=N:71I;VX\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U) M3D1%3E0Z(#!P="<^($EN(&%C8V]R9&%N8V4@=VET:"!396-U&-H86YG92!#;VUM:7-S:6]N("@B4T5#(BD@4W1A9F8@06-C;W5N=&EN M9R!"=6QL971I;B`H(E-!0B(I($YO+B`Q,#0L(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2979E;G5E(%)E M8V]G;FET:6]N/"]F;VYT/B`H0V]D:69I960@:6X@1D%30B!!4T,@-C`U*2P@ M=&AE($-O;7!A;GD@=VEL;"!R96-O9VYI>F4@2!O9B!T:&4@ M2!A2!W:6QL(&=E;F5R86QL M>2!R96-O9VYI>F4@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A&5S+B9N8G-P.R9N8G-P.T1E M9F5R2!D:69F97)E;F-E'!E8W1E9"!T;R!A9F9E8W0@=&%X86)L92!I;F-O;64N)FYB"!E>'!E;G-E(&ES('1H92!T87@@<&%Y86)L92!O65A6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A'0M86QI9VXZ(&IU2!A8V-O=6YT'!E;G-E(&]V97(@=&AE(')E<75I2!A8V-O=6YT2!I;G-T'0^ M)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q M+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD M:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!415A4 M+4E.1$5.5#H@,'!T)SX@061V97)T:7-I;F<@0V]S=',\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^($%D=F5R=&ES:6YG(&-O'!E;G-E9"!A'0^)SPA+2U$3T-465!%(&AT M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1% M6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!415A4+4E.1$5.5#H@,'!T)SX@ M4F5S96%R8V@@86YD($1E=F5L;W!M96YT($-O'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B!);B!A8V-O'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@'0M86QI9VXZ(&IU M3L@5$585"U)3D1%3E0Z(#!P M="<^(%1H92!#;VUP86YY(&9O;&QO=W,@1D%30B!!4T,@,C8P('=H96X@2!R97!O6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1% M3E0Z(#!P="<^(%-T87)T+75P($-O'0M86QI9VXZ(&IU'!E;G-E9"!A'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1- M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!4 M15A4+4E.1$5.5#H@,'!T)SX@4V5G;65N="!);F9O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@:7,@;W)G86YI>F5D(&%N M9"!O<&5R871E2!&05-"($%30R`R.#`@8V%N(&)E M(&9O=6YD(&EN('1H92!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N M=',N/"]D:78^(#QD:78@&AT M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051) M3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%)E8V5N=&QY($%D M;W!T960@06-C;W5N=&EN9R!06QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@07,@;V8@36%R8V@@,S$L(#(P,30@86YD(&9O2!)6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN M93L@5$585"U)3D1%3E0Z(#!P="<^(%)E8V5N=&QY($ES6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@07,@;V8@36%R8V@@,S$L(#(P,30L('1H97)E('=E M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-464Q%.B!I=&%L:6,[ M($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U$14-/4D%4 M24]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@0V5R=&%I;B!A;6]U M;G1S(&EN('1H92`R,#$S(&%N9"!C=6UU;&%T:79E('-I;F-E(&EN8V5P=&EO M;B!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,@:&%V92!B965N(')E8VQA6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#PA+2U%;F1&'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&AA6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\ M=&%B;&4@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@36%R8V@@,S$L(#(P,30\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!,979E;"`Q/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4 M15A4+4E.1$5.5#H@,'!T)SX@3&5V96P@,CPO9&EV/B`\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!4;W1A;#PO9&EV/B`\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!$97)I=F%T:79E(&QI M86)I;&ET>2!R96QA=&5D('1O(&9A:7(@=F%L=64@;V8@8F5N969I8VEA;"!C M;VYV97)S:6]N(&9E871U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`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`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`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RPX,S0L,C`P/"]T9#X@/'1D M('-T>6QE/3-$)U!!1$1)3D&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P M="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H M92!F;VQL;W=I;F<@=&%B;&4@9&5T86EL2!O9B!T:&4@0V]M<&%N>28C,SD[6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z M(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/B`\=&%B;&4@'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E(&%T($IA;G5A6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,2PV-#@L.#(U/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!#:&%N9V4@:6X@9F%I6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0F%L86YC92!A="!-87)C M:"`S,2P@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0^)SPA+2U$3T-465!% M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO M;F%L+R]%3B(@(FAT='`Z+R]W=W&AT M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@3L@ M34%21TE.+4Q%1E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU224=( M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@/&9O;G0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@5$58 M5"U!3$E'3CH@8V5N=&5R)R!C96QL'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!#;&]S M:6YG(%1R861I;F<@4')I8V4@;V8@0V]M;6]N(%-T;V-K/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!397)I97,@02!06QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26YT"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R8U]B,#4P M7S0U8V1?83%E85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO9#)D9F%C,F-?8C`U,%\T-6-D7V$Q96%?93AB-V0R-#0S.30R M+U=O'0O M:'1M;#L@8VAA'0^)SQS M<&%N/CPO2!O9B!3=&]C:R!/<'1I;VYS(&%N9"!787)R86YT(%1R86YS86-T M:6]N&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z M(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!%>&5R8VES93PO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!%>&5R8VES93PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO M=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4VAA6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO M=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4')I8V4\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!0#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@3W5T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1W)A M;G1E9#PO9&EV/B`\+W1D/B`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`P<'0G/B!296-L87-S:69I960@=&\@;F]N+65M M<&QO>65E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#(S-2PP M,#`\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N M-C4@=&\@,BXS,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^*3PO=&0^(#PO='(^(#QT'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!%>&5R8VES960\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^($5X<&ER960O=&5R;6EN871E9#PO9&EV/B`\+W1D M/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N-3`@=&\@,BXY,CPO9&EV M/B`\+W1D/B`\=&0@#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3XH,"XP,3PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M3W5T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$N,#4@=&\@,2XT M,SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5C;&%S65E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^,C`P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@17AP:7)E9"]T97)M:6YA=&5D/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@;F]W'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XV-2!T;R`R M+C$V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($5X97)C M:7-A8FQE+"!-87)C:"`S,2P@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M+C`T('1O("0R+C,P/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`Q,'!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.R9N8G-P.T5X97)C:7-A8FQE+"!- M87)C:"`S,2P@,C`Q-"`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`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B!%>&5R8VES93PO9&EV/B`\+W1D/B`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4')I M8V4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,38L-3,Q+#0S.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`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`S+C(X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`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`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,"XS,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B!296-L87-S:69I960@9G)O;2!E;7!L;WEE93PO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,"XU,"!T;R`Q+C`Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^("XS-2!T;R`N-3`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-C0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,38L,3(X M+#4S-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XY.#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@1W)A;G1E9#PO9&EV/B`\+W1D/B`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`P<'0G/B!)6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,2XP,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5C M;&%S65E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^*#(P,"PP,#`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,"XU,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("XS-2!T M;R`N-3`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`Q,'!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^($5X<&ER960O0V%N8V5L;&5D/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@;F]W'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XV,"!T;R`R+C,P/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@3W5T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C`L-38S+#4S-CPO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,2XQ,3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`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`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`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^,2XP.#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`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`P<'0G/B!796EG:'1E9"!!=F5R M86=E(%)E;6%I;FEN9R!,:69E+#PO9&EV/B`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`P<'0G/B`F;F)S<#L\+V1I=CX@/"$M+45N9$9R86=M M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^ M)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q M+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD M:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@=&AE M('1H'!E;G-E('5N9&5R(&QE87-E2!W87,@;V)L:6=A=&5D M('5N9&5R('9A6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,C`E(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,CDS+#8Y-CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#(P,"PV.38\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]D,F1F86,R8U]B,#4P7S0U8V1?83%E85]E.&(W9#(T-#,Y-#(-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#)D9F%C,F-?8C`U,%\T-6-D M7V$Q96%?93AB-V0R-#0S.30R+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO65A M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO65A'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N('!E'0^)S(P('EE87)S/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPOF5D M(&-A<&ET86QI>F5D('!A=&5N="!C;W-T'0^)SQS<&%N/CPOF%T:6]N M(&5X<&5N3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R8U]B,#4P7S0U8V1? M83%E85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9#)D9F%C,F-?8C`U,%\T-6-D7V$Q96%?93AB-V0R-#0S.30R+U=O'0O:'1M;#L@ M8VAA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO&5R8VES92!P M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^)SQS<&%N/CPO'0^)T)L86-K+5-C:&]L97,@;W!T M:6]N('!R:6-I;F<@;6]D96P\'0^)SQS<&%N/CPO'0^)S(@>65A'0^)SQS<&%N/CPO'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XR,BXR,"4\'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R8U]B,#4P7S0U M8V1?83%E85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO9#)D9F%C,F-?8C`U,%\T-6-D7V$Q96%?93AB-V0R-#0S.30R+U=O M'0O:'1M M;#L@8VAA6UE;G0@9F]R('-E='1L96UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`U,%\T M-6-D7V$Q96%?93AB-V0R-#0S.30R+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!R96QA M=&5D('1O(&9A:7(@=F%L=64@;V8@8F5N969I8VEA;"!C;VYV97)S:6]N(&9E M871U'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`R,#$S(%-E8W5R:71I97,@4'5R M8VAA2`S,2P@,C`Q,SQB2`S,2P@,C`Q,SQB2`S M,2P@,C`Q,SQB&5R8VES960@5')A;G-A8W1I;VX@ M3VYE(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S2`S,2P@,C`Q,SQB2`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`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)T)L86-K+5-C:&]L97,@;W!T:6]N('!R M:6-I;F<@;6]D96P\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!L:69E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'!E;G-E(&%L;&]W86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2!);F-E;G1I=F4@4&QA;B!;365M8F5R73QB65E2!);F-E;G1I M=F4@4&QA;B!;365M8F5R73QB2`R,#$S($]P=&EO;G,@27-S M=65D('1O($5M<&QO>65E65E2`R,#$S($]P=&EO;G,@27-S=65D M(%1O($5M<&QO>65E65E(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT M:"!C;&%S65E(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@ M(#QT:"!C;&%S2`R,#$T($5X=&5N'1E;G-I;VX@;V8@ M5V%R'1E;G-I;VX@ M;V8@5V%R2!3=&]C:R!/ M<'1I;VYS(%M-96UB97)=/&)R/DUA2!3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R M/DIU;'D@,C`Q,R!/<'1I;VYS($ES2!3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/DYO=F5M8F5R(#(P,3,@3W!T M:6]N2!3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/DIA;G5A65E65E2`R M,#$T($5X=&5N65E(%M-96UB97)=/&)R/CPO M=&@^#0H@("`@("`\+W1R/@T*("`@("`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`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO3PO=&0^#0H@("`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)S4@>65A'0^)S4@ M>65A'0^)S4@>65A'0^ M)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(@ M>65A'0^)S4@>65A'0^ M)SQS<&%N/CPO'0^)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)S4@>65A'0^)S$P M('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA&5R8VES92!0'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M&5R M8VES92!P&5R8VES92!P'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!P'0^)S$@ M>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E+"!E>&5R8VES92!P'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO&5R8VES92!P&5R8VES M86)L92P@97AE'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO&5R8VES92!P&5R8VES86)L92P@97AE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R M8U]B,#4P7S0U8V1?83%E85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9#)D9F%C,F-?8C`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`U,%\T-6-D7V$Q96%?93AB-V0R-#0S M.30R+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D,F1F86,R8U]B,#4P7S0U8V1? M83%E85]E.&(W9#(T-#,Y-#(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9#)D9F%C,F-?8C`U,%\T-6-D7V$Q96%?93AB-V0R-#0S.30R+U=O'0O:'1M;#L@ M8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!E>'!E;G-E'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO6UE;G0@9F]R(&-O;G-U;'1I;F<@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO XML 21 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Details) (USD $)
1 Months Ended 3 Months Ended
Dec. 27, 2013
Mar. 31, 2014
Mar. 31, 2013
Debt Instrument [Line Items]      
Accreted interest on notes payable   $ 86,087   
Sale proceeds amount 3,000,000    
Agreement One [Member]
     
Debt Instrument [Line Items]      
Exercise price of warrants 0.01    
Number of shares entitled by warrants 37,500    
Note payable included per unit 500,000    
Interest rate 10.00%    
Agreement Two [Member]
     
Debt Instrument [Line Items]      
Exercise price of warrants 1.00    
Number of shares entitled by warrants 50,000    
Note payable included per unit 500,000    
Interest rate 10.00%    
Warrant [Member]
     
Debt Instrument [Line Items]      
Risk free interest rate 0.40%    
Dividend yield       
Pricing model used in calculation of grant-date fair value Black-Scholes option pricing model    
Expected life 2 years    
Fair value of issued equity $ 92,470    
Expected volatility 22.20%    
XML 22 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
PATENTS (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]      
Amortization period 20 years    
Patents [Member]
     
Finite-Lived Intangible Assets [Line Items]      
Amortization period 20 years    
Unamortized capitalized patent costs $ 784,152   $ 739,657
Amortization expense for patents $ 10,129 $ 5,265 $ 28,541
XML 23 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
INCOME TAXES [Abstract]      
Net operating loss carryforwards     $ 39.7
Income tax expense        
XML 24 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
LITIGATION SETTLEMENT (Details) (USD $)
3 Months Ended
Mar. 31, 2013
LITIGATION SETTLEMENT [Abstract]  
Cash payment for settlement $ 450,000
XML 25 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (USD $)
3 Months Ended 74 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES      
NET LOSS $ (5,765,456) $ (2,683,517) $ (41,215,902)
Adjustments to reconcile net loss to net cash used in operating activities      
Fair value of warrants issued in exchange for services       638,516
Fair value of options issued in exchange for services 288,551 191,494 3,263,914
Fair value of stock issued in exchange for services       4,791,035
Change in fair value of embedded derivative liability 2,185,375    2,185,375
Amortization of deferred costs       78,243
Accretion of discount on notes payable 86,087    518,565
Depreciation and amortization 18,518 11,671 108,417
Provision for bad debt       42,768
Loss on disposal of fixed assets 8,109    16,942
(Increase) decrease in assets      
Accounts receivable (285) (88) (1,285)
Insurance receivable 4,325 75,000   
Other receivable       (42,768)
Prepaid expenses (59,618) (3,464) (280,526)
Deposits (228,831) (8,900) (346,949)
Increase (decrease) in liabilities      
Accounts payable, accrued expenses and litigation settlement (553,194) (301,789) 1,918,987
Net cash used in operating activities (4,016,419) (2,719,593) (28,324,668)
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of equipment (51,751) (22,867) (213,068)
Patent and trademark costs (54,624) (91,745) (836,411)
Net cash used in investing activities (106,375) (114,612) (1,049,479)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from note payable - stockholders       1,747,500
Repayment of note payable - stockholders (1,000,000)    (1,572,500)
Proceeds from notes payable       75,000
Proceeds from issuance of preferred stock and warrants 5,045,000    5,045,000
Proceeds from issuance of common stock    900,000 23,796,584
Proceeds from exercise of options 75,000    644,000
Proceeds from exercise of warrants 2,546,143    4,424,449
Stock issuance costs (170,165) (60,783) (658,386)
Net cash provided by financing activities 6,495,978 839,217 33,501,647
EFFECT OF EXCHANGE RATE ON CASH (17,580)    (19,435)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 2,355,604 (1,994,988) 4,108,065
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 1,752,461 7,371,036  
CASH AND CASH EQUIVALENTS - END OF PERIOD 4,108,065 5,376,048 4,108,065
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:      
Income taxes paid         
Interest paid 8,193    2,498
Fair value of common stock issued as discount for notes payable       483,409
Conversion of notes payable and accrued interest into common stock       275,000
Fair value of warrants issued as discount for notes payable       20,930
Issuance of common stock for settlement of payable       297,500
Fair value of beneficial conversion value as discount against Preferred Stock 1,648,825    1,648,825
Fair value of warrant liability as discount against Preferred Stock 1,547,925    1,547,925
Accretion of discount on preferred stock as deemed distribution 1,648,825    1,648,825
Deemed dividend distribution in conjunction with warrant exchange offering $ 717,594    $ 717,594
XML 26 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONVERTIBLE PREFERRED STOCK (Details) (USD $)
3 Months Ended 12 Months Ended 74 Months Ended 1 Months Ended 3 Months Ended
Mar. 31, 2014
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2009
Mar. 31, 2014
Jan. 31, 2014
Preferred Class A [Member]
Mar. 31, 2014
Preferred Class A [Member]
Jan. 27, 2014
Common Stock [Member]
Class of Stock [Line Items]                    
Issuance of stock, shares   49,000           50,450    
Equity issuance, price per share               $ 100    
Shares issuable upon exercise of warrants                   5,045,000
Proceeds from issuance of preferred stock and warrants $ 5,045,000            $ 5,045,000      
Dividend rate               8.00%    
Stock issuance costs 170,165     395,221 28,000 65,000   131,000    
Purchase price of preferred stock and warrants               3,396,175    
Benefical conversion feature $ 1,648,825            $ 1,648,825 $ 1,648,825 $ 3,834,200  
Conversion price                 $ 1.00  
XML 27 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) (USD $)
Mar. 31, 2014
OPERATING LEASES [Abstract]  
2014 $ 293,696
2015 300,194
2016 200,696
Total $ 794,586
XML 28 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (USD $)
Mar. 31, 2014
Dec. 31, 2013
CURRENT ASSETS    
Cash and cash equivalents $ 4,108,065 $ 1,752,461
Accounts Receivable 1,285 1,000
Insurance receivable    4,325
Prepaid expenses 280,526 220,908
TOTAL CURRENT ASSETS 4,389,876 1,978,694
PROPERTY AND EQUIPMENT    
Computer equipment 93,654 89,021
Furniture and fixtures 83,981 57,238
Leasehold improvements 8,350   
Gross property and equipment 185,985 146,259
Less: accumulated depreciation (46,016) (41,544)
Total property and equipment 139,969 104,715
OTHER ASSETS    
Deposit 346,949 118,118
Patents and trademarks, net of accumulated amortization of $52,258 and $42,129 784,152 739,657
Total other assets 1,131,101 857,775
TOTAL ASSETS 5,660,946 2,941,184
CURRENT LIABILITIES    
Accounts payable and accrued expenses 1,596,488 2,149,681
Embedded derivative liability 3,834,200  
Notes payable, net of discount of $0 and $86,087    913,913
TOTAL CURRENT LIABILITIES 5,430,688 3,063,594
CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Preferred stock, $.0001 par value; 2,000,000 shares authorized; 50,450 shares issued and outstanding at March 31, 2014 and none issued and outstanding at December 31, 2013 5   
Common stock, $ .0001 par value; 180,000,000 shares authorized; 116,589,055 and 111,396,768 shares issued and outstanding at March 31, 2014 and December 31, 2013 11,659 11,140
Additional paid in capital 43,820,350 35,318,751
Deficit accumulated during the development stage (43,582,321) (35,450,446)
Cumulative translation adjustment (19,435) (1,855)
STOCKHOLDERS' EQUITY 230,258 (122,410)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,660,946 $ 2,941,184
XML 29 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statement of Changes in Stockholders' Equity (Deficit) (USD $)
Total
Preferred Stock [Member]
Common Stock [Member]
Common Stock Subscribed [Member]
Common Stock Subscription Receivable [Member]
Additional Paid-In Capital [Member]
Deficit Accumulated During the Development Stage [Member]
Cumulative Translation Adjustment [Member]
Balance, values at Feb. 10, 2008                       
Balance, shares at Feb. 10, 2008                 
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, values 1,900   1,900       17,100      
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, shares     19,000,000          
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, values 250,000   714       249,286      
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, shares     7,142,858          
Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values 8,825            8,825      
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values 107,859            107,859      
Exercise of options on May 8, 2008, at $.04 per share, values 20,000   50       19,950      
Exercise of options on May 8, 2008, at $.04 per share, shares     500,000          
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, values 232,500   665       231,835      
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, shares     6,642,858          
Options issued for services in June 2008, vested immediately and valued at $.07 per share, values 395,567            395,467      
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values 918            918      
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, values 2,560            2,560      
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, shares     2,560          
Exercise of options in September 2008 at $.04 per share, values 70,000   175       69,825      
Exercise of options in September 2008 at $.04 per share, shares     1,750,000          
Exercise of warrants in September 2008 at $.04 per share, values 10,000   25       9,975      
Exercise of warrants in September 2008 at $.04 per share, shares     250,000          
Net loss (983,886)               (983,886)   
Balance, values at Dec. 31, 2008 133,243   3,529       1,113,600 (983,886)   
Balance, shares at Dec. 31, 2008     35,288,276          
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values 37,506            37,506      
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values 636            636      
Exercise of options on January 26, 2009 at $.04 per share, values 40,000   100       39,900      
Exercise of options on January 26, 2009 at $.04 per share, shares     1,000,000          
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, values 400,000   40       399,960      
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, shares     400,000          
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, values 200,000   10       199,960      
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, shares     100,000          
Exercise of options on July 30, 2009 at $.04 per share, values 40,000   100       39,900      
Exercise of options on July 30, 2009 at $.04 per share, shares     1,000,000          
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values 10,462            10,462      
Exercise of warrants on August 21, 2009 at $.04 per share, values 40,000   100       39,900      
Exercise of warrants on August 21, 2009 at $.04 per share, shares     1,000,000          
Exercise of options on September 2, 2009 at $.04 per share, values 20,000   50       19,950      
Exercise of options on September 2, 2009 at $.04 per share, shares     500,000          
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, values 100,000   10       99,990      
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, shares     100,000          
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, values 1,080,427   108       1,080,319      
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, shares     1,080,427          
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, values 100,000   10       99,990      
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, shares     100,000          
Exercise of warrants on October 22, 2009 at $.04 per share, values 40,000   100       39,900      
Exercise of warrants on October 22, 2009 at $.04 per share, shares     1,000,000          
Exercise of warrants on December 2, 2009 at $.04 per share, values 40,000   100       39,900      
Exercise of warrants on December 2, 2009 at $.04 per share, shares     1,000,000          
Exercise of options on December 10, 2009 at $.04 per share, values 10,000   25       9,975      
Exercise of options on December 10, 2009 at $.04 per share, shares     250,000          
Exercise of warrants on December 31, 2009 at $.04 per share, values 40,000   100       39,900      
Exercise of warrants on December 31, 2009 at $.04 per share, shares     1,000,000          
Stock issuance costs (65,000)            (65,000)      
Net loss (2,236,476)               (2,236,476)   
Balance, values at Dec. 31, 2009 30,798   4,382       3,246,778 (3,220,362)   
Balance, shares at Dec. 31, 2009     43,818,703          
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values 27,899            27,899      
Exercise of options on January 5, 2010 at $.04 per share, values 40,000   100      39,900      
Exercise of options on January 5, 2010 at $.04 per share, shares     1,000,000          
Exercise of warrant on February 22, 2010 at $.04 per share, values 35,713   89       35,624      
Exercise of warrant on February 22, 2010 at $.04 per share, shares     892,858          
Exercise of warrants in March 2010 at $.04 per share, values 40,000   100       39,900      
Exercise of warrants in March 2010 at $.04 per share, shares     1,000,000          
Exercise of warrants in April 2010 at $.04 per share, values 100,000   250       99,750      
Exercise of warrants in April 2010 at $.04 per share, shares     2,500,000          
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, values 400,742   48       400,694      
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, shares     483,750          
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, values     6       (6)      
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, shares     65,000          
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, values 1,925,000   963       1,924,037      
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, shares     9,625,000          
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, values 75,000   38       74,962      
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, shares     375,000          
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, values 100,000   11       99,989      
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, shares     111,111          
Exercise of options on December 2, 2010 at $.04 per share, values 120,000   300       119,700      
Exercise of options on December 2, 2010 at $.04 per share, shares     3,000,000          
Exercise of warrants in December 2010 at $.04 per share, values 100,000   250       99,750      
Exercise of warrants in December 2010 at $.04 per share, shares     2,500,000          
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values 13,816            13,816      
Net loss (1,489,190)               (1,489,190)   
Balance, values at Dec. 31, 2010 1,519,778   6,537       6,222,793 (4,709,552)   
Balance, shares at Dec. 31, 2010     65,371,422          
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, values 49,000   10       48,990      
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, shares     100,000          
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, value 82,665   15       82,650      
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, shares     150,000          
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, values 500,000   125       499,875      
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, shares     1,250,000          
Issuance of warrants in conjunction with notes payable from September through December 2011 20,930            20,930      
Fair value of revalued warrants at $.09 to $.76 per share 88,601            88,601      
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values           3,146    
Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share 46,019            46,019      
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share 52,243            52,243      
Net loss (2,724,796)               (2,724,796)   
Balance, values at Dec. 31, 2011 (362,414)   6,687       7,065,247 (7,434,348)   
Balance, shares at Dec. 31, 2011     66,871,422          
Stock issuance costs (28,000)         (28,000)    
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values 7,086,932   2,044       7,084,888      
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares     204,426,948          
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, values 1,050,000   262       1,049,738      
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, shares     2,625,000          
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values 3,312,537   136       3,312,401      
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares     1,363,185          
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values 200,000   57       199,943      
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares     571,428          
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values 297,500   35       297,465      
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, shares     350,000          
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, values 5,560,000   794       5,559,206      
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, shares     7,942,858          
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, values 500,000   67       499,933      
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, shares     666,667          
Exercise of options on April 10, 2012 at $.04 per share, values 10,000   25       9,975      
Exercise of options on April 10, 2012 at $.04 per share, shares     250,000          
Exercise of options on May 25, 2012 at $.04 per share, values 14,000   35       13,965      
Exercise of options on May 25, 2012 at $.04 per share, shares     350,000          
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share, values 2,219            2,219      
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values 759,292            759,292      
Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at$. 17 to $.40 per share, values 39,751            39,751      
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values 283,460            283,460      
Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share, values 150,631            150,631      
Common stock subscription for 62,500 units through private placement at $.80 per unit        50,000 (50,000)         
Net loss (12,039,726)               (12,039,726)   
Balance, values at Dec. 31, 2012 6,836,182   10,142 50,000 (50,000) 26,300,114 (19,474,074)   
Balance, shares at Dec. 31, 2012     101,417,508          
Stock issuance costs (395,221)         (395,221)    
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values 34,372            34,372      
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, values 50,000   13       49,987      
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares     125,000          
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, values 850,000   113       849,887      
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares     1,133,334          
Issuance of shares on April 15, 2013 common stock for services, values 49,071   3       49,068      
Issuance of shares on April 15, 2013 common stock for services, shares     26,521          
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value 5,170,595   287       5,170,308      
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares     2,872,553          
Fair value of warrants issued with notes payable 92,469            92,469      
Fair value of revalued warrants at $0.78 per share 6,540            6,540      
Fair value of revalued options $1.07 per share 1,199            1,199      
Exercise of options at $0.04 per share in May 2013, value 30,000   75       29,925      
Exercies of options at $0.04 per share in May 2013, shares     750,000          
Exercise of options at $0.35 per share on May 14, 2013, value 105,000   30       104,970      
Exercise of options at $0.35 per share on May 14, 2013, shares     300,000          
Exercise of options at $0.75 per share in May 2013, value 50,000   7       49,993      
Exercise of options at $0.75 per share in May 2013, shares     66,667          
Exercise of warrants at $0.04 per share on May 26, 2013, value 80,000   200       79,800      
Exercise of warrants at $0.04 per share on May 26, 2013, shares     2,000,000          
Exercise of warrants at $0.50 per share in May through August 2013, value 1,352,593   270       1,352,323      
Exercise of warrants at $0.50 per share in May through August 2013, shares     2,705,185          
Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share 784,247            784,247      
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $0.11 to $0.80 per share 447,975            447,975      
Employee options issued for services on January 2013 through December 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share 310,795            310,795      
Common stock subscription for 62,500 units through private placement at $.80 per unit        (50,000) 50,000         
Net loss (15,976,372)               (15,976,372)   
Cumulative translation adjustment (1,855)                  (1,855)
Balance, values at Dec. 31, 2013 (122,410)   11,140       35,318,751 (35,450,446) (1,855)
Balance, shares at Dec. 31, 2013 111,396,768   111,396,768          
Stock issuance costs (170,165)             (170,165)      
Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit 3,396,175 5          3,396,170      
Issuance of shares of convertible preferred stock and 5,045,000 warrants through March 31, 2014, through private placement at $1.00 per unit, shares   50,450                  
Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share 2,521,143    504       2,520,639      
Issuance of shares of common stock from exercise of warrants through warrant exchange offering at $.50 per share, shares      5,042,287               
Exercise of warrants at $0.50 per share in March 2014, value 25,000    5       24,995      
Exercise of warrants at $0.50 per share in March 2014, shares      50,000               
Exercise of options at $0.75 per share in March 2014, value 75,000    10       74,990      
Exercise of options at $0.75 per share in March 2014, shares      100,000               
Fair value of revalued warrants at $0.22 to$ 0.76 per share 9,228             9,228      
Nonemployee options issued for services from January 2012 through December 2012, vested over 3 years and valued from $1.11 to $1.55 per share 6,335             6,335      
Nonemployee options/warrants issued for services from January 2013 through December 2013, vested immediately to 3 years and valued from $1.04 to $3.05 per share 43,112             43,112      
Employee options issued for services from January 2012 through December 2013, vested over 3 years and valued from $0.50 to $0.92 per share 201,494             201,494      
Employee options issued for services on January 2014 through March 31, 2014, vesting over two to three years and valued at $1.05 to $1.43 per share 28,382             28,382      
Deemed dividend distribution in conjunction with Preferred Series A offering                1,648,825 (1,648,825)   
Deemed dividend distribution in conjunction with warrant exchange offering               717,594 (717,594)   
Net loss (5,765,456)               (5,765,456)   
Cumulative translation adjustment (17,580)             (17,580)
Balance, values at Mar. 31, 2014 $ 230,258 $ 5 $ 11,659       $ 43,820,350 $ (43,582,321) $ (19,435)
Balance, shares at Mar. 31, 2014 116,589,055 50,450 116,589,055          
XML 30 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Narrative) (Details) (USD $)
1 Months Ended 3 Months Ended 12 Months Ended 74 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended 2 Months Ended 1 Months Ended 2 Months Ended 1 Months Ended
Apr. 30, 2014
Mar. 31, 2014
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Q1 2013 Issuance [Member]
Apr. 30, 2013
April 15, 2013 Issuance [Member]
Apr. 30, 2013
April 15, 2013 Issuance [Member]
Restricted Stock [Member]
May 31, 2013
May 2013 Securities Purchase Agreement [Member]
May 31, 2013
May 2013 Securities Purchase Agreement [Member]
Warrant Type One [Member]
May 31, 2013
May 2013 Securities Purchase Agreement [Member]
Warrant Type Two [Member]
May 31, 2013
May 2013 Options Exercised [Member]
May 31, 2013
May 2013 Options Exercised Transaction One [Member]
May 31, 2013
May 2013 Options Exercised Transaction Two [Member]
Jun. 30, 2013
May 2013 Options Exercised Transaction Two [Member]
May 31, 2013
May 2013 Options Exercised Transaction Three [Member]
Jun. 30, 2013
May and June 2013 Warrants Exercised [Member]
Jun. 30, 2013
May and June 2013 Warrants Exercised Transaction One [Member]
Aug. 31, 2013
July and August 2013 Warrants Exercised [Member]
Oct. 31, 2013
October 2013 [Member]
Feb. 28, 2014
February 2014 Private Placement [Member]
Feb. 28, 2014
Modification of Warrants Issued in February 2012 [Member]
Equity Issued [Line Items]                                              
Equity issuance date                 Apr. 15, 2013                            
Issuance of stock, shares     49,000           26,521                            
Issuance of shares of common stock, value     $ 100,000           $ 49,071                            
Equity issuance, price or exercise price per security issued             $ 0.75     $ 1.80       $ 0.04 $ 0.35   $ 0.75            
Warrants per unit                     1                        
Number of shares entitled by warrants                     0.5 287,255                   5,042,287  
Exercise price of warrants                     3.00 1.80       0.50     0.04 0.50 0.50 1.00 1.00
Equity issuance, number securities issued for cash             1,133,334     2,572,553                          
Amount raised from private placement 5,800,000 7,500,000     8,300,000   850,000     4,836,157                          
Units issued                     300,000                        
Exercised, shares                           750,000 300,000   66,667            
Proceeds from exercise of options   75,000        644,000             185,000                    
Warrants exercised                               2,660,685     2,000,000 34,500 10,000    
Proceeds from exercise of warrants   2,546,143        4,424,449                       1,410,342   17,250 5,000 2,521,143  
Stock issuance costs including commisions   170,165   60,783 400,000 658,386 60,783                                
Market price   $ 1.45       $ 1.45                                 $ 1.18
Deemed dividend distribution in conjunction with warrant exchange offering   717,594        717,594                                 717,594
Options granted               1,050,000                              
Fair value of issued equity               519,080                              
Pricing model used in calculation of grant-date fair value               Black-Scholes option pricing model                             Black-Scholes option pricing model
Expected life               5 years                             2 years
Dividend yield                                                
Expected volatility               29.00%                             143.20%
Risk free interest rate               0.69%                             0.30%
Vesting period               3 years                              
Expiration period after issuance               5 years                             2 years
Placement agent fees                   151,408                          
Expense allowance                   $ 155,118                          
XML 31 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Basis of Presentation
Basis of Presentation
The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.  The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States ("U.S. GAAP")  for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements should be read in conjunction with the financial statements and notes included in the Company's Annual Report on form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission (the "SEC"). Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from these estimates.
Comprehensive Income
Comprehensive Income
The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  The Company has one item of other comprehensive loss, consisting of a foreign translation adjustment.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The Company's financial instruments consist of accounts receivable, accounts payable and accrued expenses, embedded derivative and warrant liability. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities. 

The Company follows FASB ASC 820, Fair Value Measurements and Disclosures, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:
 
Level 1: Quoted market prices in active markets for identical assets or liabilities
 
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data
 
Level 3: Unobservable inputs that are not corroborated by market data
 
The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
 
Foreign Currency Translation
Foreign Currency Translation
The functional currency of operations outside the U.S. is British Pounds.
Concentration of Credit Risk Involving Cash
Concentration of Credit Risk Involving Cash
The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance ("FDIC") coverage.  The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.  
Cash and Cash Equivalents
Cash and Cash Equivalents
For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.
Property and Equipment
Property and Equipment
Property and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, principally three to seven years. Maintenance and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is included in operations.  Depreciation of property and equipment was $8,389 and $5,875 for the three months ended March 31, 2014 and 2013 and is included in general and administrative expenses.
Patents and trademarks
Patents and Trademarks
The Company has one issued patent with the United States Patent and Trademark Office ("USPTO"), entitled Systems and Method for Verifying the Age of an Internet User, and filed for nine provisional patents.  Additionally, the Company has been issued two patents in Germany, entitled Virtual Piggy Bank and Parent Match, while the remaining patents in Germany are still pending.  The Company also has patents pending in Australia, Brazil, Canada and Europe under the Patent Cooperation Treaty ("PCT").  Costs associated with the registration and legal defense of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents which were determined to be 20 years.
Long-Lived Assets
Long-Lived Assets
The Company evaluates the recoverability of its long-lived assets in accordance with FASB ASC 360 "Property, Plant, and Equipment." The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.
Revenue Recognition
Revenue Recognition
In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale of the associated product.  
Income Taxes
Income Taxes
The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.  Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.  Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.
Stock-based Payments
Stock-based Payments
The Company accounts for stock-based compensation under the provisions of FASB ASC 718, Compensation-Stock Compensation which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC 505 -50, Equity-Based Payments to Non-Employees ("ASC 505-50"). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid-in capital in stockholders' equity over the applicable service periods.
Advertising Costs
Advertising Costs
Advertising costs are expensed as incurred. Advertising costs were $53,628 and $222,847 for the three months ended March 31, 2014 and 2013 and are included in sales and marketing expenses.
Research and Development Costs
Research and Development Costs
In accordance with FASB ASC 730, research and development costs are expensed when incurred.  Research and development costs for the three months ended March 31, 2014 and 2013 were $852,744 and $454,378.
Loss Per Share
Loss Per Share
The Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the three months ended March 31, 2014 and 2013, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

Start-up Costs
Start-up Costs
In accordance with FASB ASC 720, start-up costs are expensed as incurred.
Segment Information
Segment Information
The Company is organized and operates as one operating segment. In accordance with FASB ASC 280, Segment Reporting, the chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company subject to Board approval. Since the Company operates in one segment and provides one group of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the consolidated financial statements.

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements
As of March 31, 2014 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Issued Accounting Pronouncements Not Yet Adopted
As of March 31, 2014, there were no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Reclassifications
Reclassifications
Certain amounts in the 2013 and cumulative since inception statements of operations have been reclassified in order for them to be in conformity with the 2014 presentation.

XML 32 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Narrative) (Details) (USD $)
11 Months Ended 12 Months Ended 3 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Dec. 31, 2008
2008 Warrants Issued in Private Placement [Member]
Mar. 31, 2014
2008 Equity Incentive Plan [Member]
Mar. 31, 2014
2008 Equity Incentive Plan [Member]
Options issued to employees [Member]
Mar. 31, 2014
2008 Equity Incentive Plan [Member]
Options issued to non-employees [Member]
Dec. 31, 2013
2008 Equity Incentive Plan [Member]
March 31, 2012 Options Issued to Consultants [Member]
Minimum [Member]
Dec. 31, 2013
2008 Equity Incentive Plan [Member]
March 31, 2012 Options Issued to Consultants [Member]
Maximum [Member]
Mar. 31, 2014
2013 Equity Incentive Plan [Member]
Mar. 31, 2014
2013 Equity Incentive Plan [Member]
Options issued to employees [Member]
Mar. 31, 2014
2013 Equity Incentive Plan [Member]
Options issued to non-employees [Member]
Mar. 31, 2014
Incentive Stock Options [Member]
Mar. 31, 2013
Incentive Stock Options [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
Dec. 31, 2012
Incentive Stock Options [Member]
Mar. 31, 2014
Incentive Stock Options [Member]
Warrants to Purchase Common Stock [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
January 2013 Options Issued to Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
February 2013 Options Issued to Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
March 2013 Options Issued to Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
April 2013 Options Issued To Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
May 2013 Options Issued To Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
June 2013 Options Issued To Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
August 2013 Options Issued To Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
September 2013 Options Issued To Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
November 2013 Options Issued to Employee [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
December 2013 Options Issued to Employees [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
December 2013 Options Issued to Employee [Member]
Dec. 31, 2013
Incentive Stock Options [Member]
April 2013 Options Issued To Employees [Member]
Mar. 31, 2014
Incentive Stock Options [Member]
February 2014 Extension of Warrant Term [Member]
Minimum [Member]
Mar. 31, 2014
Incentive Stock Options [Member]
February 2014 Extension of Warrant Term [Member]
Maximum [Member]
Mar. 31, 2014
Incentive Stock Options [Member]
February 2014 Extension of Warrant Term [Member]
$.04 per Share Exercise Price Class [Member]
Mar. 31, 2014
Incentive Stock Options [Member]
February 2014 Extension of Warrant Term [Member]
Warrants to Purchase Common Stock [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
Mar. 31, 2013
Non-Statutory Stock Options [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
Dec. 31, 2012
Non-Statutory Stock Options [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
Warrants to Purchase Common Stock [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
January 2013 Options Issued to Consultants [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
March 2013 Options Issued To Consultants [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
April 2013 Options Issued To Consultants [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
March 2013 Options Issued To Consultant [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
May 2013 Options Issued To Consultants [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
May 2013 Options Issued for Private Placement [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
July 2013 Options Issued To Consultants [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
September 2013 Options Issued To Consultants [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
October 2013 Options Issued to Consultant [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
November 2013 Options Issued to Consultants [Member]
Dec. 31, 2013
Non-Statutory Stock Options [Member]
November 2013 Options Issued Amendment [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
January 2014 Option Issued to 11 Employees [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
January 2014 Options issued to 2 Employees [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
February 2014 Options Issued to New Members of Board of Directors [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
February 2014 Option Issued to Employees [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
February 2014 Extension of Warrant Term [Member]
Mar. 31, 2014
Non-Statutory Stock Options [Member]
March 2014 Option Issued to Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                                                                        
Equity issuance date                                                                                           Nov. 18, 2013            
Equity issuance date by month and year                             2013-01 2013-02 2013-03 2013-04 2013-05 2013-06 2013-08 2013-09 2013-11 2013-12 2013-12 2013-04                   2013-01 2013-03 2013-04 2013-03 2013-05 2013-05 2013-07 2013-09 2013-10 2013-11   2014-01 2014-01 2014-02 2014-02   2014-03
Options authorized   25,000,000         5,000,000                                                                                          
Outstanding options   14,023,330 12,228,330 1,795,000     3,789,166 2,264,166 1,525,000 16,711,141   16,576,144 17,258,644                                   20,563,536   16,128,536 16,531,438                                    
Options available to be issued   463,336         1,210,834                                                                                          
Options granted                             260,000 760,000 2,500 200,000 55,000   210,000 10,000 10,000 255,000 50,000 5,000                   5,000 130,000 100,000 100,000 125,000 287,255 100,000 100,000 20,000 100,000   90,000 35,000 250,000 20,000   100,000
Minimum option exercise price                             $ 0.99 $ 1.07     $ 2.16 $ 2.40 $ 2.00                                     $ 3.05   $ 0.75                    
Option exercise price                                 $ 1.36 $ 1.56       $ 1.97 $ 1.04 $ 1.13 $ 2.40 $ 1.67                   $ 1.00 $ 0.75 $ 2.04 $ 1.34   $ 1.80   $ 1.17 $ 1.06 $ 1.04   $ 1.05 $ 1.05 $ 1.10 $ 1.18   $ 1.43
Maximum option exercise price                             $ 1.05 $ 1.21     $ 2.29 $ 2.92 $ 2.35                                     $ 3.28   $ 2.61                    
Fair value of issued equity                             $ 62,662 $ 199,843 $ 728 $ 74,159 $ 26,954 $ 129,343 $ 124,392 $ 4,500 $ 2,316 $ 655,523 $ 687 $ 933                   $ 1,106 $ 54,228 $ 44,603 $ 32,155 $ 51,869 $ 409,749 $ 124,338 $ 26,208 $ 6,132 $ 26,128   $ 53,927 $ 27,806 $ 264,882 $ 21,048   $ 136,454
Pricing model used in calculation of grant-date fair value                             Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model                   Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model   Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model
Dividend yield                                                                                                                                   
Expected volatility                                 22.50% 25.30%       21.80% 25.60% 22.20% 22.30% 22.50% 89.30% 89.50%               23.30% 22.60% 26.50% 25.80%       22.10% 30.20% 25.60%   67.70% 67.70% 128.50% 142.10%   122.60%
Risk free interest rate                                 0.76% 0.76%       1.71% 1.31% 1.51% 1.75% 0.76%                   0.78% 0.25% 0.68% 0.80%   0.49%   1.39% 1.33% 1.31%   1.77% 3.01% 2.70% 1.47% 0.33% 2.73%
Expected life         2 years 5 years                 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years                   5 years   5 years 5 years 2 years 3 years 5 years 5 years 5 years 5 years   5 years 10 years 5 years 5 years 2 years 10 years
Options, expiration period         5 years 5 years                 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years                   5 years   5 years 5 years 2 years 3 years 5 years 5 years 5 years 5 years   5 years 10 years 5 years 5 years   10 years
Number of shares entitled by warrants                                                         1,142,588 100,000                               8,931,505            
Exercise price of warrants                                                         0.04 0.75                               0.50            
Warrants issued 14,950,002                                                                                                      
Vesting period                             3 years 3 years 3 years 3 years 3 years 5 years 3 years 3 years 3 years 3 years 3 years 3 years                                         3 years 3 years 3 years 3 years   2 years
Expected volatility, minimum                             23.30% 22.50%     23.50% 23.60% 24.20%                                     23.10% 23.40% 23.80%                    
Expected volatility, maximum                             26.10% 25.10%     25.30% 26.30% 30.30%                                     23.20% 23.70% 26.60%                    
Risk free rate, minimum                             0.78% 0.78%     0.84% 1.03% 1.38%                                     0.29%   1.35%                    
Risk free rate, maximum                             0.89% 0.88%     0.85% 1.48% 1.61%                                     0.31%   1.66%                    
Share-based compensation                   1,533,213 239,104     133,698                                 1,893,237 49,447     73,163             124,338                    
Unrecognized compensation expense                   1,594,574                                         73,163                                          
Incremental increase in value                                                                                                     9,228  
Value of warrant modifications                                                                                           $ 6,540            
Aggregate options issued                                       250,000                                 1,130,000                              
Options issued, excluded from valuation                                       50,000                                 1,000,000                              
XML 33 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Tables)
3 Months Ended
Mar. 31, 2014
STOCK OPTIONS AND WARRANTS [Abstract]  
Summary of Stock Options and Warrant Transactions for Employees
A summary of stock option/warrant transactions for employees from January 1, 2013 to March 31, 2014 is as follows:

               
Weighted Average
 
   
Option/Warrants
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2012
    17,258,644     $ 0.04 to $1.82     $ 0.48  
                         
Granted
    3,067,500      
0.99 to 2.92
      0.28  
Reclassified to non-employee
    (235,000 )    
0.65 to 2.30
      (0.02 )
Exercised
    (2,816,667 )    
0.04 to 0.75
      (0.01 )
Expired/terminated
    (698,333 )    
0.50 to 2.92
      (0.01 )
                         
Outstanding, December 31, 2013
    16,576,144      
0.04 to 2.40
      0.74  
                         
Granted
    495,000      
1.05 to 1.43
      0.03  
Reclassified from non-employee
    200,000       0.50       0.01  
Exercised
    (100,000 )     0.75       -  
Expired/terminated
    (460,003 )    
0.65 to 2.16
      (0.02 )
                         
Outstanding, March 31, 2014
    16,711,141     $ 0.04 to $2.40     $ 0.74  
                         
Exercisable, March 31, 2014
    11,436,145     $ .04 to $2.30     $ 0.49  
                         
Weighted Average Remaining Life,
                       
  Exercisable, March 31, 2014 (years)
    1.7                  
Summary of Non-Employee Stock Options and Warrants
The following table summarizes non-employee stock options/warrants of the Company from January 1, 2013 to March 31, 2014 as follows:

               
Weighted Average
 
   
Option/Warrant
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2012
    16,531,438      
0.35 to 2.30
      0.63  
                         
Granted
    2,048,750      
0.01 to 3.28
      0.18  
Issued under Private Placement
    1,723,533      
1.80 to 3.00
      0.30  
Reclassified from employee
    235,000      
0.50 to 1.01
      0.01  
Exercised
    (3,005,185 )    
.35 to .50
      -  
Expired/Cancelled
    (1,405,000 )    
0.50 to 1.00
      -  
                         
Outstanding, December 31, 2013
    16,128,536      
0.01 to 3.28
      0.98  
                         
Granted
    50,000       1.13       -  
Issued under Private Placement
    10,087,287       1.00       0.49  
Reclassified to employee
    (200,000 )     0.50       0.01  
Exercised
    (5,092,287 )    
.35 to .50
      -  
Expired/Cancelled
    (410,000 )    
0.60 to 2.30
      -  
                         
Outstanding, March 31, 2014
    20,563,536     $ 0.01 to $3.28     $ 1.11  
                         
Exercisable, March 31, 2014
    18,968,537     $ 0.01 to $3.28     $ 1.08  
                         
Weighted Average Remaining Life,
                       
  Exercisable, March 31, 2014 (years)
    1.7                  
 
XML 34 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 35 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) (USD $)
5 Months Ended 11 Months Ended 12 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended 11 Months Ended 12 Months Ended 3 Months Ended 11 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 4 Months Ended 11 Months Ended 12 Months Ended 2 Months Ended 12 Months Ended 2 Months Ended 12 Months Ended 11 Months Ended 12 Months Ended 11 Months Ended 12 Months Ended 11 Months Ended 12 Months Ended 11 Months Ended 3 Months Ended 11 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2010
Issuance of Shares of Common Stock [Member]
Dec. 31, 2008
Issuance of Shares of Common Stock [Member]
Dec. 31, 2009
Issuance of Shares of Common Stock [Member]
Dec. 31, 2009
Issuance of Shares of Common Stock Two [Member]
Dec. 31, 2009
Issuance Of Shares Of Common Stock Three [Member]
Dec. 31, 2009
Issuance Of Shares Of Common Stock Four [Member]
Mar. 31, 2013
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Sep. 30, 2008
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Jun. 30, 2012
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Dec. 31, 2008
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Dec. 31, 2013
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Dec. 31, 2011
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Mar. 31, 2014
Issuance of Shares of Preferred Stock and Warrants Through Private Placement [Member]
Dec. 31, 2008
Employee Options Issued for Services Transaction One [Member]
Mar. 31, 2014
Employee Options Issued for Services Transaction One [Member]
Minimum [Member]
Dec. 31, 2013
Employee Options Issued for Services Transaction One [Member]
Minimum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction One [Member]
Minimum [Member]
Mar. 31, 2014
Employee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2013
Employee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2013
Employee Options Issued for Services Transaction Two [Member]
Minimum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction Two [Member]
Minimum [Member]
Dec. 31, 2013
Employee Options Issued for Services Transaction Two [Member]
Maximum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction Two [Member]
Maximum [Member]
Nov. 30, 2010
Nonemployee Options Issued for Services Transaction One [Member]
Dec. 31, 2008
Nonemployee Options Issued for Services Transaction One [Member]
Dec. 31, 2011
Nonemployee Options Issued for Services Transaction One [Member]
Dec. 31, 2009
Nonemployee Options Issued for Services Transaction One [Member]
Aug. 31, 2011
Nonemployee Options Issued for Services Transaction One [Member]
Minimum [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction One [Member]
Minimum [Member]
Aug. 31, 2011
Nonemployee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2008
Nonemployee Options Issued for Services Transaction Two [Member]
Dec. 31, 2010
Nonemployee Options Issued for Services Transaction Two [Member]
Dec. 31, 2009
Nonemployee Options Issued for Services Transaction Two [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction Two [Member]
Minimum [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction Two [Member]
Maximum [Member]
Dec. 31, 2009
Nonemployee Options Issued For Services Transaction Three [Member]
Dec. 31, 2012
Nonemployee Options Issued For Services Transaction Three [Member]
Minimum [Member]
Dec. 31, 2012
Nonemployee Options Issued For Services Transaction Three [Member]
Maximum [Member]
Dec. 31, 2008
Exercise of Options Transaction One [Member]
Dec. 31, 2013
Exercise of Options Transaction One [Member]
Dec. 31, 2012
Exercise of Options Transaction One [Member]
Dec. 31, 2010
Exercise of Options Transaction One [Member]
Dec. 31, 2009
Exercise of Options Transaction One [Member]
Dec. 31, 2008
Exercise of Options Transaction Two [Member]
Dec. 31, 2013
Exercise of Options Transaction Two [Member]
Dec. 31, 2012
Exercise of Options Transaction Two [Member]
Dec. 31, 2010
Exercise of Options Transaction Two [Member]
Dec. 31, 2009
Exercise of Options Transaction Two [Member]
Dec. 31, 2013
Exercise of Options Transaction Three [Member]
Dec. 31, 2009
Exercise of Options Transaction Three [Member]
Dec. 31, 2009
Exercise Of Options Transaction Four [Member]
Dec. 31, 2008
Options Issued for Services [Member]
Dec. 31, 2008
Issuance of Shares of Common Stock to Investors [Member]
Mar. 31, 2014
Exercise of Warrants Transaction One [Member]
Dec. 31, 2008
Exercise of Warrants Transaction One [Member]
Dec. 31, 2013
Exercise of Warrants Transaction One [Member]
Dec. 31, 2010
Exercise of Warrants Transaction One [Member]
Dec. 31, 2009
Exercise of Warrants Transaction One [Member]
Mar. 31, 2014
Exercise of Warrants Transaction Two [Member]
Dec. 31, 2010
Exercise of Warrants Transaction Two [Member]
Dec. 31, 2009
Exercise of Warrants Transaction Two [Member]
Mar. 31, 2014
Exercise Of Warrants Transaction Four [Member]
Dec. 31, 2010
Exercise Of Warrants Transaction Four [Member]
Dec. 31, 2009
Exercise Of Warrants Transaction Four [Member]
Dec. 31, 2010
Exercise Of Warrants Transaction Three [Member]
Dec. 31, 2009
Exercise Of Warrants Transaction Three [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock for Future Services [Member]
Dec. 31, 2011
Issuance of Shares of Common Stock for Future Services [Member]
Dec. 31, 2010
Issuance of Shares of Common Stock for Future Services [Member]
Dec. 31, 2009
Issuance of Shares of Common Stock for Future Services [Member]
Dec. 31, 2010
Issuance of Shares of Common Stock for Retirement of Options [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock Through Private Placement Transaction One [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member]
Dec. 31, 2010
Issuance of Shares of Common Stock for Conversion of Notes Payable [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member]
Dec. 31, 2012
Common Stock Subscription for Units Through Private Placement [Member]
Dec. 31, 2013
Nonemployee Options/Warrants Issued for Services [Member]
Minimum [Member]
Dec. 31, 2013
Nonemployee Options/Warrants Issued for Services [Member]
Maximum [Member]
Dec. 31, 2013
Fair Value of Revalued Warrants [Member]
Mar. 31, 2014
Fair Value of Revalued Warrants [Member]
Minimum [Member]
Dec. 31, 2012
Fair Value of Revalued Warrants [Member]
Minimum [Member]
Mar. 31, 2014
Fair Value of Revalued Warrants [Member]
Maximum [Member]
Dec. 31, 2012
Fair Value of Revalued Warrants [Member]
Maximum [Member]
Dec. 31, 2013
Nonemployee Options And Warrants Issued For Services Two [Member]
Minimum [Member]
Dec. 31, 2013
Nonemployee Options And Warrants Issued For Services Two [Member]
Maximum [Member]
Dec. 31, 2013
Fair Value of Revalued Options [Member]
Minimum [Member]
Dec. 31, 2013
Fair Value of Revalued Options [Member]
Maximum [Member]
Equity issuance date   Feb. 11, 2008 Apr. 07, 2009 Jun. 29, 2009 Sep. 17, 2009 Oct. 16, 2009             Dec. 20, 2011   Mar. 03, 2008                       Mar. 03, 2008 Jan. 24, 2011 Aug. 18, 2009         Jun. 19, 2008 Aug. 18, 2009 Mar. 08, 2008     Jun. 19, 2008     May 08, 2008   Apr. 10, 2012 Jan. 05, 2010 Jan. 26, 2009   May 14, 2013 May 25, 2012 Dec. 02, 2010 Jul. 30, 2009   Sep. 02, 2009 Dec. 10, 2009         May 26, 2013 Feb. 22, 2010 Aug. 21, 2009           Dec. 31, 2009   Dec. 02, 2009 May 21, 2012 Jun. 01, 2011 Nov. 19, 2010 Oct. 09, 2009       Nov. 01, 2010                            
Equity issuance date by month and year                   2008-02 2013-05                                                               2013-05       2008-09         2013-05     2008-06 2008-08   2008-09       2014-03 2010-03   2014-03 2010-12   2010-04                                              
Equity issuance, number securities issued for cash   19,000,000           614,286 10,213,474 14,285,716 1,436,277 1,500,000 625,000 1.00                                                                                                                               285,714                          
Equity issuance, price or exercise price per security issued $ 0.20 $ 0.001 $ 1.00 $ 2.00 $ 1.00 $ 1.00 $ 0.80 $ 0.75 $ 0.70 $ 0.035 $ 1.80 $ 0.80 $ 0.80   $ 0.02 $ 0.22 $ 0.22 $ 0.11 $ 0.68 $ 0.68 $ 0.53 $ 0.50 $ 0.14 $ 0.92 $ 0.42 $ 0.01 $ 0.02 $ 0.20 $ 0.31 $ 0.10 $ 0.11 $ 0.19 $ 0.95 $ 0.01 $ 0.31 $ 0.02 $ 0.17 $ 0.40 $ 0.01 $ 1.11 $ 1.55 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.35 $ 0.04 $ 0.04 $ 0.04 $ 0.75 $ 0.04 $ 0.04 $ 0.07 $ 1.00 $ 0.50 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.50 $ 0.04 $ 0.04 $ 0.75 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 2.43 $ 0.49 $ 0.90 $ 1.00 $ 0.25 $ 0.70 $ 0.75 $ 0.20 $ 0.70 $ 0.85 $ 0.80 $ 0.09 $ 1.66 $ 0.78 $ 0.22 $ 0.09 $ 0.76 $ 0.76 $ 1.04 $ 3.05 $ 0.34 $ 1.07
Retirement of options, shares                                                                                                                                                   400,000                                  
Units subscribed                                                                                                                                                               62,500                      
Number of shares entitled by warrants                           5,045,000                                                                                                                                                          
XML 36 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (Parenthetical) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Balance Sheets [Abstract]    
Patents and trademarks, accumulated amoritization $ 52,258 $ 42,129
Debt discount    $ 86,087
Preferred stock, par value per share $ 0.0001 $ 0.0001
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares issued 50,450   
Preferred stock, shares outstanding 50,450   
Common stock, par value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 180,000,000 180,000,000
Common stock, shares issued 116,589,055 111,396,768
Common stock, shares outstanding 116,589,055 111,396,768
XML 37 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
3 Months Ended
Mar. 31, 2014
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 9 - STOCKHOLDERS' EQUITY

During the first quarter of 2013, the Company entered into a private placement for shares of the Company's common stock. The shares were sold at a purchase price of $.75 per share.  Through March 31, 2013, 1,133,334 shares were sold resulting in proceeds of $850,000.  Issuance costs related to this private placement were $60,783.

On April 15, 2013, the Company issued 26,521 restricted shares of the Company's common stock to five members of the Board of Directors that were valued at $49,071.  In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company's common stock. These options were valued at $519,080, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted will be expensed over the three year vesting term.

On May 28, 2013, the Company entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the "Offering"), with each unit being comprised of one (1) share of the Company's common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional    300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company's common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.


During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.

During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,410,342.

During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.

In October 2013, an investor exercised 10,000 warrants to purchase common stock at $0.50 per share, resulting in proceeds of $5,000.

In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock ("Warrantholders"), pursuant to which Warrantholders who were not directors or executive officers of the Company were given the opportunity to immediately exercise all outstanding vested warrants for cash in exchange for (i) the applicable shares of common stock underlying the exercised warrant and (ii) a new two-year warrant, granting rights to acquire an equivalent number of shares of common stock as issued pursuant to the exercised warrant(s), at an exercise price of $1.00 per share (each a "Replacement Warrant"). Pursuant to the offering, the Company received aggregate cash consideration of $2,521,143 from exercised warrants to purchase 5,042,287 shares of Company common stock.

Modification of Warrants Issued in February 2012 Private Placement and Deemed Dividend
Effective February 7, 2014, when the market price of our common stock was $1.18, we entered  an exchange offering  with certain investors in the 2011 to 2012 Private Placements to exercise their current warrants at $0.50 per share and receive a new warrant which would be convertible into the same number of common shares as the original warrant.  The new warrant has an exercise price of $1.00.  Many investors exercised the original warrants and received the new warrants.  The Company has recognized a deemed dividend of $717,594 in the Statement of Operations for the three months ended March 31, 2014, attributable to the incremental fair value resulting from the modification of these warrants.  The fair value of the new warrants was valued using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 143.2%, risk free interest rate of 0.30% and expected option life approximating two years.  The warrants expire two years from the date of issuance.
XML 38 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
3 Months Ended
Mar. 31, 2014
May 01, 2014
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2014  
Entity Registrant Name VIRTUAL PIGGY, INC.  
Entity Central Index Key 0001437283  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2014  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   116,589,055
XML 39 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS
3 Months Ended
Mar. 31, 2014
STOCK OPTIONS AND WARRANTS [Abstract]  
STOCK OPTIONS AND WARRANTS
NOTE 10 - STOCK OPTIONS AND WARRANTS
    
During 2008, the Board of Directors ("Board") of the Company adopted the 2008 Equity Incentive Plan ("2008 Plan") that was approved by the shareholders.  Under the Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company.  The Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended ("Incentive Stock Options").  All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options ("Non-Statutory Stock Options").  As of March 31, 2014, options to purchase 14,023,330 shares of common stock have been issued and are unexercised, and 463,336 shares are available for grants under the 2008 Plan.  Of the options to purchase 14,023,330 shares that have been issued and are unexercised, options to purchase 12,228,330 shares were granted to employees or persons who later became employees and options to purchase 1,795,000 shares were granted to non-employees.

During 2013, the Board adopted the 2013 Equity Incentive Plan ("2013 Plan"), which was approved by stockholders at the 2013 annual meeting of stockholders.  Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant.  The 2013 Plan is intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options.  All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options.  As of March 31, 2014, under the 2013 Plan options to purchase 3,789,166 shares of common stock have been issued and are unexercised, and 1,210,834 shares of common stock remain available for grants under the 2013 Plan.  Of the options to purchase 3,789,166 shares of common stock that have been issued and are unexercised, options to purchase 2,264,166 shares were granted to employees or persons who later became employees and 1,525,000 options to purchase  shares were granted to non-employees.

The 2008 Plan and 2013 Plan are administered by the Board or its compensation committee, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the applicable Plan.

In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

Prior to January 1, 2014, volatility in all instances presented is the Company's estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company.  Beginning January 1, 2014, volatility in all instances presented is the Company's estimate of volatility that is based on the volatility of the Company's stock history.


Employee and Non-Employee Director Grants

In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company's common stock at exercise prices between $0.99 and $1.05 per share.  These options were valued at $62,662 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company's common stock at exercise prices between $1.07 and $1.21 per share.  These options were valued at $199,843 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
            
In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company's common stock at an exercise price of $1.36 per share.  These options were valued at $728 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In April 2013, the Company issued an employee options to purchase 5,000 shares of the Company's common stock at an exercise price of $1.67 per share.  These options were valued at $933 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company's common stock at an exercise price of $1.56 per share.  These options were valued at $74,159, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company's common stock at an exercise price of $2.16 and $2.29 per share.  These options were valued at $26,954, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.


In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company's common stock at exercise prices of $2.40 and $2.92 per share.  The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore   such options have not been valued.  The remaining options were valued at $129,343, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company's common stock at exercise prices of $2.00 and $2.35 per share.  These options were valued at $124,392, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company's common stock at an exercise price of $1.97 per share.  These options were valued at $4,500, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In November 2013, the Company issued an employee options to purchase an aggregate of 10,000 shares of the Company's common stock at an exercise price of $1.04 per share.  These options were valued at $2,613, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In December 2013, the Company issued four employees options to purchase an aggregate of 255,000 shares of the Company's common stock at an exercise price of $1.13 per share.  These options were valued at $65,523, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of 1.51% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In addition, in December 2013, an employee met a milestone relative to options to purchase 50,000 shares of the Company's common stock at an exercise price of $2.40 per share.  These options were valued at $687, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.3%, risk free interest rate of 1.75% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.


In January 2014, the Company issued 11 employees options to purchase an aggregate of 90,000 shares of the Company's common stock at an exercise price of $1.05 per share.  These options were valued at $53,927, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 1.77% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In January 2014, the Company issued two employees options to purchase an aggregate of 35,000 shares of the Company's common stock at an exercise price of $1.05 per share.  These options were valued at $27,806, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 67.7%, risk free interest rate of 3.01% and expected option life of ten years.  The options expire ten years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2014, the Company issued to one of our new board of directors members options to purchase an aggregate of 250,000 shares of the Company's common stock at an exercise price of $1.10 per share.  These options were valued at $264,882, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 128.5%, risk free interest rate of 2.70% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2014, the Company issued two employees options to purchase an aggregate of 20,000 shares of the Company's common stock at an exercise price of $1.18 per share.  These options were valued at $21,048, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 142.1%, risk free interest rate of 1.47% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In February 2014, the Company extended warrants previously granted to two of its executive officers, which included 1,142,588 warrants exercisable at $0.04 per share and 100,000 warrants exercisable at $.75 per share for an additional two years.  The increase in fair value of this term extension was $9,228 which was expensed during the three months ended March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions: no dividend yield, expected volatility of 89.3% to 89.5%, risk free interest rate of 0.33%, and expected warrant life of 2 years.
   
In March 2014, the Company issued to an employee options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of $1.43 per share.  These options were valued at $136,454, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 122.6%, risk free interest rate of 2.73% and expected option life of ten years.  The options expire ten years from the date of issuance.  Options granted are expensed over the two year vesting term.
            

Cumulatively and for the three months ended March 31, 2014 and 2013, the Company expensed $1,533,213, $239,104 and $133,698 relative to employee options/warrants granted.  As of March 31, 2014, there was $1,594,574 of unrecognized compensation expense related to employee non-vested market-based share awards. A summary of stock option/warrant transactions for employees from January 1, 2013 to March 31, 2014 is as follows:

               
Weighted Average
 
   
Option/Warrants
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2012
    17,258,644     $ 0.04 to $1.82     $ 0.48  
                         
Granted
    3,067,500      
0.99 to 2.92
      0.28  
Reclassified to non-employee
    (235,000 )    
0.65 to 2.30
      (0.02 )
Exercised
    (2,816,667 )    
0.04 to 0.75
      (0.01 )
Expired/terminated
    (698,333 )    
0.50 to 2.92
      (0.01 )
                         
Outstanding, December 31, 2013
    16,576,144      
0.04 to 2.40
      0.74  
                         
Granted
    495,000      
1.05 to 1.43
      0.03  
Reclassified from non-employee
    200,000       0.50       0.01  
Exercised
    (100,000 )     0.75       -  
Expired/terminated
    (460,003 )    
0.65 to 2.16
      (0.02 )
                         
Outstanding, March 31, 2014
    16,711,141     $ 0.04 to $2.40     $ 0.74  
                         
Exercisable, March 31, 2014
    11,436,145     $ .04 to $2.30     $ 0.49  
                         
Weighted Average Remaining Life,
                       
  Exercisable, March 31, 2014 (years)
    1.7                  

Non-Employee Grants
 
In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company's common stock at an exercise price of $1.00 per share.  These options were valued at $441 fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement.


In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company's common stock at exercise prices of $0.75 and $1.48 per share.  130,000 of these options vested immediately and were valued at $54,228, fair value.  The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of March 31, 2014. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 22.6%, risk free interest rate of .25% and .25%, and an expected option life of two to five years.  The options expire two to five years from the date of issuance.  The vested options granted, were expensed immediately.  The remaining unvested options will be expensed when it is probable that the milestones will be achieved.

In March 2013, the Company issued to a consultant options to purchase 100,000 shares of the Company's common stock at exercise prices of $1.34 per share.  These options vest over a one year period and were valued at $32,155 fair value. The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.8%, risk free interest rate of .8%, and an expected option life of 5 years.   The options expire five years from the date of issuance.  The options will be expensed over a one year period.

In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $2.04 per share.  These options were valued at $44,603, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $3.05 to $3.28 per share.  These options were valued at $51,869, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years.  The options expire two years from the date of issuance.  Options granted are expensed over the term of the agreement.
 
In May 2013, the Company, as part of the cost of the Company's Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company's common stock at an exercise price of $1.80 per share.  These warrants were valued at $409,749, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years.  The warrants expire three years from the date of issuance.  The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.

In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $.75 to $2.61 per share.  These options were valued at $124,338, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years.  The options expire five years from the date of issuance.  $124,338 was expensed immediately.
 

In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $1.17 per share.  These options were valued at $26,208, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement, which is three years.

In October 2013, the Company issued a consultant options to purchase 20,000 shares of the Company's common stock at an exercise price of $1.06 per share.  These options were valued at $6,132, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2%, risk free interest rate of 1.33% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement, which is six months.

In November 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $1.04 per share.  These options were valued at $26,128, fair value.  The Company used the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of 1.31% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement, which is one year.

On November 18, 2013, Company approved an amendment extending the term of outstanding warrants to purchase in the aggregate 8,931,505 shares of common stock of the Company at an exercise price of $0.50 per share.  These warrants were scheduled to expire at various dates during 2013 and 2014 and were each extended for an additional one year period from the applicable original expiration date, with the new expiration dates ranging from December 20, 2014 to December 28, 2015. The Warrants were originally issued in private placements to accredited investors to raise additional capital during 2011 and 2012.The value of these warrant modifications was $6,540, computed by measuring the warrants immediately before and after such term extension. This was taken as a charge to operations in November 2013.  

In February 2014, the Company completed a private placement offering to holders of its outstanding warrants for the purchase of shares of common stock as described in Note 7.

Cumulatively and for the three months ended March 31, 2014 and March 31, 2013, the Company expensed $1,893,237, $49,447 and $73,163 relative to non-employee options/warrants granted.  As of March 31, 2014, there was $73,163 of unrecognized compensation expense related to such non-vested market-based share awards.


  The following table summarizes non-employee stock options/warrants of the Company from January 1, 2013 to March 31, 2014 as follows:

               
Weighted Average
 
   
Option/Warrant
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2012
    16,531,438      
0.35 to 2.30
      0.63  
                         
Granted
    2,048,750      
0.01 to 3.28
      0.18  
Issued under Private Placement
    1,723,533      
1.80 to 3.00
      0.30  
Reclassified from employee
    235,000      
0.50 to 1.01
      0.01  
Exercised
    (3,005,185 )    
.35 to .50
      -  
Expired/Cancelled
    (1,405,000 )    
0.50 to 1.00
      -  
                         
Outstanding, December 31, 2013
    16,128,536      
0.01 to 3.28
      0.98  
                         
Granted
    50,000       1.13       -  
Issued under Private Placement
    10,087,287       1.00       0.49  
Reclassified to employee
    (200,000 )     0.50       0.01  
Exercised
    (5,092,287 )    
.35 to .50
      -  
Expired/Cancelled
    (410,000 )    
0.60 to 2.30
      -  
                         
Outstanding, March 31, 2014
    20,563,536     $ 0.01 to $3.28     $ 1.11  
                         
Exercisable, March 31, 2014
    18,968,537     $ 0.01 to $3.28     $ 1.08  
                         
Weighted Average Remaining Life,
                       
  Exercisable, March 31, 2014 (years)
    1.7                  
 
XML 40 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Operations (USD $)
3 Months Ended 74 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Statements of Operations [Abstract]      
SALES $ 425 $ 88 $ 8,020
OPERATING EXPENSES      
Sales and marketing 1,197,412 894,647 11,278,549
Product development 885,974 461,385 6,127,836
Integration and customer support 187,039 119,197 1,366,490
General and administrative 1,217,303 1,035,071 12,634,642
Strategic Consulting    176,794 7,019,422
Total operating expenses 3,487,728 2,687,094 38,426,939
NET OPERATING LOSS (3,487,303) (2,687,006) (38,418,919)
OTHER INCOME (EXPENSE)      
Interest income 1,502 3,489 20,888
Interest expense (94,280)    (632,496)
Embedded Derivative Gain Loss On Embedded Derivative Net (2,185,375)    (2,185,375)
Total other income (expense) (2,278,153) 3,489 (2,796,983)
NET LOSS (5,765,456) (2,683,517) (41,215,902)
Less: Deemed dividend distributions (2,366,419)    (2,366,419)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (8,131,875) $ (2,683,517) $ (43,582,321)
BASIC AND DILUTED NET LOSS PER COMMON SHARE $ (0.07) $ (0.03)   
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 114,818,293 101,792,509   
XML 41 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE
3 Months Ended
Mar. 31, 2014
NOTES PAYABLE [Abstract]  
NOTES PAYABLE
NOTE 4 - NOTES PAYABLE

On December 27, 2013, the Company entered into two identical agreements with two stockholders that each include a note payable in the amount of $500,000 and two-year warrants to purchase 37,500 shares of the Company's common stock at $0.01 and two-year warrants to purchase 50,000 shares of the Company's common stock at $1.00 per share. The note payable bears interest at 10% per annum and is payable upon the earlier of:
 
 
a.
5 days after the sale of the Company's securities in one transaction or series of related transactions, which sale results in gross proceeds to the Company of at least $3 million;
 
b.
Upon (i) the sale or other disposition of all or substantially all of the Company's assets or (ii) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is a party other than a transaction or series of transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction continue to retain, as a result of shares in the Company held by such holders prior to such transaction, at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such transaction or series of transactions;
 
c.
February 28, 2014.
 
The warrants were valued at $92,470, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.2%, risk free interest rate of .4% and expected option life of 2 years.  The warrant values were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, Recognition and are being accreted over the term of the note payable for financial statement purposes.  These notes were repaid in full in January 2014 and therefore the remaining unamortized discount was fully accreted.

During the three months ended March 31, 2014 and 2013, $86,087 and $0 of interest was accreted on the notes payable.  
XML 42 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
PATENTS
3 Months Ended
Mar. 31, 2014
PATENTS [Abstract]  
PATENTS
NOTE 3 - PATENTS AND TRADEMARKS

The Company continues to apply for patents and purchased the Oink trademark in November 2013.  Accordingly, costs associated with the registration of the patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years).  The trademark is also being amortized on a straight-line basis over its estimated useful life of 20 years. At March 31, 2014 and December 31, 2013, capitalized patent and trademark costs were $784,152 and $739,657.  Amortization expense for patents and trademarks was $10,129 and $5,265 for the three months ended March 31, 2014 and 2013.
XML 43 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2014
FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]  
Schedule Liabilities Measured at Fair Value on a Recurring Basis
The Company has identified the following liabilities that are measured at fair value on a recurring basis, summarized as follows: 
 
March 31, 2014
 
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Derivative liability related to fair value of beneficial conversion feature
  $ -     $ 3,834,200     $ -     $ 3,834,200  
                                 
Total
  $ -     $ 3,834,200     $ -     $ 3,834,200  
Schedule of Fair Value Measurement s of Derivative Liabilities Using Level 2 Inputs
The following table details the approximate fair value measurements within the fair value hierarchy of the Company's derivative liabilities using Level 2 inputs:
 
   
Total
 
Balance at January 27, 2014
  $ 1,648,825  
Change in fair value of derivative liabilities
    2,185,375  
         
Balance at March 31, 2014
  $ 3,834,200  
Schedule of Market Based Inputs
The shares of Preferred Stock are convertible into shares of the Company's common stock, which did trade in an active securities market, therefore the embedded derivative liability was valued using the following market based inputs:
 
Closing Trading Price of Common Stock
  $ 1.45  
Series A Preferred Stock Effective Conversion Price
    0.69  
Intrinsic value of conversion option per share
  $ 0.76  
XML 44 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES
3 Months Ended
Mar. 31, 2014
OPERATING LEASES [Abstract]  
OPERATING LEASES
NOTE 11 - OPERATING LEASES
 
For the three months ended March 31, 2014 and 2013, total rent expense under leases amounted to $138,843 and $55,648, respectively.  At March 31, 2014, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:

2014
 
$
293,696
 
2015
   
300,194
 
2016
   
200,696
 
   
$
794,586
 
XML 45 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONVERTIBLE PREFERRED STOCK
3 Months Ended
Mar. 31, 2014
CONVERTIBLE PREFERRED STOCK [Abstract]  
CONVERTIBLE PREFERRED STOCK
NOTE 7 - CONVERTIBLE PREFERRED STOCK

In January 2014, the Company, pursuant to a Securities Purchase Agreement (the "Purchase Agreement"), issued to certain private investors 50,450 shares of the Company's Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") at an original issue price of $100 per share (the "Original Issue Price") and warrants to purchase 5,045,000 shares of the Company's common stock (the "Warrants") for an aggregate purchase price of $5,045,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Preferred Stock shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative.  As of December 31, 2013, the Company had incurred and capitalized approximately $131,000 of costs associated with this offering, which were charged to additional paid in capital in January 2014 when the transaction was consummated.

In accordance with FASB ASC 480 and 815, the Preferred Stock has been classified as permanent equity and was valued at $3,396,175, net of the beneficial conversion feature of $1,648,825, at January 27, 2014.
 
The conversion feature of the Preferred Stock is an embedded derivative, which is classified as a liability in accordance with FASB ASC 815 and was valued in accordance with FASB ASC 470 as a beneficial conversion feature at a fair market value of $1,648,825 at January 27, 2014 and $3,834,200 at March 31, 2014. This was classified as an embedded derivative liability and a discount to Preferred Stock.  Since the preferred stock can be converted at any time, the full amount of the discount was accreted and reflected as a deemed distribution.
 
Because the Preferred Stock can be converted at any time, the embedded derivative is classified as a current liability at March 31, 2014.
 
The warrants associated with the Preferred Stock were also classified as equity, in accordance with FASB ASC 480-10-25.  Therefore it is not necessary to bifurcate the warrants from the Preferred Stock.
 
The Preferred Stock has a preference in liquidation that the holders of the Preferred Stock are to be paid out of assets available for distribution prior to holders of common stock. The Preferred Stockholders may cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred Stock can be converted.
 
The conversion price of the Preferred Stock is currently $1.00 per share. There are no arrearages on cumulative dividends.
XML 46 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES
3 Months Ended
Mar. 31, 2014
INCOME TAXES [Abstract]  
INCOME TAXES
NOTE 5 - INCOME TAXES

Income tax expense was $0 for the three months ended March 31, 2014 and 2013.

As of December 31, 2013, the Company had net operating loss carry forwards approximating $39.7 million.

As of January 1, 2014, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2014 related to unrecognized tax benefits.  There has been no change in unrecognized tax benefits during the three months ended March 31, 2014, and there was no accrual for uncertain tax positions as of March 31, 2014.  Tax years from 2010 through 2013 remain subject to examination by major tax jurisdictions.

There is no income tax benefit for the losses for the three months ended March 31, 2014 and 2013, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.
XML 47 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
LITIGATION SETTLEMENT
3 Months Ended
Mar. 31, 2014
LITIGATION SETTLEMENT [Abstract]  
LITIGATION SETTLEMENT
NOTE 6 - LITIGATION SETTLEMENT

The Company entered into a settlement agreement with an investor in 2012, whereby the Company agreed to pay the investor a settlement of $450,000 and the investor agreed to cease trading in the Company's stock and to return warrants issued to the investor.  The Company's insurance carrier agreed to reimburse the Company with respect to this litigation.  Both the settlement payment and the insurance company settlement were completed in 2013.
XML 48 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE OF FINANCIAL INSTRUMENT
3 Months Ended
Mar. 31, 2014
FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS
NOTE 8 - FAIR VALUE OF FINANCIAL INSTRUMENTS
 
Derivative Liabilities
 
For purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity's own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity's own common stock. 
 
The Company has identified the following liabilities that are measured at fair value on a recurring basis, summarized as follows: 
 
March 31, 2014
 
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Derivative liability related to fair value of beneficial conversion feature
  $ -     $ 3,834,200     $ -     $ 3,834,200  
                                 
Total
  $ -     $ 3,834,200     $ -     $ 3,834,200  

The following table details the approximate fair value measurements within the fair value hierarchy of the Company's derivative liabilities using Level 2 inputs:
 
   
Total
 
Balance at January 27, 2014
  $ 1,648,825  
Change in fair value of derivative liabilities
    2,185,375  
         
Balance at March 31, 2014
  $ 3,834,200  

 
 
As of March 31, 2014, the beneficial conversion feature of the Preferred Stock is treated as an embedded derivative liability and changes in the fair value were recognized in earnings.  The shares of Preferred Stock are convertible into shares of the Company's common stock, which did trade in an active securities market, therefore the embedded derivative liability was valued using the following market based inputs:
 
Closing Trading Price of Common Stock
  $ 1.45  
Series A Preferred Stock Effective Conversion Price
    0.69  
Intrinsic value of conversion option per share
  $ 0.76  

The Company has no assets that are measured at fair value on a recurring basis. There were no assets or liabilities measured at fair value on a non-recurring basis as of March 31, 2014 and December 31, 2013.
 
XML 49 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE OF FINANCIAL INSTRUMENTS (Fair Value MeasurementsWithin the Fair Value Hierarchy of the Company's Derivative Liabilities using Level 2 Inputs) (Details) (USD $)
3 Months Ended 74 Months Ended 2 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2014
Level 1 [Member]
Mar. 31, 2014
Level 2 [Member]
Mar. 31, 2014
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Balance at January 27, 2014          $ 1,648,825   
Change in fair value of derivative liabilities (2,185,375)    (2,185,375)   2,185,375  
Balance at March 31, 2014 $ 3,834,200   $ 3,834,200    $ 3,834,200   
Closing Trading Price of Common Stock $ 1.45   $ 1.45      
Series A Preferred Stock Effective Conversion Price $ 0.69          
Intrisic value of conversion option per share $ 0.76   $ 0.76      
XML 50 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2014
SUBSEQUENT EVENTS [Abstract]  
SUBSEQUENT EVENTS
NOTE 13 - SUBSEQUENT EVENTS
 
In April 2014, the Company issued options to purchase 55,000 shares of common stock to various employees at an exercise price of $1.27 per share.

In April 2014, the Company, pursuant to the Purchase Agreement described in Note 7, issued in a private placement to certain accredited investors an additional 58,150 shares of the Series A Preferred Stock at an original issue price of $100 per share and warrants to purchase 5,815,000 shares of the Company's common stock for an aggregate purchase price of $5,815,000. Pursuant to the Purchase Agreement, the Company also granted piggyback registration rights to the holders of the Series A Preferred Stock and Warrants. The Purchase Agreement provides that the holders of the Series A Preferred Shares shall be entitled to nominate two directors of the Company. Dividends accrue at a rate of 8% and are cumulative.  

In April 2014, the Company entered into an agreement with a consulting firm to provide strategic consulting services.  In connection with that agreement, the Company issued 300,000 restricted shares of common stock and an option to purchase 500,000 shares of the Company's common stock at $1.27 per share, which will vest subject to meeting certain milestones.

On April 10, 2014, the Company was named in a law suit in superior court for the State of California from a former employee alleging wrongful termination and is asking for damages and legal fees to be paid. The Company intends to vigorously dispute the claims made by the former employee, while pursuing reasonable efforts to achieve a resolution of this matter.  At this time it is not possible for us to provide any opinion as to any ultimate outcome or any definitive estimate of the amount of loss, if any, although we do not believe that any outcome will be significant to the Company's financial condition.
XML 51 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]    
Estimated useful life of patents 20 years  
Advertising costs $ 53,628 $ 222,847
Research and development expenses 852,744 454,378
Property, Plant and Equipment [Line Items]    
Depreciation $ 8,389 $ 5,875
Minimum [Member]
   
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Maximum [Member]
   
Property, Plant and Equipment [Line Items]    
Useful life 7 years  
XML 52 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS (Details) (Consultant and Beneficial Owner [Member], USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Consultant and Beneficial Owner [Member]
   
Related Party Transaction [Line Items]    
Related party expenses    $ 25,000
Reimbursable business expenses 2,946 23,566
Monthly payment for consulting services per agreement   $ 12,500
Consulting agreement term 1 year  
XML 53 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Comprehensive Loss (USD $)
3 Months Ended 74 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Statements of Comprehensive Loss [Abstract]      
NET LOSS $ (5,765,456) $ (2,683,517) $ (41,215,902)
OTHER COMPREHENSIVE LOSS      
Foreign Currency Translation Adjustments, net of tax (17,580)    (19,435)
TOTAL OTHER COMPREHENSIVE LOSS, net of tax (17,580)    (19,435)
COMPREHENSIVE LOSS $ (5,783,036) $ (2,683,517) $ (41,235,337)
XML 54 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
MANAGEMENT PLANS
3 Months Ended
Mar. 31, 2014
MANAGEMENT PLANS [Abstract]  
MANAGEMENT PLANS
NOTE 2 - MANAGEMENT PLANS

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  The Company has incurred significant losses and experienced negative cash flow from operations during the development stage.  These conditions raise substantial doubt about the Company's ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Since inception, the Company has focused on developing and implementing its business plan.  The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months.   The Company currently needs to generate revenue in order to sustain its operations.  In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities.  The issuance of additional equity would result in dilution to existing shareholders.  If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would likely be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

The Company's current monetization model is to derive a percentage of all revenues generated by online merchants using the Oink service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month.  As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.

If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained.  For the three months ended March 31, 2014, and for the year ended December 31, 2013, the Company raised $7.5 million net of stock issuance costs of $0.2 million, and $8.3 million net of stock issuance costs of $0.4 million, respectively, through private placements of its equity securities and from exercises of warrants. Additionally, in April 2014, the Company raised an additional $5.8 million through a private placements of its equity securities.

The Company is in the development stage at March 31, 2014.  Successful completion of the Company's development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company's cost structure.  However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.
ZIP 55 0001214659-14-003468-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-14-003468-xbrl.zip M4$L#!!0````(`,.`K$1FQ/<3:PD!``T[$P`1`!P`=G!I9RTR,#$T,#,S,2YX M;6Q55`D``ZXI<5.N*7%3=7@+``$$)0X```0Y`0``[%WK=]I(LO]^S[G_0R\W MLR=SCL%Z(N%,9I=@.\NN8WMM9V=RO^R1I09Z1DB,'MCL7[]5W1)(((3`@(V= M,Y/$5K^J?EU=7=6/ZI_^\CATR9@&(?.]CS6Y(=4(]6S?85[_8^WK;;U]V^EV M:R2,+,^Q7-^C'VN>7_O+S__[/S_]J5[O!-2*J$/N)^3VK//UYNQ75^[/>_4?JS7D^RCP'=B&_+['E$D6:M+>EV6R5])ZT0Q2/N+R/AX'[@$ MR/+"$ZCJ]X^U012-3HZ/'QX>&IC6\(/^L2))ZC$FWULAK279QR/6SV4?LR"* M+1<^]R<-VQ\>8ZN2JLII":R/E;3`/.3LT;1(SPKO>NU2?,^5C+?6DTI9;1D&;_U8CM M>Q%]C&ZP[E[@#^M"KF3\/_*3WU1`8J$LE/ZY9[DA_>EXH>D919TX"/`C"VW+ M_4:MX,QS3D'F.7'+$K=.9[TN*Y`F*%W6ZHSH4]^.A],LUS1@OG,.WT).]=+4 MK9/]SX3BI2TN(QFY6D;P-&WKY&)R$<'3%A?)%;QD9:(P92>DBN0\P;E6%\F] M@W&9HQ(_;)TX6:K_,T\6-C.CYLR+6#3IP/?`0Q__02>\V\NW?;P=60,.K..*S(LQV6=I+LC6:AMY M/9T7)7DA.Q:(/29RA[SV&G&HS8:@QC[6$'FYJ9LM2==SC)60-,\ES-XTZ(#L M]/T@VR6Y[UOOD+9M4ZB?FQ*\I2SYN:;GZ;VA?19"MWG1I36D&8+S"5NG^%_= MF[NO[0MRW?W\^=L1Z5YV&EF:\ZT+HI/)^028]6,O"J^MB77OTK;GP)<@ILX% ML^[!>(H8#1,5+V;`ZOF!5*V*@*EB.EG(GA.PK[>G<]*ER%JK:8+&V8"5?6)@ M2A4PF/5N/OL*#&2]U=1,WLCYB-AAFIW$IE.QZ5 MFJQK6J[CMT+U80"[2]6@-26YN4=@KZ(!F#3^$.H>P/AC8]KU;'](+_PP//<# MROJ>4$7VY`Z,B-#E[;2=W^(PPHI!55WU[JS'>8RW5>^.Y;@NF[I>"/>V&#AD MY'-;C6AKIMZ5BH\9F$@V]@=,,PI@[^C?5T_#":MU+6KP`]"'.S&5MJ M9:&#WZ8NB?FB9NQ=8@<&ZV;63JD%_#:P`S'9S"8J%[P79!/M6/(VM"A+1>^- MH)?(WOIVYVK9>R%VYQYD;P.K?:7LO0'T0%(JV?;EHK:6;=_4\WN:3V#@96&I MRQ7])"4G>,K,S)/7Q5(Q7RN62D4LYU>NIE@JZV*IMG1%6=.K.`PP0:%5`[-4 M(ZX%IFQ(4U MS\\KEZ=*I^:J"+[F67DE@J43]TS\`:KJRLFX+>PNHKS M[R;KTN73[UM!#O_:,G2+5;X^[`RC"8SR1620E/44G\S!PAJDHCK*U)\J[VP2 M'M,@8B'S^CSUVG>9/;D#7CZY4#Y!K#3/UF]!_-F-/ORI7C^]ZMQ]NSXC>/N1 M7'_]=-'MD%K]^/@7M7-\?'IW2G[]V]V7"P*V#.%'QQ(0CH_/+FND0,+N;L1- M2AD+)S_6HTS)AA,Y-5*O_[D??4`:'#;&'TGR,PFCB4L_UDZ[M]<7[6\GY!ZY M_T#NSGZ]JWU<_;7[H7 M\.V.#6E(+ND#N?&'EI>DWG;__^R$R-!6^N'NVP5\P6YG=O+ME[/NY[\!1?>^ MZWP@7]HWG[N7]8NS4) M"*E#`Y=Y=`G?)",LA$L+LGM<$7\*4Z6$VUQ;6`$E5!QE=X@%VL.S\:BB MTRC(^T`A\SM=/6HJ)K$\A[Q3%.7(U`S2\P,2#2C\"2@E0Q@9@Y!0@-$A7ZS` M'A!5/N+7EGDQM#+Y#]@X-.C&F)%Y)+1<0`-3AE;P.XVPZ82XL+&`,8C>F>?D M!6\A4_I+5J^4CO2EJB-W"V#A\SX-15V%#BADJ/@>PSH\K/99-SYZEO>X%`4$ M9PTF7.@HJ ME=15>K=&4]5L;U:B?O?@B%T:8`,9TO4F[BO+K0TE>VE-I?:`VFR]5GGXZ M,$MJ*@'&4.6F^D)Q2;MY27B(99%8U2=;H>&HK:DB7M!8*1 M'3)/$8V%.LI$PVRIBFJ\0#3,JFBL$(UUT-!:FO94+#(7MZYZI_0^.F4AOPIZ M'=`ABX=)U)$5N?9YZ4&733VWI+:*N)UQ_%PW7)^-X4.[TI#CZ9QYD"OU$`J8 MSF?8IT@;)AB,RSHX3]:6.3RTBSI/Y?>@);CK0:X^P[`*84@+.9[/(OP8M:6K M#465Y5)9+O>$"NHHW7S3-7F91,\3N7V>01@K\EPJSNOQ#(:^TGI&GLU-^SDG MTNOQK"O+I^(5+&=82UG8:;26EB;+9M:0KDC4+B^MZDU`76M6(2H7-B3[9=>Q M3UJ&V6PMX%8<&V0EI3N^`=PRC04P"RD%ZYB%5[TD[`G,$&+%L&@7H5K6[YL) MKW$S`7>K6&^RR7X"%QOB]PC8SR'PS97B2]I3R/.V0/_=@)*>L)\L%P.>1I3O MV_$%_I'@2:SP6S`R`@?M%_+`H@$YGY::C1ERRR.F!DY(/OGP3W%2QW=8C]D< M*O*^=MZ^_43:MYW:CZ0EZWQ#PJ%CZOHBH@K0U*>$8H0QAGL)UG#TP;L/1Q]F M/R$32-YP9'D3;"OVK-AA2'@A;P-K3,D]I1YR.`)."QG\VKAMD#[U:&"Y[@23 MZ0BKM&8\C0(&E8]PZP/)9H!5P(:91ID'WX>"4]PP[Y M",80Y/EN8I<2<#I4%*T;VH]%X`ER6_^UP4$-,(Z=.SG"RB;$\8GG1^F&#`%Z ML9QH)T]`S_%E'DH_%Q4BMDNP`>@Q):_>KP# M;A'V$+J9#PIL)%49V0:+1G81$;Q//K?;UZ6U%96L_9B1G&QACC[*CDNCXK'0 M(%W!DC]B'@()V,+H!+'$Y",.MS7;\B;O84H`K<"A@JP>=H`+>./V''ZS,%0: M3&<_$IX1-`S@Y%&;AJ$53#@]%NE9+$@'H.B^F=2F&V^-Y<,W'/BQ"WU+H5V+ M]PFT]5OL<8F;B6'QT`'#[!TQQ#B2_Z>V/H2D[7G`"HCH"&Q"C'#< M2^3X'].=Q0FU@F1'\128'-[3(-U45''?LL=P#V)6][ MR,*0ZPS,5[L]`Y71(%=PW01@)V,H MK3<:6!%T_`11Q;U-FRN8U5QJ6]L`K6:DY&V@CA4.VIZ#_V",IK'E8B>WHXX5 M!*@L_V6Y<1+8MTI.-"SGC+42]SHU]I(%%&FA](X\ZATPK5^YZ-LQM(05UR_\M8;RXP#[7?BN"44SHGC'9UX:'HN+.N780 MF.SK<$U=;K6TEKE23SP!E(+%CTHYOZ]]?%_[R*T=H+AP&YW_D!&<`UK_`+>; MC.)@Y(>4+^,$W)'A!R>1J9[K/X1'6=]GZK.%W._CN1+7&#(^#!CX%ZE;$<;W MOX&70"*?NS=.8#UP1Q!(@VGC83J^/"(HDQ^P/OAQ+O@F4>HZ0<&61!QKPIL`3SU$*L!QX02CQXO_TEF? M;57##^H/H[!$Y#>DU8$5G4?B25+%ZOTE!4$6&WE!T M4Y=GY_S*[;UF795$,:FX8%:A_QOZY=\/2:-9[:[4?H;,V>EN`^J?&3@\&MG4 M#'':#:``-V?)N%46Z8APVC M@<=US5;586PF^/$#:44%JP]C_;"!X_I/A,+90/\M%GPSP+4:&HP_J2)PLI1( M'![T*RSX5H#3FIE#CX"$JE90>+F5I9+B;P1$`V/>R)HLL%!62Y]25PQ13"HN MN(;9(K\"X.1-@5LH6'V&/6A#Q<#1)FN*4DG?:;A.IIBBF%1<\(T!IVX*W$+! M-P(I:WHK39A9?XGH"HDLJJ0ZHH>\K/MY([ENM3Y-*F.;?4Z]N@;+SZ!*'/39@6BU7EYP>#NW&,N?%]2,0U% M?]7X&KJ>QA[&`".*;,)?RHHY2^->(1:5EA=^@L%:L`Z94K@!TZ44L`A2+9BX2O#])G\1*6/#VM M@3%AOAVP]^(_%$,MO79-@3`!(&IE39%%M[#@2DWQVJTO0U+]MV*.,AE>1A]E"-HN;R^@RW;&F[;N<[++KAJ5O:F6LKWM^7TSCN4B6I>P M.)57N2*+<\^!*Z:I9"_1[[%CEB5+76('@4T`'U0C:F7<_VA_221E>].^LQI7U9^C[O M2-8U65%U-1OXLX2RK;*XKRN/==TPU?Q5[SUQN+<+C$K35'5Y2WVX/%Y3U`+BS>9:XB]GP7[R>2-((2410)0[5D+C'FF&6AI<*&(5*'(+?41EA MD#D8AD`W\U"-3B^II]?/42\B62&__MT3E/&(5JB`'>*R(8N*(^AM3V\MU3#S MJBKD^[A)N/ITBS?_<9_.AVIJ2K.EYGRJ/#4;,K`OUT+53,-0S*W3O[=GA9JF M(64CT);3C['K0=I@7&%(./%31)TNCZN(,ML>XJ"0.5]5,^]3X!2II6:6'*J2 MN"<4#BQB_,YP.+!(\GG6K@(1&`2_+@>@(-=>QX&1/S6UDKB=<7S0,O\DS@]0 MRD^GGF5^76A)VG?_YMG]F^V]^+E@UE]>W9T1C=3Y#[?DNOVM_>GB;!V_9"D^ M]P$Y7C!XG\/+X12V+[J?+U=Z.5?>+`:M8HA(N_D@5AC56X2]CGP2/?@P=##" MM@V>C-4/:!((6,3DA=00-Q8&T&\8]HJOTU`+G*%IO&D>+IB,K(EU[])T><;B M^@5=D7>@X8]`R?,85E!?G0?+36^'8F"J41S8`XS-IQI'D)F(':8T`.]BV&&; M[W<(NM`G>P=C4JY0O2[H6+MZO%9-,.`6+RGB+N=XOH-A=/L\<@7($$QET$NOW=R0`)6XCAFB"ZHL#;-%W$<F'#!5!-6*=LFQD MS%443)?^:-J.]L-4A2P&.J_,:5$D\WGTIX',^6^1\Q2JU0PV5<5O@>B=BY^U MN,[Z1+Z;K8-@7!<1_:P>J!FN/O#9Y>5J+)R%4@>=C`O>W)*P1!!X'V0?%YF2 MN(@R@(?5\"X?LU.+;A,'L%L;8$:?*>2(7-= MJ*Q@\2C38\=1D!F2WX?=RY2^^[_9@9Y:T8-E_Q&Q69W9PW4-MGFB9OXC"OPRI MY?%!C#G6&N$\,BD?X]E&^+;?"'R"2<(D6'P>?%I:=:Y*YF6J3&W&A(VQSW?2 M,GIICC\_>[QI.*0.`YH!PE'`\)T%L$1CK#E#B,TO`L44$P.*Z^)'^*B$E2@L M;""Q]O)O6)`!=?G;)[S&E,ZE[1S-E)H.AEU"=N1'8#$G7(W\!\`JH+-7<^XG M%;D.1'O@L8X9WU9).G<9'&("6,!B::=4U[['W"Y;Z?!\-^V^SS$[4;7V6YUC MSNE]$./S/XJY[-&8)X[9@_0A7QC1Z/=/%Q9`W5,4.;Q;A8L$+>5(,Z0C\703 M_WY$XA!U-RK[3ZYE_UZ_M6&J004]XAH;YAN;GZ#Q'>KBO).>::&\3!\;JCOX MZZS2=/805:"5/GW-B9\'XD],A6$\%.DGQ//!3!GC"H]#)@RFO:/9\T5C'P^Q MN'RRZ1&,-?'#$0EPC[^'CR=-%S0"I`%R-+0?^%K&M(*$$9?U>+K"'T):_DQ; M`I[@)($P"BBW3/BT[23O4:=N18[E^66FA3?ITH-0IJK75:FNZ$<+;YM5?6KL M1IPWFK[G-]7%R#Y>6[VGZ6->E`,Q3GPR0&Q82#`^%57PX-8T_OPRT$*:/,?% MT<(7ZQ@_`]6+73RB0/YN>4)S\">M<`T,C#:*)Y62YZN&R6F!V+/$TZU`[A3G M!WR"*TY><..L+&J>\ID_@U_9:BHYU.74TSA(!W&%)\4`?['>^LYL'DFFP;^\ MDU`BIJ,),9\)CC<5E>D"X4X/:2S9(EG<8YGMB":;I/C*[R?JT1Y#$9YM*YU3 M?'F`3C=@UBVXS_U&#`-G*GH>CG4)?F:L]G6FY#5@=8![FWN6):T\0$HEB2JH MH_2PE:HI\YO^!R57QG_9^]KGMG$D[^]7=?\#SINYRE11$M]%9393Y=C.K/=) M[)3CV>P^7ZYH$;*X2Y%:DK+']]\NDU<'8;NUD/Q,&.:K5\PSY= MEDH/DM[FM>CV6ON5^/UK"&9U?*4\WHO(/+DT:L#"::3Q^RH$NDXBH&TA9-Q5 M\P94@YB^81ZS&>34Q6,+ZF@Q-H)@07]D:X1O77JR-F&#Q6EWGDM7Q=_[WTR? M3L#$WQ]3>?*E,`YIY:2GAQ)_21QMP.,0XKF5:`O78'(BN=;%.1-,6:1S8)CP M0=FXI+G!9Y84^V&'TUN7I2T7IK-V'$`LLGT?)PQJ\EKA5TV7\TIRYXDJL?%: M5%D^MZV*;FMZ0_C^G'$FX*1H.?F4/C%Q+P'GMK577-`]`>NY1>5W%[!>?+A6 MEH#EM2-2.B/@I5IKAG:H@'/;JHA@?=A!`2]1IXT,\5@(WFRKHH"-+IJ()>I& MZNA0&YS;5D4!CSJ-8"*4H]G@S;8J"ECJHH`3U-'C,X_EIFVU55'`6A?=M+10 MCC7(;;55U4WKLA=!A:(>4<#J/B9"Z;B`]B'1P<"B" M<]NJ).#UHP,[)V!ZOM>Q0N6MMJK:X"X.?9`[`P'K1Q2POH^;UC$O8DO`PR,*>+B/@(V. M"WAT1`&/]A"PVL5`(R64X[EIFVU5G3*JQ8M@>QDOHRV)DO>NA-99>UM1]9$ZJDJH3QXU4U.]JPNG7,EK*,8ZQ4LJ=B3X5.7@-&,]TJM" M,/GL8`9^U[J,%K=D,Y)WXTG7H8N&NIZQ+:>O9M9/MJS7_T_=/^-%@S^CB[OKM&/RX>'R[O'[S7NW:J;OZ5MTO]FU3:Q+Z/D!>G_!+E[\O%EZP+2\.:L*0:[1%M#-OQ=T,^@MJ^-+ MZZ!_UW6G::W4J;$K;* M3JR.DPR]:/=KLLUUK8S78DZ_RAHMYK51T&NM=!>Y*2I),R&^KB_$Y2SP;.YX M;YA5\;!B$9%[!/J=WDYKOB^\)[4%4P7O5;ZPQ M1;;>RN- M##TJJS&+*'U_L0((.W4&W4>-7_RXE+8&RP4T&`TG%(;J]EI;!3DLFQ5C. MN]EC%BU>QQYXHFVXO>@Y>[E5F2K#';E.5XTO6,'N2@PP<*WO]10RL4FNB[(B M*$HN*EG1<7:F@1T=S)GL*%ZX.`[.+(%=5'7:D)XT1.\Q7TS;66XG?HYVHF>( M,I.+^[6=XR5D1^-4N]&@1"LE/3_[^#DNF+#S&)4`54B-37YJ3,H= M3I;R.,Z8DC16R?3N9?27W7=TF0)5$P M%#6OJ:B20_D0$-.[ZQ!0RLJ!(P(9$'0UW?XQ!@1)T"(_,.N560*`,6*_LCQ0!R%$-YX5I_-FB8E]M8D]>5IV6F3UW06K4]<#@4%G(,>=2?B0EAE9'PLI_B*D/TR)[H0#`2Y`=!5)B0 MEGU+>H-529J9_K]PN%XY:,V.Q157K'B(7E9:0N\)7"6IJ+GET6,!C@X$BY`6 M53J,*CFQLCN,KF4[Z3I^,0EK8?C/`)MUNK\E=1B3VD;+<3E5L(H.A4YT2!/= M8D:K-R:5%^T@I]PF5>U9W.^IIJ)3ZP(4^70Q/M9K8T6NWWSQ1-2=V3/3M9,H MR61'Y"&:5:7E&9-2F[9K+:@K62TE\`D_VRZKT\0/TSEUA2/'AAW5]U8(W7K+ M[#=:M+_N3.5-DJ6B0QCU:9<7DK0>^HVY?JV1V+$/<[M=*WVF;(:!S#G%]O,T MI,YJRK?,<$TWHS99W^^@@/7ABZ@6#E_IV]^)_=$HJ@1&ET^ECA+(K_F6T+E9 M9E"7!5V74P4!2T^56P1Q(,]]#<)$7K+25Z)"@[+>EPI*$B8/](=&='_?&!57 M*)Q0SZ.X2&$B>=($4;74$]$!?&G?P8ZW;6?'6AO!+QTF<'2:6;I>(*LIQ\ZL M6'J>Q,-LT*XVK]>K:JAYBCWQ%OZ.2CT\ME(351XF2BU+!RFU-!H)AJIT7*OE MOA9KM;:K5AMGJ-4-ZV'EN=)C?VJ/B(BIBA*'N7;*=%/SC9E)L7W..Z*M;D7* M[V@AB8.LT%`VNFF!HMK&6DEMXZ%^AD8FVW5HJ3)>$M`Y^RNCMI=_D*>,^O`@ M91PI'74'0!G/QH\_4!_EK:G3PS12.W!X5`5)&PG=U4J-1-V@E9W7RJ]F06!- MS_O<+:[6CCELRGU)CV)JN2^/#E)761=&FMIA=55H.,T60I;JK:&R._N&!OK; MYEF'.G+H"QQZRNYEFBZR!*B;68"276X,E1JA9BLB(WI\R$S:;,[/L ML1F?OI$L/QMCGYX?1X^L)*UX+H[FI*.C5(I3%NPHMN0%;(5,-$V-W=@@Y1*\ M.ITE-S4HCP1%53IMQ_3(CNEE=DSJBPJ[5>JKYY@1[)KMN5P\DWL*K`^3V8[V M1SJF_1&7]DMI^/;W&XQ(]W6,%C'S45!TM)WK82C9-T.0N*VOI<;I2 M7P-E;;^RTK/HJ>SH3I)-S4T/IS-,=&F57XH6BM/N(E#-G(\^YM#*0_(\=P&ZFCE*2]*.8_3HR.[T85DK31%&MK`SH\<126^LLNZ M@`;`+B'O*2EX92T+7LV8"U[OA'5N5'R8FTV+)!A&AR>*)-DH6_TI]X7"G5K,05;!03YHW\31-VYQ7=NAV"X0+J/J M3Z^F'U4VFOOXQ?86@?.6KM=##0<%0T@Q@\<+ED:+BV@%26&9J*X+C<(%`F1! M,XQ5L[$U8)5;J":+:S-/46VA>/EY[C/]8 M#R_))(IVZ)95\@F5AOTV/ M+`;E.TG0%$60Z0WO9&4D2*(:E[\@E_61L3:?N6DJ!TLO*D;\#L4XV2K\R/LA M-(Q401NJ]+Z%Z^.Q]^RR4J]K-09CHI>EN-($T5*/5)W(Y:BV6US*-7;\6!W! M/KI$Q`C-J)/JK=>,31A!["P!O/EITA"`T?;QX\L+0FRV?T-6?EOQ5=V0VZ-O#:1J$5@7J)*Z) M$W^BQW/0?G'IR5$$_*^^.?]X$?W/`^4950X9)@ODS2$7``X`Q]F!8R=7:(OP MPUTA6D@6^WF>T(^H^)^%+HDW;3[C[>"T_]3[=/S[>?_V`Y/D?N?QQ MX@/L03D?"A6_]=/]P_7-PY+N)YHQI]2CP'-L*Y^'UNL=.RNTJO>0T;WKL\=M M4T5`;GN1R\Y`!^`"<`&X+0+NNO.#GIY)5WK^QXL_C<<83R87:1D4N#PH_FE] M`J3!+B\Z#>1^=8*0L-IA&$\DR65(*.C;32'PH=B[P),?JC>:V1DQ::Y]FKO, M97L4L2T-!5DS!%U5NQGF5()N)"D.2*T!!56P_XXC0+)%E*%'5RL9,F"R>5(! MDP23JM%-*.8Y0J]3.\15W:"FF>`]7=IJCV1G9>&/[+8I)>`9\`QXYEK$?%(- M>(;L44W9H]^B%=>0)N*"ZI-'0(H@ZD-:O[:;&MVNB+RZ7-M"^J@*Z4V;1T9) MGGUDIS/3`PCZH])<^KDH#)CZ-IIZL2]#LJLC7ML#'CMF$-@3.]K`1O>M)5O, MP)7C@NJ3Z_=[.:HZQT>J/\M&_`SN&5^D=\$]T[7(/5-$<,_`?+?8?(M]L6!> MG#O;?8[)LF0;`:3+^*"Z`1]+,"1=T/5ABS05O"SPL@[ULJ*U6V)_J(&7!0:\ MQ0:<0%EJD>VNGMK:EF.W@ MZO0V0A\9@J(H]9F)6O;=9/E]A\&?&\?JP#U=+7`=#^.P"QZF)NXXS=JYS6LP M7,%PQ9]+>YJQZDC91`Y@T@8,MU/S8$4LX!GPS!79@.?&15]SQK$_ M[*B5AR08J!L$6=RI)>`9\`QXYEK$?%(->(8D&!3MZ+S*GSP"4D/#(P+@[C8X:>>,6K"V[01MT5KY-H/V_+)@4(WCS)7YO53F.W&WGQL< MHN["<5D=HW-C"]C0SH*VUTW$[I)?VF/3;0M]):B<`5N1:W?(5)TZ9%`Y@S.KZ8^G24D-=<^8LD@\+0N\""O(\A9/#NY4Y)5F MJXF"'4-)$B2U8#5&!J2ZFJ:HJ"VM2+K5A:LJZO:.$UJKKD5B)3G>+6MR@!IT M">E[9I1=IO'834-5M]3?MA!6YFI@-(GWGRT6#GUM9X?62\WA%>'W)< M`7;AQTWDH3YYCI7GD-YY;N\F/A@B.NTKJ)&LNGQICBC^YR(([&RR:^/<;T MT7=2GS0UQW[47#\K0'F<8O)(0L@K]C'59$9IB-ZIJH0FINU'U_(:6/*X",AS ME.!/U/_M?1]//8=RP5IG=-%,]LRSL$-Y'IO.>.&8(6;//%.`]BSZ=?7*1`(Q M@0(Q*^&479EXCN.]TO9,(ME9]/L'8FL0`8AM8==";S9V+($(9H['-*G^XI&7 MV8X=OM%F9:6O_"002QS\"TU\HB&V&Q+V@Q#YE`9R1W]H_$0D:ZU:B#EQ[`F[ M86*_8,2BN%S1))+%K'1FZHGH[!;*B16_CB+$=,?98KZ/VWF.#NU#I#\962X5 MN?="^I@V10MS)B(SGPE3,^R&_>8L6Z-VL@;UCB+X7.4.7[V4>@>9^BT)DB+N MI>/K"LX>?$>K13.($EU7C1)=3UXS;#EDW0Z+RQ-C>M@:8* MLFP(52P";9'J9LR".MBL!Q)*DI1D3HJY<&K(4`G-;6F%IX6ZT^DJ@A9Y2 M[;U.L8OL,,*8]T1]/4(VP3*E?86KY8/F>&KC%VPU:#+Y-W)>N1,3'ZEP%!,G M]15U)R>&@B(:$DUB3B+(T@9LS\HT:XHL2)J6MFHMMAY:WRBQ&4:II5@)5HOT M/3-:6X]`LB*RS+Y:C\V.Z2*EV]JR!-EX.&L]OR38=0Z(5/95\NQ81:8[(PZ+ M501=5"IY)^U4;;VOE:BVSF^\4C#.G[$*?C4+4@65H@EY+5]`O.4H]".QWW/< M3?N-O*3;GBE86:^_4^+#D,D'N2S**-9231(,?=1A+57ZTD^LDCH159GW/F)W M]A6I6&TI$'9VV'E.,NRL26-,A=>U9&&F]@LTH)V;?IB(>.P%8;X>WT\FQ),A M>+5P,/;M)VI<773GD=X>"DM+0AZ=$^5A/47ZC/[[:OHL([QF3F1C*,C$%SY6 M^M&HEGYR[(I%Z9#4&\S]([-N1V: MSEE[!G]=.(>Z!NON>5VN`4U`1AN:=>D@ST"254%1JJ47V^H:&)&JZV6)/:FO M:.Q6J:_KW/CT21<1M0\.]^5WU+%C#OU=,Q;?\3S$LR>B?+Q$\U)?&AYD#61= MD,4N&P.9Q`EE-J!DO&_']&,R:6,'ZP[*&>OK_3CT#M-6^;C**NH'*:LN2(K< M75U5Q+)0GNBJTC%=#>P_B/S=<'K>JGI'!,;9R'I@GIR,K%+%6?Q6:JNL5?"N M2S)NK=/69%ZKP[I:>/)(2E$E0XB5-8&O.9_[Y%ZLS3+)39%MQM"&,%$G0Q'36;$V5UQ4^7[/%OK9/NBP83[&U<**9^1B-Y!TO MIF][BX"!D/R[8$E"*I=H;0G=@+2<#,\R657B^_6S3FQD))E,G^NZ4:M,%O!N_;F03KO$XL;;Q)BG"T^IBU+-:-#__ M8TT*R>N=I5VVF65ZH5VTS'VRKC3'8[K>B*UX8BM(/)]=]TW:'RFVXSQ42GA2 M(CRYSQ:UI$S9JE^H(;0G=#U39'])L$P\)$TE+!%UZ M;@\GR^MC=V"PF1'/U+'+C"6+C"`?1^8B?ANY:>'2;/JS:_\OH8[BD-`9F<^8 MYHBDR/HS\T#)BM?%S4S_7SCL/9F4-08Q9!("K29=^N[@L70/2]::J**%4"O7 ME^U*(=TY(SU(>CY8QUKL5FPB;L//8`-JLA\A1CT%R:9J!/%[@P^GZ\9-$:?V MBD><[[$KZ`*-L>,$NCZMG9]TX4ZBE<,;=99VQJK.H*D]1(MK0(8 M?Q2U&_)1GG$09TVZ"GC`4=TXBBL:==9D`H(`074-NCD5->2,8BQ-,]%6:C,+ M<1&24>`YMK6-G59KTG>6-:ZH1QG]6*6."V?*!;AL`2Z_T3E-@"7`$F#)DRMR M'C7T[U=SKL)J[4`\WR&7=7_K3J]L9X&\TY=#U05-H>=/&L<1)6^:SGMQ\2Y( MH6 M%0]NLU+RCN#['3-9OT1)R2%EQ0?7)PQU9$%5# M&&IB-S6Z79%Z=;FVA?0,UVN;]*;-(Z,D/[4E2C2U18L20FJ+,]2!K=\MM25U M=&+B**FM5KEMM]'^XX5K89_..;/MHM^2[:+@S7%!]>DG((6AK`B:TM$,=KL& M)_#F^//F6+58YLV),%')&^K`UN_FS2D=#=K/,0WW@,>.&03VQ,9QZ9MD)S[X MBFBK=K8`)/CC]/CA4R8\6K10D\.;EDWRE,J/)!]XQ:[:;2$M36XHB73':?<7=M#*/S:@N(-V;OY%^WAZO2N MH"2H8DD2[U"B]MQ"OKM_>)@"<..`[5F2H$4NYF$5U MELH&41;@&5)>`-ZN@!>,,=_"Y@W/YYCR@@)P/&G/R<,=381=IA"FMP^W4E^" M*C<T%9[C/$^JO@7IG#$K$F3*&@FP,NZGG,#1U&+M]"`-X(!50N]ML MG3KJ)FK/,1>U5@4M]*`&VIEK]WM9+$E/02D-@.,)!QLX)X,'4@&U4%[L/--. M4%[LS)7YO2:(([DXPP0^$:PO[]CZ#:BUUN8*J M5'-R#(J+U8`4*"[68C]4[.NLN)B<'+X#Q<5@N(+A"HJ+U9"8;)H)V-QS(JIA MV)!'5+B41UVJ1?37]\30I1*;N&7H6B:=E\1EA M!5G>XLG!G0K0TFR=/$*314'3E>(R9QF0:G>H=G;:BI!P5:0SH5JD*B`1`7DZT`-0`TV:O>< M$_HA7\=GB,(GU1`/`IX!SXV3#7AN7,1\4@UXYBY?UY6N1:'QQ0[3+-6T!-^"&\G\$N1U*+!&+2" M/WR!5G#/2]NT(NVW#D+JFJV^IOVPJF[F(Z/NCE#WD#-XLPL_;B*?\LESK/H\ MSTTF_JO7NW&MS[[Y3,_YZO42X:][G/&7/P\60>_9-.4%8?!]:OKXDQE@ZYOY1EL/'@F]GZB$?OW/_T#HSUF- MK1Y*-WOI^Z;[S(XB"SZ];35\^6KZUK)Q9%ND1X[;9E\71\.^N/IS@<8$/^3G M!SSY>#$AN.M1I[TG2O1OZ,7?E)XB;3U+GOXUEOWU_=7C/[[=H&DX<]"WWS]] MN;U"%[W!X(=R-1AL7)/5%]$C(#6Q*N>D,!C=W%^AB&H;S#X/! MZ^MK_U7I>_[SX/%A\`=M2Z(/QQ][8>K)OA5:%VC5SQ4!G8FKF(?OH>F'ZP@Z MLG[LK`S_7`2A/7G+TX=+%"QF,]-_0]Z$D$@QX\VI?`:DT^GQP8B)S!S3:P&: M>/[RY!;RC?0U^JOI+NCS4:RFT"5;&]&;'2"3/NHXWFOP81?CD2OK)Q\-2DW1 MIDU(A=G4E.UE4`G8L>,$YZ='"UBY]=7 MYX?P?4]`:+W>L;1H5>^AXWWQY7'2X`N`!<`"X/P#W'31UK=9&O M\1C/GK"?3"3)94AH73V5=J[8./WZO*$@:X:@JVHWPYQ*T.5M=2I'11N:*$VB MLM(D4M^0`9/-DPJ8))A4"^J$M!F*4!($/)+J5+=HN6B;E1+P#'@&/',M8CZI M!CQ#]JBF[-%O='T'MB!-Q`75)X^`%$'4AX(FBMW4Z'9%Y-7EVA;2NW#"_6@4 MG7`_*LVEGXO"@*EOHZD7"TM"MQFT1TEVM\!CQPP">V)CBUHGUW-[R18S M<.6XH/KD^OU>5C1!+/+D3IGJS[(1/X-[QA?I77#/="URSQ01W#,PWRTVWV)? M+)@7Y\YVGV.R+-E&`.DR/JANP,<2#$D7=+V@^!EWF@I>%GA9AWI9T=HML3_4 MP,L"`]YB`TY/2&N1[:Z>VMIS=U_+_*^Y[6-K$&)_9KMFA7G+_;:Q<*KCQ7M: M.E7;-L75Z6V$/C($15'J,Q.U[+O)\OL.@S\WCM6!>[I:X#H>QF$7/$Q-W'&: MM7.;UV"X@N&*/Y?V-&/5D;*)',"D#1ANI^;!BEC`,^"9*[(!SXV+F$^J`<^P M\NWTU2Z4LM"Q=3%4.RW!Z:M=Z((VU`4)JEUP3BKO>;@.)]BB*5RYK\)".;#U M+;;U8G_842L/23!0-PBRN%-+P#/@&?#,M8CYI!KP#$DP*-K1>94_>02DCDHV M>K99FR'5!:FNPU)=4E]D>T*EOEHZ(7`N"@.&OHV&7NR+!:N0VPS:<]P]NE:T M@QT##64[0,=E401GC@^/"("[V^"DG3-JP=JV$[1%:^7;#-KSRX)!-8XS5^;W M4IGOQ-U^;G"(N@O'976,SHTM8$,["]I>-Q&[2WYICTVW+?25H'(&;$6NW2%3 M=>J00>4,WCPXJ)S1V=G.505<2=_?ID/EC/:`&8:K=I3<;;9R!IST"3$E+$D% M/`.>.20;\-RXB/FD&O#^="-4C70:(BI0.K;)T"V3K0@C/5 M`K&OCLX(_9"NXS-"X9-J"`FY+;\5##'BMZ_8=,/?B[SZ#N! M7XJD%@W&H!7\X0NT@GM>VJ85:;]U$%+7;/4U[8?]5Z]WXUJ???-YAMVPUTOH M7G?6XB]_'BR"WK-ISC]FCS^9`;:NO-DNWRU?2M1^)T?J(^[:__^1\(_3EI_,;T:38P^(;]Y#E[ M?.E:U[:SH'E#V_IX47)/7Q='>E]<_;E`?P3V!]=V/EZ$_@)?H#&1''G]`YY\ MO*`G3/1D431ZHMR3Y%[H]:CSVA.5GB)M-44;6[AV].COWZ__9X[]_PDH$>0E M,\<-/I!7?;R8AN'\PV#P^OK:?U7ZGO\\(&^0!G__^N7[>(IG9L]VZ4;B,7EJ M4`O_PW62,QBF+$KT[Q;#PZH,6WALSTPG^'@A7_S:([<.5R`IH;$6IHURII4U MII45T\;>3"M'8OJ;Y]CCMZ5:9#*]<<^Q>_K7V"I,U^OM?'K]^H2=(H4>BZ8%-E=YT!H.;NPN4`?['A\$? MM"V)/AQ_[(6I)_M6:%V@E05*&Z""8#@S3(UY^!Z:?KANVW:*K1^92;XC)ODA M)V*)+CS^XPNY8H=D=!C'UW[<1,'UD^=8>X3@_UP$H3UYB]F[OKFZ?[A\O+TG M`]'"M;`?15?9$?H7+P@0`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`MM5`FYCD>J M)LD,-;7,!UC#D&QL8HBVL*M#<'P@10<4?\?^BSW&V8GQ.\]]P0&)N5D*/'CT M0M-)_W[E!>&=%_X#$ZK'WK-K_V^2_:RK]6205$=R7]%&NWJN6X\5N6#:2-6& M:EKB-3'5J9[1#&F?GMEZK*!GAHJD*Z?O%Q)[AF^W0;"@]N>:A*9QT+I]G;`U M%/LJ^9?Q)&N&2FV&JA;8"F(NU37CJ?84,6JHH*E?DWNEM&G8IN@05C0YU3^J M.%24"KRL#03$U6!]35H2"]J*F)&DGF34QHPZ)#(<$J.[?&V9FQ2S0;XE;*C4 M!H[U$S`[)X M#`:V6CD)`T9U!DH@E,T`>%29@7(= MR&*@[G&`2(_XD(9R<`]DM1(SH/?DVB%T.`-9K<0,#$D<43>$JC!0#J$,!J+; M1+EN,UJ)@5(SFL6`3$=BN=[HK"H#Q7%9#@,*94"JT1>*=&!X%!W8;&5IA>0: M([)190;*=2"#`?J0W)-KU`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`9:JT`+G49=I[`7*#,[E*E2F.(PFG24C[)B9;L5GN?T MM@=#Z8B#H;2/WCEL\NT9T"F-',11. MAAPNAF;"ILWHL5P,U:/'%HEATS85F M3AE$'ZP4[13#UDAQQ`2;M$\N(;]NR4E'BE(Q[#!2[".&9I+L6R;RB`FVO<2@ M-C-2;)K(0]%PJ!A&30V8-!"JLF*L/)S:;\584VN"XQ5CE9SVVRCM9FRE64&<9KE;T^EXE*K9ZO5TE*C:= M7>6(:1%EG]"GF4GU32_O8#'DME5QZ:3>R#3JD%E^M=)\@9+>"!-]8P(8QI9_ MNQ6NMS_%K%==)EW,>KN62<>L5UI)5LKZOBO)FAGT8M8KK1HM97W?!;.-6/ZA M1F?GC6%?DXBMTF3)(/_(!>RK:T>Y#:J>(N:<5["H ML_PYY]5JZBRUFEI+KE==)-_0KI`Z"Y1ROB&FSM*FK6"]GJ*H?'MUZJ@R MZ\5FKGVLCX;562^H!:R7F?EX3:P7E/-8LY] M^#JK'7-=>S#.V"I5X_;"C.UV*U4M?#.K-#8RMFKIJN[J&5MUGU7=2G.K-%)9 MUH/%D-M650>WB10&S;YHHJP<)XN3VU*Y".B1RXVX^)1R55()I:I&>NQ0$>0W MQ7,F:SC4R?B5I.!V\W>EZ%1STH*8U0;'7;^^8&UC_#YHP=I66Q4[OZ&ES>F5 M6L<00VY;%<6@-3^52?18DX\T,&ZU575$:'Y@/(88S>DI[\'-'W,\#K'U-\\Q0]LA+3V8(69"J7X[M?0R@:A.++RDYQQU MOQ)-I"LITW6*O[J\=_?+M!TW#FH&^_?_IR>X4N>H/! M#^5J,+A^O$9__\OCUR^(:`5Z]$TWL"G#IC,8W-Q=H(MI&,X_#`:OKZ_]5Z7O M^<^#QX?!'[0MB3X?N`_G;YY?<;=/\9?;Z]N[R[NKW\@F[OOC\^_/Z5//6=[4J(_>SXBUG;N!>3%WH38W!#[,]NUW6?T.L7A%/MHC/W0M%UD MNT'H+ZAV!XB,.^3>I`L"-"'MF.,Q'8GHHZ&/S9#>*2#2!+KR9G/3?2-W.8[W M&K!KJ;N#T'0MT[?(=3-$<]][L2W2YO/"MNA`QQK/(LQT$69#8L^QW7]A"TUL MESQ@FTZ*5@&1I_'L"5L6O8/012RZ@.R`W&/A/\BUT&,M$5K"-]:)?U)&OQ!I MO+J$,FKTT2.A=TFD.9\[!&K18X0G'V/V&Z4LBX`@BX`@XG5J$OQ2:8S)2&Z2 MP-65>8*0$+Y%76#F]DC=,^FGLA9P M70W0F6#;AFF.]FW!MAMJ]9@"_=2D9Y91<4]LBK8ICO6`=I^SLEVK3IMAD[H= M!&HAFA!W!+U0?P21CC&1C\<+WZ>//IF!'0B(N#\ST[?_E]X>)!KVH4U]MVGR M+Y8WA>:3@Y/;LH>8I(]#UL+D?A3ZGW^ZJ.5O/?;Y?7U[=UOO4_WCX_W7S\@>?['!>T10N_'BR4P,#/;SNOD+?L$.DO;OWW7KQZ!=T.-9`N(#`0#= M=D)7!N@"=-L)706@"]!M&W0?O=!TSA6X@W0``__'B3^,QQI/)186.:EW&-#7Q MF"3OWY"/'3.,II+2"?L)>L(NGMAL?F;LN2_8#VS/32:!ROSK`B!L2HP/+&\T MLW-'[:(+]/7O3D.*;S]/\VD91;3TNJGB`,-VP5`1#$459%$$.#9.*<`1K"(' ME`(,NVX5\_SPUZD=XJI>>--,\!YI[H$3/JFNI#'\D=TVI00\`YX!SUR+F$^J M`<^`9\!SXV2W#<^[).-S5FZH75K:?,@2EB)!\!OA9ZY6(JP@RUL\.7CK/4VF M`$Y*ZZ&IJ@QXM'N%$R`?D+]3=@PT`#2@PQH`MA^0?Y[(/T?;GXZ4!FR/Z>KK MH84PGGPTV+FU-5Z;V:V\VI(<;;JU<&C:3KQ5?S[WO3_L&2T7DUK>%&]3CG:< MO]KAU':CWZ%BI5"2"U[=S:7D]%-T,O`DI+O/F+]/)\$08? M=I%I,^4=>-W+G*.F_ M(7E8;9-_ZQQ`COR[D[MODJ"KAF#(VGFI[O;"ECUVFK9.J:^FION,:?V>]47F M_\?>M?>VC23YK\(;Y(!=0/;R_0BP`RB.$_@NB;2Q,[?SUX*F6C9W*5+#AQW/ MI[^N;CXEBB(ILD7:!!8[,=5LUJ^ZNJJ[NKJJ?`G5TO5]Y&[N0'5`]47=YG-\ M'*B8JQMQ)NC*3-(JU,TKOPW<>OEP;AA#7V9/Q]W#9O98IF7MI4&5MW-T2X/< M>K^3E%Z3*WAR!4^NX#.X@D>9E98\.'O&XMZS63:2TSVNEAN2!.8!3;U+DX%"EM&A1 M06F[K9,10;S#L@[_7?JV1>;[%9T49%I-/MS7X,,5XEMWPJ4\^6]; M^&_'-K5OL07"WYOO&J,3EPN[H8,3HU M=..&ONT&MI6=(.5V&!XIIL1MD4^7Z9,#:7(@U5/W1!95YY?B!.LZM#UW(N=3L$MLN=P(7Z0C\@"5X&? M/)4N![J=_Z^+BVMW52RTMJ^DXS]**N:5U;4[4"3OAG@\%%N MW+7G;TRP%G<@^P?*Z+7K8RJT=U*AO3&Z0B<_XN1'G/R(DQ]Q\B-.?L3)CSCY M$2<_XN1''(42FOR(DQ]Q\B-.?L3>_8BG>G[:N6(.^(9RW7R-?7`+]WOB;?L` MSK8#'J$F;TY^H)/\0`.\:#Z5Q1[Y5?(66X71Y8Z;RF*_B2J74UGL271'+;I3 M6>Q)=$Z4UGLTBW!5%5FJE\Z1HF>A&,2CDDX)N&8A&,X;'T% MPC&5Q9[*8K_YH+2I`.PDAL,1PU=>`'82QW&)XZ05ST_I)(:O72M.9;&'N5\; M)M53WLY)GB=Y/CO9DSR?G<7#I'J2YTF>)WD^.]ECD^>I+/94%GNZC-6+J^K5 M7<2:)'^2_+>=#W^:`=,,F'3_)/EO7?+?HNYG=0V]R?WO`Y?/%^M/MFNZ$$!T MXP:A'Y$BU$O/L:V7XF7SJI;3Y?)S7BZG#^Y^_X*?V'A/:EOQLQ,+R13OH'^\ MOEI\G]_=+/"$C-P5\JG^*-\;@]1POR5!:JG@<#G)V1/T4:1CS>5$7*>H[`P5 MR#V>=B'`-BW+B^"9CRQD/X$>F&4/M^8+N7T.*5/Q0Q\R'J*?6^0&*)B5)DF$ MEL^FC\4US$(#27)7SL*/7^#2?AH8V/[CA2KUX2/"(YF+.;Q'EAD%2=T<&W+2 M>'[(;2#@D&BBRQTM^=;S]\89$[A/\]L/W/SVBM-%?L:5FZ?B'"ZS0;F)%:M\ M*G8D\6Z6C[9@GV9TF+=;![)`V"%$D9J.D^0!AA]+TT3<(Y)Q,TT6@=OY:(M' M&_]!8\%V\<L06\ MN*(0:0TESTW+-V4)+\)''\%\"-&#!\G=WC<1FU'6#.N(:$G=N0$\2/$Y!8IE.>77H:A':#(+[G%OEC98;F-"CM!D5ZS_VH8KGKA1/;.[:F#N%\ M26D].WS$3VE&ZH)%VF3F$3]VG`!J^M&IX]%NL,5`>*66=(T'D8XA;A=@NK#5 ML6"IA:WESD?S7>./VWCP0?OY""_'!CJZIVXUJW9_.UM+V[5#O#5]0JL;-S3= M!\@R/B=&86Y9T28B-UGF&[R.L/\D6=+H/K/Q:WCC**N'-YUF<.&M89\I70@B MW6<6F\,+$?XH:?WC]N,O>*UMX56O$T#^IE]E41"-'"<:TW<^MNA\#;9DV^]B M\R-L4411T9FPY1O6ET=8@)OT+`6:9*B*5@LO)J9[;'T.I:;+@B)VC>U'@-:1 M\\5>HR,(LX;4!209BG0I2H)P@A-IOX]?ER+_>QV,&3F](^W04=8ANB6>J5BG M?_:](-@%E/^-3J$CHW5HWI6\UF[VY2GJ`I)>2EN=Z=80TN%)5P')\Q%>`%Q% MOH]PK[@`_@X@T=NZ6%>!?N+ M_;;+[+8S=$=-1#Y6)GAG@E_Z9/^$?^5UWZ%?>UY"*9HHY5>,A\CH"DN?2R9= M,G2A,9;/INU^P4\7[D<[V'I4*RW6=&E%\%2V`%5:,3ZQ&N;U"UZ$$=I3PTT& MZT)0#3EGGBH)ZQQEE\:F$J4N\,:Y0.I%,G\&]GO7=O[^"]Y4HW+,4@&SE&'6 MJS'_W#AN\!Y_X.\E1A-+C/"W?W[]'^/*?C;#F+D8I7H8`F? MKS9XL8(W_^0XZIH>%U',U6U8"K`@JI*L%D2XFKA>T+(29$$4-(F7S@M6/PZV MK007P?*2PFM"2[`WKN5MT)WY,SLF*RZ3JQI,*^&SKX1;K'H;)-3_MKB[YA3N M@KOY=K7X>LW=S?]Y?5NUI"WMNQ;;N$&=:C?@$9T@7&C^3&(%2+7&=SPY`81E M,CU\W>"9\0@N<8A?*"D0>[0F[!OD[9P4W]PKG3O+U^/D'LT5YZ(PV:1`>0=8 M$)/@#QB#9]-?Y<,WH,4[R;C4N(WM..`;GKA>PO7_,=W(Q!R,9;2$YQXV2SZR MO`>7U,&`&4`3;X7!+(FA\7PH_>"\%%^'(JEP'IB^#?56D0_G3GC.X$ED.B0* M8A61FAMDCN22?1W\;#[*)OT7+?,,]4#N$7*!;.O1=!](@=:#/26?KC5_*=J0 MEI.."U-#^!#>1:_)2;2%_-"$8SK\A63Q6UXKNAP!?NT%F7[`@4F%=CP0Y44/ MCV0^8-YLH/L@NO\WLLC9'/II8MM/3TS(0>N_01GA?OZ-<04KFVZC)\G?+K?=1G6P7 M:Z+2FJ)JO5]BB6ID6_L40;QA^A#/_@*ZXF]C'KMF*,C<;".RW''QML5Q M7N@*!VWP1V$7L[+7N#_D0JSN/0J?82=`XM=2_(@`,[B#_@`%&7KTMQ8Q33'Z\L\5??)&A>M2FDI M\:O8`5UOPRXJOJJ!V>RC-9[!Y*]D54M9Q&V=B(0"XZ5U1%^-=WZYS5W<%#.S MC/R=$3_W[NS4U7?E.2ENA0^-.X\OQBPIL\&C3&_%Y*[8)9:TQ:M, M#T`,03=TK<"3%B0/@&/,3@,511(,^15PC-5)S(7$"YINL.+8]_0*VQ'^9`W9 M'CGJ2AU69-3U#)S5Q!D:;E;BK^O=POZ(B*MT`7[57"1!G88LY5R254.NG/3[ M]/4,G9FDB[HN"8."SDS8#9[O%OB-&T0^K+AO41@Z="=R=,97OS1.1RD;OC!; M1LF26&D/JDD]$W>8+9DTA:^>2*>QA\R_K/DA7;+;C*7]D$5-K;2V!UNEX6GT?W(N5:-EWQ=@=\QY#8KZAKL;VE^ANEI$^G>DK8HW)P]' MFQYM-YW.G?UT[L23N*KTT23B5.(NN.7\#O]RR\V_?>3NOL\_7N-._[1;C^1T"`!T'@6?9)*@($DS$84H/<8!Y%J>4$/)H M/B$:96W*4^V<B@`,(\>`W$"+\[C5)<*DLTBI2(B]X8Q,6N2:RGY_"4W M#\M"OTH"6/,28H(FGQ3I.,F:IHY8.63Y20G)KM MRD;ZC8`&*@O\3!`-VKDR$U6ED\#EUD=51PU`M67)WQS.\C4>;359E;-;E1YB M/G*6IE'`QS(W7>[2Z7)N<]$R]`."02$IG!T$4:9M4@W^`V;"BKL-2;C!,M-% M*7!NL5[;%N+^@A>$R[O%+W^=D;!1O"3%K[T$(=I03GU%X:.W(MKC-^1CZI(S M]OD#3;[H\]V0&]@AQKK7)5MUK%$K\; M7)Y&>L>`PVDM?A%ZG4=@D!S; MG'$??/-/VYEQ5Z9KKDQ"X'7D>UM$I9E0%@_>E9?>U\:#B,SP!0_=\NKNEW+S M>%7/N)-0"/2`^02!$FZ:[)*]N:=1+\0TYB.G24A):HK[,DA[EF//')%[#,6- M>N$92Z>+*HFR47"Z%$AI13LK#XHABSK?+>FC\_%1!+G@ZNP!4]^=;.C[(P%4 M-"28E>SH@B%U0O#H)`;KRQ`4'(WY2N#$V,I_9"I)O%Z,$R@GJ2-4S"Z<*[S( M#!0[GVXQEJD6*+SD`L%NZO_HZFY@T^>?XO\)TB6N_"O'-/>Q(BZG&7"U/L>!)I0R9\O8CN[ZY\C(5/<7."EYQ/O9B,$C3!8OT%X4T!.G2:<;35Y'4ZN]>I[[,, M0>`NN,7R&GQ/WSYS7Z[GM]4I-%A[DJH0##,Q=A7%GUK>,FR7`!U'+&!#_'%)>+J!Z>0#[>R@N36 M5Z-J#Z<=F^6/M"P$:\1J+2E:2.KT`OBM^_XJENB>VCEZ!I0.N1!>==R1$0^`THK MSPT!*:'DH/P9TDPUU%26#]QHH':$&D'A^)ABOQ0@= MT@!E:X@#M3W%BA*P8]0/1Y5["SX,;=B/E)<5T_*R;PC1"'61B'51C=7(*Q#8 M^BN5%H6J2[74,(3Y3=3;;H3HW!/RI(W0B?P8H8K2#'FFZ&U5U)C$O><2X4?] M\;M._@?3^6J&(?*AX,05";M^0*YEHV#7T5^CY>3L?_7.?I6[X+[;A)+R(0XE-*XB_E M&I/P2WCNH)`6GN[T'D`MC;JCKK,4.O@-$B0`)[FX@^L_(DA31S3UD48]WQX4 M#5D0]-Q5R6/T]`.QUU*8*K95LMH!Q/Q=R/W'/8^4Q*N28I2/5.F]SB:$]\I_ M&9.>C[%K0'A:V#9;&^V"*&E"*10%R;@4C"Q6IAZLDM>J1D4793&?,**:LKZ` MZCL4M[AQ6])+'U$W74$6=P>I%>2]7H8+N;?Y*>E2>Q'^:EJ/>%?EOV!-"MIS M"T8UBZ(Z_'//VE(W>#&7".HP'=W!Z7.,#$E5Y.9POJ'PR@P>EW"%:856'UY^ M!%!R-JX1[C[,(42$*F)ZA1<_6V2E%0'R:5TPS7LF*;R@RKF4FJ?1/D!6L@H? M5V5#,33]%7.265HVR1`%MB))`^-/8F3-+MA6O.1E0]:,HZRL2?L`60BB;=LS\F:73"=WJ(NB;*J'K4\)*_,[J-XW+%%^2*S^@VFM`MR+HA M&'Q'="O\<;J%`MU"2G?QW>/S0<2+L*[XK0C'Z18+=(L9W4(C?HN\9&AB9X2+ MS1502KC8B'"\$<.K-;$CPMD9=%D0,>U\9X2S*S.AJ8JL="4I#$V5JDO*SE[S M!%6H70J\KETJ@FIDWZ^=K?N`.2KIL@>/:RT#U0Y=I=4:##JC';IJVS84=$HI M*37055K`P:`36J*KM).#02>V1%=I3(>"SFBI,ZL-UU#0804N"K*@=&P2ROH\ METUHB:_2*`P'G]$27[59&`P^I9R64PW#^H?1@&/J,EON/V81#XE'):NK`/P\`GM,5W MU#X,`Y_8%M]1^S`(?$9;_7GC\S+LFAFIEW7`]0,RE63NEY@[_5XM@5V&VS5.G@@ MV(Q6V([HYF%@4\HH.7F!/1!L0CMLU;I\(-C$=MBJ5?PPL!GM].01S<\&^]0]ITUO;N)6P90LG)#*T1VE':FJ8;946JX?7(QA:K&?#VZ@[^R MO?BE&:JAYV_8'"*K,VS,#+@H:KJ@,,5VGF)$Y5I;XWFU#1*:X_)3%$8^^FJ[]B;:+&E>M^!CA(KHJMN6 MS*LN M&\;$;_7,%@FKUWP6ML;T-6?*=U+?&Z_]%^M/=F"9#O13FSFE;_*'A^&]C0\?ET:(=IV8$$NTY:DYUBR/[N>3&K*YJ6 M=Q/FOMR$Q#XU@B!(@L`+=6F$7;:/\(X^L)\076)\\GQD/[ATC8UWO."-,BUP M1\W=%?G+(3D6YBMP*(!*P4*W6-^9/Y>>3WX(0]^^CT+J%%R:Z1*>Z1>3LY"& MT[/EY7%=V14+5CC?VJ`RS-ZD*3H_C2JKJ;I_L-?YN>L-[TE'O]/T M/>/T'>UU\SD%Z[>Q/B,]!+$VQB;_5C@DP?G6'AQKZ,#_H_V M_*H3G.V1R$4+&$G@FEYRIYEI0V8#D/54'4=$G=$YY2PCK& MR&I^Z+IB:/)9(+(ZF9150=+WU6E=B)^1BW]T\E%W)<]9RJ4@J:IL["JU(CTG M`6%V,JYKO&3TAX.5A`F"(1A:4QRWR'&PR,7ML##.5QO;M8,01/$)[>&KUS[+ M'J-=RHI\RC"6=5)=/W)75]8CF2EO]-J\J12-IKR1%+4+YB01,GCY3ZJ0WJ9% M3^DI?L7O3%6N4HR;J""K'-]B3>[HW`1!!&L(T-9%@&4-F)VG0W"(S)=#+".L M6XSLUC^*+N6C(!E"9&:!-%Y0E;-`9#4755[+7ZE@BE`45$$&77FBKBWII4_$ M=][<^B.R?;P5PUN8!QOOMW*14D=;L9RC>'\B"\(^V(/$]8:8U9159%64AP"8 MU00V!$TN45%M`9<6#"U'7=J4I72+`M2+KL!>2B$#!C`3=D%3JF;WN?"SDGU1 MU%7M1/P^6B/?1[2Z^]RR?`3.M,7Z.UJAS1;^#16-X5XE94+]]DPW_:JLZV)> M#]2GDRE#F"W=QL*0D;EGB^@^VE#;SEU]-T.T1#[JIK"7RJ\ M"&%Q$!LG"CK^/[%:..2"<,@7$D_[J>@I9<0V\E%>4L1??L4-]$-B4DYVOQS1 MU$N9QHUA',TFBD`$`7K@R_I@QX6EZ2_\6[CDOB)%X?%;MX^F7\:'0TV[O@GQ MKRWR_Q5`SWGD,D'.Y^\;U".O?_2=7K)@B)XT".91^.CY]I]H58+Z_]E[UN;& M;22_7]7]!YQO4C531>5T5=/7K)L`93U&=V&`^%OQ%MN:,;5> MOW7W__OK:;T?>[IQO2 M)>?DZN[[_]X\/'V]O+TA]P\W7VX>'FZNR>/3W=7_%#5GRGU5*2J20S7&VC7) MOCKDOPTG-+Q7WOM)2;=A4@@XO9C:#4C@$H,\4C/T^.W;Y#[TS(GA4S(8>Y1O M.Y&/^.39\@]GGQ3"A-V`64SJ!09SR,QCS^`B$>8\4S]P/9_HJ@+:@`A%@5VI M\AM"/5(/`1B0JW`:VGQ?#T;!+%Z`"3N2R#[APA^#E?WV[!,Q`F(X!$S[F(%$ M"0@1*I/BNS\T515[7PEPHDGNXL'1,]8)$YQ#^B&>$%V(L+8#7&0-(Q$BUYPQS>Y%T-7)MDT7"JY27) MK#(!;>R2,;X,R#-CX_'KT``PX%W1SBE`!IA/!';X9-3H+\9GD>1(D!C\!GG* M!0%[@V&$%'4%*S$KT-"VR9`2>)H%MF`GQYW"B@!)@A>76,RC)N>E+*$;)([& M?.Q.!F::KS[Q\$$8VON%@XP+;29,U>#+XPS]V7_-/XEV:=?4I-,A,$?4,:V= MI2=V.&..&7+8<6+3F/$>=NCX&C-`_"?#_F?V*[`93($,`K.:?!?(\'W79!@\ MD!<63&!BAN\$2H`%5,C+A)D3T7L-".J-!14,RXHL`YD9#-\>OQ,_IN4;)J"B MU5HPKV\%[D46=/QPBG!9R_W5WKV.Q*9VGH6>EEB6+X/'2S)XO"):3^5KW&OJ M2B[;`ML#TP+131O6EHT8,H&/N@6`1T&@_PQ9\!II$9\\8\QH(8-^:"OM?D=I M=F%FAP8Q4P^I0T>,M\0SN=[S<0E'U,"V'T)W*1VMI_1:\!Q,DRQ_5[3W*US= MBE$^)8/U`1H57O[*Y/$'B#?H=M0GE@5?@@9$PP@**!9V&)!E'8/8S!@R&[F& M%;`FL.0B5Q4-U[JJF+V8P;CF'!G,(U/#^P>P)9\ZRW=Y;,=!`9;NM34%@A@< MDFT[B98"<.6Z*(MO+GE21.#*&[1_E%`&A;A`Y%Q=_LB0!KS'93):&&`3WCB, MUS`0PHB*/0!6$D(^"L$4&5/^NFA=D]A`;1PO*@] M!N)*D=PST)?4-$*?Y@K@^M7.X[X>N%/>`L\LIK+)2K#%[ZGE3/6_IN?KE"=OD@NL.O!(@NSAN`&;><`O)/GO1F1@:#(`<`/-@/>L$1<5#9XP=@"EYP* M!]T-N=TP1'V,$7=3YY%>VC!@@(>-F-WT_.E@L9$'=3QV:KR"=O,%@$[(0Q9X M_AF;JB*#@X&/`KKYCR_P,$W%JYG(E#DP7G@E^-1\U#J=*GGWL#YGDA=8X7%& MIHI'H(UTIH/S$VI$T=P;=!(U/&.,J^RD@F-@TBB@WEDO[A4YVZ*D+]]>RTGX M\N_WF:G?5VG`.H3VV4-N9=D'?_D2U*C&HGKZ=,/FW%_VW*"OU5+["QOQRS!L MB\!>&WKV5#U]85PI!,`NW//>_`\T]ES,A?/)U]0W/<:K9R+<-GM([I<?&S6?"TS.ID)WYS1-H4J-6_(`] M>(?/5"3W/)H*'QCN*P`IXTLTII'KAVE9UX$OIQ@<)B$)SXZ`B^ECC=#&Z8`W M7-/R9@N]F?I8U%BN2:GE?P&M$1\8N!NE;@^*5-2:40>ME6YW^QV]ERZ-7P?> MWG!>T,/;7JBV?[]F9Y@?[%#`4C70#M9ZH30LB2-%G:MCQ=MD!>0H.\4A)8,7 M;JPG5EG0*TC)@QU'.'E*UJY8.Q]A7JYP;QOB?JA"VF2''O0,;:]=2HLMPKA_ M$AQ&H)`$7;V:)!#E]NM)L+I4OS0)]%XU2:!VFXT6.%1ZR0.L>D8+Z((;NGB1 M;^XL1^U.4^]6CR)'.]+;6VPHL"5!TE=U+9$@_>,A_93N:MN:!FE'6-78 M1]\(SQI;]`=JXW[@O>$%K]=TN"RLBP,.>B"QJR'#YO/K(F`[QK'&O/LF?&O, MP]S)ON,I%O_F)_5,YB=G,M:,.FBO$TU;J7QS@=L;QH>*Y0JLS6$1?K?,'?F7 MG9WXETNS%/9=V]G:1[%S/'(Y#%\<<$BAUK26IFG]?$07`=LQCH<2XY:N@2O= M/@J.-9;;/4B2O6E-M:ZUCK'$7]$I?Z_5+XMS- MX-R+=!3*;.XLA>YE2U^AHO:,<:^AJ=U6R55NJIDTF!IAC.R<.TMAG]GKYCW+Y.9P;S MTHG9=>-DV9,L>\J4#MVZSOC\ECU#("KZ`=:H[.DI=3"5XE$M(^!G;BF6++G/ MU(O/JK@C(+=/;,35YKA&U>E%)R#:'94D(J40+E0*+Z>:][8[R\#@T6=&7_+> M@\52;"ZL>%"5`GP`M:B\\O#$JX.ER%A'Q3PSG`HCAE]8+#I($97CFWB3-/:Y MF!_2PA/4^"9>%H^',88I&MBT@=5M"P19!A+KHJ?4\$,LIQZ^XJD?1,QCONO$ M]=9%[PY<,N+WLV-A_H2,;!=H0<$0\?-AHDQLS-M7!^(%."%_5$$^C#;EL;IWP7R\ M+O:&*3=8>@'2"\A8TIAQLN:M1JY`!@$Z;U/KBP)G?O`5FU`TR#6=@;)GXH@; MX^U)9B&."'W4YOSL%[`8]@0Y1Y*!,0!+9!$TG^+$+`#"6TG`$W04V@2-J)_5 M[0J>4G),-C-L&TV(1_D1.1_M/7FEA@=6ZYN!MLWAGH/!`,U]'A,.[2B6O,$X]QSJ)G%7`D]/[;^H:>T>WUQ4E]7>ET] MKF"/EF<*"G`"_HJ#;\Z>;.8/)<7T"Q`*C\86>&6NY."^CX-9L[U;^@7]7M*$ M_,'Y]Y:-:+'UF(\3RK_=[K4:6KNC;V$^EN?X[;[]9PE4Y\#L'WLL%^?X M[;Z[)9;/#+,^7USOV@V'`8P:1+(5H[=RP$$WTUK=3"OV`K!VC&']LI+;X5NS M;37L>@T#("K-;RHLD%X[ZK!G93H=K9ERW]="MS>4#[9/7!V4:\??\X*LU#V[ M44*>;U:EOO9_L&"2?B2BRU9S-%9>ZK:M,EQ_C]DIT?!(E[]E=W:WQ*,487V\ M@`#<[]"CV83"!N-E3N'H.84M\P?;;9(N?DX>9V\'1S3>X'#T]_ MDJ>'P??'P16F&1ZKE"XHPJ4Z35#*0GP=>G%N8EVPVE9XWM[!X!K[I+HO#CXZ MQ5Y-P<1PB/[+0@=1'AWSSCT8$$>/\L0V1+0@&,_43B)9W@)6-#?E69*`CID) M82_N.;K?$MUX>%_8N*?JO&/H'#ML(PC#HRQ] M@H\;VA9@]!HE+1):?&BV%#WJ",,I2(8`O\,)M`"5Z$L+"^1-^;EXA_*T32Y2 MV&8X=&B"C0"1;\=SVN(D(A^2>AS[^L:$'E&:6H%2JRQZ>WUH16UQ'RB;#D// MYT<?Z:)T,43.'@Y@X##LDL M=TVD*F\M=Y6IV[-*HQ5LT M#HAC[<(>GZ*>&#C6-06%X/(T5KJFJG#$(5>UI[>ZFI9>U`+`=H[EX2Y5UMK= MWNZQ%*GF];B*<3(J.'I4L(>=QI15W;#'DF`8[D.D6(;PVW7KXC<4M4SOME7N M%\W1M%)H1AMH7K(U9(F>]7%'_5SW\J%XMC?L8@G?$=2@`GI0N(2@+110%SO; MJ2JA&A9U#G:PHM:-X:$_[@_F.XS7O&-W;#77#=MS?J]UJ;H/J,W5"^B"JJU"3YI6MK!TEK8BT(FDKPMF%I/BE2J9C M\PLW4G;J[-/!%9[-"+1]A_&[)>A;5/XA",& MES#BN]L`R#6%DV$$4A+3(6\9$]HP!RG.(5Q%7IR+8_#QRK629H")Y>NH^J=L M+N>%V?:\L!*K8_F\W.)]9)\P#>.'AL\K)?A^CVCKB\WF_<"=8L_F5,=HS,?@ M&9^Q2`?1G\P7E;-`33KC00EQ01UYO@*SP_0&5KT8S*:>DID%_N6-H+$.QD/X M**_?0&B4SAEB%0TNUT?V_`G4D8WW(*3J M:WDA$;S"CQ'GM2T>-7P7'W[%2B&L,6V0QW#X%SP;Y<\@CC"!&:C'C!QR1M4F M]FL.8:/R8.SMGP8@59D4=XR?>:X5FD&NN[$[#V"-4L^U%'[:(!QTD[>GMM0E MZ)=V-5<`>:C054O?8+TAC(<*/'N]=2!B+L$*;7HWNDXNG;B-+I8`)3@(OAC, MXZV9GU#,LL["6Q^6/L0Q?8A]](0?@]+:[NA29/7466+L"/"OM% MJ23:WJA3;FK(A(&"A":[ M=C7*I>077;+Y?6:"K!GW8=$MC#D@X!S@``=XR`$@6]2V_9EA`DE0*_"_9WB7 M6_3W"[."R>>SOOI+ZGW>_*.%RP$P?3X;N@%X`\D3O=XO">LNNS*8:WB1%@6/#,>P:J[W^>P_P=>EH]%923DA MT4]9L3[BZA:EU2X-6]3"+]^OMF[%"Q9VD0)'ELQ%NHMI-B;\)KR-K_]P&%#X M3:HK8>D+6)*;]-Z7Z+Y,(*@[RT'V?G!]_?7[[^>7=T]/=]]^):W9SY7XUDZH MKT0F`]RL[#'(?!>JI&;?A&+5U0&7=P_7-P\)$D,;+R8&5(@/<;*UN8S7`ZN# MJYN6TNSI2KM;H&YR^&DS\M=%!VWH/AP;C:J[V6^P5M6$NI0@50_L4Q'+TJZ! M=DJN0822;_*Y_\+VLVOFQ<[Z20`-.&Q!/[QJ)6DU<9P(N05Z(6/J+'PH=F MNZ?TM';4*4#GV8J5I>[)I\&B%5.6SEBX0\!.-([@+W\V/.:&>'FVHMIKWN3`C_9`-MMF>,.M>JG9TJI3)&MWL6&05#):^W2!:ORF0_3@R/7L)X"[-ZU/%YV]'OKD.G,]M]I?2:>=0,7$_< M%/YB>!;V=1Q@VI`%KX6Y[9W.+;/=)Y/MSJMS]\/IU/#8OZA('<<<`N`C7[GB M,KZ+E_BF^X5N/[PE[V*WF\!=2IX?([=\U%+TIEJZ%OW86K0.$*TK-*^&T[5^ M([AZH,NEETM?UZ4_MAM>?+SD!T4O':]"PKMRQK2D0UX[3LHF"FK%8-6#J-XL M+^YNOHCNSSQ5AI=\M&\^BF]>E1PD.4ART&9&=X.MAV,C45=HBX\E+?-.K26) M)Q.W.$Q7ICZZ8L(E^;(&?'F/W90D6TJVE&Q9)5?D3471':UFV\YW88"MJS'K MKY!K:M+ID'KQ?D=KW?+79'NU[H=2#]^,HJ/HP`-:N[<;4E9-TJM^A/H4*-G/ M!_;8RK#8Z*F-MH[;OJU&6]U9Q%W'U6OF50M50QM*'5Y*AZN-3OLTN7;KHR?H MI1T;B:J;H%H+F^SB(?GY_;A4DGE/G7FE,JXVL:O&S^\QD_4[5FI02Z:L*@'U M$1H:JEI/Z>H%/8_J+-'UBM3+T[4NH.>X7C4[3:4VU":FMMJ-5D^FMBK&=5+7 M;Y;::I[HQL1.4ENU7"6@/D(W_"Y>Q]X^ MT0QVO8R3].:JY\TU&SU5>'.JW*BL&M=)7;^9-]<^T:#]/:;A'JAI&[XO;D+E MI^KCD_C2EZL$U(?/S+5U12WJ15YG$:^789*>7/4\.;6AQ\,EQ[?O+R\7G3N6&:C6@/K@P?VR#UZ;C-7&'`>HM*N%3O:V+=,>J MYXY%!P`:NDRK2?5=8_5]?IHF\S5TTV;,H];%%;\IR5[OKKV!*-75!?*R MX,.X@DU%4]?YA]L)0&4V)*B1B[D=AO7W1%.)P;*^Z,E= MV2T-EC18NW5^3TY$Y&E8&7N6AUH>P)+\+$_#2N:M,_-*95QM8E>-G]]C&5YA M7[?VNG"R=G%5/77!,?JZ-5L]16]W3E/2Y?9OY5RRVB7=Y"G9R@J,5/:;5>/U MY2E9F?)ZE\(FHRS)SS+E)9GW5)A7*N-J$[MJ_/P>4UZR`5R5I.?@X8ZNRE.F M,DRO']\V&TW9Y:8"H$JNE<<+WN$Y3]E_38IWCE$"9ZK755J][FG*N31-)\R[ M#1D&5`%4R;6;[=9I_=/DVO>8B\IT00M6PDY.&>`T$M#_=(?I;\?'2P)3\?G<35A%KRBD'YP]4%)8,GQ_TR75?-"*6: M4,MP4/*SY.>C@RWY^>@DKB;4DI]ENNYX1S,,\-AENDZFZPX0I/64?@=O)2@X M"G)RH9I,5,A$AE/PL^?GH8$M^/CJ) MJPFUY.?*Y>M.)2?W@R)O48L,GJEGC"EYH%.#. M3_53Q12[W&8M(2?5`;R>C+^6DVIDC*545(^_I%14'I>Z247:;[T(T#6;_YGV MP\JZF4\B?CPUC]NNC.:%6:-.[T>/$\.BEX5/KRIW.J.,;`7.=[ZX3WW5Q MS3QJ!J[W&`!I!B^&9]W;AC,P`_;,@M-[UV;FJ_AO\@AAUN>S4B,;';7?;:CS?\Z("3P`/S_0T>>S$?#..3K> MYVH3_PW;NY]"P\_5M$O^N[JZ<_[V_())C:Y/Z/R]NO5^3L_.+B1_OJ MXN+ZZ9K\W]^?OMV29D,E3Y[A^`P)9-@7%S??S\C9)`AFOUYO=Z!T^$5VPI/.EXF(9Y3PC='Z*_0# M-GI=!?W3A!*4-\-Y)@52'<^ M-?Y!/3*!-PXI=4`HX6%Q[0U\A4]>\2>VXX(^Z(^&S*;,/#7ZW0#'P%P28CY@!,S+`79\`Q!'D6WI`P):#WSQ"; MKY+A:V:-B&DX0&Q`#7@=8>+K`Q3"?F@&;A*E7A3`%_@JO[$)DZ_4&,/_;^_; MN]LVDGR_"M9W[I[,.1*-)P$X=W(.;4L996U+:RF3R?XS!R*;%!(2X`"@;.ZG MO_T`0(#$FV@`#79F-Y$HHM%=OZKJJNJJ:D]XF[TI-MU/JBCPX]UA#6FUFCF+ MSY;W)T!/W7Q'&Q`(MX2\/R-=/BW=!T3C6I2O)?ET'Y@>[0-0U]CDT5\?/[[! MG+JQUO[?WL`M0I)DW=!4,[G2O'FUN+PVM[GBY9FZ*LD=K\XH7YV26IUR6)U1 M8W6&J4Y5O<'B,DTBLK#,/W7)D8H\54Q)3:PJ2%-(:C6EE]5K121C9(_"B9S%U9JA*6UQ]=%8G.`Y M!%=;)+C*"5Y.<*U%@FLI@FN1X&Q(A MDJ26$\OEG._14/X7USG%;X8+.ZO1[;SXRX1I#J"U,5JWAWV7$Z M=W-4Q^G<31R,T[F;,R-.YYZ.BBZ7SE1/B#B=NSD8XG3NYGB"T[F;4PE.YVX. M(SB=NTF^XG2.8GLH)G'N/I@W%J=SBC;3<_DY;RQ.YP1M-%,_-XZ4-U9&W/N2 MZ6R.Q^)T M3M.F+;UQ/!:GLRQ-(2T0;11%5R:J,M6P]1M:"XVH73PBIWF20H;<-LVS1KQP MFG>8$\CIW$TJH"1R0G>2`L@9NIO,/T[G;A+^+EMQI"UK26W/@SD:JSN&?E\^ M[/OC86\MV\.9?#/?WVU(KA]J"3,/P.*CC3I".8NO5G!F&F75MY1FZGWW[7>. MO?[;F\#;@583]P[IEML=RK+\OED[_COXOK]E-+B315%Z^\_/GU`3P8UU;3M^ M@)ITO1'>7@@L1XE];<)R-#2'I8ZT3.E)RY1+2SU83XZ$Y++5@:5EQY0[-8:D%BT8/ M%HW#TGB;;UF)Y0[-8:D.RW%.3XNP'`_-8:D#2SH%J%58TD-S6*KO+<<5)"WN M+<=#ENA([SJ]K48D=#\UAJ04++4OL>&@.2P$L.J2>IDW% MB29-S9KA%@A`&@Y9)P.*64-R&"KO)2?%Y>WM)2=#E%BR4 M8F`G0W-8:L%"*09V,C2'I;+E=9*@WY[E=3(TAZ46+)3\E).A.2R%!K&!\^,2 MNW%E0%1TI54R_0Z:Q`894LP>E$-1)"'%&>K5`&F2L,YAJ0=+W6V^87X[AZ4> M+%-ZL$PY+(UAT>G!HG-8&L-BT(/%X+`TAJ7NP7##$@AZL#1)\"\BV!/P-M)Y M)1"EPS/8);=T3:.%9O"-=2\7FL'WXKTT:!AJBW7!T`R]D]8%04/Y6EH.QSG[ MR_![*%XR-`-O6W[)T`R\T_FE0<-0<\<+AF;H_2`O#1J&KA2X9&@&?@O!I4'# M4./52X9FX+U:+P>:G`3Q%C+"N45VUM["P`UDEPS-P"_%N61H!GZ/SB5#,_"K M=RX-&H:ZNE\R-`-O!']IT##:._YR8>JJW3SW=VJZGCFE&*W47G`XZDH-:Q<& M7#(T0[]CX)*Q&?BU!)<,S07B"*=>]5#"EF499@JDB>8TL*45G(;Q[0_3&DE MQ97H7MG@<7MJF-+*IBO;3WF,EQZFM-+PRN24^Z24_!>*Z7NE_@L_7VM53J,8 MWJ'^*)&UUTA:2T8LQM

W%-L"L9G0]W=WJ!#T6L$!U,Y'<(]9XO<5%[Q5?PBFZN\K2%9T/Q\>^N424RMH(' M7G(/MYXE?M][YV:`L$3,3K3]W3WV#5WC2$&"+XYV<2K#^DBZ=HZ[*GV*!G@C M-H);T1*_2Y?=#-!;B:-[M1PSCK9Q"M<6B''%T3Z[P]'BZ`,EOA= M_>QF@-Y4'-VKZOA$T<9!-EMX1A9'^^P:QXNC#_``;R5$<`51ZG<=M9L!>FMQ M=*^V;],]IEF43B;R=U`7+4FQU%P`;4@LN_[0WMB)^D%3$L#[6)P0P*V3J=_% MU99'9NP@V:YZHM'QH132;P05=O>6C610!+QV=10O*"1"G)$&3E_&>%^1+K\0]Q6'8J]C%+9W1(Q#UE"$^]OT=_(Q MK5F3A\*Q&&XG2OTNG;8\,EBB6+MJBOH\(@7U>IIO`>'W=HTD5(:(W+G(X]D; M.V>^KIFIF63>!KGKU7%T"PAA@K8U._#(99'YLV0NUXU1R1W7G@[))L27CH[]YL2!Z8.E5LQ7"B>^GWR MP_+(>+\IT:N>X*8$"!&T;DJ`'+T7OA#?9K50+Z.74#=NH/YY]IW\[0TQ/<8X M>R^BSEM>[LK-N3>#HMEU<7;'4-3-F92"W2A>PHWB,53NIWX?Y'`P.F.[._LJ MBN[#'DI2WW9%_V4GS?!#0;G=%VZM@-90%/O;]GSRT:QYRX=7G6.H14W]/J;A M8'2P1+7V56V+;.]7:]'7A#+VVD9V"D#5.)G?A_,<#`Z;R(N[E5QK+@8;4+P&+28XF)O/=](FSW_ M"">(7)@+_F9O[)RY,"X!LVPH4B$=]47]3-W'KK&P8"R_+*'T,X&SBYG?YQLDM,22O1(7613K M1^9TBN@S_O590(UJ;"B;21GYBF3I9,^)O>3<7.!>F01*N#._:_?%E421>A$6 M5S2#T"/"B_3^`$4N9WO;&XDM@"[T&)S2'X M#"`\0MQ]:L=.PFZD&%8.NNNFZO@.:L43J!7/_2Z6%=815<@])*VYB-L@7C^L MUA]>MB_KZJ9:OR[N:-A`3\S3/'Q8WY.>E)^.WNX/M3D&(S*S@TJ(K+*D^X"Z"^H.R1+.=SGT^B3[IBQ7J$= M\[O^>G@Q0=_?E`.1I/0:1L=7)ZBHRSVNJS0Y!B@"`H,*3<%9+$AWQ!<(GI^F M/[L'U[*I7XAM'D&(P?J!C41B20T7$B%C84Y;1OE-*9>AQ810`TOJ1S/"SXDD;9?YG! MZ:<$3C_E'A<3FAP#C\*<7D4LACG&*P/U\.(^S$'N0*R&.0=&!P>'4BA[R3TN M*30Y!AZ&.;T*21V*]3.\.4:0\_`&N4>Q&=XT;2^'3?442F%SCVL;38Z!;^%- MKS;VPQOCQT=;M/]Y]CVBVD>U]E$2M^0&3+W=JB2!6V^B-"*J[D2@,WAN&)+_ M*13GY1[751H=!&PQCK(F&D$./:?>[)0&.="MP\T<&=#8X20^NQ%M5B)L=Y#Y M3Z'6+_>X2-/H(*#D);IGYW8HLYF43683GD\FSDK@)-%E)P'CO]?13L/( MV"4\TY1"87?QMFILM<8!93)&1R.-N$G8P;C9+!H8A48*PM2+@JI"H/(SG>-B MR<\T"C6+#.HA,BC[+MY6Z:W6.'@6.O4J8SET)M ME>MJC8./(5.O1FY")AN[39^K[6+-[IN[OD\F]/]=,T/<7&RCM"7Q8.K1.;FN M[?H4O3$0]20RO;`S:S$<,\F@A+/PNS+7@/9C!T#Z*HB&/?N>Z#\?],6JY5*[ MNT1*>#`4X/CM%.2#&7FCXK$TE$^5?E?6&M`>2^"BKXKR3L]Z[RY6S%VL:@7OH'`.C[J$1QI81G.K(H&*R]+L0UH#V7@08O2I8 M"#!L[*4HX<%E@('6*5@*,`Z,"LYG9%`/4/I=O&I`>Z\"C%Y5I/=#/`@LC@'B M,+!`ZR3L!!9-TXKAK$4&M="EWR6H!K3W)[#HU<-:8&%\Y^)J^6ZU_,^7Y1WM M\F^+[7S99X@,D^_(Y,O0.M+(5%IV%R M9(3\QV&'=F2340/6/BAJS*&,NO2X7-63X1W?`_HQ4"(N=K$D_[V3+_A&>@V6 MM-O@&?JEOZ!'%.NWPZ!O>EIQ8B&)8\"C&,CGO%%?*Y?E4>\0K!&.L.50AUEZ M7%QK?"!&S?V8UD8D#72U#!J=!K37@'4;\'[I+ZB3N3UU,L8WG14&H!'TF'H; M7%D*7"ZF:,`DN0,FV>,!K8:C M^#F4;Y8>U]\:'004^V$F-5*JNU/T.2:WR`RLVR/Y&1\HC5T_<[#F07U7SNJ[ MPHG'%;U&!\%'/].KD=3V.W[_RZ#/9]CN0OF"MD$#'U]K)T[TB\ M1==(&'<6T!&8&(^R_U,F!-![QM MRS?&"INPB3R"!TB5S`F(V0'0O6("=N!Q*:VBNBCB?#79E3*'JQV&^8T?=N\2 M$C9N`[N;'D!8;J=2S"S@%%9>@EEX7&NJJ.[XNXYJ@HOL+0J@U4+)9:<^C2RU MJ2?N!OH:`[2=6NJ!MGF%$\_.%B$8@\>ED(KJXF3(O3+K,V3C547")FR5(>-! MJBF&?&`'D.8H8K`#CTL*%=7%S9![99?:\\+"C(^-VB8SQ@-=0\SXP!R@,+V( MP!P\KM135!W&AZ> M04EBZ'&-F);2&%BYNOB"W%P0V%:2U[W*->).4Z]N"?4X'KX[-3:![X,X#F[\ M*J`@*/2XKDM+:J\&LKEP?-3\V.;M4W-L*#=*S0^L!=X**:`<,/2Z#$Q#:?34O%=\T]3< M0O;\X^J5%7:'],SCA]7ZW6KY2D:26-/U?;/JG"K=$I^:>OY)1Q"KWL#H^`@Z M"8T^V3F`!))!)=0EAEX7H)D?BY&C`>,*"08)=;]!W7&P[YG^_O#,!PL@K*;X M30#+3%CQACV/=!"B;9V0G2IAYSCTNHS._%@@"5F,*Z:ZV;#W26?L\AWVZ?:A MHD?=:]=$/CL\YP[725L+>$S`SD@<](;=DFS4I&VP4,]20N5HZ'7%H/FQP!!C M&==*,/1J]4!2WL?*AHG*<.Q3$[&I-[-T!$'GA#K'QZ(3:M[_DD#^KX1:V-#K MXD?S8^%A5-:KD(NHS,*NC@E@C1>5>>)YG$1E!]8)BR9$L.%2-/?ESTO[A$<44(W5W-@5SLIB MX/(UW4-CWM<<+']P+U`)=9R1UV6WQH;`/U_3JX]Z<.6ACSE>M,VFEM\2G5%. M*DMV"$8)]>(EU)M%7A<"&QX(+.ED(]I(YY+K7@/H-JC[#?;'`TI'U3VJ0#*; MM'E++D8Y7:-BBRE/*D+1>N1U&;+A@4"5J#&BDG261H7*V-TO5PT-QF$T/@1- MUAG-`,II>E1PQ&@M[3M=WVQ4=ANSDHK9&/&#J::WA[JPZ$`5= M!3W%8,OLW%X>@ME`/7OD=7FPJL8CTPM%L05Y!&\]J)NW_DR&N$6;V:[Q!+[2 M&S""9A&!6?!R`Z\K:U4U1K*]HBB^ZL[M'MB.;@@6MW4C=-\37,L2>$$KB<%* MH*8Z\KIJ555C#)1<479![BT`82LIPVZM&N&IJ<LF]:13\`ZH'`V]KH^455CW,2Z5W:3Q-I" MYGKW5G38]_IB;.Y!Y^$.K:)925]!/`NTS6PDY?X>2L9BKRL!U74>F6(K"RY( MLO>/L(>MC]E9R&/+V+89HNT1F*7)MJB!9.#Q0RB7B+TNNE/7&0GA5E9`-:?= MA+DC\BUC]4;HMTD$B+@1H*SGN/LT: MH::YEZ.'.QP-UYWZ&L!U,UQ+H=8QA!JDV.OZ,G6=$5/Q7L$-47$+&6\9V[9/ MQ9&!V2@5/S"0'`P$=C5CKTO#U'7V@(KW*B";_49&P8^MW3H%1X9NDQ3\P$Y@ MMS.$ZKEZ\/[ZH[U?ONP6&^_WR_6F^WM MM]7MP^IE,UO.;[]5CZ\5_^FG]>)UMJT^/<[()\217FSSMM#4U&/6-@2TZ#<< MC:>0G[$B2UC&DS"'!'$(Y9&QQX5O+L=HU)##H:(B(0KO(ZCE"1H"!42BH!8I M`)EV'W"I@IU8]&1=;G.3P2ZD341"O_O(U@$=V4D6">`"ML43CVL*78X1BDC. MH<)C.,O`6V]I(+#\W5FVC>?8OC(%6$!9;^)Q_:;+,1H_,':HK4@@O3UVE#'< MTQOM_N69>\3GG4=DIZ5SNQM=9H>ID7TR]1Z]#0&]<8J=XSF"4]SEDFA@Q7-) M4".=>%P%ZW*,WE"4W:OHN%&V\?U#NY#&%V5[[B-'C;*;N"C@I'8(-2^)QX7% M+L?H#4;9O0J/'&5[YBW11=F>.\LQH^P#6,`)^!#J^A./R[9=CM%;B[)[M748 M9>/[ISBL2P``2B:CN!81.)QF;O+,?(_RA93=`3B MF&+?G>F$-)HH^ZWXR#&B[%9CPG,(H'&TTD M^8!-;CRY,[[)HG.,WM$J>U30:5?99I[.#*JT>:OLF=O(25?9!WI!;E+8548O<-5]JC`$Z^R9V8MC5MES]Q83KG*;JM%5/D0Y-:9]WN_74,Y1N]M ME3TJK<95MJJS[*^08T]DC#X?CQ'Z:Y)D3#MEKJS7T17@4V\2%8\FBT64"L6S M%W9(=N&]^5^=43DT)BRH%.N*.$'"@=2PKJR7ERE[U:ER1*1G`\SLMJJ,\ZX&@7&KFI5.))./32YD M>W.^-R`LN0';RJ(R4&T6,ZF^BM@K"BE;*W-9C\/2=SNQ!1B479H%:.5Z#:+J M9+9:>-#@GH]>8< MXBTL^6S6`J-B,"7@-WL)<*P+FI8`1MH!^4N``Q:1"U`.N2WJS3FH65CR>2P! M1F50L020'ACRS[1\^IX4+\FJO-O>)F6Y(:%RE9P]X=BE18VV8MRJI/[&4?ZRAZ'21<2DH6A65:@+D'5)UIC['L% M3;=D0;%&1XVARG@+<1V2X&N\2]O"YH<(TI!L;3GD=HT_X\A8V>,PO8\B62(: MC^4',C!Y96"@^Q*#8F]BXL;$O!(3@V-;0[4W2,752<;>QKNT,XS['H)T)"FZ M'1)P[<\X\E3V.!BQ)R)9*"VVQH#E4FL+0=:SP[P@C#(U@^.BR-*TKG8L[&J[ MCMR!\V<^LC]O- M)L[A(/Z2I>6Y:SF1X"M6TZ&7;]R,^A)C1G%"H([ON#.\XF?`B$VQ6IQ>[,%U M90,---BJ929$!X[@4=\9K%&.WQFLH.+$.@CLG(UXM6_H0F,M>+5Z:AG>DT$? M_"IFFO4*+M+9&?K&QHS;[\O$'PH_"T,O)VPCNX!JL;&\GGOSK37-YVU^F^2O MZ0HM>KW`%7G(AKE'R;94AL2#EH^C<=L*%S-S0OFEU&Y5N*'VVH`,X.8`;J\G MN\/!$0-L%-2M3J>EG$<#,];2TYO^G*28F3?!+^4T&_;<>'NWR/:JBO/P.8<[ M9NB.=E$U(VG[2X"QO/OJ,U92BAUS3C[,[."-7\K)=KNY(`Y;K%$ZUACRFMRT_PD,EK$81C^!#7-SC M8=P5/SW&\^WO!XH`Z0E+`LVL!@C-;=9\ORR MV;XER34>_N(B6S<:5Z!4FZTI\#/DQG_%V2[.WQ#]CEZ'07_Z1U*4R?KJ^3E9 MIW&9;-[NX.R:)\F_DCA'39.X3-2.M7#OMLZBB<_$8C$<>9J#7%#+C)&CYPLT M*FX.2,=W@LCL&=?`T5(]79LG\K(%"528<`#)?M['L`ZWRE"+H((&6MCV3T[M MT8$6/'2[#0,$&"'NJ+K8AIO$*`&!2?;C]-OIMH?$,,"+172WM7R_&6#H6P<, M#Q<8!'UZ2ZWN&\@TU;)0(K<[,#OLQL3AFH.QEBRS9&M]L%KC,-<8)B`XWXVY MICN`,0CZ.S37G6,@DU!"780M_&&N&8=+RV&4@8(?V&S"B^)O/VI[G1;-.QWU MIC=X.+;7W1==T5_/P"NQV&G+8I?0?09OV%JC8^_JFB5N\4^+\T6$"OP)^D/^ M_LKE.[#9E(=M!F%_AT:[>^1G$DRLC7\XV:S#I>O@T4#991KN0T];EN5F/!;M MCG'OP)+TS]68?MN^UD.ZZ`QI,XP7Y<(Z,`@,3W+K027;WFH:N6%+J@0`/@_T MJ_-`\I*(;_AQU*0#HW\+0J-TO9L-@_L+5=+X>FNA1@'V,`YV%EI;"1K:[ER.-?1PIJ-^\:[$?J'J:/8OE1(]8!0G3P!XYO]@,^T`S/1EJ1& M$?O6L'S6C=6X\=UDI1RL_=K?[D9%V`Q1$98%E_[>06P/R[VZB>%JL8H:QYK1 M7"I#AF-CWH7A5#Y$AJR`50=>D"W=?Q0'IM-8RAT_/K,H@@&G?W5)^E>7O,P3F/WFTN1C M8Y(OJ4Q*-G>R-H-]I]?VJ=4R.?B`>H#//UD>IE[6Y3#T[] MB+IEG1B>Q=W6B@[TT96_JA7%I<><*1@]5FLF#`'/Y$Y(>$Y>3PK,3L\W]=`8 MM:)5)"3C@G:WV7MOU6$)`D*[EET0!\Z*=*UEY2FNY*7L[\WN\2]D)1$_(L0G M3SD%9FJO:,=2_5FKQ\)2>Y61821Y&ZFYQ8S8X3F:P19Q-1F"^_0:U); M4,,"_).&H\'1E3A6JCB%P$#=Y''+3B$9KY60F+K._/,%YEZ,#:0FF#0X:K7K[4 M%3,[".5&3LJX,)@RCOX018/()W,WN=P9S#Y41=XX&+"2E28,]7KU*B,!*.T^ M)\H](*)!\I:=[\RT<"TAN6E(MDT\$@(?SOX2A+QQ,&@Y*$TH:M\F;6P,>L)F M$1IP]U]$I:0MXMZ9J>%9D'&3L=J!(#&8X>RO&L@;!U,65](DTF=FE(6776=D M,6>%$%/B)NA:Q%NDKLMX=P29"H="0-6 M3Q+%H5X_H2=TR49-N]>1%92C<`4EIDORUE#OT-!PK:,$"$DN$WLD]CJR] MS)$P:"TE42SV'&O;ENG!'D]$Y?$X2A=68EHF;6GU#BT0S_)*@)_D&J]'H@'# MVSJ>\@(=GJM<;!U> M)#_.H99FC]>O2=Z3.^VBM(*[K7NH94+/U"H$I\\PJ1A''FLEC@/=I[#"ZDR6 MQ!"'LP\F5S\^)MDU54+R&+O>K(B@@@,0GJ%LB-`$6@&*)W<7"B/)56BPS,VH MW[4IY-RXDJL&$5EO^"1@.)Q]!+GZ\3%JDTNQL'_81#I5EK@[]KLVB7P[:9*5 M@#P@Y)%(X7#V<>/JQ\><73?%DK+LQ;639X^ECD5&<8N,8HF-8N?EO+C\TSDR MBSA^'!I&';MU7R$!GYR3\2%V6X%#N>\-L(/08/`DC`N386/N#\?I!"02']2_*"E2/Z"89DDJU\QFZ)0^MJ,2.N" MW%.H=C%)R'!D=BRX:M%5+WD4XU_2W)"E6]<$G.L:^?RG7,J\5_7O+E@DDXAL MV_DD@#BZEB6*Y6CLP-CU,GJ7(.!>>KO+XZR(5P@ZE!;_UP8;VHOUOW=%B>SNMZ2\?KB+?[O9YOB'LLS3 M^UT9WV^2N^T-!)B5Y]`J1'WAB-77Q%_R(2[N\>?<%3\]QO$+_*R6\[=D4Q;U M7Y!Y<7Y:6#]5!J;ZLUY9!`W1Q,/>6"N].!P_,CM"9Y+Q4+[&F4"H)>X4'/0* M2+?@+U^V1?'7,U#U#VH`H(4`F[H6!K`'<08@#'2=#0(Y`Q44T,:"#IL)FED8 MP_`/8SCIL$]C#!TO\W#WO4'UH#>0X'WI/>38E;X>Q=2?3H9:27M+6Z[OFGV6 M.P9;]?P_TO>R^0W@'\&OY.?_GXV&WY,R3K-D_2G.LS1[+.J/Z'M]C\_*(6)_ MGV)4I)6C)N-`>?SJ24#NX?OD-EID]D5#-D%4$Y8)S?)C\I"NTA)?UP_8E#]M M-_#K%)_^>P>_R\5]`=V-58D^>5_"9,F4'8,@B<5L4G:(/5K="MTH]*NM.Q(] M;?B^A9!"*__()MD\V2MLM_1F0ML!?JKG@K^#7NEU>+;I#[CLB MDJ->77!?DO1B`'='`4BYR'9(8&Y`[DQ%9E\7H4"OCL14E8RZJ&%=]Q@)]QCH3M$8*5L)^RM52Z M=B&)T97V_98J#^[EX1=1+>MN:WE>RN7O.N$ M)C=\,=4W>F.IL,PF@OW;NLL#I3=%J*ELMRWI/_8EJ`: MZWX;K'TU&AJ\;6G*\$S@$4\BZ/O:E9"=MUY^SL3WE-6?U:Z)I'TG3VP%#CD> M,/>^K.YA,,%.R12(*WVA>T;UT#V^3FH]71Y_!-G?R815#+\&I,!TPO*ZAA>)XI=ZB"8L+2-NP0I*? M@'^2Y>WZ^%N8FP2-68[)>=X#ZC31R9,7?$S_'*IYY6D\=H MH8'"3J\?\(JAN'ZXW#X_;S,Q^Z?&HZ M%*&,N9&KTN6<9DH5`STPZ1[K\X5*?6XY!;>[^V*5IR]D!SK_)4M/R6%[H=.7 MPV5`A47Z$E-;R5+6UZ_%FK5MQS/7I94F'[UF\J7!D`%R>>#HMIO!1^NX(4-5 MCW+ZG+ON=9^Z$/_NYI[(2Y-/Q[0H"^PD2OCI1`1/Z^3I.DOVK+1"^GF/IP_! M(U$Y4M6JQM<<_*JVN2'\PG*IGM=$P"WKRJ/OV;9/56$3DV@0W4;.W#2H\Q8+ M_\!!)7)4D';9*DXM"D5G/H8YH;+"0LET%.70<<^VS$?V(GQC7YLY$1 M*B0T&QU]3G/C-83E,G`VZH#4JDN,5TPHYQ\#+\=TYQB&:QQF;X4S2J)\'F&" MH^=^3!?)@4=O]SW`PD%N60L33MPTU#YR?LW>9V839$IB=]#L>;WMY[7`$H*- M'A)N-$[#ZQZ?AOH+.(;O[C()HLUK84$U$<';`;"(*7U/"W$P7,&-+U;L-"0_ M:`%]!\-]=491IK3@/7A.4EPDK)J9*!+L^'0L9[/EG6]A]KMPK**88,][<$U' M]_9^AMWWE!`/UR5MRW#BIJ+YP=+?,?P4@$F022WY,9K3Q%:R@=)##QDV?!)> M,]KOPR]@^*8\DR!&V.YC5%H(3IFF@]5RFY1B9,1Z4Z3"F`O-Z4319\&I\$R7 M9>1P9X)K&WRL5844'T-.Q?##1;_ACX^HT,":C.>]R98DV/$)4T6QV?).0J,96_,^62:UYSV` MU&:+&D=SL'Z3QG39"T]&Y'0L/U@:N89'*+-),BW#C^&C-Z+$>?8<9+SJXD1G@L'5@J>3Z-OVY/C3S5GA9-4ZB5MUQ+3#;399Y/4,NBROK2`=+.W)V&I MJ-&=(LDJ@^D]2@IJMJ_,(L9T!KB#15V>U1X0M7>RMVP.PY',R0:EL_@DWA$. M']=%1F-V#!X08@+^]B,9LL&-&ZR#2))76Z+EJ>4D MDY@WY>O32T0:2QS#[]S)%91>>06RC4B%/)#O]4"#-2=[%6*RC*3ELU3A MKK\JD2=FWRZ4*Z@NOU&V;59^T195$T^W1'M>C&^.=\^)GG^W(+FHX` M[@E47>%R56>@[LU4\R';+WA7]D/`=^!AH=D';:I%-\Z_X)-CCH;D\S:_W&:O M<.F%0EH?VN*V5(+AWJ)8;PJM`H^D5+I/T3#BQXQW[.@EG-05H(9)HZ@H(]6^ M-?3SH8).JXMR'I:B9K"K"_Q`0C3.B@B$]@&AX+I); M\!2>OFLE0VE9(=NE:0-MOVJU14!Z6FVB[P)M4<_82>*1=6IM9`5,XVD-WZJ2 MDQE7/J=E.&XS5FE&%Y"9-C.^.,DCJQ'.)`?P=Z#;!RE)'89W4&7U.ZEJCTDO M2;,/$XIZ,SZ3Y)'5\-FZ`UB>1O-G=I//:3VSM;$J+7VV/J*-V>]&2)=U)K-U M![CYNKV]REZ3`BI+.TA:UB%MIW65:DHA"9TN=AM"3Y[->@J:U9,:1,;69H!NLTU?_%YKQT')3(C"EG")X1*M).!1W*NHNNQ:4;04ZG M".VDR]YBQF=L74FFG1..X5!Y4&I\HW^FY=/WI'A)5N7=]C8IRPUVRRX>\^0H MKYDCZP".KDN%FL$M,Y7:T+:.G.<9W_MA%'-2A6/#2J.-/V"+H&H2S4'[1D'3 MJ@GJ*L.-FYV^,CI\+.R8\23(**81KB$;9N,4]P;J7)+GR1KW39U$TK5UF+,+QW=\>VZ9(01EU3\!BP$>B,9I&M611?7;-DN>7S;;MR2I M+AZVI$#XDG7_C2*&Z'B>/L0T59)4M5;R-8?N[I@=4"\DEVIM$P&W;%5N+M0> MZ!%I`'P6OS4EQC6ZJ/RY:5`G;I_[8P9FGWH+R46O00*1_2((^]3H;\`<].A[A*/WR*:O;,O))>N19P(R-[I*.Z9CK3K4FL'W7(]AA499SK5WW3DYP89&'J<7M_<]`K&A^0X>N:?18G M*MITGB`33J,5[.A.9Z1LYI)V156F?'Q*=GS/\EW-7WW"F36#]2`<4['/0RHF ML1,V.FD&'0:=TB^DHPMR-!7'!IM$O M1I3:3X(^)O?E55:4.9:8O*5;IO>;9/^L[DT.>X2^=+!8]/CWU5#B87R(BWL\ MEKOBI\CS]!'627@)>[_;E.Y*C3PQ`Q#1* M2.)ZG<32B&6[H0^]=]_V/.B]NPO#[RP)RZ9Z>T@4X+)NH'EU'46*5VV`5B-G MH&I&O4XIF:.,UJG.3A?39PWA0FWAD@_KDP]KKBLH23HM^V/B./?J]=)2K[A2 MK^2WER0KDH)/I;XGJR1]18U^2\H]H_R^,U2Y.M37LQREH9/I6$MZ:]F!33Y& M0#Z&V>=9K*+HFEQYOJ]P!F`5P6ECE`]*YXF).#XX$_35"BJK4WV-D'P- MLT-KN.31:NU9D/7QGIGIN^?=)BZ3]).@?:-)YWL+ET?_@ MO]_D6[BZ*=]NH`@E_.W3?^_2EV?,H""($(,\56HA!::P"JD:K):^R>D"'558 MOH<)XR\(8TIJ!9D>4EZ0%:E;%F-N*G) M:"G6ZY1\_)LX75]EE_%+6L:;J6&LMP7!:@L2.%D2$K+I:^:R6H*^G8GC?X*]=YEM8=ADR$W-Y:% M1Q0]QIP-5)O2+Q6E5UR4+HJD+,[]!3IOLWMY_N;H6XI69RE\^M[M1-?@\# M+R2#XY#!,3MKW@AJY5/S8-=+\A,/CR[N"^B"KLISWU87;7K8E0Q:#<(^9%=3 MS%H$?DA"/7P2ZA$8OIZBP:]G#J5`LN0W9,=?4J$]4TG``?/6%(O<(""#1@+Y M`L/CO4ZCUV/NQB!49@_\6A=BC,4GU>MX#A_=4E/KK,D)2AE'?KNI@;7C9K0I#>U!-1^1((C0\+@5:B&TFM4Q M),?FE=OEO(R+IXMLC?X'Q9:\QAO86G%17L9Y_I9FC_^(-[OD'"ZP^IY9ED-B M*@ABI.:4LF8Y777+JO9!`G(D$9I]QL,OE&HMX$:V1%5PG!3^1ZOR&8A+4-<' MN`&5>J+$13%.3SH^#.6'PS.O1;X=.>H(S3Y*$I)+BX\C@G"O-2OTCV1?GU%% MML_/*8X60$E%+K=9"3M.LE6:%.>!U9LV6I)B#' M7G^[N_KV\Z=OEU>?;K]MR^0<9=BRH\`C8=`!.6$,S3Y$XY9)CW'G1+<\*,I. M]NK!;_+0;Y49C62D@>Q0>']RO&]QRK/(U;;JL`"J5UW#SI)R^X#_D#?W]K8/ M"VAD;`M^!#*-2H?=ZF[@NR,5U ME^PS!I:C+E;DN#=I*C:`O4=KJMU4-ZH.(*IC.;,/YJGP:YRJ!D'TNXDD!ZXD M8JK>ME!)S(&MB7W)ZC*)31(-A22V(3+[")Y:!HV;`*?1'-C2,_`G<+Y8+"SP M$N?@%=7[_X`5+L[@W]#_D72R!8AWY1,<_/])UO!GRS_SPNALX7EX=]JRK#,G M\L\"/ZR+$QN/?]WNRJ*$_T!'F'$)\+8#<*PS@-*9XQ+UWD/]5X-$B652$9!%3B M1B@G8,>!."QFVQ99=X4D?"$R^PC\-'C5KL-)!#7E`,_EHT_0;*[7*/E/#EU@ MM%_[.4YS;/VO'[H_UME;W\XC*U)'4EY48GR6-Q8U];E;]$+#;P4(2J9::<3@ M+>L28%_D#*`6B%>.TLCT%&ER?K]IUD$EGLI,=;#C__"V&)R[GF_#07%\QS7\ M:3QI,FKQHV2AW:OI>J^#&SX=_)QF:0F[>DW65QE<;#RB-S7(A/HM091&8'=?$)I$4CN*`M;^*RB>\J\WB=/,?Y M?XHSD)%$9^T,JW$KQ2+Z[4^>?69[(:[Z)]<^L^Q(C;XH<0]-T)>.KW>BHA,$ M9,,O)$%ZD=F181S2J/;IV"$M296?C!RT^I[^A M?Q4_Y]NB@,3PK$C=##'4KR#9&<1I>#YJBG1FJ['EDS&[:\$'ZSA.]7Q!2*+7(K.CIM@$46ZW6=`<<;DN?P9P M#39*7V7%+H_A>-XF9;E)<+SW_IRXR2-@>:ZZ.QI4&,2HSBMF37O*^I[KD]N8 M(0F8BH!*02K5"\$-;-E5!J^[!PT%<>0<8*:3$Q3%/4SJN#V5]/$F3VV8A MB3^)S(X4$I)+BTLD@K"E-+R1/E^2N$B>MIOUU?-+OGTE_5?NA+T(U4T?PQV+ M:0*30#7]QRHM7-OL,*#3X%6;_9,(EDT)T"["Y?NTGEF$;A<.Z4`-0PU$]V3+ M-_B9+<=3EF;K5/>"[&47KN'PR:HXXH5$#T95Q(OAS.84B<%P\^?LX@17I?'Z MK+U=W5IUMP\>TCN+V[OOQ??[_^\O'3]]L_@T__^Y>KNW^IT@LU]MP0 MO>C:]E-57=NMUFHX8-%:F'TBQB6/\AF``]2R5:EY"HGU=.M4QTW*'6?AJSOF MHD6A5@F&9:75A<-<6A:Y?AS9Y(N9'4PG*IH69U\0Y))FU@!_^?CI\]7EU=U? M%6O2)-/(1)K$/*LT+4##1Y9MD44^H]E1@4)R33W+C($;F&VXTZSUO?9N6PJ/ MAKL=2M.!80%ZZ+[/4FN3'-V10\;8[!@)2@DT4G@$1INLG!N?8Y]7]<)8.3_' M%K\'692KD.+()2-K=F0"O1"Z%[CC<(XR4[><%%'*MN=A=:G[A_N5S>!A>8:) MW/();1(H%7EDY,V.0&"41+_A'8/3:X`E^@H=(JA>ENHF]MC2LS=QLT5.!".? M?`*SPQ#8A=&]O*2#M12WV=NBV*>9>[M8K?)=O.FDJ;1#A3$"^R):K9RKGZ!JJZPOFXO\:KIS1+\K>+;(WV M9EZ0KM4']V&H+@OW<,=B*L$D4*T'8Y7PM6R\^'(6"_)!S#Z_91=&RY3`#`ME MA7C9P1YQ*NT7]DF`A@I*+/^4W.[8^)%*D>U62S!R/&B9?0;+*(EJ:\X&9]D4 M;_;!<06N:!R4KKBX(7E5FUTBQW74!8[U]"C&93H1:A+WEK9]PPD[@EHU.8>[ M7N*?0/4;YS[WZ-=3XB_H)6#'0^@MC5?WX;GC!8YE]B8W#7PM7@`%D(J@+S5! MJ^NGZ[18;7<9_O>?%N2F:>B?+<*`C;K7Y5.2USEWG-")E)W-M'H2H^HXY)JB M!Z7PD+K$HR)'!I;9D204Z+6P=7#SCV&1X MR8&1X9XE@Q1:'$QZ/,OKN[]_^L[U0NT-)&$"G=?U009>'UVL5&14>WH4HRJ= M"#57>TM;"[O:LR,;U9;9H1'4,JBVJK1`EDU!"3F<1[^W$NNJE[(=\]I3NLX_ M;)&!)B>.EME!#RQB:#&P#(!:!*Y3.W9V]Q9GK+;A2.&?;+!FI(9CA M&0KV$J?K3[^])%FQW\AP`S]4J4_=/H4UBDJ,ED[UEGJA(K0M;L M%KG69ID=PL`MDR9;S8=N>?/]^N;3][M_X5N$Z-[@#7J,5I4>*#+DANA!CWT_ M5=5W_.J3D/MIMMFGQWP"J;?['*B6=:TS@.L=AD!P;Q@.8JEB8J`.NLI.]\8[ M5Z0&0X*=5((ZWR,*N"6'"Q8YT++-/A;D$TC+22$7M"7^$8XSJ8L5@3.\C98D M>NRGGP)(16B8B'-JD7,UV^PC20YI)C/^@Y#&+3]7\-L@")Q/V[,M2[_- M%TX3SBC42<;OT[R333F+''O89A]\\H@SK:T?!E:%B2BU]`?DT&OG-3&>WL:C M:M``D4,4BQQ-VV:?G3++,IE]'P!TRKHSY\/_GI1QFB7K3W&>I=EC<;%_<^)C M\I"N4D@-?^&IVZ@\#4",]5P"UMRGJ!PL@FH*)L>(MMEGLIP2J=8#/EC+NAJH MZX&_M&J"JBICAB@6QBC9^C1))3J[GZ3U=^`E)IV0'EQ[>L M?C]X36B]R]&Q;/F4@'7RFFRV9%NH*.-'QNN,MR5L$%6^?OB<9G&V2N/-#7K, M$G[-9H/*LP)U#A,-`C%]X9.Q5ABJVNC;65$UVY.3'-OL$UT1L53/)@+8EA_B M#4G/_Y2(A%;VY6X-T&L9ZM1`;BI:*@'V'.\67H0.V8NSR3FZ;?9!+ZT(ZKE+ MA6/9+O?G.LO?15GFZ?VN1/=X0+D%-S'[N>_8AU>RQZ.3N9W]G,&$UN02BEV= MJ)A]>DLOA):]&VHX2_%TX"/9,:%U5Q=KJ2IE*XL\PQP^/!>W%V32`E*MMP6H"+^/B MZ?/'JTO\>%^ROGA&N43.?95IP'J[%",FI10U-_N+VR07K6>'9KNH%.A56\C3 M$):HR!E`A4!5"I!B,OFIQ,_4SL_.5D%_<;CZN]E<(B$&HYBZS/5-:$?185SHP M/1EK.;G[,7G)DU6*DZ"?AR@?E"KSVNY)C*7CF&MJ'I1R_'G26.PM9BR$0`"//N<9FF9?$E?D_55 M5L)^T_M-@K,P_5(D#[O-E_0!+N@7.!^RHCT@&@ABQ.04LF8L3?7PW(TL=(D` M[WJ8[5)RR:-I.XD'V_)34:;/."!QAPO!)=)#@M+-OL`_,N^Y?][E$`-<:EUD MZ\_I;^A?1>WO.I&KS!`/]RO(?@9Y&LH/U\&>4T`\)[.#<>F%T&+`J>$LFY+X M6L9#59;3(Z7X_$K\TPGIW/%=1^H$7NB1@3?[P@6M"*J]7$H<1QS^+,;A;SM4 MZ?KA:Y*OGM`-I\<\(<>I_TS+IY_3!_02S_HFW[ZF*+#@;@L=HLWV[2Y9/67; MS?;Q[3J[>TK2_)_)?0&GE^+P M[P)<9P!W`NI>3+$$P1^6H&\TU%H"LQ=*RF36XF^J0E^;`[B^>J[-0;PW!S^0 M.7A$YF"%S,%+8P[*+5@3EL`$,7>-5H]D55Z;).NQQ@!TRS#&A:G<#YYV&T#*=_OOK,Z.2S4L;L MRX[2937`J6='33-Q/S=*K=^%YZ&U%-=]OEK-ZJJSDL;L^_?2937#-6<'SJ;9 M4SKB-W%>9M3+T;Z(*BX-I^Y6I8*+R$ZGW@P]P+7<8L[:S2[JM#XX,UX:%[QN M=`(/G(/,,ASPN2HRH_O-QA;37UB7+*H!SCCI7C>37-+JH97C/%;6IR[=M"G'8H?_-@#$%,C+@E/OO[1JFPYH>U%Y'N9?;N40QHM.L*. MZ]1#(*@:^!55E/7$7P];]#Z`,X4^T+^&T_Y2;F232T&&7RAD%T;UVH,9D7X] M^))FR569/".2A`O]:M#TKT@+1N0[J03[NO`C696Q,OM^%K,LDZG``*!33[VB M:@#7DZ4!2*<^;I_C-$./`ZM[!X<"@"(=&)/PI!*T*J,YVZ\V1LR.DN209EK/ M:!`7W8Q`JBK4"+V3PA0:03\MM+^5&_KDLFED]B5T=F$FFQB&$$VA">W$'!YD ML7Y5D)5\A$_$D[K0KNV&7N7(FAV]PR[,9+HPA.B4+I!Z`%54J`EZW:1)-('> M3VK5QGDT0O*MS#XOYY!F6C]I$-?REWW.'=8',HL$CM@3[.;C_O7`)HNT%Y)E MHY*D4Z-]B]&<5:S]BYAC]6PKLD(7/2ZP",P^=F.2@Y[40FFE6#`MZ\+8MK?? MM4Q(><8H*TH^*'H5>6J:][R%/%8O=`/RNE=$#(QOMD?#+HQJCX89T2'=6W7X M7I"X73TEZ]TFN7X87F>@=W[.W3!0^*P:)0HQ%>"7M7F6BK8%?&J#OYFS,-O\ M\XJDQ;WA!+>LZZ'3XQ/[I+@^ZRNOK$12\UZ;F4K3?6[.MMQHP1"F-]".&+L9P-5T_GF;9H^7B$9Y MZU7IR(;_#\_5;D2>SPO,/@1F$8.>N&*!=0R8EK@LJ`JWWAYD#+L^20"Z(.MI MR-DQM4,U\*"9'=5V"KIJXWFB_^77BV\7/W_Z^NG;';CY%<4.O3Q_B9[:.K=:8:&*F=P^&QJH%X<(EPT^\,L?P MV!E6690?"S$"6M85D,M+>%[7`9<IVD`^>OL9E`F>3%9Y6 MSBUOL5"7CIX.A/")$)^@K4,AJ@:P1<)?S5\$Y*L9?SXD()BNHR)^B$ORT!W( MX[1(U@!1`GT$5!6\U'75:HVJ<`+CM*8OJ("F`1_2A'PV_%"6XYJ]B2(@E88P M`TYHR[HJ49%F5L%;*T1=;OC4!3UYEB=/25:DK\E5MMH^)]^2\OKA+O[M/+!Z MUZKR7MH;Z%A,+Y@D:K^X-U3)CERS':?3X%4S^R2"Y4$)0(J`OWS9%L5?SP`L MBZ@,2Y^!B[+,T_M=B;8$T97XFSA70NKHW9$Z8B$U>C3),_L(B08^@XNS+>,- MGXM#`61Y>?WUYONGOW_Z=GOUCT_@R_7M+1MEK\NG)._I"&G(YVV>I(_9Y2Z' MJK!ZN\OCK(A7Z-M<9&O\7QN\,7JQ_O>N*-$QO*.K0M9P@).\GNF;O@^@9`"W[)5I$6?8;EXXQ*2D.CL\4I)4=Q_XX_B!V=O)DB4U?"H^@BMW M2N:.YI)-9^UK\]DJ/M/BFZ4#V_6<("`K-+.O,RF2>/+E-3_VY=#4SGC!HXQ+ M?$9[_4!0P65]#]8&A&<%Z@Y@&<$(7O<0E;RY]<'8$/Z`9B?+X15)]<3*B6O9 MU,-Q<(G)!PP;V'N M=8X1Q/34X[^Y,=S]LOD)P-_`K^177C+=_=BVOAS+TW'=)B21:132`9GV)?'8 MF+NP&$&LE4R=[EMD@K]QDNEC9="H87A7&71@DJ+\#NT@-H;KFP1"@[@? MD_,@L'UE^2SH<8@Q541>Q%^&^E;D+R('?RW+7'KS"T3/?N[4%]S@EG59D,-R M;"KQ.4[S?\2;77+]@&YZEF\H:#%9G[N+P&9X='>@&3'ZTF-#9!TJ[7B!;?"Y MZ2G8RI=C)P`LT>_@%15`?F**?P0)+BF9:I3S^31<.YS91P?-W&V#4[!US/$G M,"SOGA+P<,`Y0K::>NM=CI\!@,5>$CBX:\8[OQ>K59X@U'6:%<^/U.4V.>Y- MT/4\B;U>@'=*XIL=#GYGP;=1MDC7=LP^8Z850&J*!KWH;B`+#LBG#ERUJ M;!>%+E&"SGV=+LD&=BK,#M\=0:V<4H-=*]_:8:23AIV=83H=[568G:1@!+4V M.G6ZEK*Y<[F)B^+ZX9]QGL>0LOGW]/&I_/0;7#2G17*3I^@27_5C4?U:G`<+ M1YWOQX-(C,!RQJ"YF,33&O&++#+U!&3J,7=!)%M,+;ZH1,#+NAKZ+.2FZH^J MID;M4W-S=5[:U[WKRM5::%5+$I]\8G,WOJ3*J'KND@5TB1M":E:5AE\'X.)G MH%'%FUH5ZQ:;0C*4LGZ:\399[2`9TJ2XC#>;9/WAK8^;OM[9D1Z<`E45&9E1 MK65HF)AIDEC`CC!M#,_DH$CBZ6928>RMQTN+IQC"`-"S34O8!+A_XYQ?T>'0 MY39[A;+"CTW^52;K_7G1+>Z)[*5"7OJNNI`D-BSB1Y@B*IGD,E8%RB-L"^D3/0-`/V[9P!TA(@36E1-"53Y`P4K3,!LGYE M;$$C\IT=\IW-C1^0)Z"6Z4T*5)03YGF;U5-9=0KW`%W2@V,-L&HZDJQP^UGW M&G_Y%@<=;[I);@B68C6D'PUJC1QL$IG@D-"!'"*X9I\82I9T\@F1"2[MW-A> M5%;-JIDH3S)UFCG35+UEGTF'Z1&Z*(LO(0@YFS8\N%ZZK&;,KXRHCV*MZI5B M/>?&!5BGQ0JGXNS,OR*1L)_C54)2?"*_SE8ZI_;U*C/*=4R6MF;UUK#0RQCX MFX3DFYA].6)HT".G'O=J9\KL MLP!64;19>`90RV];E!*Y6A&EV6JS6T/#_9+D8)>E0LRFBM[78+6-NJUPPK*/ MMN$$@?D^$9,L>BW\:4!=*]]<5$"5S@"I!O;U1!3D2YHE5V7R7)Q;CC8?INE4 M)O5').GG^;Z"X\_*RA\#U\O@H]Z/Z0I^104`+B%TT>QK7**#I+>/D.W0='GJ M4CT,]RN3G^/R]%/TH`Z9/,E&HXL70[;AZ9+8A9G`/:&`=>B@/%<5P)KYWA@% M(S287ZT,/V&$CT;?)8M[=$J"AM[L'-Z,DN@UTZ?@=-V,N@;XR,QK00C6!Z:$L M25'0E`6_DM*,'L?^*AUZ<:0.8?D%+CJ+BUWY!+_4_R1K]'9D[Y'90'P]5:,R MF,J.^Y"ZI^KCR=`BJW67G&QZ9I\R"\FEA]Y\X&K"-X_C5,%2UP\`-P#V+2C5 M`,K+QN:I0/=-8H;/89,`<)><&GIF'^<*R46O`V*O%HN`-$47Z'(\F*<*G34G M5?V@LDS5VHB<"#:E>J9RR.C2D(9?+-W MK3FDFAQCS1>2M%8&A#=\)S5Y',LNBVO%@!43B`G$-T*IR!NI*8%\+'ZTKUP\E MIY<&ZT=GHF!HP[/MA8].*WS?,CO7#+]06J8-;GC+1D]>FV*2?>,_-BP[X+^*?8--RF)B4R8.ZSLJ5WYA3:Y$.J2@$O?[$-U+GGT&E(&9.V[ M"<@-Q]V*729K69H;4-.MHIP;5!=246UP=5`PI)SYH8V0C6=S<&Z;^"0[X" M"5OSS7U[0U`J75N%_!"-H+\$[T8[^YF\FZIV/?628P>/Q`CY9@==B8@UN:]S M`B"=RR.=_L>.L@271[MSS^;R5+7)5R!;OQX)&/+-CM(2D&I2EV<4&HW-E^[G M'Q-(ALNCG?6,+L_!5R"G=1Z)#?)GLJ'.+I41+L\H1`JKS\;[^M+;#;EU<;G+ M\1.6V?H;_!;D/R!Y<)8K11OK%`C$M(1/Q%I)J&K;B\BK+!6)Q_#-WJCD%TJ+ M6\0-#S\BL&L_<,&5@(*),4I.8\U2BH[#1%7;BQP27^V12#K?[!`P;IE4.TN\ MP/8OK]WP*`&ZC%=4-0]C(BY^2POH5WAA'_\'?*'QUL2XS(RTIO&)BIZ]L*ML MY+[9@6!L@J@F+!,:?.FSJ"D*CL/`?D55&*\;T?*!THTW@;I=YYUFD$F$4F!V M'!B;(+I<="946CEW<$QQ.W<_MG=/VUT19^M/F^0UR>ZV'Y-5_T\53-OJUX$! MDRZQ:S$%4#L&M;;([(5<2"!7=SVRIC(\<9P&Z55KJ7H1EE47H.D#-)W@5PCK MM@!I#-QM0=U3[^\&V01*/^]]&X6N]RB?5%6X3+5*-7OS58/TNGQ4]:*\9^M` M%T[UOHU#YPQ28B_U'<8JE+1:_)N]NZU#?"WGFAH$Z=J&LY9Q@)ID@;)E#?`? M^-3_>_(2OZ$.BNN']KKE'.V0J+N'-]2MF!XS"%,KY7`5_%(1.8WSR5Y$:/86 M/*LH6I2%$=1R7QX]3R'P_,1I+BC9VIF*V)WUZ6`5/W3)0L4G-Q`,W]-ADD/U MFI$%S!&5#W9[V*A\&V^2FWR[2I)U<0?)6CQM-^MSUW(MAJ.CWD;$6$F+JZ9D M?WG'=SS+;`Z.`U=-NM'>E^A74/\,FM\9&;9Z2M:[37+]A8+2N`OKW93*6`KYROIS$LZS+(,N)2/T$?XQG@ M-,N_XI*,?BP.P/T0%\D:I;E-L@(O^R_0ZU:/V('^\+8O4:FGW2JD9@Y8JJ`O425_GI M'M4![79!JV'T2'F[7-4XP*WCG#-5^QSIU:736\D"^'U:@L[R6E8/*"*@2O`< MFGU75Y'$6A;K:K`OZRX[0,<\F(SDOEMH^(;")`-B[,I'1"H9*Z.363H;N\:> MHQ-W>W]Z4.Y9!@7M_L"E@6]%D5I[I@2X!$.F:T`/+)BJ3IWZI,[LY`':QD"+ MG=(@B!;3A/HUSR*I6^/]3BU2_ZI.2:?:IE3?I M@PF;18>)H)OL=GX8J4LEH4\0`Q=OM`.N=!4W`,*-0A*]%U21'V:':$\]-+-< MV='+I\61.GJ)X8PO/^84FCJ?#?5W8AKU;+$/@`A]?U$]2!E42PVS0]2G'YSY M;KJSB-GW6`9GFE,=LM2Y_*!2N;-V\&1DJYQTP'5:L1H$G.4K_I*LO9'9MP"F M'IKWX."-R#>1@\>3#'<*39VM@S=7TSB)@U>#P)/[@F@("?>)#`_DGWQPWHV# M-RKF@(,WN17[FI1/V_4OL"2.`5"7X4<1:H/LT^A0*C%&K1X#WZ]V7DA.[>B= MAH=S#,.L_*]Q653Z6J1G@+HVS!Z9[T+-QAZI=8[V/5;7^!V2XB,@N9NC=QJG MSCD4\W-\3@N%GPQ/LT?PO%W#,=X5.&<]6,6;U6Y#+-7V`3RBX/>?4*`[>&C> M?9C0Z'Q/B_]\SI.D3BQ>AT0&,S$_??@-,D24PZO$)/7WC;E+'ED(R*EZ]#N* M>6<9D_D9*0;IEJ@L>("%]P]KY-->OQG7%?-79K,V16I7:[U]0R>_FD-)5'3T M.PI^IQZ06:W@:*52N9;#=@V!`,U;*3S1[^U+D7-!Y44 M>XWO*VZ%3F1Z%-,(;O7Z,]SY\BB9Q1E`!;C>CNAT4R='MQ1F)A_H5#(IAR09 MI&55`8VQZ3/&*'+MU#SH?HB<7`GT;TMH8I%U)OGXD4G?9O`_B\KB^`KO^XQU M+4A5-JD:PHY6LRS7(HGN`I+]-3+\^@R[-,J)S0QIV50YJY^,V-?B,LA5&H,J MSZOG^>JR"!YT)<;H$ZAK!A\6LR*K/LPS^U;%&&S5G!SINTYYP9F4M:J-##E. MI\?P0E^KJA3>#&`XH@TNA3+2+K!U M/Y*4T]QSOW'0RC>_1[LGB4Q?ZD2F\?-VEY52>47Y9(E^8AT^(S(R2N9&N8R# MIF<6_Z,=HPB6=T])12ET(EO$Z(6MAFMYLDK2UV0-XA+\>$I73P#:/YQ['-PG MJ^WS/@7YN00_CI*&:AVY0\IU7!1SK^GT0=5!KYY^ES<)')DU(E29/B.NE#^2 M)"/G_0`]S-+*5\MY^.?(45?($"\=$7V&%6IC7="F/?"-2]/%O7]SV'7/7.Z=@ZV3A4=\=(J+?`2[` M1\9JC76=?T\?G\IO.[2U"+M.5COX.=*DN(PWFV3]X:W.)UX5+,Z#A>,KV_06 M!">%X/)&YD@5N!NV0L=S42!\X`7F[J\KD%3#5KQ\U"3ZKB"."MJXW[UL,Y#\ MEN2KM$A:FQ-\SHLP/57.-_-6W*$YC+_AL`J5L$FHA&OV^D*%N)KF3)F8]W-M M?72\S0$N?@9(RW@>;MH&I'$44%LWW]1@U?'M\_,VPU-\'>JP"`-U6GO MGD;?:%:W*+I'X9)KJ0[)\>8:OEJAE4&Y#E`"69*"M0O)=9Z,8AFOLJ+,\=[^ MY3:#,V^9PFGN0Y(E#^DJC3?DCP7\-)^3N-SE*$;=5;?4X4$DQG,Y8U"K`E=K MCF_XTTP"4JE6%WYH2_QFXK[N&6C5/@/[^F#?`*A:T*AF2I9F,U.SSB*,[ZM[ MKN,'9`?R/>K;H7B:EEL2H"ZKHE#35GM->Y"J:7L,Z.9Y8IT'P4+=&2LU#$4Z M=5K:DXK4:<()7+.W*UA%F6QFZL=S8CIJS4&XEFJ]T#OM3*T7]!-,]^,A(V9V M5@!V8::>/(:`+5MJ\,*N!N0Z2WTP>9/D>'?O`H>WG4>.K>ZU]K&>Q8_@)([T0JFT]-9)E=:.J+GH&8&%R=1M<<$3N4GU]);9\8D9W M+/98K?#<]BS;"\_=11C@=^6\(##[?A:/.)JL-@>TFO9I0WMLO<$+)'^!:K.Q M_@;R.,GS9(TW=R^J?3)7Y>YJ;Y=B/*>4HB9X?W'+]1=F6^E1W*H-\UCGR^9' M0`X)+CBW49MV2,A)ZS5+J!PK%#7]F*`^`W4WNVD@2&(KFY`=]HY7]PQ_Z()% M#&WF+TBB3;LFYT$1XZ`ZN<="2B7=2L`$6=_-V/[`#ISU;ZQ^B_H>M8_ MN0*O9)%3T50V?ZWMF?Z$&H:6VC7\U6Q)$FJ:)&5@/=+>M*6]+XWV%C@R!:DJ M7XSD[>HI6>\V215$_>$-K]+N\'5B-XP4YG(;[EA,QY@D:E)DC52R`B\TVUND M0*]ZOCH-85D7VO6Z>* M%7JAV9&S)[$K)^P)`)W[(SQ),H\L.[FS]W&7I]DCN9Z/\\4>3@P'$WY@.^K6 M+Z+P1`DO?7#VBB':=.@[9DKW@G2MQ]>D*T:;S]9/:QC309M2QK9*%=WL".GN(BJ0XHY2YH M]I?CV\C(%;-OR0_\$^8=>O%9Y,1]$#!*!JP_!#E!_%#"[]]YH9F M[^^)B*5E-N3#MFSG63F>]$@#9P`V04HH5AIU,YEA2M,_*U$T$-F1ZP7D&WKD M&YJ]OR8FF+[YAQ?BLKW[79`=;AP5P[RWW9[=FGN3N*6;N'J!)%OC)*4?TV*U MV18[^-/%?5'F\:H\=Q>1NGE'$)S,$UP)(]-_MLO>,$ZS:';.,5DBZ@V'X,:Y MO+S^]H]/W^^N/GSY!&Z^?_K\Z?OW3Q_![=WUY?\"O]:EA2*$[I+?R@_PS_]! M00.AKJ"@IE>9JC0F2K^.'-18F!TX?P*Y7D8?=W\BZE!!,$X0QA&3.R;-1MGE;K,^GVPE-WV#+6LQB' MV62J>3Q:R[)M;V&=NX&_L,G%2\?L0Q@.:52;8W9(R\\75]_!/RZ^_/()7'\& MGZ^^77R[O+KX`JZ^W=Y]_^7KIV]WM]P^11^#7;=J!9(3.HV6XS MDQQ:O!(61#1&F_&2'ER*KM?)^F.2IZ]QF;XF#9[KA^Z/7]+X/MW`#WH>69&Z M-XEX48FIAKRQ0%K#W1J:H#US(Z>$Y:+7*NZK@*(8E_O?P*;^$>3))D;O,Y1; M\(`FFU<\V6P?P/T^'X]HEI`:2IH4/88!NG*6PGW0\<[%E(M9L'KF.55QX2_, M=J#H!%#M0E&A6'Y.LSC#1$9'R=^VV4/SAU8#!Z]V[QM1P_3HO3(]8F5Z&%BA MB]=Q5F1C4^6:[6SQ"<3@=6W+>,/G=7%!6]ZA#B6EM_GT\)"LT`QSE%`$O^?D MT[^9Q]R!&+MER(,(S]X.GIO-/8_B%TCY,H,;VO(6^D$)NGU^O*'?U%25_>DT MG2C?7)N/?AR^W\;YT(,CF.(2?(4#\P0 M1B'/PNR]-V'96'V[VS+.2[[-.%&L;0_OO^)L%^=OP`[T^GAJ4O/.Q5#9,7?[0Y/TVH+CE(G0BJT[`Z07?#[N;Y$3U]`C)ZYF M9R%0+/D&%$/K1/Y@:SU\`B8FE3/W9L![K5U.%*M=5T?96][,H"]VM5 MF>AMR]&@%=V.):D"C40=_O=4(J%`+OD&U?49LQ>J'-)H8SLUI"4N`RS.=P_Z M.K3W-%!WL7FD8_G$'I1HC-CVP;A[9-Q#,N[FAE=Q2C,%L<WR MB*F["R9S-$[#:]SG4S6"*^--O\TDA MS[87'MFC=LT^!!@&K<]*]G6_O-QL"W2L>Y?':YR,NTYF#\WI,S1=^'ZIV)[H M_HSY?^_BK$Q+'+AVE3UL\V=LK?%9_:VO9-&<')W5L5'IFA_5?6AGW? MGLF>DY"`NG=IN5"V4Z>1=LX.LWVTVP*MQJJ@#"">8DV0GFJ3L,U9<8<3N7$V MC#.1F3WUR1)1RT0I">S!,X%?X_P_20GP"J32:$Z]'`\)(S%@>\Y%EH;`;!9( MDG10;!0ZFL?4G!]%,SF4YQ!+V_3(CNW@..9TU&([2%'"?,C%.+6SX%ST;GC& M8VK."D.X(/2(?37[T$*.@'IG.Q&H^[FN5R_CLGU@"K4T/M93WK>>NU<08<<7 M92/4T=1L(;@:7H)F@R6X82)O,+J/2+,V&=B!V8M(4=&4;_V)X3MP.ELI4]MJ M>:B-HA.D./W4;$?.5!>[6YV\37JN:T41L=!FIV.5):*>;50Y8`\4M:6.K3`C M4(PH\2]XQ[8.7.5945YNLV*W*=$]HL<\P3W>)?DSSH02T">['&A&3(_HL2$U M&2J-C^?,=11/P59.YQ,`EOO?05P7`+"O9\E$HTP;.0W3#E-`C@Z9N5>O3L&F MIQI_.L<3&'#21I*W!&=H3)\3<)^4/Y($+1<*E,H$7T1,X/^MX[(^9>\0E#%) MX\7ZW[NBQ(?_=]N+]3HEW^@F3M=7V67\DI;QIC^^`)^*57$"WY/_WJ5%6B:W M2?Z:KA+RGB='80/-GN]:S*UMS$2#9=@ZKOZBULT.K=;).F9/WV MATD;&VG=)LV*G(7MD>O.@=DY(*8:$BV+SXF$6_ZCCFO$[XU7(8T%>,SCK$S6 MC,N!IS1Y:%XUN7YX@`CR^AH;-`;*O*21C@77$"P2U:H[5LGV#7]O\S1XU?/^ M201+7`+LG\^IRG#>A:3YQDHFPDE9VYEP1BK!U7)D1\&"O,T2S);`73FTF'86 M1,O/:?X,KG]DT+F\?P.7GZ]Y64T6T-"*7V3K#\V;::CE1IGJC1"Z1,^G6Y2R M7\.&N&'OZF?"R=\L/'.DS>C.8CIR&_I?_HQ.QXFU/0-?D@ M0_VWSSB;`N!.QAGG/]/R">W`Q-G;39R7FS?LKW]X^YCFR0KRI5(+]-7[DG'0 M,Y*N(^F%.DAY^W^3-T!>,L?DS:O.R+QF;3NYZ6E2@:G00G%*NO$;2YYT?D.K9O M=NB`@%0335\4T$9TA-0&576-&B$V%1FA$M23S?`G(AE:#7^$2$"JB:<3"HA+ M^JKJE8([(-D8G1C:JZ)H)*@^#4GNZIM]`U5$+)W[53P`1Y8W4J:++^ES6B;- MTQ]OE9]64T)5)B1XZY=.$K]NL?-J\5?D)X52RGV>J.+WB)LF;&>?,;G2BV>YLEX"V)<\8;=-P,I5O.ST/; M.JX-R+>UR;R]8DH1:G#TY6)O)BTG+V+0)9Z"^33;P[X\_)UF2QYN+ M;'VQ?DZSM"ASG`C@TV_H6@=ZY7/AJGO'@P&)F-*)B5PK'%,KCK\P^\B20QK5 M#B`[I"5Y$Z*JJ"IJT!4E6PEFZTIG:?$L>R*H?#2GB?1&OW=9?' M61&OT#>HE*/X#+G0^G.!3F[:5'3O0\D[GI]PR_A8 MI&)0=6_)[`!L11)K\1C58&_T_07KN[@7V<+P!7JF5V7R7$"?S-$^!3>]*U&_ M$=E.J->^IA]$"_(Y(OPY'+.W(;CDF6@.'`4U/,>!7U%%@&O*<5.+#V_M7RY^ M2Q%C7'5/M]'C4*(75/*>T)#>-D*?F"[X-?%G-/N&IJ!D$VD-);QA_2G.4/## MT:H/-<.=1YH.*9(]F4TWZX,/`1^F'$@HJM M90B%WT0>Z\V-/)?P$)^(!J:;!5UCH-QJ:!)$QL/P35I3TBE*B4JZ17^!'1MD M=\QZQWV6=D?>6^QCO:'K%WY$R.H0LII]$*EQ%+1L0^F39_DSR2AZ1IY*[YJ+ M]A_@NOT_\(_UG^#_ATP2_,O_!5!+`P04````"`##@*Q$20]45/)T``#(.P@` M%0`<`'9P:6`L``00E M#@``!#D!``#MO5UWXSB2-GB_Y^Q_T%OOQ51=I$K4M_IT[[M*?^2HVVEY;&75 MU-SLH27(9A=%NDG*F>Y?OP!)D)0(D@`(D"#L.6>JJ]).`GCBB4`@(A#XZ__Y M<;![K\#S+=?YVT]&?_!3#SA;=VP]7%M_NK_^Y=6S;\NW[OYN:B]_-/ M#]<7/_WRZ5/\ZR^>NSMNX>^[3F\X,,:?!I-/AM'[?WN+OPQGO>77Z!?AW__S M+^@?CZ8/>G!^CO^7UQ<+SNC9^^"Y.^@_^R[WA/\O<'DU^B'R:^BP4Z^_GT4_JZQ6"Q^#7^: M_*IOD7X1?M3X];^_WCQLG\'!_&0Y"*\M@'_+M_[BAW]XXV[-(`0Y\]>SLQK] MFJRY\#?0?WW"O_8)_=$G8_AI9/1_^#L\Q=QBR(/\!*'N]2*P/=<&]V#?0__[ M[7Y5#C3ZI5\_FS9:X,,S`(%_9WK`"9Y!8&U-&TXC_.:S!_9_^PG)[1,6#9KE M_P[_Y-%_P;\7O+U`3OG6X<6&>/U::U:7[O9X@%-9.KLK)[""MY6S=[U#B#O5 MO'8FL&1,[*OIF$\`3>T.XN93S>4@!:(55.X#V)@_`-TLK$#R+"Y!8%HV[61V MDF>S,1]M:F2D0'-C!=93R-@'$`1V2!JJ^:08RIX.B\AL?V?(F->M&P!H>-Z0 MO*@FXDA1I_4+\"`ZSM,-@#:5#A+7;F`F+#)R;2EJ=38CM#?NCC98[V]=YP+M M'C82WNEO+3W/=")+R;@$WX5:;)M-K(3!2+BV%"-Q![TNB!#5%*3P/IX`BXA> MI(CF'K((>J#0!0G>-I`[OKE%QHIN2MZ+%.D\'!]]\*\C!.CJE5I,/I`RE<#= M_OD,%1QZ^%?_.D*7B'(R4HSV.3`L]/&!%/Z$`*U?0LY`M_%W$QD@6I&YYO<& MYP3=%`B:]0HR/T]_G"7_M>M=P8FX;X!M(T`+LM`_@GVC:,,-`<^WX#=85^$` M],\FU\"P*80(RYD:M(7AWKG>7YC^\[7M?J>=TG8O>T;Q+DIKG'W7E6.##@?3 M>UOO'ZPGQ]K#(RL\+VZW[M%!&_R=:UM;BUJ.OBEE=Z6;(_M<6YPLDWK`J4K2 MC_/=\!9I+[*I;%N1(^=04V0>N2:)K*"L:<9*#:W,,W+7X=:4A_820"Y8=&=7 M:'XL:1L\PV39(UGQS*5HUDF0C3*NUIZ&LY$3JK@4<7]QX90NX%D0>`[+C)ZV M'!YX'=J&> MLLQM^^(W.SG:6;^9]A&L]]>6`RV%9=HKQP^\(W7,6OB'WZW@V7*2'_VG!;UB;_O\%AD(TWF#J_2LUW##SZ#SS0_C M3Z_`WGQW5\[+D>U0%**Q?SWL7Y_=[&$I7B!12$C%CB]%YI4 M!#3WT%<,PD//#?P#_!>LP(9_8S`8]3[UDAT"_GN\X?>B';_W\XD[\@L>#RU" M2(HNFCCX$4!_%CI?X<3QU&UW&_^6;3X"^V\_P3_X_S*^5"+=.]>WPDC$(Y0R M1+(_,69&WQCV9Z=`9O.P>]-_##.21__3DVF^H.3MZ%=@!S[^$P3YZ-/`B'.; M_SO^8ZH9G"[/1GE7U\."*5T?_*050*5[!;L5%)OSA`S^TO!F+ON8T8>K74`T^;9^M\Y0'_`TT M5+RWWT2<*/Q>^+$`GAY`^)M4Y#IU'*!"KKT0YUUH+^^`]_`,9]4Q>(:+^S?800AF`WD&MWQPY8A2BDY,D-%[(,C* M]X_A\J>+<:/DB`96E!@$5&)2C-\#*=;PT(`*^>!)`BF&,6B4&9G1%:5'$3XQ M1R:Z<00>.`^N4[[#SHR1O-V%8@(*4(41II@M4XW9DMMF9\98WC93,K!:["B# M)6;%3'M6Q'LL5(AIOP'MTSS3AK[\20_\,60&C]ZF';[)D_Q4:C%YTK:5'N-="F16@N2+#G!F59$)5KT]^;X*@JY:N*XA[0BK>_!D(8BIHV1=P?`^5B^S`CW^`-[CNJ@`"F[C/OJ^.O(L7KFW@^>BA MP:^A\V_:?P#32RS;1)2*%PVA@M@IEJ]K$!DC%ZT]VM:NX9_Y_>%`E+H7CJ&" M[&D`T#56?+IV1'R\H(G+5[7P'"$UK5E`^\"6KDGUT-[W$CHYG[R M=17$7;YH74.]L4-3%O`V%J*B+=6#J4,$2DAP9&;006+4C7P:@R$*=T+S:+NH M6A[^Q]?E[?++U=>KVTWO[F9Y^\`8["QHN\,LE./!),K<%:EE[^?X@A'K19[B9FGO7$_3MDRN[U^8GO<&_;+OIK?S^\9H M:BRDK:9XX/9TE!*,#FLH';.O?KP`QP>?@0/V5H"LTZ@!6I^.JH"E+H%!UYQ1 ML09`,*RH]4P491U-!U71!QG&X70:*IJ*$J"2U++J13GBM_91N;_=^SFZUEQC M7S^]%_W.M_6T.0"Z$.\Z(.R>46#90N0RSNAT5%D44*.,D']F[6F[*#AU]1Q2 M?*[V>[!%;1<2<.ZA%;P'6]?96K85BB4/T$R>GUEG:BH0KB:@NE8SI0!=QJ-` M9.(+\LXNT_,CC\V\">/&-"L5>,8/8X=]X?I1Q.FY5W.SVJR^+#>K]6WOX6JS MN0DC[XQ>35G_^8%!^A^8&/)GV5S-`,H3, M3+^-N)G20[\RWJZ^5Z(6E3?/R^,1[.Y*EOR8"O:*[A;`';^-81PY4`] M#'MM)2`D(98E\G]#+Z1O3`;$"S"B.BZP3J@EXM0#KL,ET/4=MO&YX;]=;ZX> M>G?+/Y:?;ZX8S3SI!17VFU_@,2#X[,:HLHZWWGU'D?&FT^^E'L=L.I?7V:U@ M4#$%2Y1"R5[.K`#@'7MO MBS@\VW/WO5O7Z:5/OO42F'LASKWLJV^_B-+BNN_-O4>UOSX&4)Q?+<6!$2]=T%CTJD"D`XS*1F,KBF)&B/"(C MIFM0K0"_A086-+0$4VFKH9R%3)8O.%E^@DQWPGMN8-IB;>0].)@6]#4\U&$+ MWQ$-]5Y>/WCN>2EG+ZO1>\3(2 M4MFJE''E+7@1Q3TUYMBHSHM'MA<_^^6FZO;#6OH^NSA<6;]_N*Z MN^^6;2^=W-LPI-*O\4)>2IUI*OS6H?C;V2MTD\K65G6*M"MG($2S:\HVO<+" M!M@[WM;'@U$^*AXK-G<8+5;QNM&PDE>@X$+`*@`'OS\<53;]D?)X5C(#?KTN M_OHW'^R/]HVUAT>;P7`AKSR<9@I"-)M/EM7O@14@U6&-IJ5,K&1?/-?WT>MG MHT;>D,N.JA8Q"O'HL--6T:HV??X.W<8Y!:\_6&5N`K.#P"KS]:3$;2UG0R ME&S*TXDL+:TM0*'%?;$>93^_I0@L?UA(\PVC#;J>3T2VX*L73O%H:A5[U*8% MWZE0"C$:.O%G(E?%0@WC5/WQ+#K&2EDN_3Q://[G%($//65TH/(9E1KDH+`5 M909'&8SJQPN:WC?8X@4MO4;1^+J MX?CH@W\=44'O:ZT,UOF'TK?/AA+[0A:-6L-+/?MBAH2SD<0G?PO'%;.U4DLG M\3>I<'C/RCA8Y)1QL[[XQW^N;RZO[A_^HP?5&L/I7_SI" M*/DU,O*6,1M)?,>=>AYBM)=1DHD.A^*.8Y_&8/A6-I),#]>#4T&G@7\Y1V6>/C1 M.+8[&0SE1;A+!A:BK#1"2124#@2U(Q29)QSBJ1N#^4P>"<^':UQJI0MN/:#` M=5#]_);]21@A@P>W@30ATL]#S*$\%BEE@TV7R.M#+D9]-'^Q0*W\`91/) M/.EA\ODM_97XCMP2/>RQ#L'WOZ`WY?V5$[TZW#>FB['$E)70R@]LC"DY" M!Q]L(3RHV?2%:=M@]_DM_CT__D6_/QN,Y%U5K3FYEM@E$-*8=1/=6!>996>' MUY[7Q=],^PA.$Z.9WT>J.9)FV:-5&HQM2;ZD:]T]5?6J_6#C@[]``7 MA&B+!/($^L9X*O'],IHIM$0A9G1BFLQTHPDA4!MG>R!V\NZ4%@XK+%F"RTN& MQKRI50A,N#*(I2!@FU^_,@%WCL63[\O[^R5'?3PR@W'0JG"#9WD8))EE].XH#IW%0>0+UP_\\!CRF(FU9R<$*,GFC3)`R?B@.]PU+9^T?`@ MW_>]V`#U?EXYR)&R7D$OM"Z]R+ST3&?7B^U++YMAZNU=KW=U>+'=-P!J]($O M,&7);#(_3W^E/-().+L[VW0R MW0HF\=N-.MN3Q-^@A1BM>4GI/?#^;D17Q^?SR56 M+(J:IDJ^0TD_"H'"4%LG[]&"H@J/T51>N60R3(W2=_0)7&$\FLK;8S(#B:FG M+H8X*<0AKTUMZGPU?Z`NS;AWU4ABP?3)4.*$4L0F+);"%2I3"T<63-0^.YGV M7-[]D).A&A1,T0J5T1CZOC#"]_T3HW)N=]1F+G<)5B8+,)C)HWO]^8D)&,LG MCUA)M%B5HARR12=%94R7;,U4JP*533.EE.JNCX$?F,[./4#>%O+!W>>M:+[+%-Y?2R%S_>]<+M`0KJ6=@M$[<0XA$:!Y(+(M<>Y>;PGVA8+0-L2<7'@ M_0Y083W8+5^!9SZ=88GN'JKK3U.NXCVI`K4T=:U@3].UY5@^,F,9/18,#^P7 MKA/Z?T?3W@#O8$!Q>J-UB+NY#54@SDDDK/D>1^WNC86)W+,@8M+:I=)9;S'- M*70Q7=:,%L7^;F-O59!>N]X>6`$2("6H\[F\&\M-+^==:U,=T6L=\Z@#ZCIX MCKM,K9RM!^!O78+H?VDQ7DALEM/NZMZUM@DD1I+5'S;>[5%MY3MM]U=IS%HL MY1*WDG>M5)P";[%=J@8QQ[F*0;&V0H[51Y87RS.CB`#EH27JRM4.RH*7TR'C M-)=P6N47?6>R[7`ACZYZ-LHP/HR4Q&"YDNAJF!#3@"H0FDK*Q_1SR(E)K!SRAGDOJ*+:2NYEJ3C`A7(1VE:@9@9H0$J;< M"=,@X=I`A>S4C^>=VHY-LYX!H10AO#JG8'.*XAEW@?K"F5\EN7=;*$)3#H`K M`7Q<"G""X4S>@S>29_\N-8%%HKKV92#4/H>+/Z^`#JN<&:[VTGZWD\3C`NW= MEH;7C(&JGKE2XBA2%M=5'<`.Q>-E9O=(BR1Y3$GOELFRY6S3>Y$NH:.1,FPV+(,&=H7R)W-NR0]@X#4S[3+#8_F.T(PM*7E&J23C*P/YT<4 ME3JK5U8N?A4_R!AN5*3KRY*L+.(]6A"(6V@PNG0Y1RTPTEHBEX_E&$0^V MCU@>;+]UG>0!]I,WV_WLH^WBGV:'X^)A"W[CXQEV*3E:-5H[%,]8B'$KE_W' M,^QH]1_/L!-4\.,9]H]GV%O4R7NTH(]GV#^>86>GSL\]$NZ,V<[E/[#!M\!$YX9 MNQ^/U-=$[N.1>M6Y_?%(/2]J'X_4MTS;CT?J:X#W\4B]3JKP\4A]DLPNQ_*1 M&_-H^Q*(FNAH^Q?#Q2KW[?CX\7[,X1)5R2 MY7J.GNXZ5KW1.F0-.&UTUJAW@NODW?VPFM3SU"K M^3SINWF?7/QKI0*)D29T%5>^YO>O7!.BU4A0A?3(>42OXOQBSW-QPTG M2NM2TQL9]^O*JNJ2K@]KR]`F?M&G&4(#*M2'/O'V!PJ];5)@0!%]8EQ.A_1) MO.M71_1I7E%Q??IXJ+[]6&3S`7,ET=4P-Z+:0_6*&Z./A^JEWZ61#>+'0_4- MM3K!*UKXF\^C<)3A_L;O(N0=E;YTJJ=5??J<^S6K;LU+\F MT!;MJV2EI!.GFAM<^EJ\FA`2IMP)V]'$`Q*GLE/_DL2I[=BT\&X;S?OP2E8G M5\R^"RHAON4-@T0[+Z>NY2<^-U.4H\+M,XT2FD\UTK]TKI2 M)E4QYZSB]7BE`>Q08"2/$(QOQ'?MY_,#4++ MTX(=I_QKS9!+R+L2F%D,\&C:8Y.NGU-#S]QW[VVE9G#I]-M*,G/5)6+Y2%G3 M)^V*WYAO@-PE4^D"OR7G4XM%\Y%7Y9+7NWQKM/KN6IYGH^;08IQ>%\R"G%@: MIP@_XB)54BRVMT-2!9)DJ_&Q&_((J#,1Y,8WQ)JO$C=%?FT?FI:@%?5%JGX! M3SOJPGC9ZP1;4N<'2>K".WJAEK;.:I>]4.]U1OS7^$J2FITV"8VNA"35AI\O&OO^:$=P/_(/H9\4=X M'E:`UC`R!KU/O?3F+/R/A\WZXA^]]=UFM;Y]Z"UO+WN_+^_OE[>;A][/X?MX M_B]X,3D<7BT/]2>&9'YZZV_=0S3U;&9OZ>Q^-[TPQ!I][!08@-VDQIXDEU+3 MV=:3Y-EQ^3.Y&RB%S_!S?_;GLX6\"V"")RO$RHDF%39F$@73F40;ZSFRXCW/ M6]/'@SF:%N&/PZM0_;?_9Z[[UV8_G/OVG:_^\S[,OX,Y`/\R,DW MF/?CY>Z?1S\(/[=Q[\'6=;:6#6Y!L'+@B.#&]>&?HV'N//?5@M_\_/8-$F7E MK*%K`Y?N/,4TL$[Z=\A351D3YM^ZT]FL]]A#"E/18'<-]05XK]!W]?N3.3$A M(AJ1LCD(L46-L"5YMYD96VTW5:*!#N^+DU(-,LMHNT#ZP76 MO\,%K_?7EF-"H-&;--!EZ$\6,WGO)Y:-W#T*T>*H:R[U=/V7X#%`3JE[=(([ M#QRLXP&",)>XP54-WW5&52"J:\[Q$L#/;ZT0!/CO-@A%X^RRX/3GHXD\9Y)F M!MTC%RNNG4G2,?(KQ-*'$X?NXJ5[?`SV1WNY#;7,[QN3X6PDC5AE0W>/4-1` M=B8NS[H!2D1;3F\3M8[)7TS+04.N';C-O;B^%>U[2]\'B$&#R`0[B.HE"*M3K%>0ZF3^9U`L_841W:648^&8YZ,\ M"?-6KQ[F"1-GJKX=Q&T(<_<:$GAO+//1LD_Q'<[&\IXK89L+OSN1'P=[HW?F M&\I&H>@,'&J`%,_FRF./"O'/WHHR/$`@L".RJM. M-N^QT2B1RN>C,*E8@$Q?T]:-8+<@(`4^DLH!0N!C-)98M,T^'_[C`QQD"\#. MOX9,BVM4[TPO>$-)[KXQ7LC-NA4.+41G1,@UDU2CPTG]PP+?D;H&F'+,<)-: M<@^=MK>XBC!]<_D%AK731L MVR0IM:6%^*A_&.(N:5XRO-FVK$="W;S*(05P(D_::@XSJ?-;,AG0^M-%M*<=*V M_C+QVY)GTY"EC"?4(U MPNFQ:[!QE]M_'2T/?#6A$!S@O4$:7,$_>0D?=().PE!B:)1N%C*5BTW:YXX5 M"WKJQ]NYPXCG:*R@')PG"U7VQ0G@\6@FL5"Y<@(=8%`Y9OK&H&N@VJ1;*L4( MTX]5Y#-.5`"B:?^6*J;W2Y"T MIQ.9ZTK'DJDH3)++*$H!$NI[,)4'@2:!E'R;3GV7H*DK$4U?.N*X$=$D[[@` M[,Z>IH1N\U^-TC5]5P/=)MU764#7-HW^+'YK0!K92H=7B4S4.&E\RH%GP(WY`Q656KN^81@2 M(PYGHZG"A#(08L$/=,LZKASX%R!B\8)G$WG;3W8H=41>L/Q$WLJV4A&Q*T3_ M%B"/%2)U#!]S2(R>Q"M,M+-0A28\J"5;A686(ZG=`SMXQ0JE"A MLQ]E!C^#!RPM[;0P4Y5XQJ8Z"E%J`?CN=QS#..,5*%/731U MK:*^-BWO-],^@N05!!RX?.N/C?&`X:7MDD^IP@+:U78G),1ZN2);^(>:;8&H MO><]V(%#N"3<*;QOC*=S>?W,&&:B"GEXP8O)-->-3)<`',#NTD(!6`?^+\3/ M>CRBE:R0J_;/HQ/&?'ZW@N?D@LKV&3UHMM[#64'@0YTC[5<%%J;^B*IP23!V MW2D59_5YX]>H,H]1I3EP8RK/URD;60B)V);&GO8@)2]U#;G6*!!KLF*I;O%@ MHY2B!$^#P&RCL%+>XM"UFP`5EE+RW[4-.G$]Z%-P^T?_@^K]7TT;U7E%C\N? M%X?TI_,HGR%E?2PS:<[:Y/+VO(!UIS")+4E/A:(QZ+I&+*$Q]+PW:/?"XS>4 M['@D;V54=W9M7A< M%`ELAZ^4UW_`?5SZ@'M>UKEU5S_@7D08AA?$L083N1UE"T: ME7\+^0(DDE3[TQ8**KKW3G MN7O@^^',D0&#%@N!AA\>2Z"8&'-Y]19TDVB))1P()60Q]"(+_$W7@QC$C6*3 MI0\'$WF94O*@+9&!`@%=DPQ9/;@&J,G>Q)":(#\=3@'MSZVZ,P<(1E%O//,5 M(&-WA."6C!!8/RNR[WX!4X1W0"F1H2KZOC M8820E1KY]#D:PB(U.%$+!XK&#&A0FT8N=W0=%QNP"+@8A4R2>R'/PZLC$@HFN,[7=@/3W#M2Y?H15_`K?'PR/P MUOL0CO4Q\`/3V4&(SI$QYH.1/#>6;U+M<$@`@+I&]->GGD%L:&-_0,J^0ABQ MG=VE:NG=Z9?`ML=4`27ML6W1Q]X=``?TW.3I_5-\=Q!EY*830]Z**B?0"*U) M+[OIF4C4#9NYL7)9]>&J_=#RX\<3$/>/13&V2C@<3-" MEA!)^0Y%K/82U M0!(28BJ@>23')!]D3*-\D"Q_X&2XAEF=WS5+EZ]^P)1[CZ2&3,ZF*(_/A9^& MF]9H(3%N5C1NPQ3/[^U4@'0G`,S<])D2N*&4:U(2F7YU>`2['=A=`L]Z#0O5 MOYB6@SRXM9/_&73Q^HNX5%'.4IGGT[!F#'-7Q.HAV)E`P8OK6V@!&^&W=HR! MT?O40UV>;-<_>@!=V_GV]>OR_H_>^KKWL/IRN[I>72QO-[WEQ<7ZV^UF=?NE M=[>^65VLKAY8+_(<#P?3>UOO'ZPGQ]I;6Q.>;+9A>RDH^CO7MK;6>9J:X6)/ M_E,)@<:&O.*@XF'Y#4,I0!N(R6?X6W_VC9DQE+>]GC.LO4C3^0_.S=S(@)Z/F(?=@:YN^'\(6*D[R[-8E\+>>%7*U M;XSG$WF91=;IM&4-:L&&[4('DM)L08][B#,-#E?O&$8"WF71HN&;8L* M5##HVEH@KN5&3[Y"=QZM((?"="#5FZ@8OSU?@@4874N2"CHAGB$QG8_E'6;#R&X M\@/K8`;H"M%L/I=7&'LZ6%NR+UER$K]4ODZ'3LL9QM%0WCMB M='-HBQ3L""5X#??P:.;[V"R!DG8P'/ZC*[N='-HC5/@P.E)!DZ M0N9%)\8X6^`$4=O`>\O_\P(.9`7HW_JS(?&Q%E$D*1RX/5Y08=&=2UK,#:]> M@!>\W=DH#^7LD!<>1GUSI[7)D/A.F+!&6%33:"^9P@%3["WXGD'/_#B>L7136,Z&\LK-*":0VOVA!F@M`Y%,Q-2<6Z%?.C>A7S&W3]7E*]?/3MCVKYDOC3 M28S2:"&4V[H58(3F'=^-&0\6!%W?K"_^\9_KF\NK^X?_Z%W]U[?5YH_>S[?H MY7KDN/_2^_D2!*9ELZMXIA4'DDGPEGPT_B*_8G\WO=T&_JWE#\M'ER:1;*=2 M=#D[4HUK;L1CTA+"X3Q%&];GM_1W[LRWL!<*&CN=@+-##+\U#^#2/9B6`_V= MZ(*GE(7+F+$8"U$J^_)SJ3C`6[0B-)E@="]HO?\=Z9L3K+U[U%PNQ,L8&/*4 MI7!8?L4A?C(6AS&(GK)O;BT":%VM2,9X\4;.V`KP#U.>P/C>EX M1A!EP6&%]`UY0BEB6]*ZL6I%G1'(YKN;F?Z<2R#)-Y00"'E%+?;*$63RY)3Q MU#1Y9?2*6G*YWJF&D*H+/]4STM&:3JS-6X\J ML9)7IFO=V#U/4O7T&NZ.-KAF$7UWY_A'LPJ`BTN:A0>_AE'Q*#%<9 MX4_.N91+5)M\Z=Q-9PL>+/@/E#F.LLCH3#0TQF,2_PJD5?4]?DJ5?3FV$&BN M#,RJ_J(0@G%`G%P*9UMS=ZEVOA@Z%T:0`(FS_6J^;;[#%;\]H'NWP3/T1C;/ M[M$WG=T5B_W#Y!.%'0U;N/X8`GU0P8MY8#"%@P',TI/ZL, M'9C6K^O-=*P:$(A*+$A9Y0KK4/%99;C`M'Y=VUD4F,D"-$A=LMCV"I7YP(:! MKOUOUMO`A6N%JS_QJHAH3!8,>P7UA]MG!!\&W7F4GHL1D;]];7E^4(T)0QR8 M\?/*L(,+CY@C"]TX\@"V1R_L)7AW]+;/I@^63]"HSND#%M;4_,9?P3^U7@C),&8Z<3!]OGQ+\6&!Z:!>.R$!R:BD+ M(6'P,ID^KA0]&+'`]-#N(O`2+L0N1`+G-A)$Q@,&=K!\NWUR<".!H^[:.9Y0 M7>`>ZR(HJC6%=">SV&I0?;=]3G`A@&V%=DV\(PTY"_<7P#$>,'@9U!]NGQ%\ M&&`3H=VY(X2#[&P5IH#&`X;3*?,`BE"$&Q-,%>T"6Y=@&ZX6@O(_P'/7#JK9 M+0:$6&U90!*&3[=/#UX<,#%TS8>@'4=4:C=Z,B3U: MBPXK+!]OGR#\6&!Z:)=,B2`AX[!RKGYLG]$-AFO7B_ILW8/`\J(+#2E*!L/) MI>YXJI!($&+:OG]W#1X]Z,^]4=?)CEF\%[:OM\^9&FBT>(&T^4-P4;4L0QZ? M]KOMDX(+@0ZWE"FEP]^/-G4.>\)0!$;[W?;IP(4`M@[:GGX+?/D"7(C/JO(= M;Y3D2$U4,%NTBZC2@S%F"9YUAA<\Z\=DT#66>A9:?K8\=.8C;*T,R3F&3[=/ M"EX<,#&T2\CE"EX*L)B0'].D+?I1E`XM[H=GF/:Y M(@(?3![M2D#(X$31'O_J!_"VE@]V&418RX\IOZTJ32B0P%>AM0M[T2&2>30E MT\H)XL-:B95(`4YI)VI080H:6S^_N1>):,V]B1=OP)0VJ09PPEN%,/ M&1"'PP>;2+,R?]&JAA&0]F+-<_F`=H MGS#U,,%4T2X032@,NG:/(2[GM4'K/9R&Y3QA>(PQ2WL+[H':IXX8C#"%M`M' M$^")SS>HYU``#E$G M7X:$&/$C5#2HF!.2_>T126.]_^98@;\\!L\0]W^#'9KCB&N.)1\53-UR2,G- MD6F6JVM'2>)K"QB0-$UY8=HVV'U^PRY&_(M^?S88R7OTMN;D6J&60$!U[3A& MA`@[K7"'0"U32+B01N>]X5[.+A.^)+,;Z9]!.MCX`?P]`0/1?T9/`X1)B9HSRL>N`FBSG-;&QT0 MW6FG]PJ\1Y?)E$6/6<']/40!:^N%Z\--')KRZ4`:&*/'CI\?5ITSI'?IO]SZGL6P<&VO<)UZ>\N#>T21LPOSQ0I, M^^K'"T`/V&W1&'_L/<30^D:X^<5<'C9(-"VNK'RK<2BIQ+/,T7^RH%G M!LM%N$U90GSB9]`*NR0#J6U;SZRASIEF8SR?D?)JXH]L]_LA' M6,Q(I]\&.)1,0CW>D/'1M>U-`11A*/$$B3GI>".5*:=S4(DH)>CHVBV+G#F+ M-":;-V/H6T#Q207JEZOHN(O?I/MYT,YF(WP%*J8/=\A5XYA,XR;SWC>EB M+N_`V]`JNA5_J2$A;;OVU`7SZL>+Y85_)XUF0>`FI+.[&M0FS+B3-*Y"7MNN M8^7E+&]%<^M.Y,]$L&>U9J&@O2+-M5N6JA)M;=^: MB8I28O<9%:M808`P2#HWH93/F.$B4>4'6V$&VS*UO12=J4:*HW#'1W_K6=%& MW9\94U+)F/#*+,+8;1=G5<#1G9Z'S/4XIQMV=%L$:458=_#@VKO('%K;E0-/ M([8=&LVP4B%4JA!>AIMA-8=3P*>I!Y&V/1,K0;H'Z+8=/,Q&T*`_OCXZ.[!+ M0>(.3S$/IR:/&"#2MGUBZ54C?(ZX!Q!*#P&'KAP]0,1L$%]#>L,10(/!*@D9 M5)V[,[7@TO;-D5/U@S8[W/0C5>LO1L3[S6)\G[*1%;!$Q5!@3U@W*I1ECJ(_ MOG:]"]-_1MDCB5?TJ.>A7'ZM&*7,>WK&>R!--G@`\;AUG2V$Y`*>("P(1"B, M$!]2[7(#N?S2B:E$*U8H8?C[.[-("SFF$CI\$@M"B"T&$N/W`J?:+=-;A36VLKI>M7'\P#LB-*+%9QN1;=RT MY#ELV<'>G(_RZVWF#GD`P*30+O0::\9ZG_2>6S[!?UP#U,QGLIBS=#$J_E0K MXJ9=&I:M?GV*?B"["):V[7Y'[+YVO0(H&,IDJ3[:CGHS+Q=+7KMRV=,JB;A: M-,PNI?<8MR#" M@`HH>6[AL<`''99W%6(/VV>P.]IGM-^8CS:JUIY&W)]2U>PN?UA^WQ@8B_BO MM-BJH@D,RM[E":%`M!N<8M%&Q+9^`^XIX][.VH!;MGR*%M5B;7`3`(0!K@T< M,V3C:)+3R^:M&N_#`=Z#F:Z^;XP7TV8Z6)(GT$X4@PV7Y%V)V632T:VK.+2> M=`T9R6N]G@[4A+AS-SL+UID>*683M5T2YFN:A]_,M`C2P7L$OO9\O06!:MO\+7E<.DE?+"XZF#:GV]-;? MNH=H%=F^D6GK?#_YL1<=N7LE.>C$2E"GS94K\TA1=. MP-G=V:9S:QY`_"3F9#!OL0B18\9"3$FY[*E3IC4!U[679?6IM[E7\.JI'/&3 ML2"-`?&E;HEK$:@`#"(JC67DL="5U'>NY03_`SP7/3F-[]&>M.<+`<+/VQO3 M`<.M=*:/RR-`$;.3LQ4W!KJR`H$1HO(`7H%S#=T2&EC&#*D@]A':XT=--'3M MV1N#&*]X,IG*VS=.AFJ/"(4KUK7-0'HP6N^SSN(]L,T`^8]^X.=*0?WE(SR3 MFMN@;TPEMAZH-[<:YY4D&LOO2$>QV_%\+J]EA[!I"E$WT41*SC(RA*&KP;Y' M4(3>\'@TE7?'(QF&7\?"3\1F%LY5WE$^,Y`0GI=`C"E;L#9=7HK4C-'R<+GLG;Q4Z&:E"D12O48&N@SS8+]V_H MZT=FK>:IY:8PA>,[[;[_*/8>59I&FPRB.\%R(*H]/\'U,<()5?N6%5$2'2R\ MD68*BU(VNOH.3&5S3&5GY.]U1<-XR@F[5%HI38&()ZX$(-7+9)JZ69RWPVI= M)V;;$<5B<_H$V_+5M&Q$N6O7"QN!;[5]"A9YZ1J8 M%P5>^IP1ZC`B,1HM>K[OAMYD">GJ'GZT5Q3=7E%)CK.W8M2OF_]'*\8F6C%V MAOZT;1N-#YM/`^-'VT8=E*&ZQ:/1Y52,?'7X:/'8=56@;0>IWW,`Z_W>VL*_ MD@6Q;XPFQ!X38KA+&E)YNE7BI.WCKPWL.7$E`-2X^:+3#D2\$.79W)),<<9` M.RLJ?3.*RY_"YS_D6>:FEO&^](-6GE@[M.N-2$;S//3ZS8'+SUS<17VDP)).$?,V(X'GT71A1L6>5Q!N;+YHVJ3(6 MHCRW6Y(IUA$XJ9%6.G(9?[L`3=2F:.7L4-+K:-HG6U1_-B>^/"#H^BCWO)2G ML!C($P=`L_L75X<7VWT#X`%XKW#)9$'[%S_1.PA;=,>:C%O\6D)_LI#8 MPHAN#LH3D1U*S*J9;JQ*$?CBNCO4R`XJ(#A55'\#0??-L!MA>!9]=FT(AX]/ M"/"PV41TC'>"RM-1L`S24YJV7)45,4_R28M!1^KM2I;1(=XW*$^L'1\Y=(PF MBBE^=7?6WMJ&?V7E;+WP+^0=+X1DF_TX!2Q!7ZW@E2.N*M'N.11B=X+U,?`# M$YZ:G:?^;#"2E^BN&EUY(K+`EW+HPZI&`*-&6>[1"5!H_:OI_0F",#"#6W=? MQM5_(P6O:E%,77GR-B8W_.:@;L:3&\"X)7IXA=-?.=&K:F$1BH*ERL3)ZDON M:MG$='[?=CS$!X#U=P<.\FR]0)RV2-9/N/^!G]D&+R"@%@0-[%;.)8#3.EA. M^/'UGL:6H'=_2(I1T"9#U77HI3-M$2#6ONF[UC[&W?CW9^`4R^OJ1UC@L`%. M_&4`.7G\Q&LJ+>):-K#S1 M:&%+(C338=>>>:Q?SI?):87_"G\>[AVHJR;+J:[68.I321B4V,-<:.EB\L`? MJZGC!]X1_:&_#IZ!MWDVG=AE_RVL7LP$5^<+!;=BQF4H3_E6Y(F;4GZT-.-$ M,ZSN30X`89>L[NO*Z:(^-*=:UEB//BH6S\(_RZ1;1+#^6_:(_G<\F&HF>6-.8-.H& MVR-[S6_Q[?OR+/BIYE%?^7'-RRA-/(/AIO:EFP5,B1B=7>Y,? MG@`C[]C$,Z-N4I$!YI1_HYE645C6NVC9"P?K/KY4Y>>5(W M*+LT+OQ1]AS))RH+C%RI;&6M[&H#47/M$+M%2R8UYH9>*37NFHRK'R^6%_YR M`I?,EAC"YMD-$@N7"";P^*,H)H8+^VYG6@^/N,1;**(C3N3AN\%.27!CCLYU M,[*G=1NH5-GO+T9C>56TA`&59U8%2#$Y!KIYD_EE#T.E(/F$5._BAI_HH+1/ MEYV(>ZJ7N._!%L45DD,5NLYPB_JUF,$1BNAMXZ*G@)W`>@69GJ[^5Q!6=J,; M"R2K44",6H,U0Z'"IX#3Q[*=L&W!K7D`E^[!M!Q(JK,&$\G[P,+`3=X2G>E% MORP:1`@F_TT/!@P7\@*,*UQ$!"2QR]9#/E.#J1OBB$,V7#+']8 M?CCMPERC6W:#H$"Y#G[,LMP")SM7EVC[[I[$+CG0MA>=8K/+A")=R& MBI_1Q#F3\>(813HM"\61L4QUT4G:CFMFI_YN.D<3GB#`UG5V&9PVWX']"F+7 M,<)IXZ+>($<[0-"EQXPQ`X'JC=8^D02BI>UMBQ@C"(D30*1>X?\\5T&%KWAE M@)HPN.4"AE2&6\)P2XH>->/7-7CT4J!">\Z!TWC.4*LM8,CV^24:-^R^:6?` MOL(AGNE,/$G_&+9#_I':IY,@E#"+M`L@+.%"[&O+\P,>/V$\8$CLUQBJ?1Z) MP@G[4]IUFPL!XC#4`P9#Q#.&(M2I@TQ:::099_Y^=`"/56:XA(!AV*4XAE"!,/5PP831;U&JXMO9\H0V&(SOW0.W31PQ&F$+:9=9">#;/EA>\41T;""!-&6*+ M-8=3A$Z"\$K[56I&JB2PC\*N@";T2H[N,U0""!BR?7*)QDW;_B.L6DB$:<)` MK]H#MD\NL9AA:FEWV'^`<(;+9;?LT^&8GE&\X[1/)"$(I5=^-.,/W7&%&'TU M&,I?.(=IGSTB\,'&1[ML++5JD?"9$KLGUS4_"E)($$KX=3;M4J[59GC`4"FI MV':4JY-D6*W:-9)G"[EU'=):&`)^E1]L7Y79UJSK`W3K;>!R^5.3!4..B6\4 M!3A2'YWT/07-F'/KOG*ZXA/B6TZ%]_VXAFF?.R+PP9<=IGSY"$,)^IG9%6;3*181GSA!]XQZH?0:)P0A32+M`[B78`;-I>4!Z#5Z67UBB.MS#-$^9>KB@D]8VGG(R2VT M5)U0`A8`I_K\.6&(]/&.TSYUA""$^:.=>YS>,F.'9\QRPN(>J'T&B<$(4TA# M]_C4-M.KUY3!`/&-TCYY!*"#F:-=)0RU:29[@PQ.#_]([3-($$KX>*X=BR@U MC'P093AM\8[3/H.$((3YH]U=JMRU1!9T&`IB>,=IGS]"$,+\T>]J%1TZR0X/ M?S6&![UYQG*]BG>@SC"H`B/L"&EG@L[BJ)0NXF3.$BSD&:-]XM1&!G-&.[-S M?C>:'AJF2\`<@[3/FOK88-IHEYB@4BC"3CY9S/C369WQ=`2@@_T<#7,3E=A< MNUY1;\;)8LYTBY-_K$ZPB`ZIF$L3[0K#\G_V"Z:4*SF':YX\(?/#^I5W: MG4&YR`C5O4C7&1H)0PIS2;L4/&ML+'-:%1]]5FX;$X`./I%IMX612K_IX$%1 M50;R<`_4/G_$8(0+#K7;R$BEW_3P,(2?N0=JGT)B,,(4TJ[^AQ:>KY8-_,!U M0`8Z"![WH^*`1Z&)I;\(RE`)S$H):_;:D@B_-3+V1L*#"BQ/+U4=T`U M*"4.,WR*TXU94:B_#D(,>=E:@[7/*'%8X6B2GFQ"W8C/NWO2@S1BSK#QCZ<* MIP0A%M-*NV(C0IL*VA@N@HIK4'@2`A[GPW3'0*5X8/)HYV+E+]/%49/2J*YZS0F M9XQ9@MXUAFJ?1*)PPD32SBEB!RASK0$"Q%*'S3]4%XE$Q@D32;N:;,(%\P*$ M(E36^\^NZ>TR$#%$OVL-UCZ9Q&&%Z:1=?20]1+E\)82'ZYUEQH&Z1*,RC#"% MM*LL*8'GZD<`'!^N:;W_W?0\>/38`.^0`8 M(E.B61ELF!_,81VE?>H(0`>(DN<4^NB1_W7 M7W,XW\`_B'Y&_!&>@Q6@^0\&T]ZGW@/\<7C[ZN3?W7WOXMETGH#?LQSXY^[V MSV?7AECY_]&+!-?[^1+LK:T5_(*7ED/E%QT.L MG.P`T>?CCY_"!M#.L@.[GZH5*?K*A7MX<1TX5DPH8SX+HSMGSW+$D4A5R(FNWLR+FW9G6 M;N51DWVI(B2/&8;,JQ>?2*]V41!Z94O=]8!@P(_='`C4_MP?/2WGA5M MEIE.U@P!N?*O-<"PG$_`L+Z$:I/.[?I<(KX'6V"]FH\VR(#!$#*C_:Y*8B]= M<[I3C'0E0+QJ8S"?2=M>*;CVQ$FNW\> M_2";E92XR=!-H0W%9@8G*;UMWH&0JM1W^.-9CH\'"WEZ31JQ#=6N6GDL\4$+ M^SC-'6E\TMV@7:@_,:;R#I^G8_$[BO%?S7<.YC^0),QFM':L3EMG@OHYZH)D.%9%40J<);LK]Q M"V(UH0&/PK(XY'OA^@%'\!<&:[*X?!;\B&B9_A M7/SU,?`#T]E9SE-_)I6Z94,W3P-J(!(^J%^WSL$'[#RO]RL'NAFF;2S"50YB M4!Q"'5@BGXE MA(GA8E;]$3O%)0)(NG9#2&&*<=EG#/;2V:'ZV0DTTW%IK;]*<$.H;9X]]_CT M?-Y9&X(YFD`POT'D$[V<#!BNDS8TK199V1SD(YE8@8F`X9"UX:FI1]U M"7#KVMX!UYJ?/U'P`+Q7:XMVI[#B>(20^PWX`=BM#@>PLR!T]AO$.M3R'01O MB+;M%O?2,1NTNX=$"4EZ+F-YR9KI MXZJR@;!TS`;M&HA6>9I3Y&IF_$R(%_S3Y.G=S1C@H,5R@;7!JRCGXLF#' M/-8X3B<1T,RIB:&30(-3TY/'!-B3!(9N/"[R;5<.>O>STK.=93S;Z8#AD"!J MW,89*`4P3"_MXG@4IZ@(.&-1"9V1/47-&*X<29F$B@?2FE!B%FH7DBO=-3;N MRGE%CT5X$+^H@6WDH!N#0>Z\-AES96EK#:O6)LL)%^96%[LCR.56ZFV,N;*V MM8;M'K<(<&%N:==\+!<_6#DGKBPYI#1F."NPC]!^$(4-!$P.[6+]++BD$:8Q M@]_$/H+2Y""`@)_IT3@$GYZ%*;1FQI)E9!^B17KPP8#YH7%0G@*85'%F#-XO MQQ!J\X,``^:'=F%Z0N8B[CP\G*(;5V2]F7"9#]H1VM]%=1ZD9%!9?X!#XD*ABHJH%J$94C4:L(&$R MO:^0;@5.&:43E;*G&K%39"*`A,FD?PP786._C08E)PB&SNV,GU?"3:9=/N:$ M_J';(E`R!P>&K8GQ\^IR@K!\?.]3NX@M5;UYE!,SYJ%=+4GPCTX3_`P[D:1I MJ%@M41M.S,5W$!W&6`V-8KO-0C/V$12(#3.!@,FA<6BX&I=,R)PK[T@[@M+D M(("`R?$>0L-I/J58:Z;U$@=50ZC@X3#!@/FA7728"9C,O9AZN8.J(=3F!P$& MS(_W%@).0#+*(N4C<2F$Z@%5"[PP0H29]-XBPF4PI>&ID;B,0O6`76(2`2+, MI/<5#H;GR>MC<(2()*?*]39P(6HGP4^B$AJBT@V\DU"+<4*@Q"S4+HXL&+I4 M@0U1>0K>272=A00H,0NUBUQ7;!DQ4L:TS/40=8.F>CBUF,4(#^Y*IUVDFQND MC-,AZJ9,]7#=X1`!'LRA=Q&ACI$9E@18YER-9JB'4"(,R0(#YL>["%(7`I,& M6.9HAU";'P08,#\TCE.GP%R";56`=L95F4$]A!+\8($!\T/C.#4%,)D$ M#U>5!O40:O.#``/FAW9Q:D(`'^-BE)4V,?2:Y1A"A3P&$PR8']I%GYF`R90Y M,730X1A";7X08,#\T"ZF7&981R7E)7,N`T(_AE([#!40F"+:!7S9D,DX[UPV MA'X,Q2E"``)31+MH;/$=Q`F4]:!@\ZW3'J1J`!5V&`8(\/,)&L?'*F');+MU M>H-4#:`R,P@08&;H'QE+7\M!(:$BE9G6*>ZM'J+]3841!LP/_2-C99:*[M2^GDE.$&[?,R)=Q#U*@`ELZ'6RJB4 M?EY=3A"6CSFA79BKM-QEY5RXSC^/SA:M['+YU`^#?F6_FHPW"[OYQ-W_< M+-889!I5B'J3DGL6:M4.B0$3$U&[8)IH[-)RK*&H%R:Y9]%Y(A+`Q.]'OJ_Z MR&O7NP>!Y86"6._'X=KC`-!"U_NLRTW4]<"?]B)"PL1Z%\S9[`VS72U.%C8A^\NY0CP M8B>B`(O^@[#A6RQ"U..!0W+?VX2X`; M<_=]G:P(2=>OYAMZ,]L8)J'?\8B0[Q=E8KEFH!8CZX.(R?>^#EZ,N&52_J)L M)-<,.DT^`HB8?-J%X*NVD>%\,C-2]]V]M/PM_,4G<')/S]DMMUL/XKARX/C` M#S"JI'.HJ+H*X;-3B[1RP8\)O="NWK\I3#/ND:BR#>&STY;0!/`QH=]7-2]* M(]\#_P5L@XW[`(+`CMSX)P^D^1&(W)S0+6HLRCWEG81:]!0")6:AQK4>0J!+ M%7@LRD_EG43764B`$K-0N^0ZX9)CV(S6"&,:Y%ML8ZX.S73?5^&6)ST`F!;: MG:#I44F3"6.N)LUTWU>8%@0`,"VT.]L24$''_DFQJDSKO759\G45*$&[^)@0 MQD"[PR$M**F63.N];EGR=64905A\P@CM3E?R:B"-P<8UDKM88?$C0^2KJ7EI M5'1:`GC"7^W.9;1P1G<8,FG`,/9=CJ>Q<1>3$SP9"E(;FYBR#!8+>4)A[0YU MF=/OP_'1WWI6A"K$,\QAHX!?48EF)E^--BR62^J"AFV_EP9; MSKKU;IXM+WC;6YX?;+Z[FV?WZ)O.;O,=V*^@O$[M+!PX8CA;-CY!M>)=TD6` M3[?OJ]I5+*QIB''$=6&OH0GJS&R""#"SWU<5K!!822D<43<29$Q00V:7B0`S M^WW5R(J%-6,P1-U4D#%!G9E-$`%FMG85M"R=%/*/9(3'8LMY6K\BT#T`_@"F MYV=:*QBSC3L^;:_`P.I&)Z=B/$(2]$E,0COG^DHFH,;&G8PR@(Y9&O\T-[/F M$Q3M@)ZP6#M'N@K03)@R$`"NYWXTQAI9A>((I2T_M)B>G')?E09_067OO M.7.#/P.<<>Z2A5=':\0M*(=IW9/E@0.WRM#.'^4$)W/9N$8,EVFPKO"&``UF MCW8%955U[(O1;')^M_(KG-;S"-TI&K%<##8$=L(0-*W6&=D$W,DVJ;WI$XYF MYO:%P"88@J:E'WD)<"?D?5^6-XM>%)N[/H_-H3\%P&&+.XOJLR9A?FK16;8` M$EYK5XO<'*R9^R"B>KQ)F)_&O"8(`//:T*ZB^MJTO*@)X_X>O(;1B3CD`3VK M;'QBSE":1?71QAG$OM1$[-KYF/F<0^8461'LPBY/MN'Q*%<7N7$)<5STH<%@ ML7&-Z?0D(\$00%=HZ@JDBM00&U:4H7;^;(VUX-!W.9NF['%_--Y:CGC'/ ME,-`1`6V4A(0X`FH8]V M\0P"1FDVL'0#9ZA*Y1I$!;HP0I'01+NP!!+J?LDV3HN4J0%(PA>-S]9L\*1*Q=?UCF>TSG"'`$[" M(/TNCA%`F@Q.C7*V.5N!KO&UT^0>4@DNU8$I(91V5[<$()510)9;AJ(&[B*Y M")`E%-.N)"U3GG=:T81:JF??EPAK-AAB/-0?;K,BD6')2=!/NVVKN$)S=EJQ MPQ"NH?FF0J6H!0M-9*[=SK(.GH%WX1[@(,_`\:U7:!JW[@%-;C,4#ZLW'O MPB7V(3NB5VCGI^2)EQ0N9V_ZC^&:COZG)]-\^165E?T*[,#'?X)H-OHT,#[% M1(O_N-FUR";M_)RT[4D*LW^L_E'O%7B/KDJ=2C)%%\B@L$0L&YM9EPI,ZX"> M.&_:I>L2\-?[L++BV;7A4OVK?QWAXI:/?N!!BX#D$6YH4QG&EVH*8IG&MEA, MON2O;T+7#O[>*/X]S(\6V,&)0+1FM"FX#D!'G!]6J'8+XLK/?OO2/9B6TS?F M,^4`*"=YWL(8`ZF43@:DXF_!Y,^9VC=FH\%0YNS/1Y1MY]-UI+I6ONH6"<=F MCU\`G-D.KMT+^#JS1]5OQ\`/3&<']Z_^3"IURX9NG@;40,1\4#]WR<4'4C&D M`_V8P((;T1T>/WF!?C">#')/T)?N;9L>[F`_-D9UNO2T.WLE M*ED5$5YR<4I]O>&NX,[>RX#RRT=W8^#B_[SZL7TVG2?X4CI MP0`"R'6A2O1,6F2R5%`35JH?-1"1(#ZIN4!JGM?M.)\PAMRJFR"F'DV)O`LG M.`F#M$NV\((4!CE"C&JFAJD'ZPQ_\M`D]-$N:*^6+Y+1W)IWG]I>PSMW*@F" M3'1(NZI`>5Y0!D:&RU:RYZ.1FTD`..&I=DEYTGXX8_.GN&YQ\8RFA+/`"4[" M(.V20[P>50@/UV4NMG&48`TS(`E?M+LT6EP=$[7OF4TSY_WQ0$@QT/F7%2H) M*EUT4AJAW:6^2P"AVUU:K]8../!__:A(!*YDY4`G]9]')ZPQ0:5RJ:,*]VO@ M+_'&'2+%4/$@8,C&>2,:IH10ZN?$9+5R0\3(GFW0?V>K/J!A)G7)@Z>9P63C M&N-15E-'+)&VQF>H;N6-'"%DS>54*W:GU74;=[G;6=$:[DQK!^V`^6(%ILU@ M*@I.0B&6#$F+1B;5.(>;ASJA[;"_T,LHB^AH>M[^D:ZAJ3$8;]Q1ZG8CP%DZ M'*HS\\850)VEGP@M:]R'FFL)YX-DE"BC&E9CK@#ZT)YZL$AA: M*4'M)_DJ>@.COS\9;-S%\`18ED1GXS-4SG^7+(0LNT==8_=??\V)`R+^9_0S MXH_P'*P`S7\PF/4^]1)IG?R[N^]=A/ZCW[.<7K;L]3]Z4>%K[^=+L+>V5O!+ M[^?HCLTS"*RM:?^"EYI#Z=7R@J-I0VH_O?6W[B%:6*;\/1YRY>3K;./!3D8Z MQ13\"*!O#'8_5:O^/1HFK"T?CZ83:5<(DF'XRZS#3WP-R8[F*N^Z0V8@(4:@ M!&*L^P5K4[MH_ZOE6(?C(9[V:#0?2A/)R5#BA%+$)BR6PA4J+ACSQ\FTDTL@ M$@23':I!P12ML,4J(E7,7WQ/I=!4"?7INB7)S:2E_B:LKEUPW3#2I1DBM?;BRJ-BJ;Y"R7 MZ$-TQ-B5G'T4(&3QE;[H!'9Y1#'CN^A24%A;DIS,+DS_N6_,AC-2GES@33^J MB31^7N7$J$75E!M#.=E*\!%[>7"/3M!?C(:D>D$Q'"D;N?DH!B4,,0VTNT`2 M+O>SZ8,=NHP-'#]&U4,&'&'X^2W]E3OS+2S6_6YZN"0%JLP>6,$1Z9`3:53? MF"Z(C;T$F1CQ,V[>%DE&/6:K=A6HE^`Q6#E^X!T1(ID"]>A??;BD.\_:`J,_ MFQ$O-HFA(/4T6J@!X@`H9HMV=U/010+_X?CH;SWK$>S@X6C*\I#RV5]O7)9E MTX]%IM]MM)/M^!*"Y<-=>"Q/E0D#MNR#Y!;=FMK[]YZ>@YNCRC"N=X_@"T\8P46\"],VP:[SV^X*"3^ M1;\_&Q";-PIJ.E)O% MR(LCZT`3TR>L61\!\FSQW`(DSK;T2<@X63>J#Q-AJO>#*9DO*"8K:.DZ$:9T#.Z!2NO,7(D8!G=,]N<9]W&4BH/6?I>B-D M4,65G@L[7>-&596-F;[6:P>DP!@L[WIQC-$^AVHCH^OAA`&8S7_FRD-.DFF/:IS_5U'#VM2?]2KHGS%-VDJIA.82ID*ZR MKSVYA]-!8:)+1YDED8I/><29?E9Q@1:L'XM4T2!`T2:260GI8E"!),N_UKX` M&5:+Y=9&54#=X,W&73FOP(?H9E=&2N7P1&ER7V]?KC70P')NXQ3-U>2MT".8 M\5C.U6-Y*GK$+5W1J5,P%R1/)3TBZM7CB@]%SZNEE@?N,-='5%A* MV&<88E4\8[0OZ]K(8,DK>K*I6M\]""PO+CN(_8YTD2.&O"JN>:3S7+$$`@3-6[G64-&$+.F MC3RL@$TGO9FPWF=?.L^LE"'.5F\TQ1G"AA;F11?#`=EZ!/?2\K?P5YY`=L'P M-Y;;K7<$NY43`/CW,Q4*(X9(GJ1I*,XD0?ABBBD:B2B%`'7V^$YSDP+AD8&&*EE1]LWP*PK1F+7M$H:/'[*NE:6#J$57U/ M2?$5KQA+3]$@5/%:TNC(>#`;,:2B*#ZIL@S)Z\9B[&)4Z&1%CH958DJE(G_:SB(BU8?XM]PFI6 M0YXMB*LTI^RK[;Y;S%$;S^M/Y6%ZK;:HI"-%".FDE M>616:'3M0+3<;E&G;`&$X=$&MR"(4>Q/IM'3"7+(7C)R"XR@!4+7;IK0 MAWDQK=W5#]0-'."%&^/9E)1J%D,!XI@MR+YZ[;H^PE"*TZ(#>]S)Y_K3P7S< MS,SELW21LU!%2^W.TQ!N8-KTY%PY_M$+';FDR"]CGA,U-2;$=HYBA$XUAQ9, M%CLVR<8U49TE/"8L!6PHKU?[Z5`"I5XX>Z+N$\BAJWMZY[DOP`O>[N"!+H`. M.W+67PY9#,;#J;P#6>7P37*`"0M=W=1U\`R\,\!&\X$\"A`&;%+H%>O5VR\] M1T>B6R?*$X5^V60F>:X2^5?@=&97I:NW>6.9CY8=O7)PML^.!E-Y3D7QN#6X M&`I\H/U)].QQ(@F_42$L)I%B.>1'T:P='6Y*""48MMDZ`%!@L;0&,J+ M;K1'ZYSEKEB[MF;<]?T+UPDLYPDXV[=0E4W[/+)O#..N97),.LT<6K-W[`@E MIFXX49PKK,GI]+IQHB.C\4A>.(DP8FL\J%I]PVX'=)0C+,JQ7 MD+G:D/\AAO:MOS`6\FP&[ZQ:HX\(&!/#8B".Z4.Q#)[0G2QY0`NB*\_YIIV% M:`HQ+KG882&14%>WN_25M<5,&DF4IP4=,+K&.YGQDWVLJ6])N-:)SBY1.X]6 M%MB.+I2=Z:I1ZDYLF.V$A^Y`64&8\40E7,E)!H+2GQE#>Z?/#FI<\`AJY^41E>4CP$WCQPU>S[QBAN7")[VM)Y MFG-7BI:IJV?RU83#.L![RU9G?/%7"^P_AW^>>%,X,IG"WD( MB)IFPXHT(:6IQ>.MOGNPB/3.`4]HY1M9ZB=E\Y6H?86?#AW`R=`PFE^5*%^8 M0VJ5-9+GL.CJ@EP?/7@V.'JHC.7:^H'^S8^WV\$D>M)6SA&I:-RV'1`Z0'2- MB!0"%T,P&0[D79@I'UQ94Y&')F''3/5,.&.M##!]@$*,J\.+Y[Y&MTBP3Y5#_F,)]Z3K3."8NO!M/Y_+2_801!6D3??E"YMIU MZ>HU4*7"!&;M#7!4X#0G>,XF_SO06!:#MA=F?`4ZCSY)T&\O;6U@KXQ'4SD MM=BHGD!KM&#$ICL7%H07_DDYGU;V)W8CH2U^^?1#^+,UWJ_,7_T M)[,%J5^O\#2[J`FW=UZ1"W[BR';/Z-?M\SH>&`.C]ZF''GRU7?_H`=3V]=O7 MK\O[/WKKZ][#ZLOMZGIUL;S=])87%^MOMYO5[9?>W?IF=;&Z>NC]?(G.#+;_ M"UX;94/8A^/A8'IOZ_T#%)@%SQ8H+Q!=^XO`';9\>UW:>W MM;-Y!I;W.WCTK0#X_:$Q69"2!45]G`6-*\1V,,@SN5,K`S==XZ#G8/G??(AU MBLG*027.WWP0HL'0:Y[ZPZK0A&[EN@;)4!?FZTMHX5%/0X"JV(ZHP:7,@EGB MD&VQH7+]VH:^ML]@=[0!>D&A(&._"9W^\7PF\08LY2S:H@C6[H_VC;4'?6,P7"RD+8MF"@VIQ_Q< M/9CAZ4S4Z!5XCRY;C03\*X&%3D#Q"PS]R3PZ_,IA>VZ\MDA0OO)$XLI&MWDE M?@^1A..@%W@NP2NPW=")Q1`8D_E\($WZI6.W101Z0!)2S&=J%QXSDZ+X<`.G M$+^C-AY*?8VF<@*UDH@O1^@-)!^-WW$SC)&\0K""0>76V)>)*Y,!K$)#UZ`G MZ3Y2O/KA:"$O2U`\;OMTH,-$UQ-G(72?WQ!XRQ^6#Z&;R9 M1Q+[^F8&$D+'$HB3`RIY;;K:EJ^68QV.AWC!H]%J>0*6L4-`)5#C[I]06A0A4B\5]HFJ[A_G:[B]K5+]]L;Z]N+J_Y2[? M_N):SM.%ZVR!Y]0MTOYJ.N936(B`Y)*F9H;&>$$*FQ24:11\II9:;0'8^=>0 M@2O?/Z*WG1'WT/,I`(ZQ#0>#)_O!0%Z0F&X20O2+7@X9?6)%2(-=FDP6\RTL MI5GOP_LM&(T+UT>==N%F*S$`6#)T6\2@1:/#KD==ZSP83-!5&]RY)_OO?L_= M]T[N./5N,IVX:*_8))];[T\^=I/KZL5@KHZ2GD4A!XUN,Q0)OR MQKTS3Q\0FL_E)8X%39)_[V"]I08'BQK&EM]9,T;S@;R.D7(F+<0$26/=26-T MN0+3=>L3+1MY7?=5M0@4$X"[IB&Q@W#-V2FIX^3'#P2)H#N."UOSD$PGP0B< M\-6B'&39IH+R/%O&R?`K)Y1^2@5HM(<2\UHG8XD)C-2567)#H!`&#?:NQE"4 MX*MTQ]IP-[=EPEQ2YZJ&K`WAHXG#.#,6\E98,G"KABBW4U,BU)WKU[E-N'YL M=YR/[=ZN-U@O8*S`'YP M#XUAWY@N9O)\2>GS;X>5S8I%VUX.(E%$-Y^V`=C]YJ)8EPWA03C&-4L0SKG$ MBQ+-+40#NM,+2M>.%$W`&15VA7#*\V.:6XB^O"<(*N;]](/W%'!>6J@;A+/# MN^9$7A&U]/EKQ/)"L<3DGGV0NP3%KR!X=G??X&^&V'7$/T]GK0&1"T00TW>N M&WTO;-/WU_O?3816L/;NK:?GX.H'\+:6'QV[DQ_Z\4_]_FPPDG>%BF=&[?"N M+G8QIQ;O@E.XR=,#V!Z]\$FO"].VP>[S&PDBB8T.ZDU.(:;Q(8HC9@/=6'<* MZE-F:L:"URR$D1[<[X(6'N\Q+,3BV!HW> MG,'(4WRR'0&SKA4+7;L`>BD0<2(!`4$Z/?`(O6% MOWP9!2/G,M\B%S/+C@702B#&?-0SX/M8#=8C2]A\`[P#1&YJ+.3=HI$W\199 M*U\0F,C:A7YQW4E\0(AN$:';Y[>NLXW^HV\8TY&\/#+%#-JA%BLTF"/:A7(1 MN\PK_%IQ]]&\!ZD..P8Q>+5V%[S`:_=ET+.^??AXM.\I,.&'B:!?6 M0_BEEV^3*\W&**IEE>8XY2C%$.FVT'QFEM\6)7^Y!5/>S*9RNLR?#)4&V(J7&N+M^-9>JR<+=DC7A;H5N4P*$E$[=0:.G3*7)0[,SFS'KC[,D#46M1)WEVSQ@; MI'!3`7GR7VB8`SGS5;$FM8,/R>0A*S.3-S@$DGQ!&8&0U]1Z=*%^T]A9OFGL MQ?KVMZO[S0JUC+V[O[J^NK^_NNP];-87_^!N(1L73EJ/J*@BM@IA?+MN/]FX M0T/XK4S\8V#(:SQ`'+)&S@T_B`1VET?/.;UC&Y96+T7`D;2%E(S=`ZUQX MA1:)SC3Z9XZMB.JM(Y/WK78K8F240#P[TT:?F71%#U1F79+HOP#\2?B?2V>' ML>H;XX4A\=W&6I-K8W,6"*>N3;?/W-U,F\Y,8:4QGL[D74"FF4([[&&$1M<& MU>D[@?[&7>YV5K2(.]/:K9P+\\4*3#OC!Y^^GCJ92WQ*ML[,VJ"4*"2U;0E] M9H+S!ZNH]\F)9IZ8[-E08DNONM-K[8`J"E)=NS6?%JIDHD&?@0/VUM8R[?26 M[35`S1,!NF\G[V3+,Z,VW/JZR'6F@3*S+U^(3(I'V`S8Z,]F@T'S1#J?AE+L M*<.H,_V1>6,.D;\99_('P[&\:O+<>'72K#$TX4>7.!TALQB>.*1P&A<)(G=, M*%JXVHE\+2XPL,B+[O:"DK(Z==*2X%F8:[@SX]MNSBZLATMS9GYRFV@\6)#R MG3*.\'RL<5G2-=C67<]=#RI!06YCE?J-TY^>&*7K6K6,Q!C.&*A91M2O<12NB]IT&L@4-NAFG`V\@GI_A'_^),@#S MII(CR:A*^1<5F1,R5!VN@JEO#N;GYN!ZN;KO_;:\^7;56U_WKE>WR]N+U?*F MM[I]V-Q_^WIUNV&T"IDV<=>68SHH$)=&6KA-0_)9$A^&@PFIXEMPNQ&A2DWZ M:LK7Q4QBW]+2H87H-YNP9:;A3\U&_- MS`Q/;!FD?]M)9A1.J&Z1;+93#PA\N.40QL\,&C5<]D[F$'G7QF(A[V:NL&D* M,%>?WY)__4\+>%`IGM]NP"NP0S\;PB#OW$0W![$&3#PQ%^DU%(KY^48^*%+:23-%D8-Q`+R`XME`-^Q M(4>)5\R2@547,@&?UILB,`MYE"QBV*R01]T0,@&?UKM* MBD@P#+D2#)GD01;JWZW@V7)ZP3/(IA<2W%$Z`OT,-1(SG;?_\'NI0W62ISCZ M*`\1XMX;]B(I2$M($$GS/5Q)GCKK?3QY/^\+PIE_0Q,/Y[WY[D;S_LA;?.0M M/O(6BFU\'WD+M?GVD;?XR%M\Y"T^8J?U8J=?H,1O7-]?._F?W8*@OS#F\KKG M,$]'&2/-%2UEP+HS'2QJO9HF#GUC\*ZTEC'N+@<=#5,>*5#":;S%(9S/K^EOW)GOJ$_6GXWO5W< M/SA-Y827"#?/IK..7F*^16CZ`=BMG`#*R;>VH9"AILX7\FY3-KZ>+JE`N\+N M3%>C%?>`X(6PP[TAF.Q_"L]_'4T'&H

+MR]JYW"&42ZF8&HFGT\KEU,S=]6$,Q27,.8GEKICW'&3;& M=#23]]H<[[1:))L0)#OS\)6$YC?&,-_\YO[J9KFYNNS=+>\W?_0V]\O;A^7% M9K6^?>`N#K\'MAF@2),7O&T\T_&A5%$TJ6[9=L%WTPC9>#*2IS!5H_/[/05? MOOJ!8GD@?`0I"R.Z$9#]*WUC,I-H*&K.3HB]8)<\MADBL=75-^*.'\=1XB_1 M^R1.]"K)%\_U?92X&RB8#BB><%QRGYSPB_W)7*+_W]`B6J9X"Z+J3A<0-M9_=9W@V7Z+[<"U MZUU`9(YV`(_V,2P^Q"5Y91R]1#XC59D4%`PP?KYE7M4!0]=#9YC(?0`V_/.G M+\`!GFDOG=UR=[`<"QVST-$I]H'Z4/IC>5LUPTQ:YA$O9HE;J'JU+NNSX(D: M);JS`=XAK)^9T1N3@L^T+&R:Q77F4@6C8(O.YY_?LC\)KXB-)V-Y%^/HYR'F M;!WGP.":AHVL2>"-OCHB(QV%\U"H78A1,G?I08^Z#ZS=6`?HKB;%,F]QMX,X MN3HRAB1C*JKU7\G0PHE9))BT?1\E$+H>5B^>+9`F@M?[/?1-O>0M,T->OK9D MX,990`F"KIXYP?%`04=X;#E`&$S'?$K00+X(*:Y+[V@5?+EYF?,M6G//VG0" M>,!(W]M=?W<2&(9<3G;)%]N2.>TB=0VN%U`_WOL0DO8;PF3W^>W2\L`62B6C M":2Z-#;UKQY(-C,(#WF*@*3U4C2N,U;Z!M-D+.]]X*K1:UQ=2W+P=$<2_'B> MS(<=>:8D]516+.1\*0,GC,H/1]`'\D_\?4$L#!!0````(`,.`K$2XE.-A[!\``"3S M`0`1`!P`=G!I9RTR,#$T,#,S,2YXZR<:@!:R'3C_>/)E=/K]$\T/3&B;+H+@XPE$)__X^;__ZZ?_.3WM M>,`,@*T];K1)M_-EW/U-ZSDNEO6U^_N.]NYDTNN<_'AZ&K^^\I`=6OA]!+66 M;ERGAJ']KW;[H76MM1^B%Y]]^X-O+<#2U`+3FX-@8"Z!OS(M7/8B"%8? MSLZ>GI[>KQTO"$UWY_(7? M=68.L$\T#!GZ']98DE5A)/'\Z+G.G@AY\AYY<_RJ?G[F0.(F"R3O0P1AN,P7 ML`/O+-BLP!E^Z12_!3S'VLI5"^T+D!?L8"N3MNKR+/IQ^ZIO[^E^.D_>-,Y^ M>[B?4+^?X&K0-%H1)H0H,`/,#OHL>;I:.7"&XD?X(:[S/S^0?QY-'XS!3'NF M3SSD@A*'D9_/+-.U0I<6<;]3NN3Z9)8/UD`$/@GFF/'OGGT>:W9VI)8LVOA/^MZ2SO5)KA2:(^& M_X[+U:*"?SH[E#A4%OK`'L*?Z=\'H386CM\H$]R/.>QRAY1BE]PV6W81S$_@ MX>0%%(O%3Y/J;I@%(Q,7'RQ`X&!'[U%BU2PGSDLYH;W;,^3'(T=>ER,=!-=?QT)(BE![D!@.JZ_SQ.[2:)ZP4$5[5ULTS&JO#)I M[I`5DO#?AG87!DZPZ>,!F;>D@%.$L4W@--OY4+K$A:?_-*&M199H*5..-'E= MFO1,Q_MJNB$8SGH.Q%F"8[I]Z`<>K;04469K-&N4*89^NW^6/O:OO_2 MU88]K==?OM>ZP\FT_&7A^Y@>J2+S'3QMS\_`)/4*7WXY`0+!VY_^J<# M/#SH6VR&LPY:KDRX\>^`YZRQT]88BOGHN`X9Z'WQ'3B_!VO@3I]0'Z["P,_V M=Y25L_5RMEX@RW9#UVFX^[NA`RQ.EDZT=P2N1O%J:5_\2GVAX=Q;2[VQ=8F& M9O2WV#$_^-K.-5K*-UI(G*-1[V@M+?+.C\?.5Y%F0F91[=#%OZ;J-*:)W0YV MTG`,K-#S<%U_,GVGB/\^F4"?$6[6>!!K`0]F0]C< M:CAJM;)1Z_.P/_A,QJV=[GAPC"RR$*,/\9]@:C[OQ8]F8X>A7QZRH3_H#!^Z MVK3]6W=RI(`T%,B&!B=H.#1<9D-#F@S'R"`A+3+YA1,TG%R4!HAC%B$))>ZQ M4^84W@0$0;2#)\4*M^$%DJM#4MSWI_W/[6E_.-`FW>GTOGN3RX]BCR,*4!Q.:<\J/D6O"-#N6C:Z^&]D)PX?VH/TYHL/HOCTX MYIRO3(4!"H`_,C>D7T_Q`#;,@XM#'@R&4YQ/C-K?VI_NNT<2R$.";(\!5PV/ M/"ZR'<8>'8X=A2S$&*Z`A]&1M2=R_U?8\$T9Y:"Z? M?`0MY)J-TRJ3E&9IE5ZUPPBT'01MBT&C(+0TBN-*G:R$S,R<(;?9F;/J'NPX M>R8)-49F0!IKB@P-CW;.#ZDP:D_)*NRQXJ6H^&Q?T_0(YSR;NL04.'80LI!A MC/OS`-@CTPLV4]R%^Z9%L*9IX:V:77XU,IG'N'N/>7&'V3&>?M.FX_9@TNZ0 M>=-CK)"4'MG@@5G2<(J:LVNCF"C'B"(+92;AHP_^"C'&[OH@P=A]HME,(,ED M&),OGR;=?W\A\^K=K\=<0P(RD(^2%LBU@>=W_PJ=8+-'AT;7X`S]-L,'\@72 M/X?W=]WQY`<-,Z,__7:DA%SQ(=N5^*#AGB0G$_>(A MCRNPZ97\VQRVY,01[=W6K..$EUSD&:YHDMJ&]J^DB@Z2$&0^-9N&Z+ETT8:C M*#-M#^ZT7]MCG*P>\Q%)Z=''5D#2DE._[WY.#WQZR.LN5R[:@+S5'\(MA_P3 MS)KNP_3LA'TQS;1W6T0:A:1%F.@GMS$J+0U+FR%/VP([QC/9"5O6(V+Z-=TG M&GI!GUC`OF//J`Z3$$S:?<$;!10#Y-_&@UQV2%]&,QS1$N/WXIR?#G3'<"8] M"3/KDK0/;79EDB-+.ZY12D.7^,@J?SCKF/ZBYZ*G?9I8LV;/*KDY."AK9P'9 M!$%LT*@11V9(P@Q,C`79>8)S^.S$P1UVG^4$^XQQ&IY?TNF7(;FDH9R)S-,< MJ*4-_$&+3"1]$S7R&&Q4HE31R7TQOQH^ON^Z$8(=C_F3E'!^=/"-!Q8`^N3, M&^0?]')NH^,YG7[@6-+-I8W1B#5'JLA#E7A/W_XF#1^A9AER43[4M"X60;/L<(1>'_H.AE6\VO-,O9W7MX:$]_D8. M8IGT/P_ZO7X'CZNT=JRU0F@:W$=\@F)-MKR=:=*O0/;*HPGPQU_/VI$Z)GE.C M=6I"SL^_[HG% M@+3D(!*L3\GL15)\IM2P8V;ZCU1;Z)_.37/%3(9ZZTQ__T[E0<>E M7YA^/`F\D.P7)U>H?7B,[BOY>&)YP*;'`=+'*RR$["F]1,@.O?@H>S]\]`,G MH`5_]E"X^G@2O>X$8'FB17<.14^6".)1@[?IXU^(FC)_SST030]#\`"6C\!+ M.R?GQT,D)K;*,ZU@'UD-"-%M<1]LM#0=R(-@^H2*$:1^E`_!RG/(MS<_-`- MR.)ZD2?$M,CIDRE9ULB@(3!(V,CW`)N,I'A39B_PD`D`6`&V6D`9I+Q4%U*A MJC>VFSA%?9%1H+PG"3DQ1WOM%] MF`Q&>\B+ZG0,`B>^IJ?`%754*>`=[A1#5(,"ON`>98EJ4-07/*Q0LZ_MN*;O M#V?QU-70&SOS13`(B;7;I_X8X+3)HU5KNN[$@7,73,A-1CB7^@+3>U%_;TA? M_HQ9VB_1DD#`-3/F+TP/^"Q>0MEH-K!C3X"WB%;FM(H[0QK$4)6KD@<.0H,'@,+X)K" MIC)CS(I(B#;IT]K0_@0@W7YLNL,G"+PJH[50 M,TN$Q(PG*S+Q#9/DJ"=W0]QO?]K8@O22`&8' MY`I)C+CG>,L2;.F?I4-Q!QZ#W:V#J2O1N[,99IRS!M$S'Q>*.T0K=;+_[P*R MC3=<`A:+3TBBQ037HC51-;IZ<%S@!RAGD5)8@X15SX:D;%120X<2_BA?`6.6 M4`X7.'+)H.X(%(%V+UFSZU%.IRV8D*O<9[C]SRT_,6$(7992S=:\81"$B[(HZ\X.2!E+3$3'!PN MW`WV`+T.VFX'QL447;1&<5J3\M9W+E=:DM7VPWGLAR%.3_&O`'P#IN=O74'D M+_4INGV12A`H7-F:&,*=*RYB5SR8GK4@_YWV`TXB4(XS,"GURRDR+LX%:N(E M"E>_)HJC0@$AL1N,*;JL50,-%/JW]3R==O[>GD\7^A8]7Q&$VT&K-457-\UZ MGKM0A3U/`^UY2]=O"&A@YZ<OE6(-O[UA:IP3O*U!P2#!;?9R9:D MJ"*R.U.8WI:+F8F1=-/,CEJ5H#+OO_+FJWPKD[UC',#R1*3&QDK#S/MR$9$N M+E=AV7^IZ6KA7(?>-RUJY6,P=_!8QBLA6O9%N2IBXM"-VQ:(#O]_=HJ[X[Q7 M7R`?MX,/MK,DA_!%:9?HA'^)[7`)M'AQW?-1W-PC0'Q-=G-1-&0Q[T0VJ`B01/0)+V' M@'WO0!H(\R/`WN_2K>X]`X\<0$M.B:33">U`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`+:15Z\55(HJA+5TQ+A>0$"DYUPJT71<]D>Z7@TA"97C$9?5:<0%KZA`J8Q6-,S_.)]"X9^ MG?0;^0C+WE<0[_4-%]STZPJBC8Z]O+[BPIP54A!Y)OY6ORI=Y"TV.:^#87I; M!8Q)_\B"\/!=F?'%MMX[YJ/CXEXC'UGV+15:WW9*DO:$Y'Z%`0J`/S(WQ/)2 MI(4R\N-.(F3J,KP'\]E9ALL\Q&5OO_*A6:4V.I`'4?+V:R.*-^E-G_"S39=< M7;IW&S3?%;&-:),O-FU1[:X,)]`J;^?A%50!>;+QH?L<1&>:;0,4N1B1Q05L M&E3RA4#[X-:AL#\B",/9)V1Z=@V?Y.I1R2^'[3ZY3(G')U4Z5/`']R5_-70H MX0_:+SX@VYDYEND$)"36X8J(/NG\1`ZLA.0*3YHO%0U72]^2#U-\X.)PEDH% MR2'P.;.>T0[,@NO7R(;-#HC.PSV@$ MCND:MSK]O\C`W:<]AA%OJ-$-!G>)*U/9(9E%RB:4*=`.HV]Y#MM(O*,\J22[&2.)Z":AQB+'8?NX:WYI.J MELJK1[)&Z.\U#(S%T%O&^<7UQ4&__TL(P;F>NH(SVSZN2?L@YV]7NNP%R_P; MN+E\?M6ZODY_$9(WHU3H"B/W&M3O6NK1]]7#@.]1MNSAA3;U7=^%[AS? MPB_.07KI&+_7MBQLO]V'Y#(?/TBN+17/2IHN^._B:.YPWG3!RD:6RZO6I:[S MIVDWPAQOK$39R5T;*#>K&RM163I?D3SM:J^OPD_W/F`L'GD(Y]V-EBH[K1L! MRTWM1DM5EMZWY]>7A^T[NDK=(+?3OT"T;JQ$V6E=&R@WI1LK45DZ'X"OW!'6 MD#Z)%[:%<"4K7SSC:G:5LC?<"B31-N`F?;/3J'[#8QWXB#=%WA+4:IP]Y'40 M7`,OVHF9ALCG,@9%RGFF%P:A!R;`6SM6SK8T,7'%O4"N4H"`=/!&,IEP<2LV M-R>F6^IPS@>)+^,2TZUFB,_!2DZ%)5A;"=;6Q7ECO&-1KAKQRC#59AZ+\C=# MO?@,B5MRA$2"U]`%5R3$]:M&P`I8M3G(J%]9&HY!X'CQ;NT+ND5P]^GQI3#Y MN+3*3CDF,-Q$X]+Z)NA5N+]>7(=R>:YPGJ]ZAI]SDA"SA%I8^Q"/4?\((3U- MYO!3ZNS)UV1K*U]\K5&`U*%6`!=?U*U1@)H!N`)P:F'(,!KE8*YFEGE6JD;JI%%K/%XTKU:C9#*()L];>@+$E M3A0F99+3I10#+VF8E*E*G0%:T[A(9KWTDM4.GD_6FBQ#FG2IN9X^U?RD>/ M^RG_'E6@4;U,V5(WPF8A\S7:ERE;V49>WQ>"*Z0O4_;;I[W@:NO+E*TT[:.[ M1JDC>H>.J/I6M2;KFRU:!=(W@UB(\\T6K33E#P%67/[2G$HET\$2:'DGWC>G M4C%OH3Y<`S]`'KGG-UXV)@>J"8\S>33*'?P8@'#&-`Z-BH:J'4+.)I855*PA M<0<554,&V0,P!OX*6,$434`01*+MN0<$/NACU?:V?)3,:]\(IJ+B^J4.N?RP M^`*PN'ZEPC%9T`L<;.W(`S/@8=NV9T?H%Y=ZYO"(DB0[.5*]^."?.X0]X\4? M*U=4Q&L:=JQ!)D80@IZE\$ M]DOHDA,`XSLULH"2]"VY5LC..D-4@Y2^Z#FSG.XA26=SP;.)2(IV?ZZ`/P.I MH41*CR1IPD%6+N28FKHD]4^MCD14@_2^X![?B,DKZ8>2CE1$6D(?0%`KG1"3 ME]X/O%P0D);.!P\F-.?TP<@UH=^.[4GA+'SCQ;'$DX$!N?:1'\H4/`>?7&3] M68PE]4KC,YEQ101)$4P`/&N1GYTQL[*&#@FYB;&P33A6.$10B9P>*=C\R-NC M-Z!+>?]4T*:.)DE]DTKKG?DB.$!QYWC`RMVK)20MO0_H3%E)[E+I!E8%TGM" M8'`DKN(->"-O)K:6%E5]4A5"W\`X(;ITI,SWA*":NN!ILN5&_Y$ M%@OC/*+#[`Q1\`T';1JL`V"/D.M8F^C=O;;"F'AD6$`?8:W$42Z[>V'TB MM.W_DOKM>6@9[PQ,73R:G"E#'GT%/@;<7RYQW>(>T]U,$BN21=R1/IR2KO%IDE+T?\0@D58^D*+!T<7&U MBF>?/DW4=*-9]4[:KC45Z8E;-Q6IP>A:T6AK<("+SLZ2IR!G_:2X]Y:_T='L M)J>N,4\O9E(==9H*'>J#`\/397MFN528668S-CK]*C?=_61+WDD;Y:SPR_&[ M&&FPL(JOS%O#J$[G>([PBQA:_>? M2KZ@9I?;8)F]!HS/;WR98MK5T>\RGUY^C=GL"W_0I`?Q!TU&]6IPF]/"6_C8 MWT>K+W2HDJI5Q;M@5>!_D6CC'?%NW9;?-4]GGU?Q1U.J1ZC7;?YY@MB'P9'Q M4I=G=?TN\SD05];6X.+J>C"B;*##=3ZD=EXD-=C(Q4/J,Z4Q?]1`\T3Q4 MT$)DY?5#-_\>2/I6Y$/-7TE20]9?<`)D8?I;2)BM^&;84O\`E]CR!6=)"F11 MU,(&S/;;V-1SNK>_$H*$2)@7IRSI&O;^M$`=86L9*%;/];Q.B<:7%;06^5`& MQIS)A)U9"]H:G.6B/WG!2(O#G(@3?`QT.,&':GJ+@0YG^5#[.MP\PWEW0,.\ M]7?`/*W*/=4)WE!Y2];IM4_#>QH?20@T6<4+0$@K"+91O(LW;QY;RP"A3_"< M,#MJ;N/HJB>Z')1$*6R`&K-5_'5$EE146L[.O4_3:-1/2$&C==PDCPE;PI06 M+Z,_R!$>$^A!WR-S=GSY\ZC,IZRYD^AC"AU1!1GKQLW<]N[313*HY27MQ6[B M'AW$T^"Z.I,%UE;4.7WYF MR5N7;P)M\`P3U!:CO:6L[6_W,5M>_0TTQHNEBO&A-I)>[_RDW8Z*9W9Q,!_%*R+B!5ZIU!R6LP_H7!.A(DC4) M>#7H1U1SZ?#9[H`5)T?HS;\SU&,=+P\^OGV:^5;8:9-MO`LK>`6_6[L0>0BV M$!YVX*W+]#JV0D1;JZCZ2DV3:+AE)6EP>`:#1$.5*U-(N(XI?B)L!(;Z+])4->>%UO'^!*.&5S7&?('M%X^M; M6>06=P\`O!^8Y+$E+_=LF&9%_$WYSO`A35CSAVR0QF\!\X@@7$8+8*[0GD1< MN;=>D(3?PH,>P7>?_@,IW[_RUFO`X7WAI[49R%H3IPIXH,5CMUV^63K_X=-0 M`MS3%B(QES>OF9?#CP@']7BA55:YVD+%[2@;YHAL&/#;_,'J+"`Y!MM#-9P[ MF&L*+-_DY*='!/'.Z:H8)H]$.`BETP1"1P*6H>EX+VHB_;:]-C46S%.OFOA# M%%9T[L"\.;X7DMEW0MB7B7#SFD(4PIC#I+8%KE/_+:9K8#91.!?UVA:X3GU] M1F;.S>X0HJ>*V26YV:.1+%&7ZPY!$^(T0W%O+:Y_D5ZZ+2J+`@JLU`*R?Z>F M5;EFYZDN5ZF3<2JLPE7WM9F?/>J"J4>YLT-C_>K-*=AJ:CXW5.N7<#N13N76$S\G`[[\@`4FPA;W/_O<_4$L!`AX#%`````@` MPX"L1&;$]Q-K"0$`#3L3`!$`&````````0```*2!`````'9P:6&UL550%``.N*7%3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`PX"L M1/HFT0.V#P``T<@``!4`&````````0```*2!M@D!`'9P:6`Q0````(`,.` MK$2\\%'^"U,``-[E!0`5`!@```````$```"D@;L9`0!V<&EG+3(P,30P,S,Q M7V1E9BYX;6Q55`4``ZXI<5-U>`L``00E#@``!#D!``!02P$"'@,4````"`## M@*Q$QL[W'_E4`0"O=Q<`%0`8```````!````I($5;0$`=G!I9RTR,#$T,#,S M,5]L86(N>&UL550%``.N*7%3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` MPX"L1$D/5%3R=```R#L(`!4`&````````0```*2!7<("`'9P:6`Q0````( M`,.`K$2XE.-A[!\``"3S`0`1`!@```````$```"D@9XW`P!V<&EG+3(P,30P M,S,Q+GAS9%54!0`#KBEQ4W5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H" (``#55P,````` ` end XML 56 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN (Details) (USD $)
1 Months Ended 3 Months Ended 12 Months Ended 74 Months Ended
Apr. 30, 2014
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Mar. 31, 2014
MANAGEMENT PLANS [Abstract]          
Amount raised from private placement $ 5,800,000 $ 7,500,000   $ 8,300,000  
Stock issuance costs   $ 170,165 $ 60,783 $ 400,000 $ 658,386

XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 333 385 1 false 110 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.virtualpiggy.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Balance Sheets Sheet http://www.virtualpiggy.com/role/BalanceSheets Balance Sheets false false R3.htm 003 - Statement - Balance Sheets (Parenthetical) Sheet http://www.virtualpiggy.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) false false R4.htm 004 - Statement - Statements of Operations Sheet http://www.virtualpiggy.com/role/StatementsOfOperations Statements of Operations false false R5.htm 005 - Statement - Statements of Comprehensive Loss Sheet http://www.virtualpiggy.com/role/StatementsOfComprehensiveLoss Statements of Comprehensive Loss false false R6.htm 006 - Statement - Statement of Changes in Stockholders' Equity (Deficit) Sheet http://www.virtualpiggy.com/role/StatementOfChangesInStockholdersEquityDeficit Statement of Changes in Stockholders' Equity (Deficit) false false R7.htm 007 - Statement - Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) Sheet http://www.virtualpiggy.com/role/StatementOfChangesInStockholdersEquityDeficitParenthetical Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) false false R8.htm 008 - Statement - Statements of Cash Flows Sheet http://www.virtualpiggy.com/role/StatementsOfCashFlows Statements of Cash Flows false false R9.htm 101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.virtualpiggy.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R10.htm 102 - Disclosure - MANAGEMENT PLANS Sheet http://www.virtualpiggy.com/role/ManagementPlans MANAGEMENT PLANS false false R11.htm 103 - Disclosure - PATENTS Sheet http://www.virtualpiggy.com/role/Patents PATENTS false false R12.htm 104 - Disclosure - NOTES PAYABLE Notes http://www.virtualpiggy.com/role/NotesPayable NOTES PAYABLE false false R13.htm 105 - Disclosure - INCOME TAXES Sheet http://www.virtualpiggy.com/role/IncomeTaxes INCOME TAXES false false R14.htm 106 - Disclosure - LITIGATION SETTLEMENT Sheet http://www.virtualpiggy.com/role/LitigationSettlement LITIGATION SETTLEMENT false false R15.htm 107 - Disclosure - CONVERTIBLE PREFERRED STOCK Sheet http://www.virtualpiggy.com/role/ConvertiblePreferredStock CONVERTIBLE PREFERRED STOCK false false R16.htm 108 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENT Sheet http://www.virtualpiggy.com/role/FairValueOfFinancialInstrument FAIR VALUE OF FINANCIAL INSTRUMENT false false R17.htm 109 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.virtualpiggy.com/role/StockholdersEquity STOCKHOLDERS' EQUITY false false R18.htm 110 - Disclosure - STOCK OPTIONS AND WARRANTS Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrants STOCK OPTIONS AND WARRANTS false false R19.htm 111 - Disclosure - OPERATING LEASES Sheet http://www.virtualpiggy.com/role/OperatingLeases OPERATING LEASES false false R20.htm 112 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.virtualpiggy.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R21.htm 113 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.virtualpiggy.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R22.htm 201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.virtualpiggy.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R23.htm 308 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) Sheet http://www.virtualpiggy.com/role/FairValueOfFinancialInstrumentsTables FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) false false R24.htm 310 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsTables STOCK OPTIONS AND WARRANTS (Tables) false false R25.htm 311 - Disclosure - OPERATING LEASES (Tables) Sheet http://www.virtualpiggy.com/role/OperatingLeasesTables OPERATING LEASES (Tables) false false R26.htm 40101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.virtualpiggy.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R27.htm 40201 - Disclosure - GOING CONCERN (Details) Sheet http://www.virtualpiggy.com/role/GoingConcernDetails GOING CONCERN (Details) false false R28.htm 40301 - Disclosure - PATENTS (Details) Sheet http://www.virtualpiggy.com/role/PatentsDetails PATENTS (Details) false false R29.htm 40401 - Disclosure - NOTES PAYABLE (Details) Notes http://www.virtualpiggy.com/role/NotesPayableDetails NOTES PAYABLE (Details) false false R30.htm 40501 - Disclosure - INCOME TAXES (Details) Sheet http://www.virtualpiggy.com/role/IncomeTaxesDetails INCOME TAXES (Details) false false R31.htm 40601 - Disclosure - LITIGATION SETTLEMENT (Details) Sheet http://www.virtualpiggy.com/role/LitigationSettlementDetails LITIGATION SETTLEMENT (Details) false false R32.htm 40701 - Disclosure - CONVERTIBLE PREFERRED STOCK (Details) Sheet http://www.virtualpiggy.com/role/ConvertiblePreferredStockDetails CONVERTIBLE PREFERRED STOCK (Details) false false R33.htm 40801 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on a Recurring Basis) (Details) Sheet http://www.virtualpiggy.com/role/FairValueOfFinancialInstrumentsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on a Recurring Basis) (Details) false false R34.htm 40802 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Fair Value MeasurementsWithin the Fair Value Hierarchy of the Company's Derivative Liabilities using Level 2 Inputs) (Details) Sheet http://www.virtualpiggy.com/role/FairValueOfFinancialInstrumentsFairValueMeasurementswithinFairValueHierarchyOfCompanysDerivativeLiabilitiesUsingLevelTwoInputsDetails FAIR VALUE OF FINANCIAL INSTRUMENTS (Fair Value MeasurementsWithin the Fair Value Hierarchy of the Company's Derivative Liabilities using Level 2 Inputs) (Details) false false R35.htm 40901 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details) Sheet http://www.virtualpiggy.com/role/StockholdersEquityNarrativeDetails STOCKHOLDERS' EQUITY (Narrative) (Details) false false R36.htm 41001 - Disclosure - STOCK OPTIONS AND WARRANTS (Narrative) (Details) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsNarrativeDetails STOCK OPTIONS AND WARRANTS (Narrative) (Details) false false R37.htm 41002 - Disclosure - STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsIncentiveStockOptionAndWarrantTransactionsForEmployeesDetails STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) false false R38.htm 41003 - Disclosure - STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsNonEmployeeStockOptionsAndWarrantsDetails STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) false false R39.htm 41101 - Disclosure - OPERATING LEASES (Details) Sheet http://www.virtualpiggy.com/role/OperatingLeasesDetails OPERATING LEASES (Details) false false R40.htm 41102 - Disclosure - OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) Sheet http://www.virtualpiggy.com/role/OperatingLeasesScheduleOfNonCancelableOperatingLeaseArrangementsDetails OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) false false R41.htm 41201 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.virtualpiggy.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) false false R42.htm 41301 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.virtualpiggy.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) false false All Reports Book All Reports Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 2 3. Element us-gaap_ProceedsFromIssuanceOfPrivatePlacement had a mix of decimals attribute values: -5 0. Element us-gaap_StockIssuedDuringPeriodSharesIssuedForCash had a mix of decimals attribute values: 0 2. 'Monetary' elements on report '40201 - Disclosure - GOING CONCERN (Details)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: Removing column 'Feb. 10, 2008' Process Flow-Through: 003 - Statement - Balance Sheets (Parenthetical) Process Flow-Through: 004 - Statement - Statements of Operations Process Flow-Through: Removing column '11 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: 005 - Statement - Statements of Comprehensive Loss Process Flow-Through: Removing column '11 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: 007 - Statement - Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) Process Flow-Through: 008 - Statement - Statements of Cash Flows vpig-20140331.xml vpig-20140331.xsd vpig-20140331_cal.xml vpig-20140331_def.xml vpig-20140331_lab.xml vpig-20140331_pre.xml true true XML 58 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) (Non Statutory Stock Options [Member], USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2014
Dec. 31, 2013
Option/Warrant Shares    
Outstanding, shares, beginning of period 16,128,536 16,531,438
Granted, shares 50,000 2,048,750
Issued under Private Placement, shares 10,087,287 1,723,533
Reclassified from (to) employee, shares (200,000) 235,000
Exercised, shares (5,092,287) (3,005,185)
Expired, shares (410,000) (1,405,000)
Outstanding, shares, end of period 20,563,536 16,128,536
Exercise Price    
Granted, exercise price $ 1.13  
Issued under Private Placement, exercise price $ 1.00  
Reclassified from/to employee, exercise price $ 0.5  
Weighted Average Exercise Price    
Outstanding, weighted average exercise price, beginning of period $ 0.98 $ 0.63
Granted, weighted average exercise price    $ 0.18
Issued under Private Placement, weighted average exercise price $ 0.49 $ 0.30
Reclassified from/to employee, weighted average exercise price $ 0.01 $ 0.01
Exercised, weighted average exercise price      
Expired, weighted average exercise price      
Outstanding, weighted average exercise price, end of period $ 1.11 $ 0.98
Exercisable, shares, September 30, 2013 18,968,537  
Exercisable, weighted average exercise price, September 30, 2013 $ 1.08  
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years) 1 year 8 months 12 days  
Minimum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 0.01 $ 0.35
Granted, exercise price   $ 0.01
Issued under Private Placement, exercise price   $ 1.80
Reclassified from/to employee, exercise price   $ 0.50
Exercised, exercise price $ 0.35 $ 0.35
Expired, exercise price $ 0.60 $ 0.50
Outstanding, exercise price, end of period $ 0.01 $ 0.01
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 0.01  
Maximum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 3.28 $ 2.30
Granted, exercise price   $ 3.28
Issued under Private Placement, exercise price   $ 3.00
Reclassified from/to employee, exercise price   $ 1.01
Exercised, exercise price $ 0.50 $ 0.50
Expired, exercise price $ 2.30 $ 1.00
Outstanding, exercise price, end of period $ 3.28 $ 3.28
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 3.28  
XML 59 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2014
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS
NOTE 12 - RELATED PARTY TRANSACTIONS
 
During the three months ended March 31, 2013, a consultant owning more than 5% of the Company was paid for consulting and travel expenses to provide strategic advice to the Company.   On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year.  In June 2013, this contract was terminated.  Consulting fees paid for the three months ended March 31, 2013 were $25,000. Reimbursable business expenses of $2,946 and $23,566 were paid during the three months ended March 31, 2014 and 2013, respectively. 
  

6R0$KY1&6![^&:.6(;OR&VGS]9W>[/;=`5S^+HN MFZ^79K5T:TF%%+A8H.FULV6JFX.-'V@N^A< M6YKHW^WIP<4#3:T/;BG0W8:?+Q/H+KKJEI[5<]7=H413;`1;ND=W&]3L#6C; MZ11H\KHA^=$=%^.%%+A8H/OSHSLN[;IPH'OTHQ4.=+=`]^5'*QWOT1<)]"#\ MZ(Y#H)<.=']^M,J![DYU]^='RVK'D;&+!'H(?K32;2()?:`_@^#%7?P*O]D^ MJH>QN_20?WJ_MN9_7C_.7]PU\`47ST78>O;<=E;"QEV`-24,#^L=(6`4+__F M@%&1,'I7@G/`V@.LDXO".6!4`*-6-\L!:P*`T9!)=*\M9X#1@+<\#H`$;MNG$.&!W`J%U"S@&C`QBU.Y8Y8'0`HW:7/`>,@N]%\X+Y M<0/VU?;_O/4`N(,$\X`?T&E:FO66+@L?\JO#5%0=)HHZK1+NK)6/&LY^+S:/ MX*15[7=):7!.$`[C/G"I:>@NWA*O-(.KF";1O.7MI=A'"J M7-FVK6Q[N92>P"GIM/K47!R<_=Y''\*I<.D\&TYZ*7PEG4>@;W M<4.V%SAI9?^5ZU:^55*`DU9N8"F>BX:25G5H&IR)R_4H!3EJYJV6Z5N;"20%-6HFMI;I6Y7!2@)-6%F49G++. M+:&V71.*.9:E=BW/-J`@G+1RTDO#0&..&U"[L;#@9<.XQBX$U^CRL)K^=87# MQ;B/&^PBC+O4QQ>,<2^7UT48=QFKOVR,N[^W+G)ZN!S3Q+C?*^LB8ZO+J-/E M8=SO)6:A'$\YQIW(<2_WET48=YEWUA/&M&ZI*WC9H'RG3LO6Z%]1-UR,>_2= M.,;=8-RK[]1ERO=E8]R;[]1IKL7E83P(WTGN-)9Y<1@/PG>B=C$PQW@POI/2 M:2RS58R_[#;/P+M?XK_ZLUWPXGKV_Y[;7B=O5$AK7#@\A91%E,Y,7[3\:W>9 M/A$TQ$GF8S$P/GY1$AKQS4^R)N)_6@`G;T%LHZ"8C5`X?JP8!59!>+7LM?6\ M!K>N]S-\-F@5B^/!NQ4,=:HH2AOQGI)5C0F83F1%DB714-KP[KI!YIYL4S?? M@3>W??0"\M[S(,D;-<(BVJ=K8G'R6`D6ACDU-*6-O+V\!3&-0F01UT3AY+$2 M%"15F4IJ&P96YRC\!NS52P`6LU?@62L0_@4\>/;\S+2L>N^B)C>_/G[\UQ9X M_\+()8&3(7"35K+JZJWT8J!L7?B*H!0GK?3O.1O*Y_*7/M=^Z5>PL:!'Y:P^ M0`IZUCS86>LGX&VD`ZS=OO)2TR.8FH;22H;_.&&AML&4QI3$=NK#NX+E MUO66P`YV<"FMPI(Q+B2JBH^`E<3143XP8@H8,987%8&1.4H)-&T%8/-7V"XT M.$35+BKI(?O)RLH^I)BV"TYZHE4%XZN$LA]U"/HY+ILW1S M)4+N(1]')0^5#CJB97N6"M=AA;C0[V^?C4O+!AGKN'1T$T@.%AH'(W^C[^1. M#[ZEU$>%?O)Y-BH2%4>#2;5YV M-BXMQ_9'APO]NV7R+6,.2[8:ZR3%G3LL37"A?WCR#X:IV`D'JZL!PGJI@O_K4&> M/A>3_*&J5(1R5#(37+NY$203%Y/#4@@+_9L],F%1N`XKA(7^#1TY3@L7ET)< MZ-^UP:WC!K#0OS.#6\>UO99.+K\8&2X_>Z[O4P`'C]MC/9@LJ@8TL&E!@I?' M,BY]U8-1W>^91Z6OK\M]ITZ61"S*$PKHW#0 M:?"A1BA(LJ&UTE]R;"ATV+Y0%K6IPE'(U4C5.JB=:*2Z[0MU63.F:AL=/4>' MPK0R"B<:J2X*4TV?2AR%/(W442O/J2Y)DMK&76*C1*&;WL^2*LJ*HK1IMXX+ MA4X:/2NZ8;9SY=JH08`_B;GG8N5@G#Q>8C+)4Y6#4JJ?FH*2]WA99:LL&UQ? M54(E-_&U&BIU`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`F(Y<-=WO_Y>GZ=O;Y[A/\[,G> M`%_X`KX)7]V-Y81_?;S[GYMW@@3?%7WP]/LG^(D=6!"0\+/?;NY^_CN2_O=CS%\$# M_][9'J0;FM,&JH^=A]6/8#D+^,>YNW(PPZ-)IE8"OJ.?`5ZNM5ZGEFPA/>4+ M&VL!A,`5P&:[=O<`O@0-NH"OFP>NYPODRV@L2.6-!565L+1L3WBUUCOX9?@' M-*D5\JJ$!?SS)$7PZ"$R]<.#:*89DPE'0^.@;Y!1=[[MK/#G[]<6?.)Q_N*N MX8@;=P'6Y'7QF!@TUXN(@7[%0\.?K$"P?6&W)A-:[S%QYF@]3!EP8 MD@1.SH&,!,^!1]Z\]>)\"OF_,-G5WA%T;P7(`#>!JXJ"TWT"9PQ]JZ%"NO"V(9D MMM$VF3,FW'A\&\Z*/`SQ`7"O6J`W9'\?X)4+*![G[(4,$?(?_.H*"@1Q!]_9A1!9=LZ>C-+IYOQIM.P(*K2R\`0;YR M$<<@&A$F\@_+>MZG*`YW[HA;D-S!1V)QK+EZN"PX7GHEY"\9D\:402Q&\+$. MB@3I!FNQ"+=786O9BVO(D'-KBU0>XDW\"BB@<,7^?UJ;[8__1S%_C.85"Y*U MW4(%B>A]+$F3DZT%;KHWSB*]Y9Y\*?JES'@KM'NJ&%PD4V^V@V+M(3V!10:K M<3(T'BYEQGU%UN(G]QOPR$_VQ@X*++-V7G!R?YVD:2W>3J]EEV"5E(&89>BT ML_91PZ@:YUZGFCM6Q1(04>GG',8<&+N]H[H(1F4BEEZ(S&$LD\9.KDXNEL;R8A`.8YDT=G*E;TD1%OO2 M^.MV2Q?&HQ<,S^&0Z"G5H[6/&L;^'0ZY]$B&PU@&XP`<#IF6^W]9,/;M<)BE M!^@3'LV<7Y&1U(S9_'%=:)S MH,?P<`IG8EAS]([/[L)>VG-RD+)\`M[&QWDMZ%S&6B=G^\'UCX&D\8J3.^-$ M75%:@O)DK"241WT@IEIV&([&FC,@/$K@2K0OR^E@WRF)C]8-5>5L=;8-:\[96#P7&"&3F(M9T5/BVT(89P M=N]1D@M94Z6O\MRJWG.KVLNC.DDV^G+_="-(PK7P^.MG.,SOPOVM\'CW\Y>[ MV[L/LR]/PNS#A_M?OSS=??E9>+B'$-W=/-9)IV+%>R\./GA/4K"`3Y+R6G_L+U@9T&!M5>K_94`U?Y$^.%-(@7DS5]1LHH% M5=PLVPG3D,(DJH]@C5)N`$H: MN07/WL[R]H(D70FR*!H3G*+A//O;'[-^2DV/3"0`\Q?'7;OP]WF8I8)SJQ9@ M;;\"#V>+N#C;30#P"QMHD,#)N.M=G/Y",EX"7_#W?@`V*#_-_>8+ M6SA5E+:",DW@-VU/F+_8ZP7\$"6J0%3@VJ_PE^=H@4O((^&7/0LJ8O((3E=9 MV(@Y_"O!MUZA)B;?FD,]#YD7)9ZL;/1Q.-G45.!"%\"'^)'L&#PSDHR$IH(^ M"L+=.UHJ2L-R=P&D#]RWX8N%.4HZ>]X+*\MVHLPPLK0X*<9'*2\;V_=Q5M0+ ML!:8D2$/DC0;]-;TH^C-/@B$W99DH^W6)$%I%V7FQ-:AX&,"P*?7R.SS)\+] MSA,@MSAS>PL!=9=+O!7[`J$C9IN_P^FXOB6\!];\Y4KX`%D8XN78%AX(1=K3686KAQO+^!&AK M%,`2#A_@C+:;G0<'C4!/<3M:&."4.!MI*B0LH9@2R<&9BPCL M-R3K4#+>A+R!4QR1J#OP8YP^!Z7223SQ(=0("5&Z)R^&%MRK-=_#_[I046&5 M,X/O^N'-A_N'AQE4IF@*)'W/AX*QMCPR.\<*,]KFIT-OPS&A&O4S]24FT3<+ MRI*U<^8O!QW\ZV,H-7(D0>A3PNM0>`ZK18)UA;_C0$WS8I$$R[FUM2#3H\0Y M2$4H:G#6.#F7J%JHP)9$T=23A%Z-B+99]#>40#A'1H"U\@`IRB",@G:>%Y2- M>B5X(+#L-:;="FX\2/5&ED-'13G:8 M*-FH5R3L,-).)YO*<5SR:=K&SC#%8XS@X/Y:+T MSP-MX7==G*Z=SA1&'(QS/24!"MD:)]7[Z'UH9O$^FW[1`BQQ:K$5[<*8C"C] M%,YWA52`A_8.-LC><=`BT/2PY*!W M[1QK!\U.E"2>M;87ZQ5NR@#:T'"%R);,7."OD\>)L(*FG0=U'2Y3`-O@('/H M/:$%B;9Z-&V\=]J;Q$MM!^G2,-,?*I=XSR8IZ7.2>8Z>O87?@QA?_S?^WE=H MRPK&M:@@UOH*5KLU&>/Q^I\33%0/6;/K/=8S4%F@G'6T=<[7NP7`M2VA$W@\ M@:7K!O"K.,D>5]%@L_RX>">K4"=[V1GTB79[!P/P&.!ZEQ_>I"IYFE8+84Q^ MGLT>"D?+>O+-7X]LSKBH"%$?\0`I+B1,XJKDT@Q MPS:A5!)<&^(TQ_!0,1MFBSXVO`)<7$-> M%&$:;DX):W#F.,C^_0JP:T-<6LS'_Q4[MWL`S4KH?L%A/L)%XJM5%.QP0_<) M;EE+N/TM:[PNR/O\`=L)S_>?$!%.O=;$&[LD%B[=5A' MA+X1O$`3*-SDP@E\MN!.';U=Q4H."4Y$?.B$PZ4NL&YZC0,IT;AXD]U8>T35 MN%JJPBI5OL.>LE$DH.<&RP)YVG;N$+R MH*9(N.A/D*A!Q#$2W]]MP@(HS-\6M.7G0,+Y((,Z[,Q!LQ M_M-!1`YO(56U)`I-*GO)ONT?RR3PH*?KY-BGQ(>$=HOKP0T0*1GD4*+M$1L= MB5K@4.?`+\TCPQ39.3AXD[O"IV.'V('+0HXMBFAB=SQ-+#AM_TI(FU(6VFX! MA(G$S<)W'VPO+IAG".8MLCC_$97/'MR[NT/U+)MRFC!7DYQ_J`D.F0QS6%2, M3FJ041CWZO#AUMKCLQ*\\/86ALD0U]#.86SL_VF7AQ]`[\)`I&X26]J19 M/'Y4H=-"Q6[(8O,6%PG!^GSH5D%LEH^Q@O937BD)?^/C'>2'!>'!6YXM14PW M#T%--@3\FD78$2.TFY"J3+$%BET17HS-K61S#2O7=$.L:Z/A@^1XWVPX0>@; MS=?P,7MIA^\/]R"R;R"M'QE[[N%(#SEJZ.!M!?<>X+^KPS:7?#2E3*-9?T(1 M,T%Z)_SWSD58AX$SCO'/7PG_#@6XKGK>>YSF,#PO(_&@)Z2Q4%I!HKR M#KK(!21'9BXG>[N[Z1I3WCYISA*>1(7GB,F_))LY+>%VAYJRI'N\P!T#]2:* MAH8@QKV,_$/"(5+1*M!3NTV['($%3[4-?8"D$@=.L*`[/H>F=[^B_#@HIPM[KF> M%5+"W8L.4=8/).OLJ^W_"=W75W>-4]L^6/X+8ZP5.23HU`&?_RR@,>_;45*' M=>30V@')*PQ5:X#3YU#CMCF`*O06H+Y;:^$C&4W.@%>W*6#8F*DUH8$H/4 M`D"T`&QO!]A1LI#CY`<3M*UX`'(@WH%PGMP&FN?P&\7-0`]=$`\M57<^6.[6 M`LKK]./&I3A&<77(VE[OP\`13@-_!0X^@_TZ0`';VMA``SZ`7B@;;P: MY&:_6-Z*Y+0?;+6K,"O[#Q0@V:".MXF$J+"Q(SH$F0B_;G$'3N1#D#P0E-1] M=6B(N;!]+)^A3;+-).15V-73#Z-L4&'L-NA0!8>1$P1%KP=H5W1(T]GP6#*A M8?#C4`V18TQ$8FFP(S=_8XS?TY\SB1='#=6NG\^'1N!%EY>N'"/2G<^.'-KX\/3_=O_GI%$@Y18M)C M(L_X,]%8B+__`6W>Y3Y2;+,5.0@M1=WT<9[ M=4"VV*RLA+BQ;)CGEUHO200+6]9^..MLA MH5[;UA5TB*W_M=>HT,:Q%J3()JR#.70@#\'[X,;J"X((+*B7?GCS\.'IS5]S M#M>Q>O5]%VFT9+(92:7V#OF1:[""=%J`)>ET';;0#N=]R,!+;`1$/Z&,^PVR M#_\W.FA)[W7/)$_X=*M+[7'1BXBQ^`UXX-!E>A&::;(8[G,7K_O.,,L^N<[J M^A/N,3W#=@6CF@^@X&;<4!ZE:"#G/:R2":L+UFBM:[S6\)RGJ&>Z,A6%-Y'1 M=R6@/@K!5=IZG;Q)S<$#KS;XEO6>);&AH/%%C(47N*,C"4#&&CD&(;F=)`/. M]J#I0ZX-]*,L3$"BNT'RN)RD?X7J%K\)AT=(HLJ!!JAW^=<3@IQ.$HEN?%[Z MO$)3VX_ZF4?Y MX:AP$F>2HT`WSBJ'AB"RGM"NM=U"K0(-3924O(1N)/(I#^M(Y!.3%Q/JHV[O M.!G\@`7Y7&TU-=F^DEQ'S-3A M#1<,::V[4YU3)=.;9'DCVVVY3%:3O-^MUZAL%GUC]AY^XXL[@3-7FV=IY)$W MKA/X@=2M$.I4>#_?<,WA4`OU8NN6""RBF]@P(_#YTGE7%@.O;2_D]LE(C,DS$F")6%"=XKLE4,:QA_SGQT,,C.37SB$S0*O:RB#G M(?'YE+#A_H`KQ1,32*B=R.R#EO=B-P]&%%6^T/@RR1H6GJSOS-4#Y*:8Z:I( M=$0B]9\4E>&U!FBM5\\L*S7Y$2$EL`C MI7+1-W,S^[$I$D;_+%PAM"9U3="31HTYO'V87@^PL?<,@F_(JRHN`8#O0ZD` M164(V%@,]2\*@N'D`^L[SOC`2@R)OXV3*#?Q,11^*['@#K<[.18QW^!+4:$[ M(1BIFCCS"HGZRY2S8`_PZ=I%)E%06)1&%(MW=ZH4$&TE\(WD(`[Y;.+***(TS?U#X%[WV#S@Q M?Q&>R7#;E5^:QR_-XY?F\4OS^*5Y_-(\FZ%+\WK<6HKZ(S+MOS6U!6:+5Y3( M@I4=/IEA!:WDQ,,3>R\^B\9<#BUYE`"*).7DN_@TYR^:V-?BT1HP/)$>0Y.O=)5\_!=54Z\4W>"L?=8YJ.\+#W!#Q0V? MA\3-9Y7A3\-0VB'$=6-Y#NYZ&B\VD2<5]XM+=-N!QA`ZLY^'KLP:Q[)`-`K* ML,1=M#/9_WU8;YLTPP[=*W"A/$[)JB\'5SC1TPU-I&26YE6X%Y".(5'D!'_M MZLAF2]0DA]L2_,F^QHN$%N2/:$YP!&C<7B5B1?YA":$1F21.5+%_H`P9F43C M472+2VEC*<6-P*]WV^'M.?4/_0[;CBPV#7]$J/LXEFPRG#AQB^21$2\;UZ;'W<1\LNA)(1/+!K2=(O)\C7:; M,*GWQ0;+Q(#HN@44![Q&;9B\1!(?+L,FY?(D*O(!/WGS']'?$A$]Q])L*CC9Y+[G8Q6<.2_Y"8I*2+6R2/0V3&`ESRT'G&TM4:Q>WKX$4`2O+6>^@)N[A162)YX\%S'?CS'+!V#C##L;P,V^SHG"M`QB'W2&4U!3@0/://H?U]L+&+&]L]1!''X^^'BN*\029379].5-'0)YJD M*S5UBH1U"AI!S!JCX!Y+13&GDIZ\SO',A0R3MIHXT63)@/^2R_6UFJ*M>JV( M9(3,,0IHJQF2)HHB5=J&*00W84)#1*W4QW"W4=-[C?#=M]\Y]OIO;P)O![+O MW10-=.^F))X\?;KJ[YNUX[^#8_XM8_^!(TEO__GYT^,<6AK6-*'&YC37R^CN"1#BA_KTY8FWNK5R4<3EQ51UFBQN#B1R(X_-<_2 M[QFC]*_E,R951=>7KB6M.379I*;OJZ[@2.O76X&J4)-GI>H*CC>`>BN8:HI. M;0^HNH*CG:#F"J8&K15HE5=PM"746X$$%1R];:'J$HXVAYI+D"25W@91=0E' MVT3=)4PU6NI(G,B2*FGG;Q99P_2_6S1?7&KW&.+BY,:+.]I8AK@XI>GBCO>< M(2Y.;;RXH^UHB(O3,F=596LJ7TTZEB*>1E+:VYN:(G2T5PT0(:.QRC_>Q0:X MN'`_F[:SGQT/T_?BI#,6=[*?#6UQQG0UN,0I>(2CO>A6DN8RK*LF[1. MT-2J2SC:;6HM01>GFJS2"^=57,+1%E-K"?)4@7),[7QJ6G4-1SM*/6'0%,G0 M-8E:0*_B&HXVCEIK0*%Y4=%H*24X&\BJ+>P8IZ,,8,LXG52E/:-L+6E+S#04 MPYC2VS0J+N)XUZBW"$6&7#:E=PA4<14G&T>]5:BZ:&H:K56HE5=QO'?46X6N M*O!_M/9PK?(JCK>/>JN03%5719WB!E)Q&<<[2$W!T%0-HDA)OHW,^53:1&I* MAJ(9LB)3V@K1-J(K+>PB)X,,8!-IN+#TEC*XA;T>`6IC5BM`I3(-EG#Z6-'QXCG3_^(&X'#)?5QIE+.JG&_SRXG::SUQ4F+S MY?[I1C"%:^'QZ?[#?_W]_M/'FZ^/A[Y_-__]Z]W3[\R4?K9=@/3QT!IY:7M^ M(/Q[!P%'MP0LPY9`R<8+`%\<@LH849]IU,C_%35"W:ZM>7BMMAOVYXDO'3JM MO4WV&")M1\,G<#6P#SD`-=VWT/68\Q?+C^X+@./]9:)K)IVAB5>B*&;WJP[[;X8U51X@M^KA!MBVGT$: MTF-L*E[IAL).J7';_';O"#-(F[4@:5<9#!;6?\O3*TV6XAM+4:NI&DQ%^M*_ MHM:VFV?@Q4^1QB+PEX]Q[V#2TATA@YN48L[[BVI>B;J4TZ4<;0U_A%=R1X6Z M8:/R_'?B.\KB%JJHU'BU\L`*-Q$.VV;!.<<,+UV)A//JRY)_&/%X69H$UX4Z MRAR:LI9>KK;SPU:ZZ<;&Y!58,)'6BY?XU;)IWU@PUE> M'8J=2:,U?'\`Y((-^?L[U!X`LC-J8[,0]C98+ZX.?9%?7527'5T.(D.#X_]> M"1ZZEWN)>I[%]QQY8;OFR=3\O^2.R6B$<"5K>XF_@"$,+T#+(4U$7C@$:F!S M>.)P:V;4'3KJT9LYUGTX3M1F&%\L\)RHS(Q;T9(&;N@=N`LTUM?`VURT$OEL M[079R%(A1WM4XAJ@ATB^9E#X0J6,[SF?S_&-[O@A1&$777<#I1&A1VY1#F_, MB_M30!8B&U5*E"$+7FDZ_']-P1:OG[N121-#Q#L9^IKP`YK_FWMTI0,$%]T/ MB><%T!T;^`O/@'1ZW<`1,&LL<7NC'Z2_AMWPJNE%W)4I:LZ7TCAPM.L7:[T4 M?A`GVE_)A4'QR.DQ`M)M&5T'G5H2]/S%1'\^W-`]ZEB#IQ-BMK16^AQBK>P>DM'W> M.*C5-&G3&`U0&"6V(7$1/V]C<0X<:.KXA M*I83F]()2DM$+C,A.S8A:@@.UYK9D-R"9V^'[FR+6^[%MBIR)=:`-`P_#56Y M">,J#*!'USV[NP!WY$-_C7&,^U/&[L0R3_9^>!,:=N&XR-DY];32W\&-:<-6 M@4'BXB?"6V$76Y=TL3TV4LES*_@-)PP[H"ZZR#W`5]G9FPWT_*+;ED*+%;6& M3:X3\3%8I)>+;V.VD9D;WC&'/OPAO.`T>7=,-AE(1ZM]%'H]B$CDG)$[4/&% MJP[DFN";>YTTVZ](V``WW457.6%9LN;_1OUIL?7][ZAUN^#L4$"J`!(KOF?G MV%\ZF=8//H2KP+Y/>8`_8/_5$MY\!0?6"I%%5SD]'+TMXKHTI\:^R\$QP;1/ M7UJ$7B^CF.&5I"HD$',R^;2^@4I#E:^@@Y,@2T(Z#E$UQO5*F]W:\M5/K6YM MG_%-Q_,8N;CC5-@%U4ZK+EEX"#74P\&OQ=>EP)_A?\+@($.Z^09W)T5:*UZG M'C5&Q3=+X%OT\#4[!_%R=]Z1&6.AX,`$W?3W#41AKZR@B)504Y&097T/QS?F M83/,.!*6:(1APATV.[!A0/G!G:3+W^)@BV9 M2BYSB,_X_"*FVD']9$W"3RZ-:=\E&M2D*]5._6$6MY6T7J,VNM14NM1#NLQNEU/LO\COK8I[`MY MZWH?L(&?7FW)U\D"9&DJX4)=M9@MBXF0.4I,#++#G93@*?"?XZ3Q2C/OCD"J M/I$U'9.IC$"AW(8$2J8%(Z[/'*6$0*8H9I3^#HQ"F@379BB56$A.L=`AJ5/# MO0>R1BFFD&QH^DG=VL#HHV/ZD'+Q"B*FI41,(_310_JVXOG)@ M!,(B9HAB"R*6,4J)B*F8A8Y+/@9&(2UG;5DL)*5$[)`0CIL2-Z#05,YH3#PT M^DC5Z5.F@FISD,:"CI:K$^AXFX\))#<5,64JZ\<%TL,BD"35TT$')8U^,W'; M;S1&,PE#2FC8&DB2SY`P<4KH(S>5,%&6%/6DNG!8%$*NC0I97:Y"H4+W*'.4 M`@K)D$(3Z@KH"_B&_^274R;^*C)<4/6BJ$\4S<3V2\*^R]4^:LH"(CWUT4!% M0Y6805/MI!RR=/;TB:,5]$K/I0<1IJ-GRTF@FM4WJ>Y(@"];$&6%7$*1NC*A MR94+>2,5DP;?O3`\TG1PQTXDT348KIIF>U;F2+;E4B MW^5TJQGYKK6-#I-N9BMT.QFE))30B6K#-X]5LFK3W^S#'\SHLF9"\I;2*#US MVF2AY`EFW=M12;`*5[][]L&_=\`);EY1(LU1$X.\O_*F!:-O6B`IJ&O!K^\? M;_[[5_AGX>8?\-^/?>>Y55U"(@F%D1G?1;7I.-GI,/_CFC?\H8V%/+,P2-.* MRD_@-U\MJ!1VO@`VV[6[1S6`!3FULIYL>3"J"K)Z%^4FL$F7_!VG+6?4^2Z` M/_?L9Y)*"H^)$LDX*1!/)`FZ>)PBF9/";$C'K%:A/A-7YB8+/3/JD^.A3].T3ZF; M3MC&O0ZBHO:MO5KMGRWX5O@NVP_"=.U#SCIZ,E%B4$RU1%DH*;W-0'KKN2C[ M+FSM4'%X0CY(Q;`$WPGL8$VZ>3CN!F(4D&2Y1.U!BM23.`O9Q\P"T<25WU$> MGT&2^!":A\OD,]/TN("?%JND*_H1YZ;+]W$M0)1L:GL;+"2$#03,G2AYEU7SC=#,9O=0B41EIIDM2TZ+\)THCS,ESR=UB]6JK8\VB:LH M=1HUE$#:2O!WSW_`]:"7;0#`)(A4V\9>(WWF(&)<*NL=>M*(5QGLAQ*,'6L3 M[11KZQLDJ(V;`_@[W.``)>;OO"#.I,:9UKB@!$X`?NC8%LFPM=!7-JC^/-SY M4:T1Y$Y43.6YSFJY6^/6'DCC(.Y`O&*C3/8_,6_#X1?6QEH!DCX.GT0YU\A^ M@,A"O84Z$$R$[$OCCXW77')GW2>?ZG.`LI21HD.&C+UR/6C)K/=0-?K;79A) M/5];]L87-A84P.=]F"V=6C?FT34@6S>N8@*6#S=2E%<.EO#+4473BPUP90`4 M"'>].V2.VVCX`-(J(,;5W?QW4#B(`[/ZD>T'KU@ M8I-7HJXW4$UL,(2[``H;2M_'GR_`$GX5%VZ@/BR;$.5T]X8U?!NT+98":4>P M#EYP0ZIO0%BX>#K/8(T71;0*FD#XEJ@#C`^9%B?*'S;=4R4`9V(Y>!IMW87WUPO[P)J4*\]?1'W&'MW6%MJ0PL7[76*@/[ ME12*Q@S"T(Z!U.'6`UOK4'YXD$<_JK/QP_XQ2/>AFH^HV1#2%$CGP3T'/K%% M%2HKX``/[@5[]'>P)9X&EOQ?'>QWX"T%U?S@$D^D_!RX#T2.RL;Z\Z"2R.:0 M*$H)-0TN.L-CPIE##8OJAK#6PJ8&_#X(RY+6MO6,JE3L<*A%7*1!C!D\>UR% ME_-,D"HE(:W1,JB#GLN;C@SYS%A]MN.^%`?1FCV:4R937:#2IFHEBZ*V4:?1"IC8WJ-)R#=60 M##EY6T^S>0^`;$8YV1J4_.0;ET/ESNB&(8?=N8/.\?$C6-F@2$^``]] M!1.[I;%(!6(SSBXL:>R`LP=*3KDA.0OSC2^7G%+FAE6_Q+9TUSO*<S)M4[R8=,SLQ;P\]FSHLE9\U+@*LQ)_4` MZ$")6?/BX6JLV0$QH\3+.$OW"7B;D#B9?SL$"752--[\`"1CD)\>I-]C^R7S M_8G9?P3/P1UH?/$,5_;8'W+WR: M>M3H1)Q,S9`2M6><=$W2L&>I0%L+X[`=ZQ\<(;L^1):FJF'(6LR3 M9R]CT,3M_GSWLNC+X-'KX(C(ZDG=X`C)YBG;X,C(Y@G9X,B8LA6'VH&\+NF* M#G';.:'MJMM\*@^KU22K09&3FL=SF>1DI!'_T`BG:P9N4*=4[#4JI_A1OI8- M,H:8/4HO?'D3%MJ%#6GB-J6/8>GK+5S.+Y:#[AY"`;8P_O01S/'U]>BC?Y"K MQN\.-Z3-'-+(9#$+)/7)5>4'X.$D:XQ$IV]D.;WC(J!IZ#:K`P:D,3H/P MV)D']AR<2N!4"[F==;!\W'!_JDCA'M3I>B\.62;/:2\"FE(WI!"%JFX(%[7. M1(W!0^>SR:2$9+I_!=X3NLSQ=W2W7TPI]+PF/KEFR^C4?FT_1TOH\=C7ZG[1 M%PPTDQ';"P.)S=.)"P.)U;.X"X2)Q>R3"X.IF3MV7C8&!ZDN2`SF<%P81-T< MX;%COM\[AU>KX:L_6][\!?V>?.\W]\G->#GT:$7MR954I1:\[;^V)S_-4`RY M(L[MK_F"<1ZEFS8RD,;IIHT,I+&Z:2.$:8QNVLA@&J>;-C:01NBFC0RBCMPT MYJSW_./&'.<0OE9ZM$-[@UJ5.Q M[MYT]F(O"-!1YKG$F.`N@7*`)S@HL%V:"LP#+Q9G@3(!R628X"Y!T8X*S8+'AG!<%M8Y# M+P&+[#)WL5ZU1_UA(6G5AAG&8=.[$"OX6X25.I@,XT$1N9E%54SE85A4@R-S M?0NIG,S]6TB#(G,E+[R8JK6\\$0'Z_:7Q#`,30S/$EB&8'@.BLAE5DLQ/:M: M+9S#LSF\@15?PN"=6?'AVO%JWEL^6'QP-UO@^!9I\#GW\.4CUAK_"/^.:9"B M9J,1HE(7S9`FBF;B#J7&H4-IHQ*7W+$*.-J49>.(HQNM)TG9?^_L8'^XLP3R MBNWBTEW$<`B))_?F^];V\("$E+4>@2O6X7HU0U6K=(:%_HJ:ZJ6K7BLB&2-[ ME)\>M.@>FGH3ZY8(=-OC_O0@MT6$\$L?H1J1DRM-?AZ'SDP9\S#D9O)[D3R4 MAMB#5J+:]!.US"EO@93-<6VUG`T5K@&HXLU2"VN M03I=@]F%3"LMRK1RL@:)^OZ`WMN63!^/%:Z!^OZ`WMN63!^/U=4:D"YIBY>. MQZ*]/T0V/[)QSI7IO+%HVTN)]T[/E8>\L6C;&LGWGLM+>6-UQDN:J9]KM^:- M1=O62+S7.'>?SANKLS682*NTM(:CL<(UZ%VLH35Y.!J+MJT1QU-$76E+MQZ/ M%>YQ8A=K:(N7CL>B:"^APR+-$!/2US#"FS7*3^%#E&A?<=XE5,^>-RW]0^B= MM,*:T_MDE)#>-'RT<-[35N9]/$HX;QI^63CO*B&\\GF?A/#(0S3T8SAOO95Y M'X]"<][80D]&Q_/E4DS)I7B8MQG.^WB4G\A#-&Q,4Z\^[^)3@IQYJW3FK>+= M(AFY;$COK%%^"K]&A]Z5YUW2:C%[WG3I?3Y_9XT2\CHMKT'M:0VG\H\8:CN,?E'1_VM^3U/9\UJ.QSHBE?=FAO-W[ M97A1JO\`O%\=.\A85N)K/NFU[-;D(L]W8T%DVEBZ=BZO MD244$U+1HE%0#O1>4FOP7)5G^S+!E`+*59GW$*@V(D.L.X*-Q!CKAF!=&V22 MJ)KZ""1S-'99-^3JQC:31*UPPV2&N<9AHE59<+&15GV$'LTT[!&*WW MSFSKV6M)A!:>7-5@*GD(F8B9]XRV>K%HIKDD%UI+)?-N1*&8?%"R9/5QJU[$:+%!OL7EHT+"&RJ;> ME&#%+%7V7#<$JV<6EN>A)H&G8A;JPV@*;XZ3I_7B3B6/]1AVDLJ,II*I-R17,4>5/-97 MT$EJ1*33B,*.=$FTT@"3C3)U'6X23%-)J5N-,$FFD3J)M2D-MS@>F>A M<<29PK5J]<),Q4_U&&6J:C#ES+P9K2IQ4\Y3?868JEA+.5/NBT@CBB_1(U+7 M89-J%L#`.&DT(1-Z).HF8%)M\Q\:]XPD6+);[Y6:&3I%SPPZ3%(P[R94*F&B M@F>&&1TIF'`?Y!E34(0:@<82#J%"H*$%0@8F8..)?U`ASS`B'T/CF7$$/#Y; M>UFK5Z)5\$B/!5I*24IRP:P;4*B8>PH>Z:LT2RG(@RR8;O>D&5%1%BWRC*0@ MBP9YNB[&DA1SRHIDC:8.BP9Q2@,\[=1@J?7WJ-[891S55W"=AERC9T_1$SVV MZ]%*0CKYDZY/GE+&R7FBK_8\6DVZ5)2HENDRFG8\M(@SBB8\-(C3=>L=R339 M$*F1]-JA09K2F$TK'79*$GP'Q"GC:*ES:!]4[Z"J[+D>#ZO*#)NRJ3'JU-995-X6,]2;HC,I494>TD M2BN:+IW>5\,&'S&=+ATN-G7Y+#E+G);?P5+OX4E/5Y+)&>9YO9D/@W+LWT[6 M"\G8OJ.L;-7Q(#W;J[$@ZL\#`D@EDU%4A24V2$ORF$ MC&:#F[H*R5=AXL,@G(K^55MV"^F8,60GPML-P1H:NX44Z\W8[8YD#8S=4I+U M8NQV)):5C-UB,:QE[*JF.1*%ULC8+:9D3\9N1P1K8KP5TZL?XZT;H;X"M3^Y?',F.W\A#=6&GY:5]GDK(U4[=E@G9LO47T[4^`6Z9?Y\;<*"G8 MJ6TW.@J>VFEGBW"^Y3<^ZG5K[HV/?EU:?_U3#Y^/GD4\/$)?0:?3`N`&DQ\: M&2\K!-4JZ2XM&-4Z\2XI+-6NT'8%6[I+N@R%6KA.LFAB6W M$,.J(K*:F!QG__3BN;O5RVRWVOE!G?/NFN/TEC6F%Q&UYB*&3-HQI97U3LBQ M))OU2LBN4]`D19,5.3?]>%SB/IXLM5[)6+JWMY*[ACA3,R^%,T>2WE9S\261 MQD:C]9GTIHN:9!3YD(U65$)S_?R0;O4A>CQEE^FXTKS;D*E$BXJ>*8O(RGKIN-*$^Z#/&.RC:@1:"Q6$14"==[1-/.F MX\$*V'C,("KDZ<8`RK[I>+@\,Q*SY]#DOLIU@)6?F_1W*:!;`S,K%][V`G9.KZUL'B\-)PI8[U*P<[(5*IU=3* MA8/%T:8!L]`8;AN$:XU/%FO:3"7/#=IH*IE[4XJ5<%7)<\.TFTHFW2>IQF0Z M42?46(PGJH0:FODT8.$;CP5%E4S#L*&&S$9,*3R)M^8:!59 M*^_!8=M2>;/NEUIC-*L]K"UH-`(GF*W@OVY!3)8* MWX03UZ6)K!FJAM2J6LPQJ`6GEFS!"7_#BX=CB-FC%&W^FB9)1LPZ%6:;H,.M M97L8R_OES;]W=K"_\_T=6."5Y_P-S9/,4JVX5C6U5O5:$'>GM;8V%/[[RQ"E8ZE:=3N=N%JH;9VD*/QBIB M7],T5*5C2*.FQI)F=XJD9FMH6GL=C%=6C M3$U-[7JA6HL+U:J*J&PJ'8NHJ9IB6RL]'JMPI:IB=JMVX>RD%E/@?S4MJA\8`#-XCF[\\W:A(A\,7 M^]$#4TW-<,MR)TEW\6.S%!H38GQVPEFD&)>5T%PWC&R/;$X(OE=T9RC0V"%F M@2P_N?JTXL*/OS[IY]I?ZIS0"EFJ61!-+^_-BNQF1:Q+IMHA.;J]GIP-'FEF M:!42I5=#JS5]TNE%[&R0I>/;K1DA2I=75K-!DE)KI'#Y5:V1%G>;L#[FDVT] MVVL[V!^O^OCO:*K3TF6&[8+ETV5.:RQ3TE3=E#,"]\>3:F]I72'8P]*.JK\: M.`OQ2DN*P5J5TKBY-3ZF^*I= M$8/Y:%/[)!E!W(D.41B/0%'0)*S'HBB0A.VH5/L$*;4G6HE/G;O'H"\@PMPO M/[B;C>L\!N[\SULXP]-*ZJ<7S]VM7L)?;[[/7RQG!?^^!)[MK&:!)GX`\&LI M,YK>\+FN?/N^>SK#38PR9^BM;3SXL!E_8ISHK(9R1D!V%B/RC).]ZXB_K,GB M5#'Y)E`=(29CJ*P3G<$8+>,D[R:""/6/),6=#!C7/XGFCK1?THW#D-D)$OH, MLAQ7?-->Z#B!Z]B3B'`WK;5DDF;=9&WWSBUX]G:6MY=0[W5TH;(H%=*X MZ3`3?)%RQ6;;A5C&=NXS? M#H*(9<'!8GI5#0Y>R+[3J%M[,4-V&-S&RSFQR\EUU*$M'M^J*$IB^- []: M`3AT0@]DL=`FI?4:1#*S:B!53-GZXH'H9A.;U9S*6I;)2FNI'<&7*2&T7M,- M?!F92M/3,PM::QPO;@U#L(4X=FMQCP:&!C'84ABZL]A'`4.UW(]"JM>S^$U9 M%973@SRNQVHCURAX6XQDES[%*$`H\TF*Z5W=)^G*:!N]T#2)MA?+3-=NCS]S M%M&Y0X(2TC$)LNA:]5F40Y]IG6:11TJ11SIDX8OU@[YQ75_#B0^!;`T-S$(R M]F!@=DNP!J9@*<$Z-@6[(U@UHZV0/K6,-M4T#7T$DMG,9"JF8^R75F(TT_9L7!0 M290E1=75H[R17W8.4$3X!CG7G-61.?LK7%(![:F]#5%9JHJ3G,))/N`D-<%) M%E55GIIQ6_'.UMPMJOFN$+VW=8-J1OH]A+0[-,L\VG&AV=#W*$2W#]]C=*`T M\&]*0>G:OQD5*-5\J$(,:OE0NFBHAM'A-G99BJ^9:U<,;_>NW:@@*74?"ZE? MU7V$KU6.6NXZ74'GC:F>]7:)91[C:>5=?.?40RJY@K*\E6861_0S^$0+"=BW` MR`#INJI`5DW9F')-USJ.C%E;4*HW6 M>KM$LX:$M?2NWDK.IE43Q%M:Z"7`.%9GC6E`QNB>,0M(YPZ9J)JZ4C4.R55= M=2!'Z7PQ"T:\NFTSJU92VNN6MD:XA:B^_KJ\YL.JV::]+B8B\)TK'6G(T"F#'6 MGC$/3.F((^$"QA5`1MAC9JIZ-JQ(_O9 M\N8OBH32/5L]`VOI73VFKTIUCL!:6FZ78-:0KI;>U5>AH50U4:>E=5X"BF.M M+60:D#'6%#(+2->UA+A3/5=TK<,XRNI!9N$H/?]JIVJPQND7EZ7JLC2V.L%; MU[O=!3L//`+OU9[#OSKH9!"11HI2+%6S;AU@DU'[O$^@@GFX:&@9CN8YJ\$0>PQ56@R9RY]=>&:;)U<1AE- M.45B?*4KPR-RJ<7>2D$*8G)-J72\=6E,/K:*D@Q:W,\#]QEX)AS%O<0Z8T2RV;HBJW)3O*ZV.'BYG<'^ED;O!)2O07JEL MI^FR6`>D885&(4!#-.<'0^P&51>EQ!Z:43\(8E>KI"BD;,C>BAXK);;77@Y[I!]E MK>.PR#NZ*L?AD+?K^D9#GK82JAF#YAAA6>-PB%MJ?+=2T`C9N5K?Z4M@Y['5 M,=X[LZUGKW64MM$H[[ED@![3F]7*K4-*UG`V+:LZ@"4#])62K)Y'Q'K^=3=$ M'&4:<7>D&UU2<#>DZSK%5S%--5E':BKV0<81 MFHU=D['S*K$:)B338CY*H[)K(G9C8,IM[>B#Y\GQF9Q?W%<<5T7=)\1;U_O@ M.J_`\VW7N5\F0["()O4MT>:C]YC:BQ)[J[)S\P72A:@Z\SO$7UTUIY7R'[D:&F4"\-!)7F;XMY,&3-E0&ID4 MC"T=.$$2,Z1)NL]%Y$V9YW@.]8;NT6V0\#\UI:'>ZB@BTT`.Z@W=E[=`#9+& MVFE@D(S=21@@N:@=$>^,M.SK1[";>S1`V;"\26=Q-5\TCEU;N6C,&(Y MEB^D'=)6Y\SR489N/Y:O8*@T':D5V3T11VA)=DO$`5N3[(KW*&W*;DDX/+N2 M878(TBCNSY[;"!U??FVIFFF+%:Z+X0KS!9A'M_-WF.#J,PC:^=> M<$V;5G7)N/RU*']CNW2\%5+5OJ>0QEM[=!&GZ)]*-W?26'@_4'1$9"X@SAPD+IV$%73-!6%Z\N.4>;^X=`AZL@_K'QBQ\6O M1?$;J7OXV?+F+X1.M\=T0I\"X+3O';;Y4D1.N:K'H*0`40Z`R$V<0TE2X#]U MCI;:7'@O0-<4Q#9?V@W06:75=6R=-E=\F0@W=`P+$1^*8S@BB!JXA:40#<$M M'`E$U9S"0D3JW3ZEFH91)XC&%>79$#?R"(LA'X9'.!*`2OW!0BRJ^H-&Y>LZ MN>2U)7E-G,%BP>O9&73OG%?@!Z[GWSG1/;^BT:ADJ?I8*)=6KUI=8UR+T(&. MLG&-0S:NWL1UD[5J[<6K+Z9-4E=F\,ICY9*Z0AYT8\H/A7-ID;-A#5,A/?OW M5'HF:(-ZIE*"]NM7]$C0:K5-A?2KY06TJ59K&AA]4KE1L5,QU?LVQ'LD9YG9 M7$RYJF;SA;)JDT*H8D[MUW)%E^A^!?X6S(,G]Q$$P9I8[BL/X!^B7E5&[;.* MIB/WF*VF5'8%FRZ.'BQ5.;[IR'UEEBF5+K%NNBK6\1AE%MB0B3VZ;*ZA$KOK MK"S9U*'1R'5-`2+CRZ`:*JE+(]^M9$)!EM=HF3LC8?F19"VA.R@"^WD-'CRP M!)X'%I@X,V>AB2HR>G^S/,]R`K\\Y'_K[HI#_M)'=[VV/$C.7^'*3@%G-3/PXN!_<4W":N7#&VW)7K>TH1%"71DD(8JT9+B*[G3ERMB94< M%O8]L6Y"`9EGC7B!@V2F2B>5?4]OX"S5<8P@XK"Q;3E,8-UYR("CW3/:G480 M.-I]F@8GT8"SO8;\^`)'ND^DNW7^.=9]8MUE+(`BTLYLZ]EK2Z'$B*1\ M)+7G_1*Q-.[;2GTX9$E=N@26'$-1=NVU%]FK#0?KL:.6#'5`>[Q:$`B.S/0[ M^*CSQ\Z9![;KH%S++VX`_`=K;T$;_^YPOQ1;57XC6T+PNIUZU]V3OY&MB5I>3KSJ[LE7S5[,E":M6KZA!-Y?24 MK?G^X$5Z"S5IX^/7]I[L/ MPIOKMV]_4SZ\??OQZ:/PS[\_??XD2!-1>((8^3:"QEJ_?7OSY8V008&GKV^_ MH[$D]'#XXW60>'*R"!9OA.OK_UP%/Z(Y+.Q7]*,0_BSXP7X-_O;FX]WCPZ?9 M[^^$9[3Z'X6GFW\^7=]]^7CSY>F=(&Z#-]'S<`V/@>4%MYZU0F0C(Y<-=WO_ MY>GZ=O;Y[A/\[,G>0.O["_@F?'4WEA/^]?'N?V[>"1)\5_C!;S=W/_\=OOW9 M72]^%#[/OOY\]^7ZT\TMF5#\R5?R+?P1PN?:6MLKYYWPQ\X/[.4^9RG"E_NG M&T$6KN$P7V8_WWR&?Q7@E+\\HI6\/9=*SY[P-AZ@ZF@UB=0V19Y>@&#-Y^YF M:SE[VUD)2]N!TF1;:SAA*\!"X@LOUBL0GJ'[(&P]L(6^PD*PH&+9H`>"%RN` M_P+"!S*(\,U>K['GQ``O M\!G;F>_0H8'@PU782WL.59>P=GT?T@>Z,P+XO@6>#>"`"\$!*RNPX0SGEO\B M+-?N-P&)JN#"KUA(('QAL?/(7`%4VZ]@[6[1PM`25R!O/CY`,U[89`3/LN$' M_NX9:9L`T6?A[IX#P7IV=ZGUXS'^CV+^""?Z;*_M8"\$;B-Z9$*Q<`7'#1!] MUKL%'`[2RUH@D,F?,1H;>_42"-"CVZT#0@HT/SA/B#/\[Q+^:OM0Y<*W!Y;M M!/O)Q?+_(R0D0-2$VQ[$^2K%R8@1E^Y\YT,F%+=Q>2MG]&:QM.'*('7H>?+?]`',(8FB(H[OS4!`(2Q9"_QEQ MXA)*A8VX&+*7#U<)D0?20PAP,WO_!BS_!L"Q=+`,8EPSM&T-E.VNX M'H+S83$(9#1"K$>B!6')=8+U'KX8+'PTOQ5PT,0`7,PK0&*`YNHM@)>H+[C(<()123&9]-XD%\:XVE;`&0?G`6;^$#X-\[I`E\`(D#-0K(7AZBHAU: M;&@$:[$(=_1H@&_N;KV(1!O.8&&O=^@;:)XQV^"(T0O$$'@Y9%RF5HN5`3+_ MT"CATA*O7NXQ`2.:(^7N+;_!&LD'(FI@>^0?!#7W=8E?)`2-#29K06YP/6#PR:! M$;/\P\RCG>4*KLB&\R:OPSN<)6P@VWA0XU[!];]"ZD'4ETLP#X2C%UXEE'.\ M2>!W$FA\A%Z2ER]5OSYE;HRAAD#*"`3V_V(BP5\68(UX$2(-.=?&@$`2SN$W MX3:-Y0%*92C)?BSF"^%Y#_%!*DK8P*^_("]'0$`1[7=O.W]"P<.1SHGP.?X& M8@:X0:^1,4/T"(#XP;<`"[(%UI-0^WOXI=BXMN9$LV*]DS2)7*B/U,X9YA9XZ4(SY8/,&M!1H,V%]29^).5YWZ# M?(C^0-@;3A(M`%+O!>[_\&LA37PH!`M$C#7:O_S8%#E2>4A8YD%:6R>40$J! M;K>N%W#^AE^]6V;L,H2WDEO1(F>31NR55K1DVS]1HB'O^"^(\$B=EN]7F,/6 M!%BDH7;H^`/^V2*,0-@8/PA"#9L8,&FR[N!_UT=*/CFY3"Z^A4O#3/GB@!E^?0\L+_Q:=#=-]$TEO61LD"^$O^@3#1J\ZS52 M(5";(`'V`^SI1QLIV1#@YW\1)W+T7?+:OQ@3I<;3ZN%IC[2:@%IJC?56>"ERO43VG;*)2]$\<1;1MI7LZ4A,?='.T/RQTR M%9#/@'<[-V6")?;&Y&O@UK+RK`WA5?1U*T`BA_\&!X!_7MK$H$KH%*1[%@#) M//H:MI66.R3]Q&SVKT+G$6D:(L+8HUE`!D"HDT!&*0Y,305OAZ M8&.X84(7!@\3*AR#2 M0XZ+HQ$>$E<_)QX!OQ99D9C#089M;>,&D82X7K@F0,0J7`-9$E[AJ73\Q_7U MC;-(A\A.OA3]$H:*\R*1R4@F4>,/UAY]#:K5#\@,6"-#/SJ^?0!>W.:&!#CK M/8-BEP8^G-(GJJ;6S+6(PY]&>,)U/$C1E4'RH2]1S4DG2`1UPVP^=W?8%7_P M7,=%L0VLW;ZXP>\@F"W<+=R$']RU/=^3?Z-P,/&O8>-'Y]^_P0_@,KF)/X!SI]@3OS@;6$-&\)D+D$ MR%U"R%X,[9$S;#@XA"2Q" M@B*O_,@9/]U"LB*FM,V8)FK_+'635'S0?X86A;L'X!['+_V9LX@/^C#1$UD^ MMU`1_6(Y.\O;(\5]=`4D^N@?#"TXOU3FE]/2[K/+1& M@X2TO1#6Q7M)R33:&K,21?/)E:;3UMFDI?GD5CR=6T'&B$D]:EA9+4@?$"&' M"RR+)?(#(N0P@>VZ:%\W5%G56]R[6Z(&YYD:/,-D0X(!D7&8L);:[JVT2.`* M@'U.8;']PRD1,RE'[G4-B?;%?8UH)I[0+*;3+!"E$KQHO`I="FLV=*3$%!;B MX999LR]':A1@-'1_"M'HQ_T9#1P-G)92.+IW6D8!1S57HY#ZM5P-23&D::ZA M06.=(\>PAYX6[%8]N&]C0*,4I^KD.Y5?2ZN"2F(41,?J%B* MAN(#';Q'^?2`3*YQ0"9)T'G4RDXL.YU#/VF=4T71ZLD?K?5S;LC@AI$D;5XH M?&-)S[Q0^,:3B'G!`(XCY?)"`1Q+*-,H+!:\T`-!*PN0(_(]P%K_L M')`Y@Z.W/KGF.6B?\384YY0:&J5R"FSY$#B5AFB4,@7)>').1P.)U-3V+Q23 MX=G^3($RIB3>T8`B-76R2B5E6$X64Z",*2MZ-*!(%6/[A8)1+Z-9,V4SOQJ) MTEHO`\WN\],55=$YF+1$LU&@J5A4AQ9H8@J2\>3RCP82J3PD5"@054-"?-NB M*5:E&+922\$W*YJ;59.P>O%>-;"P.E.`C+KJY)?=.J(/24Y#:;,E%!*?7,EL MA,>Y+[N$"#>#@(P]F,HH)&..VC$(2=?A(5F6S)HFVKD+O1`@1QU,8!"0;OQ6 M+D^TY&G$_DY]"CT!Y\G]8CL`77G?$2J9[V3Y&ON+@:>AZ5UZTSN[IO<``6I@ MB)<"Q*XA/C"`NBXLUF195:C;$9D+ODAX&QGKQ7"S;*P/#)Y2T[T0B:JF.Y>Y M;F6NB4%?+')#,.CO''2$()EP/*/=VO#Z(Z/2[88%B*)Q+4)_*:0T_"VN!1]. M`>+02&TT)+699&KX6TQJ@Y,ZEZN;^33%;#T0GV9HQ#::$KN0L3FQ"SB[OC-8 MSMD#<`:'1FRC*;%+.9L3.X.S*WG1Q8Q3O+O1/UY56+4T-G@2S6IW:#P4=>GC14@H^XX&C()!]I"=%0 M2=YU49`Z%>L4%S=:V4B0&6L]SU`)7FK*MU*APP6@L@",L[@FIDC.I0^VL[I_ M!5[&90^S0-*?7+4Y!F>_<>1MJ=B'9L0-JL8!SDA;5;$/3M=-JQ13UZ0&=L#9 MR[TX8,?:Q(I]:$HM[E;:67%)ZTK2QMG>ZM[Y;'GS%Z4TA5>N#T#=D4=>#3\T M4H\Z-7A8I!YU-?S0B#WRI.!A$7O4U?!#(_;(DX&'1>SNJ^$E43>T6N'SNNMB M&Y'N,X4571-KE$Q>&B`C+HD?&JE'G?<[+%)W51+/U7T9RY?BT$HR,%?R94I^ MG'7Q0R,TFRF^"1J@/_IWJ(NH[2X>//L5KO=A;W/8!_'P.:I$G]60WM(+B\Z\M\/Z%:98DF0Q)-A'%FN1* MK:!7VJ4$3U$,>:(J4^UL\3L:J2(=C='0$2KBENB8&JD2'16J_'CTY&_`7KW` M+6_V"CQK!2H1M,80W6P-1=04)TH!-6LL96!D[5EI0F/%I$C6C,9%I>:9GC+\ MVAJ,Y6/.`1.4U1.V@9.4Q:.=`9.TZS,%Q=34:8;M?M92&"$UD['I`1.TF[`H MY%CM4CF6P4#;@[5'!MG],K;-9BOXKUL`?$RA@K_#2>K21-8,54/;@EK,7)9HQ0%WS5)%:.6M`5S3*STT5I#`].=`[#P4=J@_^*N%WB- MF7^93'7L9I2NBF0))EP463]YMDQF1/Q/N)S,Z207@CCNO>6#Q0=WLP6.;R$F MGGF>Y:SPZM_O#U\):3/[9GF+D-MGJY4'5I"9?X9/!+$+24A!9^S(ZU--&;L6 M$&XM`7,`*_(#X4]3]4RPK%,2K&J$+P/!^C<^+E\)L2QZ@F1@WDZ+Q8O&PPA]'AG(`:4CFOB.+2D>HZ M)RY],D9%H=*U=@'+6>K(8$O9Z^>?(P[+OKA(",\]PCS'_.!2>`:$PSC-%^&3 M',*&^U\-""N>SG((>Y/"/G-!Q(G6LA]W&1`>26$IA)6E\%(@W-J>10Y+PE<5 MY7#+H#>BQ\5SPZ`VXBGGAD'IAC[W]$2^,>>&0>B& M/LV#5B/UG!L:ZX:AQ+ZXW3`$W5"#&RJ&L1O:#>TY\)P;6M`-?095Y8DI6IMI:Z7K'B^2 M0TAJ2V=[,HQEVU'<@O'[+W"3)I)""3,Z,=M^T1I4[+6UO*H+1*[?RN?6LJTN M!KFAQ"WB2R$YFC6?&?/'H.$8_3 MHUX!]:$X.:T=QW'4:Z'>KYG=6H(&1[V"`==G[=@8]O)=@!I_+&QG10'2G,%1 M`Q.M9BWMX7XM51M2J4/>&L>`T;0F1@=%"A\=4%Q^Q!B-IB9]Q!@=Z;KRFO0" M7=>O03)BC*8U,2K0=;V>9(T8H]'T=A@Q1J1/6XU>0R>Z;B"]`,:,T;0F1B>Z MCF/4B:X;0\^N$6-TI.L:V'7GG0H:;9WGCAFC:4V,"G1=$]M;Y;9W75W7>>\[ M)C#ZS?+PV?U)4?]YZ.0.BWKOJC@-76K4OW=ZK8AD##%[E))&K.VD0>@L0(6RICO98U2C$DBJIQ0+)EA%S>?*Z,G(Y2(B/3J3@US@YD MCPX2`VIT71:K02*)J8-`,901?+]>UB@5JC>8`(1TM6\7C?28T34C4Z6*=)1= M+)(Q2@D4JHFJHLZVD;,7EX#B5S@-_W'W[,\]^SFL.3SZ#!TMXV;XRK0*5\JI MX\J#UZ"%S?!/1RDFQ50^:.ZCF9%U?'_VUO8[-`B>?3@(_EO\UPVP_)T'?B*_ MD:_\O[?IO^'!WAY&RQP==;C/'MKV7566]'?P&TU'QF;>MQ"RH]-_II8>&4: M$E.990*6,2H=^FUW)V1+3PA]H0YWAPH"#Y[(9U!3^0PJMB1T#:D#398,^"_Y MH![2TX&*S0[VQV2%"X2?+VW@"3ZZ$@2D+@WQP7RR#SV#S#%^ZL.'W?*B2__9FYU^O+&O[ M#FDI\.\=?/SF%?[K:;\%L^^V'U]L@L>)IXE^C6XVF;XE?WSS4\Y8Y*7_[VWF M7$ZX([V(Z-,4'4%'ZT`_'3`+AX[_MO10\!9I!Y!IWCIOZ2G MDWAU]%'(.N=QDRBC6V;053-)OF*6IP)(.?3TA[7E^_?+Q\"=_]F!Y8X-&J\187!,8$0954R/JJIHKCD(2O8`UI!TU=+]@_02/#M^8XB/5^ MG_Q+;3[#9LL'.,YN'=C.ZM;V-EP@1BD0X8VD?&?(XBKH9&YY6CF`=C:@;OBS?_WL%91E=?/]KP7W?P__'I4;.= M]A8\>SO+VS]]W)UO.8NG;V#]"CZ["SCWN64'KG._?#BZ8OM^"0U6N#WW M*^YR?19$7-$;"\JM-8/EKVX7CQWMWHY=@(X%U;F0O0?KMJR5%N3(S?.4HBEHJ#]6%BJE7!]S$YXM!GG MI^K\I)_D$3/&490VRBA[\WX9[X>'4U84(.-,5I7)%%-3)K(B2:RR6!RILAT[ M`)_L5Y1(&EC.RGY>@YGO@\!_O_]L_>%Z1/\T5F,0$LAHG+,J$4_Q$X'Y_U&O"\9G/?9X/V; MS7;M[@$(:PY)6<*MZST"[]6>@Z25<>\`+@[UQ8%Q(Z-#,>!\(R9JCKD)@?C' M^LZ$&N4F1-N\STT(5GB?FQ"TQ>&R38@Z8L#Y!I?TRL?5S8QQ3A]!U*=O+N>Q M.CRF:K+ZC^QPIV@>OM M\>ED:&ZU7P\4'H&&['OO?46W,3?>OL-A.-O79WM4)#""",#@&9_23O`9):,? MES&@.H:4H_3D1OX3%Y%F(C*"0,&EBDA!L<_-]X"\/-Z)GD#5XF\N(\49I*B<4EA55)^L9R:VPF/C#:6 M$Y7+R>7("8_N-I*3])4B7$KH1G=Y/E=O;)Z\38*S^:#9G.<<-&5S1D^#!\'@ MG).2U^_P4]_5.V3#PEF]`G[D>Q$\?["%$R=;G/<';"DP4N?#3]HZE5Z^8XU' M:CF/9U^*R'3_+X94>@SN!NSD:8C22=W,O# M.!]U<",/W(AGSN(]<,`2SL5:WW]S`&]$58O7IKPC8Q9[Q=?=A'>+$C7V%RTFXQW9:S`99ZVJK!5>V<4YJX4+NS@_L7\'UM!I+9&;8/0I[]P[ MULZ]$D5^4JZEQ(56^#=91S<+R9!_\&$]WPN&>1P>(E>'ET)X>^$EIO>!0=): M3-%:)'NN;I".V[+(&WED^`?W\\"%;TI>A?ABX^.(J+%'U.JCSRJB$-R:["92 MW29$/`[+33OI)#ON'G7#M^]>+VVA&K&>5J7 M-MXQYW&-=[$:KU>^XXU06^$[%GV*7OENROFN,=]Q3JO#:1KGM,J<]@CF.\\. M;.`_[+SYB^6#V0J:*_=$EO,=U$-Q'X+*N^9 M7$S8%1,U*\ZCQ9D;[)Z4XI4-*[:1IK4:QM00A57X7UQ?@!321??U.F28^X%G MSX-:UZ;WJ(AF6\]>9ZBBZ!W]ZIT&LJ#V)0M'(L"B&'`>&P2/24=90-@$Q%E` MJL'3UK/U[FRQL!&'6NL'RU[<.1^LK1U8ZWY9JVZR8HAV/ZRE*YRULEEK/M]M M=K@\#$?FX$](%2[^V/E!_Z8Y4SPVA?_A3)9M-P:6[8#%C>4YMK/JL^*&,:92 M3.CVR8HDLB0!OW$>/X2D MW[MW6>.L9.,Q^`GS[NUEM/7Z`E5Q^OK=F1/?/'UZ$V_?)[ML2@3R=D4N$6Q( M1,9-[/TWP6"9]941W*]V&:Q?;S/@XM!('*01W,AY&>)PDY:%4VMH0"EO[(H# MWQW&)PZ]9^*Q)0Z)AJC<,B_-S51H815D M7([$5=@9/,83X8MY+-PVA]7;@C4F4SB3U64R[IG48S&9LUA-%N-;93T6$WD7 MO,PKF\*Q[I>/+Y8'_/MEXOJ`1"`2;ION;O7RX-FO$+6'M34?0+DT4RPH32'S MI6]JE25-,R_Z%DNX4?X/\/#_WZ"F!"_>(03YSV@O17%;.Q6?+F[_@$M#] MK>VE^_I^`^O7=$CIR3WD+2 M0\R0LWF:S:.X&F?SP;-YG2`:9_,DF\NF:G('FEFCYQ$^S+V#K@2%>]',"@JZ M:I3+"&T9T4QC!*6OERHCA;?(Q!4@/!6G%4'11U`9R`6%[R741$32IA=]XP3K M(E+W!)P+23,AX=X[LT*2=W$&%Y*6A43CYWK,"LDOEK.S/&YPT1831NM3!B$> MG)-PV,>4HT0*>02W5Y[)47':.5/:]B.85SI/^&RO@1^XO!BPJ8!PWW;<`O+D M1BUT^![24$2X9\NFB%3/6.4B'M1(1'BN*G4!X8FJ MO?,X3U1E@\=YEFI3'D?)=SR$SZ:I4R-%E;L#9\H(3[YC4T9FN]4NW5.#"TC[ M`J(9&C^68%-`?MDY@(L'=?'@AQ)LBD>EA%0N'6=*!S^/8%,ZZ@9;N7PTD`]) MF_+#"#;EHV*N-I>/\^1C#/>D7J1\5,Y`Y1)REH2H!J^)8U-";L&SQT6$NHA< M=HKV&:+!V0BSD32=:-*4>3Y"B?JX])PHL@_N9NLZ\%>_&5\E+IYXW#W[<\\F MK/45S(']:CVO>8YS+2;3.)-59S+.6E592Q(-G7-69F9)@KDX/U7EI\3_>N"D MT=-:5`BM30-=`FVBX+DB2:S+[JWMV`'X!(W0Q9T36,[*AN;!S/=!X+_??[;^ M<+T/:\MO+LD/$!(&ZU;Q8+_O8/(`>\^,WA%GM.J,QFOUQU2KWR;/`.!']"CM?BCYT?].R0L\9C4TWF3);)9%]!8-D.6-Q8GF,[JSYM7<:8 MZM!*0!7U,13:7<9M]%^@P(0I1\>-[!^!]VK/@9^P]Y]>/-!G0(I9F9`U0QE! M\MYER,2M97O_L-8[<+_\"E[1#_%A`.?]1KPOCZ`YP67P?LW]H->V2TQ+!+>0 M1BD1][UV?&59(B1N'S$B$3=\@^A`'`PN#J,3![X[U!*'J'$?CRC5;8_'C+W$ M(TH-98)'E!B2"1Y1:IOW>42)%=[G$:6.)();2*.4".XS-)4('E%B12)X1*D+ M<>`1I?&)`]\=:H@#\IFGO!*M>OL%R'._.O80:R`9Y#R-%LLFYL"X70@_E M=A?L/!#YQISCZG"7Q?B^68_%>(.S MD34X8XT%>>=H!CM',\ADO.L(&YVC&6,MWCEZX)VC&>,GIEM1#9_6XO1:$2=3 M2>;F+S=_#X\@KJ#%@G`Z^H$%X6\&%G=)%GE=\_&6P4K9&DM9J"'_U9&(D$E[ MD@B>E\U@VAV7B#,E0DI*1&P2BKQC)E,=,Z7ZYH=$UP(N9BW>,9.]CIFL\1CO MF,E`QTS&F(IG?#"?\<$@Q_%@T0A,?\:8CDQ]1YGEA_PZ2OSPI8 MBY_GL7>>QQJ/\?,\!L[S6&,J43?X>5YQL6,:\.[_%X1A/>@Z:;[6%K,.XJ MP-FN!MOQ;"RVL[$8Y#ANRM4WY7IMP,,@C^F!=8UB_P8HWI>&(R@XG)##(9S]9@(S&9,=;BB'*U%,TEK^%M,:X.G\+&4PAPL=<"A]S/,93^(:?PL<< M4XFZR7,/6@@"]9MNQ2#;\XXXF6YGM+/*8RGFL;F8[=P'J,AEW`9@JGV"1Q7CY!%/E$RRR&"^?8+Q\ M@D6FX^D:C+>^9(_I>$-?IAKZ,L=@O"B,O:(P%IF,Y_\S413&&FOQHK!A%X6Q MQD\L%X4-D-;&M:@=:`U_,\/+!/0)OZRMH7$[Y,O:(L#KL&#(%1194$9,3FI` MU6M1(>)N3ED7]W!E-6@=+9\NK0_B'JM6G=>`,E4#&@)93XQI[R0%K,5K0-FK M`66-QW@-*`,UH(PQ%4\L8C"QB$$>XQ4L]=.^W3OG%?B!ZW%]5HO7>"%+%J_E MG8QRWJK#6SQWC:W<-099C.>NL96[QB"+\=PUUG/7&&0Z?M+">NX:>TPG\=RU MS,V4W)UO.8L;>_42 M1#J-;*]W#E=JS7F.)XFSER3.()/Q!"$VDL098RV>)#[P)''&^&D$6:-#H+7E M7[O+,"D7)0U/IKK&8E*N[4`B0E$XK"0>//Q+FY12<0:]KFD'Q8:R'V7)@/^2 MQZ'>/JPM'SJ()#K1F6JK-56X$X-_[Y`J?H7_>MIO0>.)'HW5K1Y.,Z^:2,2G MP;QA[KTA\GSPH>>#IQDC635`G3%X-C<3V=P]<@C/Q1YF+G:/+`'QXJD[U0+O M#QY8`L\#BT$>__3(0Z+)XP39:B7-,I?#$)%_-1:&:,6SBID!CS:[%&Y03$V9 MR(HDL3\6$$<(J?\R^6=ZB44@C.HC]'^#A_\<'L:%)`TT0.-=79%8X M[05DNBC7>'*_N$Z4M'6A;"UQMAX?6U\P3S.^A0^%ET?!$HK)=^]CUKAW`.ZM M/P(M=Z&;=X*K^>8]/JZ^8);F>W<;K#P&CM`,"7.$HACR1%6FV@7SQ1>4[&`% MN\#U]CB^=U\G3[#.1+]:SJIYNL-GV[$WN\TE,JFN<"9EA$FM[Y?)I)>]MY[' MGF/@`]64,1]HVA3E%THF.EF/+MB\4*Z(C2NZ&BL\FPL/X^^]KR@RTUB#A<,, MWJVY!<_>SO+VB?(M='E\`(!S\ST@+X^)\@2\"]+)D2QRZ[8S&>2F;4,.Y:8M M&QQZ:79MQ*$H#*IP@X9!@P;/^,&UG0"%O9!M\``\G,H8-25[\.PYP"_CU@[[ MDGK9'N@9HCD*)N"-!EAH--`OB_"ZL<&V">B3,11S(IFFP3I?W%JV]P]KO0/O M]_&/?X?OL+SYR_X3>`7KQM9_/-Z=L]T%/AY,OB`&,3B#U&<0Z7(81.8:I`&# M*)?"(+R/S/#ZR/3'#6RW*:%-*?E:-E";$I/4YO*;&ZJ&@YZ^@?4K^.PNX-SG MEAV@>-!Q0>[]<@G!<59]BAH"N$L&XL7=->.)E\@TTK6L(Z91N$/(ID.(`.R* M021>W3U@4XXJ)RB'AGY3WHJ*H5942KH5(77&X*VH6&M%U36'\%94@V]%U3%+ M\#XAC/0)Z9@O#DGVJJ@KRL779-*O!:%V:=@K?E4R:O-B8Z<[5:0Y@Q-97-)F MR`ORNN7O<60M]\BD/&N9&2;M.7&Y-R9EW(8<6T%>YWS`BX!8*[&XM.V4%P&Q MQJ&7MI?RTH+AE19TSP2\M("QTH(>6(2?`[)06M`Q8_"\ST$G"W3,#0SG?79" M*9)@(Y&T/4G"H0R95UV+TIZF>TWX+*+#$X/G\$\YUG!S8T_W?> M_,7R06R[]\GD&N6-]9C)=<[DI4Q>>;?D3#X,)@_KNC5CPGA\CVY=MWR(A&J\ M;(JALBF9*!'EB$1\-9*![HF#%X\<"@BP>!]<#BW"3@P4/KF/&X![@^N8);@'QYX'UP.+<).#!0^N M8\;@'MR@/;B.N8%A#XXRI43S0"F9>W#L>'`1<)TQ!O?@&//@.N<0[L$-W8/K MFB6X!\>@^N8);@'QYX'UP.+<).#!0^N8\;@'MR@/;B.N8%A#XX^ MI43Y6D+MR'%K7>[!L>/!8>`Z8PSNP;'GP77+(=R#8\"#ZY0EN`?'H@?7.8MP MDX,-#ZY3QN`>W,`]N$ZY@6D/[EQ*D4_@#_\?4$L#!!0````(`,.`K$3Z)M$# MM@\``-'(```5`!P`=G!I9RTR,#$T,#,S,5]C86PN>&UL550)``.N*7%3KBEQ M4W5X"P`!!"4.```$.0$``.U=2W/B2!*^;\3^!RUSF3F`$6\ZQCM+V]!#A-TX MC'MW]K112(6I&2$Q51(V^^LW2P\0#XD2J&15Q_:!-D*0F5]^E965]=#/O[PO M+6V-*2..?5O1:_6*AFW#,8G]>EOY-JT.IG?C<45C+K)-9#DVOJW83N67O__U M+S__K5J]HQBYV-1F&VTZO/OV//Q-&Q$+OLNTAX<[[GFYNWMK;8FU/60!9=?-S7#6=[PWZLWFWHE_,;[C%JFN_T.?UMSZ"O<5V_? M!!]N;^7"]G[]K>G?J_?[_1O_T^VMC)RZ$7Y4O_GM\6%J+/`258G-\3(P?(N1 M3\R_^.`8R/5!CGT]KE7S9FMSXAW\736ZKTNL$L,9($:_F\N*)[? M5KC?JI%KN)8_^%=F;!7=YVY6P"E&EBL+\+JY2JM[Q_"6H,K`-H>V2]S-V)X[ M=.GC+J27B3"1H=@CLM$KYJH]`6Y,2)>E%(C&T+B7^`6]8S$MB"M9BWOL(F*) M*F-*UN8%S2QA9*1`\T!<\NHS=HI=U_))(Z3/#D/9ZF1QF<5,789>7QT70^#9 M<'\)*6)+:4Z3%::`COWZ@"&FBD'B6`5HDL5'CB6E61UHQ/M&T[/P9/[5L>]X M[V%QY^W?-:`4V4&DS&@"2$B2>(.L"A(14D,+[4($L+EI) M<@$1=YJ"W`G6"-`5` M(VL<^WSW<9S\(X<.01%G@[-U!-P@PE_<>:%H0X<0Z9MP1U8K;,Q?B[0A0Z?@ M(RQ'-8B%?M\YF=\AMAA9SINH2L9NZ1C:>PQ<(&)C5P@_1%H'GT'9[)6L M4',I+6NOR"985_NX%IZ-G-#$I;C[BP,JW<%8$%,[BT:OAESV\1[96:XH7F"; M05-^<)APSVQ)KZ!D04XI-OYUFT7AR7Q$;(@4!%ECF[G4$ZX9SM?.7$K!.UVW6"WH@:`9L8@+`>01(^8! ML`-W]VW[&1L>I="F/R-&,L48WS;F6$L$?]&9%%Z<,7/[<6B:?_&-N`MB;S_Z ME4!63(W%)@@0R-Z`E92L_0X_ALXWYM>?UMAZ>7/&]LK+-BCRT9BOE_/UPC%, MR[/(1P"2(0OT%9:2!2:5C++`25Y8]Y'N!]=#]Q+?A"2]?K#:VJ MW1-F6`ZG![R9/`V?!R_CKU^TA^%@.IQJ/T9-17/F&HR3M5WE5-N6)36_+JG% MBZ<_:3^&]OP4ZB4V6WA*ZJT"&AVMZLZ-W:GJKUMGW6'S"=X[8S)_Z]%CU%:$5GR5NWF#+ M9=$5[MMFM:Z'DZ@_A)=%M=BWTN)SO`Z-2)"'F6,;FON_,:+,-[CYT0;O]!$R M/=8"!C1"84Z=Y;6^=IT\8'0H#`%N*XU:G?^K:&^8O"YWC'#>,Y-/]RE4!"N(\=W),S98`8.+*VW=-+ M0)JM1JK1YC24(7&:WP]QGO$2$0C1E/?<#!S`C?9M[GTH?4[JI0Z)SL,:4DDO M#95^OCF5O(BF-?5Z#_*8[;@W_C?C.0RO2VM[A6G!O"2UN)TYR^"_,+!-_A^O M`*V1Q7_Y"3)OQQS;!N4>O-7*=<'L'@.CI$`2%'D$L7%2YA MU]A>8R9F>+M>-+L$E2L]NRX!6:WT)<'PL,`@8GBK<'8)*E=Z=ET"3@_]\0Q%G`24%$K]QF8OWO,#6:8HQG[+_P5FR.'3C%=$P.S M6KO7Z$OSNI@.I:9#=AC52F*F"T3Q9XB0)I_FP3;S?["F=_IU>;W'::&EYH$` M3FKE%V/&/#YM,IG[,\:Q=3TQ7D_HG87($H#AGI3&ATRZE)HFEZ,:LJ>M!GL& M2X>ZY+_^SVSG5/D*%^9",.QWY=6ETB27FAJBD(5$Z*A(A'L\<_G$,5^#]43Q MDGA+,*TG,<,X)UXA2IP!+^1%5PU>W.,5Q0;Q?P;^MG"X+2!ND44-$ M@U*S(RN$(4%Z:A#$QXMO[X>.\=[Q9N[E%$B9='<7(DP';B$A'57!EB#1Q%YCNK`.D]&97WG*C\PHH1I94_")Z M'-5'E:$'C,U6B)C#=UX&]+G?*)(<^^(5HT8*=A$QCNJGRA`#!FD\#?/I'Z5A M>J-19*=SK()B!#F#8422HS*I,B2)TK!PBQL?SQL&];`9VU3#`V9=WB:"RY12 MC$B9<8ZHI4CA=;B<81,PW.W*V@T(CS\#X&M]O2>/4YG5*36=K@(W:15(24,4 MH&=@;+(1P!K?@\;+T6!17VXA+E&T1'YRUY>6Z:Z%)301BSI'4A"H2%^)Y\L*E>ES=KDR2VU!P0PDJMY2%QDW:+&NZ< MY=()SBGAMC7EU>7/RE>&$.?14VOI1]RV^,E`PW=,_4-GN&T2]TV833`?K)OEP2N)&ENN4*S>?\L-=K8TM M44-Z<0;&GQZA^!$9"V)CNN%/8(`K*_XQ;U(2]SZ(*2&10)?OE:^6OQ(1:]\9=%K3Y1HI9XH<;S9\8(3 M)9)V3&8Y4H+G#[S!!G.NK-9M263TH30A`I]>%8@ATB"+3]R82V(3Y@:GS6[G MCNN=OKSP?49Z'NWRO&.V2_TR0*%6Q7F*+8N'(-M\1/0/S,/1UJA.5^*`,5EP ML:X5!$"Y0L`<,^9KP'=10[="D>%&^Y^V!K;UGKPMQV)*%.OM"X!1:]SOK]L( MP]76FF:_+6\_V`F)Q?KTG,EJ57=]:[CQ.]NWT^E@5J\O\=BU%-$?X%(1$-0: M%[]0M,96\!1"3%U$;)YE;CG;[4AT;JKL8KTK#H-:6_GCG3'AFKUE3KWHDC@S4B_DG&+TYLNC!\*`0_;-S@`W)=7G^:49O+QW>J'S]S MI<^^M_-FGK&)\1(=/R>!\*J3;?(6VFG+6S!P5GZYW)X-KO+5SLYP88UMCP?E MCBYQIB\2D[MG3T2CG=].F%;:EIJ3T6G=LF+4_.K83I3*![;OQFPP:)/7`R7) M+9*\8L:KE?4&TQ@\@P\L&O.D'J[4=+W7EU<_3!*;BSLS<'2W`4(`AM+&J03/ M!B;L-HMU)-:1#J1]G!^3C59L!?'_=ZA<1@$IFT_*29')/C9A]]66&+=/2,S# MSV*&?)=)9#;3U4HEKUTAT#A8(1`^.E/;?W:FX+J`D\_=S+P<(%R9T:FWY>U+ MSK!V)47'.X_RQYZ"JCV)QPG&1>41"9+PW9[YEF1;:=M_4K$9VKV[>;+X4U=C MR\%X?Z2W&[K4K2&)HHOPH+#IBO7%\2WWS5Y3WMJ:G$\G..>O),/4&N>>/I%^ MX-XA2C?0^_J/MZQU>BUYVW6%5,C/HXGQ?YM+9(5$K1![?&`77\D9@M+N2)PN M29-\?@1.9HT,:+&_V_:3,`CUYWF:UIFS3CT/;VJ>W6_+2("$= M"O1Q=DS4RH]BY\9LC6GH#7D%JV.!5XRH!$[#V476ECRC,BB2!W>%G';8WV0$ M2:VL@M=G@GT>K]@V-KZ%R#I,FO1&KR$OOQ#2H7#W9T=&K4XK?C+%%HUF2^(A M#BU_]'B%"?F9/Y\8<14IM:7YU50Z=YY!0*U0S]<4 M$G]%!PNW"@6)"3^WLJM+?.QUBN`/]J\@)&I%Z/#$V[!`W6M*S+OW1.4R[9TZ M9Q![D,UI"]6*KR-BPYZ^S,_]:;$8D"Z\.)\F0$$M9IAXJS>%^JO M:&@WZO)FH=.%7U[V.7E@1VA0H]>3-U64+#@/JF;V5<1>03P4BTL>A3;I45ZP M&I%W_A<+;:JW=7G3N(ER/]3%8FBHE0H^\"/->9(T7JZHLPYJZQ%MZSUYJ6"R MX`_UL2`>:G5``\/PEIY_@+#(D_\2P:NUNUV)#]S,24NI_#F]!BE6YL\=Z/(M M792+88:FJU9GNK\;+RSYMSH]>8LE3TC,HW$(58-B\_.I5JOEP]ANS,"4KMZ4 ME[L?2BO<>6GFJG7XR,`T22#_"1$87]ZA%7&156OW=(DSTJ>%%NY&`>/5.@7J M&?.S-;`Y1)"1VZ]LK]^=$X-`!].IMV4^4^*<`H4[.2,F:AW^%`M$TP6B>.K- MF$')#)N?/?>;31CSH(<)+@:GGL<>(=G5._)F*J[1["/C^54P*K9=\-!LMF83Q=]H,06C-_Q`MN,K/%N^]C(H6"&'+S"KF@EZ[(O7;JJ;Y[Z&GQ[:,7 MG.Z[]V/'6U$S'?)[Y-2ML[IZ7]X9+"F"+Y^V4/IHJ$RN^-Y.@4J+,!$*3[RV M!MBY+B0UGAN^_]&:O M+GE_8^Y*YS;'GVOS%*%H3HXJ721,S#3"#_C+##$,5_X'4$L#!!0````(`,.` MK$2\\%'^"U,``-[E!0`5`!P`=G!I9RTR,#$T,#,S,5]D968N>&UL550)``.N M*7%3KBEQ4W5X"P`!!"4.```$.0$``.U]6W?C.)+F^YZS_T&3\]!5#ZD4=5>= MKIU5^E+C'J?EL955T_.RAY8@BUTRZ28I.SV_?@&(H"@1)`$0((.V^IS.RK1D M(.*+#[=`(.*O__;C:=-Z07[@>.ZOGZQVYU,+N0MOZ;B/OW[Z?O]Y>G]V=?6I M%82VN[0WGHM^_>1ZG_[M__SO__77?_G\^WUOW%V?>[B_]J73H; M_+M!Z_KZK/73I_O+LT\_?_X=9A^/S+ER^OKZ_M%\"T0_JW`^26@/[SV%G9(04[\ M>E*JWI=8Y\QOD']]9E_[3'[TV>I^[EGM'\&2B9A2AM_))PQUJ[4#V__7"(7!K>TC-URCT%G8&RP&;7/MH]6OGXC=/C/3 M$"G_E?[D(7AFWPO?GC&G`N?I>8/Q^E)*JG-OL7W"HDS=Y84;.N';E;OR_">* MNY!<2QLY)@3[9KOV(R*BW6+<`B%9GHQ`=(4']Q.:VS^0F!1.:%B*;VPT88&2/07#NA\T@9>X_"<$-)(R3/'D/3XLB8;!,L+1-RW7@APA// M&[&7D""ND>$T>T8^1L=]O$9X3A6#Q-M4((F,C;R-D6%U)!%9&Y?;#9JM;CSW MC*P>&V*\PV]-?=]V=S.EI`J!AT?QQJY"$XE)PML8F21N\:X+(R0D@A'>1P+( MF.C9B&GN,(OP#A1O0<*W.>9.8"_(9"4FDO]LQ#KWVX<`_7.+`;IX$393@(R( M$GJ+/]=X@.,=_L4_MWA+)"B,D4G[&!@9^@3("'\H0+-GRAF\;?S#)A.0J,D\ M^[5"F?`V!8/FO*#$Y_N/D^2_]/P++(CWAN06`J*00_X(5Y6BC1<$)F_&-V2U MK,#M:7&^]55*3%RK1$T2HJ.CD'GF=F#GIZ MLOVWV>K>>72=%3ZRXO/B8N%M7;+`WWH;9^$(VS&PC:RN8C+*RUJCL%+#`XMJ M:'PXXP%QRQ MLRN>?AQC"[R$L/*>K$AR(R/KP,DFZ%>K;X3+D1,/<2/F_LW#(IWALR#R71F) M'A=FV4=69._IV4=KY`9X*%][@?#*O#'N09%!RC5C.&RS%^2'#I;F%G>/?!\M MZ3B5D6WQ'%0KG*A4)H2ZM!W_=WNS1;/5I>/BF<*Q-U=N$/I;89_AZL5;&7%X MY\N6\`5=._:#LW%"/(%\0W:PQ&K$ZX=-_[HWQV\*_87Z[?=!&&[;UA+WWFA"WX"G>\! M]3^]H,W\U;MRG[=RAR**QNKE:?6R]A;+S7;CU`&(Q"Z0"FQD%YCE,I*!TW\6 MN8K`=F7B17]-2AC?RSEN^&7I/'V)OO/%WASM/3(N\]@])KD('%#9$K^I72K7 M"Z?*@AW^LG;9UKA!?[%]0)_Q3\D">WS?)RQH3DO:I8Y[^+STGFQ'5>2L9O3+ M2YO__(2>'I"O*BRO#9/(HI6]W83EH3UL)UMB_$7'=(OK6QGY`FU\_X1_\OTLB-5YP7M#RR@WQ08EL=J9!@(\>6!%TA;>Q0;O; MZPS;D_:0"R>%Y\[5A2V\*_1CX4$ M.-1N0T(J/)_AGZO>?L>1TP]=GMK]T7A@2DEQ,814W9-MZC.E5[[W5,*DH5<" M,,_'1VH:1D3^AYNDX^D70G:T_/43W@:@_0\]-\3\O-C=*>/!A!YW^]9GW_%\ M?";_]1-N81M@[3WJ$MF?R*-A+K62[G#$'PC111RZ41-'0W;KWP.TVFZNG15J M6YWN9%*]?GL)*AT"H_00D$4I8G^7L5\CD7.6305*1TO&;[X7!%B!7J];@9F3 MG0*R;!86D3%[,(TY??+\T/D?>ITR6QT#T!Y,QAU3)LWONF[+"@,3V;&0<6M9[6'E1#V6P\36*46]( M5]VC/G\`E#"P`/]S@#.X"A1Z_Q/L_^L7CK]7U!%L<1S!]]^_WE_\Y_>+FWGK MXO=2+N&".%MIWS"UPFRUNX[?3456I]LWM3M/=U?"[XM\!P73PUO[:'\]Z'2- MG3!R^M4P]@0,$OMQA0"`?<`X\YZ>/#R)+>T$*H:,2,)=P-\#AUW,=+QW^*%K:^ MU>]R[BGX,5?<)C2S*@/4_=*5K#7VL+%#:T#E7(/D,:U,$^SL*9JS7XA?/((;+S2@VZ MUM"8VY'380DGQE%KN(&=L;IXY:E(@ZA/'>03,4;LOBA4'8@[L,SD9\J$I28_ MG4844#\VXP"N&64/((;LJOF\J-'02@#%EA\-P%K^"(7K.`X)(S$R%BR<#XRINP[]/%W;/OIJ8_#)FS@\<.T=$^+D M4%_?]E^YM=]HTK]7VU]&C^=_BQ*FW")LDV7;&D[Z`V/::Y75^.#@71$90QOV M?<7NZ?]5$&S),WLL/=5R^D0>MK ML8G"5REW=V2/93)'&C_8C:5G\X,O9.1T2" M.C@@BTQDYS%,.W,]7F"V(A@5UK7)$2VF[PQ4V2X0Y*Z0[\ M(C_O3L3416J)ZR"5<52=&OHN507-DG.UE4(`_(NG7*5-A914S,7JU*B&BYS@ M$A$$0+PY*O?JHM/IIEY=S&=G_]&:WG->>N/Z=W=E#Z_B#-NM^C6 MI;7S=[9L=]F*-JBMY"U7:^7YK3CQ]L_JSS<,YO^6?OM!G3TQ?WH#8U/S04<& MKPZ"+&_V7@!W2#3KCH;$ER8#`&F:07+L+WQR4`QO\ZI<&R=!:`7YP MF%HCFS(X>&NJ6;!!+,?YX3)$T5VP1V\X,/8VAO52XG$$:8*%<_>&QMBJ-B@#@F135%'-XS&:Y>X,-\4V*;>A@C:0ZNL-^P MA9ZV[!5)KS!U"-C(2`'/55EDPSM8$?I M[/-,J&^HHC04X[&Y6&M=4I9./T M`<.0.>4/EG6;-`.:1CP#40VTO-Y?LG9&76/!VJ7%*^&9T,L;X^F[JYCE"T:: M?C*E8*/W M^2(#&MX&XOT+S03\0%%2_8L?>#?@!.C6=Q9H^A"$OKT(VUUKV.5$SF3DLC`B MP_MF72'LP)\GE%1_NEPZ.^GWU]=!#`,&W=SS+I.2OV_.BAH-^-L)/2.7;`AW M0>/DB=C06/I([>*^;X[F6@?V,P^-JA^L+G15X9X`-_+J(/ M@3\0>2F#EM,7Y-N/1X"0![5@5W=!)3X,ET4M"?LU"]7VH1B0!VE`[A`1;E>D MFVZ#MO9FCOPG"X-C,D=!]0HU@/+U61CX(Q]]'I*B^<#D!3"Z#E,UUJ%/D8\[*M2,;3`E+X01UM]D$B*V+5J2=)P&`_>DY6D@^4IAWG!'M_S^G`RF`=B5G2-P`QEIUFKO M^^3$\='3\%FP01T<@3\>90NL!OOVA!-!0#4XCB.@L0+B0E*L:)#C.S42((ROOV+25F MEM2;A![GW&/H04B6&`#F7L''KP;\G)D&>=^4/'2XP$_RI&%&B'PTDS(;W5(SH5(SH M5(SH5(SH5(SH5(PH:9-3,:)3,:)3,:)3,:)3,:)ZK*KLP[T^%2,Z%2/2=2&0 M3:93,:)3,:)3,2(-(@,:WJ=B1+I9>BI&5`OK3L6(3L6(FL;94S&BQ,@]%2," MR=%3,:)3,:*:>7N'PJ1I0/R*D8$2#*UV?A4S&B4S$BZ,EM3\6( M3L6(=)-.'\:QD]6"R"7UBR/N:_]3RGS(I*[)V/%L.GB7*?-/)5=.(Z6*DBN= M=SEZ3L7L/MS8T%#,CI0?>H=#X51[Y4,.!PVU5RP\(M[=@#A5=_R0`T)+=<=& M#HA3,2)@"9*-6@RVE[&LZJ=B1$TD[*D8T:D8T3NALGPQ(JAQ?:=B1,TL1O1N MP_%.Q8B:-QV*%2-ZIR%\IV)$3:2L6#$BH*%YHID93\6(RA_O3%E4P!7OTBC=*JX]3%'1VT5 MM^"6^#C;V$$P6_U!EB(WG/EW9*=(`;,ZEK&1DMFK^JCA-AG9P^IT.Y6JHHW# MXN9AA!;#`7PEN`+%#:WS=?"R2E6JXB5G&R*&`_PB;(5Z&`KY*&M/KC)1:V05 MF[DH#DH8\M+C99R4>4V8(E@&S(QB1=K`OL].2#]_]1+2BWLM>$W4;PNN-K#O M;R/IK]P7%&"X#MDD?M&:U4R]-LG5"O;]XY$&A\P2#R/*:@:&7;A:-?S*[11` MF5MI#-O==Q8A6E(G(2L[-^P82]_)[;%IP95%L,%>[W<^8.9ZOW?P'U?X_U0B MNI/N6OT^Y]B:,:<5-:?.SKR6(PL142TMHFH[H MZ1"U:IYQ3L1R^L(_&0OK([I-TV0_KK#_N;7]$)$],-YNS=?>-K#=Y079K+'^ M]GLP2SP46+19P\3+@IM13T5[V*OI)7KPL5)OQ_HO7'XN=JN<9KMJTZ M$K#/Y-]LK!*6^^T>O>#_K(7U&PS%+:W625$YBO.H3%_ MMA9H&,9\+8D`;)\!=PVZ(746T@J)N]P$6X5A3QG=8<>@,H)B;0H5$H_P%VP5 MAC%E=(<=8)DQVV2H)'Y5)-PN$(-*Z0\\R<$B]/`O8Q4.M@=E6N-V: M3:JD/^R:.I%*NYW?I>,'8;%BXEK/NO%>Z&]/W>4Y6M"_%F@VX-V69B99D6J] M9AN7P()9&:A/BVE&EB@A^@XDO)9RC0.QL3P2S,3`G5<'I\.+#9FP.(<)<>L* MMPOD,"6E/[,I4-=58A;Z;^1[,Y?$&V;[UWE!H1E6E6BY9KLJ8L`L"]N/=>B8 MP\>*S0OOZ,\IDB?CEN2U"V.TRNG/;`K4G37%XFPNG=7ADD)URN9K1_RH+-U^ MW5OF,G@P6P/UT:-(I<%0?+T5;;;^FWMI[5F4!E#'%-9G MBZ5Q4'"[]1=K.T#31Q\=KB;#KD1RQ:+V:C:AE+[,=D"=3G$@R;$+/9.3XLNG M5-OU#TLU')A]@;J;$GKQ=G\46; MK=FJ*MHS@P)U-!5XOC.4&XO/RO(=`/$3JR'"S`W4^R2N45_"4]P,PRKHSJP) MU._$]Z6M'9_<;W"\:>(>)XF60?H3"S%@EFV*ERE#H<%8XE&R6*,@7!`RFC-3 M`O4IT:U@2AV!0QW64,H=H=(+A&UR.6R8]>%ZGS@:'E<,3*@E>1X2;!JDG8M1 M8*]&@'JBQ-2:^[8;V`ORPT1"#*RDI&M#J:-&&+X((48#R$XM&243^3>PDI)O MQY0Z:AH-N`@Q&D#V?4DI2<+_$VJ*QT^6Z:IQ5."CQ,@`U%&&U9RZR[]MN<>2 M*!T/;^4;B$?RJ'11O_%+H<*,#M29)J=>UJHW$,]?4+[#1A&B"#%&#Z#.-V5E M#U;#@?C-9OD.FTH/+F*,'D"]>>1V`6N;?F)2-#].^F/QK8-B+P!N7DIBPZP/ MU.,7/S`3UJW?&4G$_4JW7[/%2^'!;`W4)JH(PP$ZIED?-W8\O/?_,#M:$GCUC MR<6%Q8`U>#,1@IUZ[9"Y-UO2TFSU'4,63+?A&DOZ/[2Z:[^GLG'(:;/N02J@ M*NP\:WQU=EL&S$NB%U5&/(9,H$4H5LM4$W;6+;XRS.F55$<\?D2H32AVRU$5 M=BHM;F66F(UQ4-L9/K&AY=&.#1"*'K98^@7%"!2K@*;JX^AY42M^KG22^L7VW MBD!`:"(.&_",7KE^H-0)8V2NP)6P'&`.8048`<\)=>M["X26P25&99]IX_BB MHVT-.KS4,GJ,+B9#]0:7QP9XFJC",F=95OP`-6M&%0`2>82DY9T7ZQ.JTK?YXQ`D?U#^!'_=<[]R=AP/PA$J8 MP4^>2QH4XVX9!:+M+O/=HCZR^,6/F]%N#0T<(!."IDZ*))IBMXETD6:S. MO"`DA.P-S>VL_$R3=``-X#I=L@1NT21-#'7CFIK+:)U;`/Q"YP$#+Z0OR[4=T M<,]!$!D;VR-4I$3SN*E@'>#YJ!([L,C9M7T(%KZSTQ=OPGB9D[7O1#E=U[H9 MS8<">%ZJ0Y_)+L2-I%E:SKVOZ-[;+'>3JK.XP&R)A#($GO#H<$CO:SU9G]K.# M9T*\,4>+<#<\[FQZ2T*J,XEGN9)LO>X904I]X"FL=MZU*'*:;'2<,"27VW'^ M17*LYSD=,TQ9V%[UQI-2$7C."*K$0_$YY>'XG')I.SX%8HIA>XH/U#OB(O_) M:I-*\F8=&$;DKNFL:-P&P$M0ECTP_T:OW9)^'-X;9!A>BT-9F^>-84 M9<5Y(^T;"M?>\CN-X1A.!O#8EB]T@V@GCC[P3!Q:$6`S_;GS@D\`[O+.#JD_ M<&`N7MNT^`WG9)%%&#N!GLF,8/&[M\'-;+"2#`USX2,5*/!.&)IM%<91H,=+ MK6C<.<&?E_C,=N62(+\@C+%HQEK.$[_A_"RR"&/G>SO$T#]^QPK'[CYR=IOP M*O_63$2.I`WB7`'.C%Y``X8BE-P@]+=$I9T&R0=+V4)LU##!959GI@+JV\U.#'.7B$:^9)-ILW9=*8@H# MSW=_J%(4-T/O7?;JI')DM;O#CD319Z4^ZK:N`A3[&^$!1%,7YTX=5)025H") MAPF'IS^$ZPC(6-:>!7U*`9CR#RU7S.(VM1CZML=K^8ON`/N.?XE4IM>,4 MCCKD)?*@BE@=:Y(VE\$D)W6:500&@[E>M9F3GM_F^%>H[+V!,0L>=%27U3*T MC0VE?Q[79BC9U6KW&5VN5-\0BW8"?^E.@[$/^@&Y=L>NO$-ZTWH:XL?7C%:J MMY>`.ONP'I`&.63/]GI&1N(^WYJ\LJG=-PO7:,!P(%W M3D(VXQO[=A2^2YC"D$DQ'/#:Y M?(?56U8O2'M&C$?U#-6_?CG""&/PY^X3S@>L%2C._;_UT0Q`)G1?T<^NG-W>V$\HJA7` M-NA%BL^PGY<SM)E0;'06>14.4 M*>=@%5IOFEOJX%_65@#;!2F/WAL8\*8E^ M-!`I&UY&&[Y>X)T61XH9.KN8X(U)44WQAG.,XNL%_SR?DMO0DB!K#ZZPW[") MGK9/D;B]GKE$A0<]Z2)0!LR,0EG:P=X[?K-_'$@],E:<^:"GJFR2H1WLG=X^ M^DS=7[F+5>N/QSU3,7?:I-3L:WDGX:*Z3:\46PHX9/$=Q)::,G%^("KH`/`F MQ^V;,J="D#_HJ/"CW;BA82MWV*G;QCQ,8EOJC\329DOEI]W7<1C3H#/JMB?` MWLW'XI6XV-=+&E,(5;J+*QAF^LD47_P;,,;Q7$LLL0Q_(6%F:/GKI]"G[PZC M'WINB'Z$%QO:Q:^?`O2XRX:I<5#;FTV]@QA:\@L=@UBU[[AP_='#$9H>Q=@9 M6[NX@$:USL0B(M:!?=.@L6+%#@Q:R-9LH+M.<=\I,46LPQ(YO#-B'HW)%]O9 MD`7WTO-I`E."`.^Q(:R)\UCJ=TI3"5M%;`6:L4(9`?*>@*2!)Z^=OMG^GRBD MD07L`<5YE`FM!V^I%Y#\G;)6TF81;Y&_ MP$W0DE;TG=\)H7`#-(R4%6C8";&U+[,18\192 M/.(VVGR5##BO?%7L+B$]1YVT:?B$A^%S86%**SWMJT]%:)X M;UP6+%K1!7KQAX^5^'#I!TDDVE9OP,O$[I'_@B?M8([!"6R:H([F M45M[&ZQ4P#)(CCJ\(CFZ":LJ7U/HJ`-_X"7K*SC_1*_+\`@<3YI\D(WT:`IY MJ[3G/OGE^RVH.)92SN54P$V,R2AA%Z%;7#'3E?*[QS M?\'$1[O$I,'K9RC M%?+]3&Q)FODK=TGN0;?VYB`/6WLT-G>:5Q<+-N.TP,VNZQJU\8M>&\2OM;Z[ M6(E$LGWB-0L.-*;/JJ^]5^3O_N8\.2'Q851=J5N/Y+!Y697-&'4;=217A.'[ M\_,Q#-U^(ZA[)/D'HFZ.S1AU@3[=^Q!5K0S22*D"5G<"DPQ5^%MCA]1X4O&L M9D(/V.2LQY[LZ`(YN/RA&)0'&5#FR'^R,`C6Q.QS92-R-X#$QNW%ENGW-C/3 M/WY'01B7KK6HM[3BPY":I`T@I@&;L$T"4-?/86HZEFM_^D2>P[4GO:ZQU^]Y M'<-FBB!DD>&!3D%"7L]$T!+]*_Z<3L$D7Z'$<_%2?0'G@BX864J8]Q:+$PT6 M-PC]+?EA,`O7R)^O;3=ZUO@[=:LGGC6.)_!6,TDM8'.V#ELR>C?*Y:M6=7R9? MBG?*37'HF2\'?'2YC@P)%S\6F^V2C$DR"'CAA?ND+$Z`B!9;+*J# M@C-[LT'+KV_1]X+HBP%Y<68LM+2D;+"IHP]XYD5K$L,.+I;C#P^T,[;Y5Q&H M@5P2AY@1"/P!5.QA5_)IX6Q%[C^"W!>&HXZYN%&SLL-F975V8WMWH)$GRACO M8G1V>XID'9]^.=;98,2]-C$;P$+= MUF!G#J`O@Y3A9'N8H[&'3UN\-)RZ/1?\WAM`+S-0LVD.Z*)[>!--TM0&[4FO M;ZP&"*<_V-3(!XAMJ:!>T:>$[U)N!RK`+,1?BDEF7;%>< MC)3[=&GBF!O["9U3@3!2-:;W41!8B%]<^$A%3#=T7E`B0#^(ZCYWK3XO/T<& M[7-:JH+^.LS,!H0@*`;+_6H8&#3/_-7[;^33 M_U]0QVX4;Q&I1K.IQ2KQ-K@97!%NMVF\4`(,]OXI4FGFHCFV*^"19M MMJ$,D(++8'%Q[0>>S#+I0Z73CV+I>&E!(ZL142TMHDKLJ_/9*0^O2/WZM+XF M9QE6Z_SSDH.*9IZ-F\,S':)6S;-Q"9Z-34]F>YZAE;W=A/J)=J"/FD-'V7Y< M8:.=X\X9.O?8RX;$5K(C+FA^8X9)E@5MG%Q<6%/8&Z8C/?"Q@*>*N-^DL#U8 M=LO7%W:-0[QYFZ^];6"[2[I]3UU%^,Z+'9)=W()N'!-;N;',SE>ADYJ-7!X9 MV.7Y_F:[6QN?VU^Q[&_WZ`7_9YW0&?]\\X(*9ZC!0/P,K*''FCFA&3/8+S,O MT8._UY:.`05E^V/Q.'<-/=9,$,V8`2^H^`U_<7V/%A[13'X4B"\@ZAW5S`<] M"`$/:Z=*7CHKM;E0?'I0[@<""3'L63.[2A]U3^UE<8%> MS!G#0']=7L4A+]UP5MBX8CDX&`BOKZK=5+WI4!I9(`G MB[SQ7A3)/9B('^T4>ZG9^!JP`?Z2+7)]B_FRSO#?MYN07)?L%>V+'^K*=5;W MSD\;4L!3'L>*DGL0)'(7PM=6/(1.0X]0R*$',^!%)64]75Q=!^+\*-U?PSR# MN7@!?ZA/O6#*6O8[XLZ#$CW5?9S4@Q'PXH7?[$)/"9?H0YF)0;Z+VN>"()3%!7B)/S$/&7D)OXNA-PC%7G!$>+!`ZK=U'WZTX`. M\`RS^Q!Y>1W[$DN_26#!6?^1EB_/#+`4P4*SW!\ M)Y?XPJ_>45/6@%R$V,8/*`T$><[W<(M[@%6[:<8LD(L.(P#0F.%4$+R,BN)^ M0-5NZO8$:T"'$0#HK9^@BO%*A[\:Z4@*ODB$$:OVTPP*Y./#-@-`)X&C.T[! MOBC[GU?65R8W8'>^`O1FK.B M#28CY4"/9JSVY9%A:SW02W\!!2\]/RNCRF`REGD:K-X5?!H(H12180#T\C<= MY2`XTTWZ$N\(%'NI>]-7'ANV"@"="KCQ#>)*BOM_U#N"&`$BC1"C`=!`H.,P M-^$U;R*3@%^QE]HW@J6Q84L`T$M`"8KSU2P9"-8,'NA"B9$!Z(6@K*,C$M1*41X:="X"N`KPP)S$=B8]+W/K*_0`,`Y/&AX4$`UT+>&%.XCJ*.P*5 M^P$8!B:-#^,`T'@`41V_.1L4A)Z+$AJ*.P45>VF(_7.P8=8'>@MPD%7UTMOZ M!X]B+S;DK6SA?H>H*Y%!2D.7=9\2-*,&NR0'.1,=/X24T%$\R:1Z1W7S00M" M<74FL"Q@R9>/LBM(J"J1AZ)L?P`XH0TO=I:`28V=Y[2,FN*73*7ZJOM,J0LG MYE6`3`>2=/M2(CA*%9Y0[JID+ M>A!BLP/0C82X8X6OI?@51(F>&N-\RL6(,0'HOD%4R^D3)^W:BH7X'Y%$O M#6%`#C;,^D"W">E8>WJ2SO&MS?8.%JLOX7XLT5/=AP@]&#$F`-T8R&N9"+C% M6DK$)JKWU#@F<#%B3``:I\AY@)>AYDZUV>JK9_O+A)[B?LA2?=7,!FTX,3X` MC5@2US-U`8-U5*E^)=E/8WB0@P_C`-"+ZAP=+WZ$NQ*MLU54(G"._*>$AN+N M1L5>X-I?%!OF,P`:L7K\'(^JE\/OA(*RN4ME.ZD]9+DL,LST0*,3Y%]B'FQY M)!Q&)7H"1@)%C-C]0GW;PK]^.4+J&O]S]PGG`]:*$Q().IUAZW/K/K1#&I5_ M\'=OU3I;V^XC"EJ.BW_N+?Y<>QNL;?"7U@[XUD_GN.V%$_[,A#O0Z_7UM?V" M0=W:&TR5Q[?VPGOZ0A6+.YFMHBZNW&0'N^:CQ@\51V1R7J+E)]'ZX6?>T[/G MXKXB0ECC$<<#DC3%R@X>J#VVP>='VW[^@FG?^X(V8C' M_!Z%>,Y5`#?TY.V`B8AG=7B%2?4(G^I-VP`M,@$;DGGZPJXEGI#\?OL0+'QG M-XO$[YO[EOA1.[^Q.JU2H%MLHT&3;'2'%LAYL1\V**&1^&%8M%DP=LO3-[;@ ML`?0@M/ETMGU?FL[RROWS'YV0GO#%N4Q9XCIF1IS.Z[3TN\6:J/3)(N+R. MJS6?(`2P'T&Q;^0Z;0X8T0+!?1>QUC91;)2:\ MJ;LD5[`#/,U%M[/!5:P\47V^]KWMX_HXXQ!&I#?`B'S'\,6C8\!;X@L98U2J MNFA5&=2PGV`8!R0>C(..^#5K15*],^ZEH8;]S*,($`9$ANITJ,U<1!2V],UK M@KW"XHX"5!$W@,9WEE28[1)V&NN;>$2[;10[N&!%]``:[LE"E8[S+MXC_\59 M$&5HO$N/S)R_HR!$RZNG)[1TL-J;-XP('1!+/'EVV::1;!FD3@Z# MOLIE=ZE>`:U3:E`Q/2J@W9Z^(_$MG$(/@`V\`KG73`##K`G7MY9X59BXM M433::Y2J$-0/)`$"'CM[C+*)JBOZ0)1J,/FL"$-$/`:OKP-SW;S MUNOD[&7%$^%)ME[_7D]0=>`5>84U2VQAQ6=WR=:!&C6M.GL+"-1W)A1(N7/R M6V,Z/>7<&?8.[PS%)W-#4H"[?"T+)?!*G6DG%5.X:V5/?Q(\D>^@;B^=#`#, MNN"==,7*)3R0*IH!L('3$`"ODEMPPHPUM?(]KZ&GS3E;W%]CJ)"&AU&AB8XY?#2YW(9;K%9\0(FJ^QVXHKA#P=+DN565 M`1!E=,#(:`34HZ=9__TPLC2Y?%5E:#2-TC`R&@'U(1;,O)&ZUC!O"=84F%W< M&R!JR$'#4DX!]3DJ:YI8?#4%8!?WUA`2I*%A)&B0KS!2KYMSV!ZKO&,7[J%^ M?Y($!,S`#7(79FJW/VR/55ZV"_<`V,!I")B!P7L,]]J=HT61NVRDX!\`&3D/`#`S48\CQAS+EK+QX!?&<9@H]U.X2 MEH&`&1BH'U!*NT3L@O@+>X4>`!LX#4']-0>5I^A>SI7S6&4(BW!=UFU<. M!#9P@3H[]_6H@KF744F..G9V<6+,]W/F!2'&;#SDF%I7C3UUP:IEB"8(V60` MU"&:_3YLD#W1#4KD'BAJO_8MFKCZS+3@W9R%NB4VGR42#Q2U#]:T:?69:9OB MX-P7!B'>O2SB#DN$NQ;W4/,"+@V6N)W);KWOK+:PZ,RIXG]=>,_KF-F<^*G,ED=MZ_4855)T9M3%^ MK@S-$G-0F6N(W-:!&C6M.C,J4,=6;K`#/MYY[C^V[H+(]X<3KF^\$`6W]ANI M\4K3YD9I#2MJ22/LA"`HD:T`,F8!-33HAN`?31-5U/]'F4AFLVD M-)"L+!A05TQ1@.8="AV?@CE;]:D&T<%V&G8'G.P-XNY:C3T#XHPZ9(PH0!T[ M6K1.Q.^*;T$U]MQ`HJ0A8T0!ZB8ZTOI0:0SC;K*,9LXXM@3/G9EE`+KIT-_^ M1/G=E@&!:J6588`9VX#ZK$R"L3]@3)2?AAD0Z/VP+0TP8QM0!UI!N/J-][(+ MM"'ZXPD>;Q]?D!]@<6>KY-Z1.^(&/4U[IS)R`%H@=<')*`4T,,(`!HE#B*9= M5ADY&D^I-)R,4D`]PJ(83"(0#A_AL6=W$]Z8TN1G4A8")IG4@61,`NJ&U@W` M?BCU-/F9E(5H-I/20#(F`?5]YX0EYUR<#TI5<2WHH/;($`D`F'6!^J-EE$O$ MO90JZEK0`5SKI@&(K#L"ZB/FW<@E3WH9@42 MP1%EXK*+.H!KW30`S+K-\,86)N"@Q1*QUA;;<_0GG!PNFE)2J/0/:-]6%CY& MG6:X5LOHGKC$T)3(0J7_QE(G#1^C3A/]I`77ZHDJ3Q$6U/6B:HC.();YVFJ4:^]X9R)@T=(TU#')U3=\FV<(D-G'5\!44OG-33L`GV M4B\)%*!@QFZ(+U)0P\0=HWH"1ZF^&F'X-"S,_$`=B'L]]ZQ=K:G6Z5J\_ZK-=900/<5.2.G!6-S/`F?D2T/-R-<0?WK1_?0W M^XV4?;2Z\5&LW^/$-FB:Y)0$`$2IT@`R]H!WQY=7/A'>H&F64A*@N>Q)`\C8 M`]257S0;=\>#D;7?AWKG3K#`7WQ$!V]TW.5TL?!)&DPW1+B5D$'#.Q%IBA_1 M+AP@UAD%/F+D!.AE0U7`)+8)FL)3M`OW/AF9!IXQ$N@E1"XPY%;W#@7/:!'. MO7L4AIO=?O311_0O3/TQ)^%(7],6354&0/S2`2.C$="[!\WZ[X=17]->356& M1M,H#2.C41-O"XZR/\S7CA^^K1P_".>OWGSM;0/;78%Y;L0CU_):BJY M:T(^0/0S#3^C9A-O$?1BDWAVJZF,KPGYWBTUT_`S:C;Q=D$+-KR-B::[5A/R MO3=JYL#/J-G$NP>]V"2&K:8[6!/RO5MJIN%GU`1Z,\%Y3$\30%OT*H;_V+JO MDM)697H'<&XJKMPPCZ*EG-Q9J':M>T\LRN0+WY'-7(;<4@F[## M4A55&BFNVYRJO>5M*D0(:IH.*Q28'ZD\U%PEJ=N6?% MC]5I"*SX;5M58KV7L.-LL&,"`O5$BV*R>PJ0",&AM][YH%AS;S(X`$4\MU1E MC)/!2Q]+],T207($6T&ZIA]0/W/QB%)Q*+I>Y2F2:IWQKXTU#'[@'K)16Z& M*`2[:Z'+XVLA\E.$7+D[2TUY_0V(!XB/AL&/B0G4S5\=-HGH.$UE`@R(]UZ) MF0:?$=,">EF1PB:Z61MP`#A\9,,VVNWN8"1Q@UR^PYK)4PJ@F`Y`+SK*:\N& MP`!O/BHD!8AY10-8,4&`7D04YD'H]X;=T6B?3H]4^I682ZUQPA>)8=&TANF5 M#-#R90[RF(E`KR,JA"4Q3#5M]DW(]VY9F88_YB;0JXE+V_'I(66VND,OU*48 M^2FMSBCI5!R+7_8+M5DM!Z35C.T&U9=_',&2#%O)HC`E9HEB6R)]U!S((PM# M;&>@?B(E!1/3D/BH+=%3`VR>AB2V/%!'#$?-7GQ\I_%J5C^+W.*/-A5[J=WB MLE`P:W>!>C<454S06OR]=ZF^&F'Y-"RQ_8&Z,SB*[IUUN0N9^!-%I3YJM[<< M#+&=@7HEE!1,T+G$0PGQGAI@\S0DL>6!>@'2!0B3^Y9=`/HPB]TJ[Y[DNJG+ MYNI@Q`8'>K16U7%/;:77%BJ=-\U'70.Y[;DPX`,QBL]I%+N ML7XRE(`H9@30F#<-ZB:&@4II[9+]-HX=:;ABC@"-3$O'T2?*?16$C[)@J63Y MIU[JG;Q^"A>_LX,'`T(3A),0T MR+S_BZ-0R?V11-%T3;U62R`#4,7L`.J:NT'AE;OPGM"U%P1MJ]<=LH. M'G15\0J6I65L'J!^E2P=)V9,E.Y.R$[YHL])>ELB=L^XV+0K@]2:I*F5J69, MK7@C3K1>&Z$=XL4N[^>NG`#WN*C!KY*.]V:BQ M,!%@<+CM.Z[,2M=%\?LYX79KBZ<05S>^<05Z-L\.$AD=;FO$K]I$FH02"<-7 M,C8:T,,R+7>+=R7//EHC-W!>T&X9PQL2Y#RZ9UO?1^[B;8XY&MBT5C+>LM)_ M;6SZK[BD+EX!9ZNY_>/6\^D'8>@[#]N0L'CNW6)8W+"-[%0+"?ML>&-*:]G]:WU46OG%**V-1[U3"G"[5$GMX5,$].\0']&2!-T M=)[(%.^YG[%B]G83&J/D\+U0TI`B-5)R*$7)88*21@)W]I3D8%#F'8>+UX+0 MP9N/6VPWA':\WKSTM@4/##A5QTE=O'W"[WNJEN%3XR_=-&C`#JMT5K_QU8")*0!T?YE]T[N+U1L-$[OF?D?'I?9QPU"NMO,4 MCLT(=/=V3JK++L^=%V>)7/S?8'?AB>6Y;UU1,&5[ M6*JN^-6?AAZK-;QFB&)&0-W/B5YA$M,F_3?DW\D[3#S+\:+*IZ'5&>Q!ZP<@&!WB$;,4!,3Z#QLOM8C;DW72Z=G22WMK/$H]%^=D)[(S%@,X[E M%!!QSUDE,E5+PLIACGD'-!),KA1.3JI]L7N.EX27;\:D<0M4Y_[O4Z!ZA)I,N%(WC=W(9@L)CF0%]ME"Z*4O`< MC?S^H#/W)MV#24#"D5VY@+#VL&8-$-.SOBO?OWXY`A1C]N?N$\X'K!4G)!)T M.J/6YU:,]L'?O57KC.ZA@I;CMNB]T]K;8'6#O[1V(5"MG\YQVPLG_+GUTRYB M>8U"9V%O?F;"'NCY^OK:?G'\<&MO,#$?W]H+[^D+533N=+:*NKQRDQWNNHLZ M.^CI$!7T(\3[0[3\5#QN[T@W-,RKWQL.3`6NQ;VH1]O1)KY1"A!1AT9%_<:A MFM(`SH:7C5N^7M6$F!35%&\X`<%\O:J)N2P3!IR2V]#C M&UE[<(7]ADWTM'V*Q.WUQIPP-3WB'O2DBT`9,#,*96EGP?_<87_3T&D$V\7;V8[ M:2VRCA<%S>D\#/!!/@S+%U/,X$A?8T7]Q?8!?8X7#BT[#4.TDMMI:#$43S&# MPUR;04X)&AJ?H*'QZ1D$'"-P.8@/]#OWS/F6W,G<(@SH/$KMMSNQ@W;9& MW9&Q#;*X'-4ZLM3PB9@-],7!X9K,'&C3)V_KANU)CU?A7>>+07['%?LGQ2"( M[`@T"H_*_-7&DR5Y]H@7T5TR`W(W\$AQ^/JV_\JM_4;?R[S:/HM;PL1=(2?< M$B:[.UZWK>&$E_=3TR#7+W#%LX%9Q".Z`8WX.T\!+?%!;2A12??HMZLU M1H[H$>9`HS$/EZ5SK'"`5Z.^L<'$Z:_.=?A88=ANIK3L79*412*H@=-"W?`? MJ!#A#_22_VQC!T$<:#_S[YS'=7BS)0W.5O=H@;?KH8.",WRL0\NO;RQH(OIB MT!YU>*G6]`RLDK)5RP)]0$:$@1K9+.:+3%WEFG2R2@L:)38AHEI:1-66MT4> M7A$G<5I?\+?1@D"DKG[A\DR'J%7S+#-ME:B^\&^OA?51VY`HVX\K;&ZAY.B& ML3L8E4PZ=-2B8;IE@2Q4'#JM,^RK[FC=C\0>#'CUH_3LG@YZJMF$65K#=O$6 M524_RDYQG%4GIN98XFV^ECXA#U@5W&"[](K"=!,98TV;=,[JLWG&BK>;9\9"7 MXEGYA-H$;$>NWO'KKP;:D;QT2VBDDB0IMU7(MN3KSJP)-`8G:]%(*"*>X"R_ ML9IM)ZXI,QG0P(;<,_[F!'ITS57H'0H=/THS$&TQ]CI*9(53[@>X^87P81P` M>N3)WV?PKU*REJV>N$=*5[>0&:*('B,,T%-5294/%L=>N6(N*MTVFS!<]!AA M@%YD%LVB^RC\V2I90#BAJ$HM"Y7.()-#"BE&B28>\Y-7^=ZY$RSP5QY14E_\ MC>EBX6_1\LH-$?[]Q.5^3]PO9T@*R"32@RUC%U`/0RX").7I'0J>T2*<>_OEJ>//CH*$Y&HU:ZA1\BLD<>,,02HXR*A6_04B0J#IUCZ/*DP@DBB#GR9 MKFKFA"Z4V%.5AKH^TL=[B6+:I-:&>N-M2I0MP\15R MJ#"C`WT#R"D*PI1+Z"+NORQLKV9S2NG+;`?4,YE=T&6O"N_IK73=&JB6R]26 M&0ZH=RA;E;WKHM\924RL`BV"-1]79V;!)KIK#A0::W++0+&CO.:P<]`4^1KC MD!ZBD:;#+IQX)A7M82;_V$0IJB8O:M0K8F7W?8&1(D@YL/^3HQ%?@/ M9_AJP8?%SP`=T'DAET><5@F%RFL43/R,J.;,E$!W3;D!04<:23S6$FL5C#&% M=6<++5!_47YXU]'>05=H&YBI5T5[9E"@,VUZ^[`O!RKU?)A4Q2L3M*#6+;C- M5WGT8"?8DW.-)LZ&5G\@3@_%7L#MS*2Q85OS9M:`ZG>LCM7ZW"+WYQLOV/J( ME('Z_NW;].[OK=EEZ_[JMYNKRZNSZ82=9YN M?>\9^>$;'KNX>7=)J/),PY!P2Q$W^MTA9]73DV!$H'^A`9!U\?N\#9$?-QIQ MT[(,YIOC]ZEA%*N8*G&Y6X`$[(PWEUO?I=EZL=Z7S@^:MY=YRWL38_G=L[NM MV9Y">,#V;V6J__6-`+`K@-$==4T5=!/H7WWF$;9MUM7#ULYN0SE$,(?C[#3'VNXQRV_>ZX8ZI(3G'WZF2^7ZS1 MA,NP[XE/)[5/);0V\.97L\ MWI;SMQG24)>_K:!TD*HQ"P\R7)A.9;^-E/TN:T3`!<'+7:SWTQ?K-[/YQ7WK M=OKWZ=?K"^6[\^03][(WY(?U)/=G3ZO7-[8%R>A3?;H\C`!A%<7HP][I-EQC MZOP/K<[8EW@&+]2FAO$C:@!^;2$!76%OLHX*))/2I;>(OLFF.DC$(V8V5+N1 MLK2"O=4ZU/F;'9+R?&^D=F-[-!H8"YG)[K8&.PIA`-OO=JC"I;U@U<='PZIF M^'VGM9N0JS_L$DN'"K!$-G>8@[3TYA)/+`O\@?U(.,G+(&S"I'EBU&YD08Q@ M/W@\59W521#MI6>!/MWAZLG>0-!]R/XA1%(Y8[=F*@)!X8=*F@_KU?:7%S^>'9]^F6YYK.%X9.S67).0 M-7#'`+RP*[M%`V&._"?R$,(2?R22^,T:#)4A-_"J6LKTBE-Y3/$Y](GE8`G7 MWO([_B:FVV3`<8?4/)KSA6[2Z!:''_C+[D1*F+U?`VO0[XPDRK9EM%*#107T M`5ZB2RLG\2J$%OB,=.Z\.$OD+N]V:]%D8.SX8%S\ID\3128!7GDL3Z7?O0U& M9H-EI4I-^N:"3,7%J',2DL$(>(TR(V/@$(PHDH3LE1 M[LEDX0:H/<`+EJFI^KBS&JR7HR_P7')WZ'DWWP>'5;C:%K\HIJ;XXXQ>:S"= M"`#0*Y]&6\-(\K.M[R,:@'WCN8O=/]J6->2E^M-C3@$!:K"L)"S`2YL2[?H%O?6R"T)`E,4;#V-DL:[B!>X8+;1AT'UR)=@!=O MS-774.X=[8]K]@^\[M>>3Z-G2!_1HZY)IV<^BU"Z8]-DS$T7E(M#JEID8W,$ M[8(CB,O(<[%049XO:VSN'32W1W7F)L_044+0#J_X@+;4J(>]:>"HF`DX-2Y3 M^L9OC080)\IHV8VD'@R&QC:O!SU5;J$L/6&_T2N>^8P_M%=<`3+N)))ML7?B M`ZLS-*8'KT<-Y),RS/XV(%_])CR3IZ]ZR$IY-/R"2)?AQ)@I\WJNS:2"<`!Y M5E]0K6#OA#M\1DN5Z5J#,2?M1691@KS&ZC*7N(H&GY;J&XO'\TFT!N(9Q6#8 M`+=/]34A:9)9N$9^]'>6=KPW-*=,0=\Z6"IH(AY!\]$`OG')7NH,)6=37^GE MQU95*FA+02UFCLQ]2DKW:G(7ELE!EZ.QH:R251*P*A6J("`G86:Q[M4D02R1 M/%-@8VC*B*7WR;(^*4.*J/ND"K@H99K#Q#+9^H-/YRJ@MJEUK7)&&E*D1D9R MENDB_>$GBA4ZCJ5F%W,G3DDAXQ)W@S%G$I064QN=9&$M/AVG-04_W0F!D)HG M8'*KO)C5&NS&%?2X@NH]>@[IL7[^ZLW7WC:PW>7% M!KT@=^Z=HP7_(U8`SN*Z8C)TTMBS4=IF&6R?Z=8(@K#=-]-''U%M9VZ+N_D5R3M\>W=Q>7%W=W'>NI_/SOY#.0]Q%#_G/)`HK60-[;))B:-L7+2M MZWU@3L<:FXHUXO:H)6:*M/CUC;;/\F!/!A6$3!WWJV&TB9F%$R^5@\&[J:B6 M`X[9U'K:.$O:V86[GF]]4H0;85B7NUCI&_1*/\(:C;H&D\`)R6"6RKPX5&EH M8"_F1^FIHR=G45[<2:]K.,"/WW'E5A5$H?:]P"E-;$6$T)XD%NA;(A92?XEQ M8O0GY3N26[C=OQ#^A/YSZBZ9NFVK/^&=P;15GBDA6^64T0:7@P5V\NCI\A_;(*2/8>?>=+ET=J+8E(Q15$7NA65&]&3*#*^5$2 MM8@20#/S9"JW5XEFX,='ZU''Z*MV(2G@&#\''^`YS9,`L(B13M=80L]T=V7N M,J,YF#8Z97<'!A\6B0Q"B,C:.0*X*&&<<< M*5+99T71;,*>348I0]L?C13)5S%B`9V[TCVQ6,C.L&-<4Q%)=(X).>.F""\) M'/R]H@PPAK9=`%EO6E.`K.=L1%6!@[!'-;YMVOOANYV!92I`5ZND&H:0GBT% M8+!TQ3Z;I1BO*IPNN[R;"&L#)JB@\F"-H_SBZ0$M\<'S'-'78\X+2I8^37W( M9'QK3ZR)L6Q'JD+!',.\L.+RJ,,..4Z`%FNV=_^TK:XU,3:R\OMN#$?$(80= M2:RPHS0]Y6K;BNK$.W4KMVVN`?=/8U+X@E;VMZBK=5B5NHI(@ M_^&$:\=MA6N4O*N*$2=W6^0SDA[)=M_^$K3V&[^#2Z]M0"ZU*.2M;FMG`&.W M6URZO%)-TJ29K2+A@_2>%4O^G0A.Y9Z_>CNY3Y=@ITNPTR78Z1(,[G7`Z1+L M=`EVN@3[`*P_78*=+L%.EV"G2[#3)=CI$NQT"=;(2[`^S(IU:1U^PTU>>T$P M<].?W:`0:S8VEFE'6IH&$TD<9]@I56BV*?IPMVT-)P:3(<3]-,;H?&A@9\3( M?*5]L5JA!2'GT7-MFF^4,R-DY$^5;K\QUBZ%'.QL%Y3(&`:T)$YT?,BS=U#[ MMOM(=Y=?W_9?N;7?R(^FK[:_C'+3[7WVM`S7?&V[45WR&P))0&N7AQCKP%E0 M0^'Q,IX8N\6J7)W&<+A60\-.[W&*$3G%B)QB1$XQ(J<8D5.,2"-B1*QN^D7S MW<7U='YQWKJ=WLW_WIK?36_NIV?SJ]G-O7*0QAW:V"'9#/CAVQSO$P)[01?\ MLN$3&>WN]S#]0<]8'OVBSM57U?V3["S@OKX=?!(E)AGUS"?;EY!(PTB6-G`Z M([\:A._&B2Z&H*%IWMP0R6CYX@!UX#HEL@>LDFF'\:]^6E<\^ MS06(9M:)(+A#_]PZ@1.B>^2_.+2L`X;B#BV\QYW!VH-QOUMKHNKR.M3)T>K- M!/L:YQO>Z*PW;]%HO/3\,ZS>=A,Z[F.D6X"5B\N-D8ID(_$*=I*MUTF,$D#` M3HM//;+W:(-__O@;3-UE]/E$T8Q"'UZ\1CM!=K8?GUCJYV$('4201$O MV$Z_/9GWE0.1_T2OHCBI9#.&>` M%SGJL$J<`M+Z5=(6OEO"7+SS6`H&^-'IL@@8BMNND[`5J%0;83DQY[DP@`\L MSY*^`D=1V:O8:^<)GS'B&_^WZ"EC=&'1L[K&LL#G]JR9E1E&V2>;$`,!^`9L M[:#]:];9:H4/%'ZS2;RE^+#XA'6Q7?LQ5HGL M/SG.:/&-=4;#%1M-2>%X#P,R]#G2R79#?*S;%R":O;JQ+EV54U%.@[4835!! MZ+5/N`2,U@""QN:-*+;\^G;N^&B!<4WPD>/*D!N`Q?V`&(]R<,#VHY>XY35> M8$7W1;F6\Y4AK36?KT2+LY0Q>L&%9SZ"0-(A9(7^1#\G?SS8`<(_^?]02P,$ M%`````@`PX"L1,;.]Q_Y5`$`KW<7`!4`'`!V<&EG+3(P,30P,S,Q7VQA8BYX M;6Q55`D``ZXI<5.N*7%3=7@+``$$)0X```0Y`0``[/UM_A4-6Q>WNR,AF`.^"/XW&'`_B?_]>O3X_!:[7>+%;+?_E#>#[Y0U`M M[U;SQ?+KO_SAEYL?+F[>75W](=AL9\OY['&UK/[E#\O5'_ZOZ?_S__$__U\_ M_/!N7/SIE3QGW<:=/Z"_M/5:?J_N`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` MXK:7#=%@]4S9W6QG#K/UW<`\\U_\^6Y%8ISG[0^/I]9$?M(Z)$=3KJ.3A$F> MRK>N-JN7-8O0GAZ).#1VK98__'+SAV`QUQ-L"A\&[,NS@'Q+AC^`KP/V>4"^ M#U@#__//^^$PBX[\S:,C5T)'D:11',&4I3!EL?_X:-=*'"';CC7+%$Q:Y:N! ML@&@/!.@O#)X/!-X;+3@P;K=7+QL'\AD_G..C<%A6*,6&)Q\ M%"9E"+.0P2PDOMB^D"H.EP01>8Y6`O@DV']CWKQM>WWWYMWGY4_G@/F9&*8A MAVE(_;7P=FU<>W5!N8Z\^0:,?6;*V*\VFQ=F%G'FSH]#IX:-O$N33@/G'X23 M."Y@T`L8],POT^[3P[GG[A&FU6V?!?"%63-VXZ]=F/&PGZY'G'F/!,:\A#'/ M_33D=DW&\<^],K7[YH4)@[Y^V;*=WL7R*[&%S"');O1LV+1[=>JT[^97A`S" M'&03F(/"+PL?TL6YNQX0J,-E-[ZR8.9NG+=;,Q]VXP;N]7+YV%N MS;\/=J]G_0K:U1`8_C3.,]QAIJ@*MOVZH!Q3^KM@_\.SH/'3H/ZM+?,NWK1Y M%_+F'99%."G.XRS.4]PQI[0NX@;_6JV_K%2]NZQ<`("YDJ%_6"P7V^JGQ6LU MOUJ2E>#KXLMC=;'95-O-Q=W=R]/+(TW07X`$K+*+1L%19(W2R`NDAP4C`U"C M0Z4QNEI'&:S6L-N13%##QIR23KB2,7&GG\@/E]M-0/A2L%W/YM73;/T/$CC, M]LT$%*N+NB%W4+1"LGR"X@D/4V@LCDN8 M?(%MS@1W=9&.6K:!I"';=/>MA3(C65NR0AHQ@N:$'(HVP,@';#-EL&&:X"XZ MTE/,"0G4$K&!'U/51X?RM)2'Y!-[A7G]G9M$B8!B[>AH+R.(.#&`K:H$=SF2 MFD(CH$%0M%,4:%9MB)J*`YHU#@8&:-7)A]DDA**Q#*H/$MQI9`5MW)(H$9%. MN9-F85Z;"/5V?)*5]O8*NSLV;^V="O59^D%1PH3-0P[;5PGN/+*\,J-Y^5ZQ M.CV\2NV'B%DX\^RN[%S(H_./B+.!&O<<"A,2W'5-DIJ,XGTXBIE>FU= M'U:8Q3`[NXB=%C4:C-L.R=?(;Y2JHBZ=J.:>;]!\>9]0Z MAMC[IKH[_[IZ_?.\6H#%DS\<&SKYJ\-V]4RZ7\3:?(]^11Q'`EGD"+8_4]Q; MTB+B.S%,`4&FN]\$]$<&#*Z'9V`QN!.^4B/X1IQ;%U=:!8KBPJ^JU/N_(`BE@\J MY/]3W%N6DIHX<8)R,DWYSP/X?4`_",@7`?W$K`$;<)3C&/#I>9*N#R)(ZD2P M^9OBWCB4T,*V6Q47Q:"]UC?F72SGE\LMF9FKY?UJ_<1*5RZ^;+;KV=WV/`J3 MJ&T?Y/5Y\95::#*)N7W2OQ%J4[-Z6$WJ706QR.=A$:=A"%M0$23C4]S;?3IJ MV39N#=FF];>LZA&^#AJ?!W^O&_@_-FW_^.9-3XR_<:FGE/67\:0N0XA@`S;% MO=>GHY:X]<^[;Q@UAH)6&:VC`-82N"WP`_F[#5EWALY\BU*6SC[,(&%8]&/; M/_V"$4-P/3%L1V$_.B*IBA/>+2G4WJ@YDX$O`O:)83,VP+S',N-.`M,RS!'< MT=/2@]7%$5$&&N&2ZE\/?>F,AX=/9@TVFZQVTUV_WOJ%U((<&)( MDZ>XM^7D%!G!ZPZ(=&*Z+'HT;[C&_:T;PQWPM8W!C6"+/X9]SA3W5IJ$%F[] M;)\HQDUU=Y4W9+:RH0)G64,]:-^,F?:+?&RD1[^FG`MN88AA\R?#O8DFHX93 MSRH@T-Y8.1?02\BUSKM!G^K*5#O]Z>&O>25@#-M(&>[]-U$57'G2`3D,6^8M M$>\\&JROD35(VJP9.VP5\-C\V(\808+=\1AV@S+<>VT"TCOUB]UR[(V._D;? MT@RZ/CN6UNGHV(_X9=(Q[.%DN#?%!B1WY=;:N]/5\MY]>O_ MJKZ3ADTEB%K;US,U,9%KF^OX]03JT&+84\EP;V,)ZV#;#D4%F?)L//]EP'X: MD-\:-$X#"ZUKXSQ9>CM^3,,]Z:2FD*.'+&<5#M3;WO30/GD@;BQF//8""R_ MRY?W?DK#`M@X26#'+\.]&Z6LDTLO+RV=31Q\6#Q6ZW>S;?5UM:;K?FS4\`]: M-V'I_>(>FO;1;^G(0B22\(P?[ETJ<24<&J^`.+6ULI\&]6^-V:8Q.N+&-CL( MQ^%O2R@52GB^#_<^E)@";@C%@!3F3/%S]75!:[.6VX^S)WK%CZD-TK;F31CC M@,"'UGC\XPGDGQ.(CW/<.TZB*KBQR$$Y:IO<_S"@OS1GE,86;U=&V;%\'_^8 M!L-PFVH"P7".>XM)0@N'"[B(/$9,].?9DA;IMZA=4R M0DW9CP/^Z^#O]/>@W`"$`9JGN-.H9E7>T/)F6IO8NW>CK6,VDIC6JC[ON( M7@\2`W=*)U#PF./.CBIH8]OERHLTO?KX[OKGR^#VXG]?WB@?F6KIMX$H\O^& M0BFC%F[(:TLJU6/D!TL?F80<)H%[%]QY4Q5UG'AP!<$.C-V&A;ORX4XM7,2- M[S^+,SBOG$[@@$6.._TJKH\!]/$%:%R?F+"O5]&.U#5;U1P&A&)O@KOF9>3.W0C+&-/,3JM'S M41J'&4P!%.\5N$]'2&IBFV[(B3/=_3R@OP_>V;!KLFPLUFPC!TX"QMEDJ/K& MAI4?BF'+Y@>5'4;`<1-1@9QORZHR'@9:Y>D%P5FP_T;AE*2\H3BF...B0H+^ M'#=1I#'RDR'2NHQ,?]JE&J(_E.S7^)A+X^/F[J&:OSQ6U_?O5D_/JV6UW&ZN M[SLBCMO9E\=FCBZ+!\_!JT-&0S(]%)D=DAI86JT2N"8L51$R5AQ%N(-GX[K: M7K!,"SRM&PQ6]\&^2?I??1FFX.^L[4`Y>VK$=*TL@'ZC^629U&@U9YO\DS(% MFXG`9G`33!OJ.EEL+0@NAFW>9/#'3^O5ZV)#)D\R?[R7_#U_HH0TRY])7\Y_ M6LR^+!X7VT6U.;79PL6B+"65*0CK#L4I?"5;9+R9V4,,]H`[`6A43W>+L+ZP M!R"MFV/`A`;9K;V-)@VNO(HV:GG5]0FN/:NM5(NU!X==OC`!X\"=S32MJN-5 MUHC00^`].T`N1?+GZI$^W1[0M]LA$KYX?%Q]FY$)DT?Z(AF"M%&!N44UBK-$J_/J5D*AH.[(-Z\LN[6 M8T,2'^!ZUV:3-=-F@\-V#:[,.L9K>7GV$]$]"[5*LVPQR,!H,C`:W`EF&^HZ M7K"-"3X]@BV!^/:A"FZVL^T+LWQO5^Q?:.@\6W[_'YMN5R`'])^JK[/' MGV=;.BZ$=KQ;+6G"O"(R53)4I'PNE/5[=7?[FXO;K^&-Q')#6QOA)(B=-NQ(%+1Q MXK_EY9J^FVT>@F?X+KA?K8/-[AL+IF[%@8]KZB>>O.^K-`OY#,"Z&>.N*9%5 MQ;8OEY1G6O^>&3;P^L8GDO:]7MU5U7SS@9C'U7+SLJ:)[GUKNPJS"QI5LRSY M>9A.6M\,-F3VT@)IHL'$`.Q`HM!8DH8E3"WNP@UMW:S#2%/`:=U`0*TCV#71 M`-=9L*\OWC?C#G%V.)5'B#ME8/*-I=$DRB'NW!!3A'; MRXJ4--./U[>7-\&GB_^X^/&G2_67NP_ZW.>H\JR(K*T#'9V:-.(>3=JM^/@B ME!0NC8#JZ!CW-KVD)DYGR\\7MU<>_!#]=7MQHW%$'W5W?_U1M-E75BHIH M,O@H@JZE]O1OPGCEU#LTZ-YOTZ0H8&K@&$:).R>OJ)$;DY<5:PJ?T8(>^-"D MFQ:R&$O%!U@`T5)T,/@M97XI,#\X]!!/<*?OE75R5&R@)MW)^J!Z.0'K_W.U MW/(3:1\KEC,H[%UYU]NWGNW+JG5Z]T#K=U$>LW.VDRR"\<>=>E?0QO8"("]2 M\VH.]LU90+^JCRZ?!>1#*S9O^1:.L6R^Y[Z-UN\(*\W*$":%>QW!7)IK>K[>PQ6%.3YW?J!2]+,OC!(VM$R_0_O&S)$O/S8KEX>GFJMX??O[#; M64*VGU\Z`$&7%$;A(*%J!S"Z6V`3Q_U6"A.'.U.NJ9D$6*CQ&@&+I(P`&\O@ M<,&*D(!CB"EUMI!&<'W!)$M@;G`GWW74<"_#W;%0:0%*["Y M6MX2F%3_4,8=I+F';G/0YA^W$?=C.F(;*'K MEY8NQ:U'2I6E[=O*UL+V MN7J:+6@&\OK^PV)S-WND_3"J58P*Q%:Y[`-2=#AD@-G19A3#P?QX@KOXP)2* M&,`I(*<,/'?-T6(&:)#AU#E,1^.A.&&JQ$O;VZ1G%`K(O(6X*R*,Z8B&EXI( M2WEIHGJ!UT&O=`-O]M@XAGDDXLFE5[:75?HZ=VAK5 MT_8B:E+8@^OYCM90:'"_3T$/,1\OO`9OZC-BP9:O['LK0.^YQ$^K_2*/\JP\ MCZ(X"G'7K-A1V,FR;$5T`4?P;O7TM-B"+_B%,>J/J^4/[^CYST?F!(Z<0W"Q M7A/Y52X[^,MJ-?^V>'R\6,ZO2-_+KPO2/EP$W'+"+TI*>]4!4J+H@5Q3ZQK+ M!X)$18(>Y:&B/ZV5ZD30@Y_71Q>_GQ5OT`2G?/S4?7T\+>TBD@ M@1YFU%3GW*A";8GF=;^7#Y`PG4 MM]5/B]?J)-CX\?O/L_]?32<0=(^NJ9GM9T)1O"M__P!HX72B"+]\#UDC`6B'Q,VE'DAGU2/C3 M8EE=;:LG:EH3>YDG$0FLH:A'1P'X[+\FDQ>QR8NX\\,=.BOK-")@>@4;0LK? MZ=(")CB$"<8= MA!O1;T1D"0LY@+*S@]6(MA7\'5HSAKE?-M7]R^-/B_OJ/)Q$Y1A(VXM@"UZ] M2@Z#JO%Y'B4E3![N(R7RRHP'EPZ)^K%Q%L!G`?W.)ABLQ/G8P'`2](M\#L%I M/6&X#W8HZ>,D`:`BV6$:X+DBHSU7QL`GR!S\9;W:;(A%Q+&]"V@[>C5FZ0.J MM!CWP1=LD`L89-QUVX(:N#;@'EFFORQG8+3$F=_-GA?;V2/[,R2N@KO51B-[ MU3[QMGF,0QON8RL'7^11R3/CN"LGA>1WR$DZA3BD(?QG9P'[H>Q+0^S;GZNG M+]7Z/"Y3>\?A#KK2,\T!J?>O!S5_EJ;P0ED616P<4]SE]Y76MZ6V=:@-.E4I3!7N'5YEG6P#0%6P MP_K3@9PE^UX2.9^K1X(\LCZLM]]OU[/E9G9'9W!_&W22)O9NWASJ70\E\KK5 MV!C\$NY`S>`.5'ZB!W?*1%4EV\A0E&OZ^?*GB]O+]\&GB\^W_Q''/Q MCCX0JEX7VB5*^_70>6JO/E1"$CL0$5-Y""[=MP?G,)V\IA=WT#E`$E.5Q@<2!)>>-I:R?*2/](`MTV&N$-B7=7&6H@$Y9OR[P/60-!LP4Q- MZLW+ETWU7R_TKMY7&BKM%L@T"BU&-!V]:L8OPKKLHI6N+\"3\9<:H#`XQLW$ M9%6Q'IO(R3.]^>7'F\M__X4^P'[Y5ZV#.,<]'QS#C>W5XW7V:]:J^]3ILNO& M-W&6\+&'@QXQ;IHDJ8EKJ^X79[K_>0"_-^BI6^S`SH'LTZ1EA.6P`0DS=?G!T)R(F,(&<8^*NA=;6S9BMJXNG MUU[&D;VKXOMZUC--.9UJ"^W[*J=A`#UNQW;E<=-X*3V<4!$9B:;?B$U7ZW4U M9VZ\KE":1/:JUWHZUF0@,AKM*$?/1V%>9L@+?H:EMTX>!D68PD^"BV#WHX#] M2K7:C>+GQ]FFFK];/=$S\JQ0OG&MW(_?]S_A-]]=?)NMY]=LLC9_(3_<;JZ6 MGUAE_7F8E8G%#22CPFH"Q/;`[4!EMJ,\2VA\EH`M;56<`[H^7:M#OZW@)TR!XC9B6#J_5]M:#7 M5DI6<]N"BIW,V&_`QYSFV(QVE,/C.9,\*[EU^A,R;7YG.UV1)BON4$B,G&3_GD46+OP)*:4`92?28& MXB#OI])@6<\M\I(7$_HYR0)J"@G)P`!:":"9W9H,+=&W5^JV>!C`EW.%0U>Z MEFAOH\HS2+9O8`#[E5-3[\>CDO5>H4Y*533N*KJ MJ-\Z4QB%]M[/:^W2J!%W:=%AP76BK@@GX#YP+Z^#84CL%:3%7E<.T MQ]T1,=E5G6G4NEEOQV!YIV9MME.3+K.M/R"#';/!3B!&PKZ?)*&&:^/MD>74 M?NFOE2YX;>F5W_!'7):]^_,ZNS5NQUW:]%CR[HI#>EZ?X#*&BX_O@[]=?/Y\H7-0 M4%C0YO9(XTA,D9?V*MDTA7.$8-&1D89P1\-@'#&<0IJ`<>!.B%K2V$F&U([L M/5`>![_C+L"8\:N^!']965Z1UZ%FS@.$2RGMIUH7_L?I$"WW/HS"+\I;%N^.H@RTYQJT*DAB= M74'[_I.Z=)I53K^O[E@F-@[)X$50*!(S$E?"PWI9B;OL1T\Q)\NQEHC3QM=G M1V7O!+9D_%@;03PY"^B2-AI./[Y`XC\KLP1M;=^)O&B`W#E\+0B&#>LV\X%' MH$IX#)8TY0MT931RC5D)V0[!NN$5/HA`^K=J\?6!+/L7K]5Z]O5H]:#5I6UK M*SKH]FF!!M"20]T"\V^\A1FT,+AV%'SM*,$<<E!3T[&_:OQ.[,>YO>3E05=Z%CT@ M=6W!AS\+DSR'&D5(0F43W!8K(+UM_SHLPI3_1-%__KQ8'DQD8>_TS4%7FN;7 M+_7._`Y^1D<]84/NT-I)`YZG6VK M3X^S.Q98D64R+=OJ*CJ611-E!C,()K22Q8_1_E%.I-L/YC, M)(O,<^14W*B>6!8:$6'E5I^@;C)@;3K%G&"2Q3_0G29FE!JD9\SH%&<3F.(8 MIACW&0?#FKI*Z)@5N\;@V1$(C]%W=@2_M,?I"[OJGLQM M`G.+^TR&6451L4DAD8>IY>%.F#;@GJ8]2)1I M&`**#&8]A5G'?6&J'85'X*/Z4G<0TQ-&6C<=\+9-4U0E2U;GJMZ!5HB]2K1< MLZ0X!X/(P"!PWS)I2^41^:P)^<6)[0"*]9FNDFTK4U[O4"Q"@B4:KI-Y/-N0 M@T'@W@ZSI/%8M-B`[,/\>*!T3/*A7EKER&X52.+,XBN\=3=ZR.N1=O>`[NXG M=&<3[DF(H%HWQAT9#DANFU#V=S]E_ZQTH03[LGX@),[LW=S3Z,B`F75)?&!H MC4UTN+\@@AH.Y$]8#FRAYN[AVK^\EA=WP_6=F^ZBKOAIJ"D M*"P^`V%*3,WZ=WNCM;M1Q5@7>9:Q=RU9*3TU%=R[Q785MPU2J])/Z];I,561 MJ_`WO7?A*][7I7KVXZ?]39F3W.+=UMKRC70VIF=\M*^OW[=-S(J=?RYSEE[. M,MS!CB6-K;L!*V+K/W^A<_&IYIFOB_E\`::T/VZ_OQ:'F+S%BX!MBCZ2MU`; M55/O8/1W&X9%&4*,7D",CON$[0BC@=8!*:MD]&V>??>-]T`WZJ]1.T$9RO/` MWOLNXV_X]';+4XR0RYG`Z9(<^1ULUM=4?-E\C5N3U6W4UQN.LSBZ9^4W` M_'"?@G,U!-@C*D$]P),$/_:'43_R,(K_[C#'4Q>D-7K$PF".K^]"F>[QY_8S MF_Z&]Y5G\)P2NZ2'F&B(^WR4FP'PR-=T:V$T87-P41/TB?SV-NRNYPW=WF;3 M3?5*0*P>@OL0SC"%N`^9C3DL'KDT6=WL.3KSB:(OPR/T17J$/E>T(FBQ_/IN MM629KY?9XVVU?B+A:V;U`4[W&AGPC*-/P8&7="X-*Q*EP,%=^3G^X#CQF&-J MZ-!O[B0*&B(%5":/?*B]_;_??:CL%(SI0^E[CRD/LW`?XT0P.NZV$4?5\W1/ M<>_R?EK<5T<.\O0FX^"/WZO9>O.G4:)JX-:[K7F:[Y:X7LB*$"A"X,%Q,1SP M'O7']J(B.,P8\F4;]R$*I^/@24@KI(SY;0$>HP9UQZ@=H7(K3E]#\\BK&*^Q;.V/U]M%<'P[ MA./;X=LN#9<;""]J*J54FAZRC7&\P>[VK=.R'9E;<.R*@\-!B`^5:5?1T3/< MB`:7+H50HAO^)@J>)`?$-T8BI9TQ:M+>*TZOY#:YXK-3LI9NZ>B8&2<$BI(V%C$OSRFH?>)';<,EG#V0M@&KON+XH%K*$$10/A[^)DR:R M(^)52"6GVRZVFNM=`*PO_?-BS;[9R4]K_U*&C!3EJ=@6D<=V-$)C:,Z]G':7 M1DG*SR%$;[W(>U![`;=1@MM85E]GVVI^.Z;W&%)GRGY2S:F/>UHLJ;QJS]%8 M$+6OFO/RUVVUG%=SNM#&$Z>I&B4YT?D0U<&UZ&>&K]C.(/R/8/,S>NLUVT9& MR)_TCPEU#>2#I,3PS$FZRAS]%GVDA5R3FD0,$;#/$GE0JCW^".'/3IE0TVC: M:B=0(W$U<.8EJ.7RS&<6O_M,^V,[NL\D41%_]2'RH#)[_!$2]YFDT2\K1!&P M@K:M4?*8B;4/J_5]M=C2.ZN:2:$,X>6YW1*/Z[O$AM"47VKK+:^?FX&'`?+H M;5=HBPX!=C8FJ(?1,W*-/H-%3;@0N1R4J7R_7([Q3'Y+;_6]AO!\*SP0D4=O MNWI;9AB\V!*44&CZN=H2WL)"7%,,S)^FF,.NWZ2-=,#2!1PXS MN,4HAEN,HK==9FIJB'QE=BK*3F_Q9JGD$.=FN_*WZ,H?MNUL@JCX4NH*J^:=EC:TR5"!^2&F/GM?XP3K+Y>F37R*LBW?=I' M8A2P$R5Q50R2(>@4R7E#(2"YR6GY[6R,YZ9Z>JU/G<%N4PP%AO';+L97&0XO M5_Q/S2+9?(,;8GC@/3CL@CYH37EI01ZY@?8$]CEC=]V M09+2>&`/9524,EHAR00(=A($?]S)\*>Q*B:%(8>R>O)M>#/C<=%@SZP0#UZ! M3>"2]_AMES$ICH@7T9&:;M//U=WC;+-9W"^(QZ)6'_QQN_I3L%PM?ZB>GA]7 MWZMJG"),I@_[1:U4K5-W?B%VN.,D*1\")Z0WF$:]DH0H$-A#;5T"6Z[QV]Y[ M-S1"OD2(9M35WM62%,,39^AF]^NWX0OMA)L2DC"+A]JY^&W74FJ.C!E/'J9C/NM^'[[`2GXI+4&SQ00)S`;G/\MLL'3`V1 M/^&KOK*G\>R?MZNC:';,.O/KE^UF.UO.%\NOITA+'#*V#CE&=D_BHV/,#W5U M"<5S/,R`H_+)VRX]I5XLD/A34)+3B_]S%5'?^A\3?B[KQ$:'NN^)HUHKV"`;_ODA^@0B/N6 M9PA&EO.1XB0QA::-WQU'/.2_EW-ZR8&3][/H327EZGF[SMPR*#NOL8P[1JTNXI<`0MQS:.\WB'-R[" MYGX.[RO/4EKUFI4Y.Q9(%J;?F)MH&P"/]FZZM3![*J/I3HI4A\<34-F--ZF=QPM>)QF?V%8%/#D5PK5]LD;/ULA,0P>>9\A76SY MH.#OM.>`=_U_4+DBG(?`_'-%YHOJ.NR6'?V!>H>4;Q&\\?IAJ8'PHT!.1B5^ M=O[/?YNMX0X=UK3K$UQ[B?MOS\[*(O(B9]NG!AI/(SO6%IS/\&7I.=SVD,+Y MG>2-%_+JC8R?N6`%30_S/M_J2T]G_-)3S-M/@J##GE!^2P[.9O*Y5P2:S"S@ M"JKD-Y-KDAD1'Q/5$OI)NC&;>>W-@(*U&H+/G&1E,N*SC4:5L>S-;`^\L$\S M+`BQ;[#SU/.Z09OC,GIZRZ)R0OFNC6C":R?(_N*CLZ';[OUPD>/DR'YWD0I) M-;."$"Y0%]"EGI\7LSHP.))N-E6:`NY$P4P"%3%;_.XP$0S^:`XSC9)T MPF,GS\_-6!X:<9=)&ONR&I$0ZJ@Y99]7<\II=^]>XN*&TF\?9T51XN6&DNJ, M[.KT!]^8JY,6)4\F<*8]];P.W^[(H.>&6NJ9Y8;-US#1>G'BT/C1^I0CTE#UY"Q\4(#]_=&H37B*<5S&DRLEO3&G)C M'DU&BCS).0GP_)B#M4%!3_Q4-3/+^?BCGVCIG@HT<3*]-^T-S?,["2G8T@X/ M;J>>'[2P-RI^L#IE_?9/C^)B<\,7+0\!K`SQ,CP][4;V<\:GQICOTY4L3T*^ M?>AY0;33@4+/&$UJ:Y9%MCYLL7MH\4]XZ:4I'X"3E6K.R;H2 M9>RNU#2RX@6E)=)T7$9&8.=LI%NC+R5$29A!KCI#?O##@'H"L"X!ULOJ*\W8 M*P);7]1FB?&&?2<'+MX!%6)&!G\7YQ+DOQ+%/CW.[IB+.8_"M,Q;"MHZ+F<6 M;5%,`2O"R)`,?\!\'NU_;-?_C MJ[C3LC"/!8-4UY1>LB@Y*7V;Y'"I8X:[7-R(?LCPTR?K()AT"%N+@$>B]=)- M:H6E%KHD>C,.,SU->_`FTS";;+BA+,-==6Q6T?$0J"[T(!3=[A[(5S_3/-BN*BG&I" M?VFN0Q%1:/JYVHY'>"2K_@\6Y5`\S3&2F.B\A^+86G0P?1(5?('C%YW" M4^.9YQ6ACH;(43('B;I[)S8FY6&5`G61P*:N$CA8NO,1K[70DWY<7R8_M,:N MK>WOF5MDP9_K@U,=;_V-),4A\<0G*:IW6MH3_'&[^E.P+^P9@V`-5R\=[ZID M<>R.6$F*A\`):8VE4:J^AHB'QR6OKJMM5S#NKUOX*MI.;P?*9(Z^*=#,"OK@:(6V.WE"R\X22M;OO<)[_ M^(UB20'/@>6XRU7''AH<&VMVE=QOJ.$ZBZQ\>Q/.:U5_(U=G MF;]65>'JI+"$:M8<=V7QV$.#A9'957.?/I)!E%, M#KOC.>[J;VQ#Y8NS-*OV4,;,J$M]O]C]9&K'9CICL(DC,OS-,Q2OM64XRXX=Z*_N*MIT47`Q[A08KKO MA#Y@R9K0NK\E^/OM[,MC%=!N`];O_\'A7:PDTWX3WN4D$V;<,,NHC#(P3;X+ ME..N*'=4!>2>YR'&R3&9?*3.O.^BC-6=#H M,JC[Y+X)J`SM]BRH.]9F-M:19&>_\#?IE`XXC[7>Z$J93\!ZX31YCK>PW/$H M6.<^;O5I\A_2\@\UL>DF0Y*4Y_+I2S6?5_/W%;M_8/%:_66V6/ZTVFRNEZ?_ M]K':GI=AD=D[\R\MCYY',*$^Q;I\.V&1DR%(SZ,\C/+D/,YBS(]&&]-/^@B: M/$)-R3I]]T#C%WIA[/ULL0Y>9X\OC!M4O)%@OFLE>%S,OBP>R73)P>\#:?BO MM-WK>X[?G^J&SI.0O:XE>C"^IRD]C,C)2-'0]P49W*3$:^@BHEM?8P2$F'XX M,,EO/!+>F6$PVP1S$J*O7LC?SKX2`&RVP2=B/]5Z32R7+1\63#6,/+#5,)(R M5KSUG2*BBQOK?'7W0A,SC,:8M=?)'Z:W#]61&R5#>NP\J:]=DE&9;1[('U^K MS7:Q_$I&/[A?+&?+._H?,Z!/BVIS+F>_%_/_?-ELJ8([*3?\H88/A*,1819W MI-&TB.PE?L5DT(.`JIYU'D7P>T)04[I8$KY:7^6>XSXZIJ>8DZ2JEHCM2\(F M6,`U8P1:U:]W0&EHCG3#6[.*(BL)3X0H.LE&"GZ?9#&;1?Z,:H[[7).Z4K;S MA,J23?=?4M#4WP;\8X:4&TVD;&Y7GRLZ`8M'&FY<+>]63Q6-1VY7[\A*]VF] M>EV0<.+'[[]LJOG5\OJYHO6^RZ\7NZ7NXLMFNR8KWWDZL;>/8$-@4R"T.(2G MB#7869CF,9A<"'GF`B^;=#L([CR"94T:'F03;%?!KJ^`=!9`;\$?:7]_HO], MNPSJ/FE-Q!]IMV1U_E.PZSG8=QW\O>Y<7`^#8TIO7:%C3[3>>:(E\42/I"?ZM_3/+,!^`;\3K'9N9Q];2_J: MI]5ZN_AOECBXOG]??=F^YZFG3^OJ:?'R=)Z6A<5X8*A[33<@K]T.U(.?D@F, M0IA'.+-5X#[5HJB1]=5>2:QI\S-*_^F'0?UE\$?^[9]LH<'..HH%#:=+W/`D M4;^6\L0&/'53X#[(H*R3F\5'4;KIQ=W=NJI1L=M'6-'L[):0TN?9=[I[K8.+ M#W5&]]UJL]T0H\D31Y`X[-DD&H9T:@?"T5ZR>15U1C!_(<%. MEH1YO65V1[^R8/$.*)%SBQ\@0L=?92G,`MQD7^`NXI95Q2WU&93GQ,!W7P3O MY"VZL`"G\; M``HU`!1/8`+A@MT";V6LMEZR`+I<*CY>HR-E+WPNR5\;!0Z<@3X^&TT,*V:\ MI'0'GW9);*!(5.=^+'6T`CXQ9Y,:0:E!@;O,PX1Z$M'):CM[-(DJ*4&G'R]O M@ZN/[SY?7MQ4)A2X M*T&T=;,=%>D*.&7[M/1=GP:Z!8-_"60!M6$:/G:L<<*+G]/(%X6DLXTG(R^0B MV%I&?%S#A&I.4M&:0@[4]C8/>]"*18U=FD-!K]>+KPLRM?1O]S9FD>0-=F\2 M2$+:M2.H[5/J`5GV*(MA/Z'$O9>OJ)';%4=4K-.EIOZ2[>J;6&/ZS,7!XC(B M&`:6D]8Y8MF@&&8)DJDE[JU\99U&6$#$I9ON/Z(KQ\'*P.*;V=W=&LZ'$.FJ MS9;^817R!<;^7."5*3]LL97N@7I[<=J6=TO[A:SQ[U('ZH9O?F5&%I2 M6(61K$3ZR-(?@R;8I%N+TR2+)NSX'?*$G0GUG$%04]`C'O=E]R$!W`ZF\,_& M#_`R\0E?G)$Y8UN]5\N[%]K8^Y?U8OGU(YR[O%Y_FA&M9H_\OQMW:YWG.?4K M%IF?EG@&(&MV=`[PJ]5T.`E#GON%XL42=T60)8U=,$_S8@,SK=N%*HN@;CF` MI@/>%CWKS%O?_56C_;$`;V]9?@N`;U^P]>R(<3E(2D=0EEGB+HNRIK.[I=V" M]$?K?9-56\G=/*\KPB:H0.3/CZR"]V(Y;Y9\G1=Q:N\,J8@$NK!5T7&/3(&O MPV@WD5`V5^*NPE)7ROZ"JBC9M/GE6;#[ED6LS:\M`L32HH<*("U+U_#7.3]_ MQHD.3\'A+K32TLO1$J0NX0%<(*NCC)'+^_OJ;GM]?\DO"_D\VU;7R_;]=!+N M;A?+%[)"\M.*J^7FO`SIG226%AA=Z?2P97YL:MQIMYSF*>YM;D,:VEZRS(@Y MA68HYZL;"FA+]`A53V7)OL%@W^)(\+6R_+T1^)XLF]HM1U$99_%Y4A9A44"V M$/>":DEC)TNM'=FGEQ\^7+Z[I07-E__[W;]>?/S+9?#YXO8RN(9B3`O7+1XM ML2AO6SQ9ZH9N"T1>^B@BONU%2D`&R#RP'P77NXNM@I_4[JG=WZ#[?K%Y7FT6 M<-KL8K.IZ%'*29J'UBA?;]]Z!BRK5FW"_=\5DQ`W%1,1W[8)"\@PI;^IKTXB MQ*GQ0TJL/JWIS27;[^S!A2TC4L]03DC\^N/+G+&HQ2.C6G^9;?:_IW]QNWCZ M4JUW?V<%#79N2!\?#H=7GP]/9EBDQ"EYC(A:`0%,Z%Y>+BS,E/Z"HF+.?C-[ MI)"X7_S*,LKTAW(F#;<1W8P2ZV%`4>]Z5GML.BUF9[\LHS* M/(,3:S$[5%-,<'MN00V M[L#)RU#.=E7BU:_TI;,*GARCK7R%/4<2<6P?V5NOI@#[N;JK%J^T=V*/D<7" M4Q$1;(&Q5\EAZ#4_)Q/(?6\,\XB[1%1=J?'6O@')!I>Z_?:M3%PO*]8TNQZ^U"MZZ19&$4N5Y!3 M$4QC0TC);FBT?1XG$#''*X19X[\ M[9]-8.9\T\"W@R$8,FY'(Z\.T=1LIYRTGY?2/ M=0M_"N:\#8HIQ?*9+ED:^?:&524N=X3[9+$&)"&]!=#4U@Z9QP(*31(H-`G1 M%TAHJS?B`B4JX_`JU6C)QE+59W.NURLL6)-9N5HGFFT1P@M1"6SKA[[56:@H M./8:)BYJ`W;S)NP>S551L-3E/J!CA0)YX7().Q+`.)2&%>S!S\G'Q#G"IGH" MF^JA;R4/8BJ-L":)R-6Y#M&/&QD]B[!PE<0;#QF@3"H7#<*CC_-DI(O MX;`-'OI6@""BD/NE04"JKH6!?QKP;VT!P=6B,`X21!:$PV^3C*=F>"`)6^&A M;W4'HDJ-MB`("CBM85`7>=HLQ'&%A7$K<;HQL5C.X;MZ>89R$)B<(O2C6F!8 M"<>VJR1V7>E:ZJ]0N\M\N!G!5\T89LVQ+YQ/B"[ M?1K2+\"T_H'2>;.V^;.4Q[1K="U)R.;/V,E1'I_`GF>(?;-Y6'Q'"<1!0?8F MJ'#ZEM^)>GW/+AR_6,[Y12*;#ZOU3;5^7=Q5F^OUN\?9XHFX7&I=]ARCC"R: M1JRI]L[*Y=J91,COOE'2Q[H+5A!JNKN.>W4/=^FS`TWUA^PBWOI3>BS/8E(JV5S%#\&^0>5*#`U3M++*>03%D^5.9?YIAB.$#$<*FY\1[GUF?'QW]?$OP<6[VZN_7MU>74J^RRXN M6^L-IF$<)?;JX?6$FY3UEG^ M#MN!@3$$VS@M)Q'NQSMN0'?^QUH9[M6C*#S M:OE:;;8=A"Z-G*^C/?)8`:&4_@.XZVN+!C1P2B.%3>D(=RF`*15'6C)EY1Q: M-'?M68PM14S196R)$8JBL67O_+/=82[)L&GES:R&V;)&MBXM9/&NM)YPK4`H.C#Q"NX*:TLO84E)!/`MECY0JRZ3-V%+: M.EW&EE[!5C2V%&V81C/("ZP,:3AF;"DIZSZV?`'$DO^O!JSAN')_7KV5S-E[ M4D=>'BL`E-)_`'-];=%@I@#:!*?_8R\3.M(JCK1*F*++ MN!(C%$7CRM[Y9[>`0HEB!A<'Q+CO;C"GY)AQI;RX)W'E]:?+SQ81V!30Q[FHZ,PKB62A[I%19)FW&E=+6Z3*N]`JVHG&E:,,L MDO$R6RNKX9AQI:2LIW'E:@=8C;@2WK2BCP%2>[+X--I!7]JXZ16[`8/&[Y*2 M/RZ70;5CC+[P=$!X!ZM.OP3,)/FC:/R9U8OM=KWX\K)E3S)M5\&GV5KZ39>. MZ;45/EFVRK:H9_\[>$(G2J$.-X.*OQA]%::``JZBE6%1IA\O;X.?KF]DHPTR M5L3=[M-_R_FNS.1J6STU`]S,XGZ5J!B:UJNN[Q1@IYF MUAVUEGA3_GEC8XF>9=N7,+(FU!-FTH9EQ]%CA='I^B`^FW1#/^;S"9?4Q+CO M`M+6ST42@WG9N2>EKV\]`,EJ5:.F_SLZ31'< MK9!!/5J,NS1011T!;)BX*T5!M.G-[APG.S1]1W^K9NVWJXN[_WI9K*NKY99( MMZ!O4_)+2K]CX^_YF)TKXHX*;A>)<6=XE'5R#`-9^::? M2)_++>-89!&95T^S]3\L(\)*8(('$">1R/"WNS"_#R[>U@LJ_5W0MTNR=\\TW^F!A.5#E>(5BD,HT)8 MTTYL=+3`KOB+8/)XJ07NRV7T%!MKU9`1+#7N"F)A25EBD6^*2:`)'2^4=>J1:24ODX;B\-M;1 M(BW2=/<)7%EV%NR^H@O*_KN@_M`!5JPD>W%CY23C*]-*G,5)B7OG6D4=)WE= M!<&F!Q"9\W\-R'\^[\`$EY3--L&\JI[(?Y-?P28X^4H60:N[JIIO/A`#V]^B M]F[U]+1:,IG/PW02VZMA'.Q?%RWRZNTQ,O1M%O*'7'*H04UPUP6K*61_55&0 M:EI_%="Y#IIW8\*7L-Y8PX*E-00+%EK6BX%OXR)A5UG/MM0<%:?'?MNH,?@)L\K![)5,CNR0E9BG5O M/H;Y]WKUD\^RB-^4E4,!68(]%2JIBTOO+B+0D<'S3P+V34`_DK;SU\6&S,B' MU?K]ZN7+]O[E\>*.I8DV9*&/[+KYSJZU[5Q&J8:=]WS&]C2Y^X%RF`1Y"9*" M.J[=S6NIZM\6B067V/MZUO/SF6UJ@V]_SO&*?ET0*%* M@KM,2$4=1\5!"J)-=]_0A*(Q\BYF*U8<_=@`.''TO9]E9!)@2J`8)<5=_2.M MBVU'+RO0WMXW4+.@1]YO'F;KZL?9IIJ_6SW11XO9F?OS,"LG]DYTMG>J9]O" MBM16W?$!(8ZP@5'`[EZ*>Q-50@O;EBPNRI3]](T?\./?.40^!6S`I;@W/24U<1)%Q]VQ_!).+8(R-]/6L:O91..\OO^RK/"U@N"]C-2'%O?$KK8MV#2PHTW7W` M*EWH$7KVC?)1^=UYRFI.\)5'J;W;>)I=Z1IRK]![RVW^C#[Z":,)>\@I[MW, M8>'MV^:`!/R(+?S$A-G9H0^6S>Z4*AS\K(PG9-!@Y&`_(,6]T2@BOAM2,"S( MP9O8S=(FOO)OMX\[9ZE4&\).F-.C(+]25E)MSO/$XO'6X][TS'58]MIB3WX9 MAD7$"FYBMH>51LA+/\04L.TPA:28LE_!^2#^.T,F:>6N2D7*=Y.E8TE`@ M26$T4QA-W(Y45`4)9ZI^(:2@,--;VD7CFL?*B(WN+Z^)4GM'/+MZ-6NSW;IT MV>[^"^(/!QUU<(:N*$YHK*=1T?Z?]Y?_^=/GQ1O9&^\O9>DD\^^93M:[3;HL[TO_[ MQ>/+MIJ?EY/<7G)KH',]VY;6K#;QH0_#B`0;,`\%S`/NV@HE?6R[;Q6AIO5' M`?DJ8)^=!>Q#YMGYIW;LWXI31V'_)RY^X,/ZDML09J>$V<%=+FZMWP<7']\'[JY]^N;U\']37#`=D40C>7?_\\_7'X.9?+SY?2F+BZ4LU MGU?S]]5Z\4J(_VOUE]EB22\XOEZ>_MO':GM>AG"P/`JMP$16'DW@&%!_AR7I MMF+J\7#O&:HK)8ZGY]5F0;^^U<"5JIC3^E^#_3\']-N`?AQ<+X.V'Y`&Y&#V MEVI)XNI'@O2+^=-B2<_LLY8X]3L/)UEI+SP>Z%T/0O*JU8`9^C*.RY@Y0E;- M0-PB[G(G%75L4R\%F:;\&\:S#K^J`VI+MF^%=^&P_1/B-?`E)P)Q"9,3PN3@ M+H]25G>C8OK$EMZET?P(AG M,.(1C#AN,B2IB6WG+B?.OH"$%;/NWWQ2SHY>+0D@J\UVY^W"+$TL&O-!;[I& M/"3ZWGH/?QF36!I&-H:1Q5WW)"*^?3L=E&%:_T:-8G1.IYUC,VY,\?1PS-%/ M^:*50**X@(UFY,5-HBH(V*2)0S""XNS-LU(S3_JV!W6]X++KUNC^56GO`IVN M;G7M55B9O=UV?<)&FSL#V,%#7B,EJXH3SI0)VE9K$A+R@UV[%3B: MI/:NBVWO5,^,A16IC;CK`^8O8/>A@+VX%/?&OIPB3KRQE$CT,G'2X:-9P[7B M@<<5%F;*?LDQ8?1)6*5CK>+K6UH/K MEE_<;7L.O?D[MI\[@:&$_=P4]_ZYD/P2CE3K*?-!252?VVTV??$Z6SS2$P*W MJ\85J_PJ`[9#3Z<[M)?:DI3&H!TKJ=YJZ2(M15'HD>V+:V3;1ZN)U?9@>OTM M?;JD>5LV_YR76#G"DGV/CQ9+_:N&0$OTQ0#DIR!457*_MH@+MUMN@HO;V\]7 M/_YR>_'C3Y?![?6N!.OV^MW_^M?KG]Y??I9_`7YW^`)$V['A."XM4J2N?C6A M(:%.XS'JKF]8\`2[LR7LSF:XJT&D=7%C]I)2U:>"M@_5FF<+@S_R'/B?C-NW M'7(UFGV?$J;.;]))">%6"74X&>Y2#SE%K-,C&6FFS5_OZ-&E69/>;<7'J<64 M^&#WEBR\6[M!0]_7*&1%`95G)50H9+A+/Q0U&LWT>\7JQX!R/8BXP5A)K*.! MPTFV76"6V.H+)3LE5$5DN`M+E'5RDH-7E6YZ??NOEY^#JX^$SE\22,`Y.\EE MX?JP9YXOM+D2M/2H9^QB*M3VW?KKJ,APEZ+T2&W;;7=W/;T^\:9BFGU,X^^S^+<]RI/!'QK?O,81FF[#S8/=#&Q9LA[;3"O7JO'E<+# M\ZQ3?M1EG\8J+5;SM_1HP*P'53BPYI-?)\C+1GJD=N)]6[OF3K<^**54$M([ M>?;\JS/[:_>F1[\F4Q06,=`OW.E?`>G=^.5BI\UQH6]JXU%1-"SYJ5%6T\6"34 M`,O"0%%/"16^R+,&>HHY@866B-,;>KZU^KJX(SQZN7EYE*?-LL9CZPDO="AI M>]9+I`'BR^`,1PDGDC+Z=L^P M=;=MTSQ[73'[:1KR&YQ+.#B7X3X((R2_2_?:)<2A07Z0-LC/U;RJGFBUWB=B M=]5Z7MB7BWG=)*S-+3X9-Q`_WHFJZ+>_O&XP6^S$'G5J+`.MFU9 M5)#I_H?![I=051WL?BMKXJ_5\J5B/63VGM>JN]$UV$YA]W99_X3=3`+/2DZ@ MR##'7<8Y)+J3I7Y`B.G-Q4^R=P&?SIHE9VG'Q%I<'_])&D<1C`^4_.6X4VF] MIWHD?_65Q%8_S];_J&CR8!<&9WENKP2FNV,]VY-2:/<0 M4/='><*?]II`.5Z.NT)!4A/;%BLGSI3_G(7KNP_4PG01.[#SBM6(AGWZPE7G M1R3@+*,R3_GB!!5U.>X:1@5MG*SW\G)-;V:/%3QZ\51_(F??M^O9:T5S8I?T M*HWM;+&DV\@[B\@SB\4.O7WK6;FL6K6A#WS'4BWP)MD$4N8&:O#*VF8JT1-RFH7"M^8T:7_E; MM?CZL*WF%Z_5>O:U^OCR]*5:7]^S5P>N7[:;+>F'+!(G;W$4D]C>A;1J0NGA MP]A`U,!1;;",$KY>X][E,**?;7B9$'):-Q+P5@)HAEZ/RQK:!(VFM)^?T35$ M*]3+1T2>D#7%!M.PC%/.*7!O[IA1T`F=,R)JRWLW?[N\^LN_TC]<_/7R\\5? M+@_>O+D)KG^YO;DEO[_Z^!=KVTEV+A/&LY]T>.'P\(>LQ@[O6B:N@``P="\; M%A9F^E.UV?QS\)[\FBQ,<_[/Y`^;[7KQY87=V"YGX1=W=ZN7)/5Q^NWEU\O`TNWKV[_N4C.V[VZ?JGJW=7Q+&K'D:_67Q= M+NX7=[/E]E2^V^K7[8_D5_\@\7$8V:LR%Q-",X^KJN@NIRO8`)M*B%KYI9`Y M[C,^>HJYR?3JB"@!([O8L;.AAQ`[IQM]8@WD.=]?Y9>P%[B+'C2TLKX!J"S: MM/%IL/\VJ#\._DX_#]CW\@_A$%D7A-Q=;#;5=O-AL5QLJY\6K]6WBE-E]Z&.A<,WJ0U6P70PQ\F!>X"XV$Y+<>*0@( M,6W\B!WEWYR!C_X>_)W_7V5'+3K[5KPT"KL^8?]#'X9E&,8%.VJ.V%,K:.*$ MW\O)=&KZ]TQ!/< M-7HJZMCV]`HR3=DW=/-M_Y4YUR]I,U96`(38.%D/Q+[/Z>4/21+"W.&N\E/4 MR,GZH";;'BF?2!^$[;/[#>3P\&ZV>:`G8,G_N?ROE\7K[)%=F4B3V,CQ" M(NBA05'+&@QBGY,5/&?O.J51#%.$NQ900RO;RX:Z:%/Z#9S+IG]H?&UN#9&S M)BM+"#K,G"P@@E-81F64)3")"4PB[A)#+;V<+"8Z$G;#1Q(BJZ?G=?50+3>+ MUPHNE6PG('E8V*LS%)5"$RC*NNZP(MI"5-13A;?>0ETAZZN*BE33@Z]V+XT: M6TMDC+BF@+M(XLXW.(NZ9/524W2XF:<*V8D<4%&5MZL0Z=G,^+ MS3_>K:OY8DO_=)Y'$WM'-'HZUK5^"8WV!M_]451D$8PX[DHE81WL^W\Q0:8' M/PSHOY\%\%O^'^:\_[!-6'+X(UIYBUOO_HAYEA2F!G>=D806CIRWJ#Q'!K^Z M;UH[<=^OJ\=7MA=!8@(Y`[^E%SL>+M40#AQ.L/ MSA'+4*0P2[`XA[B+*Q0U/+]7U_8?%KY:;[?KE:9^1.B]SB]6C0B+HV;^BEC4*Q#X/XS*"5'<,J>X0]UZTAE:V MEP9UT:;TTX!]2SG2[NN@\;FY%4/.KJRL&^C0<[*&"'V><^<6PWQ"FB+$O5NM MIYB3%45+1!$L2>)EM:X67Y?O7M;K:DE6MO5LN9G=L8-R%\LY^\]'%M^<;H5, M8HM1B+)EXV3[#PIXGB2LR+4XJV"M5]E-\NF'>$[$/ZH M4!,&^S6WLU]/!`C#TMZ3!%W=ZD%.0ID:4=V?Q)-H4@*3R8#)X"[QDM3$B?W+ MR33ES]^2W\O>03L\\U;XWEAF?,+6>@:ZC`L89]@""'&77,DI8IN)24G3,%]S MF8&/U;=&I?!ZM21_O*L:0=>I9/'$WH$F67'T@&!`^3U`%EL2\!^3J]A:YS*/IA@:\>Q M+2T$6(YCMRP-0]^6*?*[T$15L+\<",DQW?\N@!^>!?#3']AOG:P.'U?;_ZBV M'&;MWI+$%DE;<=7K\^(K-?1D$G,SIW^CUYFUA4!)SQH;>NVR(YRX]V;,*&@; M5T:DG))6NI>3@#04D)9V"\_X!,W*0N0+09.!8D=385'P[3KF9B."3T"\ M?M296^D^T5G]5)'_G1,.^3C;;-B]/G1B+^;_^;+9TO[>5YN[]8+-]GF8%*F] MRF%9 M?O_T2&^W6\[I(G MZ8>D3'.8)MPUH:HJC8N(?N%V:\?AHF$;&VYIT\C8$"=0I\>DR@EH5:XA/FEG,^^JU>EP]-]ZFJ_<0TZ*PES(3D$`/+&HJ M[E\3%_B:[HA!!,@G$'=)F+).MK&B*MBT_A">9-M_6C^8.!)@K-`O7(`Y(5U" M7[.D"<];U/%GELHE5 M;`STKXL,>?7VN!C\EA:_@FM+(9D?X2XZ4U7)$2*4A)OR[X+&A]8P8(E08<%` M"YD:_#:9I'`A83J!*<&]B:^HD7TBI2)6F^V;8TXWU5>ZK'RNGE?KGFO`LSRQ M5Y@O)(,>/E35W+TC)?9]7F2XM_VD]+"-!QEAIOS'P>[7HV'`SDN$Z#!P^@ZA MV/=%GA9Q<1X1.DMO\DFBL$RA[`_WCH8)]9QP*`."[M!TM;Q?K9\4CB*R6V=^ MG&VJ.;U2DL0SK(UK-H4DW+EBUY8M7BN:)]M=W9&5A;V]<06)-/%D9`AVZ%)I MK8@2W$DM#:VLKS[*HDW9IS]\H=\&S8_/`OBV[!EBNV-S)?2VSL[-V>86\ MTW5-H;4H*J(B/$_2,DE*..F-G/@94]+-&F=*W"E[Q9UC]=/LN\)QM9OM;+W] MY?GBCG1(HJ]J0U-PM57E(7WOU]:2UMVS)H"D5-H!I>^K)"J@WBZ%>KL(=^6Q MM"[6ER-)@:;L@Q]>GH/])V_,6*05;N'"(D\8Q-$/BXA?Y9G" M]8,Q[@R1@/2V6<*P""H8;==O=ZGX&#=^D$A-7^[+_:T8KU+%]N<3U:@_BKU MX.^W,WK7D?F#?BV&XO:DTPA($#_==/@D7\%G"^\BHZ:,DUA<6JSIS=U#-7]Y MK.!)]K9S36R"*D5#NOEJ3%8RRF-8WY3K8FGZ/>@BQ MHC%%D(&&"6E("KRP,JBA=:R9DW4*305SWA;YP[ZQ8+$,[O;-!=](>\$W:#"H M>(L$N=#D>-@4#*7>$C@/@RI3]H`WD6%00Q?AE3EQ1P,H78"WWVDJ94;F[CW+ M:I9Q8O')O=,.]?`FI`&%3]L/XS2/8KR'K/I$MK[\]'0^A7]CT3W]QV!._E7' M\-ZMGIY62U9ULKEXV3Z0*?AO@JP7:M!P\1![$>D\RB99V[9WQUJ@U(E),^%*.GBV,;%I)K"/P<;6MD4S';_3MTT&?)7 M`H7@^7$&Z;"SX)5.L%-L"!(E_\!Q2(?DYPYO6**DBPN*HR)8O3K47P4<,/#[ M8/]!`'/-+V4\@U?OSB4?TJJ^K%]FZ^^WWU:W#ZN7S6PY_T`4VE;5\A.`\5.- MQ9IT_5Q1+2C+CMH>?^B`BW)'>I`QJ1]%C7I[A*JFB,^0Z"MF?;71%G%:MQ!0 M^PSX1\'NJ^#O\'O9Q^CT;4QPS?$71(=KC^9,XBW[TE?,Q:JD+>4>2*2)H&XC MJ!MI05;=CCF(W7ZK'E^KGU=S=A_J8KM:7M\+6&.LM63)=VH<>4;T[@"A0MO, M(O"F`,PJ.<82IR[NM/Z(I;U6]P'/HFWJVA\2<357Q`@'.-770L_1.;A&JIH" MWAM?S"HYTMJI+G''.@H-!LT6R0)J?E6](+;P^&%QOWTXT>98?BYW1%"8B*^@ MTAWHX=&$/G4E1$];=6`.;XS]#H*^>D4D);S"EK(4C/ M8'DS%?!IV)G8\V?^X.:DEDZ^+9BZ'*8N95.7X(WPC.IHN_;.E*`<1ZREUJ4* M`;($::,_T#JD@SK36'.01G5T009-"GRT5NVR_QI`NB5]#BV=S-[: M+D?KPX](PP9PHRC_`5R$VH`926!&VKHY67HT!.1P8"VT+CGN`2*S MPJ!$2,>*(M)(6/!Y2F&>"I@GO%O"AK1SNHIHB`Q!I MHXX_,YB3$N8$;Z&H&>7S%YL$'V(#84TV%TYD>9QZ?R9@953;0Z1I-`WS'<%\0XED.;KM\<:'8R.8BE"Z3^,NVBGMG'$8!Q0VY! M9QEFZS^<._BO>M,U#8-2W1(J#U/D):"V=';(DLU+7Z/YD#0O&@B^-XK@;[/U M_)8H??'K@EZ"9^^:^8.>-('8*_0.4P>_BMB[]TD:(0=%I]#6V697SU/V+P'] MI^#O]!\E3>S=XVRSN;[G-QQA#:U(79_4F;U MKCK4Q*:XZY+E%+%ML%+23-FO&S=MD'$.V!?F;/K]ZFFV6!([B-H2#1:M&CJV M8-==&O5:=OU1$I7Y187UCSN?JO M%\)!YK>K=[/'QYO%\NMC=5/=O="Y_66YV#+2&XLGWHQT:@$*!O3N18UT^XP^ M)A,P`J@I27&7]UC5>Q0T&A*>(_=ZC]SK&KG00^.?-D'=27"["F@W`?03U!T% MM*=1D2Z8G'M[4#]-TYDT&^[PH2PFQ5V@9%5O5PD[FTJ\-'N1/4GE& MVN?9H20$JX$2GQ1WG95=Q9TD]:RJ,.6X)@3]6XWK=8WK[2IX)L(]S.@;R\LJ MF,WG"YC-8$,O%P_N&E?S2P(=KC2G'\(]Y33"2KC: MV[1EWUU`4E.*NT%)32!Q0K]7ZRTH94BK"'3Y$L6E\H6SZ M[`;^ZY?M9CM;SNG[1'F81/;2--T=&S/Z88U:+/[DHW"2QQD,/Q3O9+@+J:1U ML1X82@I4VS;[@K\,<18TOC)OXK9=NWL3[W/JQQ_!K2Q)RJ-NJ(/)<)1!'G MGE`CDN$NZ]'4S+9_UQ-O6G]NXZ(T::L2?F@4(R1.DVN"3;![N>CDY#`Y4&N1 MX2X$T-;-59),5]`]0DP<[I.V*M%WL3$BXB3W)-A"SJ>"4U/8),]PUQ[HJN8D M?Z0II#4H_-_5>G6]K,C_UWVS<6O1PC`/@`VUPK>))D`"0M@8SG#OZIM0SS414Q7T@(R% M!K%"OIZ_7[PNYM62_-_-=KWX\D)G]6KY;K7\SY?E'?V/ORVV#WS#L2[\KU^4 MHJ^23:027+H]ZB++@L9[P&DW3H+0I,">(C.FI7VJ9TK4*305U&T%S<;HF;9& MI]$C]DO3&5FYXQ/L#,>@Z(KM=7?[ZO%BS)9VM!@JOTPLV MKX<]?55JH$FV1'UJ.F%'%8N,;02DR%^W,:.@*UYH1-JI7"MN4"2VJ/D`HI/% M2K(A-EDI3!;N37D]Q6PO25K2<8P$^\\#^#Z@#>QS=+>KP#52Q"(H'Y!R$D?) M-91S_Q;!W.4P=[@IG2$-G4139F2=[G\2/`.$9O=$JF#!&U%"#?_VXFGU0I_R M?3=[7FQGCZ2KZFY+:S1_K#[/%IMJSHQ-(FJ2;-X(;C1T.0*.<$OLPLT<"C9" M*%7-<)<9&]+0T:*C*>9N]:F7&6B(G@W@305U6W0%^K$*H#E'4)*+>)!CJ3/F MD9Q#*`$)H9@UPUTZ;$A#QU&/IKC(025%ZY!CJHO8B;;$;X3.H4`\A"+:W(M@ M2%M%E]1.5]CIY6:[>*+Y\=5]<,=!M%T%7ZI@S3ZD-]@\\Q3Z'B2;+9'4-MZ=`9G+1TC22F(\@-*0R&5G(/T*922UFR<$$I6S.,5ZDQP MB3KC/SBW"RUV((F9G_Q6DEPG;G'5I91DG]FZI:^G0)&`Z-&A'`_PX"R>XJ[B[A79KQ8V>I^^KU^IQ]W[,22SQG+="D24,4E;G# M,E>/C[,UY%S(MZR1RU^WU7)>S6/VLAU[#8WO"<"!J=R+(AI-!4>(*Q1%G7)O M_5RM@Q?I*YBDC$F%S(P-@`'7W/XU9!C9XV9Y!&?(O*]PKUC4@:D%!N/;?5#46_/+!2P5Q7!^?$<]S$:#:W&B79E1'1K_O7= M8GO6S\PITW7\I^W:P(&0]/U8:&F"'-V(:%UM(P/BY$%XG.V8%S?A$<'L]]VK635VW.'3IK2D7N-2J'[A1)8'&T'%B2D9H4YC8$"6-!W.!_='<,*[ M\"F1*JD7#KK4+R0:,)B@26-@09(@\>]Y(CL#ZAK#00/DI]_U%$-`C09$W/,B M$]L(D)WZ7'U=;(A"G%(K%\`>MV;2Q`4D;;?MDP\A@\U=#-3Y%[BO=U13R"V[ M$93JQ)/S_.C^0SOFK,1BQK'G(=[2,=)P568,5?8%[OL9U10:AZD(2C>68:LP MDG'L>H"#'']8GQXI8*!AJ['P:6]76*,16(>H;'7-PMJ,&2^6],%K.M!DFN#M MX#!IK2T3,^23]HR:LHBT'<9\^FD:3U*T'C>;K"V"TCU9I&+32RN4K>H?6/%6K*,$J((-7^K3#:TSC<59/4^)[ M#V.5W*VO*![(_DJWS!.6DPD8!61_2I_VILVI/$+^V)CPTR8F9^SWAM'XN:(\ M>['\"M+0O_[P0H_J[2U4^6T2BMJS`:!UIF'CI/87+A7$SITZ:Z,8U' M9\1*8@LOI;O6Z_43_@UZL+*8BIJT*4[L!7X5.+&0761@%W"*I_2IB,"8QF@X ML9+X;P#(AEBQ%SB69\7]+>?<+'(P"]A!*GTJFC"G,@Y6K";\],."3$CP//O. M>#&_'+6ZJQ:OZA48U?RGQ;*ZVE9/L/^;JK#>1B.F,-0OURDRFK]/HSC->3#A M2U5%C_SNV&.W$,TEA"P%?Z>_"]@/E?^+3+8PY&_SUN5INJHO'Q]4WZJ$_K-:[1QDOOI+_^5#1"PO3LH@DO*%(HYHF MJBCWSF+%OH_B*$2^)2REB'7_*2/-E/\ZV/T\(+]O/`K*O@CH)U:-6I!0HS/J M4W(L//H1\NT<*47<$%D9D7:6/:M_;M6`19D".@MN81+BPXR\H$!*$6?<0D:J M4RL.[HE_WMTL$,R8?[ZOI*\B_E!]6;_,UM]OOZUN'U8OF]ER?KGX^K#M?B*\ MD'AM3*YU/8/7UJ0V?,F&V*40$3_\R,-BW#699A2T36",2#FM6PE(,T'=3L`: M,O;VN:KE"2X6/H#H=/E0FCXX@YE`Z6V)F^Z;4=#5BT+:JEL?R7=_?5_0& M?FY^29A$$IDEY8Z,8TI9OQYX";899W&*_*""OG(C$#TY"3N6I;J1%FS5[9@# MV>VWZO&U^GDU7]PO[F:+[6IY?2]@D!(''(QT:AQ\1O3N`:)"^]0JD!>$F%5T M!("J2]L!5F@P:+9([\PR#MU_>WG\?K&<7[Q\?=ELFPH]+)BSJ.\LNORU6M_1 M%SYKJ7E4MJZ/W.7DTE0B1A-M5Q]"BM(W M(2/41%C&DRB$1Y22"))7N"L6=%5S0>PTY`.HL`9:(ZA=.;TK9$@L-ABAT;Z< MB+1!G\NC4Q1%,$4Q3!'N@YWZRKE<4K0D!:2DVXZQ>J^6)466AQ":M M<,-ZF-"1OP8%_?^%V^%[@2'W5"G,"^Y4M1D%G<##B*C3?X\H.$)=?VX[2 M]8Q-;*GQ#4(G"Y#R;"*OVM;2R\ERHR,AP]&LQI'9]+&>@0F&\[[AYC3,5W># MN#=@M/1R%=SK"(EX#;HE_[F9W=$AN5Y6#1N4N)M:OT>7.!/46`UT[8U3#XH[ M!6U02UQDL$]415@VF@Q(FPA@:H,XXH:I)JGLM@K<23^#6B(DG'WRBM%/?-"T M0DYQ8U.7N':;`>Z-*H-:XB2U?2+[N9:2GS>L5^(LB7Z/(^&U3V-MN#8:IU:! M>YO`H)9H*>^)J`9@2C\:'Z:6*2]"F)JCO$=6@?MJ-X-:XJ:\)_+*4UX1%BTR#E/3(#W->+&M02/>4]$7GLM?2F(G,X%ZB.RB0N(Q5M5QM[JM(W`";6 M!'L:H0RA:"*#H@GTJ-)2S0$=U9&/X08:L%$/+&];X@L62FBT+CY";;!"5#I% MO*0HARE"3P@UE7.XU.A)RI`2F2E]E+*-:P-#2X\&.B3:8?-3<'=5POR@KV_4 MU\\!L=(6DH$$6K%WYDK1ZL2)%G+XM%(N\8;J!;\`#P5*#&VX<6-H4=*C!2T"[<`$P>7"*1S%#M&7(.KKYY"A*0MYR-#6)W='F&9H M,E8GS]"0PJ>7H0TWM",$<*%P"D>T0_0%2"8T'(&A:8@+:T[8M>9(/BZ@:&W2 M%`TI:OHHVG`[-2V`BX-3.,0=HJ^H-:"@:XJF+NH`7!31(K4%M%*/_0Q#%_!1.26&L0`Z%]79&:(P^J%63U<;=& M2$H&*P$]OS"N\G*! M%D$-Y:#3>?+9AYH=/>UPT*L^$:7`9>S`N;8IFJ1B.,&F2-,ZY]J'`@8][1!1 MN#XY^P@='H`9I7LX$:9*!;LGUX.".CWM<-'$/E%]6-=N";2:5BGQX*!.7XZ1 MUZ^E,O0.FJ5S[L'.DJY^Z.ADBY#*P&-MC0H]2Z02&?3TB>7)K+^%A,B`?CC) M98NDHO1R?+C9HIC(\&:`9IY,\UO8B1K0#RW5;!'6DS6O>?5.(EM#J-23:_SU M:*@.OH.K:WRH8M?3#A_)/!91'6XZ-P9IFZ(M>HD';`:HY>%<>U"MJZ<=4EIY M+*WP$LEC4=&L:S?5W0LQ@T6U^424?IAM MJHNOA*@VJU2)0C6CS6!%NE>JX]`$U=M'-8H+%\/M/9M!'4C MP:Z5L6"EPQ6QPTJ0)0K.K8]I?W'51N2'PD+NR2%**&FQ0NQ8$N6#@I/I8[PE MKMJX3%!83L=KU#21>3;8H8TM$W\S(@YK9MA=X[7#1VAC`!,\TR_LOT)+E)^@.ET45*; M1'[]`MS.B/P)<$,:NEJBS(B+'55B490?H#J)FB1;ROD<%FP.,[BD$?G;QJ94 M=!)%&1)VCZE9$U/$;">6<=1QN5$A<;I%O@>K:!+32!!0[7?4Q9,HFL`4PDV. M$>XB8'-*CDS\Q"456J6,W!NH8XYF&"`JA$GSP*ZKZ^BLPCTE&5P$B?Q!<)-J M(F&$,C)W+V':EZ;IF*,1-H@*8+*IR4M:C3)\3S, M8.KD=V(-U2DFSB+@BD?DC^(:TM`IK].3=8^EL#PSDN>[OMNN0*P#B:B8IY96 MQN(L3KAA/;CHR%\C1;P-=@%CRM.P<`$C\E?=M76SS=AT!9SR!@+6PN'"0AL9 M`2""%`TO0DZ)F>PLE3!+L*<>X2YNT-;-%1W3%10A5,3X%UZDG+`NX3;X;;X9 MWX&`??((=^&"OG).N):VF#N@,)(U*0T!H_U1D0[S2J2IEFCS1D"BH,NQS!D(:.V9JFN-A1)47@D(.JB\R)ME33"=A/R&&/.\9=?F!*19?$3E?8 M':;@>3:#_&Z?T>.G,/XV6Z]GR^W)==7))(\F"@Q/M`-#"-+0YP1#PFW%:1XE MN*L*U)5RQN5D)6LL-&VGB>JOM:]/_S3[3M?4Z_O=`S477\G_?*BJS7F4ED4H MCHJ>IO3L7T[&VM)[OXKB"/E-7"+BV[9>`1FF_#?!]7WCC2/VLX#^SH(UBG&< M<:WQA+L,#B7N5).(^$XXAX`@T[T=SI@=WMNQ0\$(=EQ#/(U,!T<0]_:`B/BN M8DH!6::W#U5P-]L\!*N7[?WCZEMPOUHSBPRVJV!+_O'YT%HE'^[F(FRN[V^V MJ[M_U,SYW6JSW9R'"4VF$BLH#BV5CPD;C_O9Y@L;E)?-#U]GL^<_T^L`_EP] M;C?UWU";CG^8A#]PJ^9_W=NU$K(LCL^HSOX*<^2055FC)O5JJ@C;OFO MU?K+2M,+RX@V9;\,%G5H=T=_&RR6=X\O\\7R*_GOIZ?%AMZ4)`F`]>JNJN:; M#\1Z:CFNUS>SQ^KZ_O*_7LB$$HLI:87["7,P!(-!`33!H*+@#A("'[/I@M*6 M',K$8MRUK^I*N:$HJN)-ZR_W*%G=!Q7[)'A9+K86H9&]=6BS"X]J+%RB-J8:#B,&"8MP;+L1$&15P[UD#'R%*.V)% M,(V)&"Z]T49_(_5>()0/YU`3&2///.EKYSS^4)/SB'MM&%I@]-GIU6\<+951 MM.RWPL[#=)).G$3LK?U;@5*O>@,(:GY;)&D<07:E@&JO&/G>@:I.8Z)E4+HC MC-10H'$)C+<]4%B/U<<%A6BPTO@VBR<\F0)%PS'N0E0UA48*2OJE.H)!DU@U MBA/4H7#*[Y(B=Y.QLD>P!)1JL_W3S^(PA@DIH$(QP5TR*J^,2YL7DNC(W@W& M#=U&89T$C6'IO=3G]#.V!D/E8`&5@PGN2DX5=9P3'D'!>K@.#P4D[?[?7V9K MHL+ULFI4QETNOCYL3XJ!L[#-VW=$RZ+MZAFXAO2UL0LWP7:*(@C0"MA,15Z, MJ:N:;9>O*=^4?\]>&S\HSF1MZ-8NR]N68-X5*S1. M=2FL0*'U4%462MP6(]BL!2`(R=Z+@ZZS?`F?`]A#37!O86MJ-@J'$A:O>WDP M<792VJQT"-3HF!"D3YV7DO"E&S9*$]S[U9J:C4J>A,5$!@X-YC0Z-L1X4^=! M55["7,"V:()[>0LA]I+CWWS2T M&I4\"8F(%"`:!`H-/L2(5-\L\<0'[K(,#:W&HT]"\@%S"F,["&A_Z"0+4UW> M9/S%%AWY^VV__4VKJ$PF4+I?0,5,BGO36ENWKB]+:/;N$Q*7%"$4-'A4AB0(LBC.EZ5HI,$U0@EE*.E M'FYV2RDW(JN2$).3*^UGO+@@M\2X1;:&,VEV)="R$4BH:7"$"9%&8'L)'HPO MH5HM]6)W6T,Y1PQ+7<+=NL&:L%?^(65E8[1B]UQ'>U<\BT-.:?_'ILLGCJ6 MI&-+.=?F6Y8VQ)7D'\!$9[D"G(K$GKJ[;2%Q+6,"^A<-@M8B,@>D1 M+00($:99G;/$"3&4NZ5>;)6KZS8RR1(6%"%4M!@6`J2(\JON`A].A*'&(?5B MO7##9@"A(O\Q((;;@/=EH1:T MA(*WS(M:$G7=7)$K50'W*P9=*PYB^%2"?Q92^6%1/8QLV\V$M7U6R4%418 MO&Y0F(PWA,U*9^T8'1."ZT;GW"0P-[!EFWFQ;:ZJV:AKAK"8R,`A%XKCPD9G M&#[00AT`QC`UL'^;^;%]KJJ:TQ!<4C- MW4,U?]F_`T`MOIK?SKX\5M2_11*W[_`Q8^\-L7?U(6IJ_6ST]5\L-0_`%O6GX*VOWQ^_[G_"W2"^^S=9S]C]_)<'I M8OGU4T5L8$X$S4J+*0^3HFI"SNZ@[=!IM)L\25@9?(;\:@"+6EOG;=9$G[+O M?OA"/PR:C0>-UH,OWX/F[W@/`6O]#/Y/P'L)H!L,SL+*G?MOW5F<+N4FNTFC M:)*P\IP,>1K7IMINZ(`]!:8UUI]=8OW#;+'^Z^SQI;K8;%Z>ZG=MGBN:PO[K MZI$T\T@,Z/-L6U%KMOCLA@,-1O(,6D.L[3!D>B=$-H/K#DK(PV7(:X]''!7< M[D9;OVG]Z^!U]W/$+@E7"/,F79*Y@$>B]YR$U&"9L$XBK_T>:TC0ADIZ>IF( MHZ@$`1,A:,AP%NS\VUZ,@,KAR,GQ!Z9V;PANKI9`"VG^+Y:XU,>\!"/Y))D1 MT79!1R\X[OKBM47(C*9;XI&\A=00FG,7+;W1@Q]UC3L<%LQQUU$['`5/'(:H/E/V MTVI.I7U:+`E;(`1C0]N6?.;1JMGCBH6\]!SF8IV>WO(,'M$M)G`8/\==8NYJ M"-#&,G)ZF(A=KAO!2MUGL%BZW0WB0ER_;#?;V7*^6'[]6T6O)*KF%Z_5>O:U MJ@G7I_7BCN4+"H198CDMQG5-ZD-MRET)2\"627Y0`PK;$2$_' M*6]E_QKV,_VU8X8DC2&4K.EMNBOC[$I4@CR#2UF+"5QFD2,OWQ]Q6+"S,`W= MC#*SAAQG02U)P$4):ED")HPC#\C^=@-')9JA38DP.FR3=21O)CALVCZKM9^H MX.E)7BZ=(S^+85UYM/Y'5`,37@;ZJD\]N0[\^@&!*[SSQH^8"]7:^N$O,603 M,$8H1L^1GW=Q,@"X`R\95::_+!?;3;!@/\:S6RUX9O(WM%MMCC)T=P8[FQ"" MAW!31OY&2_:D!P$MA9#5!*A$\&,_E?B14PG^NP,J$>RVNG=]!E>.Z80`8D1/ MI/Z&G$C+F5=;9@<[&"&\OE&\T4([Z4$0]R*:IVI=:>27-]GT'JBX):-[L9Q_ M(B/ZEMS!)8Q9`LPQQD62^ ME]`8&X3128PI383R(1NA0Y&TTX!>B4B[#6B_P=^A9Y7CU+O-B7A"#;ZPYC1, M;=5T"7R`4/A1FD[*N#R/"9DH/2AB;15:'`&OU?K+2BMV;Q-@^O-L_8]J"[N8 MDO9%KX"#J/[]RWIW\J\9[7]8K=_--@_G81[E%A^JS^U_O5.J`MV`>/G:0T8O"@ODBX.R4F[2OJKB3?FU=@M^H>U9L'RAM\($F_W=,8L]ANXL8>@C MF2/2]+O58:A/,!<8$!T0.NWR&&MGJT`642@Z`$+HZV@LS"<\ MB0VG*PKDQ5&&5!QUI127T_!!EWI#0;7:2<-8W:^=R-`JMU9V-$:+5I(2C`1. M3A;("Y",*3G^6BDC[G3W`\5#K.V"L+LV3M(5L<6;1D7EL`(L(74'\-3:1EG/ M%/)Z'D651EK=AN3J#?O8QW;2FGUFY')=0H`:T56HI0T:#!1P$JU$7L"BJM.8 M:\R@=*<)S5=V\Q(-Q^RF-)EH'ZMO[%\VU)B*MK)4^]C9R6`/-WUJBF"F\7V8 M9070`MC9*;W<1A/1:LSUIE\TD26'M``_,,C16LS(^4HS#EJD5IC&]^R\,Y\^ M[O.\W#@3TVOTE69(PND57V8:Z3[RI[O5T]-J&6QHRWP!D@,-Z_SZ'B*J=Z2U MQ79+SV7L7F^@Y;F)Q$M1@PWJ6;^*O+7E#W_+QIXP,SKV$21:2]Q[5U-2L7K,O'8^:G5?.#']/UF`T^>)D(-NE+W-L\ M&EJ)V[I>7;NZB()6?V[-[,4N8,5C]2>T9O!;?L8PAM1@!">.2MPW^*@KY830 M*(O'S7U/9>Y6K]4:SGW/U%P\/Z=QM7RM"!M:7R\;;Z33UVI$^4M7.WJ6+2%= M;="=GT"&&P[.17#4I<1]N8NL*K:YB:0\]>6Y0?U!0+Y0?-5LV!`$"L)4>CZA*]5">SY1W!U=HE[ M.U=:%R>T0%:J4W,-S1CK[;=5PQS:JI3$C'77CE%C[9.NPUCWG\!(PG5?$=2G ME+@W3V55<4P"AN0Y-5+RA34S52,!SNQTD`0[M25I612,"0 M7&X-5HD$.+/7(1*P^Z1>HGA^IH#!Q+U1**W+&"1@4*I3G#[D@VUE M6?V&>M"&$2,=DNK(0`]_SD9N`I=D126,'.Y-.1DU'"WX(K+LC)$=O]<.GCHF M76Z1=V:+G8M[V\BQ9\R*>`(CAWNO3$8-QXNZB$P6C/)PJ6P[`CELDV87\2&I M6DSRB`A-X"6;.(1QP[VI):.&0_\X),NA*6KSRHY)E_>/3FRQUS_N?E]O]4T@ MFQQ',':X]YOD%!G!1PY+U6V:DINGUW?;%?F,M'#[L'K9S);SVX?%>EM5R^-; MR.;<0I))'DW$@R'I#O2,VH0^U.#EVXG3/$KP^F%UA:P'4LJB3?F7`:U35'3. M&@8CZ+G]0<"ASU><%KSL6%TA%VN`LG0[%-!EH/XVJ#\^O=IQKHB4]]4=^ZQ% M0GX^#:H^?UX\TM3&CN=3\Y)X_EBQ&SW0F-.-(D>U-3JA&=XB!UVUK"\DF@). MZ^]A/:E?O>)E_-M5Y(S>X$M%/!EBG[;'YQ5LOM`[M)_7LU6QNT+D&O[M:\#CUQYWCA3S">_;T/Z7_1<^N[&R, MWNY0@=TUKGX@OYA7K]7CZIE=_[79TE=2R9_8OY[1HR[OWOW'?_SP\\_T^Z>9 M[.&N#]67]X]&&64MGKJ`FIJ<,5L7LN;N";V3#SYA>0W6!/W#^\6ZNB-F.#+ZC*]R6.&G MNMIUSCW>#*`9Y7"M>CV2RJ]\?*_ENH:C&@+_;;:47+'WYU2H64K4"6ATI0<^ MLSI2Y.FTR"8<[Q%H$ZI97_4,"#GE;73$;F&H32V-F)W@TN8WM@Z7-[U`;*<12.L9BUF9VTUPX0MW=7L:'+Q[I^94`WG:G8BI\9J MIGX\^N*1V6\%#U[]2%^3:SXZ=_DK_6-UGI9A6YV;F1<-Q&300YVJGO7Y:\'O MZ0GA*.5GV1,X,(R7*NHK9GW=TA;QX#W%N\9G5G%BY9T),5FEJ)(Z1%0G/@:!%MNOOTX"W1@S='^>>26"'S]_AAL=YLFV7= MWZK'U^IH,:1O#[\\;ND)6;X61H2GM;TTU<'B-+K2Q(E1'7?HT6B5WE5!IA4F M.85)QLOK+&EK'6W&19ZR)@/6YM%9!M9L"^]K-*W*^DQ8KV"@Y3=$3V_BT3X[>6M'43W1F7 MF\,T/*.9RJBEU,00*(\Q!3 M'9&>\I3B+3LVHIO3*$Y#4*QKU_'IA"@M4O/$T.A1&F.:20+LI,$H2B*\Q](, M:(:$$':()PDIW:H07;,S2@51`4J5!K;.*_)M:CW-,%'`#AG[">#8(#)+_E"A M2)GXM4UDC'PC6T\S9*2O0TSDZU.CG&^21Y$]SF>H8-&D?JH(:Q3+I7F4OHG8 MJD28EC'VK:Z3Y@M`9/$VWDJ?1A&F9I6G?@2:0ZJ M`?AK7?#J:^C9UI:&FLXYH[JLK:CKJJ`ROL!)6:;JVH8<<`(KFD![_(4\,J4P MP?"X;>A9=*:EZ&@KG8[4'N%/,61##K_A0$V@N9S/;LIF-X%'?$//8C8=/<<) MWS0DWD=R;56)VD![^?JRV7Y8W%/RNGUHR'SY6+T*[)B3>">>2)!,S?XT`6A> MVQT8=9MFLY_E+,C(D>^KF=;5.@TU+/`4&@QV+1XNB]"HG4(18Q8L2E+?"&!; MR*L9HRB8413(M_!,Z^J,PAH6?*K;X%AP%>2T;P2MIUQ7LVG.KK(2#`'Y&5?C MRKIAO:;%KI?9,&6G95PCZD0HQI.MXBJ"/V5+$YQR!4C=M\P*!`W";4(L]TE05, M,:\4]J%TS9RJ(\5U6D(WXCQ+%UT*R=M2Z!S*'&Q7Z<0%\H;UDL-=Z_&8".XO M3:%,./(M*:FA)P[V*2:L'/=T$_YUFJ=1WHD)=ZJGY+-+OX=;$YCU.+;\PU>]($4Z_0.X@<_"I,TS"!-U\BY$?2^^1V8\`] M$DS9/P;T7X._TW^7-+AWC[/-YOK^;[/UF@1%U^O/BZ\/6^AG8O&%P\YN]2Q1 M0IO:+'L^(0X@XT>%TYB_IH?:5*5U<6*^LE)-V0?!ZC[@GY`A#]A'YBS\_>II MME@2JXC:*ADLVCAT;,'*NS3JM?/Z(S8/<#@WA8KU^VFRVA/HOEU_-\$K>E@2T:?:-W"Y;?JUNO^3>_A-F!!ZY2>#DGPKWS MJ:K2>$`8%F[*/R"`V/_6DOU;>9(6B?V?I&.'ORSXLU$IYY:X]QN5]+&=7E41 MJMO_GP77JAAX7]VQZ'.HNN?GQ6.UV:Z65:.H7^*Q6<5N]#!@3K<:&ZHMTAKX M#'?PJJN:;<1HRC>MOQX M]R#TE<,"L$X))2%F8*NO363Q*A")`^O*'9E'F:I^?2@3K&2B-`1W78N^WA8L"58L.(O MN$X+5S1GUC^F**>/EKM;Y;;*I/Z\5==9X746XM&:@NERX\S8W''IW*;89A4L*V M1P;5@\C/PYI6U3[[-"KOM&XO:#88-%H,OI$F@WV;9T'=:L":=8Y>*UM9'J.W MA;FJFPC=J.%U4!D4'\;QF\5ON[*.F*UAL:>PU@95#7!>D?E8;A>OU;9TY0>8.1DK"%1IZF:-;8QU-AF4.X7X\[MBRG@Q'2%1)GN MYBE@$[6C@FJDK^[SIEJ_$K.^>9BMJQ]GFT/\D"[7##VS1_9'\N]_G3V^5-0N MHDP\5:C5F9YUF];SV/[5VB5$/TZXI\%=%&=43]M4SJ2PT[JQ@+<6L.8"UMXA MMVNT&-1-!JS-43`IF/SP'Y2G21`#!L`=+N[B):-ZNDJ-F!1Z^KEZ)EU6-.NQ M?:B"10."BQJ"BV7P2K^EY2'5?[V0"?SA"T/O71.]LSU)W`1_O%^M">.;$5&K MLV!#1635)1NZY)X%+\O%=G,&_Q6L^`),OE@1&=:\#]+M9KMFX[3Y$\1Z5;VG M=Q;,%^OJCF!E$]"LSEVUWLZ(F'>-),Y_$7ZZN/^^6'X-J#!;HLN6A8VSS;ZA M\U$\BQA3]=^Q=+)=#=.%DM48=V&P43V=FX^>_O5IOMQ]7V/ZKMY^IN]76Y^.]J?EY&K:<#S61MK(GM`-=F1E,* M\DI=0KJ!QW?<^'"7BSH?"SRNPZ!6TU^6Z]UO#CE(]2O],SH78V5;YS?K8M1R M"$I=YFF]+P'GPF+<)4IN!P)%%L*4-AUI"A[H-%L\"W9]!M#I6<"Z/4QFT([) M+[?!]VH;[/N6=$TL$J*;U#-B'N]GVRJB1:Z)1'EA2Q.:`!>2:8?-EE_':1X7 MN#=?^\2V;O?=?4_AWX+Z'P/ZKT$D9U0?JB_KE]GZ^^TWPM"_7])#'@]#918M M=U`4;14+'49HH$L]H[6C));@W."UJ;1MB]D2?UDT' MT'8`C3NZG\JHF0OFO]\6MD]SX>9L!0*9'$I<$MS;NA:U=I4GMZ?"U$#3(P); M+/W\MG!]DI'MVVK]5)]M#).H4&'<4MV80JRN;JH;]U$L&LCN-Y?.D";,8^KH5/#Q/J48EG)CJQA2UH_`70- M'<,2)41 MU]8NFW9?DD(Z"N)!7H^4\NB#[^F"QYHSAT'11[-(-"2Q=:#O7@SO! M-FEI"[\G+_%NP5/3<03T*0G:`4"+EX(8,$WIK*IOV.O+H"K--US+E^"N)#:F MH_OLJ)[`7H)0-@/J&P9[LIV2;1HP%7@G,,%=FH=C@!QG4$=4M9%K;7D+V4"> M]=]F2]K\347,8ZYR0TB:2*1;]7K3\Q?&-:V=AF;#+,E>P&.A.=PTFN*^'L6. MPK;IM!6II[S5`)IU=HF**6,6I-EO`;>GA-N(1<"SHCD0O11WN9X=A5U1<2O2 M3_5:'0>U8KS\+8#VA*%+-=R^H5W`,Z0YD*P4=Z+8BKY.^+,-R7?+;=19>&!P M;7TEKHH0]N'"B78#ED@A&^C2$%Z-ZGP"6HW6V34E^00,`A[Q3G'7!EK4VAE7 M-BYZ@S#OVG;/FDU8N2QU?A/0[B'1VJ8"S\OD4".>XJX/M*BUJM\U=9(I[<]BFVFY9MWD%=DMWF-MGWU"WS(I$ MFAIT;)-P&S)K.<;]9M#`^S6-'89?,VJSH^X1VPCAU:)]30VB@<$0T32>* ME%JM2X/(-:9S*W`56XCX.5"'I%LLUJ/0K6-JC`UT/2(P%:@V][CNI]LJ[5>7XD` M.QX%KR+RB'(;5ML]\3:KP)Y^=Z>TC:W0.XF'3B]?[UY.IR=D)5XBU^C*$'"- MZ'@"6(56XRQ.2T_8M(9ZSFBSNHP-?BQ[^)ZTY0QTY*<-@TQM@F[7E6O0]>FH M#KI]JVS&/6&Y&NKA`]V)C!J@HU^8`EW'F:?60H0TU,&<:$^F(:>A83?BA!NE MA\7XC>\9[@?+S2GI'GV*DK9CL.?$K\%$KX9]RB:!/(1@3\I'<=(A49!Y_7)*KW7F,YRR5FF:!*YBSKPX(J.M(CJNV2^OA^@SS#*1@4^=8;9.-#R%E7EQ]%1;15SL MLE_8(6ZIC;.7Q^\?%NO-5JT`5.+J;/6>-+%F4L,=VM0;A5K)@M5*YLC3F^:T MM,XRC8DZI4T%K"UW)TH,V*@HV_08ABV,4W?:2YAVY(D5 MA(*DTV,,GA)/Y4;YN8%L`E.-?)O!H)IN"*@Y@6%)#&V>Y2`=U*5P1SW`=QV-FO"-"(P#>39'./*NN2V1B6?:K_;`&TK_=5JNV9;,5@# M\NT/\]HZ(\-FY895-XJLDV*%,A3V-+DD%79=96-,MT,@*K28%I,8^?U=FJJY MH;3*\M4$UED-FZ[MR2QZON&J8X%3G%SDQR8T57.X="D+R=>IEMU#'%B2"OM\ M`U-7B*=>$7&=32TS4SU!&V#7@6;U77,T_%90T_[H:7-)DYAMMX2WZBQ:_U34O/ ML18[':&]`J!:C(8??X/QFG7[@Z[ZEFT]=1S-&JI"$BP*EC$WID M]`@'5;[!IRVP4IY#[&6).HJY"Y\TI!QW11*--&2>)Y3OPBR M!68V$H0_DSEX^+"X5WON1N)J(>6.]-!F4K\:<^IML@F.$YC@""88=]1F7%?; M%-.TP%/68,!:=,0W#=BL(.OT%Y2G#%1WXE.8>"AES7'G(HWKZHJ)FA9\JMR@ M\4&B>XRY#-J^L$]9J4F*.P[:KANSR5DW# ME2&NGF*S@[KJS#[WPE`MF^,N7S:OK%/R:E+RJ7J+[I$IP5\]!68[@U5JM'[V MEV?/H::VP%WL;$%;=QS6J-Q\\8SLDEA6&G!R_:?$6;-2DLOJ=&@`G8;U/0"I M5MLLDLFY==KF*<8<]L-#J$`I<)<' MV5/:'96V(3Y?G^.PDU*[7X=;XL!L8H]2FP]WC>JJ"MOV?3IPY"'4L!2X:XLL M:8R-2HN)K4ZD72LRPXFDZ*%\YG&T0>BT+;G;@,N8A(FD72A@6PO M9M&DK%D7H`0;C+,X"SVH\5'7S#7IDQ.O;57:M="3L30$*/%'*H@GEWCW0;4? MLZ#2T*X+5L)-4O]8^I#'T-#--;1D!6P#E]4W5?0-4(W\^0*O01HH-\-^)2RD M=1N%`LI*N2.`EAX"TSAR6Q M1IY=HBO7:.O341UO^U99&/#6('>J'CZF>"*C!N#H-U9!U[8=*_$2LUHO3J`V MK)DDRHX;I.FJ%&KN2[_R'&H*(D%:OY226#.]=2QKBV89)"J8*;/'U@F&(OC2 MAY,+N@HBXY']TGJ&-Z-)$%1P4TV`M$UO!I7JI0_'_G05Q)0*Z1>U)Q]BI`CJ MU\73RU/-7.,\;L$+'R`V./>SS1N1V9+G=$DSY/RI;W."CYA]6 MZT_KQ>ML6WUZG-U5=*VK_5Y:%E+'4]3[TK50HUKN+5JGV2B.)M@MWX!^]B,6 M?2$)B(Y?.*T,[NWIF9XQ`H@.4"FGLG%?LN[A:FF$ABCTR M=E)$%"`RQPK1H4B)"79.)/:B/BW-$+&_'C$QKD]MSY%*%:3+]^$`5<-:24&J M]8U/[],8W7JAH'D=PDF!2']?2,?8#!(\1!!2(W>MLXG]`C<-O?`0NPX)^VC= MN+`Q2>D0X4:1SK5.'_9*(`V]4%&Y#B''7(.$[^+,U+-V3JX;-:)5!Y1$+YJ- M)U'";\MB%QID$Z]8G9::CDF>CJPM>+-YA[>.9:HM7N@!-[AXR4POO^0J@^GU M:BW34G.DI4U'9H^0IQ1MH0?>4+0E,;GI!"8WAQ259DI^^,-NT@(V:SN_:==>Q6)K#/9Z$B\/?,B&.N)A6`%# MC7L#44TAVS&PDE34HH-Q+%HP>L5@TJ<1J=!@\P"GA,'&75NBII"K*%-)NFG_ M5[)6_P:T5YL1"3MBV@I>8G<8.&1E=NX"6FHRS$VEIE>N.ZNDN0F!7<2W"*[NGXBLV6G2"] M64]@UD.8==SE:,9U=;2S9%;J/2ZM[=F+BMQR05HI<5&08C=N0#BLFRP$3U]/ M)=,;9S"]L/D=XJY.,ZPI%KHJ)J[L>N@J>NPT5,-$%1<*U4EJ^VS#:^01%$6% MN(O5#&N*C:"*B>T=',U24UQH5*:E[7,-)0H1%.2'N$OI#&N*BI**R3Q(2'6A M=WVW76ELGDD43ZGWI`=`HQK6&-1HE&U-X>:B!K2SS3_U19SR)AQN#;8(+9RC M*%,MJ#E(P1C4K@=F$N%]#"5+$1R!"7'OR)M6=00`ZLC;@49["5%]:Q6,`7T% MXVD4J#?E"91[1U`<&^(NH#>MJJLXT+#<'J)2+!3T%90GP:#FA(^V1/M\2AG)ZY.\;FE44 M"3,5DU9R!;20CI&R4;.<%!7\E/EH^T3#UF_,MWYQ%[.95109%Q63VC,<&F6A MJ&"HRD#;ISF%:8:JQ0AW]9I913&Q3S&1A[BG-N;N[Q=W1-=WJZ?G:KEA3N<\ MC-.H[48!,[=:M'6I"2\Q)7;@:?TYX1]9"+%X##42$>[J,1DUW!B^N$#3FVI) MAC/X*_D@^$3:7LSI@;O5??#S;/V/:KM8?@WH6O,3^??E!OYK^3)[#.X:;9NT M].PM6/IIL-3V\S3BET#$4!H;(=\7$]7!>H@C*,BT_N'_"-ZI6^L0,\@F,MO` M-KF-K*0[XQ18#_D!^!CVYB/<94QJ"EDW6Q6IIC736.R81J7+-`3M1#2:1F#2 M+=&Q",?C#@,JOR+)MWP+ MPPY9]!@VFR/D=0"J.CEVWL*"M=CX=J;GQ$0Q]TYIV##Z=`8]@OBI#O ML:OJ-))+%Q:PW>)_<&CQ@NE'-`9_FA<1''K8KHFA8"%"OG^MJI.;C(FB=):, M_=-JL=S^W]5Z]8$(_JE:WSS,UM7EK]7Z;K&I/JU)4/ON<;9I&I+$S2E2C>N! M0%>/&A!R[;`;VR9\#P7V,B/<6\Q&]+--@4P(.66-!+25@#83D'8"UE!0MQ2P MI@+6EEOX"#(E_/@Y95`JI^P?@K_3?U*QJOI8 M7IRU%=D8M"L3OK=7X@/;JIW6 M>83]IDAS;4HR3NQ@TSK&G9TWI:(;F)@1=GK<3D!-*3A\K&.["G9&8^2=`T-& M*I80\A^,)PDCO7;!$B#7ET"I5(Q[-\&*OK832C:$/H7K!P[7QDLDMTCA*IB` M\A^OIPDJ$[8`R<8$:F=BW-LA5O1UE<"R(?P)<*4:E8/KS=U#-7]YK*[O6?S_ MXVQ3S9L5@A?K-272=(`V/W[?_^;3[#O]NXMOL_7\=O;EL3I/BJ(M]V4F&#,F MIA[F+8Y6C7YS7;`JYPGL22>P31?CWONQKKL3MFU;BVG=`2U-9Y__\(5^?U#9 M&S1[";Y\/_@A[RE@705_9YU)+O,W9+*9NU&Y>(@C*BGVW*;4+(Z:X1AY='F3%*L>24[]`[75YU9SW!G>\WHI^;9=*` MI`W\4>*(&&Z"\:SO>#N-9O6G&?>&L1']7$6K)H3%ON:=U)82VY0XEJ;>DS/\ M#6NH`+Z31BG#P;W[:$`[1"2S0T0%N.F>OS=ABL;I)3JPZ5#+UKG&O>%I0#ML MM+)#SF%2B0%@Y@DE.H1IDH6-8UT7LW,YD7>=5[LH`Z M50U[02=Z=V54IB4+&BEMR'L:.=B[F%I6XY94\?E#).8NT'CFK:28/Q]*`[Y4=05YE" M&73B84I40U4TY%5,7FGJZBRD[+16T[05&1@U*&O[E$.Q9`I5SHF'"1T-5='1 M53&YQ>+Y9?*7%> M$/NJYE?+]Q49U*?%DC5^??]^L;E;O2RWM$X>[FIFI]>O[^^K-?GR_6Q;,1A( MO)R(50]-)X)4JY;9V3DIK"+#?0KP8G8*%WDFN$_&^3:4UH,/O\9C"C=T_-A; MZQ_\R$O]^>^XV,%.[F`O>'#-SP]L@H;LP5[XX&H9'(A/OZ@5@-.$H`*_+:16 M(J!:O+5U0S100ZK(6U\X6@)-K#(#O.&%]Q2NQTUP']'T;2B=!.M+Q6GB1"D(M>7MD&%1@KW2B?(S_#Z-I9N$CF>C1\WW.TCA,4RF!]$"*O[8,6S2E5]E^`S[=:BCV^>G!9:'>'9+TLO;-D4W:%K MUA]4)?Q.1\,%"E44QH-!6Y]*#WSH.S?1;C_CB+<>8L MC:&,,#M7K/S&W98>*Y3NEI4/08"60?E0BKS(:X3AP,?-S"@VY92.LJ7[V6(= M/($#>IT]OK!K7>Y63T_$GVW8A6S;A^J(2S59UM/L>[!<;VA M6G8SV4LF[>:V6O*_8^%99FF#SJ[H>+V;_ARX<(:R4K*0)8*][0QJOU+D97GX M1\]GEFAF")3VUPZOTA+=&PNHQ/U[?9]X^K+4C0D/)?5X_S MS5_6%9%]??LP6^YE.\GB.G+ME__U0H!SM=QLUVR2-]N/]C:[EE:A)S>1LR0@KR<=YP104N2M=0RD4\% M`8*&!`$3(=@2&>HZX[,`Q*"[1B`(=K^'*]/ZQOV>N0RLK`AI',8Y%%JF;ZB& MU^"0X,[$ZBDW_=N,=D%+8J^KTK_7N/=#(X!NGE0H>[\NP+E].=/GU M>;%F/]X%5E$8V:6()N0TX)!JS'31SZ)/-C,,*FK$X)E4&`C9&G7M'J> MRZQ-V^,Q;](%M+,-(WW$:1Z5'I3Z&576'0LP*?9T%]94>T`_NTQ<[[C&Q6;S M\@32?%YL_O%A75572S)6A&E\GFVKGV>_+IY>GBA=GK05T8T93`R M,/Y3N![MQJ%P(!!V;^@IA?/3&XY`X6H1V!(.SUWD4+2=>9`P'W%HW@B%ZU7R ME,(Y=5H?7^A-N/7E*QQ!);>J9PO2ZF/U8;5F9PXI5K(2O:LY M%AN'QQ$83-..YZ3+/(LY]X73"=D;/8VB,@Z^N"$19>QXH[KGX'ZUAMLEL+DE MU'&2;V[)6M1TW&7]VB&OZ^KK;%LQD3>[TWQ16J0N;@[K%V,D;R$]-MK.8JC'*$KB-^H; M!%5'RU3$Y#=P$5;M-G8]`1W9T!=EG)[\%X6'A1O[WXSK,,:-'*055%T?]2->SB>DQO7VH@MD. M_,MJ&RQW28H-(PNU0_CC:LW_YF6YV&[^%'RE+1(>,7]AMV32.X_AI$7P[6%Q M]Q`LEG>/+_-JTWA=@OW%'&YPIS9O[`8A32P6+.3F+2Y+Q7]W^=U-5\0 MG)&/7I[)3^^J]7:V6-+W+.8+:/69G6BG6JPK-B+G;IW6X!.Q1D;`F!N.CXZ@HJ+NE?[7K M&*T+C`.SM^`_S M09F@L;W1,ACI0?`E4!/6:/K19)!&?ZH0EQ$CH/]%Z5%?7#963-:XIQNVT>@6 M;#G!MY_=)>^X_DUD^$RYLY.^ZHU->.PC+V!C\VWGF,4'P0L^)*S.M/'+VHYI>(I]<+>_6[(/98[.E=ZL-J]\H$)Y*EU!A)'^B-\C:+D:J M>VJ@8DK.&U\0DC-9AOI`[VS]J['\DC"8^%MO/IZ"E.\_BM7D<_ MH#):U]$OMX%=KKJ#`'IP7OQG\Q%%RUM?OS]D*3,':E[+T=M^.7^)D$<%<"]5 M_I:VY,8>2(3QX\A#HOW`_.&K\F?!-_I@,:3_J^"!"DC^BTD(#X"$D_\/;!5L M@I6U9RTW74Z&_<\MF-C*&POU7I M#9*[<+UI`5?`Y)Y?`61P&'#X.G,*"06@FX$(%.@F[38@C@<"4MIS\'?H^_^8 M<$3@?/='_G]9$H-D_ATV*FBOFP/__IG*_]/J6[6&/RV>%EOZRL#$]<-M9D2W MX9FL#6J_BS+5;9BPBR;R,(9+_'(?G\VU.1CC!+\6->KT5V>GEX($+[3?@'7, M2SZ9;]K0%T(XW6*]!ZS3LX`)`/\1,!$P^BV'3.JWX[<$J96I;MDM>RF8-E^* M?;QIQ.YPC$BUK"HVY9CLN-M\9X<)V*&/ MAXPMCH57L9F`0E9#,]:_B=#L+ZO5?'.QG']<+:NGY\?5]ZJZJ=:OI*O-[9H( M,+NCPC3+*:[O;ZOUTZ:WBBB?V'[JU9KPIAR7HX$]=5UV.BZBPA=_97,`W#DI MBUH<>";6#\M3-WH*ZJZ"1E]G!U55=-N.]6>IO,HN?BR'<+]=Q]03QEGIF+V- MZDN5J-41C5_N2/PV?`>QX,]BC`&,^RUPY&6QO.LX/8#]_\6OM0H M&M486\`A)K9RA-%L_G\$T($<[F^_K6X?5B\;TM_EXNO#]J2L?+UXG6VK3X^S M.\9"?J[8(?`HS.)"_!R&6B]Z@#6F60U2Q0;92T?\M<@"CCL7N!\)-:NH;4@: ME79*6@OJY@+67NM!"&@SV#4:_!V:E:Q5T[51P3MX?(3?Z6TY6A/-*Q?AZ%R! MNR+5K*+B^-.[]<:HU%.UUMRB3^P4D8_@.XE+U1K,^>S"71\E'*DO<%=9&M;4 M201J5N8ID:DX6?461E>]_[M:KZZ7U2U!3@6T]6I)C[PL7BMV)GIOCVT/HG4C M3:A=;6RI2M]`DU@3:1R&&9P+*G"7^*FJY(`=JLC%>"#],"!?!NQ3'EX%NX_A MI((K"(A3/908:*5S$C,#=0+(-U5557)(T53DPP<&8>:%$@MM[$IB7J`NK\!= M?ZFJDBN^I"+LUGF0B386&&S9B^TKR'QF_0!OLM'0)KW&6 M?*G&?1FDMFZ.Z)&R@/NE@?T/),Q&1H@<4T((D4ZN)#Q-<%%4">?>2MQW%VKK MYI@]*0LZ%6[`.D2D^!-"A'0QJ.$V^)T;)6S!E7"L"GE%E+YR+EF5NIB0>#*Y M>O`D5LWFTLS>O=\'7>D!8D#JVN8/?Q9%93R)SI,R+S*ZG546$>Y=#A'QG=BM M@"#3739TNPH^D?8>9IN*%N_2:WC@&(*:@5*P?%HMEMN;ZK5:?J`PJ=:L&N#@ M$,6[Q]EFTW""$DE1^1[TC->(1K6)*S3&7$M>@FN!%$:)NQ3&G)*VHP5CDDY9 MM,":"EA;P0?FZ>FA'G8AX=$Q'M;B"!`3#"5\PMAI<*$ZJP4/!B$_4N*N:3&G MI*MPPYC$4_F6W"%,+!+Q"6`G/$V^,4Z0"QY!0IU@B9O.&=32">LS)^_TG\[S ME+UQ9'SM^IF,_T-C=_\#T6J[K:HE?UT%]N9O5Y>\3)3;8L*N/A)&EUHO>@@S MIAE%F6)C<19G(5Y4:6IE'45Z\DW9YP&UQOH(-Z\T(2%6_\,CD%%>BB2Z,HLK/1W;L"73(IWG".^VC0G5G"]/"D+NUZBX!57[+\?$E>): MY1>P^E-'""2ZUQ:MS=O&>5C.A&J9% MK$=.R87LUBWBZJQDPQ0C"S'624>NP#:LGQS2CMNCDYSY'VEU*X9H#>L0<7`% MT\R\&S`VXXL7-C2I+EQM4YKZ'W=U*X9KT>J04G[)VC6DB+'KN^U*@SQ);&ZI M]Z0',J,:4I!I-,B8"=Z:"P.:65^U]&6<\B:&XZX1,26X\19D M&-#,Q>*E+^8.6.[B+>6WW4\N":J(R;&=/;ZOB'[S]XO7Q;Q:DO]+I%M\>:$_)#]9+?_S M95OD#_O&Z'V:=_OF@F^DO9UOVCWLL.)-HO8V@LSC=W?3 M/7"._0W>32.W@^""T3C5R*#+D60X07[8- M_NF\F+#3R/2W(X-8D!J\310?+N]&S07O!III-5TLT89EWC_'>-<%Z8T.IB57 M9@EV\8F`M%JOJ_D-H0#5YJ))62=M+SIVX-E`EWI8MJ,SA;&)E@E92Q!S<),J M6E^%#0HK3YYW+0;09'"A&+$;M5?!1?=M@?1PL35F%7@SV]FFYS5^KS99T>_U:K=GE M\_]1S=;T'4E&&N;T^W1RNRJC^C8B:N*I1)&9>PGUO`"*$:4^8P1!B#T7$[PA M^8@C8ITWC*?;=%<3ON*Q`-]XI"%!_7AS0`$2<`%HF5ZT"Q!J&5CQWEGP2L0@ M'Z^(&$$$4?$!1\;3[TWZP"OE_L!2_B`L4M.Z'\W1^O;ZG;5,F07VW"2WJ[" M)&ZB-99XL<&]A';]GY,1%7%_%@1AU^#@/80^XHB,3O[LZ2;F^TC8VO!\R<[S MP8U)<7C&_AI<'Q$%?-_VVXIZN"U[GN_$#=(D(][:`$4<$`PNTIYX!3VC*`4INJ`F/V2EGCOHY,QFM\';%-A0Y3"=Y M++'OYDXR1P[/Q@A*^3E]`6@%^@3OD_>F=,)Q5GUA[01L=.K=N;T?6; MQ[2\.L`FG3,(1=,T[C?HS11IFR&#QUM^-,)(H*)IQM0RY-%XK*KOU=QQM(&\ MYL4VBFY767&`28F*97>2C>;5]$=0TZG)"L#NSGV33DUU)#!S-$6=5#Q:W.+1 M)F>-C0[]Q]7]SM0$@"2AH*"@FQ" M_I>=Z9@D>]B<`;0VJNBI[[\@8J:UF%?+UF?&JFK)ZJ8E;GE2[<<4IK2U.X27 M9'.T[#A''![HZN405FH2MD(*UB#^\BK#$"W]WK\JR1'E&E"BI-E31!T16JV) M14Q/=?5R0C8UA51"E1LXL7_>,*N3J7[3ZFT<9'5JJ@,OWBB=9\07"QK2#NWJ M=2CG`=J^U5<(`MS22?QV\ZW`<)+O-M^C,"EDD"74JAZ`E`6G.!'[.(TF40'[G(BS&TJZ MN,"`BF!3^A&$1]3FU_R[G?'3(TVY!&4"BKBTO.+B71D]CMKYV=KV)W22_I=\`P?6K=U>6>/S-@[ M7;W(C'CAZ045<>SHQ:22-GA)4G]0G3SO<%X0AFXBWP(C;*AW.^>K&7LG#LR*#[-\!:,C30:#H,^ MEWJ-[L60.;'=581I*'/9AR.YD'NQ[L%SXL9X]\S`$S!PO/?3C30:;X*/M:HV MHB=C%0+8Z-@Q&)'0,2\=F5LZUC3O%,P;[W';D4;#?SK6JM?83LPD';M:OELM M__-E>4=M\[C$ZFJYNV6;2!KNXY](:1O02/<6G9*1L1AT/@J]T-N:2Q(.L-N: M>52`]P921]J/ZUR,Z2'B3!9+\M^[WEI*&B'[OK\2O^UYMM!",*>#&!-!VYMQ M'Q)!F++EE6!Y)5B>#S6.5K4?/<@RIHH9%T)^L7<@"/P%7!1&$2)Q@X/9WI$X MBZZ1,.HJH!,PL)096#H!`_.ASL;^MJF5G MZF=_M=N>HR?6 MGKD]V_W]K"-Y>WBYHXV:(*L0-1!S_>[P3D=S/'_'MS!\*,\>9UC&C?7L*^C> MV6'U=?O=XR1"R>ZL[\$[&DZWWJZQ85M`[@/Q[?-C#\O;8G>M.KIT>,8KC*PB M%!NY\]O?C43NFC8/Z9K<)QY/>O)]$-1-= M7G1$(=DE('Z5>"(8K5%\[OAZ=[KBG6C$>KALC8K1](S(=T8$'"@:3&F-`/UW-VUK*K#Z:;^.%"$8K;%2`>.K_KNK-C2@/.%,+Y[13#", MK<-;\MJ=LX+/=7-1V:4S?AUO0#-FOS&Z?:@]*D]N;O]K].'=^0XO*?C;=^F8 MZ7@3H7X=.4$S9K\]:GXX`*C3W+WH8.9XR#H*EJ9._$.ZB(QKVP0\D M\)I='Y)[)I5U2P`,2JX*XY.3(G*8O;@CH_#R2%;R^2WI9X?`Y`/,!O=^MOG"1OAE\\/7V>SYSW2O_,_5XW93_PV%GA55)."DK0I^GD6XZ7MLFJ(`ZE%I`$`2$WP0`:DVL$T)YF:;OX,>+U\HP%.;S!P?,-E?3G>#+RR/M;] MOX)0T_U'`?WJAZMEP+]3MOH:-IO;58=(U]L'(E%:I*%%"`B*H0L'96WWV!!M M(B3N*H$)A",U.?*U04\S^WC1$6_:^#S8KH(C(-$H@K=Q%K!6;,/(#I?""J-3 M2B4^FT6TVCL>#6)9I]!$H,B@PJNYI-,F8HDX(;"EQ:F.,]/FQ/ M80'\EH#?9?65QCWV$"PM_/0&;FBIDW%W]->JB.T4ZWU5/57S]XO7Q;Q:DO^[ MV:X77U[H#T\RB1VO4-$=[;AL(:0=R7(G0ID"M=MQ.T6_S?[C+,Z\\0HN!L(= M<7:@38-G![>G-+L1KT*?0=UIT.R5_:Z1]J<=![SGH.XZJ/N6\TZ-4W:\?.%E MN]G.EG.J11YFD"[R7'ZFJ(XX^ MPE\7J_G-=K;>JJW7"N)-?YP]TF58K4!0S"K"MVCJH;2IAR$,?@I7Y19XCT:K MJB-KZI=+16*J()PY0W_YLKE;+]CL;#ZLUEF43B:T3FS364^V>\#A/`H).Q+G ME(:Z-8<'L[JW04>G!S;5>"]8L:&J;6YG6-XIM!=`#'C08D":#/9M!KS1@+<: M[)H-+K8!:SCX1;H$LDL=OBE"3;1M&TX2GB8VUJ0E'0)3<]\GA:`\@WV?`O?F MFII"8P&C5ZH^\U?;7A,U$\&*/PP6'9YD#?N_)$L]C#9LR62P)5/@W@M35X=*42,G^U)JLK5: M]I=J;MAO?Z[N*L)WOCQ6#:O)]"G)<;MV+%U`^B&;/VD"I@.*>3-X2KW`>Y>_ M"=7&HBZ"\O7Y^'T3SG"AR6S&!H8XV^F8GARF!_;7"MS['KJJC1[\F;5-,V@S,HZU1ZFWS78@!-!A=J^^27 M3\^/J^]5=0W.`VJ(/JS6I-77Q5VU^4#L^]]FRY?9^CO!7,3SP?7I6?I7?ZTV M6]+MU1-18#';5H_?+Y9S=AGM_&(;)K>K)*JOJ*7K212)8]JI<'KH'WL<:S_A M5@ZZLH0%K"PY;&>7N'=448R/;<^$0']B3=LN\$I.@M>N3M<--PAO?.-GU=C MQ]2(0V3'U(A+U'RW1'L`8SZ`UZ_5FOQK5?U'-5MO=F-(OT\GMZMR/XI)F+0> MS;;E'Z4E'-E)FAA18YY27I@XBXO)&X^=U4<%?<2LK)HB*6SCA+4,`14B8%($ M3(PF+V0M45$")HL-7GB]W`]5TKP)E/YWKL*D[@)U7AB MSOF9E]"N\W,RHJ+.SX(P]%A9B+L`=L11&=OYV5--S/E=+YNNKY:`7]G;D('[ MO6\K&O9VN#\:%E-A`I#&JOOKILT=JP09J/!VE<8'L5S;C82Z;D];,D?NSL8( M2KLY?2$@0\[307`59HGWQE(<@X/&Z=G24-KW]:3WY7Q+3=EU##GQ],`_X M3^?$!UK>^]`=0':LG">I)GDL40/L3C+Z,/IJ5YW"A1P[7'I2XS]F[&X3Q78TA380]#'^4=-]A M3['OQ%XUASIDC&7PWXX74X+W)P-PA( M,M>&U''D4133S[]6Z[O%IKJ^Y^-`%$IJA:[($'QOO#+/WIZOJN5YE.:I3"65 M2B>:[L&07CL/H-9>%!8A\MHD+<6L1Q$ZTDWKKX/K^UUP0,E]LB/W]#8(T@B4 M.?)F@KH=IT@27(6]0]+I6JH^I4T65H7(H\D-\25N,Q;:;/)&-'`SQ"&;\XQ\)\2`>JCYY*&L M&I#3IY5Q6@M+3K MHH^L#4X?KP%-K!T+:40YVU-FC1[@2H0MBD\N\OMA-%4;BR7*"-F3!(G3QG*U MJ@%V9C2M*&=\Z@31`V0)$4/QJ45^5Z>F:B,20ADY]=#EA@\V`A2))Z&T.AL% M:9UZ:L*M0?\CY&>"C"B(E"T>2JG/&4TE'55,TRJ!1`1!4V2R.??>U7HH*(B9 M6!Z*JKP`&DI"JEBE79:)"'[&&&=SSKVK$%%0$#G[/)16$X+Z)#3?B=Q;82%S M+EZE$^.04]*K!VDB[=$I]:YP1$*Q$Q9F/+4;C6CC,&ITT'D2!*B?Z+3Z5W-AX1B(](]<2E1 MHZD1>126:9ZE^$I#1RUT-;F\=W4>TNJAI'^',NJ20%-Y17F#M,@(T8#.##ML MS'CL7>F'M'IXF>*AH$HKG*$\HKPEVJ2-:.!FB$(VY]F[DA!I]5#3R4-9-2"G MFS>\6MZ0V>)W7TV*9B%F+6.8)#H[UH,]&`:8BD:=L!INC!Z%+R;\E;H2CL)[ M!BYE)9WS2%5)6]DDH8^[U@)H[N"LC!$&*6&-JDL98H`)+%RB4UJR*2U"F%+/ MRJZ4E1QM$5.5>`K_VKSYHVUQ6QQCCU_SD:A?'*1AIHHA&V+@#0=H@A,<3F"" M)S#!GE5>*2LY3K"F*FXK?Q2`F*&XK4=L=G<0V*7.QO-@#^Z0UJF1"M)X8^!* MX8*V(H)9]:S`2EE)3!RR5U(E#OE7$S=525BC!0XY-L#T..3!E,*%944"4^I9 M"96RDA@Y9*_$4_:O="W#1QV/K=,\=1P;;UK4\6!>X>G"(H9Y]:R>2EE)=-2Q M5UQUZFCD$L;KY04QA<=P0E_PZ`AH=+:R!]HWC#)Y;3HQ-M04?2-J$O'H.X79 M]*S.2E%%YX113UB=P;-WME(=PO:H&H@AA9=`$"8VGR',)[\SVK-2*T45 M1PO`U.2=WFQ7=_\8RN`+8$XW#.L4OQ&RE#;(H9403%X;>:CMJ#YE)#RL9@\^ ME*%G!5:**N(AA[UR*I!#(YE$81LT30['190&.3R81AX\0UE!Z%F5AZ**R,AA MK[#JY-!N,N/8'HV3PW'AI4,.#^83RG9*V-<,/:OQ4%01'SGLE;<_-^^$%-8/ M9E+))V5[U)).M'CA4!?&D::@4P_6!EMCN>`"4E8EU.Z$GI5VJ&LY`D=4%+6+ M)NZ>C*W;LY%&%#=)]>4,,2TAB57"IHMOSR2I:SGBTJ8HLG#JHX%` M]HI9.>Y"IQRN(0:@2-`F.,V0X2JAE,>WQY74M1PK=%.4MRMZ$\":L>Q^M^C[ MH"<-+7%+2U&<@DY*D&O6&120\2JAIL>W1YC4M43%+7M%5>.6AK*0XB9I@UN. MCC--;GDPKY`#*V&#U+>'F-2U1,DM>T4>S)R,S"F/C=0"IQP=>'J<\F!Z>6(, MZGU\>XM)74M\G+)77BU.:6A3H.XK(NB9=$0\D1%*V=&#-<"):R2`MZ[&Z,26 M*9S&**%(P;>GF)25')%.RDDZR"9YG MF)251,`CY2263U%&;"MN8I--#MJI-IE$ASP9*MD_PSQ0@.(@W]YJ4E9R;"(I M)^X@C^P$F?'4Y(G@C2`GMD,C+<=MXAJI8*T1'Y0$NF1>B6G!O'I78:*H)"8: MV2NI$HTTG),:E)7$2"-[)1;/1HY!'X_M MTSQ]'!MQ6O3Q8&83F%DH&O+M729E)='1QUYQ=>BCH2SDO\V6+[/U]RCKJ;M( MM.CC0`_&L2:O40_6AAICZ>5H`O,*]4*^O<&DK.0(]%%-TB[ZR%L+ZN9L9"&% MK5&=/J(%F!!]%)O2$*84-G!\>X-)6CSR8$H+F%*^@>-= MO8BBDAAY9*_$@VG(4>GCL7V:IX]C(TZ+/A[,;`DS"Q5!OCWGI*PD.OK8*ZX. M?32;ADQ[RBMT'IL9ZL`6TL3U&09:5ULLM3SAD3C4`_GVC).JCN,Q1SE!AXAC M:J\*4M00M6DC-F3)D,;^V81H.X1=F]B[XA`U'<>GC'(""]<_[C!G;_]:U$1U M>2,VR$FPQO[)A:J$$.I_8N^*1=1T')DSRDD[1!D[T64ZX7@B=B.4T7E:9J@# M9R#KU$S/Q+[6@TCJB)`Q]@HLG&,<@2D>FZ9QIC@RU'288K.B;@*E/B&4^L2^ MUH5(ZHB-*?9*J\$43>467QZ_QWWW2NF])-/7O'F`R>G2!Z^^EIC'C#DI@>J> MV+_2#P4-Q^"'\F)VLD/25!"W7=!C*ILH9'X:S!`?EL18X?`<-9R##5.2$^D`GQP<$I33CW@(*=V+_J#@4-1^."\K)V M,L%^/)G+&+:*W`A-]!Z-Z6O>$:PZ=9&&53-RCE.82*C.2?RKX5#0$`T/[!53 MG@>:RA$*F9]I'C@JEC1XX,$9QBPN9]X5VFAH.!8JY*\J%V+$@#)^K/10E:H'D>A`Y10 M%#4\BT`M(MAD3+PKL%!0<,082EY:C*#:AQR9WD,M/:V[P52G)K*0:K[H&$-! M=03E,8EWE10*"F(A>KU22A,]0QD^(O1CZBN=FA2-B_X#$+52^)=B82\?N.P M/#DA^T@>;\E2,F_0Z+26)$SH$5V0^F>.YV%A3R/UKA1"7K]QER,Y884K^!BN MV'Y3,=:BI!,Z88*58.#4/Y$\*0MU+:EW-1'R^HT8-LE)VAF=N13>H-&9 MI79WAW,'%S<$\,V>^ICM8.D?LCH7:^P0LD&B[3NADQ9_?`VVQ@K#^*,S,>S!I][50ZAJ.<)2I2AJUX*U:RZ([)TQ%#=) M]<4+,84\4PR;B:EW91*J6HZXJ"F*+)RY:"#07OVYN+$J9S$0`U`D MHR$XS9"@BJ$N)O6NID)5R[&R&XKR=N4X!+!F+-'1+7HCT-%[/V&H"X>0Z]1) M"7+-0P^75XI1Z)8=_FZW7L^7V>OFA^K)FKT&&MP MI1T<;XAA4S3SI>A#6TMWG%)7U`-.R1NCG+)N+JC;,YBO5#!):4[I`\[Z.*7L MO,(]=PELG&:^U(%H:^F>4^J*W)^O_,81N#I`H/%;=!6,599;^@#`'FXI.\UP M)5X,!769+]4CVEHZYI:Z\D[5L::;KQ00O1'Z*+V_(-R%0\AUZJ0$N8/KDF$G M*($BA\R7BA-M+5%QRUY1U;BE7KY2P21M<,O1<:;)+0_F%79]$MCUR7PI.M'6 M$B6W[!6Y/5^)AU,>&ZD%3CDZ\/0XY<'T0D5Y`K5%F2\U*-I:XN.4O?)J<4HC M^-K/E_/9AL=Y6U?(\2G.UBWKE^C$,/G7M.A$HW&04 M%MZ\6JFHFW,Z*2E@&XGL4>9JK7>JKTMLX@.O45!=U=<-TVCT+VM0TQ$HA#\4T M0"3-['LKVJ==5HD)B<889M,`?#E"H*4A:K9Y**OZNLFW(#+^X3J!GJ M!G["O8T#M4Y-=0''&Z8S[\VI'BT-L8+O4$P#$#07^`E(SW8;F7DJW;:OT-DX M..S24Q>&T"Z=?-_JH)44Q`K"`RE-8/"O9O8:TDE3]N^W#^O5R]>'BY>O+YMM M1UY>[=D+Y2[-PU%?YSY02K=.XP[_%DA5-<<`J**LG3!E[35A^CW@;0;0Z"%F MS>V\*UNN>KK47[0*)4Z53,.7P[+Z:HZ60E44N"][DTX:V9L%P'9["%NCV_C* MAJN15O47K6()5A6S\.:A>7TUQTRU*LIL#K$&,J^2.C0V"90>"-'L>'3T=NIO M$,*-[+PWC]R;4M8#KGPHL6G&;"S3I&G8SN@S4F#;H-)-R_&OJEQ/65]H]:'8 M1I9J4_4*FA;MCF,CA;05OMVT%_]*V?64]8A['TIN$-8&*'@NMV>I=$V^2F_F M`:RE:1]H)1IF^_+^Q<<*&H[!I>7%["30N>O=V:OE!3&%QYY+8PH=Z/4V;QIK MLKIT@ZN_)78D-H1K5A*XDSWSK=)624/WX%(1LQU"LQA!+<^)W`?9N9;O:R2AN,1215QA6YPVU#NN$>9^7LV1,U2-9&#$6(" M21F1"85KGA.X5SWSK1!!2<.1TB\JLK8'9P-H,I5EZ1"X<#N],RW>@$E#=%PP%XQY3F@D1O81,W/-`<<%4L:'/!@#N&6 MY@3NK?0N6Z&D(3H.V"MN[TUKHW&_8W,TS/U&A98Z]SN82'X=,]Q_[MWA*"4- M<7&_7ED5N9^96]2NEN^K.WBPHC,.R;7.1@WU8!Y:TAKUH6N@,3:E&=#Y%.X[ MSWW;YE95<@PJJ"1I)QNL6[.9%!2U1@U.B!5@8LQ0:$KAP9P4+J#,?=MT5E5R M3'ZH)+%XFO``>E;8HJB5JA-&K+@3HHU"\PLO?:=PNWGNVZ5JJDJ.1AZ5Q.WD MCP,0,Y<^[!)['\[D6H<)AWIPA[1.C520UHP*4H@*4KC6//?M"C55)3%1R%Y) ME2BDJ9RBJ#5:H)!C`TR/0AY,*=0)I+#GDOM7L*&F)$8*V2OQ<)9Q/.IX;)WF MJ>/8>-.BCLUYS:""((6RG-R_D@XU)=%1QUYQU:FCJ>PCJW#LB6>T#MSU-F\> M8W*Z]`&LKR5((O,@`.IS"AJ,Q07E9.VE@'YK,I0];!6X$)K$%#F@KSI+311I4!X4$G,U#?4[A M7UF'@H9H.&"OF/(1^IO)_-V3* M>-YR4G0$(EJ'_P>[,`\N>9WZ`#;4&IW6@D?,&13B%/X5:BAJ.08?5!.UDQ/N MF@N@/2NY06&3U."&>'$FQA'%YA5BYPRV4`K_ZC04M1R3*ZJ)/(5_%4D:'D+0 M"GD4ME5U`HD7?T)$4FR6X:!?!G4YA7]%'(I:CD8HU>3M))5#2#.75.P4O!'E M:#VL-=B%0\!UZJ0$N$:\4-1A.)3G%/Z5<2AJB8I8]HJJ1BQ-)1R%3=(&L1P= M9YK$\F!>>6#.-V7\J^A0U!(EL>P5>3@1.2:?/#91"WQR=-CI\"39A*5UTNX!C4*23]E1ZR3Z=#)H1Y,PTU!HVZT#3;& MIC6!"R4R*.LI?:L"4572/954E+2=25XO=U<`\^8L9"C%K5&91^(%F`B+%)Q2 M.+:4P^Y.Z5M)B*J2XW%(18D%ZQE7#>C1Y\R4>R$2.3!^/[=,\?1P;<5KT\6!F80,UAVJATK>J$E4ET=''7G%UZ*.I M+.3NE'=/9*/U8,M@%^;1)J]3']R&6F-S6T"".8=BH=*W,A)E+G]*U\1%G+,:FDFLCB*5>`$HQ"O%IIF'#%`M5/I65:*LY6C,4DW>3FHYC#5SJGT M^E=DHJ@E/D[9*Z\6IS2=KXQ[2C$*K>=EAONP!SH)K410U]D2,BLD+V.;6^+B%JM/-3'B4(IL#LPU5*D7('FR[A/)AP56(]HFLIL7M]M5RPGVQ,+:3U>,]B%>=S) MZ]0'NZ'6V.SF/(S(8';]*U!1U'(,CJDF:B?%Y,T%4=MNN:F4IK!):A!,O#@3 MHY=B\PIGD`N^/^1?68JBEF.22S61Q9.9>P1:I)C"QJK.,/$"4(A?BDTSG$8N M3M))?#6#.7Q.P4O1'^:#V*,]B%0\AUZJ0$N6;DD//( M`>J00O\*512U1,4M>T55XY:FLI?")FF#6XZ.,TUN>3"O4`=1PEY0Z%]IBJ*6 M*+EEK\C#>6QD5K@E*,#3X]3'DPOU$&44'\4^E>BHJ@E/D[9*Z\6IU3) M5WZ8+=9,HNO[SQ5K8'[-)G\33O):9&:0$D_K"#6J!RM5N6L@B7V?1I,ZO17B M+B=1TLF3#TO=L(DDSR6N)Q5I$U;AMXK M];"=-SZ/TSQ&?BA&2H_Q[/I4F"%[9E^8->>+;13=KO)L;Q[$;(T8]7'+MDQ; M0(-A`S]I),[B),==*Z&@S7C&WB72D,F3&)U^&+`O-4V_)EQ7+`7^M\7VX>-J M6VT^S;[/OCR"8Y1XND6X86.&+RU_B]T/M$$<483\.@UY91Q:O9A$1T:_RU#! M5P']+&#?!?Q#.9.GSOGZP/_S\M>[ M!Z(@^??[:KU8?KW8II-W%?E9P[?&I<1A?7N2Z('*Z0C5*+38*76F*>Y*6@?: MV\:Y?16F=1?4+4`G`6S;TFZ"UK0V[ZK^BZ#N+*A[HVLH[R]07$3M:TH)/^OK/)#PMO"B5W(MJCZ8#]K MOGXW"96WZDT:O]C._5N"^\F^OC&S@9+\$DY]AKZ0>M-*.]GUMR;^U"BPU6I- M=93;5[&4B:/UW$2ECAV532">P;4L)9PBBG`77=E3&G.&K5=R,QDVE6,I>Y58&R<;"/"T%,_A[^Z! MG803_E>?UHO7V;;Z]#@C_T08T<4VFK3$IQ+5,O8E,N40'([8J<.PUCFUT#+F MT2.<"8YPGUP;;U#<.1S'FATX)/`NK3M^_.6Y>H]O?[/S7H:`"Q'LI&"E>A-3 M.P/V42B=:?C=W^]IG[M.>=3V,15C0QD#:QCT[9M,KO_JPG+6/9KN%^ MB!).K$>X3UB.-RB.$SN.U9LZ=EVZFSOFAZ>129$XK'/$7'BP1K*C MC!-8F>$*@`CW@=?Q!L7G4+)7,Z>A)+84V#$*$822OCDNMZ'D@2FG8,I00A'Y M4K?J>E#>0BC9JV'[OOIO*X0\1N7X(:1O?LQI"'E@SQG8,]1S1[[4ZKH>%.]# MR%[UW(>0>N4%$`]?+.?U.:+&8(3'H\!`EBO'A:+=&/4U&KIU.!#A%L,B29,P M`@N!4O#(EYI>(YHZCK4TQ3T-H#8!:7%_PJX)TO`T1G(,0;40QQ,,#@8CDG,= MPUQ#"6?D2]VM$4U'"ALTQ1X"X]DA&L].X:A'ZN5-5HFI>P+'(4XM.=D\=045 MEY$O-;)&-!V#_6K*?$II-R><=D:@F44IJX]M?:DGFIS!LCG`;0O@MB_+Q=8I MM6UL1!;6":Z%75EM/3617>^K,0OBB1THNXQ]J9(UJ"]2XMLKM"[]-5%>IFK% M=KDP(K@:X\4'IL"3&+`/'GM5A&I&7^0.O2K"-*,O9C[=*_EXK-I`S='F(*%.AB.<1&&8P$)`Z`JD:`?G=T M)^,WAJ.+ZCKTJ]G0_-F\@NNU5<(SHUL`1'!=`11/= M>NKHQHAN#VP=$MV! MW<-5)R$4PL5^%0T['YLW%-WV*OH&G5\2%6D>9KN7$G?7*]++#SN'BX3ZQWFI ME)Y&-Q;;FA'+LM^S-G;"3L^0!.S"S)SGTUI53SBB/9(B MN&I;]&T*C,ZHC<.!OQ!*L!*_RM(=CPP:-F=5 MS:-7F1;+TXLG.LA=!8S&)7RLQ8I%$K%YZ._<1:]/6'<>+6.WLM<99E.?[H?IY]OWVV^KV8?6R(5KIQG42#TX/NJ:Q M*>D\(+T'=?=!W7_0&ZB"$-"7![[,%&_[+?LR!?YFV-!]+QPQ/QQ(F)IQQ83I MV1GI^XQT?L#.J$\CZ([/=LQLUL'-POH.$]8')V<>^#-C:;??LD-32;^9M?30 M]VH1\\.!)]%F7+=1G9KQS)JQX:DK&P@LC>Z6&A;0&P?7.9XC>+E:%@H`WXM$ M;`W*&XI'#S4;-RJU5/EK#:;H0E3/W=Z8X6H3![[7C-@:E+<6NAZJ-Q;7LU,/ M9PVD^.)8S[W>J#%M$P*^5Y/8&I0W&-\>:OB6/!_;@=Z?^5V]7VSNR`^_5A]7 MVVKS:?9]]N6Q(K^[N+M;OU3SJR59JJH-[#S/VZY82^FSI*9"7+/2V75YUD=2 MU-T9%H3=5<9OX8[@KK+$[POKW`S0V$&O$RU%`^!#88+;5;`3)V#R!%P@]FLN M4E#+!(7"